

## **Nutrition: A Lifespan Approach**

#### Simon Langley-Evans, BSc., Phd., RNutr.

_Chair in Human Nutrition_

_School of Biosciences_
_University of Nottingham_


A John Wiley & Sons, Ltd., Publication



This edition first published 2009

⃝ C 2009 Simon Langley-Evans


Blackwell Publishing was acquired by John Wiley & Sons in February 2007. Blackwell’s publishing programme has been
merged with Wiley’s global Scientific, Technical, and Medical business to form Wiley-Blackwell.


_Registered office_
John Wiley & Sons Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, United Kingdom


_Editorial offices_
9600 Garsington Road, Oxford, OX4 2DQ, United Kingdom
2121 State Avenue, Ames, Iowa 50014-8300, USA


For details of our global editorial offices, for customer services and for information about how to apply for permission to
reuse the copy r ig ht mater ial in this book please see our website at [www.w ile y.com/w ile y-blackwe ll.](http://www.wiley.com/wiley-blackwell)


The right of the author to be identified as the author of this work has been asserted in accordance with the Copyright,
Designs and Patents Act 1988.


All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form
or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by the UK Copyright,
Designs and Patents Act 1988, without the prior permission of the publisher.


Wiley also publishes its books in a variety of electronic formats. Some content that appears in print may not be available in
electronic books.


Designations used by companies to distinguish their products are often claimed as trademarks. All brand names and
product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective
owners. The publisher is not associated with any product or vendor mentioned in this book. This publication is designed to
provide accurate and authoritative information in regard to the subject matter covered. It is sold on the understanding that
the publisher is not engaged in rendering professional services. If professional advice or other expert assistance is required,
the services of a competent professional should be sought.


_Library of Congress Cataloging-in-Publication Data_


Langley-Evans, S. C.
Nutrition : a lifespan approach / Simon Langley-Evans.

p. ; cm.
Includes bibliographical references and index.
ISBN 978-1-4051-7878-5 (pbk. : alk. paper) 1. Nutrition–Textbooks.
I. Title.

[DNLM: 1. Nutritional Requirements. 2. Diet. 3. Growth and Development–physiology. 4. Nutrition
Assessment. 5. Nutritive Value. QU 145 L283n 2009]
QP141.L2 2009
612.3–dc22

2008053122


A catalogue record for this book is available from the British Library.


Set in 10/12pt Minion by Aptara ⃝ R Inc., New Delhi, India
Printed in Singapore


1 2009



### **Contents**

Preface xi


Acknowledgments xii


**1.** **Introduction to Lifespan Nutrition** **1**
1.1 The lifespan approach to nutrition 1
1.2 The concept of balance 2
1.2.1 A supply and demand model 2
1.2.2 Overnutrition 2

1.2.3 Undernutrition 4

1.2.3.1 Increased demand 4
1.2.3.2 The metabolic response to trauma 4
1.2.3.3 Compromised supply and deficiency 6
1.2.3.4 Malnutrition 7

1.2.4 Classical balance studies 8

1.2.5 Overall nutritional status 10
1.3 Nutrition requirements change across the lifespan 10
1.4 Assessment of nutritional status 11
1.4.1 Anthropometric measures 12
1.4.2 Estimating dietary intakes 12
1.4.2.1 Indirect measures 12

1.4.2.2 Direct measures 13

1.4.3 Biomarkers of nutritional status 15

1.4.4 Clinical examination 16
1.5 Dietary reference values 16
1.5.1 The UK dietary reference value system 17
1.5.2 Dietary reference values in other countries 19


**2.** **Before Life Begins** **23**
2.1 Introduction 23
2.2 Nutrition and female fertility 24
2.2.1 Determinants of fertility and infertility 24
2.2.1.1 The endocrine control of female reproduction 24
2.2.1.2 Disordered reproductive cycling 25
2.2.1.3 Polycystic ovary syndrome 25
2.2.1.4 Assisted reproductive technologies 26
2.2.2 Importance of body fat 26
2.2.3 Role of leptin 27
2.2.4 Antioxidant nutrients 28

2.2.5 Caffeine and alcohol 30
2.3 Nutrition and male fertility 32
2.3.1 Determinants of fertility and infertility 32
2.3.2 Obesity 34
2.3.3 Diabetes 34

2.3.4 Alcohol 35



**iv** **Contents**


2.3.5 Zinc 35

2.3.6 Antioxidant nutrients 36

2.3.7 Selenium 37
2.3.8 Phytoestrogens and environmental estrogens 37
2.3.8.1 Phthalates 37
2.3.8.2 Phytoestrogens 38
2.3.8.3 Pesticides 38
2.4 Preparation for pregnancy 39
2.4.1 Why prepare for pregnancy? 39
2.4.2 Vitamin A and liver 40

2.4.3 Folic acid and neural tube defects 41
2.4.3.1 Supplementation with folic acid 42
2.4.3.2 Fortification with folic acid 43


**3.** **Pregnancy** **47**
3.1 Introduction 47
3.2 Physiological demands of pregnancy 48
3.2.1 Maternal weight gain and body composition changes 49
3.2.2 Blood volume expansion and cardiovascular changes 49
3.2.3 Renal changes 50
3.2.4 Respiratory changes 50
3.2.5 Gastrointestinal changes 51
3.2.6 Metabolic adaptations 51
3.3 Nutrient requirements in pregnancy 52
3.3.1 Energy, protein, and lipids 52
3.3.2 Micronutrients 54

3.3.2.1 Iron 54

3.3.2.2 Calcium and other minerals 55

3.3.2.3 Vitamin D 56
3.4 Diet in relation to pregnancy outcomes 57
3.4.1 Miscarriage and stillbirth 57
3.4.2 Premature labor 58
3.4.2.1 Pre-pregnancy BMI and pregnancy weight gain 58
3.4.2.2 Alcohol and caffeine consumption 59
3.4.2.3 Oral health 60
3.4.3 Hypertensive disorders of pregnancy 60
3.4.3.1 The etiology of PE 60
3.4.3.2 Nutrition-related factors and PE 62

3.4.4 Abnormal labor 62
3.5 Nausea and vomiting of pregnancy (NVP) 63
3.5.1 NVP as a normal physiological process 63
3.5.2 Hyperemesis gravidarum 65
3.6 Cravings and aversions 66
3.6.1 Pica 66
3.7 Gastrointestinal disturbances in pregnancy 67
3.8 High-risk pregnancies 68
3.8.1 Gestational diabetes 68
3.8.2 Multiple pregnancies 69
3.8.3 Fetal alcohol spectrum disorders 71



**Contents** **v**


**4.** **Fetal Nutrition and Disease in Later Life** **75**

4.1 Introduction 75
4.2 The developmental origins of adult disease 75
4.2.1 The concept of programming 75
4.2.2 Fetal programming and human disease 76
4.3 Evidence linking maternal nutrition to disease in later life 79
4.3.1 Epidemiology 79
4.3.2 Criticisms of the programming hypothesis 81
4.3.3 Experimental studies 82
4.3.3.1 Global undernutrition 83

4.3.3.2 Micronutrients 83

4.3.3.3 Macronutrients 83
4.4 Mechanistic basis of fetal programming 85
4.4.1 Thrifty phenotypes and genotypes 85
4.4.2 Predictive adaptive responses 87
4.4.3 Tissue remodeling 87
4.4.4 Endocrine imbalance 89
4.4.5 Nutrient–gene interactions 90
4.4.6 Epigenetic regulation 92
4.5 Implications of the programming hypothesis 93
4.5.1 Public health interventions 93
4.5.2 Trans-generational transmission of disease risk 93


**5.** **Lactation and Infant Feeding** **99**
5.1 Introduction 99
5.2 The physiology of lactation 99
5.2.1 Anatomy of the breast 99
5.2.1.1 The nipple and areola 99
5.2.1.2 The lactiferous ducts 99

5.2.1.3 The lactiferous sinuses 99

5.2.1.4 The alveolar cells 100
5.2.1.5 The rooting reflex 100
5.2.2 Synthesis of milk 101
5.2.2.1 Foremilk and hindmilk 101
5.2.2.2 Time of day 101
5.2.2.3 Course of lactation 102
5.2.2.4 Synthesis of carbohydrates 102
5.2.2.5 Origins of milk fats 102
5.2.2.6 Milk proteins 103
5.2.3 Endocrine control of lactation 104
5.2.3.1 The breast during pregnancy 104
5.2.3.2 Established lactation 104
5.2.3.3 The breast after weaning 105
5.2.4 Maintenance of lactation 105

5.2.5 Nutritional demands of lactation 106
5.3 The advantages of breast-feeding 107
5.3.1 Advantages for the mother 107
5.3.2 Advantages for the infant 109
5.3.3 Recommendation to feed to 6 months 112



**vi** **Contents**


5.4 Trends in breast-feeding behavior 112
5.4.1 Reasons why women do not breast-feed 114
5.4.2 Promoting breast-feeding 115
5.5 Situations in which breast-feeding is not advised 117
5.6 Alternatives to breast-feeding 118
5.6.1 Cow’s milk formulas 118
5.6.1.1 Milk stages and follow-on milk 119
5.6.2 Preterm formulas 120
5.6.3 Soy formulas 121
5.6.4 Hydrolyzed protein and amino-acid-based formulas 121
5.6.5 Other formulas 121


**6.** **Nutrition and Childhood** **124**

6.1 Introduction 124
6.2 Infancy (birth to five) 124
6.2.1 The key developmental milestones 124
6.2.2 Nutrient requirements 126
6.2.2.1 Macronutrients and energy 126
6.2.2.2 Micronutrients 128

6.2.3 Nutrient intakes and infants 129
6.2.4 Transition to an adult pattern of food intake 129
6.2.4.1 Weaning 130
6.2.4.2 Nutrition-related problems 132
6.2.4.3 Barriers to healthy nutrition 134
6.3 Childhood (five to thirteen) 139
6.3.1 Nutrient requirements of the older child 139
6.3.2 School meals and the promotion of healthy eating 139
6.3.3 The importance of breakfast 140
6.4 Obesity in children 141
6.4.1 The rising prevalence of obesity 141
6.4.2 The causes of obesity in childhood 142
6.4.2.1 Physical activity 143
6.4.2.2 Food intake 143

6.4.2.3 Genetic disorders 146
6.4.3 The consequences of childhood obesity 147
6.4.3.1 Immediate health consequences 148
6.4.3.2 Tracking of obesity: consequences for the future 148
6.4.4 Treatment of childhood obesity 150
6.4.5 Prevention of childhood obesity 152


**7.** **Nutrition and Adolescence** **158**

7.1 Introduction 158
7.2 Physical development 158
7.2.1 Growth rate 158
7.2.2 Body composition 159
7.2.3 Puberty and sexual maturation 159
7.2.4 Bone growth 163
7.3 Psychosocial development 165



**Contents** **vii**


7.4 Nutritional requirements in adolescence 166
7.4.1 Macronutrients and energy 166
7.4.2 Micronutrients 167

7.5 Nutritional intakes in adolescence 168
7.5.1 Factors that influence food choice 169
7.5.2 Food consumed out of the home 170
7.5.3 Meal skipping and snacking 171
7.6 Potential problems with nutrition 172
7.6.1 Dieting and weight control 172
7.6.2 The vegetarian teenager 172
7.6.3 Sport and physical activity 173
7.6.4 Eating disorders 174
7.6.4.1 Anorexia nervosa 174

7.6.4.2 Bulimia nervosa 176
7.6.5 The pregnant teenager 176
7.6.6 Alcohol 178
7.6.7 Tobacco smoking 180
7.6.8 Drug abuse 181


**8.** **The Adult Years** **185**

8.1 Introduction 185
8.2 Changing needs for nutrients 185
8.3 Guidelines for healthy nutrition 186
8.4 Disease states associated with unhealthy nutrition and lifestyle 189
8.4.1 Obesity 189
8.4.1.1 Classification of overweight and obesity 189
8.4.1.2 Prevalence and trends in obesity 189
8.4.1.3 Causes of obesity in adulthood 190
8.4.1.4 Treatment of obesity 191
8.4.2 Type 2 diabetes 192
8.4.3 The metabolic syndrome 195
8.4.4 Cardiovascular disease 196

8.4.4.1 What is cardiovascular disease? 196

8.4.4.2 Risk factors for cardiovascular disease 199

8.4.4.3 Nutrition-related factors and risk of cardiovascular disease 199

8.4.5 Cancer 207

8.4.5.1 What is cancer? 207

8.4.5.2 Diet is the main determinant of cancer risk 208
8.4.5.3 Nutritional epidemiology and cancer 209
8.4.5.4 Dietary factors that may promote cancer 213
8.4.5.5 Dietary factors that may reduce cancer risk 217


**9.** **Nutrition, Aging, and the Elderly** **227**
9.1 Introduction 227
9.2 The aging population 227
9.3 The aging process 228
9.3.1 Impact on physiological systems 228
9.3.2 Mechanisms of cellular senescence 228



**viii** **Contents**


9.3.2.1 Oxidative senescence 230
9.3.2.2 The role of p53 activation 231
9.3.2.3 Telomere shortening 231
9.3.2.4 The INK4a/ARF axis 231
9.3.3 Nutritional modulation of the aging process 232
9.3.3.1 Caloric restriction and lifespan 232
9.3.3.2 Fetal programming of lifespan 233
9.3.3.3 Supplementary antioxidants 233
9.4 Nutrient requirements of the elderly 234
9.4.1 Macronutrients and energy 234
9.4.2 Micronutrients 234
9.4.3 Specific guidelines for the elderly 234
9.5 Barriers to healthy nutrition in the elderly 235
9.5.1 Malnutrition and the elderly 235
9.5.2 Poverty 236
9.5.3 Social isolation 237

9.5.4 Education 237
9.5.5 Physical changes 238
9.5.6 Combating malnutrition in the elderly 238
9.6 Common nutrition-related health problems 239
9.6.1 Bone disorders 239
9.6.1.1 Bone mineralization and remodeling 239
9.6.1.2 Osteoporosis pathology and prevalence 241
9.6.1.3 Risk factors for osteoporosis 241
9.6.1.4 Dietary interventions for osteoporosis prevention 242
9.6.1.5 Paget’s disease of bone 244
9.6.2 Immunity and infection 244
9.6.3 Digestive tract disorders 245
9.6.3.1 Mouth and esophagus 245
9.6.3.2 Stomach 246

9.6.3.3 Small intestine 246
9.6.3.4 Large intestine 246
9.6.4 Anemia 247
9.6.4.1 Iron deficiency anemia 248
9.6.4.2 Vitamin B12 deficiency 248
9.6.4.3 Folic acid deficiency 249
9.6.4.4 Cognitive impairment and anemia 249


**10.** **Personalized Nutrition** **254**

10.1 Introduction 254
10.2 The individual response to variation in food intake 255
10.2.1 Genes may determine food intake 256
10.2.1.1 Regulation of food intake 257
10.2.1.2 Regulation of macronutrient intake 257
10.2.1.3 Regulation of taste 257
10.2.2 Genes may determine nutrient bioavailability and utilization 258
10.2.3 Nutritional regulation of gene expression 258



**Contents** **ix**


10.3 Identifying disease risk biomarkers 260
10.3.1 Nutrigenomics 260
10.3.2 Proteomics 261

10.3.3 Metabolomics 263
10.4 Genetic influences on response to nutrients and disease risk 263
10.4.1 Obesity 263
10.4.2 Cardiovascular disease 264

10.4.3 Cancer 265
10.5 Nutrient–gene interactions—a lifespan approach 266
10.6 The future of nutritional advice? 268


Glossary of Terms 271


Index 291


_Additional resources are published on the book’s web site_
(www.wiley.com/go/langleyevans)




### **Preface**

Themodernscienceofnutritionhasarisenfromhumble beginnings, moving from a poorly respected sideshoot of many older established disciplines to become
an active entity in its own right. Nutrition is now
rightly seen as being at the forefront of modern understanding of health and disease. Many of the academics in the field have come to nutrition tangentially
through many disparate routes, usually becoming immersed in the subject through research interests based
in other fields. My own background was in biochemistry and microbiology, and my early interest in nutrition came from tantalizing, but sadly vague, mentions
in textbooks that suggested that key processes such as
the development of cancers might be, “regulated by
nutrition”.

The lack of specific nutrition training of the current crop of academics in the field reflects the fact that
20–30 years ago there were no degree courses in the
subject. Interest in nutrition has increased exponentially since the early 1990s and it is pleasing to see that
degrees in nutrition have blossomed across all regions.
In the UK alone, a prospective undergraduate considering training in nutrition will be faced with a choice
of over 250 university courses with a nutrition component. Nutrition is also recognised as a key element
in the training of all health professionals. But what
is nutrition? In my view it is a hybrid subject which
crossesoverdisciplinesasdisparateaspoliticsandeconomics (which are the global drivers determining the
food security of populations), food science and agriculture, the social sciences, psychology and sociology
(which govern eating behaviors and food choices of
individuals), biochemistry, physiology, medicine, and
pharmacology. This book aims to provide a basic text



for undergraduate students in all disciplines that impinge upon the nutritional sciences, including those
training as health professionals as well as those reading nutrition as their core subject. It covers nutrition
from a range of perspectives including those of the
physiologist, the molecular biologist and the public
health nutritionist. I have assumed that the reader
will have an understanding of the basics of the subject, namely, the properties and sources of nutrient,
and have focused my attention upon how nutritionrelated factors shape human health and disease across
all stages of the life-course.
One of the main challenges for the modern nutritionist is to translate complex scientific concepts into
simple advice about food and health that can be understood by the lay public. The conditional nature of
the subject, namely, the way in which our understanding advances and throws up controversies and contradictions, is a constant theme running through this
book. For each chapter I have attempted to provide
a balanced view of the evidence base, but inevitably
the chapters will reflect my own personal view of the
subject matter. The reader is directed to the extensive
bibliographies that accompany each chapter to obtain a more detailed perspective. My profound wish
is that students who use this book will emerge with
significantly more understanding of how nutrition
regulates metabolism and contributes to health and
disease, than I did from those tantalizing sentences I
encountered in my own training.


_Simon Langley-Evans_
_University of Nottingham_



### **Acknowledgments**

The writing of this textbook has been a massive undertaking for me and during that time, a number
of colleagues have provided comments, support and
encouragement for which I am extremely grateful. I
would particularly like to thank Professor Andy Salter
and Dr Sarah McMullen at the University of Notting


ham, for their understanding during the times when
writing has displaced other calls on my time. Special
thanks go to my family, Alison, Effie, Hugh and Hebe,
for their immense patience and vital inputs to the

process.



# **1**
### **Introduction to Lifespan Nutrition**

**Learning objectives**



By the end of this chapter, the reader should be able to:


r Describe what is meant by a lifespan approach to the
study of nutrition and health.
r Discuss the meaning of the term “nutritional status”
and describe how optimal nutrition requires a balance
of nutrient supply and demand for nutrients in physiological and metabolic processes.
r Show an awareness of the factors that contribute to
undernutrition, including limited food supply and increased demands due to trauma or chronic illness.
r Discuss global strategies for the prevention of malnutrition.


**1.1 The lifespan approach to nutrition**


The principal aim of this book is to explore relationships between nutrition and health, and the
contribution of nutrition-related factors to disease.
In tackling this subject, there are many different
approaches that could be taken, for example, considering diet and cardiovascular disease, nutrition and
diabetes, obesity or immune function as separate and
discrete entities, each worthy of their own chapter.
The view of this author, along with many others in
recent times (Ben-Shlomo and Kuh, 2002) is that
the final stages of life, that is, the elderly years, are
effectively the products of events that occur through
the full lifespan of an individual. Aging is in actuality
a continual, lifelong process of ongoing change and
development from the moment of conception until
the point of death. It is therefore inappropriate to
consider how diet relates to chronic diseases that

affect adults without allowance for how the earlier
life experiences have shaped physiology. The lifespan
approach that is used to organize the material in this
book essentially asserts three main points:



r Describe how nutritional status is influenced by the
stage of life due to the variation in specific factors
controlling nutrient availability and requirements, as
individuals develop from the fetal stage through to
adulthood.
r Show an appreciation of how anthropometry, dietary
assessment, measurements of biomarkers, and clinical
examination can be used to study nutritional status in
individuals and populations.
r Discuss the need for dietary standards in making assessments of the quality of diet or dietary provision, in
individuals or populations.
r Describe the variation in the basis and usage of dietary
reference value systems in different countries.


1 All stages of life from the moment of conception
through to the elderly years are associated with a
series of specific requirements for nutrition.
2 The consequences of less than optimal nutrition at
each stage of life will vary, according to the life stage
affected.

3 The nature of nutrition-related factors at earlier
stages of life will determine how individuals grow
and develop. As a result, the relationship between
diet and health in later stages of adult life, to some
extent, depends upon events earlier in life. As a
result the nature of this relationship may be highly
individual.


Although we tend to divide the lifespan into a series
of distinct stages, such as infancy, adolescence, early
adulthood, middle age, and older adulthood, few of
these divisions have any real biological significance
and they are therefore simply markers of particular
periods within a continuum. There are, however, key
events within these life stages, such as weaning, the
achievement of puberty, or the menopause, which are
significant milestones that mark profound physiological and endocrine changes and have implications for



**2** **Nutrition: A Lifespan Approach**


the nature of the nutrition and health relationship.
On a continual basis, at each stage of life, individuals
experience a series of biological challenges, such as
infection or exposure to carcinogens that threaten to
disturb normal physiology and compromise health.
Within a lifespan approach, it is implicit that the
response of the system to each challenge will influence how the body responds at later life stages. Variation in the quality and quantity of nutrition is one
of the major challenges to the maintenance of optimal physiological function and is also one of the
main determinants of how the body responds to other
insults.

Inconsideringthecontributionofnutrition-related
factors to health and disease across the lifespan, it is
necessary to evaluate the full range of influences upon
quality and quantity of nutrition and upon physiological processes. This book therefore takes a broad
approach and includes consideration of social or culturalinfluencesonnutritionandhealth,themetabolic
and biochemical basis of the diet–disease relationships, the influence of genetics, and, where necessary,
provides overviews of the main physiological and cellular processes that operate at each life stage. While
the arbitrary distinctions of childhood, adolescence,
and adulthood have been used to divide the chapters,
it is hoped that the reader will consider this work as a
whole. In this opening chapter, we consider some of
the basic terms and definitions used in nutrition and
lay the foundations for understanding more complex
material in the following chapters.


**1.2 The concept of balance**


Balance is a term frequently used in nutrition and, unfortunately,theprecisemeaningofthetermmaydiffer
according to the context and the individual using it. It
is common to hear the phrase “a balanced diet” and,
indeed, most health education literature that goes out
to the general public urges the consumption of a diet
that is “balanced.” In this context, we refer to a diet
that provides neither too much nor too little of the
nutrients and other components of food that are required for normal functioning of the body. A balanced
diet may also be viewed as a diet providing foods of a
varied nature, in proportions such that foods rich in
some nutrients do not limit intakes of foods rich in

others.



_**1.2.1 A supply and demand model**_


There is another way of viewing the meaning of
balance or a balanced diet, whereby the relationship
between nutrient intake and function is the main con
sideration. A diet that is in balance is one where the
supply of nutrients is equal to the requirement of the
body for those nutrients. Essentially, balance could be
viewed as equivalent to an economic market, in which
supply of goods or services needs to be sufficient to
meet demands for those goods or services. Figure 1.1
summarizes the supply and demand model of nutritional balance.

Whether or not the diet is in balance will be a key
determinant of the _nutritional status_ of an individ
ual. Nutritional status describes the state of a person’s
healthinrelationtothenutrientsintheirdietandsubsequently within their body. Good nutritional status
would generally be associated with a dietary pattern
that supplies nutrients at a level sufficient to meet
requirements, without excessive storage. Poor nutritional status would generally (though not always) be
associated with intakes that are insufficient to meet
requirements.
The supply and demand model provides a useful
framework for thinking about the relationship between diet and health. As shown in Figure 1.1, maintaining balance with respect to any given nutrient requiresthesupplyofthenutrienttobeequivalenttothe
overall demand for that nutrient. Demand comprises
any physiological or metabolic process that utilizes the
nutrient and may include use as an energy-releasing
substrate, as an enzyme cofactor, as a structural component of tissues, a substrate for synthesis of macromolecules, as a transport element, or as a component of cell–cell signaling apparatus. The supply side
of the balance model comprises any means through
which nutrients are made available to meet demand.
This goes beyond delivery through food intake and
includes stores of the nutrient that can be mobilized
within the body, and quantities of the nutrient that
might be synthesized de novo (e.g., vitamin D is synthesized in the skin through the action of sunlight).


_**1.2.2 Overnutrition**_

When supply does not match demand for a nutrient,
then the system is out of balance and this may have
important consequences in terms of health and disease. Overnutrition (Figure 1.1) will generally arise



**Introduction to Lifespan Nutrition** **3**


**Figure 1.1** The concept of balance. The demands for nutrients
comprise metabolic and physiological processes that utilize nutrients. Supply is determined by intakes of food, availability of
nutrient stores, and de novo production of nutrients.


trients have some capacity to cause harm. Accidental
consumption of iron supplements or iron overload
associated with inherited disorders is a cause of disease and death in children. At high doses, iron will
impair oxidative phosphorylation and mitochondrial
function, leading to cellular damage in the liver, heart,
lungs, and kidneys. Excess consumption of vitamin A
has been linked to development of birth defects in the
unborn fetus (Martinez-Frias and Salvador, 1990).
Overnutrition for one nutrient can also have ef
fects upon nutritional status with respect to other
nutrients, and can impact on physiological processes
involving a broader range of nutrients. For example,
regular consumption of iron supplements can impact upon absorption of other metals such as zinc
and copper, by competing for gastrointestinal transporters and hence promote undernutrition with respect to those trace elements. Having an excess of a
particular nutrient within the body can also promote
undernutrition with respect to another by increasing
the demand associated with processing the excess. For









because the supply of a nutrient is excessive relative to
demand. This is either because intake of foods containing that nutrient increases, because the individual
consumes supplements of that nutrient, or because
demand for that nutrient declines with no equivalent adjustment occurring within the diet. The latter
scenario particularly applies to the elderly, for whom
energy requirements fall due to declining physical activity levels and resting metabolic rate (Rivlin, 2007).
Commonly, intakes of energy that were appropriate
in earlier adulthood will be maintained, resulting in
excessive energy intake.
The consequences of overnutrition are generally
not widely considered in the context of health and
disease, unless the nutrient concerned is directly toxic
or harmful when stored in high quantities. The obvious example here is, again, energy, where overnutrition will result in fat storage and obesity. For many
nutrients, overnutrition within reasonable limits has
no adverse effect as the excess material will either be

stored or excreted. At megadoses, however, most nu


**4** **Nutrition: A Lifespan Approach**


example, a diet rich in the amino acid methionine will
tend to increase circulating and tissue concentrations
of homocysteine. Processing of this damaging intermediate increases the demand for B vitamins, folic
acid, vitamin B6, and vitamin B12, which are all involved in pathways that convert homocysteine to less
harmful forms (Lonn _et al_ ., 2006).


_**1.2.3 Undernutrition**_


Undernutritionariseswhenthesupplyofnutrientfails
to meet demand. This can occur if intakes are poor,
or if demands are increased (Figure 1.1). In the short–
medium term, low intakes are generally cushioned by
the fact that the body has reserves of all nutrients that
can be mobilized to meet demand. As such, for adults,
it will usually require prolonged periods of low intake
tohaveasignificantlydetrimentaleffectonnutritional

status.


**1.2.3.1 Increased demand**

There are a number of situations that may arise to increase demand in such a way that undernutrition will
arise if supply is not also increased accordingly. These
include pregnancy, lactation, and trauma. Trauma encompasses a wide range of physical insults to the body,
including infection, bone fracture, burns, surgery,
and blood loss. Although diverse in nature, all of
these physiological insults lead to the same metabolic
response. This _acute phase response_ (Table 1.1) is
largely orchestrated by the cytokines including tumor
necrosis factor- _α_, interleukin-6, and interleukin-1
(Grimble, 2001). Their net effect is to increase demand for protein and energy and yet paradoxically


**Table 1.1** The acute phase inflammatory response to trauma or infection


Acute phase response Markers of the response



they have an anorectic effect. Thus, demand increases
and supply will be impaired leading to protein–energy
malnutrition. While in many developing countries,
we associate protein–energy malnutrition with starvation in children, in developed countries such as
the UK protein–energy malnutrition is most commonly noted in surgical patients and patients recovering from major injuries (Allison, 2005).


**1.2.3.2 The metabolic response to trauma**
The human body is able to adapt rates of metabolism
and the nature of metabolic processes to ensure
survival in response to adverse circumstances. The
metabolic response to adverse challenges will depend
upon the nature of the challenge. Starvation leads to
increased metabolic efficiency, which allows reserves
of fat and protein to be utilized at a controlled rate
that prolongs survival time and hence maximizes the
chances of the starved individual regaining access to
food.Incontrast,thephysiologicalresponsetotrauma
generates a hypermetabolic state in which reserves of
fat and protein are rapidly mobilized in order to fend
off infection and promote tissue repair (Table 1.1).
Physiological stresses to the body, including infection,
bone fracture, burns, or other tissue injury, elicit a
common metabolic response regardless of their nature. Thus, a minor surgical procedure will produce
the same pattern of metabolic response as a viral infection. It is the magnitude of the response that is
variable and this is largely determined by the severity
of the trauma (Romijn, 2000).
The hypermetabolic response to trauma is driven
by endocrine changes that promote the catabolism of



Metabolic change Catabolism of protein, muscle wastage. Amino acids converted to glucose for energy, or used to
synthesize acute phase proteins. Catabolism of fat for energy


Fever Body temperature rises to kill pathogens. Hypothalamic regulation of food intake disrupted, leading to
loss of appetite


Hepatic protein synthesis Acute phase proteins synthesized to combat infection (e.g., C-reactive protein, _α_ 1-proteinase inhibitor,
and ceruloplasmin). Liver reduces synthesis of other proteins, including transferrin and albumin


Sequestration of trace elements Zinc and iron taken up by tissues to remove free elements that may be utilized by pathogens


Immune cell activation B cells produce increased amounts of immunoglobulins. T cells release cytokines to orchestrate the
inflammatory response


Cytokine production Tumor necrosis factor- _α_ and the interleukins 1, 2, 6, 8, and 10 work to produce a hypermetabolic state that
favors production of substrates for immune function, but inhibits reproduction and spread of pathogens



protein and fat reserves. Following the initial physiological insult, there is an increase in circulating
concentrations of the catecholamines, cortisol, and
glucagon. Increased cortisol and glucagon serve to
stimulate rates of gluconeogenesis and hepatic glucose output, thereby maintaining high concentrations
ofplasmaglucose.Thebreakdownofproteintoamino
acids provides gluconeogenic substrates and also leads
to greatly increased losses of nitrogen via the urine.
Lipolysis is stimulated and circulating free fatty acid
concentrations rise dramatically. These are used as
energy substrates, along with glucose.
The response to trauma is essentially an inflammatory process and, as such, the same metabolic drives
are noted in individuals suffering from long-term inflammatory diseases including cancer and inflammatory bowel disease (Richardson and Davidson, 2003).
The inflammatory response serves two basic functions. Firstly, it activates the immune system, raises
body temperature, and repartitions micronutrients in
order to create a hostile environment for invading
pathogens (Table 1.1). Secondly, it allocates nutrients
toward processes that will contribute to repair and
healing.
The inflammatory response is orchestrated by
the pro-inflammatory cytokines (e.g., TNF- _α_, IL-1,
and IL-6) and the anti-inflammatory cytokines (e.g.,
IL-10). Whenever injury or infection occurs, the
pro-inflammatory species are released by monocytes,
macrophages,andThelpercells.Thelevelofcytokines
producediscloselyrelatedtotheseverityofthetrauma
(Lenz _et al_ ., 2007). The impact of pro-inflammatory
cytokines is complex. On the one hand, they activate the immune system and protect the body from
greater trauma. On the other, at the local level of
any injury, they increase damage by stimulating the
immune system to release damaging oxidants and



**Introduction to Lifespan Nutrition** **5**


other agents that indiscriminately destroy invading
pathogens and the body’s own cells. The production
of pro-inflammatory cytokines therefore has to be
counterbalanced as an excessive response can lead to
death (Grimble, 2001). This is the role of the antiinflammatory cytokines and some of the acute phase
response proteins, several of which inhibit the proteinases released during inflammation and therefore
limit the breakdown of host tissues.
In addition to stimulating proteolysis and lipolysis within muscle and adipose tissue, the cytokines
have a number of actions that impact upon nutritional status. Firstly, they increase the basal metabolic
rate. An element of creating a hostile environment for
pathogens includes raising the core temperature of the
body (fever). This greatly increases energy demands.
The capacity to meet those demands through feeding
is reduced as cytokines also act upon the gut and the
centers of the hypothalamus that regulate appetite,
effectively switching off the desire to eat. As can be
seen in Table 1.2, the increased metabolic rate associated with the response to trauma greatly increases
the demands of the body for both energy and protein. In severe cases, requirements can be doubled,
even though the critically ill patient will be immobilized and not expending energy through physical
activity. This can pose major challenges for clinicians
managing such cases as the injured patient maybe
unable to feed normally, and due to the anorectic influences of pro-inflammatory cytokines, the capacity
to ingest sufficient energy, protein, and other nutrients is greatly reduced. Enteral or parenteral feeding
are therefore a mainstay of managing major injuries.
With more severe trauma, the mobilization of reserves can produce marked changes in body composition. Muscle wasting may occur as the calciumdependent calpains and ubiquitine-proteasome break



**Table 1.2** The metabolic response to injury and infection increases requirements for energy and protein


Nature and severity of trauma Increase in energy requirement (× basal) Increase in protein requirement (× basal)


Minor surgery or infection 1.1 1.0–1.5
Major surgery or moderate infection 1.3–1.4 1.5–2.3
Severe infection, multiple or head injuries 1.8 2.0–2.8
Burns (20% BSAB) 1.5 –
Burns (20–40% BSAB) 1.8 2.0–2.8 [a]


BSAB, body surface area burned.
a Dependent upon level of nitrogen losses in tissue exudates and age of patient. Children with burns have higher require
ments.



**6** **Nutrition: A Lifespan Approach**


down proteins rapidly to make amino acids available for gluconeogenesis and the synthesis of important antioxidants such as glutathione (Grimble,
2001). Body composition changes are beneficial to
the injured patient as they primarily generate glucose.
This is the optimal energy substrate for these circumstances, not least because it can be metabolized anaerobically to produce ATP in tissues where blood flow
may be compromised and oxygen delivery impaired.
In the short term, the hypermetabolic response and
the accompanying anorexia of illness are unlikely to
impact significantly upon the nutritional status of an
individual, although nutritional status prior to onset
of trauma would be an important consideration. For
example, the nutritional consequences of a fractured
femur in a young, fit adult male may be dramatically
different to those in a frail elderly woman. Prolonged
periods of disease accompanied by inflammatory responses that drive hypermetabolism will, however,
promote states of protein–energy malnutrition, such
as kwashiorkor, or can produce the emaciated state of
cachexia. Cachexia is characterized by loss of weight,
decline in appetite, and muscle atrophy due to mobilization of muscle protein. It is generally associated
with underlying chronic illnesses such as cancer, tuberculosis, or untreated AIDS. Nutritional support
(i.e., supplemental feeding) of chronically ill individuals or those who have suffered more acute trauma
can limit the impact of the hypermetabolic response
uponbodycompositionandoverallnutritionalstatus.



However,thecatabolicmetabolismcannotbereversed
until the injury or illness is resolved, so the priority
in these scenarios is limiting weight loss and loss of
muscle mass, rather than achieving weight gain.


**1.2.3.3 Compromised supply and deficiency**
Clearly, there is a direct relationship between the supply of a nutrient to the body and the capacity of the
body to carry out the physiological functions that depend upon the supply of that nutrient. As can be seen
in Figure 1.2, the range of nutrient intakes over which
optimal function is maintained is likely to be very
broad and there are a number of stages before functionality is lost. It is only when function can no longer
be maintained that the term nutritional deficiency can
be accurately used.
A nutrient deficiency arises when the supply of a
nutrient through food intake is compromised to the
extent that clinical or metabolic symptoms appear.
The simplest example to think of here relates to iron
deficiency anemia in which low intakes of iron result
in a failure to maintain effective concentrations of

red blood cell hemoglobin, leading to compromised
oxygen transport and hence the clinical symptoms of
deficiency that include fatigue, irritability, dizziness,
weakness, and shortness of breath. Iron deficiency
anemia, like all deficiency disorders, reflects only the
late stage of the process that begins with a failure of
supply through intake to meet demands (Table 1.3).
Once the body can no longer maintain function using







**Figure 1.2** The association between nutrition and health.
The requirements of the body for nutrients will be met by a
broad range of intakes. Very low and very high intakes of
any nutrient will be associated with ill health. The transition
from intakes that are meeting demands and at which risk
of disease is low to intakes that would be associated with

disease is not abrupt.



**Introduction to Lifespan Nutrition** **7**


**Table 1.3** The three stages of iron deficiency


Stage Biochemical indicators and reference ranges


Normal iron status Hemoglobin 14–18 g/dL (men), 12–16 g/dL (women). Serum ferritin 40–280 µg/L, transferrin saturation 31–60%


Depleted iron stores Falling serum ferritin. Normal ranges for hemoglobin and transferrin saturation. Ferritin 13–20 µg/L


Iron deficiency Transferrin saturation falls as transport of iron declines. Hemoglobin normal. Serum ferritin _<_ 12 µg/L. Transferrin
saturation _<_ 16%


Iron deficiency anemia Hemoglobin synthesis cannot be maintained and declines to _<_ 13.5 g/dL (men), _<_ 12 g/dL (women). Serum ferritin
_<_ 10 µg/L. Transferrin saturation _<_ 15%



nutrient supply directly from the diet, it will mobilize
stores. In the case of iron, this will involve the release
of iron bound to the protein, ferritin, to maintain
hemoglobin concentrations. No change in function
will occur at this stage but the individual will now
be in a state of greater vulnerability to deficiency. A
further decline in supply through intake may not be
matchedthroughmobilizationofstoresandsofulldeficiency becomes more likely. This situation in which
intakes are sufficiently low that, although there are
no signs of deficiency, biochemical indicators show
that nutrition is subnormal is generally referred to as
_marginal nutrition_, or subclinical malnutrition.


**1.2.3.4 Malnutrition**

Malnutrition describes the state where the level of nutrient supply has declined to the point of deficiency
and normal physiological functions can no longer be
maintained. The manifestations of malnutrition will
vary depending on the type of nutrient deficiencies
involved and the stage of life of the malnourished individual. In adults, malnutrition is often observed as
unintentional weight loss or as clinical signs of specificdeficiency.Inchildren,itismorelikelytomanifest
as growth faltering, with the affected child being either underweight for their age (termed _wasted_ ) or of
short stature for their age (termed _stunted_ ). Specific
patterns of growth are indicative of different forms
of protein–energy malnutrition. Wasting is associated with marasmus where a weight less than 60%
of standard for age is used as a cutoff. Edema with a
weight less than 80% of standard for age is indicative
of kwashiorkor.

From a clinical perspective, protein–energy malnutrition is the most serious undernutrition-related

syndrome. Marasmus and kwashiorkor are classical
definitions of this form of malnutrition. Historically,
marasmus was considered to be a pure energy defi


ciency and kwashiorkor to be protein deficiency, but
it is now clear that the two are different manifestations

of the same nutritional problems. Marasmic wasting
is a sign of an effective physiological adaptation to
long-term undernutrition. It is characterized by a depletion of fat reserves and muscle protein, along with
adaptations to reduce energy expenditure. Children
who become wasted in this way, if untreated, will generally die from infection as their immune functions
cannot be maintained during the period of starvation.
Kwashiorkor is a more rapid process, often triggered
by infection alongside malnutrition. The metabolic
changes with kwashiorkor are strikingly different to
marasmus as the adaptation to starvation is ineffective. Fat accumulates in the liver and expansion of
extracellular fluid volume, driven by low serum albumin concentrations, leads to edema. Micronutrient deficiencies often occur alongside protein–energy
malnutrition and may partly explain why individuals
with kwashiorkor, unlike those with marasmus, are
unable to adapt successfully to malnutrition.
The causes of malnutrition are complex and are not
simply related to a limited food intake. Where intake
is reduced, this is often due to food insecurity associated with famine, poverty, war, or natural disasters.
Reduced food intake can also arise due to chronic illness leading to loss of appetite or feeding difficulties.
Malnutritionwillalsoarisefrommalabsorptionofnutrients from the digestive tract. This, again, could be a
consequence of chronic disease or be driven by infection of the tract. Losses of nutrients are an important
consequence of repeated diarrheal infections in areas
where there is no access to clean water and adequate
sanitation. Malnutrition may also be driven by situations that increase the demand for nutrients including
trauma (as described above), pregnancy, and lactation, if those increased demands cannot be matched
by intake.



**8** **Nutrition: A Lifespan Approach**


Malnutrition is most common and most deadly in
the developing countries, where it is the major cause
of death in children. Stunting and wasting among
malnourished children have long-term consequences
too, as often the reduction in stature is not recovered,
leading to reduced physical strength and capacity to
work in adult life. As poverty is the most frequent
cause of malnutrition, a self-perpetuating cycle can
be established, as the stunted child becomes the adult
with reduced earning capacity, whose children will
live in poverty. Stunted, underweight women will also
have children who are at risk due to lower weight at
birth. Pregnancy is a time of high risk for malnutrition
in women living in developing countries. Stunting is
commonplace among women in South and Southeast Asia, and is often accompanied by underweight.
For example, in India and Bangladesh, up to 40% of
women of childbearing age have a body mass index
(BMI) of less than 18.5 kg/m [2] (Black _et al_ ., 2008). Iron
deficiencyanemiaisendemicamongpregnantwomen
in developing countries, with prevalence of between
60% and 87% in the countries of southern Asia

(Seshadri, 2001). Maternal and childhood malnutrition are believed to cause 3.5 million deaths among
the under-fives every year (Black _et al_ ., 2008).
Developed countries also have a burden of malnutrition among vulnerable groups. At greatest risk are
the elderly, who may develop protein–energy malnutrition or micronutrient deficiencies due to specific
medical conditions, or through low intakes associated with frailty or loneliness. Surgical patients are at
risk of protein–energy malnutrition as a result of the
inflammatory response to trauma. As in the developing countries, poverty increases the risk of malnutrition among children and immigrant groups. There are
many ways of targeting these at-risk groups, for example, monitoring the growth of infants, or including
regular weighing and nutritional assessments of hospital patients. Malnutrition is easily treated through
appropriate nutritional support.
The prevention of malnutrition is a major public
health priority on a global scale. While a lack of food
security and the risk of protein–energy malnutrition
remains a major issue for many populations, there
have been a number of success stories in the battle to

prevent clinically significant malnutrition. The basic
approaches that can be used to prevent nutrient deficiency are diet diversification, supplementation of atrisk individuals, and fortification. The basis for these
approaches and their use in the attempt to eradicate



vitamin A deficiency is described in Research highlight 1. Similar strategies have been used to reduce the
occurrence of iodine and iron deficiency diseases.
Iodine deficiency is an important issue for populations in all continents except Australasia. Availability of iodine is essentially limited by the iodine
content of the soil and hence uptake by plants and animals.Iodinedeficiencydisorders,includingcretinism
and goiter, are a major manifestation of malnutrition,
with approximately 740 million affected individuals
worldwide. Fortification has been the cornerstone of
the fight against iodine deficiency, with the Universal
Salt Iodization program providing iodized salt (20–
40 mg iodine per kg salt) to 70% of households in
affected areas. Where the iodized salt is consumed,
marked improvements in iodine status of the population are rapidly noted (Sebotsa _et al_ ., 2005). Although
there are still significant numbers of individuals at
risk of iodine deficiency disorders, due to lack of coverage of the USI program (Maberly _et al_ ., 2003), this
fortification approach is widely considered to be a
public health nutrition success for the World Health
Organization (WHO).


_**1.2.4 Classical balance studies**_


Nutritional status with respect to a specific nutrient
can be measured using balance studies. These have
classically been used to determine requirements for
some nutrients in humans. Essentially, the balance
method involves the accurate measurement of nutri
ent intake, for comparison with accurate measures
of all possible outputs of that nutrient via the urine,
feces, and other potential routes of loss (Figure 1.3). If
there is a state of balance, that is, intake and output are
at equilibrium, it can be assumed that the body is saturated with respect to that nutrient and has no need
for either uptake or storage. This technique can be applied to almost any nutrient and by repeating balance
measures at different levels of intake it is possible to
determine estimates of requirements for specific nutrients. The balance model works on the assumption
that in healthy individuals of stable weight, the body
pool of a nutrient will remain constant. Day-to-day
variation in intake can be compensated by equivalent
variation in excretion. The highest level of intake at
which balance can no longer be maintained will indicate the actual requirement of an individual for that
nutrient.

Nitrogen balance studies were used to determine
human requirements for protein (Millward _et al_ .,



**Introduction to Lifespan Nutrition** **9**


i



~~**Research Highlight 1**~~ ~~Strategies for combating vitamin A defciency (VAD)~~ i



i


VAD is one of the most common forms of malnutrition on a global
scale (West, 2003), with greatest prevalence in Africa, Central and
South America, South and Southeast Asia. Subclinical VAD blights
the lives of up to 200 million children every year and is a causal
factor in up to half a million cases of childhood blindness and up to
a million deaths of children under the age of 5 years. VAD is also
responsible for stunted growth in children and may cause blindness
in women with increased demands for vitamin A, due to pregnancy
or lactation. In 1990, the World Health Organization pledged itself to
the virtual elimination of VAD by the year 2000. The strategies used
to achieve this goal provide useful examples of how all common
nutrient deficiencies might be prevented at a population level. Three
main approaches have been used to tackle VAD:


1 _Diet diversification_ . For many populations in areas where VAD
is common, the range of staple foods consumed is very limited.
For example, rice is the basis of most meals for many in Southeast
Asia. Rice is a poor vitamin A source. Diversification programs include health education and promotion of consumption of a greater
range of foodstuffs and the development of home gardening to
provide vitamin A sources. Faber _et al_ . (2002) showed that a
home gardening program in South Africa increased knowledge
and awareness of VAD, improved availability of vitamin A sources
and increased serum retinol concentrations in young children.
2 _Supplementation_ . Inmost countries where VAD is common,
children are now supplemented with vitamin A, using an oil cap

1997). Such studies involved experiments in which
healthy subjects were recruited and allocated to consume dietary protein at specified levels of intake. After
4–6 days of habituation to these diets, urine and feces were collected for determination of nitrogen losses
over periods of 2–3 days. On this basis, it was possible to state dietary protein requirements for different


−
**Nutrient balance = Input** **Output**


Measured level of

nutrient intake



i


sule, two or three times a year, often coupling supplement doses
with other public health activities such as immunizations. Berger
_et al_ . (2008) highlighted the major disadvantage of supplementation, which is that it fails to reach all those in need of supplements.
For VAD, those most at risk are preschool children who have less
access to school-based supplementation programs. Often the poor
and those most in need of supplements are least likely to receive
them. Supplementation is expensive, which may reduce efficacy
of the approach in impoverished countries (Neidecker-Gonzales
_et al_ ., 2007).
3 _Fortification_ . Fortification involves the addition of nutrients to
staple foods at the point of their production, thereby increasing
the amount of nutrient delivered to all consumers of that foodstuff.

VAD in several countries has been tackled using this strategy. Red
palm oil is widely available in many VAD-affected areas and is a
rich source of ß-carotene. In India and parts of Africa, the addition
of this oil to other oils traditionally used in cooking, and to snacks,
has been shown to effectively increase vitamin A intake by the
general population (Sarojini _et al_ ., 1999). Zagr´e _et al_ . (2003)
showed that introducing red palm oil to a population in Burkina
Faso was highly effective in reducing occurrence of VAD. A similar
approach involves increasing the vitamin A content of crops such
as rice, either through genetic modification (e.g., “golden rice”)
or traditional plant breeding (Mayer, 2007).


stages of life as being the lowest level of protein intake
that maintained nitrogen balance in healthy individuals, maintaining body weight and engaging in modest
levels of physical activity. Nitrogen balance studies are
problematic in several respects, including the fact that
24-h urine collections used in such studies are often
incomplete,becausestudiesmayfailtoallowsufficient


**Output**


Measured losses
via urine, feces,
skin, and hair.



i



i


Balance=0 indicates that there is no net storage or loss of
nutrient.


Positive balance indicates that there is net deposition of
nutrient to the body pool.


Negative balance indicates that there is net loss of nutrient.



i


**Figure 1.3** Determining nutrient requirements
using the balance method. Precise measurements of nutrient intake and of output by all
possible routes enable determination of nutrient requirements. The highest level of intake at
which balance can no longer be maintained will
indicate the actual requirement of an individual
for that nutrient.



**10** **Nutrition: A Lifespan Approach**


time for subjects to habituate to their experimental
diet and because factors such as unobserved infection,
stress, or exercise may increase demand for protein.
It has also been impossible to use balance studies to
examine protein requirements for all age groups and
in all health situations, so requirements for pregnant
and lactating women and for children are based on
balance studies in young adults and make estimates
of allowances for tissue deposition, growth, and milk
synthesis and secretion.


_**1.2.5 Overall nutritional status**_


The diet delivers a multitude of components rather
than single nutrients, and it is unlikely that any individual will have a diet that perfectly achieves balance
for all of them. For example, an individual can be
in balance for protein, while consuming more energy
than is required and insufficient iron to meet demand.
Hence,itisoftennotappropriatetodiscussoverallnutritional status of an individual without consideration

of nutritional status with respect to specific nutrients.
Whether considering the overall nutritional status
of an individual, examining nutritional status with
respect to a specific nutrient, or investigating the nutritional status of a population, it is important to take
into account a broad range of factors. It should be
clear from the above discussions that intake is just
one component of the supply side of the balance
model. Nutritional status is only partly determined
by the food that is being consumed. Nutritional status also depends upon the activities and health status
of the individuals concerned. Trauma and high levels of physical activity will increase demand, while
a sedentary lifestyle will decrease demand. Most important though is the stage of life of the individuals
under consideration. Physiological demands for nutrients vary to a wide degree, depending on age, body
size, and gender. The impact of variation within the
diet upon health and well-being is largely, therefore,
governed by age and sex.


**1.3 Nutrition requirements change across**
**the lifespan**


Nutritional status is determined by the balance between the supply of nutrients and the demand for
those nutrients in physiological and metabolic processes. So far in this chapter, we have seen that both



sides of the supply–demand balance equation can be
perturbed by a variety of different factors. Intake, for
example, can be reduced in circumstances of poverty,
whiledemandiselevatedbyphysiologicaltrauma.The
main determinants of demand are, however, shaped
by other factors such as the level of habitual physical
activity (which will increase energy requirements), by
gender, by body size, and by age. It is this latter factor
that provides the focus of this book.
The demand for nutrients to sustain function be
gins from the moment of conception. The embryonic
and fetal stages of life are the least understood in terms
of the precise requirements for nutrition, but it is clear
that they are the life stages that are most vulnerable
in the face of any imbalance. Demands for nutrients
are high in order to sustain the rapid growth and the
process of development from a single-celled zygote to
a fully formed human infant. An optimal balance of
nutrients is essential, but the nature of what is truly
optimal is difficult to dissect out from the competing
demands of the maternal system and the capacity of
the maternal system to deliver nutrients to the fetus.
The embryo and fetus represent a unique life stage
from a nutritional perspective, as there are no nutrient reserves and there is a total dependence upon
delivery of nutrients, initially by the yolk sac and later
by the placenta. The consequences of undernutrition
at this stage can be catastrophic, leading to miscarriage, failure of growth, premature birth, low weight
at birth, or birth defects (MRCVitamin Study Group,
1991, Godfrey _et al_ ., 1996; El-Bastawissi _et al_ ., 2007).
All of these are immediate threats to survival, but it is
also becoming clear that less than optimal nutrition at
this stage of life may also increase risk of disease later
on in life (Langley-Evans, 2006).
After birth the newborn infant has incredibly high
nutrient demands that, in proportion to body weight,
may be two to three times greater than those of an
adult. These demands are again related to growth and
thematurationoforgansystemsasinfetallife.Growth
rates in the first year of life are more rapid than at
any other time, and the maturation of organs such as
the brain and lung continues for the first 3–8 years
of life. Initially, the demands for nutrients are met
by a single food source, milk, with reserves accrued
from the mother toward the end of fetal life compensating for any shortfall in supply of micronutrients.
In later infancy, there is the challenge of the transition to a mixed diet of solids (weaning), which is



a key stage of physiological and metabolic development. The consequences of imbalances in nutrition
can be severe. Infants are very vulnerable to protein–
energy malnutrition and to micronutrient deficiencies, which will contribute to stunting of growth and
other disorders. Iodine deficiency disorders and iron
deficiency anemia can both impact upon brain development, producing irreversible impairment of the
capacity to learn. Obesity is now recognized as a major
threat to the health of children in the developed countries. In this age group, it is not simply a product of
excessive energy intake and low-energy expenditure.
Increasingly, we are seeing that the type or form of
foods consumed at this time can influence long-term
weight gain, with breast-fed infants showing a lower
propensity for obesity than those who are fed artificial
formula milks (Arenz _et al_ ., 2004; Bayol _et al_ ., 2007).
Beyond infancy, nutrient demands begin to fall relative to body weight, but still remain higher than seen
in adulthood through the requirement for growth and
maturation. These demands are at their greatest at the
time of puberty when the adolescent growth spurt
produces a dramatic increase in height and weight
that is accompanied by a realignment of body composition. Proportions of body fat decline and patterns of
fat deposition are altered in response to the metabolic
influencesofthesexhormones.Proportionsofmuscle
increase and the skeleton increases in size and degree
of mineralization. Nutrient supply must be of high
quality to drive these processes, and in absolute terms
(i.e., not considered in proportion to body size), the
nutrient requirements of adolescence are the greatest of any life stage. However, adolescents normally
have extensive nutrient stores and are therefore more

tolerant of periods of undernutrition than preschool
children (1–5 years).
The adult years have the lowest nutrient demands
of any stage of life. As growth is complete, nutrients
are required solely for the maintenance of physiological functions. The supply is well buffered through
stores that protect those functions against adverse effects of undernutrition in the short term to medium
term. In developed countries, and increasingly so in
developing countries, the main nutritional threat is
overweight and obesity, as it is difficult for adults to
adjust energy intakes against declining physiological
requirements and the usual fall in levels of physical
activity that accompany aging. Reducing energy intake, while maintaining adequate intakes of micronu


**Introduction to Lifespan Nutrition** **11**


trients, is a major challenge in elderly individuals.
Chronic illnesses associated with aging can promote
undernutrition through increased nutrient demands,
while limiting appetite and nutrient bioavailability.
For women, pregnancy and lactation represent special circumstances that may punctuate the adult years
and which increase demands for energy and nutrients.
Nutrition is in itself an important determinant of fertility and the ability to reproduce (Hassan and Killick,
2004). In pregnancy, provision of nutrients must be
increased for the growth and development of the fetus and to drive the deposition of maternal tissues.
For example, there are requirements for an increase
in size of the uterus, for preparation of the breasts for
lactation and for formation of the placenta. To some
extent, the mobilization of stores and adaptations that
increase absorption of nutrients from the gut serve
to meet these increased demands, but as described
above, imbalances in nutrition may adversely impact
upon the outcome of pregnancy. Lactation is incredibly demanding in terms of the energy, protein, and
micronutrient provision to the infant via the milk. As
withpregnancy,notalloftheincreaseinsupplyforthis
processdependsuponincreasedmaternalintakes,and
infactwomencansuccessfullymaintainlactationeven
with subclinical malnutrition. Adaptations that support and maintain breast-feeding may impact upon
maternal health. For example, calcium requirements
for lactation may be met by mobilization of bone
mineral, and if not replaced once lactation has ceased,
could influence later bone health. However, although
nutritionally challenging, most evidence suggests that
lactation is of benefit for maternal health and actually
contributes to reduced risk of certain cancers and os
teoporosis (Ritchie _et al_ ., 1998; Danforth _et al_ ., 2007).
Lifespan factors clearly impact upon nutritional
status as they are a key determinant of both nutrient
requirements and the processes that determine nutrient supply. In studying relationships between diet,
health, and disease, one of the major challenges is to
assess the quality of nutrition in individuals and at
the population level. Tools used for these nutritional
assessments will be described in the next section.


**1.4 Assessment of nutritional status**


The assessment of nutritional status is necessary in a
variety of different settings. Working with individuals



**12** **Nutrition: A Lifespan Approach**


in a clinical setting, it may be necessary to assess dietary adequacy in order to plan the management of
disease states, or to make clinical diagnoses. Public
health nutritionists require data on dietary adequacy
at a group level, in order to make assessments of the
contribution of nutritional factors to disease risk in

the population and to develop public health policies
or intervention strategies. Nutritional assessment is
also a critical research tool used in determining the
relationships between diet and disease. These situations, which rely on considerations of the likelihood
of nutritional deficit or excess at the individual or
population level, use tools that aim either to measure
intakes of nutrients, or the physiological manifestations of nutrient deficit or excess within the body.
Tools for nutritional assessment include anthropometric measures, dietary assessments, determination
of biomarkers, and clinical examination.


_**1.4.1 Anthropometric measures**_


Anthropometric methods make indirect measurements of the nutritional status of individuals and
groups of individuals, as they are designed to estimate the composition of the body. Table 1.4 provides
a summary of the commonly used anthropometric
techniques.Informationaboutrelativefatnessorleannesscanbeausefulindicatorofnutritionalstatussince



excess fat will highlight storage of energy consumed
in excess, while declining fat stores and loss of muscle
mass are indicative of malnutrition. Extremes within

anthropometric measures, for example, the emaciation of cachexia, or morbid obesity, are useful indicators of disease risk or progression in a clinical setting. In children, serial measures of height and weight
can provide sensitive measures of growth and development that can be used to highlight and monitor
nutritional problems.


_**1.4.2 Estimating dietary intakes**_


Estimation of dietary intakes, either to determine intakes of specific macro- or micronutrients, or to assess
intakes of particular foods, is a mainstay of human
nutrition research. A range of different methods are
applied, depending on the level of detail required. All
approaches are highly prone to measurement error.


**1.4.2.1 Indirect measures**

The least accurate measures of intake are those that

make indirect estimates of the quantities of foodstuffs
consumed by populations. These techniques are used
to follow trends in consumption between national
populations, or within a national population over a
period of time.



**Table 1.4** Anthropometric measures used to estimate body composition and nutritional status


Component of body
Technique composition estimated Limitations


Body mass index (weight/height [2] ) Weight relative to height Does not distinguish between lean and fat mass. Does not
measure the composition of the body


Skinfold thicknesses Fat mass Requires skill in measurement. Makes assumptions about the
even distribution of fat in the subcutaneous layer


Waist circumference or waist–hip ratio Fat distribution A good indicator of abdominal fat deposition. Requires set
protocols for measurement


Mid-upper arm circumference Muscle mass Prone to measurement error. Unsuitable for some groups
(e.g., adolescents) with rapidly changing fat and muscle
patterns. Good indicator of acute malnutrition


Bioimpedance Fat mass Influenced by hydration status of subjects


Underwater weighing Body density, fat, and lean mass Requires subjects to undergo training for an unpleasant
procedure. Underestimates fat mass in muscular individuals


Isotope dilution Body water Influenced by fluid intake of subject. Analytically difficult and
expensive


Scanning techniques (NMR, DXA) Proportions and distribution of Expensive, restricted access to scanners. Use ionizing
lean and fat mass radiation, so unsuitable for children and pregnant women



**Introduction to Lifespan Nutrition** **13**



**200**

**180**


**160**

**140**

**120**

**100**


**80**

**60**

**40**


**20**

**0**


Food balance sheets are widely used by the United
Nations Food and Agriculture Organization (FAO) to
monitor the availability of foods, and hence nutrients,
within most nations of the world and are published
on an annual basis. They allow temporal trends to be
monitored easily and apply a standardized methodologyonaglobalscale.Afoodbalancesheetisessentially
compiled from government records of the total production, imports, and exports of specific foodstuffs.
This allows the quantity of that foodstuff available to
the population to be calculated (available food = production + imports – exports). Dividing that figure
by the total number of people in the population allows the daily availability per capita to be estimated.
Figure 1.4 shows data abstracted from the 2004 FAO
food balance sheets, indicating how daily availability
of protein from plant and animal sources varies with
different regions of the world.
Food balance sheets are subject to considerable error due to assumptions that are made in their compilation. It will be assumed that the nutrient composition of a food will be the same regardless of where it
is produced, which is clearly incorrect. For example,
the selenium content of cereals from North America

is considerably greater than in the same cereals from
Europe. The balance sheets also assume that all available food will be completely consumed by humans
and do not allow for wastage, or feeding to animals. It
is also fallacious to assume that available food will be
equally distributed to all people in a population and
the sheets make no distinction between food available

to men and women, to adults and children, or to rich
and poor.





**Figure 1.4** Availability of animal and plant protein by world region. Per capita availability of protein from plant and animal sources calculated from
the 2004 FAO global food balance sheets.


Food accounts are a similar approach to estimating food availability, but instead of collecting data on a
national scale, they are used to measure the food available to a household or an institution (e.g., a nursing
home). By compiling an inventory of food stored at
the start of a survey, monitoring food entering the
setting (often measured by looking at invoices and receipts from food shopping) and taking into account
any food grown in the setting, it is possible to calculate
the food _available_ per person over the period of the
survey. As with the food balance sheet, this method
does not allow accurate estimation of individual food
intakes and does not allow for food wastage, but the
food account can provide data on dietary patterns of
families or similar groups at low cost and over an
extended period of time.


**1.4.2.2 Direct measures**

Direct measures of nutrient intake collect data from
individuals or groups of individuals and, in addition
to their obvious application to clinical circumstances,
are well suited to research in human nutrition and
epidemiology. Although more robust than the indirect estimates described above, all direct measures of
intake are prone to bias and error and results must
always be interpreted with caution.


_Dietary recall methods_
The dietary recall method is not only one of the best
methods for examining nutrient intakes in a clinical
setting, but it may also be used in research. One of
the major disadvantages of the method is the need for
a trained interviewer to spend a period of time with



**14** **Nutrition: A Lifespan Approach**


the patient or research subject to elicit detailed information on all food and drink consumed over a recent

period of time. Most dietary recalls will be based upon
intakes over the preceding 24 h, but in some cases may
look at 48-h or 72-h periods. Information obtained
in this way can then be coded for detailed analysis of
energy and nutrient intakes using appropriate nutritional analysis software or food tables. Dietary recall
methods can generate detailed information on types
of food consumed and portion sizes. The use of photographic food atlases showing portion sizes for commonly consumed foods can enhance the quality of this
quantitative information. Spending time interviewing
a subject also makes it relatively easy to obtain recipes
used in cooking, and information about cooking techniques (e.g., use of oils in frying). Like all methods of
estimating nutrient intake, the dietary recall is prone
to inaccuracy due to underreporting and overreporting of food intake by certain groups of people. It is
also dependent upon the memory of the subject and
so loses accuracy when attempting to estimate habitual intakes.


_Food record methods_

Food records, or diaries, administered to subjects for
completion in their own time are widely regarded as
the most powerful tool for estimation of nutrient intakes. Subjects keep records for extended periods of
time (usually 3–7 days) and note down all foods and
beverages consumed at the time they are consumed.
Portion sizes can be recorded in a number of different
ways,withthesubjectmostfrequentlyeithernotingan
estimated intake in simple household measures (e.g.,
2 tablespoons of rice, 1 cup of sugar), or an intake
estimated through comparison to a pictorial atlas of
portionsizes.Toimprovethequalityofthedata,intake
can be accurately determined by weighing the food on
standardizedscales,takingintoaccountanywastage(a
weighed food record). Frobisher and Maxwell (2003)
found that in studying intakes of children aged 6–16, a
food record with a photographic atlas of portion sizes
gave a good level of agreement with weighed records.
In some settings, it is possible for a researcher to do the
weighing, thereby reducing influences upon the subject consuming the food. Inaccuracies in estimates of
portionsizesareamajorproblemassociatedwithfood
record methods, particularly with some subgroups in
the population, and methods should be chosen that
best serve the purpose of the dietary survey. Surveys of



small groups of well-motivated people in a metabolic
unit lend themselves well to weighed record methods,
while in large surveys of free-living individuals, these
are rarely practical.
Food records have a number of strengths compared
to other methods of estimating intake. Complex data
on meal patterns and eating habits can be obtained
throughstudyoffooddiariesandthisinformationcan
supplement estimates of nutrient intake. By obtaining
records for periods of 5–7 days, the intakes of most
micronutrients can be estimated with some degree of
confidence, in addition to energy and macronutrients.
For some nutrients, it is suggested that records of 14
or more days may be required (Block, 1989). The major disadvantage of the food record approach is the
reliance upon the subject to complete the record fully
and accurately. Maintaining a food record is burdensome and it is often noted that the degree of detail
and hence accuracy will be greater in the first 2–3 days
of a 7-day record compared to later days. The act of
recording intake, especially if a weighed record is used,
can change the eating behavior of subjects and hence
lead to an underestimate of habitual intakes.

Like other direct methods, the food record is prone
to underreporting and overreporting of energy and
nutrient intakes among certain subgroups in the
population, due to the tendency of individuals to report intakes that will reflect them in the best possible light to the researcher. Bazelmans _et al_ . (2007)
studied a group of elderly individuals, comparing selfreported intakes on a 24-h food record to estimates
of likely energy intake based upon the subjects basal
metabolic rates calculated using the Schofield equation. It was found that approximately 20% of men and
25% of women significantly underreported or overreportedtheirenergyintakes.SubjectswithaBMIunder
25 kg/m [2] (i.e., in the ideal weight range) were most
likely to overreport, while 13% of those with BMI in
the overweight range and 27% of those with a BMI
in the obese range were found to have underreported
their energy intake. Obese and overweight women are
frequently found to underreport intakes in dietary

surveys.


_Food frequency questionnaire methods_
Food frequency questionnaire methods involve the
administration of food checklists to individuals, or
groups of individuals, as a means of estimating their
habitual intake of foods, or groups of foods. Subjects



work through the checklist and, for each foodstuff,
indicate their level of consumption (i.e., number of
portions) on a daily, weekly, or monthly basis. Semiquantitative food frequency questionnaires also collect information on typical portion size.
Food frequency questionnaires can vary in their
complexityandlength.Oftenaquestionnairewillconsist of 100–150 food items and will therefore allow
for a comprehensive coverage of the dietary patterns
of a subject. Some questionnaires are much shorter
and may be focused upon a particular food group
or the main sources of a specific type of nutrient.
For example, Block and colleagues (1989) developed
a questionnaire with just 13 items in order to identify
individuals who had high intakes of fat. This was used
as a preliminary screening tool to select subjects for a
more detailed investigation.
Foodfrequencyquestionnaireshavemanydesirable
attributes for researchers wishing to estimate intakes
in large populations. They are self-administered by
the subject, are generally not time consuming, and
are unlikely to influence eating behaviors. Data entry can sometimes be automated, reducing the analytical burden for the researcher. Moreover, the food
frequency questionnaire provides an estimate of habitual intake over a period of months or even years, as
opposed to the snapshot obtained by looking at a food
record representing just a few days. However, the food
frequency questionnaire can be a weak tool when considering portion sizes and is therefore less effective for
estimating micronutrient intakes than a food record.
Food frequency questionnaires must also be valid for
the population to be studied as the range of foods
consumed will vary with age and various other social
and demographic factors. For example, if attempting
to survey nutrient intakes in a population with a wide
ethnic diversity, the foods and food groups included
onthequestionnaireneedstoreflectthatlevelofdiversity. A questionnaire that fails to include staple foods
consumed by particular ethnic groups will inevitably
underestimate their intake.


_**1.4.3 Biomarkers of nutritional status**_

Biomarkersofnutritionalstatusaremeasuresofeither

the biological function of a nutrient, or the nutrient
itself, in an individual, or in samples taken from individuals. These measures can often provide the earliest
indicator of a nutrient deficit as they register subnormal values ahead of any clinical symptoms. Biomark


**Introduction to Lifespan Nutrition** **15**


ers are therefore useful in monitoring the prevalence
of nutrient deficiency, measuring the effectiveness of
the treatment of deficiency, and assessing preventive strategies. Given the huge difficulties of making
accurate assessments of dietary intakes, as described
above, biomarkers provide a useful means of validating dietary data and are often measured as adjuncts to
dietary surveys. For example, in the UK National Diet
and Nutrition Survey of preschool children (Gregory
_et al_ ., 1995), measurements of circulating iron status were used to back up food record data collected
on iron intakes. The doubly labeled water method
(Koebnick _et al_ ., 2005) can be used to validate energy intakes estimated using dietary records or other

means.

Biomarkers of nutritional status are often regarded
as being more objective than other indices. They include functional tests, and measurements of nutrient
concentration in easily obtained body fluids or other
material. The latter type of measurement can be a
_static_ test, which is performed on one occasion, or
may be repeated at intervals to monitor change over
time. The relative merits of these approaches will be
discussed later in this section.
Functional tests measure biological processes that
aredependentuponaspecificnutrient.Ifthatnutrient
is present at suboptimal concentrations in the body,
then it would be expected that the specific function
would decline. The dark adaptation test is classic example of a functional test, which determines vitamin
A status. The dark adaptation test measures visual
acuity in dim light after exposure to a bright light
that densensitizes the eye. Reformation of rhodopsin
within the retina is dependent upon the generation of
_cis_ -retinol and thus the visual adaptation in the dark
willberelatedtovitaminAstatus.Measurementofthe

excretion of xanthurenic acid is a functional test for
vitamin B6 (pyridoxine) status. Xanthurenic acid is
a breakdown product of tryptophan and kynurenine
and is formed via pyridoxine-dependent reactions.
Nonfunctional measures of biomarkers typically
involve direct measures of specific nutrients in simply
obtained samples from individuals. These are most
commonly samples of blood (plasma, serum, or red
cells), or urine, but could include feces, hair, or, more
rarely, biopsy material from adipose tissue or muscle.
Static tests provide a snapshot of the nutrient concentration in the sample at a given point in time and
could be misleading as they often provide an indicator



**16** **Nutrition: A Lifespan Approach**


of immediate intake rather than habitual intake. For
example, plasma zinc concentrations will vary hugely
from day to day, reflecting ongoing metabolic fluxes,
and fall by up to 20% following a meal (King, 1990).
Wherever possible, repeated tests should be taken to
increase confidence in the measured biomarker, or
tests should be performed in a sample that provides
a stronger indicator of habitual intake. In the case
of zinc, plasma measurements are of limited value as
most zinc is held in functional forms within tissues

and less than 1% of the total pool is in circulation. Red
or white blood cell zinc concentrations could be used

as a more robust biomarker, as could white cell metallothionein concentrations (metallothionein is a key
zinc-binding protein). Hair zinc concentrations give
a better intake of long-term status. Zinc is deposited
in hair follicles slowly over time and so using this
sample source removes the influence of shorter term
fluctuations in status. Similarly, the EURAMIC study
(Kardinaal _etal_ .,1993)usedmeasuresof _α_ -tocopherol
and ß-carotene in biopsies of adipose tissue to assess
intakes of these vitamins. As fat-soluble vitamins are

stored in this tissue, this gave an indicator of habitual
intake over several weeks.

The levels of a measured biomarker are only useful in estimating nutritional status if there is a linear
relationship between the measurement and intake. In
addition to this, and the need to make measurements
in a relevant sample, it is important to appreciate the
nondietary influences on the biomarker that could
skew the interpretation of any measurement. Some
measurements could be perturbed by the presence of
disease, or the use of medications to treat disease. For
example, serum albumin concentration can be used as
a marker of dietary protein intake. Serum albumin declines with low protein intakes and in clinical settings
can provide a predictor of morbidity and mortality associated with protein–energy malnutrition. However,
as described earlier in this chapter, serum albumin
concentrations also fall with infection and inflammation, and in seriously ill patients, albumin could be
administered as an element of any intravenous fluid
infusion. Either situation would render albumin useless as a marker of nutritional status. Like any measure of nutritional status, biochemical indices can lack
specificity and should ideally be used as part of a
battery of tests based upon dietary assessments, biochemical measures, anthropometry, and, if appropriate, clinical assessment.



_**1.4.4 Clinical examination**_


Performing a thorough physical examination and obtainingadetailedpatienthistoryisaneffectivemethod
of determining symptoms associated with malnutrition in individuals. This approach can be most useful when dealing with children, where the paucity of
nutrient stores can mean that clinical symptoms develop very quickly, as opposed to in adults where the
symptoms are generally a sign of chronic malnutrition. Obtaining a patient history can highlight key
points that are missed when assessing dietary intake,
or using anthropometric measures. Reported loss of
appetite, loss of blood, occurrence of diarrhea, steatorrhea, or nausea and vomiting may all be indicators
of potential causes of malnutrition and should trigger
further investigation. Physical examination can assess
the degree of emaciation of a potentially malnourished individual. Careful assessment of the hair, skin,
nails, eyes, lips, tongue, and mouth can also highlight
specific nutrient deficiencies. Bleaching of the hair is
indicative of protein malnutrition, while cracking of
the lips can suggest deficiency of B vitamins such as
riboflavin. Pallor of the skin and spooning of the nails
are clinical signs of iron deficiency. Evidence of rough
spots on the conjunctiva of the eye will accompany
early stages of vitamin A deficiency.


**1.5 Dietary reference values**


Dietary reference values (DRVs) are standards that
are set by the health departments of governments in
a number of countries around the world. DRVs are
guidelines that can be used to define the composition
ofdietsthatwillmaintaingoodhealth.Therearemany
complex systems of DRVs used in different countries.
These vary according to national health priorities and
policies, according to predominant health status, socioeconomic status, body mass and rates of growth,
and with local factors, for example, the composition
of foods or other lifestyle influences, that determine
the absorption and hence bioavailability of nutrients
(Pavlovic _et al_ ., 2007).
DRVs are used in a variety of different ways. While
some systems, such as those developed for the UK, are
generally intended to be used only with populations
or subgroups within populations, others (e.g., the US
Dietary Reference Intakes) are used in providing dietary guidance for individuals. On a population level,



the DRVs are useful yardsticks with which to assess the
adequacy of the diet of a population and hence protect
individuals within that population against the adverse
consequences of either deficiency or excess. By using
DRVs as standard measures against which dietary survey data can be compared, it is possible to estimate the
prevalence of risk of deficiency for specific nutrients
within a population.
In some countries, regular surveys of national dietary patterns among age and gender specific groups,
for example, the UK National Diet and Nutrition Surveys (Gregory _et al_ ., 1995; Henderson _et al_ ., 2002) or
the US National Health and Nutrition Examination

Surveys, are compared to the DRVs in order to highlight potential nutrient deficiencies. In other countries, food supply data at the national level, such as
the food balance sheets collected by the FAO, can be
used to crudely estimate the average per capita availability of energy and the macronutrients and compared to international standards. Although such data
are prone to error, as described above, they can be
used for tracking trends in the food supply and determining availability of micronutrient-rich foods. By
comparison of such data with DRVs, it is possible to
uncover evidence of gross inadequacies in the quality
of the diet across whole populations (but not subgroups such as children or the elderly). Standards for
nutrient provision based upon DRVs can also be used
in the planning of food supplies to regions (e.g., in humanitarian aid), or in menu planning for caterers in
hospitals, schools or other institutional settings. Many
of the food labeling schemes used in supermarkets are
based upon published DRVs for specific nutrients.


_**1.5.1 The UK dietary reference**_
_**value system**_


In 1979, the UK set a series of DRVs termed the recommended daily amounts (RDAs). In 1991, a new
series of DRVs were published to replace these RDA
values, as they were considered to be prone to misunderstanding and misuse. The term “recommended”
wrongly suggests a level of intake that an individual must consume on a daily basis in order to avoid
adverse consequences. The new system of DRVs produced by the Committee on Medical Aspects of Food
Policy (COMA, DoH, 1991) therefore dropped the
word recommended and was developed to indicate
different levels of intake that would be suitable for
healthy populations, broken down by age and gender.



**Introduction to Lifespan Nutrition** **17**


In setting the DRVs, COMA reviewed research for
each macro- and micronutrient in order to determine

the levels of intake that are necessary to maintain normal health and physiological function. In considering
the available evidence, the key issues to be explored
for each nutrient were as follows: (1) What level of
intake is necessary to maintain circulating or tissue
concentrations within normal ranges? (2) What level
of intake is necessary to avoid clinical deficiency in individuals or in populations? (3) What level of intake
has been established as being effective in treating clinical deficiency? (4) What level of intake has been shown
to maintain normality in a biomarker of adequacy?
As shown in Figure 1.5, the relationship between
nutrient intake and disease risk is not linear. At low
levels of intake, the probability of adverse consequences(deficiencydisease,lossofphysiologicalfunction) is elevated. With rising intakes, the probability
of such consequences declines to zero as intakes provide the requirements of most of the individuals in a
population. At higher intakes, the probability of adverse consequences associated with overnutrition begins to rise. In developing a set of DRVs appropriate
for a population like the UK, in which the economic
wealth of the population makes overnutrition more
likely than undernutrition, this continuum between
risk and intake must be recognized.
In common with the US and other countries (see
below), the UK DRVs were developed to map onto
the expected distribution of nutrient requirements in
a population. As shown in Figure 1.6, this would usuallybeexpectedtofollowanormaldistribution,which
actually relates to the left hand side of the distribution
of risk plotted against intake (Figure 1.6). In this context, the mean value (midpoint) in a normal distributionwouldrepresentalevelofnutrientintakeatwhich
the requirements of 50% of the people in a population
would be met. Within the UK DRV system, this point
is termed the estimated average requirement (EAR).
When a population is consuming a nutrient at a level
close to the EAR, it can be assumed that for 50% of
people, this will be sufficient, but that for up to 50%,
nutritional status would be compromised.
The other DRVs are set at points that are two standard deviations either side of the mean. The reference

nutrient intake (RNI) is the upper value and within
the normal distribution would represent a level of intake that should meet the requirements of 97.5% of
the population. When a population is consuming a



**18** **Nutrition: A Lifespan Approach**



**Figure 1.5** The association between risk of
nutrition-related risk and level of nutrient intake.
EAR, estimated average requirement; RNI, reference
nutrient intake; UL, tolerable upper limit.



**1**


**0.9**


**0.8**


**0.7**


**0.6**


**0.5**


**0.4**


**0.3**


**0.2**


**0.1**


**0**



**EAR** **RNI** **UL**


**0** **5** **10** **15** **20** **25** **30**



**Level of nutrient intake**


nutrient at a level close to the RNI it can be assumed

that for most individuals this intake will be sufficient or will exceed true requirements, but that for the
2.5% of individuals with extremely high requirements
nutritional status would be compromised. The lower
reference nutrient intake (LRNI) lies at the lower
end of the normal distribution and represents a level
of intake that would meet the requirements of just
2.5% of the population. If a population was consuming a nutrient at a level close to the LRNI, it could be
assumed that for most individuals, this will be insufficient and that deficiency disease would be rife.



For some nutrients (e.g., pantothenic acid, biotin,
and molybdenum), COMA had insufficient data to be
able to derive estimates of requirements, but recognized the biological importance of these compounds
in the diet. In the absence of extensive information,
the Safe Intake was set. This is an upper level of intake set at a point likely to prevent deficiency and
avoid toxicity. Safe Intakes are of greatest importance
to vulnerable groups in the population such as infants
and children (DoH, 1991).
The DRVs are published as a comprehensive series of tables (DoH, 1999), which, for most nutrients,



**70**


**60**


**50**


**40**


**30**


**20**


**10**


**0**



**EAR**











**0** **5** **10** **15** **20**


**Level of nutrient intake**



**Figure 1.6** The normal distribution as a basis for
DRVs. UK DRVs are based upon an assumed normal
distribution of individuals’ nutrient requirements
and level of nutrient intake. The EAR (estimated
average requirement) is set at the center (mean) of
the distribution. LRNI (lower reference nutrient intake) and RNI (reference nutrient intake) values are
placed 2 standard deviations below and above the
mean, respectively. The nutrient requirements of all
but 5% of the population should therefore be met
by levels of intake between these two values.



provide reference values for males and females separately and for different age groups (typically 0–12
months, 1–3 years, 4–6 years, 7–10 years, 11–14 years,
15–18years,19–50years,and50+ years).Toreflectincreased demands for nutrients during pregnancy and
lactation, some tables show additional increments of
intake for pregnant and breast-feeding women. For
micronutrients and trace elements, published values
include all three terms (LRNI, EAR, and RNI). With
respect to protein, only EAR and RNI values were determined. Given that excess energy consumption is a
driver of obesity and related disorders, it is undesirable to set reference values at an upper point such as
the RNI, as a population that consumed energy at that
level would be expected to have a high prevalence of
related adverse effects such as obesity. DRV tables for
energy therefore include only the EAR value, and include modifiers to allow for levels of physical activity.
Humans have a requirement for essential fatty acids
and children can develop clinical deficiency of linoleic
acid. There are DRVs that indicate minimum intakes
of essential fatty acids, but as low intakes of the majority of lipids are not associated with adverse health
effects, the three main DRV terms are not applied to
fats.Instead,COMAsetpopulationaverageguidelines
for consumption of saturated, monounsaturated, and
polyunsaturated fats based on percentage of dietary
energy provided by those sources. These guidelines
represent maximum intakes in the light of the established risk of cardiovascular disease with high-fat
intakes. In the same way, COMA set guidance values for sugars and complex carbohydrates based on
percentages of dietary energy intake. Population averages are designed to encourage lower intakes of nonmilk extrinsic sugars and fats, while increasing intakes
of starch and nonstarch polysaccharides (Whitehead,
1992).
In the UK, the DRVs are not intended to be guidelines for individuals. It is generally considered a fruitless activity to make estimates of nutrient intakes for
individuals, given problems with obtaining accurate
dataonfoodintakeandbecauseitisimpossibletoestimatewhatthetruerequirementsforanyindividualare
likely to be. In making assessments of dietary intakes
of groups within a population, the RNI is considered
to be the most important benchmark for comparison. The nearer the average intake of a group within
a survey is to the RNI, the less likely it is that any
individual within that group will have an inadequate



**Introduction to Lifespan Nutrition** **19**


intake. However, the LRNI value provides a better
indicator of the likely risk of widespread deficiency,
whether clinical or subclinical. The nearer the average
intake of the group is to the LRNI, the greater is the
probability that some individuals within that group
are not consuming that nutrient at a level adequate to
meet their requirements.
An example of the DRVs in use is provided by the
study of Cowin and colleagues (2000). This group assessed the nutrient intakes of 1026 18-month-old in
fants living in the southwest of England, using a 3-day
unweighed dietary record. By comparing recorded
intakes with the RNI values for micronutrients, the
survey concluded that intakes of most nutrients were
adequate in this population group. However, for iron
and vitamin D, it was noted that mean intakes were
considerably below the RNI, suggesting that these nutrients could be a cause for concern in this population
group. Indeed, for iron, where the LRNI is 3.7 mg/day
for infants, it was noteworthy that the 2.5% of the
populationwiththelowestintakes(i.e.,thegroupwho
might be expected to be meeting their requirements
despite low intake) consumed only 2.4 (girls) to 2.7
(boys) mg/day, figures well below the LRNI. Data of
this kind can be the start point for further studies that
identify the causes of deficiency and for formulating
appropriate interventions and dietary recommendations (Cowin _et al_ ., 2001).
Although not intended for use with individuals, the
DRVs could still be used in a clinical setting. When
working with healthy individuals, assessments of dietary intakes that indicate intakes below or close to
the LRNI could indicate a dietary problem and might
be a stimulus for a more in-depth assessment of biochemical or clinical indicators of nutritional status. In
planning a diet for an individual, delivery of nutrients
at the level of the RNI would be a basic priority to
ensure optimal health.


_**1.5.2 Dietary reference values in other**_
_**countries**_


The UK system described above is just one example of
DRVs defined with the purpose of guiding the provision of healthy nutrition on a population-wide scale.
Many other countries use similar systems that have
also been derived to map against the normal distribution of nutrient intakes against provision of nutrient
demands. This approach is generally applicable for
westernized countries where the nutrition-related



**20** **Nutrition: A Lifespan Approach**


**Table 1.5** Definitions of DRV terms used in the UK, North America,
and Oceania


Dietary
Region reference terms Definition


UK LRNI Lower reference nutrient intake

RNI Reference nutrient intake

EAR Estimated average requirement
Safe intake


US/Canada EAR Estimated average requirement
RDA Recommended daily allowance
AI Adequate intake
UL Tolerable upper limit


Australia/NZ EAR Estimated average requirement
RDI Recommended daily intake
AI Adequate intake
EER Estimated energy requirement
UL Upper level of intake


health concerns are usually focused on the consequences of nutrient excess rather than nutrient deficiency. Table 1.5 summarizes the dietary reference
terms used in North America, Australia, and New
Zealand.
Among the countries of the European Union, there
is considerable variation in the terminology used to
describe DRVs and in the precise nature of recommendations made for particular population groups,
most particularly children. There are suggestions that
the European countries should harmonize their DRV
systems(Pavlovic _etal_ .,2007),andthatinthecourseof
generating a common system, a further review of the
evidence could be conducted to determine whether
regional variation reflecting health status and other
local issues is necessary or desirable. The Scientific
Committee on Food of the EU has defined three levels
of DRVs: average requirement, population reference
intake, and lowest threshold intake. In general intent,
these terms map against the UK EAR, RNI, and LRNI
values.

As in the UK, the countries of North America reviewed their existing reference values, originally set
in 1941, and replaced them with a new comprehensive format in the early 1990s (Kennedy and Meyers,
2005). In Canada and the US, the EAR and RDA terms
are exact equivalents of the UK EAR and RNI terms,
but are used in a different manner to that seen in the

UK. EAR is a term that would be used to estimate the

prevalence of inadequate intakes in a population, but
RDA is a term specifically intended for use with in


dividuals. A habitual intake below this level would be
associated with increased risk of dietary inadequacy.
In population surveys, however, comparing mean intakes to the RDA would tend to overestimate the likely
prevalence of deficiency, as it is a figure set at a level
wheretherequirementsof97.5%ofthepopulationare
being met. This means that a significant proportion
of the population is likely to be exceeding requirement (Kennedy and Meyers, 2005). For example, if
the RDA for iron intake in children is 11.2 mg/day
and the mean intake for a population is found to be
8.4 mg/day, it should not be assumed that deficiency
will have a high prevalence. The majority of children
in the population may be consuming well below the
RDA value and still be achieving requirement. This
could also be seen as a problem with the UK RNI. The
tolerable upper level (UL) term is defined as the highest average daily nutrient intake level that is unlikely
to result in adverse health effects for almost all individuals in a population. Effectively, individuals could
use this as a guide to limit their intake, and at the population level it provides a benchmark against which
estimates can be made of the likelihood of problems
related to overnutrition. The AI term is similar to the
UK Safe Intake in that it is used only where there is
insufficient data to determine the EAR for a particular
nutrient.

In Australia and New Zealand, the system of DRVs
is broadly similar to that used in North America, except a fifth term (EER) is defined for energy. The EER
comprises two separate terms. The estimated energy
requirement for maintenance (EERM) is the energy
intake that is estimated to maintain balance in healthy
individuals or populations at a given level of physical activity and body size. The desirable estimated
energy requirement (DEER) is the level of energy intake that should maintain energy balance in healthy
individuals or populations of a defined gender, age,
weight, height, and level of physical activity, consistent with optimal health. Although complex, this is
an important distinction as the EERM represents an
actual energy requirement of an individual or group
of individuals, while the DEER allows calculation of
energy references that can be used to guide weight loss
in a clinical situation (National Health and Medical
Research Council of Australia, 2006).
In less affluent countries where there is a high burden of malnutrition-related disease, the priorities of
governments are different, and DRVs are set at levels



that are more appropriate for a setting where maintaining and monitoring food security are the main applications of the figures. Often the values used in these
situations are obtained from the FAO, and focus heavily on setting levels of intake that will provide the basic
requirements of most of the population, and therefore
avoid widespread clinical nutrient deficiency.


~~**Summary Box 1**~~


Nutritional balance depends upon the supply of nutrients being
able to meet the physiological and metabolic demand for nutrients
to be used as structural components, or as substrates and cofactors for metabolism. Undernutrition or overnutrition arises through
disturbance of this balance.

Undernutrition can result from either a decrease in intake or

an increase in the demand for nutrients. Increased demands are
often a consequence of physiological insult or stressors, including
trauma, pregnancy, and lactation.
Prolonged undernutrition can lead to micronutrient deficiency
or malnutrition, which are common among infants and women in
developing countries and among the elderly and poor in developed
nations.
Stage of life is one of the most important determinants of
nutritional status, as the nature of demands for nutrients and the
way in which those demands are met undergo profound changes
over the human lifespan.
Nutritional status can be assessed using anthropometric methods, using different methods of measuring intake, through clinical
examination, or by measuring specific biomarkers. All methods are
limited in their scope and are prone to inaccuracy.
DRVs are standards for nutrient intake, which are set by governments. They are widely used as the basis of nutrition-related
advice and interventions. They can be used as research tools, as
guidance for meal planners and caterers, and for the monitoring
of food security at a national level.


**References**


Allison SP (2005) Integrated nutrition. _Proceedings of the Nutrition_
_Society_ **64**, 319–323.
Arenz S, R¨uckerl R, Koletzko B, and von Kries R (2004) Breastfeeding and childhood obesity—a systematic review. _Interna-_
_tional Journal of Obesity_ **28**, 1247–1256.
Bayol SA, Farrington SJ, and Stickland NC (2007) A maternal “junk
food” diet in pregnancy and lactation promotes an exacerbated
taste for “junk food” and a greater propensity for obesity in rat
offspring. _British Journal of Nutrition_ **98**, 843–851.
Bazelmans C, Matthys C, De Henauw S _et al_ . (2007). Predictors of
misreporting in an elderly population: the ‘Quality of life after
65’ study. _Public Health Nutrition_ **10**, 185–191.
Ben-Shlomo Y and Kuh D (2002) A life course approach to chronic
disease epidemiology: conceptual models, empirical challenges
and interdisciplinary perspectives. _International Journal of Epi-_
_demiology_ **31**, 285–293.



**Introduction to Lifespan Nutrition** **21**


Berger SG, de Pee S, Bloem MW, Halati S, and Semba RD (2008)
Malnutrition and morbidity among children not reached by the
national vitamin A capsule programme in urban slum areas of
Indonesia. _Public Health_ **122**, 371–378.
Black RE, Allen LH, Bhutta ZA _et al_ . (2008) Maternal and child
undernutrition study group. Maternal and child undernutrition:
global and regional exposures and health consequences. _Lancet_
**371**, 243–260.
Block G (1989) Human dietary assessment: methods and issues.
_Preventive Medicine_ **18**, 653–660.
Block G, Clifford C, Naughtton MD, Henderson M, and McAdams
M (1989) A brief dietary screen for high fat intake. _Journal of_
_Nutrition Education_ **21**, 199–207.
Cowin I and Emmett P (ALSPAC Study Team) (2000). Diet in a
group of 18-month-old children in South West England, and
comparison with the results of a national survey. _Journal of Hu-_
_man Nutrition and Dietetics_ **13**, 87–100.
Cowin I, Emond A, and Emmett P (ALSPAC Study Group) (2001).
Association between composition of the diet and haemoglobin
and ferritin levels in 18-month-old children. _European Journal of_
_Clinical Nutrition_ **55**, 278–286.
Danforth KN, Tworoger SS, Hecht JL, Rosner BA, Colditz GA, and
Hankinson SE (2007) Breastfeeding and risk of ovarian cancer in
two prospective cohorts. _Cancer Causes and Control_ **18**, 517–523.
Department of Health (1991) _Dietary Reference Values for Energy_
_and Nutrients for the United Kingdom_ . Stationery Office, London.
Department of Health (1999) _Dietary Reference Values for Energy_
_and Nutrients for the United Kingdom_ . Stationery Office, London.
El-Bastawissi AY, Peters R, Sasseen K, Bell T, and Manolopoulos R
(2007) Effect of the Washington Special Supplemental Nutrition
Program for Women, Infants and Children (WIC) on pregnancy
outcomes. _Maternal and Child Health Journal_ **11**, 611–621.
Faber M, Phungula MA, Venter SL, Dhansay MA, and Benad´e AJ
(2002) Home gardens focusing on the production of yellow and
dark-green leafy vegetables increase the serum retinol concentrations of 2–5-y-old children in South Africa. _American Journal_
_of Clinical Nutrition_ **76**, 1048–1054.
FrobisherCandMaxwellSM(2003)Theestimationoffoodportion
sizes: a comparison between using descriptions of portion sizes
and a photographic food atlas by children and adults. _Journal of_
_Human Nutrition and Dietetics_ **16**, 181–188.
Godfrey K, Robinson S, Barker DJ, Osmond C, and Cox V (1996)
Maternal nutrition in early and late pregnancy in relation to
placental and fetal growth. _British Medical Journal_ **312**, 410–414.
Gregory JR, Collins DL, Davies PSW, Hughes JM, and Clarke PM
(1995) _National Diet and Nutrition Survey: Children Aged 1 1/2_
_to 4 1/2 Years_ . _Volume 1: Report of the Diet and Nutrition Survey_ .
HMSO, London.
Grimble RF (2001) Stress proteins in disease: metabolism on a knife
edge. _Clinical Nutrition_ **20**, 469–476.
Hassan MA and Killick SR (2004) Negative lifestyle is associated
with a significant reduction in fecundity. _Fertility and Sterility_
**81**, 384–392.
Henderson L, Gregory J, Swan G, and Ruston D (2002) _The National_
_Diet & Nutrition Survey: Adults Aged 19 to 64 Years_ . HMSO,
London.
Kardinaal AF, Kok FJ, Ringstad J _et al_ . (1993) Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC
Study. _Lancet_ **342**, 1379–1384.
Kennedy E and Meyers L (2005) Dietary reference intakes: development and uses for assessment of micronutrient status of women–
a global perspective. _American Journal of Clinical Nutrition_ **81**,
1194S–1197S.
King JC (1990) Assessment of zinc status. _Journal of Nutrition_
**120** (Suppl. 11), 1474–1479.



**22** **Nutrition: A Lifespan Approach**


Koebnick C, Wagner K, Thielecke F _et al_ . (2005) An easy-to-use
semiquantitative food record validated for energy intake by using
doubly labelled water technique. _European Journal of Clinical_
_Nutrition_ **59**, 989–995.
Langley-Evans SC (2006) Developmental programming of health
and disease. _Proceedings of the Nutrition Society_ **65**, 97–105.
Lenz A, Franklin GA, and Cheadle WG (2007) Systemic inflammation after trauma. _Injury_ **38**, 1336–1345.
Lonn E, Yusuf S, Arnold MJ _et al_ . (Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators) (2006) . Homocysteine lowering
with folic acid and B vitamins in vascular disease. _New England_
_Journal of Medicine_ **354**, 1567–1577.
Maberly GF, Haxton DP, and van Der Haar F (2003) Iodine deficiency: consequences and progress toward elimination. _Food and_
_Nutrition Bulletin_ **24** (Suppl. 4), S91–S98.
Martinez-Frias ML and Salvador J (1990) Epidemiological aspects
of prenatal exposure to high doses of vitamin A in Spain. _Euro-_
_pean Journal of Epidemiology_ **6**, 118–123.
Mayer JE (2007) Delivering golden rice to developing countries.
_Journal of AOAC International_ **90**, 1445–1449.
Millward DJ, Fereday A, Gibson N, and Pacy PJ (1997) Aging,
protein requirements, and protein turnover. _American Journal of_
_Clinical Nutrition_ **66**, 774–786.
MRC Vitamin Study Group (1991) Prevention of neural tube
defects: results of the Medical Research Council Vitamin
Study. MRC Vitamin Study Research Group. _Lancet_ **338**, 131–
137.
National Health and Medical Research Council of Australia (2006)
Nutrient Reference Values for Australia and New Zealand.
http://www.nrv.gov.au/Energy.aspx. Last accessed February 18,
2008.
Neidecker-Gonzales O, Nestel P, and Bouis H (2007) Estimating the
global costs of vitamin A capsule supplementation: a review of
the literature. _Food and Nutrition Bulletin_ **28**, 307–316.


**Self-Assessment Questions**


Assess your understanding of the concepts outlined in
this chapter using the following questions:


1 Explain why requirements for energy and protein increase following physical trauma.
2 Describe the main causes of malnutrition.

3 What is meant by the term nutritional status? How can
it be assessed in individuals?



Pavlovic M, Prentice A, Thorsdottir I, Wolfram G, and Branca F
(2007) Challenges in harmonizing energy and nutrient recommendations in Europe. _Annals of Nutrition and Metabolism_ **51**,
108–114.
Richardson RA and Davidson HI (2003) Nutritional demands in
acute and chronic illness. _Proceedings of the Nutrition Society_ **62**,
777–781.
Ritchie LD, Fung EB, Halloran BP _et al_ . (1998) A longitudinal study
of calcium homeostasis during human pregnancy and lactation
and after resumption of menses. _American Journal of Clinical_
_Nutrition_ **67**, 693–701.
Rivlin RS (2007) Keeping the young-elderly healthy: is it too late
to improve our health through nutrition? _American Journal of_
_Clinical Nutrition_ **86**, 1572S–1576S.
Romijn JA (2000) Substrate metabolism in the metabolic response
to injury. _Proceedings of the Nutrition Society_ **59**, 447–449.
Sarojini G, Nirmala G, and Geetha R (1999) Introduction of red
palm oil into the “ready to eat” used supplementary feeding
programme through ICDS. _Indian Journal of Public Health_ **43**,
125–131.
Sebotsa ML, Dannhauser A, Jooste PL, and Joubert G (2005) Iodine
status as determined by urinary iodine excretion in Lesotho two
years after introducing legislation on universal salt iodization.
_Nutrition_ **21**, 20–24.
Seshadri S (2001) Prevalence of micronutrient deficiency particularly of iron, zinc and folic acid in pregnant women in South East
Asia. _British Journal of Nutrition_ **85** (Suppl. 2), S87–S92.
West KP (2003) Vitamin A deficiency disorders in children and
women. _Food and Nutrition Bulletin_ **24** (Suppl. 4), S78–S90.
Whitehead RG (1992) Dietary reference values. _Proceedings of the_
_Nutrition Society_ **51**, 29–34.
Zagr´e NM, Delpeuch F, Traissac P, and Delisle H (2003) Red palm
oil as a source of vitamin A for mothers and children: impact of a
pilot project in Burkina Faso. _Public Health Nutrition_ **6**, 733–742.


4 What are the main advantages and disadvantages of
methods used to assess nutrient intakes in populations?
5 Describe the systems of DRVs currently used in the UK
and the US.

6 Discuss how DRVs are intended to be interpreted and
explain how they are used in practice.



# **2**
### **Before Life Begins**

**Learning objectives**


By the end of this chapter the reader should be able

to:


r Describe how trends in modern healthcare have made it
both possible and desirable to change diet and lifestyle
in preparation for pregnancy.
r Show an understanding of the endocrine control of
both female and male reproductive function.
r Discuss the contribution of body fatness to initiation
and maintenance of normal reproductive cycling in

women.


**2.1 Introduction**


The twentieth century saw a profound change in the
manner in which human reproductive health and
function was managed. Medicalization of the process
of childbirth and the management of pregnancy, while
not necessarily popular with those going through the
process, transformed human reproduction. In the
early part of the century death rates among newborn infants were as high as 150–200 per 1000 births,
and pregnancy related complications were the major
cause of death among young women, with death rates
of 5–6 per 1000 births (Office for National Statistics, 1997). Improved medical care, hygiene, diet, and
housing conditions have brought death rates among
infants down to 4–6 per 1000 births, and maternal
deaths are now very rare events (less than 0.1 per 1000
births).
These changes have also transformed the priorities
forresearchersandhealthprofessionalsworkinginthe
field of human reproduction. With less emphasis on
the avoidance of catastrophic pregnancy outcomes, it
is now of prime importance to promote good health
in pregnant women and to ensure achievement of
the optimal maternal environment for the development of the baby. In terms of nutrition, it is becoming



r Critically review the evidence that commonly consumed
agents such as alcohol and caffeine may have an adverse effect on female fertility.
r Discuss the possible contribution of antioxidant nutrients to optimal fertility in men and women.
~~r~~ Show understanding of dietary factors and nonnutrient
components of food that may have an adverse impact
on male fertility.
r Describe the importance of reducing intake of vitamin
A and increasing intake of folic acid, for reducing risk
of embryonic malformation in the earliest stages of

pregnancy.


clear that many of the important changes that women
should consider making to their diets need to be implemented before conception. In most western countries, the majority (60%) of pregnancies are planned
and this allows scope for optimizing nutrition. Attaining optimal body weights, avoiding potentially harmful substances, and increasing intakes of nutrients that
are of greatest importance to fetal development are all
most effective when achieved while planning a preg
nancy.
Nutrition may also be of major importance in
achieving conception for many couples. Nutritional
status, and in particular female body fatness plays a
role in determining fertility. This chapter will primarily set out the key nutrition-related issues that impact
upon the ability of men and women to conceive a
child. Infertility, which is also termed subfecundity, is
defined as a failure to conceive within 12 months of
unprotected sexual intercourse with the same partner.
Infertility rates are rising across all westernized countries, as evidenced by a 14% rise in the number of
fertility treatment (e.g., in vitro fertilization) procedures carried out in Europe between 1998 and 2001.
Estimates of infertility rates suggest that around 9–
10% of the adult population may have problems and
15% of couples will experience subfecundity.



**24** **Nutrition: A Lifespan Approach**


Consistent with the changing priorities in relation
to how reproduction is managed in developed countries, the chapter will also consider the dietary changes
that women should consider ahead of conception in
ordertooptimizetheirnutrientreservesforpregnancy
and minimize the likelihood of embryonic exposure
to harmful agents in the first few weeks of life.


**2.2 Nutrition and female fertility**


_**2.2.1 Determinants of fertility**_
_**and infertility**_


Female fertility is primarily determined by factors that
are seemingly unrelated to nutritional status. Whereas
men generally retain some degree of fertility throughout their adult lives, women have a fixed reproductive
span that runs from menarche (the onset of reproductive cycling) to menopause (when reproductive
cycling ends). Infertility or subfertility in women can
arise due to problems with the endocrine regulation of
reproductive system function, or due to other medical
conditions that impair reproductive capacity. These
medical conditions include infections of the reproductive tract, ovarian disease, trauma to the reproductive organs, endometriosis, and polycystic ovary
syndrome. Although these reproductive events appear
to be determined by age and ill health, it is becoming
clear that nutritional status can have some impact on
the timing of menarche, and hence duration of reproductive span, and upon the maintenance of normal
reproductive cycling.


**2.2.1.1 The endocrine control of**

**female reproduction**
The endocrine regulation of female reproductive
function is extremely complex and this text will attempt to give only a simple overview. Within the
ovaries, women have primary follicles containing immature oocytes, which are present from the time of
birth. The hormones involved in the regulation of the
menstrual cycle function to facilitate the maturation
of a small number of these oocytes, the release of a single mature ovum in each cycle, and the preparation
of the uterine lining for the implantation of a fertilized egg. The menstrual cycle comprises two distinct
phases, with follicle and egg maturation occurring in
the follicular phase. After ovulation, the cycle enters



the luteal phase, in which the corpus luteum (remnant
of the follicle which released the mature ovum at ovu
lation), acts as the main controller of the uterine environment. It can either promote the maintenance of a
suitable environment for implantation or pregnancy,
or in the absence of fertilization, it can degenerate and
promote the sloughing of the uterine lining and hence
menstrual bleeding.
The endocrine factors that regulate the menstrual
cycle are shown in Figure 2.1. The hypothalamus is the
central integrator of the cycle, acting through production of gonadotropin-releasing hormone (GnRH).
This stimulates the production of two hormones from
the anterior pituitary. Follicle-stimulating hormone
(FSH) acts on the ovaries to stimulate the maturation
of the follicles and to drive the production of estrogens. Estrogens also stimulate follicular development
and act upon the uterus to build up the endometrial
lining. During the follicular phase, estrogen concentrations tend to be low, but this is still sufficient to
lower production of FSH from the anterior pituitary
and GnRH from the hypothalamus, through a negative feedback mechanism. The other anterior pituitary
hormone produced in response to GnRH secretion is
luteinizing hormone (LH). The ovaries are a target for
LH where, like FSH, it stimulates follicular development. The ovaries also produce the hormone inhibin
in response to LH and this selectively inhibits the secretion of FSH (Figure 2.1). This, together with the
effectsofestrogen,meansthatLHconcentrationstend
to rise toward the mid point in the cycle, while FSH
concentrations tend to fall.
While effects of estrogen upon the hypothalamus
and anterior pituitary involve negative feedback, estrogens exert positive feedback effects on the ovaries
to generate more estrogen (Figure 2.1). This means
that by the mid point in the menstrual cycle, estrogen concentrations spike dramatically. Rising levels
of estrogens have a paradoxical effect upon the hypothalamus and anterior pituitary and now start to
_stimulate_ secretion of LH and to a lesser extent FSH.

The resultant surge in LH is the trigger for ovulation.
The mature follicle ruptures and releases the ovum.
At the same time, the corpus luteum is formed and
the cycle now enters the luteal phase.
During the luteal phase the key anterior pituitary
factor is LH, which stimulates the corpus luteum to
produce initially low levels of estrogen and progesterone. The concentrations of these sex steroids rise



**Before Life Begins** **25**


**Luteal phase**



**Follicular Phase**































Feedback effects of

oestrogens inhibited
by progesterone.
Negative feedback
by progesterone
only in late luteal
phase









**Figure 2.1** The endocrine control of female reproductive function. The menstrual cycle lasts for an average of 28 days. This can be divided into a
distinct follicular phase (days 1–13) during which estrogen, LH, and FSH stimulate follicular development. Ovulation driven by high concentrations
of LH and estrogen occurs on day 14. The luteal phase (days 15–28) is driven by hormone production from the corpus luteum, which produces high
concentrations of progesterone and estrogen to prepare the uterine lining for implantation of a fertilized embryo. In the absence of fertilization,
feedback inhibition of progesterone promotes the degeneration of the corpus luteum and menstrual bleeding.



gradually, and progesterone in particular reaches a
very high concentration. This inhibits the further production of GnRH and hence LH and FSH, and thereby
prevents the maturation of further follicles should a
pregnancy occur (Figure 2.1). If there is no pregnancy,
the corpus luteum degenerates as LH is no longer produced to maintain it, and hence production of progesterone and estrogen ends.


**2.2.1.2 Disordered reproductive cycling**
Disordered menstrual cycling can arise for a number
of reasons. Stress, excessive or intense exercise, smoking, ovarian or uterine disease, use of certain medications and treatments such as chemotherapy, drug
abuse, illness, and emotional traumas have all been
showntoimpactuponhypothalamicandovarianproduction of hormones. Any problems with secretion of
LH, FSH, or estrogens will impact upon the normal
reproductive cycle, with several possible outcomes. In
some women, menstrual cycles cease entirely (amenorrhea), or the cycle may become excessively long,
perhaps lasting for 45–90 days instead of the usual 28



(oligorrhea). If there is insufficient production of LH
or estrogen, then there may be an absence of ovulation
(anovulation). As will become clear in later sections,
poor nutritional status is a major cause of menstrual
cycle disorders and hence an important factor in unexplained (idiopathic) infertility in women.


**2.2.1.3 Polycystic ovary syndrome**
Polycystic ovary syndrome (PCOS) is one of the more
common medical causes of female subfertility and
infertility. Women with PCOS develop clusters of immature follicles within the ovaries, all of which fail to
develop and eventually form fluid-filled cysts. Generally women with PCOS will either be anovulatory or
will have infrequent periods and oligorrhea. One of
the features of the syndrome is the production of high
concentrations of male sex hormones (androgens),
which can often manifest physically as excess facial or
chest hair growth (hirsutism), loss of head hair, and
acne. In addition to producing abnormally high levels
of testosterone women with PCOS generally overproduce LH.



**26** **Nutrition: A Lifespan Approach**


Obesity, and therefore nutritional status, is a major
determinant of risk of PCOS, although it has also been
related to a family history of the condition. There is a
high prevalence of obesity among women with PCOS
(Pasquali _et al._, 2006) and abdominal fat deposition
appears to confer particularly high risk. Women with
central obesity of this nature tend to develop insulin
resistance, which is characterized by excessively high
levels of circulating insulin. Insulin inhibits synthesis of sex hormone binding globulin in the liver. This
protein plays a key role in controlling the access of sex
hormones to their target tissues and in the absence of
sex hormone binding globulin, concentrations of free
androgens rise. Obesity also favors increased synthesis of androgens and other mechanisms operating in
adipose tissue serve to drive hyperandrogenaemia.
Weight loss in women with PCOS is effective in
restoring normal endocrine functions and reproductive cycling. Pasquali _et al._ (2006) reported that a
12-month period of dieting to promote significant
weight loss in women with PCOS, significantly improved symptoms (partial restoration of menstrual
cycles, reduction in hirsutism) and that these changes
were associated with markedly lower circulating insulin concentrations, improved insulin sensitivity,
and lower testosterone concentrations. Clark and colleagues (1998) reported that moderate improvements
in body mass index (BMI) associated with a lifestyle
intervention program (exercise and dietary change)
for anovulatory, obese women (mostly with PCOS),
produced dramatic improvements in reproductive
health. Weight loss of approximately 6 kg resulted in
90% of women returning to normal ovulatory status,
with 77% becoming pregnant within 6 months.
Several studies have examined the optimal weight
loss strategy for treatment of PCOS, and have concluded that high-protein, low-carbohydrate diets may
be most effective. High-protein diets promote satiety and therefore reduce overall energy intake and,
importantly, produce less variation in insulin secretion after a meal. Galletly and colleagues (2007) reported that these diets produce positive psychological
effects in women with PCOS and improve compliance
with lifestyle change. Marsh and Brand-Miller (2005),
however, suggest that high protein diets may actually
worsen insulin resistance and are no more effective
than high-carbohydrate diets in promoting improvement of reproductive functions through weight loss.
A review of available evidence suggests that a low-fat



dietrichincomplexcarbohydratesmaybethemosteffective strategy for promoting weight loss, combating
insulin resistance, and improving PCOS symptoms.


**2.2.1.4 Assisted reproductive technologies**
InfertilityisestimatedtoaffectuptoaquarterofEuropeanwomenatsomestageoftheirlives.Inaroundhalf
of these cases the cause is unknown and most of these
women will seek assistance in becoming pregnant. A
number of assisted reproductive technologies help to
overcome fertility problems in both men and women.
Some of these involve fertilization of the egg outside
the uterus, for example assisted hatching, in vitro fertilization (IVF), and intracytoplasmic sperm injection
(ICSI). The outcome of these techniques may be influenced by nutritional factors, partly because nutrients
in the culture media used during fertilization need to
be present in optimal concentrations, but also because
nutritional status will influence the processes through
which eggs are collected from the woman. This will
typically involve the induction of superovulation using drugs such as synthetic gonadotropins.


_**2.2.2 Importance of body fat**_


Body fatness is a major factor determining the span
of reproductive life in women, and as illustrated by
the example of PCOS, determines some of the risk of
developing menstrual cycle disturbances. It was noted
several decades ago that young women who partake
in high-intensity sport or dance activities tend to exhibit delayed menarche and will later be at greater
risk of amenorrhea or anovulation. Amenorrhea is

also observed in women who are excessively thin, or
who undergo extreme weight loss, either as a result of
eating disorders (e.g., anorexia nervosa) or through
other restrictive dietary practices. Weight loss equivalent to around 10–15% of normal weight for height in
women is associated with menstrual cycle abnormalities. Obesity is also associated with amenorrhea. Together these observations suggest that both too much
and too little body fat can have an adverse impact on
female fertility (Frisch, 1987).
Young women at the present time are significantly
taller and heavier than their counterparts in earlier
centuries, and with this change in growth they are
attaining greater proportions of body fat at earlier
ages. This secular trend is associated with a trend for
menarche to occur at an earlier age. In the nineteenth
century, the average age for first menses was between



17 and 18 years old. By the 1920s this had declined
to 14 years and by the 1990s was between 12 and 13
years. Over the last century, average age at menarche
decreased by 3–4 months in every decade. As children
become fatter in westernized societies the prevalence
of very early menarche is increasing, and it is now
not uncommon for girls as young as 8 years to enter
puberty. Adair and Gordon-Larsen (2001) studied a
population of US teenagers and found that the odds
of early maturation (defined as first menses before age
11) was twice as likely in girls who were overweight.
Girls maturing early tended to be shorter and around
3.8 kg heavier than those entering puberty at a later

age.
The growth spurt during adolescence is obviously
associated with a significant increase in both height
and weight, but is also a time when body composition
undergoes major changes. In girls there is a relative
increase in proportions of body fat, which increases
from around 5 kg in total to 11 kg. Lean body mass
increases to a much lesser extent. Frisch _et al._ (1973)
studied adolescent girls and found that on attainment
of stable reproductive cycling all had approximately
22% body fat, regardless of their absolute height or
weight. These studies identified this proportion of
body fat as being the minimum required to maintain
stablemenstrualcycling,andhencewomenrestricting
diet to promote weight loss and women engaged in intense physical activity develop amenorrhea and other
cycle problems as they fall below this fat threshold.
There is a difference between menarche and attainment of stable and regular cycles, and the minimum
threshold of body fat required to trigger menarche is
lower, at 17% of body weight (Frisch, 1987).
There are therefore minimal levels of body fat required to support reproductive function in women.
It is easy to see how such a system has evolved in
humans. Body fat is essentially a store of metabolizable energy and provides a metabolic indicator of the
nutritional environment and fitness of a woman to
support a pregnancy and later breast-feed an infant.
Mechanisms that prevent conception during times of
famine would have been a considerable survival advantage to early humans. Allal _et al._ (2004) showed
that in developing countries such as the Gambia, delayed reproductive maturity and hence a later first
pregnancy allows women to grow to a greater height.
Greater maternal stature is associated with reduced

infant death.



**Before Life Begins** **27**


_**2.2.3 Role of leptin**_


There is a simple hormonal signal that links the body
fatness of women to the hypothalamic–pituitary–
ovarianaxisthatultimatelygovernstheirfertility.Leptin is one of a group of peptide hormones, termed
adipokines, produced from adipose tissue. Other
adipokines, including resistin and adiponectin have
been suggested, on the basis of animal studies, to play
a role in controlling fertility, but there is no firm evidenceofthisinhumans(Mitchell _etal._,2005).Therole
of leptin is firmly established. Leptin is the product of
the _ob_ gene, which is only expressed in adipose tissue.
As a result, plasma concentrations of leptin are closely
correlated with the overall level of body fat. Leptin is
a satiety hormone, which acts at the hypothalamus
to suppress appetite and increase energy expenditure
through thermogenesis. Satiety effects are mediated
indirectly as leptin, within the arcuate nucleus of the
hypothalamus, stimulates release of further satiety inducingpeptides,includingneuropeptideY(NPY)and
agouti-related peptide (AGRP).
The first clues for a role of leptin in controlling fertility came from studies of a range of genetically obese
rodents. The _ob/ob_ mouse produces a defective leptin
that is unable to bind the leptin receptors, while the
_db/db_ mouse and _fa/fa_ rat have defective receptors,
which do not fully mediate the effects of leptin on
binding. All of these rodent strains exhibit problems
with fertility. The female _ob/ob_ mouse is totally infertile as it never achieves puberty and cannot produce
mature follicles. These mice have abnormal levels of

FSH and GnRH in circulation. Similarly, the female
_fa/fa_ rat is rarely fertile, having a suppressed LH surge
and lower FSH secretion, preventing normal ovulation.

In humans, changes in leptin concentrations occur around the time of puberty, but only in girls. As a
result, womenhave higherleptinconcentrations (normal range 5–20 ng/mL) than are seen in men, at all
ages. This reflects their higher proportions of body fat
at any given weight or height. Leptin concentrations
in women also vary according to stage of the menstrual cycle (Goumenou _et al._, 2003), which suggests
that there are relationships between leptin secretion
and the reproductive hormones. Sustaining normal
ovulatory cycles depends on a minimum level of leptin (approximately 3 ng/mL) and women who are
anovulatory have lower concentrations than women



**28** **Nutrition: A Lifespan Approach**


**LEPTIN**


**Adipose**
**tissue**



Oestrogen













FSH LH





**Figure 2.2** Adipose tissue derived leptin and the
hypothalamic–pituitary–ovarian axis. Leptin from adipose tissue promotes production of GnRH, FSH, and
LH and therefore has a stimulatory effect on the
hypothalamic–pituitary–ovarian axis.


tin stimulates phosphorylation of STAT3 and hence
gene transcription to mediate cellular responses. Leptin resistance involves impairment of both Ob-Ra and
Ob-Rb function (El-Haschimi _et al._, 2000). Impaired
Ob-Ra function is poorly understood, but clearly reducestheamountofleptinreachingtargetsites.Leptin
up-regulates expression of SOCS3 (suppressor of the
cytokinesignaling-3),whichisaninhibitoroftheJAKSTAT3 pathway. Thus, the very high concentrations of
leptin associated with obesity will suppress leptin action in the hypothalamus and remove the stimulatory
effectofthehormoneonthehypothalamic–pituitary–
ovarian axis, leading to disordered reproductive cycling. The _fa/fa_ rat, which has leptin receptor defects,
provides an analogy to the obese woman, and their
reproductive cycle defects are similar.


_**2.2.4 Antioxidant nutrients**_


A free radical is any molecule that has unpaired electrons and, as such, these molecules are highly reactive
and short lived. Free radicals and associated oxidants

formed from oxygen within biological systems are
termed reactive oxygen species (ROS). These include
the superoxide (O 2 [·−] ) and hydroxyl (OH [·] ) radicals,
hydrogen peroxide, nitric oxide (NO), and lipid hydroperoxides (Halliwell, 1999). As will be seen in later
chapters, the reactive nature of ROS gives them the capacity to cause widespread cellular and tissue damage
that is associated with the development and progression of many disease states. Exposure to ROS is an unavoidable feature of life in oxygen, as they are mainly
formed as a by-product of mitochondrial respiration.



with normal cycles, while amenorrheic women have
still lower concentrations. Leptin also explains the relationship between body fatness and age at menarche,
as a threshold of 12 ng/mL leptin is required to initiate
cycling.
Figure 2.2 shows how leptin influences the
hypothalamic–pituitary–ovarian axis. Leptin receptors are present in key nuclei of the hypothalamus
and in the anterior pituitary and it therefore directly
influences the secretion of GnRH, LH, and FSH. In
the absence of leptin, the normal pulsatile secretion
of all of these factors is lost (Goumenou _et al._, 2003).
The _ob/ob_ mouse, lacking leptin, is analogous to the
excessively thin woman and both will have fertility
problems for the same reasons.
Given the stimulatory role of leptin upon the reproductive axis, the negative effects of excess body
fat appear to be paradoxical. Obese individuals typically exhibit very high concentrations of leptin. The
explanation for the negative effect on fertility is provided by the concept of leptin resistance. The effects
of leptin within the brain are mediated through its
binding to two different forms of the leptin receptor. The short-form receptor, Ob-Ra, has a transport role and carries leptin across the blood–brain
barrier, thereby providing access to the hypothalamic tissues. The long-form Ob-Rb receptor, is membrane bound and mediates the physiological effects
of leptin via several signal transduction mechanisms,
as shown in Figure 2.3. One of these mechanisms is
the Janus kinase (JAK)-STAT3 (signal transducer and
activator of transcription 3) pathway. Binding of lep


**Before Life Begins** **29**



























**Figure 2.3** Leptin receptor signaling cascade. Binding of leptin to the membrane bound Ob-Rb receptor activates multiple signaling pathways,
including the phosphoinositol 3 kinase (PI3K) pathway and the RAS-MAP kinase pathway. Binding of leptin activates JAK2, which phosphorylates
STAT3. Formation of phosphorylated STAT3 complexes drives activation of transcription of target genes including NPY and AgRP. Leptin resistance
develops through leptin up-regulation of the expression of suppressor of the cytokine signaling-3 (SOCS3), which inhibits the JAK2-STAT3 pathway.



Other important sources of ROS in biological systems are shown in Table 2.1. ROS have the capacity
to damage all components of cells, as they will react
with all types of macromolecules. Thus, they damage
proteins (e.g., protein–protein cross-linking), nucleic
acids (e.g., DNA strand scission), and phospholipids
in membranes (lipid peroxidation).
Life in oxygen is only possible due to the presence
of antioxidant species that have the capacity to neutralize ROS (Table 2.1). Most aspects of antioxidant
protection are to some extent influenced by the diet
and nutritional status. The antioxidant enzymes gen

**Table 2.1** Reactive oxygen species and antioxidants in biological systems



erally have metal ions at their active sites (e.g., CuZn
superoxide dismutase), and scavenging antioxidants
such as ascorbate, ß-carotene, and vitamin E are all
obtained directly through the diet. These scavenging
species must be constantly replenished as interaction
with ROS leads to their destruction.
The balance of antioxidants and ROS may play a
role in determining female fertility in a number of
different ways. The key issues relate to the role of ROS
in determining normal menstrual cycling and the environment in which sperm and ova interact, leading to
fertilization. Normal reproductive function in women



Reactive oxygen Ion-binding
species Free radicals Nonradicals Antioxidants Enzymes Scavengers proteins


Superoxide, O 2 [·−] Hydrogen peroxide H 2 O 2 Superoxide dismutase Ascorbate Albumin
Hydroxyl radical, OH [·] Ozone O 3 Catalase Polyphenols Ferritin
Peroxyl radical, RO [·] 2 Hypochlorous acid HOCl Glutathione peroxidase α-tocopherol Transferrin
Alkoxyl radica,l RO [·] Hypobromous acid HOBr ß-carotene Caeruloplasmin
Nitric oxide, NO Lutein


Note: Reactive oxygen species are either generated endogenously through processes such as respiration and the respiratory
burst of immune cells, or can be derived from exogenous sources (pollutants, drugs, food contaminants). Enzymatic
antioxidants are present in most cells and some forms occur in circulation. Scavenging antioxidants are generally derived
from the diet and are found in body fluids and the cytosol of most cells. Ion-binding proteins are transport proteins that
provide antioxidant protection by removing free iron and copper ions, which can generate free radical species when they
react with oxygen.



**30** **Nutrition: A Lifespan Approach**


isactuallydependentuponthepresenceofROSwithin
the ovary and in particular, within follicular fluid
(Ebisch _et al._, 2007). ROS appear to be essential in
allowing only one follicle to mature within each cycle,
while many more undergo regression. Although generally perceived as damaging, the ROS are therefore
required to drive normal ovulation. Studies of women
with endometriosis, in which the tissue that normally
lines the uterus (endometrium) grows in other areas
of the body, causing pain and irregular bleeding, show
that they may produce excess amounts of ROS. Agarwal _et al._ (2005) suggest that NO may be of major
importance in the development of this condition.
While ROS appear to be favorable for production
of mature ova, beyond the point of ovulation, high
antioxidant concentrations appear to be important to
ensure a suitable environment for fertilization. Studies from assisted reproduction indicate that embryos
in culture that are of poor quality are generally associated with lower antioxidant concentrations in the
culture medium. High levels of ROS have been shown
tolowerthesuccessratesinICSI(Agarwal _etal._,2005).
Most IVF media now generally contain antioxidants,
including catalase and albumin.
The major antioxidant found in the ovary is ascorbate (vitamin C). Ascorbate has a number of key roles,
including promoting the synthesis of sex steroids,
involvement in the synthesis of collagen for follicle
growth, and corpus luteum development. Ascorbate
also protects the ovarian tissues and follicles from
ROS-mediated damage, ensuring that the stimulatory
effects of ROS are kept under control. Concentrations of ascorbate fluctuate during the menstrual cycle
(Luck _et al_ ., 1995) and are at their lowest around the
time of ovulation, when ROS levels peak.
While excess antioxidants within the ovary might
suppress follicular development, there is evidence to
suggest that antioxidants are beneficial in achieving
fertilization, embryo implantation, and pregnancy.
This is presumably because ROS are toxic to sperm
and early embryos. Genitourinary tract infections in
women are one cause of infertility and will generally be associated with increased ROS release from
neutrophils and macrophages of the immune system.
High levels of NO are noted in the fallopian tubes of
women with such infections (Agarwal _et al_ ., 2005).
Polak and colleagues (2001) considered the potential
of ROS to prevent sperm from fertilizing eggs in the
fallopian tubes. They measured total antioxidant ca


pacity in peritoneal fluid (a proxy for the environment
in the fallopian tubes) from normal fertile women,
women with endometriosis, women with blocked fallopian tubes, and women with idiopathic infertility.
This final group exhibited the lowest levels of antioxidant protection, consistent with the hypothesis that
ROS can kill or damage sperm before it reaches the

egg.
These findings raise the possibility that for some infertile or subfertile women antioxidant therapy may
be a means of improving fertility. Unfortunately, there
are very few studies that have evaluated this, using
robust methods. Henmi _et al_ . (2003) carried out a
randomized-controlled trial of over 300 women, using 750 mg/day ascorbate. All women recruited to the
trial suffered from luteal phase cycle abnormalities,
and the ascorbate supplement significantly improved
their endocrine markers. Most importantly, while
only 10.9% of placebo-treated women became pregnant, pregnancy occurred in 25% of the ascorbatetreated group. Westphal and colleagues (2006) have
performed small-scale trials of a nutritional supplement containing antioxidants. This combined iron,
zinc, selenium, and arginine supplement was shown
in a randomized-control trial of subfecund women,
to boost pregnancy rates from 10% in placebo-treated
women, up to 26%. Ascorbate appears to be the most
promising antioxidant nutrient in treatment of female infertility, however, and supplementing women
with ascorbate while undergoing IVF therapy may be
of benefit as the vitamin appears to boost the effectiveness of drugs that promote superovulation (Luck
_et al_ ., 1995).


_**2.2.5 Caffeine and alcohol**_


In many parts of the world, it is part of the normal culture to consume alcohol and or caffeine in the form of
beverages. These widely consumed agents are known
to be highly active substances that are capable of exerting toxic effects at high levels, and major metabolic
and physiological responses at low to moderate levels
of consumption. Both alcohol and caffeine consumption have been linked to problems with female fertility
and indeed may interact with each other in lowering
the chances of conception. The impact of alcohol is
explained in Research highlight 2.
Caffeineispharmacologicallyactive,actingasacentral nervous system stimulant. It is consumed in a variety of forms, principally tea and coffee but also as an



**Before Life Begins** **31**



~~**Research Highlight 2**~~ ~~Complex relationship between alcohol and fertility in women~~



The consumption of alcohol has been widely reported to impair
fertility in women. A standard unit of alcohol in a beverage is approximately 12 g of ethanol, which equates to a small measure of
spirits, or a half pint of beer. Studies that consider the relationship
between alcohol consumption and fertility tend to be cross-sectional
cohort studies that examine the impact of consumption on fertility
endpoints in a large group of women. In this way, it is possible to
determine _odds ratios_ as an indicator of infertility risk. This can be
examined as a dose–response relationship, comparing risk against
units of alcohol consumption.
Odds ratios (OR) are an estimate of the risk of an adverse health
event happening. If OR is less than one this indicates decreased
risk, while OR greater than one indicates increased risk. The OR is
generally shown along with the 95% confidence intervals (CI), for
example, 1.4 (95% CI, 1.2–2.4). If the CI cross over the 1.0 value
then this suggests the effect is not statistically significant. So, for
example OR of 0.83 (95% CI, 0.6–0.9) suggests a significant 17%
(1.00–0.83 = 0.17) reduction in risk, whereas OR of 0.83 (95% CI,
0.6–1.2) suggests no significant effect. OR are widely reported in
nutritional epidemiology and similar terms such as _relative risk_ or
_hazard ratio_ may also be seen.
Most reports suggest that alcohol consumption increases risk of infertility as reviewed by Barbieri (2001). Moderate alcohol consumption
(4–7 units per week) was noted by Grodstein _et al_ . (1994) to increase risk of ovulatory infertility, OR 1.3 (95% CI, 1.0–1.7) and of
endometriosis, OR 1.6 (95% CI, 1.1–2.3). However, not all studies


additive to soft drinks and in some over-the-counter

medicines.Severalanimalstudieshaveshownthatcaf
feine can have adverse reproductive effects and that it
is potentially hazardous to the early embryo. However,
in humans it is more difficult to interpret the findings
of studies that relate caffeine intake to reproductive
function, and to develop a credible explanation of
how it could reduce fertility. Certainly caffeine can
deplete the body of certain micronutrients through
either inhibition of absorption (e.g., iron and zinc), or
through increasing losses (e.g., calcium and thiamin),
but these nutrients have no clear role in determining
female fertility.
First concerns over caffeine and female fertility
arose when Olsen (1991) reported that subfecundity
was associated with very high intakes (8 or more cups
per day) of coffee. However, this negative effect on
fertility (OR 1.35, 95% CI 1.02–1.48) was noted only
for women who also smoked. The study has been criticized on the basis that it took no account of reproductive disorders, or key factors such as the frequency
of sexual intercourse, which would clearly determine



back up this viewpoint. Hassan and Killick (2004) reported that while
heavy alcohol consumption by males ( _>_ 20 units per week) increased
the risk that a couple would be subfecund, OR 2.2 (95% CI, 1.1–4.4),
alcohol intake of women had no impact on the outcome.
One explanation for this discrepancy may be that alcohol is consumed
in different forms and in the process may deliver other compounds,
including antioxidant flavonoids found in red wine, that might also
influence fertility. Juhl and colleagues (2003) studied a cohort of
39 612 women, comprising 35% of all pregnant women in Denmark
at the time of the study, and evaluated the impact of alcohol from
different sources on the time taken to conceive a child after cessation of contraception. The consumption of beer by women had
no effect on risk of delayed conception (more than 12 months to
conceive). Wine at all levels of intake resulted in a shorter time to
conception and reduced risk of delayed conception, OR 0.71 (95%
CI, 0.58–0.88). Spirits at moderate intakes (2–7 units per week) also
reduced risk of delayed conception, OR 0.56 (95% CI, 0.41–0.77),
but at higher intakes impaired fertility, OR 2.40 (95% CI, 1.00–5.73).
Although allowance was made in this study for confounding factors,
the authors could not exclude the possibility that these findings reflect other characteristics of the women. Wine drinkers tend to also
consume a more balanced diet of healthier foods. The relationship
between alcohol consumption and fertility in women is therefore
highly complex and is strongly influenced by social status and other
characteristics of women.


odds of conception. The findings of Olsen are, however, largely backed up by most other studies that
have considered the effects of very high caffeine consumption. Bol´umar _et al_ . (1997) studied 3187 women
from five European countries and were able to allow for all sources of caffeine (although coffee was
the chief source), major confounding factors, and for
the regional and cultural variations in how coffee is
prepared and brewed. Women who consumed more
than 500 mg caffeine per day (in excess of 5 cups) had
a longer average waiting time to pregnancy on cessation of contraceptive use (8.9 months compared to
6.5monthsinwomenwhoconsumedlessthan100mg
caffeine per day). High caffeine consumption (more
than 500 mg/day) increased odds of subfecundity by
45% compared to women consuming 100 mg/day or
less. The effect was stronger in smokers (56% greater
risk) than in nonsmokers (38% greater risk).
Hassan and Killick (2004) reported similar findings from a study of 2112 UK women. Tea and coffee
consumption was a determinant of risk of subfecundity but only when consumed at high levels. Seven or



**32** **Nutrition: A Lifespan Approach**


Proliferation of the diploid
progenitor cells of the male
reproductive tract.


Formation of the immature
haploid gametes. These
cells are undifferentiated and
lack specialised structures.


Formation of the mature
gametes involves the
development of the head
section (acrosome),
specialized mid section and
tail.









**Figure 2.4** Endocrinecontrolofmalereproductivefunction.In
males, pulsatile hypothalamic production of GnRH stimulates
the release of FSH and LH, which stimulate the production
of testosterone and the development of mature sperm in the
testes. Testes derived inhibin-B and testosterone have negative
feedback effects in the anterior pituitary and hypothalamus and
thereby regulate the hypothalamic–pituitary–testicular axis.



more cups per day increased risk by 70% (95% CI,
1.1–2.7) after adjusting for alcohol intake, BMI, contraceptive use, and frequency of intercourse. Women
who consume excessive amounts of coffee also tend to
consume more alcohol. Hakim and colleagues (1998)
found that the two factors together contributed to reduced fertility and that lowest conception rates were
associated with highest intakes of alcoholic beverages
and coffee. Current advice is that women who wish
to become pregnant should reduce intake of both alcohol and caffeine, with 6 cups of tea per day, 3 cups
of coffee per day, and 1–2 units of alcohol per week
suggested as sensible limits.


**2.3 Nutrition and male fertility**


_**2.3.1 Determinants of fertility and**_
_**infertility**_


While the origins of infertility in women are often
complex and difficult to define, male fertility is readily
assessed through simple measures of sperm production and quality. In general terms, the fertility of men
depends on the quantity of sperm produced (defined
either as sperm concentration per milliliter of ejaculate, or as total numbers of sperm produced per ejac


ulation) or the characteristics of the sperm produced.
The latter can be measured in terms of sperm motility
(the capacity of the sperm to swim) and sperm morphology (assessments of the proportion of sperm cells
with a normal healthy structure).
The process of sperm production is termed spermatogenesis and this takes place in the seminiferous tubules within the male reproductive tract. These
tubules contain two specific cell types that drive the
process. Germ cells are the cells that have the capacity to develop into sperm cells. These cells are
supported by Sertoli cells, which surround the germ
cells, providing a protective barrier, and secrete nutrients and hormones. Spermatogenesis begins with the
most primitive stage of germ cells, which are termed
spermatogonia. As shown in Figure 2.4, these cells
go through rounds of mitotic and meiotic divisions
before undergoing differentiation to produce mature
sperm cells with specialized tail, mid, and head sections that can perform the required swimming and
fertilization functions.

Spermatogenesis begins in males at around the
time of puberty and will then continue throughout the adult lifespan. The process is regulated by
a variety of hormonal factors which are produced
by the hypothalamic–pituitary–gonadal axis (Figure 2.5). The hypothalamus produces GnRH in a



**Before Life Begins** **33**


**Figure 2.5** The formation of mature sperm. Sperm
production in the male reproductive tract consists of
mitotic and meiotic divisions followed by a differentiation phase in which sperm acquire their specialized

structures.

















pulsatile manner, with concentrations peaking every
90 min. Thus, a new batch of sperm cells can be produced every hour and a half throughout adult life.
GnRH acts on the anterior pituitary to stimulate production of LH and FSH, each of which has different
functions. LH acts directly on the Leydig cells of the
testis to stimulate production of the main androgenic
steroid, testosterone. In this context, testosterone is
responsible for the stimulation of spermatogenesis,
but this hormone is critical to male reproduction in
other ways, as it initiates puberty, stimulates the male
sex drive, and promotes the development of the male
secondary sexual characteristics. Testosterone stimulates spermatogenesis through action on the Sertoli
cells. These cells are also a target for FSH, which
has the same function. This endocrine axis is subject to negative feedback regulation at two key points.
Testosterone negatively feedbacks on production of
both GnRH and LH, while FSH secretion is directly
controlled by the production of inhibin-B from the
Sertoli cells. As Sertoli cells require both FSH and
testosterone stimulation to maintain spermatogenesis, inhibin-B effectively limits sperm production by
reducing FSH production.
The male reproductive system may be particularly
vulnerable to adverse effects of poor nutrition or environmental exposures by virtue of the way in which
it develops and functions. The repeated production of
new sperm over rapid intervals throughout adult life
means that short-term influences on spermatogenesis
may become important in determining fertility. Fetal



life and early infancy, may however, represent more
important points in life when food-borne influences
may have the greatest impact on later fertility.
Initially both male and female embryos develop a
common ductal system, termed the Mullerian duct
that will ultimately go on to form the reproductive
system. In males early formation of Sertoli cells results in the production of anti-Mullerian hormone,
causing the Wolffian duct to develop. This eventually
forms the male reproductive organs. Masculinization
of the reproductive tissues also depends on production of testosterone and its binding to the androgen
receptor. There are many defects of this process that
have been identified, which in the most extreme cases
will lead to ambiguous genitalia, intersex, and infertility (Sharpe, 1999). Development of male fertility
therefore depends heavily on Sertoli cell numbers and
function, which peak at around 1 year of age. Earlier
in the chapter, it was stated that a high proportion of
female subfertility and infertility can be attributed to
specific medical conditions. There are also conditions
that affect the male reproductive tract that can impact upon fertility, of which the most important are
hypospadias and cryptorchidism. These appear to be
the product of adverse influences on early life development (Sharpe, 1999).
Hypospadias is a defect in which the opening of
the urethra is misplaced and may be at any point
along the shaft of the penis. This is one of the most
common birth defects of the male genitalia, occurring in as many as 1 in 125 boys. Like hypospadias,



**34** **Nutrition: A Lifespan Approach**


cryptorchidism is a defect associated with early development of the reproductive tract. Cryptorchidism
refers to a failure of the testes to descend from the

abdomen into the scrotum. This occurs in approximately 3% of babies, but will resolve in the majority,
leaving around 1% of mature adults with the condition. Both of these conditions can reduce male fertility
(e.g., around 10% of men with cryptorchidism will be
subfertile) and there is some evidence that the incidence of these conditions and other defects of the

reproductivetract(e.g.,testicularcancers)isontheincrease (Sharpe, 1999). On a global scale the numbers
of reported hypospadias increased by almost threefold between 1950 and 1980, while cryptorchidism
cases doubled between 1960 and 1980.
It is estimated that problems with male fertility
explain around 40% of subfecundity in couples attempting to conceive a child. There is a suspicion that
this figure is on the increase, as many studies have reported a decline in the quantity and quality of sperm
in westernized countries, across several decades. For
example, the European average sperm count in the
1940s and 1950s was around 170 million cells per
milliliter, but this had declined to 60 million cells
per milliliter by 1990 (Sharpe and Irvine, 2004). This
decline has been questioned by some researchers as
surveys conducted across five decades may fail to use
equivalent methodologies, but the balance of opinion
is that men of the early twenty-first century are less
fertile than their grandfathers. Interestingly, surveys
of the same indices in developing countries show no
change in fertility, indicating that the decline is a feature only of westernized nations. This clearly raises the
question of why this has occurred and here attention
must shift to the environmental changes that have occurred in western populations over the same period.
While there are a number of environmental factors

that may be of importance, one of the main changes
from the 1950s to the end of the twentieth century
was the industrialization of food production and the
profound change to the type of diet consumed by the
population.


_**2.3.2 Obesity**_


Obesity is a major problem for all western countries, and the rising trends in overweight and obesity largely mirror the time period over which male
fertility has been in decline. Rates of overweight and
obesity have roughly doubled every 10 years over the



last few decades and in the UK, like most of Europe,
overweight (defined as BMI over 25 kg/m [2] ) is now
seen in two-thirds of men over the age of 16 (WHO,
2005). In 2005, 21.6% of British men were defined as
obese (BMI over 30 kg/m [2] ). In the same year 60.5%
of US adults were found to be overweight, with 24.3%
of men classified as obese (Ogden _et al._, 2006).
BMI appears to be strongly associated with indices
of sperm quantity and quality. Underweight men have
low circulating testosterone concentrations and consequently fail to maintain normal spermatogenesis.
Several studies similarly show that overweight lowers
sperm counts. Reports suggest that subfertile men are
three times more likely to be obese than men with
normal fertility (Magnusdottir _et al_ ., 2005). Kort and
colleagues (2006) reported that numbers of normally
motile sperm were reduced by 80% in men with BMI
between25and30kg/m [2],comparedtomenofnormal
weight (BMI 20–25 kg/m [2] ). A 96% reduction was seen
when comparing normal weight men with obese individuals (BMI in excess of 30 kg/m [2] ). Moreover, there
was greater evidence of DNA fragmentation damage in the sperm samples from overweight and obese

men.

Obesityhasimportanteffectsontheendocrinecontrol of spermatogenesis. Men with excess body fat have
lower circulating testosterone concentrations and also
producelowerquantitiesofsexhormonebindingproteins, which play a key role in the transport of testosterone to the gonads. The lowering of testosterone
appears to be driven by a reduced secretion of LH
in response to GnRH pulses. As shown in Figure 2.6,
there is a cyclical relationship between obesity and sex
hormone production in men, as while excess body fat
lowers testosterone production, the lower androgen
stimulation of the adipose tissue reduces lipolysis and
hencepromotesfurtherfatdeposition.Obesityinmen
isalsoassociatedwithalowerproductionofinhibin-B.
While this might initially be thought to promote spermatogenesis by reducing negative feedback on FSH
production (see Figure 2.5), lower inhibin-B production is likely to be indicative of lower Sertoli cell numbers and hence reduced capacity for spermatogenesis.


_**2.3.3 Diabetes**_


Diabetes, both type 1 and type 2, can impact on male
fertility. Poorly managed diabetes results in damage to
nerves in many parts of the body (neuropathy) with
the most commonly reported sites of injury being the



**Before Life Begins** **35**


**Figure 2.6** The relationship between
male obesity and subfertility. Obesity and
insulin resistance are a cause of infertility as they interfere with the normal secretion and transport of androgens. As
androgens are activators of lipolysis, further adiposity is stimulated by impaired
action of the androgens.







eyes, kidneys, and lower limb. In men, diabetic neuropathy may also impact upon reproductive function
and approximately 1% of subfertile men are diabetic.
While other aspects of nutrition tend to impact upon
sperm production and function, diabetes promotes
infertility by causing erectile dysfunction and interfering with the ejaculatory reflex. The majority of diabetic men do not suffer from these problems.


_**2.3.4 Alcohol**_


Excess consumption of alcohol has been linked to subfertility in males, in studies of both humans and animals. Studies that compare fertile and subfertile men
indicate that alcohol consumption is generally higher
in the subfertile population. Raised alcohol intakes
are also associated with lower total sperm counts, semen volume, sperm motility, and increased numbers
of sperm with abnormal morphology (Emanuele and
Emanuele,2001).Themechanismthatdrivesthisprocess is not well established in humans, but studies of
animals indicate that chronically high alcohol intakes
lower testosterone production, and that ethanol may
be directly toxic to testicular tissues. Certainly the increased numbers of sperm with abnormal morphology associated with excess alcohol may be suggestive
of a spermatotoxic effect.



_**2.3.5 Zinc**_


Zinc is an essential micronutrient required for the
production of a wide range of enzymes, receptors, and
structural proteins. Zinc is an active site component
of over 200 different metalloenzymes and is chiefly involved in stabilization of protein structures, synthesis
of DNA and RNA, formation of chromatin, protein
synthesis, digestive processes (notably the pancreatic
enzymes), antioxidant defenses (cofactor for superoxide dismutase), and oxygen transport.
Zinc is postulated to play a role in several components of male reproductive function and zinc deficiency in some parts of the Middle East has been
classically linked to delayed sexual maturation in adolescent boys. The testes have a very high zinc content
compared to other organs and tissues, and zinc concentrations are particularly high in the seminal fluid
produced by the prostate gland. Data on the role of
zinc in maintaining fertility in human males is sparse.
There are reports, however, that men with low sperm
counts(lessthan20millioncellspermilliliter)havereduced seminal zinc concentrations compared to normospermic individuals (Fuse _et al_ ., 1999). It has been
suggested that a small proportion of idiopathic infertility in men may be explained by poor seminal zinc
status. Intervention studies that have considered the
impact of zinc supplementation on fertility suggest



**36** **Nutrition: A Lifespan Approach**


some improvements in sperm counts, motility and
morphology, and increased testosterone concentrations. In the study of Wong and colleagues (2002), administrationof66mg/dayzincsulphateover6months
had no impact on indices of sperm quality or quantity
in fertile men, but in subfertile men increased numbers of sperm with normal motility and morphology
by 74%. Despite this major increase, the mean sperm
counts in these subfertile men remained below the

20 million cells per milliliter that the World Health
Organization (WHO) use as the cutoff to define subfertility.


_**2.3.6 Antioxidant nutrients**_


Free radicals and other ROS were discussed in the

context of female fertility earlier in this chapter. While
ROS are generally perceived as having negative, tissuedamaging effects in biological systems, it is important
to realize that endogenously generated ROS also play
a number of important physiological roles. The manufacture of sperm is one such role, and ROS produced
within immature sperm cells are important in the production of the tail sheath that encloses the mitochondria of the midsection, which will ultimately generate
ATP (adenosine triphosphate) and provide the motile
function of the sperm cells. ROS are also important
in the functions of spermatozoa during fertilization
and are generated to promote attachment to oocytes
and to generate the acrosome reaction, which allows
the sperm to penetrate the zona pellucida layer of the
oocyte.
AsROSarecriticalfornormalspermfunctions,mature sperm cells are less protected with antioxidants
than most other cell types, although the immature
cells are rich in the antioxidant enzymes superoxide
dismutase, glutathione peroxidase (GPX), and catalase. Mature cells are vulnerable to damage by ROS,
which will principally cause fragmentation of DNA,
theprimarymorphologicalabnormalitynotedinsubfertile men. Immature sperm cells are vulnerable as
they are producing ROS for differentiation and are
present in a membrane rich tissue. Biological membranes are rich in polyunsaturated fatty acids, which
are a major target for ROS-mediated damage. There
is clearly a delicate balance between oxidative and antioxidant processes in sperm cells and their associated
support tissues.
Onthebasisofthis,itiswidelyassertedthatincreasing antioxidant intakes, particularly through supple


ments, will improve fertility, especially in subfertile
men. Although there are biologically plausible mechanisms that could explain any beneficial effect of antioxidants, there is a lack of clear evidence to suggest
that antioxidant therapy is truly effective or necessary.
A number of studies have compared subfertile men
with healthy, normospermic donors and reported that
subfertile men have higher concentrations of ROS and
lower concentrations of antioxidant nutrients in se
men samples (Moustafa _et al.,_ 2004). Other studies
have shown that the addition of antioxidants, for example glutathione or α-tocopherol to culture media
used in artificial reproductive technologies, boosts
conception rates by increasing the motility of spermatozoa (Ozawa _et al._, 2006).
There are few studies that have considered the

impact of antioxidant intakes within a normal diet,
upon indices of male fertility. Eskenazi and colleagues
(2005) assessed intakes of vitamins A, C, and E, along
with zinc and selenium using food frequency questionnaires in fertile men. The intakes of these nutri
ents were then considered in relation to indices of
semen quality. While zinc and selenium intakes were
not associated with markers of fertility, higher vitamin C, ß-carotene and _α_ -tocopherol intakes were all
associated with greater semen quality. Considering
all three antioxidant nutrients together, it was shown
that higher intakes increased sperm concentrations
and numbers of motile sperm cells.
Studies of supplementation generally use very high
doses of single antioxidant nutrients and their findings are largely inconclusive. The lack of clear effects
may be a product of adverse responses to high local concentrations of antioxidant compounds, many
of which have a paradoxical pro-oxidant activity in
excess. Menezo _et al._ (2007), for example, reported
that while multivitamin supplements reduced DNA
fragmentation in sperm from subfertile men, the high
ascorbic acid dose appeared to promote sperm chromatindecondensation,aprocessthatshouldnormally
occur only after fertilization of an oocyte. Where studies performed in subfertile men do find beneficial effects of antioxidant supplementation upon indices of
sperm quality or quantity, there are rarely clear benefits in actual fertility (i.e., the ability to conceive a
child) and many of the markers remain below normal
thresholds. For example, a double-blind randomizedcontrol trial of L-carnitine showed that numbers of
normally motile sperm were almost doubled over



**Before Life Begins** **37**


**Table 2.2** Environmental sources of human exposure to endocrine disrupting chemicals


Source Examples Putative effects


Atmosphere (inhalation) Polyaromatic hydrocarbons Suppress estrogen metabolism
Cosmetics Parabens (in shampoos, perfumes, and deodorants) Estrogen mimics
Phthalates Suppress testosterone synthesis
Nitromusks Inhibit hypothalamic–gonadotrophic axis


Food chain Plasticizers (phthalates) Suppress testosterone synthesis
Polyaromatic hydrocarbons Suppress estrogen metabolism
Pesticides and fungicides Estrogenic and antiandrogenic effects


Water supply Atrazine (herbicide) Estrogen mimic
17β-oestradiol Estrogenic effect



90 days of high dose (2 g/day) treatment, but the
achieved sperm counts were still less than half the
WHO cutoff (Lenzi _et al._, 2003).


_**2.3.7 Selenium**_


Itiswellestablishedfromanimalstudiesthatselenium
is a key nutrient for the maintenance of male fertility. Selenium deficiency in animals or the knockout of
key genes in mice that lead to production of selenoproteins, leads to lower sperm production and poor
sperm motility. Selenium appears to be particularly
important in the formation of the tailpiece in mammalian sperm. As described above, this is a process
that involves the generation of ROS and a balance between oxidative and antioxidative processes is critical
in normal differentiation of the spermatids. Selenium
is a cofactor for the antioxidant enzyme GPX, and
in sperm the GPX4 isoform appears particularly important in tail formation (Beckett and Arthur, 2005).
Although there is clear evidence that many subfertile
men with sperm defects have abnormalities of GPX4
in their sperm, it is unlikely that in most cases this is
due to limiting intakes of selenium in the diet.
Inpopulationswhereseleniumintakesarelow(e.g.,
Scotland), there is no strong evidence of lower fertility, although selenium supplementation may increase
spermquality.However,adetailedstudyofmenwhose
selenium status was controlled for a period of 120 days
while living on a metabolic unit (Hawkes and Tuek,
2001) suggested that while a high-selenium diet produced large increases in seminal selenium concentrations, sperm motility actually decreased. This suggests
that the common recommendation to consume rich

sources of selenium, for example brazil nuts, for men
preparing for fatherhood may be ineffective.



_**2.3.8 Phytoestrogens and environmental**_
_**estrogens**_


In developed countries, populations are constantly
exposed to a range of chemical agents that have endocrine disrupting properties. Endocrine disruptors
are agents that interfere with normal hormonal functions within the body, either by having a direct hormonal effect, or by opposing the actions of endogenous hormones (antihormones). Human exposure to
endocrine disruptors comes from a wide range of different sources (Table 2.2), most of which are unavoidable due to their presence in the food chain, atmosphere, and water supply.
Endocrine disruptors are known from studies of
the impact of human activity on wildlife to be particularly potent within the reproductive organs. For example, tributytin, an antifouling agent used on ships
was found to be an antihormone blocking production
of estrogen and masculinizing shellfish. The excretion
of estrogen metabolites in urine from women using
certain oral contraceptives has been blamed for the
feminization of male fish found around sewage outlets. Clear examples of effects of endocrine disruptors
on human male fertility are more difficult to demonstrate, but there are a number of agents that have been
proposed as potentially harmful. These are described
below.


**2.3.8.1 Phthalates**

Phthalatesareaclassofchemicalusedtomakeplastics.
They are widely used in the production of cosmetics,
toys,andallmannerofgoodsthatrequireflexibleplastics. Phthalates are known to adversely affect the male
reproductive system in animals, inducing both hypospadias and cryptorchidism and leading to reduced



**38** **Nutrition: A Lifespan Approach**


testosterone production and sperm counts (Sharpe
and Irvine, 2004). Exposure to phthalates during human fetal development has been linked to feminization of baby boys and this has led to widespread concern at the potential for these agents to enter formula
milk consumed by infants during the critical phase of
reproductive development. However, levels of phthalates in formula milks have been shown to be low and

are now monitored. Studies show that phthalates also
appear in breast milk, as they are excreted following
maternal exposure. There is also some evidence of associations between phthalate exposure and fertility in
mature men. The mode of phthalate action is simply
to inhibit testosterone production. Measurements of
phthalate metabolites have proved to be directly proportional to sperm counts (Sharpe and Irvine, 2004).


**2.3.8.2 Phytoestrogens**
Phytoestrogens are plant-derived compounds that
have a weak estrogenic activity. Within the human diet
they are ingested either in the form of lignans, which
are present in vegetable matter, or as soy-derived
isoflavones, which include genistein and dadzein. Intakes of isoflavones within the diet vary immensely
both within and between different populations. Average intakes for omnivores in the UK are around
1 mg/day, while vegetarians have much higher intakes
ataround7–8mg/day.IntheFarEast,soyisconsumed
as a staple food, for example as tempeh or tofu, and
intakes are around 25–100 mg/day.
The estrogenic effects of phytoestrogens have a
number of positive effects upon health in women,
which will be dealt with elsewhere in this book. There

are concerns however, over their impact upon male
reproductive health, particularly as within a western
diet soy is becoming very widely used as an ingredient
in processed foods and as a meat substitute. Studies of
animals suggest that phytoestrogens may have effects
on both young, developing males but not mature individuals. Several studies have shown in rats and mice

that comparing offspring of pregnant animals fed diets containing soy to those fed a soy-free diet, reveals
differences in testicular weight, circulating FSH, and
capacity to successfully mate with females. Atanassova
and colleagues (2000) found that adverse effects of
genistein on indices of fertility in male rats were at
their greatest when it was administered during puberty. In contrast, Tan _et al._ (2006) studied the impact
of feeding soy formula milk to baby marmosets and



found no gross effects upon their reproductive organs
in later life.

In humans, dietary phytoestrogens appear to have
pronounced effects on endocrine markers in women,
but not in men. Trials that have considered the impact
of high dose isoflavone consumption in men indicate
that there is little risk to reproductive health. Six weeks
of consumption of flax seed had no effect on plasma
testosterone or sex hormone binding globulin (Shultz
_et al._, 1991), and the study of Mitchell _et al._ (2001)
found no effect of 40 mg/day isoflavones on sex hormone concentrations, testicular volume, or indices of
semen quantity or quality. While data on exposure
of older men to phytoestrogens does not clearly support the evidence of risk inferred from animal studies,
an impact of phytoestrogen exposure during infancy
cannot be excluded. Early life exposure to isoflavones
through sources other than soy milk formula in infancy is difficult to evaluate, but there is some data
suggesting an association with reproductive abnormalities. A study of the ALSPAC cohort, a large longitudinal study of pregnancy and childhood in the
BristolareaoftheUK,suggestedthatvegetarianmothers were almost 5 times more likely to have baby boys
with hypospadias than omnivorous mothers (North
and Golding, 2000). This may be attributed either to
the high phytoestrogen content of the maternal diet,
or to greater ingestion of pesticides and other contaminants on fruit and vegetable matter. There are
no data available on fertility rates or markers of semen quality from individuals exposed to high levels
of phytoestrogen in fetal life or infancy.


**2.3.8.3 Pesticides**

A huge range of organic pesticides are present within
the environment and many of these are known to have
endocrine disrupting properties. Of greatest concern
arethosethathavethepotentialtoenterthefoodchain
as contaminants. Vinclozolin is an example of a pesticide that has been linked to male fertility problems in
animals (Gray _et al_ ., 1999). Vinclozolin is a fungicide
usedintheproductionof oilseedrape, peas, andfruits
such as grapes. Studies of this agent in rats and other
species show that, at doses that may be consumed
by humans, it can feminize males and damage their
reproductive capacity. As with phthalates, the early
stages of fetal development appear to be a sensitive
period for exposure. Although there is no clear evidence of harmful effects in humans, approvals for use
of this agent on strawberries, tomatoes, lettuce, and



**Before Life Begins** **39**


**Table 2.3** Organic food, pesticide exposure and semen quality


Study reference Comparison Outcomes


Abell _et al._, 1994 Organic farmers compared to printers, electricians, and Sperm counts higher in organic farmers (100 versus
metal workers 55 million cells/mL)


Jensen _et al._, 1996 Organic food association members compared to airline Sperm counts higher in organic group (99 versus
workers 48 million cells/mL)


Larsen _et al_ ., 1999 Organic farmers compared to traditional farmers No difference in sperm count, motility or morphology


Juhler _et al_ ., 1999 Organic farmers compared to traditional farmers, No differences in 14 different indices of male fertility
considering consumption of organic produce


Kenkel _et al_ ., 2001 Traditional farmers and low chemical-exposure risk Farmers at higher risk (OR 2.13) for reduced sperm
occupations count



raspberries were withdrawn by the UK and European
Commission in the 1990s.
The impact of pesticide exposure upon fertility
might best be evaluated by considering the effects
of occupational exposure in farmers, the individuals
who actually make direct use of these chemicals during food production. Organic farmers, who produce
food without use of chemical fertilizers and pesticides, make an interesting reference group. A number
of studies (Table 2.3) have compared sperm counts in
organic farmers with other groups of workers and
have found that the organic farmers tend to have
higher sperm concentrations. However, such studies may be flawed as they fail to take into account
the other occupational exposures experienced by the
nonfarming group. The study of Juhler and colleagues
(1999) avoided this problem by comparing 14 indices
of sperm quantity and quality in a group of organic
compared to conventional farmers. No differences in
any of the indices were noted, suggesting that agricultural chemical exposure did not impact on fertility.
The lack of clear risk associated with direct use of the
chemicals would suggest that the much lesser exposure experienced by the majority of men via the food
chain is unlikely to be harmful to fertility. However,
it is important to note that there are no robust studies which have considered the impact of exposure to
pesticide contaminants in food during the first year
of life, or fetal development.


**2.4 Preparation for pregnancy**


_**2.4.1 Why prepare for pregnancy?**_


With modern healthcare and an increasing emphasis on maintaining and promoting health, rather than



treating disease, provision of advice and care during
the preconceptual period is becoming more commonplace in developed countries. The main aim of any
work in this area will be to maximize the health of

both prospective parents, and this will maximize their
fertility (as described above) and minimize the potential for the early embryo to be exposed to potentially
harmful agents. To achieve this aim it is necessary
to address the controllable risk factors for adverse
pregnancy outcomes while parents are still planning
a pregnancy (Table 2.4). Clearly, not all such factors
are directly related to nutrition, but social, environmental, and behavioral elements are all interlinked
and impact upon individuals’ attitudes, choices, and
opportunities in relation to lifestyle and diet.
In addition to maximizing fertility, it is important
to eliminate the potential for an early embryo to be
exposed to factors that could exert harmful effects
should a conception occur. To this end, the preparatory phase before conception should ideally involve
lifestyle changes for both men and women. Although
women are preparing and providing the environment
in which the fetus will develop, their chances of success in making lifestyle changes will be considerably
greater if they do so in partnership. Men are therefore
responsible for much more than maximizing their
own fertility and should cooperate with women in
maintaining a healthy body weight, in ensuring that
immunizations against infections that might harm
the fetus (e.g., Rubella) are up-to-date and in reducing exposures to alcohol and tobacco smoke. From a
dietary point of view there are two important changes
that should be made to minimize risk of birth defects.
These are increasing intakes of folic acid and reducing
exposure to high doses of vitamin A, both of which
are described in more detail below.



**40** **Nutrition: A Lifespan Approach**


**Table 2.4** Factors that impact on parental health during the peri-conceptual period


Controllable factors Examples


Environmental factors: the influence of home and workplace Hygiene, sanitation, occupational chemical exposure
Lifestyle factors: the health choices and behaviors of the parents. Smoking, alcohol, diet, exercise


Uncontrollable factors Examples


Social factors: the circumstances in which the parents live Family income
Access to healthcare, education
Physiological factors: the underlying health circumstances of the parents Genetic disorders, age, obstetric disorders, infection


Source: Adapted from Langley-Evans (2004).



_**2.4.2 Vitamin A and liver**_


Vitamin A is one of the essential nutrients in the diet
but intake should be restricted during pregnancy due
to a well-established association with birth defects. In

the diet vitamin A is available in two forms, the first
being animal derived retinol, and the second plant
derived carotenoids. Due to this diversity of sources,
vitamin A intakes are generally described in terms
of retinol activity equivalents (RAE) with one RAE
being equivalent to 1 µg retinol or 6 µg ß-carotene.
Generally, intakes of vitamin A are measured as mg
retinol equivalents or international units (IU, with
one RAE equivalent to 3.3 IU). Once within the body,
vitamin A undergoes extensive metabolism as shown
in Figure 2.7 and in addition to mediating some of
the classically defined functions, such as formation of
rhodopsin within the retina, is an important regula

Diet

RAR/RXR
binding



tor of gene expression through the retinoic acid and
retinoid X receptors.
Vitamin A was first shown to be a teratogen in studies of animals. The administration of high doses of
retinol and all- _trans_ retinoic acid during pregnancyinduced abnormalities in almost all tissues of fetal

mice, rats, hamsters, rabbits, and nonhuman primates
(Soprano and Soprano, 1995). The demonstration
that the same effects occur in humans has generally
relied on the observation of the adverse effects of certain pharmacological agents. Retinoid derivatives are
widely used in the treatment of skin conditions such
as severe acne. Pregnant women who used products
containing 12- _cis_ -retinoic acid had babies with craniofacial abnormalities such as cleft lip, with heart defects, and with abnormalities of the central nervous
system. Such products are therefore contraindicated



Rhodopsin


11-cis retinal


11-cis retinol



**ß-carotene**


All-trans retinal


**All-trans retinol**


Diet



13-cis-4-oxo
retinoic acid


All-trans retinoic

acid


9-cis- 13-cis
retinoic acid retinoic acid



**Figure 2.7** The metabolism of vitamin A. Dietary
sources of vitamin A deliver preformed retinol (from
animal sources) or ß-carotene. Retinol from the diet or
formed within the liver is used to generate rhodopsin in
the retina, is converted to retinoic acid which modulates
gene expression via the RAR/RXR receptors. Retinoic acid
can be metabolized to a number of intermediates that

are known to have teratogenic properties in animals and
humans.



in women who are pregnant or considering having a
child.

There are very few recorded cases in which overconsumptionofdietaryvitaminAcanbefirmlyattributed
as the cause of birth defects in humans. However,
where this is the case (Soprano and Soprano, 1995)
the defects generated tend to be highly variable and
to occur across multiple organ systems, including the
heart. Martinez-Frias and Salvador (1990) compared
Spanish women who had given birth to babies with
congenital malformations (cases) with women whose
babies were normally developed (controls). The overwhelming majority of cases were unrelated to vitamin
A teratogenicity, but among women who had taken
megadose supplements of vitamin A, there were significant associations between consumption and malformations. As shown in Figure 2.8, at doses below
40 000 IU there was no increased risk, but over 40 000
theoddsofmalformationwereincreased2.7-fold.The
greatest risk was associated with consumption of vitamin A alone, at doses of over 60 000 IU. Further
studies have gone on to suggest that vitamin A doses
of only 10 000–25 000 IU may be harmful during embryonic and fetal development. As a result pregnant
women, or those planning a pregnancy, should avoid
vitamin A containing supplements. Typical multivitamins available over-the-counter contain approximately 8000–9000 IU. Although the Martinez-Frias







**10**


**5**


**0**
**<40** **000 IU** **>40** **000 IU** **66** **700 IU**


**Vitamin A exposure**


**Figure 2.8** Vitamin A supplementation and fetal malformations. The
relationship between vitamin A supplementation and fetal malformations was explored in a population of Spanish women. The data shows
odds of malformations associated with vitamin A in a multivitamin
supplement, higher levels of vitamin A in a multivitamin supplement,
and with megadose supplements of vitamin A alone. Data taken and
redrawn from Martinez-Frias and Salvador (1990).



**Before Life Begins** **41**


study suffers from the generic problems associated
with case-control studies (choice of control group
can be problematic, study cannot firmly demonstrate
causal relationships, exposure to nutrient has to be
done retrospectively and may be inaccurate), together
with the data from animal and pharmacological studies, it appears that excessive levels of vitamin A consumption do play a causal role in development of fetal
abnormalities.

Liver is a major source of preformed retinol within
the diet, and a 100 g portion of beef liver may deliver
32 000 IU vitamin A in a single meal. The vitamin A
content of liver has increased with intensive farming
and so the associated risk in modern times is likely
to be greater than in the past, when pregnant women
were actively encouraged to eat liver as a source of
iron. In particular, liver appears to increase circulating concentrations of two of the most teratogenic isomers of retinoic acid, namely, 13- _cis_ -retinoic acid and
13- _cis_ -4-oxo-retinoid acid. Arnhold _et al_ . (1996)
showed that feeding male volunteers fried turkey liver
significantly elevated concentrations of all metabolites of retinol within a short period of time. Similarly,
Hartmann _et al._ (2005) found that feeding nonpregnant women 120 000 IU vitamin A in a liver meal
greatly increased plasma 13- _cis_ -retinoic acid and 13_cis_ -4-oxo-retinoid concentrations. Clearly, with these
observations, alongside the studies of Martinez-Frias
and Salvador (1990), caution is appropriate and liver
should be avoided by women planning a pregnancy.
An important consideration is that consumption of
liver appears to increase circulating retinoic acid
metabolites in women, to a much greater extent than
consumption of a vitamin A supplement of equivalent
dosage (van Vliet _et al._, 2001).


_**2.4.3 Folic acid and neural tube defects**_


Neural tube defects (NTDs) are among the most common fetal abnormalities observed in western populations. These conditions, of which the most significant
are spina bifida and anencephaly currently affect 0.3
births in every 1000 in the UK, representing around
150–200 cases every year. However, the true number of NTDs is considerably higher (approximately 4
cases per 1000 births) and most affected fetuses are
terminated after diagnosis with antenatal ultrasound

scans.

Spina bifida and anencephaly are different manifestations of the same developmental problem.



**42** **Nutrition: A Lifespan Approach**


During normal development the embryonic neural
tube, which will go on to become the brain and the
spinal cord, undergoes a process of folding and closing
to form an enclosed neural canal. This closure of the

neural tube will normally occur in the fourth week of
gestation, a time which is generally too early for the
mother to be aware of her pregnancy. Failure of the
neural tube to close results in permanent disability,
the severity of which depends on the location of the
tube lesion. A lesion high up along the neural tube
will result in anencephaly, a condition in which the
cerebral arches of the brain will be absent. Babies with

anencephaly will inevitably die, either during gestation or within a few hours of birth. Lesions lower

down the neural tube will result in spina bifida. As the
spinal cord is not fully encased in bone, it is vulnerable to injury and damaged spinal nerves and cord are
associated with paralysis, incontinence, and in some
cases delayed cognitive development and learning disabilities.

The risk factors for NTDs are well established. A
family history of NTDs increases risk dramatically
and couples who have previously had an affected child
have a 100-fold higher chance of having another with
the same defect. A woman who was born with a neural
tube defect herself has a greater chance of giving birth
to a child with spina bifida. Use of medications that
target epilepsy is also associated with increased risk
of NTD. Certain ethnic groups are more at risk than
others and US studies have shown that spina bifida is
more common among Hispanics and whites of European descent than among the African-American population. This may in part relate to dietary practices,
but is also explained by the occurrence of key genotypes for enzymes involved in the metabolism of folic
acid, for example, methyl-tetrahydrofolate reductase.
This latter point gives a clue to the key nutrient that
can modulate risk of NTD.

Around the time of the closure of the neural tube

there are a number of processes that increase demand
forfolicacidanditsmetabolites.Folatesareimportant
cofactors for the synthesis of the purine nucleotides
and thymidinylate that are required for cell division.
At the same time as the neural tube is closing, the
embryo is establishing the early cardiovascular system
and so cell division to close the neural tube competes
withproductionofredbloodcells.Iffolateisalimiting
nutrient at this time, these processes will be compromised. While red cell formation can be recovered at a



later stage, the neural tube closure must occur within
a critical time period or, NTDs will result.
The link between folic acid and NTDs was first
noted in the 1960s when it became clear that women

pregnant with affected babies showed abnormal
markers of folate status. This prompted Laurence _et al_ .
(1981) to perform a trial using 4 mg/day supplemental folic acid, administered to women with a previous history of NTDs. While this trial indicated that
supplements could prevent recurrence, concerns over
the design of the trial cast some doubt over the validity of the findings. Czeizel and Dudas (1992) reported that a combined supplement of 12 vitamins
including 0.8 mg folic acid prevented NTDs in a population of pregnant women without prior history of
abnormalities. Around the same time, the MRC Vitamin Study Group (1991) performed a randomized,
double-blind trial of 1817 women in 33 centers, across
7 countries. All women had a previous history of a
pregnancy with NTD and were randomized to either a placebo group, a group given a supplement
of folic acid alone (4 mg/day), a group provided with
a supplement containing vitamins A, D, B1, B2, B6,
C, and nicotinamide, or a fourth group provided with
the same multivitamin supplement plus folate. Supplementation to 12 weeks of gestation produced the
greatest beneficial effect when folate was given alone
(72% reduction in NTD risk). Folate as an element of
a multivitamin supplement was effective, but less so
than as a single nutrient.
On the basis of the MRC study and the work of
Czeizel and Dudas (1992), it is clear that increasing
dietary supply of folic acid will reduce the risk of
a pregnancy being affected by an NTD. Accordingly,
theRNIforfolicacidincreasesduringpregnancyfrom
200 to 600 mg/day. However, as neural tube closure is
anearlyeventinembryonicdevelopment,anyincrease
in maternal supply has to occur prior to conception
to ensure risk is minimal. To this end there are two
strategies that can be used to protect the population:
supplementation and fortification.


**2.4.3.1 Supplementation with folic acid**
In 1992, the Chief Medical Officer of the UK announced a firm recommendation that women who
are considering pregnancy should take a 400 µg/day
supplement of folic acid for 3 months prior to conception and for the first 12 weeks of pregnancy, in order to
reduce risk of NTD. This strategy was devised with the



intention that it would reduce risk by approximately
half. Supplementation was considered necessary as
achieving 400 µg/day extra intake through diet alone
would require impossible increases in consumption
of fruits and vegetables. Women with a prior history
of NTD were advised to take a 4 mg/day supplement,
the dose noted to be effective in the MRC Vitamin

Study Group trial.
The early response to this advice was poor and as
reported by Kadir _et al._ (1999), folate supplementation had no significant impact on prevalence of NTD
over the first 5 years of the policy. This apparent failure
highlights the main difficulty with supplementation
on a population-wide scale, which is providing the
necessary health education and awareness campaigns
to ensure a high level of compliance. Some studies
identified very low levels of knowledge of folic acid
and NTD risk, not just among the general population, but also in key medical staff dealing with individuals most likely to become pregnant (Pearce _et al.,_
1996). Effective health education campaigns in the
late 1990s reversed this trend but as shown by several
studies (Sillender, 2000; Langley-Evans and LangleyEvans, 2001) only 27–35% of women took supplements in the period before conception, with around
65–70% consuming them once they were aware they
were pregnant.
The main failing of supplementation as a strategy is
that around 40% of pregnancies are not planned and
so additional folate may not be consumed until after
the neural tube has closed. In addition, there are a
number of high-risk groups who are unlikely to comply with advice to take supplements. Women from
poor backgrounds, for example, tend not to buy supplements and were found to be least likely to take them
even after confirmation of pregnancy (Langley-Evans
and Langley-Evans, 2001). Younger women, women
of lower educational achievement, and women who
smoke are also less likely to use folate supplements.


**2.4.3.2 Fortification with folic acid**
As described above, the major problem with a prevention strategy based on supplementation is that full
coverage of all of the at-risk population can never be
achieved. The UK experience also shows that it can
take many years to educate and train healthcare staff
and to increase awareness of the issue in the general
population. Some countries, most notably the US,
Canada, and Chile, have instead opted to add folic



**Before Life Begins** **43**


acid to staple foodstuffs. This fortification aims to
provide all members of the population with adequate
intakes of folate to prevent NTD in pregnancy, and
given that folic acid also reduces risk of some cancers
and coronary heart disease, should have additional
health benefits among the nonpregnant population.
Fortification with folate became mandatory in the
USin1998followingaperiodofoptionalfortification.
Manufacturers are now required to add 140 µg folic
acid to every 100 g of grain produce (such as bread
and pasta). Pfeiffer and colleagues (2005) examined
the impact of this policy on folate status in the US
population and found that fortification reduced the
prevalence of low serum folate concentrations dramatically, with benefits observed in all ethnic groups,
in both sexes and in people of all ages. Williams _et al_ .
(2005) reported that between 1995 when optional fortification began, and 2002 intakes of folate in the US
population doubled and accordingly the prevalence of
spina bifida declined by 36% among Hispanic women
(the highest risk group in the US) and 34% among
the white population. Similar declines in prevalence
of anencephaly were noted.
Although highly successful in improving folate status in the general population and in reducing prevalence of NTDs, the fortification policy brings with it
some associated problems. Higher intakes of folic acid
can mask the symptoms of vitamin B12 deficiency,
which in developed countries is most likely to occur
in the elderly. Careful monitoring of vitamin B12 status in this population is therefore advisable in populations consuming folate fortified staples. There are also
reports that improvements in folate status can have a
negative impact on patients with established cancers,
as a rich supply of folate and therefore of nucleotides,
aids tumor growth. Some studies have suggested that
folic acid can increase risk of breast cancer, and in
particular, Charles _et al._ (2004) reported that women
who had taken part in a trial of folate supplementation during early pregnancy in the 1960s, were at
greater risk of death (not significant) from breast cancer (hazard ratio 2.02, 95% CI 0.88–4.72). Kim (2006)
similarly reported a 20% increase in breast cancer risk
among women consuming 400 µg/day supplemental
folate. Many consumer groups also object to fortification as it is seen as an involuntary mass-medication
of the population that is difficult to opt out of. Given
these concerns, a decision to fortify grain products
with folic acid was delayed for many years in the UK,



**44** **Nutrition: A Lifespan Approach**


although it is now recognized that the benefits in
terms of protecting infants from NTD and the rest of
the population from major disease states, outweigh
the small increases in risk to some sectors of the

population.


~~**Summary Box 2**~~


Reduced risk of infant and maternal deaths during pregnancy has
shifted priorities of medical care toward optimizing parental health
in order to maximize fertility and reduce risk of fetal abnormalities.
In women, the key determinant of fertility is a healthy body
weight. Low levels of body fat or excessive adiposity disrupt the
actions of leptin upon the hypothalamic–pituitary–ovarian axis and
prevent normal reproductive cycling.
Consumption of caffeine and alcohol appear to have a negative
impact on female fertility. Antioxidant nutrients may increase the
likelihood of natural and assisted conception in women.
Male fertility appears to be decreasing and the prevalence of
abnormalities of the male reproductive tract is increasing. This may
be associated with increased exposure to endocrine disruptors in
the food chain and environment. Obesity and alcohol consumption
reduce male fertility.
Zinc and selenium are key nutrients associated with male fertility. Suggested relationships of indices of fertility with increased
intakes of antioxidant nutrients are of interest but, as yet, inconclusive.

Vitamin A is a teratogen associated with central nervous system and heart defects in the human embryo. Women considering
pregnancy should avoid rich sources of vitamin A, such as liver,
and vitamin A supplements.
Folic acid protects the embryo from NTDs during the first few
weeks of development. In many parts of the world, public health
strategy has been based on prevention of these defects through
supplementation of women who are planning a pregnancy. Fortification is a more effective strategy, but may be of detriment to
some groups in the population.


**References**


Abell A, Ernst E, and Bonde JP (1994) High sperm density among
members of organic farmers’ association. _Lancet_ **343**, 1498.
Adair LS and Gordon-Larsen P (2001) Maturational timing and
overweight prevalence in US adolescent girls. _American Journal_
_of Public Health_ **91**, 642–644.
Agarwal A, Gupta S, and Sharma RK (2005) Role of oxidative stress
in female reproduction. _Reproductive Biology and Endocrinology_
**3**, 28–48.
Allal N, Sear R, Prentice AM, and Mace R (2004) An evolutionary
model of stature, age at first birth and reproductive success in
Gambian women. _Proceedings Biological Sciences_ **271**, 465–470.
Arnhold T, Tzimas G, Wittfoht W, Plonait S, and Nau H (1996)
Identificationof9-cis-retinoicacid,9,13-di-cis-retinoicacid,and
14-hydroxy-4,14-retro-retinol in human plasma after liver consumption. _Life Science_ **59**, PL169–177.



Atanassova N, McKinnell C, Turner KJ et al. (2000) Comparative
effects of neonatal exposure of male rats to potent and weak (environmental) estrogens on spermatogenesis at puberty and the
relationship to adult testis size and fertility: evidence for stimulatory effects of low estrogen levels. _Endocrinology_ **141**, 3898–3907.
Barbieri RL (2001) The initial fertility consultation: recommendations concerning cigarette smoking, body mass index, and alcohol and caffeine consumption. _American Journal of Obstetrics_
_and Gynecology_ **185**, 1168–1173.
Beckett GJ and Arthur JR (2005) Selenium and endocrine systems.
_Journal of Endocrinology_ **184**, 455–465.
Bol´umar F, Olsen J, Rebagliato M, and Bisanti L (1997) Caffeine
intake and delayed conception: a European multicenter study
on infertility and subfecundity. European study group on infertility subfecundity. _American Journal of Epidemiology_ **145**,
324–334.
Charles D, Ness AR, Campbell D, Davey Smith G, and Hall MH
(2004) Taking folate in pregnancy and risk of maternal breast
cancer. _British Medical Journal_ **329**, 1375–1376.
Clark AM, Thornley B, Tomlinson L, Galletley C, and Norman RJ
(1998) Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment.
_Human Reproduction_ **13**, 1502–1505.
Czeizel AE and Dudas I (1992) Prevention of the first occurrence
of neural-tube defects by periconceptional vitamin supplementation. _New England Journal of Medicine_ **327**, 1832–1835.
Ebisch IM, Thomas CM, Peters WH, Braat DD, and SteegersTheunissen RP (2007) The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility. _Human_
_Reproduction Update_ **13**, 163–174.
El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, and Flier JS
(2000) Two defects contribute to hypothalamic leptin resistance
in mice with diet-induced obesity. _Journal of Clinical Invesigation_
**105**, 1827–1832.
Emanuele MA and Emanuele N (2001) Alcohol and the male reproductive system. _Alcohol Research and Health_ **25**, 282–287.
Eskenazi B, Kidd SA, Marks AR, Sloter E, Block G, and Wyrobek
AJ (2005) Antioxidant intake is associated with semen quality in
healthy men. _Human Reproduction_ **20**, 1006–1012.
Frisch RE (1987) Body fat, menarche, fitness and fertility. _Human_
_Reproduction_ **2**, 521–533.
Frisch RE, Revelle R, and Cook S (1973) Components of weight at
menarche and the initiation of the adolescent growth spurt in
girls: estimated total water, llean body weight and fat. _Human_
_Biology_ **45**, 469–483.
Fuse H, Kazama T, Ohta S, and Fujiuchi Y (1999) Relationship between zinc concentrations in seminal plasma and various sperm
parameters. _International Urology and Nephrology_ **31**, 401–408.
Galletly C, Moran L, Noakes M, Clifton P, Tomlinson L, and
Norman R (2007) Psychological benefits of a high-protein,
low-carbohydrate diet in obese women with polycystic ovary
syndrome-A pilot study. _Appetite_ **49**, 590–593.
Goumenou AG, Matalliotakis IM, Koumantakis GE, and Panidis
DK (2003) The role of leptin in fertility. _European Journal of_
_Obstetrics Gynecology and Reproductive Biology_ **106**, 118–124.
GrayLE,OstbyJ,MonossonE,andKelceWR(1999)Environmental
antiandrogens: low doses of the fungicide vinclozolin alter sexual
differentiation of the male rat. _Toxicology and Industrial Health_
**15**, 48–64.
Grodstein F, Goldman MB, and Cramer DW (1994) Infertility in
women and moderate alcohol use. _American Journal of Public_
_Health_ **84**, 1429–1432.
Hakim RB, Gray RH, and Zacur H (1998) Alcohol and caffeine
consumption and decreased fertility. _Fertility and Sterility_ **70**,
632–637.



Halliwell B (1999) Antioxidant defence mechanisms: from the beginning to the end (of the beginning). _Free Radical Research_ **31**,
261–272.
Hartmann S, Brors O, Bock J et al. (2005) Exposure to retinoic
acids in non-pregnant women following high vitamin A intake
with a liver meal. _International Journal of Vitamin and Nutrition_
_Research_ **75**, 187–194.
Hassan MA and Killick SR (2004) Negative lifestyle is associated
with a significant reduction in fecundity. _Fertility and Sterility_
**81**, 384–392.
Hawkes WC and Tuek PJ (2001) Effects of dietary selenium on
sperm motility in healthy men. _Journal of Andrology_ **22**, 764–
772.
HenmiH,EndoT,KitajimaY,ManaseK,HataH,andKudoR(2003)
Effects of ascorbic acid supplementation on serum progesterone
levels in patients with a luteal phase defect. _Fertility and Sterility_
**80**, 459–461.
Jensen TK, Giwercman A, Carlsen E, Scheike T, and Skakkebaek NE
(1996) Semen quality among members of organic food associations in Zealand, Denmark. _Lancet_ **347**, 1844.
Juhl M, Olsen J, Andersen AM, and Gronbaek M (2003) Intake of
wine, beer and spirits and waiting time to pregnancy. _Human_
_Reproduction_ **18**, 1967–1971.
JuhlerRK,LarsenSB,MeyerOetal.(1999)Humansemenqualityin
relation to dietary pesticide exposure and organic diet. _Archives_
_of Environmental Contamination and Toxicology_ **37**, 415–423.
Kadir RA, Sabin C, Whitlow B, Brockbank E, and Economides D
(1999) Neural tube defects and periconceptional folic acid in
England and Wales: retrospective study. _British Medical Journal_
**319**, 92–93.
Kenkel S, Rolf C, and Nieschlag E (2001) Occupational risks for
male fertility: an analysis of patients attending a tertiary referral
centre. _International Journal of Andrology_ **24**, 318–326.
Kim YI (2006) Does a high folate intake increase the risk of breast
cancer? _Nutrition Reviews_ **64**, 468–475.
Kort HI, Massey JB, Elsner CW et al. (2006) Impact of body mass
index values on sperm quantity and quality. _Journal of Andrology_
**27**, 450–452.
Langley-Evans SC (2004) Before life begins: preconceptual influences on child health. In: _Biology of Child Health/Aspects of Bio-_
_logical Development in Childhood_ (eds S Neill and H Knowles),
pp. 1–21. Macmillan Palgrave, Basingstoke, UK.
Langley-Evans SC and Langley-Evans AJ (2001) Use of folic acid
supplements in the first trimester of pregnancy. _Journal of the_
_Royal Society for the Promotion of Health_ **122**, 181–186.
Larsen SB, Spano M, Giwercman A, and Bonde JP (1999) Semen
quality and sex hormones among organic and traditional Danish
farmers. ASCLEPIOS Study Group. _Occupational and Environ-_
_mental Medicine_ **56**, 139–144.
Laurence KM, James N, Miller MH, Tennant GB, and Campbell
H (1981) Double-blind randomised controlled trial of folate
treatment before conception to prevent recurrence of neuraltube defects. _British Medical Journal_ **282**, 1509–1511.
Lenzi A, Lombardo F, Sgro P et al. (2003) Use of carnitine therapy in
selected cases of male factor infertility: a double-blind crossover
trial. _Fertility and Sterility_ **79**, 292–300.
Luck MR, Jeyaseelan I, and Scholes RA (1995) Ascorbic acid and
fertility. _Biology of Reproduction_ **52**, 262–266.
Magnusdottir EV, Thorsteinsson T, Thorsteinsdottir S, Heimisdottir M, and Olafsdottir K (2005) Persistent organochlorines,
sedentary occupation, obesity and human male subfertility. _Hu-_
_man Reproduction_ **20**, 208–215.
Marsh K and Brand-Miller J (2005) The optimal diet for women
with polycystic ovary syndrome? _British Journal of Nutrition_ **94**,
154–165.



**Before Life Begins** **45**


Martinez-Frias ML and Salvador J (1990) Epidemiological aspects
of prenatal exposure to high doses of vitamin A in Spain. _Euro-_
_pean Journal of Epidemiology_ **6**, 118–123.
Menezo YJ, Hazout A, Panteix G et al. (2007) Antioxidants to reduce sperm DNA fragmentation: an unexpected adverse effect.
_Reproductive Biomedicine Online_ **14**, 418–421.
Mitchell JH, Cawood E, Kinniburgh D, Provan A, Collins AR, and
Irvine DS (2001) Effect of a phytoestrogen food supplement on
reproductive health in normal males. _Clinical Science_ **100**, 613–
618.
Mitchell M, Armstrong DT, Robker RL, and Norman RJ (2005)
Adipokines: implications for female fertility and obesity. _Repro-_
_duction_ **130**, 583–597.
Moustafa MH, Sharma RK, Thornton J et al. (2004) Relationship
between ROS production, apoptosis and DNA denaturation in
spermatozoa from patients examined for infertility. _Human Re-_
_production_ **19**, 129–138.
MRC Vitamin Study Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study.
MRC Vitamin Study Research Group. _Lancet_ **338**, 131–137.
North K and Golding J (2000) A maternal vegetarian diet in pregnancy is associated with hypospadias. The ALSPAC Study Team.
Avon longitudinal study of pregnancy and childhood. _BJU Inter-_
_national_ **85**, 107–113.
Office for National Statistics (1997) _Health of Adult Britain, 1841–_
_1994_ . Stationery Office, London.
Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, and
Flegal KM (2006) Prevalence of overweight and obesity in the
United States, 1999–2004. _Journal of the American Medical Asso-_
_ciation_ **295**, 1549–1555.
Olsen J (1991) Cigarette smoking, tea and coffee drinking, and
subfecundity. _American Journal of Epidemiology_ **133**, 734–739.
Ozawa M, Nagai T, Fahrudin M et al. (2006) Addition of glutathione or thioredoxin to culture medium reduces intracellular
redox status of porcine IVM/IVF embryos, resulting in improved
development to the blastocyst stage. _Molecular Reproduction and_
_Development_ **73**, 998–1007.
Pasquali R, Gambineri A, and Pagotto U (2006) The impact of obesity on reproduction in women with polycystic ovary syndrome.
_British Journal of Obstetrics and Gynaecology_ **113**, 1148–1159.
Pearce HR, Smith NA, Fox EF, and Bingham TS (1996) Periconceptual folic acid: knowledge amongst patients and health workers
in a London teaching hospital. _British Journal of Family Planning_
**22**, 20–21.
Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, and Sampson EJ
(2005) Biochemical indicators of B vitamin status in the US
population after folic acid fortification: results from the National
Health and Nutrition Examination Survey 1999–2000. _American_
_Journal of Clinical Nutrition_ **82**, 442–450.
Polak G, Koziol-Montewka M, Gogacz M, Blaszkowska I, and Kotarski J (2001) Total antioxidant status of peritoneal fluid in
infertile women. _European Journal of Obstetrics Gynecology and_
_Reproductive Biology_ **94**, 261–263.
Sharpe RM (1999) Fetal and neonatal hormones and reproductive
function of the male in adulthood. In: _Fetal Programming, Influ-_
_ences on Development and Disease in Later Life_ (eds PMS O’Brien,
T Wheeler, and DJP Barker), pp. 187–194. Royal College of Obstetrics and Gynaecology Press, London.
Sharpe RM and Irvine DS (2004) How strong is the evidence of
a link between environmental chemicals and adverse effects on
human reproductive health? _British Medical Journal_ **328**, 447–
451.
Shultz TD, Bonorden WR, and Seaman WR (1991) Effect of
short-term flaxseed consumption on lignan and sex hormone
metabolism in men. _Nutrition Research_ **11**, 1089–1100.



**46** **Nutrition: A Lifespan Approach**


Sillender M (2000) Continuing low uptake of periconceptual folate
warrantsincreasedfoodfortification. _JournalofHumanNutrition_
_and Dietetics_ **13**, 425–431.
SopranoDRandSopranoKJ(1995)Retinoidsasteratogens. _Annual_
_Review of Nutrition_ **15**, 111–132.
Tan KA, Walker M, Morris K, Greig I, Mason JI, and Sharpe RM
(2006) Infant feeding with soy formula milk: effects on puberty
progression, reproductive function and testicular cell numbers
in marmoset monkeys in adulthood. _Human Reproduction_ **21**,
896–904.
van Vliet T, Boelsma E, de Vries AJ, and van Den Berg H (2001)
Retinoic acid metabolites in plasma are higher after intake of
liver paste compared with a vitamin A supplement in women.
_Journal of Nutrition_ **131**, 3197–3203.


**Self-Assessment Questions**


Assess your understanding of the concepts outlined in
this chapter using the following questions:


1 Describe the endocrine control of reproductive function in females.
2 Describe the endocrine control of reproductive function in males.
3 Explain the relationship between body fatness and fertility in women. Why do underweight and overweight
women have difficulty conceiving a child?



Westphal LM, Polan ML, and Trant AS (2006) Double-blind,
placebo-controlled study of Fertilityblend: a nutritional supplement for improving fertility in women. _Clinical and Experimental_
_Obstetrics and Gynecology_ **33**, 205–208.
WHO (2005) The SuRF Report 2. Surveillance of chronic disease
risk factors, World Health Organisation, Geneva, Switzerland.
Williams LJ, Rasmussen SA, Flores A, Kirby RS, and Edmonds LD
(2005) Decline in the prevalence of spina bifida and anencephaly
by race/ethnicity: 1995–2002. _Pediatrics_ **116**, 580–586.
Wong WY, Merkus HM, Thomas CM, Menkveld R, Zielhuis GA,
and Steegers-Theunissen RP (2002) Effects of folic acid and zinc
sulfate on male factor subfertility: a double-blind, randomized,
placebo-controlled trial. _Fertility and Sterility_ **77**, 491–498.


4 Describe trends in male fecundity and discuss the
nutrition-related factors that may limit fertility.
5 Review the evidence that there is an association between antioxidant intake and human fertility.
6 Explain the importance of folic acid during the periconceptual period. Describe the different approaches
that have been adopted in developed countries to improve folate status in women of childbearing age.



# **3**
### **Pregnancy**

**Learning objectives**


By the end of this chapter, the reader should be able

to:


r Describe the physiological adaptations that occur during pregnancy and their role in maintaining the products of conception (placenta and fetus).
r Show an appreciation of the increased maternal de~~mand for energy, protein, and micronutrients during~~

pregnancy.
r Discuss the adaptations to maternal physiology and behavior that enable nutrient demands to be met even in

relatively undernourished women.
r Demonstrate an understanding of the importance of
iron for the maintenance of normal pregnancy.
r Describe the nutrition-related factors that determine
the risk of miscarriage and stillbirth.


**3.1 Introduction**


Human pregnancy is a period of remarkable adaptations that impact upon physiology and metabolism
in a manner that is unlike any other scenario, at any
stage of life. Pregnancy does not only involve the development of a new individual from the single-celled
zygote formed by gamete fusion at the moment of
conception. It is also a period of profound alterations
within the maternal system, as considerable changes
to the endocrine milieu dictate adaptations that maintain and support the pregnancy, prevent immunological rejection of the fetus, and ensure that maternal
homeostasis is maintained.

Human gestation lasts for 40 weeks, timed from
the last menstrual period of the mother. Birth in fact
occurs 38 weeks postconception. The 40 weeks of gestation are divided into three trimesters, which correspond to the main phases of embryonic and fetal
development. The first trimester (conception to 12
weeks) is the period of maximum vulnerability for
the embryo, as at this stage it has to implant into the



r Show an understanding of the risk to the infant, associated with preterm delivery, and describe the role of
nutrition in determining this risk.
r Describe the hypertensive disorders of pregnancy and
discuss the physiological and metabolic processes that
lead to pre-eclampsia.
r Discuss the potential for nutritional intervention for the
~~prevention of pre-eclampsia.~~
r Discuss the high incidence of nausea and vomiting and
pregnancy, describing the possible hormonal causes
and impact of these symptoms and associated eating
behaviors upon pregnancy outcomes.
r Demonstrate an awareness of the fetal disorders that
are related to excessive maternal consumption of alcohol.

r Highlight the hazards associated with obesity in preg
nant women.


uterine lining, establish the supporting placenta, and
undergo development from a cluster of cells to an individual of approximate human morphology with a
vascular system and a number of functional organs.
The first trimester is the stage where the formation of
all organ systems is initiated (organogenesis).
During the first trimester of pregnancy, women acquire an additional organ. The placenta is a major
organ system, which may weigh as much as 1.5 kg
by the time of birth. It is formed from a pooling of
fetal and maternal tissue and provides the interface
across which nutrients, gases, immune signals, and
hormones can be transferred in both directions. Dur
ing implantation, the chorionic layer of the embryo
projectsvilliintotheliningoftheuterus,aprocessthat
is aided by release of cytokines that enable the embryo,
firstly, to adhere to the uterus and, secondly, to invade
the tissue. Within the chorionic villi, the embryo establishes a network of arterioles and veinules that will

eventually form the umbilical artery and umbilical
vein, within the cord that links fetus to placenta. On
the maternal side of the developing placenta, uterine



**48** **Nutrition: A Lifespan Approach**


tissue is modified so that uterine arteries feed a series of blood sinuses that form around the chorionic

villi. These sinuses fill with maternal blood, which is
then drained via the uterine veins. The chorionic villi

enclosing the embryonic and fetal vessels are thus in
close proximity to maternal blood, allowing exchange
of materials. Gases, such as oxygen and carbon dioxide, and most nutrients in maternal circulation can
passively diffuse across the two barriers formed within
the placenta (the chorionic membrane and the epithelial cells of the fetal blood vessels). Some nutrients,
particularly the minerals, cross the placenta by active
transport.
The placenta is therefore responsible for supplying
the developing fetus with the nutrients and oxygen
it requires, and also removes the waste products of
fetal metabolism. The placenta has other functions.
It effectively acts as a barrier to the passage of many
potentially harmful agents. Water-soluble material requiring active transport will be effectively barred from
the fetal circulation, so only fat-soluble toxins and teratogens, for example, alcohol, are likely to cross from
mother to fetus. The placenta is also a key endocrine
organ, synthesizing many of the hormones that shape
maternal physiology during pregnancy.
The second trimester (13–27 weeks gestation) is the
period where most of the emphasis of fetal development is on growth, with the average fetus increasing
in mass from approximately 25 to 875 g. By the end
of this period, the fetus is considered viable, that is,
it has a reasonable chance of survival if born prematurely, despite the fact that many organ systems are
immature. During the third trimester (28–40 weeks),
growth remains rapid and the fetus will quadruple
in weight. Some of this increase in weight is due to
increased body size (i.e., truncal growth), but there
is also deposition of stores of fat and other nutrients
during this period. The third trimester sees the maturation of all organ systems in preparation for birth
(Table 3.1).
The maternal hormonal environment is trans
formed during pregnancy. Initially, the remnants of
the corpus luteum and the chorionic layer of the embryo are the main sources of progesterone, estrogen,
and human chorionic gonadotrophin (hCG). These
hormones act upon the uterine lining and prepare
the maternal environment for implantation of the
embryo and formation of the placenta. Most of the
events in the first trimester are controlled by hor


**Table 3.1** Development of the human organs during gestation


Organogenesis Formation
Organ begins complete


Brain 3 weeks 28 weeks

Heart 3 weeks 6 weeks

Lungs 5 weeks 24–28 weeks
Liver 3–4 weeks 12 weeks

Gastrointestinal tract 3 weeks 24 weeks

Kidneys 4–5 weeks 12 weeks
Limbs 4–5 weeks 8 weeks

Eyes 3 weeks 20–24 weeks
Genitals 5 weeks 7 weeks

Spinal cord 3–4 weeks 2 weeks


mones of ovarian origin. These are produced in response to embryonic chorion synthesis of luteinizing
hormone in order to maintain the corpus luteum.
Beyond the first trimester, pregnancy is dominated
by progesterone produced by the placenta. Estrogen
concentrations also rise to more than the peak level
seen at ovulation. The maternal adrenals undergo
change and increase the production of cortisol and
aldosterone, which have important consequences for
metabolism, transport, and processing of nutrients.
The placenta itself releases hormones, such as placental growth hormone, that have important metabolic
functions. In addition to these agents, there are a
wide range of hormonal products that have importanteffectsuponthematernalbrainandwhichmodify
homeostatic processes. These include corticotrophin
releasing hormone, galanin, renin, cholecystokinin,
leptin, thyroid stimulating hormone, serotonin, and
growth hormone.
This chapter will describe the physiological and
metabolic changes that occur during pregnancy and
how these alter maternal requirements for nutrients.
Discussion will also focus on the importance of maternal nutrition in maintaining a healthy pregnancy
and the relationships between nutrition-related factors and adverse pregnancy outcomes.


**3.2 Physiological demands of pregnancy**


Pregnancy is a period of intense physiological adaptations and involves constant responses to the need for
oxygen, nutrients, and to the changing hormonal environment.Overall,pregnancyisananabolicstateand



hormones produced by the placenta ensure that nutrients are metabolized in a manner that allows main
tenance of maternal homeostasis, provides support
for the growth of the placenta and fetus, and prepares
the maternal system for later lactation (King, 2000).
Many of the adaptations that are necessary to maintain a successful pregnancy occur at a very early stage
of gestation. Although growth of the fetus is limited in
thefirsttrimester,asdescribedabove,thisistheperiod
where implantation occurs and the placenta becomes
established. The maternal cardiovascular, renal, and
respiratory systems undergo major change, early in
pregnancy, to be able to support placental perfusion
and delivery of oxygen and nutrients that will drive
the later growth of the fetus.


_**3.2.1 Maternal weight gain and body**_
_**composition changes**_


Weight gain in pregnancy can be highly variable, but
typically will be of the order of 12.5 kg. Most of this
weight gain occurs during the second half of gestation.
As shown in Figure 3.1, only a third of the weight gain
is due to the growth of the fetus, and most of the
increase is attributable to maternal changes. Some of
the changes to maternal weight are explained by altered cardiovascular and renal functions, which serve
to increase the blood volume and drive retention of

water in the interstitial compartment. There are also
major increases in the size of the uterus as the pregnancy proceeds, and the breasts can increase in size
by up to 0.5 kg. This latter change appears to be an
adaptation to ensure that the breasts are ready for lactation after the birth of the baby. Women also deposit
large reserves of fat, typically in the abdomen, thighs,
and back. These reserves start to be mobilized in later


**8**



**Pregnancy** **49**


**Table 3.2** Optimal weight gain for women in pregnancy is dependent
upon their pre-pregnancy BMI


BMI at conception Optimal maternal weight gain


_<_ 19.8 12.5–18.0

19.8–26.0 11.5–16.0

_>_ 26.0 7.0–11.5



**6**


**4**


**2**







**0**
**Conceptus** **Mother**


**Figure 3.1** The components of maternal weight gain during

pregnancy.



Optimal weight gain ranges are those associated with favorable pregnancy outcomes for mother and fetus and
which lead to birth weight between 3.1 and 3.6 kg (Butte
and King, 2005).


stages of pregnancy to drive fetal growth, and also act
as an energy source for later lactation.
As will be described later in this chapter, maternal
weight gain is an important predictor of pregnancy
outcome. Insufficient or excessive weight gains are associated with poor outcomes for both mother and fetus.Desirableweightgainsarethereforeinarangethat
optimizes maternal survival, reduces complications in
pregnancy and labor, and which give the greatest fetal
growth and protection from morbidity and mortality
(Butte and King, 2005). It is suggested that the optimal range of maternal weight gain is dependent upon
maternal body mass index (BMI) prior to pregnancy.
As shown in Table 3.2, women who are underweight
prior to pregnancy should be aiming for a greater degree of weight gain, while the overweight may need to
control weight gain to some degree.


_**3.2.2 Blood volume expansion and**_
_**cardiovascular changes**_


During pregnancy, there is a need for the maternal
cardiovascular system to adapt in order to supply enlarged organs and maintain the perfusion of the placenta. This ensures an adequate exchange of materials
with the fetal compartment. Placentation necessitates
an increase in the overall volume of blood within
the maternal system and this is achieved through a
repartitioning of water between the intracellular and
extracellular compartments. Overall, body water increases by 1.5 L (pre-pregnant body water volume is
2.6 L) within the first 20 weeks of pregnancy, and continues to rise throughout gestation. The volume of
water held in cells (intracellular fluid) is unchanged,
and the increased fluid volume is partitioned between
the interstitial spaces and the blood plasma.
Increased blood plasma volume has a number of
important consequences. Firstly, the fluid expansion



**50** **Nutrition: A Lifespan Approach**


enables the delivery of the increased workload required of the heart during pregnancy. The heart needs
to deliver more oxygen to tissues than pre-pregnancy,
and the increased vascularization of the uterus and

placenta require a greater cardiac output. The heart
increases in volume by approximately 20% during
pregnancy and this enables a greater stroke volume
(the amount of blood pumped from the ventricles
with each contraction). The pulse rate increases, typically rising from 70 in the nonpregnant state to 85
by late pregnancy. The combination of raised heart
rate and stroke volume increase cardiac output by
40%. Cardiac output is an important contributor to
blood pressure, but the latter remains largely unchanged, as the peripheral resistance to blood flow is
reduced.

The other main consequence of increased plasma
volume is a change in the composition of the blood.
Overall, the plasma volume increases by 40–50% over
the course of pregnancy and this results in a reduction in the concentrations of many plasma proteins,
most notably albumin. In order to meet the increased
demand for oxygen transport, there is greater production of red blood cells and as a result the total
amount of hemoglobin in circulation increases (Figure 3.2). However, as the 20% increase in red cell volume achieved by full-term gestation is considerably
less than the increase in blood volume, the number
of red cells per mL blood and overall hemoglobin
concentration fall, as gestation advances. This makes
diagnosis of iron deficiency anemia more challenging
in pregnancy as the stage of gestation has to be con


sidered. For example, a hemoglobin concentration of
10.5 g/dL would be indicative of anemia in a nonpregnant woman, and in a woman at 20 weeks gestation, but would be considered within normal ranges at
30 weeks.


_**3.2.3 Renal changes**_


Modifications in function of the kidneys are among
the earliest physiological responses to pregnancy. The
purpose of these adaptations is to support the cardiovascular changes, modify maternal fluid balance,
and increase capacity for excretion of metabolic waste.
Tubular reabsorption of water and electrolytes is increased during pregnancy, and although pregnant
women experience more frequent micturition due to
pressure of the uterus upon the bladder, the actual
daily volume of urine produced is only 80% of that
seen in nonpregnant women. Chapman _et al_ . (1998)
observed that blood flow through the maternal kidneys, and hence the glomerular filtration rate, was
significantly increased by 6 weeks gestation and that
renal function reached the maximum for pregnancy
by as early as 8–12 weeks. Increased renal blood flow
and reduced arterial resistance in the kidneys are an
important mechanism through which maternal cardiac output can be increased without producing dangerous increases in blood pressure.


_**3.2.4 Respiratory changes**_


A number of changes take place to improve maternal gaseous exchange. These adaptations ensure that


**Figure 3.2** Changes in iron status during pregnancy. The total
amount of hemoglobin in circulation (□) increases, but due to rising
plasma volume, the hemoglobin concentration (■) decreases.



**600**


**400**


**200**


**0**



**10**


**5**


**0**



the maternal blood is enriched with oxygen and is
effectively cleared of carbon dioxide. This maximizes
concentration gradients across the placental membranes and aids delivery of oxygen and removal of
carbon dioxide from the fetal system. The maternal
diaphragm takes on a greater range of movement and
the ribs flare outward. This means that during early–
mid pregnancy, there is a greater tidal movement of
air during each breath, and effectively more fresh air is
inhaled and more used air exhaled with each breath.

As pregnancy proceeds, the mass of the uterus and
fetus press upon the diaphragm and limit this tidal
movement, but respiratory efficiency is maintained
by a more rapid rate of breathing.
The efficient removal of carbon dioxide from the
maternal blood is of importance for the nutrition of
the fetus as well as for gaseous exchange across the
placenta. Carbon dioxide is transported in the blood
as bicarbonate ions (HCO 3 [−] ). With less of this anion in circulation, there is a reduced requirement for
appropriate cations (Na [+], K [+], and Ca [2][+] ) to be in circulation and these are therefore available for transfer
to the fetus for growth and skeletal mineralization.
Maternal blood concentrations of cations therefore
fall from around 155 m.equiv/L pre-pregnancy, to
147 m.equiv/L in mid-gestation.


_**3.2.5 Gastrointestinal changes**_


The maternal gastro-intestinal tract is influenced by
the high prevailing concentrations of progesterone
and estrogen. These produce adaptations that increase
the capacity of the gut to absorb nutrients and hence
increase availability for incorporation into maternal
orfetalstructuresandstores.Inthestomach,thesecretion of gastric juices is reduced, but gastric emptying
is slowed. This means that ingested food is churned
within the stomach for a longer period and is more effectively pulped. This improves digestion lower down
the tract. The motility of both the small and large intestines is reduced, and this exposes food material to
digestive enzymes for longer, and also increases the
duration of time during which nutrients can be absorbed and water recovered.


_**3.2.6 Metabolic adaptations**_


Demands for energy and protein are increased during
pregnancyandtheseincreaseddemandsarepartlymet
through adaptations in the metabolism of macronutrients. There is an accretion of approximately 0.5 kg



**Pregnancy** **51**


of protein during pregnancy, around half of which is
deposited in the conceptus (fetus and placenta). As
described in the preceding section, pregnancy is associated with decreased gastrointestinal motility and
this improves the absorption of amino acids from ingested food. Absorbed amino acids are transported
to the liver, where normally they would be used in
protein synthesis, or deaminated so that any excess
is excreted via the urine in the form of urea. During
pregnancy, the enzymes responsible for deamination
areinhibitedbyfirsthCGandlaterbyplacentalgrowth
hormone. This means that more amino acids enter the

maternal circulation and these can be used for expansion of maternal tissues and the placenta, or exported
to the fetal compartment.
The hormonal changes that accompany pregnancy
serve to create a state of insulin resistance. By the
second and third trimesters, pregnant women secrete
2–2.5-fold more insulin than in the nonpregnant state
(Barbour, 2003). Despite this, the disposal of glucose in the skeletal muscle and liver is suppressed
and as a result the circulating glucose concentration
remains high, ensuring the supply to the fetal tissues. The mechanisms through which the insulin resistance of pregnancy develops are not fully understood. As shown in Figure 3.3, normal glucose uptake by tissues such as skeletal muscle is dependent
upon translocation of the GLUT4 glucose transporter
to the cell membrane following insulin binding to
the insulin receptor. The insulin signal to GLUT4 depends upon binding of phosphorylated insulin receptor substrate 1 (IRS-1) to phosphatidylinositol 3kinase (PI3-K). Formation of the IRS-1–PI3-K complex is the key event that activates GLUT4 translocation. In pregnancy, it is apparent that the formation of this complex is inhibited, and this essentially
limits glucose uptake by maternal tissues (Barbour,
2003).
Inadditiontothese metabolic adaptations that promote maximum availability of energy substrates to
support the pregnancy, there are behavioral adaptations that similarly make more energy available to the
developing fetus. It is generally reported that pregnant
women alter their profile of food choices and consume
smallerportionsoffoodonamorefrequentbasis.This
helps to maintain raised blood glucose throughout
the day. Furthermore, as pregnancy advances, most
women reduce levels of physical activity and this reduces overall energy expenditure (King, 2000).



**52** **Nutrition: A Lifespan Approach**


Insulin


|Col1|Col2|Col3|Col4|Col5|Col6|Col7|Col8|Col9|Col10|Col11|Col12|Col13|Col14|Col15|Col16|Col17|Col18|Col19|Col20|Col21|Col22|Col23|Col24|Col25|Col26|Col27|Col28|Col29|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||||||||||||||||||||||||
||||||||||||||||||GLUT4||||||||||||







Glucose









**Figure 3.3** The role of GLUT4 in glucose transport. GLUT4 translocation is a key step in movement of glucose across cell membranes. In pregnancy,
the formation of IRS-1–PI3-K complexes is inhibited, leading to insulin resistance.



**3.3 Nutrient requirements in pregnancy**


It should be clear from the preceding sections that
pregnancy is a time of major remodeling of maternal tissues, deposition of new tissue in the uterus
and in the form of the placenta, and of considerable
metabolic change. As a result, maternal demands for
all nutrients would be expected to increase markedly.
It is, however, becoming clear that in normal pregnancy, the same suite of adaptations that leads to
increased nutrient demand also optimizes bioavailability and utilization of nutrients. As a result, major
changes to maternal intake are generally unwarranted.


_**3.3.1 Energy, protein, and lipids**_


Pregnancy considerably increases the maternal demand for energy in order to drive the growth of the
fetus and placenta, the deposition of fat reserves for
lactation, and the expansion of maternal tissues. The
increase in maternal body size in itself will increase
the basal metabolic rate (BMR), and will increase the
amount of energy required for physical activity. Estimates of the total energy cost of pregnancy vary
greatly, but in general most studies support the early
work of Hytten and Leitch (1971) who estimated that
the increase in basal metabolism (30 000 kcal, 126 MJ)
and the extra requirement associated with increasing
body size (40 000 kcal, 167 MJ) totaled 70 000 kcal



(293MJ)overthewholegestationperiod.Thisequates
to an extra requirement of 250 kcal/day (1.04 MJ/day).
Studies of pregnant women in developed countries
show that this energy demand is not met by increased
intakesofenergy.Durnin(1991)reportedthatwomen
typically did not increase intake at all until the third
trimester, and even then, increases were only of the order of 100 kcal/day (0.42 MJ/day). Despite an apparent shortfall of energy intake, the women had normal
pregnancy outcomes. This and other studies strongly
suggested that pregnancy is associated with adaptive
responses to conserve energy.
Conservation of energy may involve reductions of
either basal metabolism or physical activity (King,
2000). Prentice and Goldberg (2000) suggested that
there is wide variation in the metabolic response
to pregnancy. While most women increase BMR as
would be expected with increasing tissue mass, some
women actually exhibit a decrease during early gestation. This form of energy conserving response is most
common among women who are undernourished,
with limited fat stores and high demands for physical activity to ensure survival (e.g., women depending on subsistence agriculture in developing countries). In developed countries where the food supply is secure, most energy conservation is likely to
occur through reduction in overall levels of physical activity, or improved efficiency of movement
(Durnin, 1991). A number of studies have shown that



pregnant women perform a similar range of activities to nonpregnant women, but generally avoid more
strenuous tasks (King, 2000). Given the greater body
mass in pregnancy, any weight-bearing activity should
involve greater energy expenditure. However, where
weight-bearing exercise is unavoidable, some pregnant women appear to reduce the pace or intensity of
the activity (e.g., walking more slowly while carrying
a load).
It is clear that the control of energy balance in pregnancy is subject to a diverse range of influences and
there is a high level of interindividual variation. This
is explained by the fact that energy requirements and
processes that match intake to expenditure are influenced by rates of maternal weight gain, fetal growth
rates, maternal lifestyle and activity levels, maternal
body composition, and genetic factors (King, 2000).
In the UK, COMA suggested an additional increment
of 200 kcal/day (0.84 MJ/day) to be added to the EAR
(Department of Health, 1999). This assumed an average pregnancy weight gain of 12.5 kg and a fetus of
average weight at birth. Women who are underweight
prior to pregnancy and those who are unable to reduce physical activity may require greater increases



**Pregnancy** **53**


in energy intake. In the US, the RDA for pregnancy
includes an increment of 300 kcal/day, targeted at the
second and third trimesters.
Thereareundoubtedlymajorrequirementsforprotein during pregnancy. Growth of the fetus, placenta,
and maternal tissues all require protein deposition.
However, there are no recommendations for major
changes to maternal intakes in developed countries.
In the UK, the RNI increment for pregnancy is a mere
6 g/day, while in the US, an RDA increment of 10 g/d
is advised (Millward, 1999). With intakes of protein
in developed countries ranging from 60 to 110 g/day,
there seems no need for dietary change to meet demands for protein. However, women in developing
countries and women from poor backgrounds may
struggle to obtain dietary protein requirements. As
will be described in Chapter 4, this may be associated
with long-term disease risk in their offspring.
The dietary supply of essential fatty acids may become important during pregnancy. These lipids give
rise to the n-6 and n-3 series of fatty acids, which have
major biological functions (Figure 3.4). The longchain polyunsaturated fatty acids (LCPUFAs) from
theseseriesgiverisetothepro-andanti-inflammatory



n-6 Fatty acid series n-3 Fatty acid series























































**Figure 3.4** The biosynthesis of long-chain polyunsaturated fatty acids from the essential fatty acids.



**54** **Nutrition: A Lifespan Approach**


eicosanoids and hence modulate cell-signaling pathways. LCPUFAs are also involved in the regulation
of gene expression through their interaction with
transcription factors (Wainwright, 2002). In humans,
LCPUFAs are heavily concentrated in the brain and
retina, where they account for approximately 35% of
the total fatty acid profile. The fetal and neonatal brain
has particularly high demand for arachidonic acid (n6 series) and docosahexaenoic acid (DHA, n-3) series.
While these can be synthesized de novo from the essential dietary fatty acids, as shown in Figure 3.4, in
the fetal brain the activity of these pathways is low.
There is consequently a dependence upon their transfer across the placenta from the maternal circulation.
The accrual of DHA, in particular, in the fetal brain
and retina occurs largely during the third trimester.
DHA is incorporated into phosphatidylethanolamine
and phosphatidylserine in these tissues (Innis,
2005).
Transfer of LCPUFAs from mother to fetus appears
to occur at a rate that is closely correlated with maternal intake. Maternal concentrations are predictive of
arachadonic acid and DHA concentrations in umbil
ical cord plasma and red cells at birth (Connor _et al._,
1996). The best sources of LCPUFAs in the diet are oily
fish, eggs, meat, and certain seed oils. Maintaining an
adequate supply to the fetus appears to be critical to
neurodevelopment as maternal intakes are predictive
of brain fatty acid composition and size in the fetus (Wainwright, 2002). Depletion of DHA has been
associated with reduced visual function and learning defects in children. Intervention using supplements of cod liver oil and other n-3 containing sources
have suggested that maternal supplementation from
the start of the second trimester may improve visual evoked potentials and performance on tests
of intelligence and achievement in infants (Jensen,
2006).
A number of observational studies have suggested
that low maternal intakes of LCPUFAs may be associated with adverse outcomes of pregnancy. High
intakes of n-3 fatty acids have been proposed to extend gestation, increase weight at birth, and reduce
risk of premature delivery (Jensen, 2006). This raises
the possibility that pregnant women might be recommended to consume supplements of these lipids. For
some groups of women, this could be more important than for others. Vegetarian or vegan mothers, for
example, consume a pattern of diet that strongly fa


vors the generation of n-6 series fatty acids over the
n-3series(Sanders,1999).However,well-designedintervention studies that have considered the impact of
LCPUFA supplementation upon pregnancy outcomes
have been inconsistent and inconclusive in their findings. Balanced against the desire to boost availability
of substrates for fetal brain growth are concerns about
the contamination of fish oils with mercury and other
potentially teratogenic agents. Moreover, some studies have suggested that fish oil supplementation may
increase maternal bleeding and risk of postpartum
hemorrhage (Jensen, 2006).


_**3.3.2 Micronutrients**_


**3.3.2.1 Iron**

Maternal requirements for iron during pregnancy are
high, with the fetus taking up as much as 400 mg
over full gestation, with up to 175 mg accumulating
in the placenta (Whittaker _et al._, 1991). With further allowances for maternal production of red blood
cells and blood losses during delivery, an extra 430–
1000 mg are required in a normal pregnancy. To some
extent, these requirements are delivered through savings associated with the cessation of menstrual cycling, but women still require an extra 1 mg/day in
the first trimester, rising to 6 mg/day in late gestation.
Little adjustment to the diet is generally required, as
absorption of iron across the gut increases markedly
from 7.6% of ingested iron in the first trimester to
37.4% by 36 weeks gestation.
Poor maternal iron status is a recognized risk factor
for preterm delivery, low birth weight, and neonatal
death, particularly in the developing countries. Iron
deficiency anemia is highly prevalent in many populations, and in some parts of the world more than
half of pregnant women will be affected. The timing
of onset of iron deficiency anemia is important in
predicting outcome. Klebanoff and colleagues (1991)
showed that there was no association between third
trimester anemia and preterm delivery, but risk was
increased by almost twofold in women with anemia
between 13 and 26 weeks gestation. This is in keeping
with the fact that iron deficiency exerts its influence
onpregnancyoutcomesthroughimpactuponthematernal plasma volume expansion, which is at a critical
phase in the second trimester of pregnancy.
Elevated hemoglobin (greater than 14.5 g/L) is
also predictive of adverse pregnancy outcomes (more



preterm delivery, more low birth weight, and greater
risk of fetal death), suggesting that the relationship
between iron status and pregnancy outcomes is Ushaped (Scholl and Reilly, 2000). Raised hemoglobin
is indicative of a failure to increase plasma volume and
the ensuing hypovolemia results in cardiac output and
placental perfusion being suboptimal.
In developing countries, iron supplementation
may be an important element of antenatal care that
could significantly reduce the risk of perinatal death.
Many studies have shown that iron supplements,
either in isolation or when combined with other
nutrients such as folic acid, can increase average
birth weights and significantly reduce the prevalence
of low birth weight (Mishra _et al_ ., 2005). There is
some concern, however, that giving iron alone could
lead to other micronutrient deficiencies, for example,
zinc and copper, by competing for gastrointestinal
uptake. Some studies suggest that optimal supplementation strategies should include a wider range of
micronutrients (Zagr´e _et al_ ., 2007).
Among better nourished women from industrializedcountries,thebenefitsofroutineironsupplementation are questionable, and in many nations (e.g.,
the UK), this practice has been abandoned. Given
that iron supplements lead to constipation and other
gastrointestinal symptoms, and are expensive when
administered on a population-wide scale, it is reasoned that supplementation should be reserved for
women with greater need, for example, those with
multiple pregnancies, or women with iron deficiency
anemia. Even among this latter group, the benefits
of iron supplementation are unclear. Certainly, iron
status is improved by supplementation (Scholl and
Reilly, 2000), but there is little evidence that the intervention will prevent preterm birth or reduce the
likelihood of low birth weight. Most trials to assess
the efficacy of supplementation are hampered by the
fact that they only recruit women with preexisting
iron deficiency anemia. As anemia is generally diagnosed only after the plasma volume expansion has
been largely completed, it is unlikely that intervention will have any impact upon adverse outcomes
related to impaired cardiovascular adaptations to

pregnancy.


**3.3.2.2 Calcium and other minerals**

The fetus accumulates large quantities of most minerals during late gestation. The fetal skeleton de


**Pregnancy** **55**


posits calcium, magnesium, and phosphorus in the
last trimester of pregnancy, and high uptakes of
zinc, copper, and other trace metals are also noted.
In some countries, notably the US, these increased
demands associated with pregnancy have prompted
the inclusion of pregnancy increments over and
above the published RDA values. In the UK, however, there are no extra allowances for pregnancy,
as it is assumed that maternal adaptations are capable of providing sufficient mineral to maintain fetal
demands.
Pregnancy is associated with improved absorption
of most micronutrients from the digestive tract due to
the increased gastrointestinal transit times. Increased
absorption and the mobilization of minerals from
stores in the maternal skeleton ensure the fetal supply.
In the case of magnesium, for example, the fetus accumulates an average of 8 mg/day over the full gestation.
To meet this demand, with an average absorption of
50% of dietary magnesium, and to meet the demand
for magnesium from the placenta and other maternal structures, pregnancy increases overall demand by
26 mg/day (Department of Health, 1999). Given that
average intakes are in the range 200–280 mg/day, this
is a small extra demand that should be easily met by
release from the skeleton where 60% of magnesium is
stored.

The same principle applies to calcium, phosphorus,
copper, and zinc. Demand for zinc is considerable in
late gestation at 5.6–14 mg/day, which is in excess
of normal ranges of intake. However, zinc supplementation studies have shown little or no benefit for
pregnant women and their babies. Similarly, studies
of pregnant women with mild–moderate zinc deficiency show that there are no adverse consequences.
It is therefore assumed that the increased requirement
is met by mobilizing stores (Department of Health,
1999).
The only circumstances in which mineral nutrition
may become problematic in pregnancy are when the
mother is still growing. Adolescent pregnancy is a risk
factor for many adverse outcomes of pregnancy, and
much of the risk is associated with competition for
nutrients between the growing fetus and the maternal system. Antenatal mineral supplementation may
therefore be appropriate for this age group.
Iodineisanessentialnutrientforfetaldevelopment,
where it is particularly important in the development
of the central nervous system during the first trimester



**56** **Nutrition: A Lifespan Approach**


Dietary vitamin D 2 and







Skin



**Figure 3.5** The metabolism of vitamin D.



Bile

salts



25-hydroxy vitamin D 3 1,25-hydroxy vitamin D 3 24,25-hydroxy vitamin D 3
**Active** **Inactive**



of pregnancy. Severe maternal iodine deficiency is associated with fetal death, or with cretinism in the
affected baby. In countries such as the UK, where iodine deficiency is extremely rare, the extra 25 µg/day
iodine required during pregnancy is comfortably delivered by dietary sources. However, in countries
where iodine status tends to be poor, pregnancy is
a time when careful intervention should be implemented. Most countries where iodine deficiency disorders are a problem have implemented fortification
schemes, such as the highly successful Universal Salt
Iodization program. However, several studies have
suggested that these programs either fail to reach a
significant number of pregnant women, particularly
in developing countries, or lack the capacity to produce sufficient increases in iodine status in pregnant
women. The World Health Organization states that
urinary iodine excretion of 100–199 µg/L is indicative
of healthy iodine status in nonpregnant adults, and
that this should increase to 150–249 µg/L in pregnant
women. Burgess and colleagues (2007) reported that,
in Australia, the fortification of bread with iodine did
not significantly improve iodine status of pregnant
women. Marchioni _et al_ . (2008) reported that 92%
of women in a sample of Italian pregnancies had inadequate iodine status, despite a program of salt iodination. In both the Australian and Italian studies,
the median urinary iodine concentrations reported
were around 80 µg/L and hence well below acceptable
levels.



**3.3.2.3 Vitamin D**

Pregnant women have increased requirements for
vitamin D, by virtue of the increased mobilization
of calcium for transfer across the placenta to drive
growth of the fetal skeleton. Pregnancy is associated with changes in the metabolism of vitamin D.
Concentrations of the biologically active form, 1,25dihyroxy vitamin D 3 (1,25-dihydroxycholecalfiferol,
Figure 3.5), are increased, while circulating 25hydroxy vitamin D 3 (25-hydroxycholecalciferol) decreases. Pregnant women show a marked seasonal
variation in vitamin D status in climates where sun
light is markedly lower in the winter months, and as
a result, their babies are at greater risk of defects associated with calcium metabolism and dental problems
associated with vitamin D deficiency (Department of
Health, 1999). Javaid _et al_ . (2006) reported that vitamin D insufficiency was relatively common (31%)
in a population of otherwise well-nourished pregnant British women. Eighteen percent of these women
were classified as vitamin D deficient. Interestingly, after adjustment for appropriate confounding factors,
the mothers’ 25-hydroxycholecalciferol concentrations were predictive of their children’s bone mass at
9 years of age. This supports the idea that maternal vitamin D status is of major importance in fetal skeletal
development. In common with similar recommendations in other countries, women in the UK are advised
to either increase their intake of vitamin D-fortified
foods, or to consume a supplement of 10 µg/day.



**3.4 Diet in relation to**
**pregnancy outcomes**


Human gestation is long and has evolved to maximize
the growth of the brain and produce an infant that is
well developed and relatively mature when compared
to many other mammalian species. The long gestation brings with it an extended period during which
the developing infant is vulnerable to adverse factors
that impact upon the mother. Many of these adverse
factors can compromise the pregnancy by imposing
physiological and metabolic stressors upon a maternal system that is already operating outside normal
functional limits. Although modern medical care has
drastically reduced the impact of an adverse environment upon maternal and fetal health, pregnancy remains a hazardous process. Nutrition-related factors
play an important role in determining the outcomes
of pregnancy.


_**3.4.1 Miscarriage and stillbirth**_


Miscarriage, also termed spontaneous abortion, is defined as the natural end of pregnancy at a stage of
fetal development prior to the fetus being capable of
survival. With modern medical technology, fetuses of
23–24 weeks gestation may be considered viable, so
miscarriage refers to loss of pregnancy prior to this
stage. Later in pregnancy, the fetus may die either
prior to delivery or during the delivery. The former
case is termed late fetal death, while the latter is referred to as stillbirth. The death of a baby within the
first 28 days after delivery is termed neonatal death.
There are a number of indicators that nutritionrelated factors are predictive of miscarriage or later
loss of the fetus. Miscarriages occur in approximately
15% of pregnancies and their causes are generally unexplained. The major risk factors for miscarriage in
the first trimester of pregnancy are a previous history
of miscarriage, assisted conception, being an older
woman, alcohol consumption, and having a low BMI
prior to pregnancy (Maconochie _et al_ ., 2007). Women
with a pre-pregnancy BMI below 18.5 kg/m [2] (i.e.,
underweight) have been reported to have between
24% and 72% greater risk of miscarriage than women
with a BMI of 18.5–24.9 kg/m [2] going into pregnancy
(Helgstrand and Andersen, 2005). It is suggested that
this risk may be associated with lower circulating leptin concentrations. Leptin plays a key role in the regu


**Pregnancy** **57**


lation of ovarian function and is also involved in promoting angiogenesis, which is an important process
in the implantation of the embryo and development
of the placenta.
Overweight or obesity do not appear to have an
impact upon the risk of miscarriage in women who
conceive naturally (Maconochie _et al_ ., 2007), but in
women undergoing assisted reproduction may increase the risk of early spontaneous abortion by up
to fourfold (Yu _et al_ ., 2006). Women with polycystic ovary syndrome find conception difficult. Among
such women, obesity increases risk of miscarriage by
25–37%. Wang and colleagues (2002) showed that
among women undergoing fertility treatment, both
overweight (BMI 25–29.9 kg/m [2] ) and obesity (BMI
_>_ 30 kg/m [2] ), significantly increased risk of miscarriage. Risk increased in proportion to BMI, such that
women with BMI in excess of 35 kg/m [2] had a 2.19fold greater risk of losing their pregnancies. Obesity
also increases the risk of later fetal death and has been

shown to increase occurrence of both stillbirth and
neonatal death by more than twofold (Yu _et al_ ., 2006).
Alcohol is often identified as a risk factor for miscarriage, and pregnant women are advised to avoid
alcohol completely, or to reduce intake to one or two
units per week. Hannigan and Armant (2005) suggest
that alcohol is a particular cause of spontaneous abortion later in pregnancy and that rates of miscarriage
are up to threefold higher in heavy drinkers compared
to nondrinkers. Despite this concern, it appears that
moderate amounts of alcohol consumption (less than
14 units per week) do not increase risk of miscarriage
significantly (Maconochie _et al_ ., 2007).
Several studies have identified caffeine as a potential risk factor for miscarriage, and although the data
are not clear-cut and the area is controversial, the
Food Standards Agency in the UK has recommended
that pregnant women reduce intake to no more than
300 mg/day. This is equivalent to approximately 3
mugs of instant coffee. Weng and colleagues (2008)
studied a population of over 1000 women and found
that consumption of caffeine at a level above 200 mg/
day from any source (coffee or other beverages containing caffeine) increased the odds of miscarriage by
2.23 (95% CI 1.34–3.69). Women consuming caffeine
at lower levels were not at any significant risk of miscarriage when compared to nonconsumers.
Some degree of protection against miscarriage may
be obtained through appropriate dietary advice and



**58** **Nutrition: A Lifespan Approach**


change at the start of pregnancy. Maconochie and colleagues (2007) found that women who took micronutrientsupplements,notablythosecontainingfolicacid
or iron, reduced risk of first trimester miscarriage by
as much as 47%. Similarly, women who consumed
fresh fruit and vegetables on a daily basis were half
as likely to suffer a miscarriage as women who did
not consume these foods daily. Kramer and Kakuma
(2003) performed a systematic review of the literature
to explore the influence of nutritional advice to pregnant women, and supplemental energy and protein
during pregnancy, upon pregnancy outcomes. They
did not report any significant effects of advice or supplements upon risk of miscarriage, but found that nutritional advice and balanced supplements of energy
and protein reduced the occurrence of both stillbirth
and neonatal death.


_**3.4.2 Premature labor**_


Babies who are born prior to 37 weeks gestation are
termed premature, or preterm. Preterm delivery is the
main cause of perinatal death and neonatal morbidity
in developed countries. It is also associated with significant levels of disability among children. As such,
premature birth is associated with a major human
cost, and also has a significant economic impact upon
health services, due to the expense of neonatal intensive care.

Intrauterine growth retardation leading to a smallfor-gestational age (SGA) baby is commonly associated with preterm delivery. There are many other
known risk factors for premature labor, including maternal infection, psychological trauma of the mother,
and maternal smoking (Table 3.3), but around a third
of cases are of no known cause. Lifestyle factors including nutrition-related factors and excessive physi

**Table 3.3** Risk factors for preterm delivery


Risk factor Explanation of risk



cal activity are believed to contribute to some of these

cases.


**3.4.2.1 Pre-pregnancy BMI and pregnancy**
**weight gain**
Studies of the relationship between pre-pregnancy
BMI and weight gain in pregnancy suggest that risk of
preterm delivery may be increased at either extreme
of their ranges. Obesity and overweight are widely
regarded as risk factors for preterm delivery. The association with risk of preterm delivery in these cases
appears to be a result of the increased prevalence of
complicationsofpregnancythatstemfromthegreater
blood pressures and relative insulin resistance that accompany obesity. These are more likely to necessitate
medical intervention and premature induction of labor. A study of the very large Danish National Birth
cohort (100 000 women, studied between 1996 and
2002) showed that a pre-pregnancy BMI in the obese
range (over 30 kg/m [2] ) significantly increased risk of
both induced and spontaneous preterm birth by approximately 50% (Nohr _et al_ ., 2007). This risk was
enhanced by excessive weight gain during pregnancy
(more than 676 g/week). However, a study of a cohort
that included only women screened to exclude those
with gestational diabetes found that there was not
an association of overweight or obesity with preterm
birth (Jensen _et al_ ., 2003).
Maternal underweight has been shown in some
studies to increase risk of preterm birth to the same
extent as obesity. The study of Nohr _et al._ (2007)
showed a 40% increase in risk comparing women
with a pre-pregnancy BMI of less than 18.5 kg/m [2]

to those with a BMI between 18.5 and 24.9 kg/m [2] .
Lower weight gain in pregnancy was also associated
with greater risk. Other studies are consistent with
this finding, but often report a lower degree of risk



Multiple births Twins and other multiple pregnancies are often delivered early for medical management
Premature rupture of membranes Delivery necessary to avoid infection
Obstetric emergencies Maternal bleeding, placental abruption, or other placental problems require delivery of baby
Cervical incompetence The weight of the uterus in late pregnancy may not be supported by the cervix, leading to delivery
Pre-eclampsia Delivery is only option to prevent maternal and fetal death
Maternal age Mothers under the age of 15, or older than 35, are at greater risk of preterm delivery
Stress Only extremely traumatic psychological stressors will cause premature labor



(Sebire _et al_ ., 2001). The risk associated with underweight and poor maternal weight gain is almost certainly attributable to maternal undernutrition and a
lack of sufficient reserve of energy and other nutrients to meet demands for fetal growth. Merlino and
colleagues (2006) demonstrated, in a small cohort of
women, that underweight women were at greater risk
of preterm delivery when in their second pregnancy
rather than their first pregnancy. This risk was greatly
increased if weight loss corresponding to 5 BMI units
(kg/m [2] ) had occurred between first and second pregnancies. Although this is indicative of a role for undernutrition in promoting preterm birth, studies that
have considered iron deficiency anemia (Scholl and
Reilly, 2000) or the impact of protein and energy status (Kramer and Kakuma, 2003) have not identified a
clear and unequivocal role for specific nutrients.


**3.4.2.2 Alcohol and caffeine consumption**
Alcoholconsumptionduringpregnancyhasanumber
of adverse impacts, of which the most important are
thefetalalcoholsyndrome(FAS,seeSection3.8.3)and
alcohol-related birth defects (ARBD). These are consequences of alcohol consumption at excessive levels,
with women either engaging in regular binge drinking (more than 4 alcoholic drinks in a session) or
chronic daily alcohol use. It is clear from studies of
such women that alcohol has an impact upon gesta

~~**Research Highlight 3**~~ ~~Advice to reduce caffeine intake in pregnancy~~


Caffeine is widely reported as being hazardous in pregnancy, if consumed in large quantities. In the UK, women are advised to restrict
intake to 300 mg/day or less, from all sources, in order to avoid risk
of miscarriage in early pregnancy, or preterm delivery later in gestation. Associations between caffeine and miscarriage risk are well
established, but the relationship with preterm birth is controversial.
The idea that caffeine may be a risk factor for preterm labor is
plausible, since caffeine is known to cross the placental barrier to
act in fetal tissues, increases maternal catecholamine production,
and diminishes placental blood flow. Moreover, in pregnancy, the
metabolism of caffeine is inhibited, producing a more protracted response to any given dose. Coffee is the main source of caffeine in
the diet. Although most women become averse to coffee and reduce
intake during their pregnancy, it is still consumed to some extent by
70–80% of pregnant women.
The perceived risk of preterm delivery associated with caffeine
stems largely from the fact that it appears to impair fetal growth.
Martin and Bracken (1987) reported that the risk of a low birth
weight baby was increased by 4.6-fold in women consuming caffeine in high quantities. Fetal growth retardation is a recognized



**Pregnancy** **59**


tion length, with somewhere between 25% and 50% of
FAS-associated pregnancies ending in preterm birth
(Hannigan and Armant, 2005).
The impact of lower levels of alcohol use is less
understood, particularly because factors such as low
socioeconomic status tend to confound possible associations between alcohol in pregnancy and preterm
delivery. Some studies have suggested that even low
consumption of alcohol during the final trimester of
pregnancy may increase risk of preterm delivery by as
much as threefold (Lundsberg _et al_ ., 2007), whereas
others have shown that occasional consumption or
even daily consumption in small quantities carries no
associated risk (Jaddoe _et al_ ., 2007). The systematic
review of Henderson and colleagues (2007) suggests
that while alcohol may be a risk factor for other adverseoutcomesofpregnancy,consumptionofupto10
UK units of alcohol (80 g) per week was not associated
with increased risk of preterm delivery.
Caffeine is a widely consumed stimulant, which
may be consumed by pregnant women in the form of
beverages (coffee, tea, and soft drinks), or over-thecounter medications. Although there has been sufficient concern that this may be a risk factor for preterm
birth to prompt advice for women to control intake, the evidence base suggests that beyond the early
stages of pregnancy, the risk is negligible (Research
highlight 3).


risk factor for preterm delivery, but very few studies have unequivocally shown that women consuming caffeine, particularly in coffee,
have greater risk of premature labor. Eskenazi _et al_ . (1999) reported
odds of preterm delivery of 2.3 (95% confidence intervals 1.3–4.0)
comparing high coffee consumption to nonconsumption. Other studies have highlighted moderate caffeine consumption in the second
trimester as a risk factor (Pastore and Savitz, 1995). However, many
of these earlier studies may be misleading as they either relied on
mothers recall of caffeine consumption, retrospectively, or failed to
adjust for confounding factors.
Caffeine consumption tends to be greater in women who smoke
tobacco, and smoking is itself an important risk factor for both low
birth weight and preterm delivery. Studies that robustly adjust for
smoking habit, and which have collected data on caffeine consumption prospectively tend to show that there is no risk of preterm
labor associated with caffeine intakes, even as high as 400 mg/day
(Peacock _et al_ ., 1995; Clausson _et al_ ., 2002, Chiaffarino _et al_ .,
2002). The view that caffeine is a hazardous substance for pregnant women may therefore be unmerited once pregnancy is well
established and beyond the vulnerable first trimester.



**60** **Nutrition: A Lifespan Approach**


**3.4.2.3 Oral health**

The risk of preterm delivery increases in all situations
where an inflammatory response is mounted within
thematernalsystem.Thepro-inflammatorycytokines
and prostaglandins, that are released in response to
infection, promote the premature rupture of membranes. This may lead to the spontaneous initiation of
premature labor, or prompt the need for a medically
induced preterm delivery.
Periodontitis is an oral health problem and represents one of the most common chronic disease states
on a global scale. Milder forms of periodontitis are
noted in 50% of the population at some stage of life
and more advanced destructive periodontitis is noted
in 5–10% of people. Periodontitis is essentially an
inflammation of the gums, which in mild cases manifests as gingivitis. In the more advanced form, the
disease results in destruction of gum tissue and underlying bone, leading to tooth loss. Periodontitis is
the result of infection of the gum tissues by anaerobic
bacterial species, such as _Porphyromonas gingivalis_ .
This infection results in activation and recruitment
of neutrophils to the gums. The subsequent release
of reactive oxygen species causes local host tissue injury and the associated inflammatory response has
systemic effects (Sculley and Langley-Evans, 2003).
Periodontitis-related inflammation has been linked to
development of other conditions, including coronary
heart disease (Beck _et al_ ., 1996).
Systemic activation of the immune system and elevated concentrations of inflammatory agents may be
a trigger for preterm delivery in pregnant women.
Unraveling the true contribution of periodontitis to
risk is problematic as the condition is far more common in cigarette smokers than nonsmokers. Smoking
is in itself a risk factor for preterm delivery. Pitiphat
_et al_ . (2008) reported that, after robust adjustment for
smoking, women with periodontal disease were more
likely to have a baby that was born prematurely, or at
full term but SGA (OR 2.26, 95% CI 1.05–4.85). Further evidence favoring a contribution of periodontitis
to risk comes from some small intervention studies,
which have shown that effective treatment of periodontal disease during pregnancy can reduce the risk
of preterm delivery and the delivery of SGA infants
(L´opez _et al_ ., 2002; Jeffcoat _et al._, 2003).


_**3.4.3 Hypertensive disorders of pregnancy**_


Rising blood pressure is a common feature of pregnancy and reflects the changing renal function, re


quirement to maintain placental perfusion, and alterations in fluid balance. In some women, the increasedbloodpressurecrossesthethresholdofsystolic
pressure over 140 mmHg, and diastolic pressure over
90 mmHg at which hypertension is diagnosed. When
hypertension has onset in the latter part of pregnancy,
this is termed gestational hypertension. If hypertension has an onset in the first 6 weeks of pregnancy and
persists throughout gestation, it is termed chronic hypertension of pregnancy. Neither of these conditions
is of major significance in terms of maternal or fetal
health.

In contrast, pre-eclampsia (PE) is an extremely
dangerous condition that threatens the lives of both
mother and fetus. PE occurs in 2–7% of pregnancies
(Poston, 2006) and is characterized by the development of hypertension after 20 weeks gestation and the
urinary excretion in excess of 300 mg protein/24 h.
In some cases, blood pressure may not rise above the
140/90 mmHg threshold for hypertension diagnosis,
but will rise sharply (more than 30 mmHg) over a few
weeks. Although not used as diagnostic criteria for
PE, affected women will also develop severe edema
and metabolic disturbances. PE is a progressive condition that cannot be reversed or controlled. Without
intervention, women are at risk of developing eclampsia. Eclampsia is the end stage of the PE disorder and
is characterized by maternal seizures and coma due
to edema of the brain. Eclampsia can result in multiple organ failure, renal collapse, abruption of the
placenta, and death of both mother and baby. In the
medical management of PE, in developed countries,
the usual protocol is to monitor progress closely and
deliver the baby preterm. This is the only way to bring
the maternal disease to an end. As a result, PE is the
major cause of preterm birth (accounting for around
25% of cases).


**3.4.3.1 The etiology of PE**
The primary cause of PE is defective placentation
(Poston, 2006). Histological examination of placental
tissue from affected pregnancies suggests that there is
a partial failure of the invasion of the uterine lining
during the early stages of placental formation and as
a result the formation of the spiral arteries is incomplete. Blood flow through the placenta is reduced and
the capacity to maintain normal perfusion of the organ is impaired. PE is generally regarded as being a
two-stage process (see Figure 3.6) and this placental



**Pregnancy** **61**





















**Figure 3.6** The pathophysiology of PE.





defect represents the first stage (Roberts and Gammill,
2005).
The second stage in the development of PE is the
appearance of the maternal disorders. The impaired
perfusion of the placenta is believed to result in the
release of factors that impact upon vascular endothelial cell function throughout the maternal system. It
is argued that one of the key drivers of this dysfunction could be oxidative injury in the placental tissue
(Poston, 2006). With reduced placental perfusion, the
placental tissue is likely to undergo periods of hypoxia
followed by improved blood flow and renewed delivery of oxygen. This hypoxia-reperfusion process will
result in the release of free radicals and other reactive
oxygenspecies,causingplacentalinjury.Inresponseto
this injury, the placenta will release pro-inflammatory
cytokines and activate cells of the immune system. In
effect, a systemic inflammatory response is initiated.
The inflammatory response is the main driver of
the maternal disorders associated with PE. Primarily,
it generates maternal vascular endothelial dysfunction
and the main consequences of this are hypertension
and a reduction of the blood flow to major organs,
including the brain, kidney, and liver (Figure 3.6).
In the liver, the inflammatory response is responsible for metabolic changes that are remarkably similar



to those that are known to occur in cardiovascular

disease (Roberts and Gammill, 2005). Indeed, PE is
often compared to a speeded up form of atherosclerosis, specifically impacting upon the placenta. Proinflammatory cytokines are antagonists of insulin action and as a result PE is associated with insulin
resistance. Maternal circulating free fatty acid and
triglyceride concentrations rise, as does low-density
lipoprotein cholesterol, while high-density lipoprotein concentrations decrease. Circulating uric acid
concentrations also rise dramatically in PE as a result
of declining renal function. Uric acid concentrations
are a powerful predictor of poor maternal and fetal
outcomes (Roberts _et al_ ., 2005), which may indicate
that urate may have a role in the progression of the
disease.
The true determinants of the risk that a woman may
develop PE are unknown. It is clear that not all women
with placental dysfunction go on to develop PE, which
suggests that the presence of other factors is necessary
to move from stage 1 to stage 2. Some of the risk may
be genetically determined, and certainly women with
a previous history of PE are at increased risk. To date,
no genes that predispose to PE have been identified.
Lifestyle factors including diet have therefore been a
major focus in research aimed at the prevention of PE.



**62** **Nutrition: A Lifespan Approach**


**3.4.3.2 Nutrition-related factors and PE**

While it is suspected that dietary factors may be important in determining the risk of PE, there is no
convincing research that implicates any one specific
nutrient (Roberts _et al_ ., 2003). Historically, it has been
believed that variation in macronutrient intake was an

important factor, but contributions of low-protein diets, high intakes of n-6 fatty acids, or low intakes of
n-3 fatty acids have largely been excluded.
A number of micronutrients have also been suggested to play a role in development of PE, largely on
the basis that women afflicted by the disease manifest
abnormalities of biomarkers of mineral status. Gener
ally, these changes are now considered to be a consequence of the PE rather than the cause. Iron represents
a primary example of this, in that women with PE
manifest reduced serum ferritin and transferrin, both
being suggestive of low iron status. However, both of
these proteins are involved in the inflammatory response and it is more likely that changes associated
with PE are explained by this role than it is that iron
deficiency contributes to disease risk. Magnesium status has been shown to be poor in women with PE, suggesting a potential role in the disease. However, trials
with magnesium supplementation have not provided
any benefits in pregnant women (Roberts _et al_ ., 2003).
Similarly, it is noted that women with PE excrete less
calcium in their urine than is normal for pregnancy.
Supplementation trials, often using very high doses of
calcium (1.5–2.0 g/day), have been shown to reduce
the prevalence of hypertension in pregnant women
by as much as 50%, but appear to reduce risk of PE
only in the small subset of women with very poor
calcium status going into pregnancy. Excess dietary
sodium is closely associated with hypertension in the
population, and in PE, the retention of sodium with
declining renal function is the main driver of edema.
In the 1940s and 1950s, low-salt diets were widely
used to attempt to treat and prevent PE, but the practice was abandoned in the 1960s. Advising women to
consume a low-salt diet has no impact upon risk of
PE, nor does it prevent the appearance of gestational
hypertension (Duley _et al_ ., 2005).
Due to the apparent role of oxidative stress in the
development of PE, a number of studies have focused
on the potential use of antioxidant vitamin supplements as a strategy for prevention of the disease. A
small-scale intervention using a combined vitamin
C (1000 mg/day) and vitamin E (400 IU/day) supple


ment suggested that this could reduce the risk of PE by
76% (Chappell _et al_ ., 1999). However, when the same
protocol was repeated in a large-scale, multicentered
randomized placebo-controlled trial using women at
high risk, there was no reduction in the incidence of
PE and, alarmingly, the antioxidant supplement increased the risk of low birth weight by 15% (Poston
_et al_ ., 2006).
Pre-pregnancy BMI is the main nutrition-related
predictor of PE risk. Studies suggest that women
who are underweight going into pregnancy are at
lower risk, while, in general, obese women have substantially elevated risk (Sebire _et al_ ., 2001). Jensen
and colleagues (2003) reported that women with a
BMI over 30 kg/m [2] were at 3.8-fold greater risk than
those with pre-pregnancy, a BMI between 18.5 and
24.9 kg/m [2] . Studies that have assessed the impact of
PE in one pregnancy upon risk in subsequent pregnancies suggest that gaining weight between confinements adds to risk. An increase in BMI of 3 kg/m [2]

doubles risk of PE, even in women of normal weight.
Weight loss decreases risk (Walsh, 2007).
The association between PE and obesity is most
likely explained by the fact that obesity creates a proinflammatory state, with adipose tissue expressing a
number of cytokines. Obesity is also associated with
insulin resistance and endothelial dysfunction, independently of pregnancy. Thus, for obese women,
there is a low-grade inflammatory response due to excess adiposity, superimposed upon the low-grade inflammation that occurs in normal pregnancy (Poston,
2006). This may make the progression from stage 1 of
PE (placental dysfunction) to fully symptomatic PE,
a significantly greater probability.


_**3.4.4 Abnormal labor**_


The duration of normal labor, from the first onset of
contractions to delivery of the baby, can vary tremendously in length from just a few minutes to 2 or 3 days.
On average, women experience labor of between 4 and
8 h. Labor has three stages. In the first stage, contractions result in cervical dilatation, thereby opening up
the birth canal for the passage of the infant. This first
stageisthemostprotractedelementofthelabor.Inthe
second stage, the baby moves through the vagina and
is born. The third stage of labor is the delivery of the
placenta. Risk of fetal or neonatal death is increased
in protracted labor, particularly if the labor fails to
progress once full cervical dilatation has occurred. In



modern medical management of labor, a failure for
labor to progress will result in intervention to protect the health of mother and baby. The most extreme
intervention is cesarean section, but other interventions that may be used in the second stage include
the use of forceps or ventouse to deliver the baby (instrumented delivery). For most women, labor begins
spontaneously, but if there is no onset of labor beyond
42 weeks gestation, it is normal for medical staff to artificially induce labor, either using hormone administration, or through artificially rupturing membranes.
Thisreducesriskofadversematernalhealthoutcomes.
Interventions in labor are not closely related to maternal nutritional status, but it is clear that maternal
BMI is a predictor of these outcomes. Women who are
overweight or obese are more likely to require artificial
labor and to suffer complications in labor that result
in cesarean section or instrumented delivery (Jensen
_et al._, 2003). As gestational diabetes (see Section 3.8.1)
is often seen in obese women, there is a greater prevalence of babies being large-for-gestational age. This
contributes to the greater need for medical intervention and also increases the prevalence of shoulder dystocia in babies born to obese mothers.

In contrast, women who are underweight appear to
have lower risk of labor complications than women
with BMI in the ideal range. BMI less than 20 kg/m [2] is
associated with less frequent induction of labor, fewer
instrumented deliveries, and lower risk of emergency
cesarean (Sebire _et al_ ., 2001). Postpartum hemorrhage
(PPH) is one of the most serious maternal complications of labor and is the major cause of maternal mortality. Between 5% and 12% of women experiencing
normal vaginal delivery will experience PPH. In developed countries, medical management means that
the death rate is low (less than 10 cases per million
births), but in the developing world, PPH accounts
for around 125 000 maternal deaths every year. PPH
is more common in obese women, but being underweight reduces risk.


**3.5 Nausea and vomiting of pregnancy**
**(NVP)**


_**3.5.1 NVP as a normal physiological**_

_**process**_


NVP is a commonly reported symptom associated
with early pregnancy. Most studies estimate that the



**Pregnancy** **63**


prevalence of NVP is somewhere between 60% and
80%, with generally higher rates of occurrence in
westernized countries than in developing countries
(Furneaux _et al_ ., 2001). Given the high prevalence,
NVP is widely regarded as a normal, but unpleasant
feature of pregnancy. It usually manifests somewhere
between 2 and 6 weeks after conception, and for many
women is the first sign that they have conceived. Generally, the peak in NVP symptoms occurs between 10
and 12 weeks gestation and for most women, the condition disappears by 20 weeks. For some women, NVP
continues throughout the pregnancy.
NVP is colloquially known as “morning sickness,”
but this is a misnomer. Although most women will
experience nausea or vomiting in the early morning,
there are also peak times for symptoms at other points
in the day, and episodes are often triggered by exposure to cooking odors, or the preparation and consumption of meals. NVP is for many women a debilitating issue that can cause major interference with
the pursuit of normal day-to-day activities. NVP may
vary greatly in severity (Coad _et al_ ., 2002). In mild
cases, there may be nothing more than the sensation
of nausea. Moderate cases may suffer some episodes of
vomiting, but in severe NVP, women may struggle to
retain the meals that they have consumed. The most
extreme manifestation of NVP is hyperemesis gravidarum, which will be discussed in the next section.
NVP is more common in some groups of women,
most notably those having their first baby, women
with multiple pregnancies, those of greater BMI, nonsmokers, and women with a family history of NVP.
The causes of NVP are not fully understood, but
most evidence suggests that the symptoms arise as
a consequence of the major endocrine changes that
accompany the early stages of pregnancy. Estrogen
and progesterone concentrations are high at this stage
and both may contribute to the development of NVP
(Coad _et al._, 2002). Progesterone is a modulator of
muscle tone in the gastrointestinal tract and may promote gastric reflux by causing a reduction in the patency of the esophageal sphincter. The mode of action
of estrogen is unclear, but it is noted that women who
have a nauseous reaction to oral contraceptives based
upon estrogens are highly likely to develop NVP.
hCG is produced in early pregnancy and plays a
key role in the implantation of the embryo and establishment of the placenta. Many lines of circumstantial
evidence point to hCG as an important driver of NVP



**64** **Nutrition: A Lifespan Approach**


**200000**



**150000**





**100000**


**50000**


**0**
**0** **10** **20** **30** **40**


**Weeks gestation**


in the first trimester. Firstly, there is a close temporal
association between hCG secretion and NVP symptoms (Figure 3.7). The onset of NVP for most women
coincides with the first appearance of hCG, and the
peak in hCG concentrations in maternal circulation
falls around 9–12 weeks, shortly preceding maximum
symptoms of NVP. Women with the most severe NVP
are found to have elevated concentrations of hCG
compared to asymptomatic women, and correlations
have been shown between hCG concentrations and
the severity of NVP (Furneaux _et al_ ., 2001). hCG has
a critical role in the establishment of pregnancy and
disturbancesinthesecretionofthishormoneareassociatedwithadversepregnancyoutcomes.Womenwho
underproduce hCG are more likely to suffer spontaneous abortion in early pregnancy and have a greater
risk of ectopic pregnancy. Extremely high hCG is also
predictive of poor outcomes, including fetal death,
premature birth, and lower weight at birth.
As mentioned above, NVP symptoms are the norm
rather than the exception for pregnant women in
westernized countries. The very high prevalence of
a condition that is so debilitating, and in rare cases
lethal, to women in early pregnancy, has prompted
some researchers to propose that it serves some function that increases the chances of reproductive success. One view is that NVP serves to change patterns
of maternal intake, and that this prompts the ingestion of foods that are optimal for the development of
the placenta (Coad _et al_ ., 2002). Most women with
NVP quickly learn that, unlike most nausea, these
symptoms are alleviated or suppressed by the regular
consumption of foods that are rich in complex carbohydrates. An alternative view expressed by Flaxman
and Sherman (2000) is that NVP has evolved as a
defense mechanism to protect the early embryo from



**Figure 3.7** The temporal association between symptoms
of nausea and vomiting in pregnancy and concentrations
of hCG.


maternalingestionoffood-bornepathogensortoxins.
The peak period for NVP corresponds to maximum
vulnerability of the fetus or embryo to abortifacients,
infected foodstuffs, or teratogens. NVP leads most
women to avoid ingestion of caffeine containing beverages, meats, fatty foods, burnt food, or spicy food.
It is argued that many of these foodstuffs would have
represented a major risk for pregnant women in the
early history of humankind.
There is a wealth of data to support either theory
of the origins of NVP, as clearly women who exhibit
mild to moderate symptoms are at reduced risk of
a number of poor pregnancy outcomes. Czeizel and
Puh´o (2004) observed that women reporting that they
had suffered from NVP had longer gestation periods and had a lower prevalence of premature delivery. This finding confirms observations of a cohort of
300 British women (Figure 3.8), where an absence of
NVP was associated with a 3.26-fold (95% CI 1.19–
8.91) greater risk of premature delivery and slightly
increased risk of cesarean delivery. Within this study,
it was apparent that NVP had no major impact upon
women’s actual consumption of nutrients in the first
trimester of pregnancy. The only significant differencewasthatNVPsufferersconsumedlessalcohol(an
important teratogen) than women who were asymptomatic. Maconochie and colleagues (2007) reviewed
the major risk factors for spontaneous abortion in the
first trimester of pregnancy, using a large UK population. Nausea was found to be the most important of a
number of factors associated with reduced risk of miscarriage. Women with NVP within the first 12 weeks
of pregnancy were 70% less likely than asymptomatic
women to lose their pregnancy, and those with the
most severe symptoms were 93% less likely. Boskovic
_et al_ . (2004) did not find any benefits associated with



**Pregnancy** **65**



**25**


**20**



Preterm delivery

Cesarian section

Other labor interventions



**15**


**10**


**5**


**0**


**Figure 3.8** NVP is associated with reduced risk of preterm delivery. Three hundred pregnant women were questioned about symptoms of NVP in
the first trimester of pregnancy and the outcome of pregnancy was followed up. Women who reported no NVP symptoms were significantly more
likely to give birth prior to 37 weeks gestation. ( _Source_ : Langley-Evans and Langley-Evans, unpublished observations.)



NVP, but in their study, they only considered women
whose symptoms were controlled using antiemetic
medication.


_**3.5.2 Hyperemesis gravidarum**_


The severity of NVP symptoms varies enormously between women, but only rarely does the extent of those
symptoms become so great that there is a threat to
the health of the pregnant woman or her child. Hyperemesis gravidarum (HG) lies at the extreme end of
the NVP spectrum and may in fact have completely
different causes. HG is characterized by intractable
nausea and vomiting, which results in metabolic disturbances, ketosis, dehydration, reduction in maternal blood volume, and loss of around 5% of the prepregnancy body weight. Like NVP, the onset of HG is
usually between 4 and 10 weeks gestation and the condition resolves for most women by 20 weeks (Verberg
_et al_ ., 2005). For 10% of women with HG, the condition will continue for the whole of their pregnancy.
HG is relatively uncommon and occurs in 0.3–1.5% of
pregnancies (Bailit, 2005; Dodds _et al_ ., 2006). Women
who suffer from HG in their first pregnancy are at very
high risk of developing the same degree of nausea and
vomiting in subsequent pregnancies. Trogstad _et al_ .
(2005) found that odds of recurrence were as high as
26-fold. The risk of HG in a second pregnancy appeared to reduce if the second child had a different
father to the first. This suggests an involvement of pa


ternal genes in the development of HG and may give
some clues to the etiology of the problem.
The severity of HG symptoms will generally result in hospitalization for appropriate treatment using vitamin supplements, and intravenous infusion
of fluids and electrolytes. Before the introduction of
this therapy, HG was a cause of maternal death for
around 16 in every 100 000 pregnancies. Most HG
cases are successfully treated through fluid infusion,
andifthisdoesnotleadtorecovery,womenaretreated
with antiemetic drugs. For around 2% of women with
HG, there is no response to treatment and it becomes
necessary to terminate the pregnancy (Verberg _et al_ .,
2005).
Although,withtreatment,theimpactofHGonmaternal health can be greatly reduced, there are greater
risks for the fetus in an HG-complicated pregnancy.
Tan and colleagues (2007) reported that the severity of
HG as measured by biomarkers of maternal fluid and
electrolyte status was a determinant of pregnancy outcomes. More severe symptoms were associated with
a greater prevalence of gestational diabetes, more intervention during labor, and more emergency procedures. Bailit (2005) found that HG was associated
with shorter gestation, a greater prevalence of SGA,
and greater risk of fetal death. Within the same study,
it was shown that babies born prematurely (24–30
weeks) were at greater risk of death if born to women
with HG. Dodds and colleagues (2006) largely concurred with the findings of Tan _et al_ . (2007) in that



**66** **Nutrition: A Lifespan Approach**


the increased risk of fetal growth retardation and premature delivery associated with HG was confined to
women who gained less than 7 kg through their preg
nancy.
Failure to gain weight and less effective perfusion
of the placenta due to reduced blood volume expansion are the most likely routes through which risk of
adverse pregnancy outcomes are associated with HG.
Certainly, there is very limited evidence that HG has
a major effect upon maternal nutritional status. Despite reports of numerous deficiencies of vitamins and
minerals, attributed to raised demands of pregnancy,
reduced food intakes, and greater nutrient losses, the
only consistent findings relate to thiamine and vitamin K (Verberg _et al_ ., 2005).


**3.6 Cravings and aversions**


Just as nausea and vomiting are common symptoms
experienced by pregnant women, the majority of
women in the first trimester report changes in preferences for certain foodstuffs. These changes are often aversive, with women rejecting foods or beverages
that might have been staples within their diet prior to
pregnancy. Food cravings are strong desires to consume particular food items, which may not have been
major elements of the pre-pregnancy diet. Surveys of
the prevalence of food aversions and cravings suggest
that between 50% and 60% of women will experience
these changes to their eating and drinking behaviors
(Furneaux _et al._, 2001; Bayley _et al_ ., 2002).
Aversions reported by pregnant women are most
commonly to caffeine-based drinks, red and white
meats, fish, and eggs. Furneaux and colleagues (2001)
observed that two-thirds of pregnant women among
a sample of 300 reported aversion to coffee, with 54%
developing an aversion to tea. Other foods rejected
by this sample of women included spicy foods and
foods that were fatty or greasy. Cravings in early pregnancy are often for foods with a high sugar content,
withsweets,chocolate,andcakesbeingwidelyfavored,
along with fruit and fruit juices.
The reasons why women develop cravings and aversions in pregnancy are not well understood. Some
researchers have suggested that taste and aroma perception is altered by the hormonal changes that accompany early pregnancy and that this produces a
preference for sweet foods over bitter foods, and a



dislike of the smell of foods high in fat (Coad _et al_ .,
2002). There are also some suggestions that cravings
and aversions have no biological foundation and are
instead the products of cultural expectations. One
proposal that has received considerable attention and
popular support is that cravings and aversions are an
element of the broader spectrum of NVP and contribute to fetal defense during embryonic development (Flaxman and Sherman, 2000). It is suggested
that NVP symptoms lead to taste aversion learning, in
which women are conditioned to avoid foods that are
associated with bouts of nausea or vomiting (Bayley
_et al_ ., 2002). Within an evolutionary perspective, this
conditioned behavior would lead to rejection of the
foods most likely to carry toxins or pathogens that
might threaten fetal survival.
Support for this idea is partly provided by evidence
that women suffering from NVP are more likely to
report food aversions than those who do not. Bayley
and colleagues (2002) noted that women whose NVP
was moderate to severe were more likely to report food
aversions, and suffered aversions to a greater range of
foods than women whose NVP was mild, or absent.
Importantly, the onset of food aversions appeared to
coincide with the onset of NVP symptoms. In contrast, cravings were no more common in women with
NVP than in those without, and tended to begin much
earlier in pregnancy and several weeks ahead of any
NVP symptoms. These findings are not supported by
all studies (Furneaux _et al_ ., 2001), and in contrast
to the Bayley _et al_ ., 2002 study, Coad and colleagues
(2002) reported that women with NVP were more
likely to have both food aversions and cravings than
those who were asymptomatic. The roots of cravings
and aversions may be different, however, and cravings
are often reported to occur in women whose NVP begins very early in pregnancy. The high-carbohydrate
foods that are most commonly craved often appear to
be of benefit in suppressing or controlling feelings of

nausea.


_**3.6.1 Pica**_


Pica represents an extreme form of craving behavior, which in addition to being noted in pregnancy
is associated with mental illness and some micronutrient deficiencies, including iron deficiency anemia.
Pica is the ingestion of substances that have no nutritive value and pica behaviors include the consumption of clay or soil (geophagia), ice (pagophagia),



laundry starch (amylophagia), or other substances
such as soap or chalk. Pica in pregnancy appears to
be a behavior that is most commonly associated with
women of low socioeconomic status, often including those from ethnic minority groups. Mikkelsen
_et al_ . (2006) noted that among a large (over 70 000)
well-nourished Danish population with relatively low
numbers of ethnic minorities, pica was a rare behavior
that was reported by just 0.7% of women. This was
in stark contrast to figures quoted for the US, where
pica is commonplace (30–50%) in migrant women of
African origin or African Americans. Indeed, such is
the demand for material among such women, some
US stores stock clay for human consumption (Stokes,
2006).Rainville(1998)foundahighprevalenceofpica
among deprived, mostly African-American women
in Texas. Pica occurred in 77% of pregnant women,
with the most common substances consumed being
ice, or the frost from freezers and refrigerators. Although commonplace, there was no evidence that the
pica behaviors had any negative effect upon the outcome of pregnancy. However, the women with pica
had lower hemoglobin concentrations at delivery than
those without pica. While this US study could not
with confidence identify iron deficiency as a cause or
consequence of pica, due to confounding influences
of maternal smoking and educational achievement,
other studies show pica and iron deficiency are closely
associated. Pica was noted in around 20% of pregnant
women in an Argentinian study (L´opez _et al_ ., 2007),
with women reported as consuming ice or dirt. As
with Rainville (1998), birth weight and anthropometry among infants were not compromised by pica,
but markers of iron status were greatly reduced in the
women with pica.
Associations of this nature have lent some support
to the concept that pica develops as a response to nutrient deficiency. Consumption of clay, for example,
could be seen as a means of ingesting the minerals
present in the clay matrix. Malnutrition could thus be
a trigger for pica, explaining the higher prevalence in
women from deprived backgrounds. However, studies using clay slurries in artificial models of the digestive tract show that clay, for example, would tend to
exacerbate malnutrition as iron, zinc, and copper become bound to the clay matrix, especially under acid
conditions (Stokes, 2006). Geophagia could therefore
promote malnutrition rather than be a corrective behavior. In developing countries, soil and clay are likely



**Pregnancy** **67**


to carry pathogenic organisms that may cause harm
to pregnant women. Young _et al_ . (2007) examined infection with nematodes in an African population of
pregnant women. Pica was common in these women
and the main behaviors were consumption of clay
(7% of women), ice (21%), uncooked rice (55%),
and unripe mangoes (84%). Although there was no
clear difference in risk of infection when comparing
women with geophagia with those showing no pica,
there was a tendency for greater levels of hookworm
infection in clay eaters. Hookworm infection is an
important cause of iron deficiency anemia in African
countries.

It seems unlikely then that pica develops to replace
nutrient losses or address deficiency. It is possible that
these behaviors may help women deal with nausea
and vomiting, but far more likely that pica is a cultural phenomenon. This could explain the very high
occurrence in women of African origin (Stokes, 2006).
As described above, there is no clear evidence of pica
causing harm to infants. The potential for harm is
clearly present though. Pica, particularly where consumption of clay or soil is involved, has the potential
to introduce pathogens or toxins such as lead to the
body. There are also reports of pica as a cause of gestational diabetes. Jackson and Martin (2000) reported
two cases of pregnant women with uncontrolled diabetes in a home setting, which spontaneously reversed without treatment on admission to hospital.
On investigation, it emerged that these women were
consuming large quantities of laundry starch (corn
starch) each day.


**3.7 Gastrointestinal disturbances**
**in pregnancy**


As described earlier in this chapter, the gastrointestinal tract undergoes a number of functional changes
during pregnancy, largely under the influence of progesterone. These changes serve to slow down transit
times and hence maximize the absorption of nutrients
and reabsorption of water from the tract. A combination of these effects of steroid hormones on the tract
and the physical expansion of the uterus, baby, and
placenta as pregnancy progresses can produce a series of minor symptoms of the gastrointestinal tract.
These cause discomfort to many pregnant women but
only rarely impact upon pregnancy outcomes.



**68** **Nutrition: A Lifespan Approach**


Heartburn (dyspepsia) is a symptom that afflicts
many women early in gestation due to declining competency of the esophageal sphincter. In later gestation,
the pressure of the uterus upon the stomach can limit
the total stomach capacity and also drive gastric reflux. The period of rapid late gestation fetal growth,
where demands for nutrients and fluids are at their
greatest, therefore corresponds to the time of lowest
stomach capacity, so at this time women need to consume smaller but more frequent meals.
Constipation is also a common symptom of later
gestation, impacting upon around a quarter of pregnancies (Bradley _et al_ ., 2007). This is largely a consequence of the slow transit of fecal material through
the colon and the highly efficient reabsorption of water. Dry compacted fetal material becomes harder to
pass and this can also increase the risk of hemorrhoids, which are another complaint associated with
pregnancy. Certain factors increase the likelihood of
constipation, including low intakes of water, low fiber
diets, reduced physical activity, and the prescribing of
iron supplements to combat iron deficiency anemia.


**3.8 High-risk pregnancies**


A number of pregnancies may be considered to be at
higher than normal risk and merit close monitoring
and possible medical intervention in order to ensure
a successful outcome. Women may be identified as
being at high risk on the basis of preexisting medical conditions (e.g., type 1 and type 2 diabetes, as
described in Chapter 8), socioeconomic status, and
lifestyle factors. Maternal factors that are associated
with greater risk include pre-pregnancy underweight
or obesity, low socioeconomic status, a history of eating disorders, HIV infection, and alcohol or other
substance abuse.

Maternal age is also a major indicator of risk.
Women over the age of 35 are at greater risk of PE,
preterm delivery, placenta previa, and cesarean section. Consequently, fetal and maternal mortality rates
are higher in these older women. The reasons underlyingthisgreaterriskarenotfullyunderstood,butcould
relate to a greater level of obesity, preexisting hypertension, and insulin resistance in this population. Risk
associated with pregnancy also increases markedly in
adolescent mothers. Adolescents are at greater risk of
iron deficiency anemia, preterm delivery, and having



babies that are SGA. This partly relates to their often
poor dietary behaviors, but is mostly explained by the
fact they are still growing themselves. Girls continue
to grow for between 4 and 7 years beyond menarche, with the phase of maximum adolescent growth
occurring between the ages of 11 and 13. Pregnancy
before the age of 14 will therefore be complicated by
competition between mother and fetus for energy and
nutrients. As a result, adolescent mothers are unable
to lay down sufficient fat reserves in early pregnancy
to drive fetal growth in the third trimester, resulting in
fetal growth retardation. For similar reasons, women
with short intervals between pregnancy are perceived
as being at higher risk, as their capacity to replenish
nutrient reserves between confinements is limited.


_**3.8.1 Gestational diabetes**_


Gestational diabetes is a syndrome of insulin resistance that develops during pregnancy. In the past, it
was referred to as latent diabetes, in reference to the
fact that it most likely represents a state in which the
metabolic stress of pregnancy causes an existing prediabetic state to progress to a symptomatic state. As
already mentioned in this chapter, pregnancy is a state
in which the mother becomes increasingly insulin resistant. This produces a metabolic scenario in which
postprandial plasma glucose concentrations are elevated, and on fasting, there is greater mobilization of
triglycerides, free fatty acids, and ketones (Carpenter,
2007). This ensures substrate supply to the placenta
and fetus. In 2–3% of pregnancies, these metabolic
changes lead to gestational diabetes (GDM). There is
a greater likelihood of GDM being more common in
women who are obese, who have a family history of
diabetes, or who have other factors that predispose to
type 2 diabetes.
In most cases, GDM is a transient state that resolves with the end of pregnancy. However, women
suffering from GDM are more likely to develop type 2
diabetesatalaterdateandaround50%ofwomenwith
GDM will also develop the condition in subsequent
pregnancies (Reader, 2007). GDM is associated with a
number of adverse pregnancy outcomes and, in particular, is closely related to the hypertensive disorders
of pregnancy (e.g., PE). These associations suggest a
common etiology that relates to inflammatory processes associated with insulin resistance and excess
adiposity (Carpenter, 2007).



**Pregnancy** **69**

















**Figure 3.9** GDM is a condition of maternal insulin resistance. Maternal insulin resistance drives glucose across the placenta to the fetal tissues.
The ensuing increase in fetal insulin secretion drives excessive fetal growth and leads to LGA.



GDM has a number of negative impacts upon fetal and infant health. One of the most significant of
theseismacrosomia,or“largebabysyndrome.”Babies
are defined as being large-for-gestational age (LGA)
if they weigh over 4.5 kg at birth, regardless of gestational age. LGA is more common in pregnancies
associated with GDM. It makes an operative delivery
more likely as the large baby is unable to progress
through the birth canal without sustaining significant injury such as shoulder dystocia, subconjunctival hemorrhage, or fractures (Hadden, 2008). GDM
promotes macrosomia of the fetus through spillover
of glucose from mother to fetus, across the placenta
(Figure 3.9).
Infants whose mothers have GDM may also suffer a
period of hypoglycemia after birth due to the steep fall
inglucoseinputonceoutoftheuterus.GDMisalsoassociated with fetal hypocalcemia. High prevailing insulin and insulin-like growth factor 1 concentrations
in response to high glucose concentrations drive calciumintobone.TheGDM-affectedfetustendstohave

high bone mineral mass, but low circulating calcium,
and in extreme cases, this can lead to convulsions after
birth. In addition to these immediate hazards, there is
a growing body of evidence that suggests that the fetus
exposed to GDM is more likely to be obese and to developtype2diabetes,laterinlife(Hussain _etal_ .,2007).
Women with GDM require careful monitoring
and nutritional management to limit the risk of ad


verse pregnancy outcomes. Therapies aim to control blood glucose concentrations, without the use
of insulin injection. Management is therefore focused
around control of carbohydrate intake, while maintaining appropriate rates of weight gain and intakes of
other nutrients. Prospective studies from the US and
Australia have shown that such approaches are effective in limiting the need for more robust medical
intervention and reducing the risk of serious perinatal complications (Reader, 2007). Physical activity is
an important element of the management of GDM.
There is evidence that increasing activity before pregnancy and maintaining this during gestation can reduce risk. Care needs to be taken to monitor blood
glucosebeforeandafterexercise,andpregnantwomen
should avoid periods of vigorous activity in excess of
15–30 min.


_**3.8.2 Multiple pregnancies**_

Multiple pregnancies (twins, triplets, quadruplets, or
greater) are associated with significantly greater risks
for a number of adverse maternal and fetal outcomes
of pregnancy. Naturally occurring multiparity is relatively uncommon, with around 1 in 80 natural conceptions resulting in twin pregnancy, 1 in 80 [2] (64 000)
resulting in triplets, and 1 in 80 [3] (512 000 leading to
quadruplets).However,thenumbersofmultiplepregnancies have increased markedly since the 1980s due
to the greater use of assisted reproductive technologies



**70** **Nutrition: A Lifespan Approach**


(Brown and Carlson, 2000). Often techniques such as
in vitro fertilization result in the implantation of two
or three fertilized embryos to maximize the chances of
a successful outcome. As the majority of women undergoing assisted reproduction are older (greater than
35 years), the combination of multiparity and greater
age has a particularly marked impact upon their risk
profile.
Multiple pregnancies are more likely to result in PE,
HG, and iron deficiency anemia for the mother. The
babies are more likely to be born preterm and as a result are at greater risk of all complications associated
with prematurity. Much of the risk of preterm delivery
isrelatedtointrauterinegrowthretardation,with50%
of twins and 90% of triplets being SGA. The combination of SGA and prematurity is a particularly high
risk for neonatal death (Brown and Carlson, 2000).
As with other outcomes of pregnancy, maternal
BMI pre-pregnancy and weight gain during gestation are the strongest predictors of the outcome of
multiple pregnancy. Yeh and Skelton (2007) showed
that in twin-bearing women with BMI _>_ 29 kg/m [2],
birth weights were up to 170 g greater than in women
with BMI _<_ 19.8 kg/m [2] before conception. Achieving
a weight gain in excess of 25 kg across pregnancy could
increase the birth weights of twins by up to 500 g, and
furthermore reduced the risk of being born before 36
weeks gestation and of SGA. This was emphasized by
the study of Flidel-Rimon _et al_ . (2005) who showed
that in women expecting triplets, achieving a weight
gain in excess of 16.2 kg over the first 24 weeks of
gestation significantly reduced the risk of SGA, irrespective of the pre-pregnancy BMI. For triplet pregnancies, having a higher pre-pregnancy BMI, even if
in the overweight or obese range, reduces the risk of
negative pregnancy outcomes.
Final achieved birth weight in multiple pregnancies is most closely related to weight gain in the first
trimester, with the period 20–28 weeks gestation also
being of great importance (Luke, 2005). It is suggested
that to minimize risk associated with multiparity, the
early phase of pregnancy should be targeted with appropriate advice to maximize weight maternal gain.
Just as with singleton pregnancies, weight gain should
be greater in women of lower BMI, and reduced in
women who are obese. However, proposed gains are
considerably greater than for singleton pregnancies.
Underweight women carrying twins should aim to
gain 22–28 kg over the first 28 weeks of pregnancy, at



a rate of 0.5–0.8 kg/week in the first trimester. Women
with BMI in the optimal range (20–25 kg/m [2] ) should
achieve 18–24 kg weight gain, at a rate of 0.45–0.8
kg/week (Luke, 2005). Higher gains are desirable in
multiple pregnancies as preterm delivery is far more
likely, so the period of intrauterine growth is shorter.
Maximizing weight at delivery greatly reduces risk of
morbidity and mortality in preterm infants. In all
pregnancies, the function of the placenta is declining
in late gestation. In multiple pregnancies, the decline
in function is more rapid. It is suggested that more
rapid maternal weight gain in early pregnancy helps
to establish a more robust placentation (Luke, 2005).
Women with multiple pregnancies are assumed to
have significantly greater energy requirements than
womenwithsingletonpregnancies,basedpurelyupon
requirements to achieve the optimal weight gains described above. Brown and Carlson (2000) have suggested that over a full pregnancy, this extra energy
would be equivalent to 150 kcal/day, on top of the enhanced requirement for pregnancy. Pregnant women,
in general, begin gestation with normal insulin secretion and sensitivity, but as pregnancy proceeds develop an exaggerated insulin response to feeding. Insulin concentrations in late pregnancy can be more
than three times greater in late pregnancy than in the
nonpregnant state. Pregnant women are therefore insulin resistant and this metabolic adaptation helps to
shuntsubstratesacrosstheplacentatothefetus(Butte,
2000). This is enhanced in multiple pregnancy, and as
a result, maternal glucose concentrations tend to be
low and glycogen stores deplete very rapidly. Development of ketosis as metabolism switches to the utilization of fat, as will occur rapidly during periods of
fastinginsuchwomen,ispredictiveofpoorpregnancy
outcomes (Luke, 2005) and so women with multiple
pregnancies are advised to consume food frequently
(three meals plus three snacks daily).
The US Institute of Medicine has made recommendations relating to intakes of a number of micronutrients in women with multiple pregnancies. These recommendations are not matched by equivalent advice
in other countries. Women carrying twins or triplets
undergoasignificantlygreaterfluidvolumeexpansion
in early pregnancy and as a result tend to have worse
iron status than women with singleton pregnancy
(Luke, 2005). Iron deficiency anemia is seen as a risk
factorforpretermdeliveryanditissuggestedthatmultiparous women should be supplemented with 30 mg



iron per day from the 12th week of gestation. The
Institute of Medicine also recommends that supplements include zinc (15 mg/day), copper (2 mg/day),
calcium (250 mg/day), vitamin B6 (2 mg/day), folate
(300 mg/day), ascorbate (50 mg/day), and vitamin D
(200 IU/day) (Brown and Carlson, 2000). The potential benefits and hazards associated with this intervention have not been well defined and it may be
appropriate for women to meet the increased need for
these nutrients by consuming more nutrient-dense
foods. There is some evidence that essential fatty acid
concentrations are reduced in multiparous women,
suggesting that there may be increased demands for
these nutrients. Increased intakes of eggs, fatty fish,
and oils may therefore be appropriate.


_**3.8.3 Fetal alcohol spectrum disorders**_


This chapter has already highlighted the risks associated with alcohol consumption in pregnancy, in relation to miscarriage and preterm birth. Extremes of
alcohol consumption, for example, where pregnant
woman is an alcoholic, are associated with a range
of fetal abnormalities that are collectively known as
the fetal alcohol spectrum disorders (FASD). FASD
is defined as arising when a child has confirmed exposure to maternal alcohol consumption, craniofacial
abnormalities, pre- and postnatal growth retardation,
and neurocognitive defects. The related disorders are
FAS, partial FAS, ARBD, and alcohol-related neurodevelopmental disorder (ARND), in which some of the
features of FASD may be absent, or specific elements
may be more pronounced. For example, in FAS, the
confirmed exposure to maternal drinking is often absent, while in ARND, the neurocognitive defects are
the most pronounced manifestation (Mukherjee _et al_ .,
2006).
The prevalence of these disorders is difficult to estimate as affected children can be undiagnosed until
they reach school age. Estimates for FAS vary widely,
but 1–3 affected births per 1000 appear reasonable
(Hannigan and Armant, 2005). Prevalence rises to 60
per 1000 births for pregnancies where the mother is
a confirmed alcoholic. For ARND and partial FAS,
the prevalence is likely to be higher and is possibly as
much as 30 cases per 1000 births.
Alcohol is able to freely cross the placenta by diffusion. This means that fetal tissues are effectively
exposed to the same concentrations as the maternal
tissues. However, the fetal system is unable to me


**Pregnancy** **71**


tabolize alcohol as effectively and so effects are prolonged. When alcohol exposure occurs during critical
periods of organ development in the first and second
trimesters of pregnancy, there can be major impacts
on organ growth and morphogenesis. The central nervoussystemismostvulnerabletoeffectsofalcoholand
it is believedthat as much as 20% of all mental retardation in developed countries could be related to FASD.
Affected children are born with microcephaly (small
head), functional deficits (e.g., loss of hearing), and
go on to have lower IQ, learning difficulties, language
deficits, and social and behavioral problems that often lead to disrupted schooling and alcohol and drug
abuse problems (Mukherjee _et al_ ., 2006). The heart
and kidneys are also major targets for ARBD.
TheimpactsofFASDuponaffectedchildrenappear
to be long lasting and certainly extend into adulthood.
Follow-ups of children born with FAS show that abnormal behaviors and psychological disorders persist into adolescence (Steinhausen and Spohr, 1998).
In adulthood, it is clear that while some craniofacial abnormalities are resolved, stunted height and
microcephaly are not. Adults with FAS show a high
prevalence of moderate-to-severe mental retardation
(Spohr _et al_ ., 2007). Given the potentially devastating
effect of excessive alcohol consumption in pregnancy,
it is alarming to note the growth of binge-drinking
cultures among young women in countries such as
the UK. Cessation of drinking should be a priority for
women considering pregnancy, as the greatest effects
of alcohol may occur during embryogenesis and may
precede confirmation of conception.


~~**Summary Box 3**~~


Pregnancy is accompanied by major maternal adaptations that
support the development of the placenta and allow fetal growth
and development. These adaptations, and the growth of the fetus,
greatly increase the demand for energy and nutrients.
Changes to maternal physiology, behavior, and the mobilization
of pre-pregnancy stores are often sufficient to meet requirements
for nutrients without changes to intake.
~~Optimal maternal weight gain in pregnancy is a key determinant~~
of pregnancy outcome. Advised weight gains vary depending upon
pre-pregnancy BMI.
Nutrition-related factors are predictive of a number of adverse
pregnancy outcomes, including miscarriage and stillbirth, GDM,
preterm delivery, and the hypertensive disorders of pregnancy.
Maternal obesity is a major risk factor for most of the adverse
pregnancy outcomes.



**72** **Nutrition: A Lifespan Approach**


NVP is a normal feature of the early stages of most pregnancies.
These symptoms may be protective and are associated with a lower
risk of early miscarriage.
HG is the most extreme form of nausea and vomiting in preg~~nancy. This condition requires robust intervention as it is associated~~
with greater risk of both maternal fetal deaths.
Excessive alcohol consumption in pregnancy is associated with
neurocognitive and other congenital disorders in the fetus. These
abnormalities are collectively termed the FASD.


**References**


Bailit JL (2005) Hyperemesis gravidarium: epidemiologic findings
from a large cohort. _American Journal of Obstetrics and Gynecol-_
_ogy_ **193**, 811–814.
Barbour LA (2003) New concepts in insulin resistance of pregnancy
and gestational diabetes: long-term implications for mother and
offspring. _Journal of Obstetrics and Gynaecology_ **23**, 545–549.
Bayley TM, Dye L, Jones S, DeBono M, and Hill AJ (2002) Food
cravingsandaversionsduringpregnancy:relationshipswithnausea and vomiting. _Appetite_ **38**, 45–51.
Beck J, Garcia R, Heiss G, Vokonas PS, and Offenbacher S (1996)
Periodontal disease and cardiovascular disease. _Journal of Peri-_
_odontitis_ **67**, 1123–1137.
Boskovic R, Rudic N, Danieliewska-Nikiel B, Navioz Y, and Koren
G (2004) Is lack of morning sickness teratogenic? A prospective
controlled study. _Birth Defects Research A_ **70**, 528–530.
Bradley CS, Kennedy CM, Turcea AM, Rao SS, and Nygaard IE
(2007) Constipation in pregnancy: prevalence, symptoms, and
risk factors. _Obstetrics and Gynaecology_ **110**, 1351–1357.
Brown JE and Carlson M (2000) Nutrition and multifetal pregnancy. _Journal of the American Dietetic Association_ **100**, 343–348.
Burgess JR, Seal JA, Stilwell GM, Reynolds PJ, Taylor ER, and
Parameswaran V (2007) A case for universal salt iodisation to
correct iodine deficiency in pregnancy: another salutary lesson
from Tasmania. _Medical Journal of Australia_ **186**, 574–576.
Butte NF (2000) Carbohydrate and lipid metabolism in pregnancy:
normal compared with gestational diabetes mellitus. _American_
_Journal of Clinical Nutrition_ **71**, 1256S–1261S.
Butte NF and King JC (2005) Energy requirements during pregnancy and lactation. _Public Health Nutrition._ **8**, 1010–1027.
Carpenter MW (2007) Gestational diabetes, pregnancy hypertension, and late vascular disease. _Diabetes Care_ **30** (Suppl. 2), S246–
S250.
Chapman AB, Abraham WT, Zamudio S et al. (1998) Temporal
relationships between hormonal and hemodynamic changes in
early human pregnancy. _Kidney International_ **54**, 2056–2063.
Chappell LC, Seed PT, Briley AL _et al_ . (1999) Effect of antioxidants
on the occurrence of pre-eclampsia in women at increased risk:
a randomised trial. _Lancet_ **354**, 810–816.
ChiaffarinoF,ParazziniF,ChatenoudL _etal_ .(2002)Coffeedrinking
and risk of preterm birth. _European Journal of Clinical Nutrition_
**60**, 610–613.
Clausson B, Granath F, Ekbom A _et al_ . (2002) Effect of caffeine
exposure during pregnancy on birth weight and gestational age.
_American Journal of Epidemiology_ **155**, 429–436.
Coad J, Al-Rasasi B, and Morgan J (2002) Nutrient insult in early
pregnancy. _Proceedings of the Nutrition Society_ **61**, 51–59.
Connor WE, Lowensohn R, and Hatcher L (1996) Increased docosahexaenoic acid levels in human newborn infants by admin


istration of sardines and fish oil during pregnancy. _Lipids_ **31**,
S183–S187.
Czeizel AE and Puh´o E (2004) Association between severe nausea
and vomiting in pregnancy and lower rate of preterm births.
_Paediatric and Perinatal Epidemiology_ **18**, 253–259.
Department of Health (1999) _Dietary Reference Values for Energy_
_and Nutrients for the United Kingdom_ . Stationary Office, London.
Dodds L, Fell DB, Joseph KS, Allen VM, and Butler B (2006) Outcomes of pregnancies complicated by hyperemesis gravidarum.
_Obstetrics and Gynecology_ **107**, 285–292.
Duley L, Henderson-Smart D, and Meher S (2005) Altered dietary salt for preventing pre-eclampsia, and its complications.
_Cochrane Database of Systematic Reviews_ CD005548.
Durnin JV (1991) Energy requirements of pregnancy. _Diabetes_
**40** (Suppl. 2), 152–156.
Eskenazi B, Stapleton AL, Kharrazi M, and Chee WY (1999) Associations between maternal decaffeinated and caffeinated coffee
consumption and fetal growth and gestational duration. _Epi-_
_demiology_ **10**, 242–249.
Flaxman SM and Sherman PW (2000) Morning sickness: a mechanism for protecting mother and embryo. _Quarterly Review of_
_Biology_ **75**, 113–148.
Flidel-Rimon O, Rhea DJ, Keith LG, Shinwell ES, and Blickstein I
(2005) Early adequate maternal weight gain is associated with
fewer small for gestational age triplets. _Journal of Perinatal_
_Medicine_ **33**, 379–382.
Furneaux EC, Langley-Evans AJ, and Langley-Evans SC (2001)
Nausea and vomiting of pregnancy: endocrine basis and contribution to pregnancy outcome. _Obstetric and Gynecological Sur-_
_veys_ **56**, 775–782.
Hadden DR (2008) Prediabetes and the big baby. _Diabetic Medicine_
**25**, 1–10.
Hannigan JH and Armant DR (2005) Alcohol in pregnancy and
neonatal outcome. _Seminars in Neonatology_ **5**, 243–254.
Helgstrand S and Andersen AM (2005) Maternal underweight and
the risk of spontaneous abortion. _Acta Obstetrica et Gynecologica_
_Scandinavica_ **84**, 1197–1201.
Henderson J, Gray R, and Brocklehurst P (2007) Systematic review
of effects of low–moderate prenatal alcohol exposure on pregnancy outcome. _British Journal of Obstetrics and Gynaecology_
**114**, 243–252.
Hussain A, Claussen B, Ramachandran A, and Williams R (2007)
Prevention of type 2 diabetes: a review. _Diabetes Research and_
_Clinical Practice_ **76**, 317–326.
Hytten FE and Leitch I (1971) _The Physiology of Human Pregnancy_ .
Blackwell, Oxford.
Innis SM (2005) Essential fatty acid transfer and fetal development.
_Placenta_ **26** (Suppl. A), S70–S75.
Jackson WC and Martin JP (2000) Amylophagia presenting as gestational diabetes. _Archives of Family Medicine_ **9**, 649–652.
Jaddoe VW, Bakker R, Hofman A _et al_ . (2007) Moderate alcohol
consumption during pregnancy and the risk of low birth weight
and preterm birth. The generation R study. _Annals of Epidemiol-_
_ogy_ **17**, 834–840.
Javaid MK, Crozier SR, Harvey NC _et al_ . (2006) Maternal vitamin
D status during pregnancy and childhood bone mass at age 9
years: a longitudinal study. _Lancet_ **367**, 36–43.
Jeffcoat MK, Hauth JC, Geurs NC _et al_ . (2003) Periodontal disease
and preterm birth: results of a pilot intervention study. _Journal_
_of Periodontology_ **74**, 1214–1218.
Jensen CL (2006) Effects of n-3 fatty acids during pregnancy
and lactation. _American Journal of Clinical Nutrition_ **83**,
1452S–1457S.
Jensen DM, Damm P, Sørensen B _et al_ . (2003) Pregnancy outcome
and prepregnancy body mass index in 2459 glucose-tolerant



Danish women. _American Journal of Obstetrics and Gynecology_
**189**, 239–244.
King JC (2000) Physiology of pregnancy and nutrient metabolism.
_American Journal of Clinical Nutrition_ **71**, 1218S–1225S.
KlebanoffMA,ShionoPH,SelbyJV,TrachtenbergAI,andGraubard
BI (1991) Anemia and spontaneous preterm birth. _American_
_Journal of Obstetrics and Gynecology_ **164**, 59–63.
Kramer MS and Kakuma R (2003) Energy and protein intake in
pregnancy. _Cochrane Database Systematic Reviews_ CD000032.
L´opez LB, Langini SH, and Pita dePortela ML (2007) Maternal
iron status and neonatal outcomes in women with pica during
pregnancy. _International Journal of Gynaecology and Obstetrics_
**98**, 151–152.
L´opez NJ, Smith PC, and Gutierrez J (2002) Periodontal therapy
may reduce the risk of preterm low birth weight in women with
periodontal disease: a randomized controlled trial. _Journal of_
_Periodontology_ **73**, 911–924.
Luke B (2005) Nutrition and multiple gestation. _Seminars in Peri-_
_natology_ **29**, 349–354.
LundsbergLS,BrackenMB,andSaftlasAF(2007)Low-to-moderate
gestational alcohol use and intrauterine growth retardation, low
birthweight,andpretermdelivery. _AnnalsofEpidemiology_ **7**,498–
508.
Maconochie N, Doyle P, Prior S, and Simmons R (2007) Risk factors
for first trimester miscarriage–results from a UK-populationbased case-control study. _British Journal of Obstetrics and Gynae-_
_cology_ **114**, 170–186.
Marchioni E, Fumarola A, Calvanese A _et al_ . (2008) Iodine deficiency in pregnant women residing in an area with adequate
iodine intake. _Nutrition_ **24**, 458–461.
Martin TR and Bracken MB (1987) The association between low
birth weight and caffeine consumption during pregnancy. _Amer-_
_ican Journal of Epidemiology_ **126**, 813–821.
Merlino A, Laffineuse L, Collin M, and Mercer B (2006) Impact
of weight loss between pregnancies on recurrent preterm birth.
_American Journal of Obstetrics and Gynecology_ **195**, 818–821.
Mikkelsen TB, Andersen AM, and Olsen SF (2006) Pica in pregnancy in a privileged population: myth or reality. _Acta Obstetrica_
_et Gynecologica Scandinavica_ **85**, 1265–1266.
Millward DJ (1999) Optimal intakes of protein in the human diet.
_Proceedings of the Nutrition Society_ **58**, 403–413.
Mishra V, Thapa S, Retherford RD, and Dai X (2005) Effect of
iron supplementation during pregnancy on birthweight: evidence from Zimbabwe. _Food and Nutrition Bulletin_ **26**, 338–347.
Mukherjee RA, Hollins S, and Turk J (2006) Fetal alcohol spectrum
disorder: an overview. _Journal of the Royal Society of Medicine_ **99**,
298–302.
Nohr EA, Bech BH, Vaeth M, Rasmussen KM, Henriksen TB, and
OlsenJ(2007)Obesity,gestationalweightgainandpretermbirth:
a study within the Danish National Birth Cohort. _Paediatric and_
_Perinatal Epidemiology_ **21**, 5–14.
Pastore LM and Savitz DA (1995) Case-control study of caffeinated
beveragesandpretermdelivery. _AmericanJournalofEpidemiology_
**141**, 61–69.
Peacock JL, Bland JM, and Anderson HR (1995) Preterm delivery:
effects of socioeconomic factors, psychological stress, smoking,
alcohol, and caffeine. _British Medical Journal_ **311**, 531–535.
Pitiphat W, Joshipura KJ, Gillman MW, Williams PL, Douglass CW,
and Rich-Edwards JW (2008) Maternal periodontitis and adverse
pregnancy outcomes. _Community Dentistry and Oral Epidemiol-_
_ogy_ **36**, 3–11.
Poston L (2006) Endothelial dysfunction in pre-eclampsia. _Phar-_
_macological Reports_ **58** (Suppl.), 69–74.
Poston L, Briley AL, Seed PT, Kelly FJ, and Shennan AH (2006)
Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamin C



**Pregnancy** **73**


and vitamin E in pregnant women at risk for pre-eclampsia (VIP
trial): randomised placebo-controlled trial. _Lancet_ **367**, 1145–
1154.
PrenticeAMandGoldbergGR(2000)Energyadaptationsinhuman
pregnancy:limitsandlong-termconsequences. _AmericanJournal_
_of Clinical Nutrition_ **71**, 1226S–1232S.
Rainville AJ (1998) Pica practices of pregnant women are associated
with lower maternal hemoglobin level at delivery. _Journal of the_
_American Dietetic Association_ **98**, 293–296.
Reader DM (2007) Medical nutrition therapy and lifestyle interventions. _Diabetes Care_ **30** (Suppl. 2), S188–S193.
Roberts JM, Balk JL, Bodnar LM, Beliz´an JM, Bergel E, and Martinez A (2003) Nutrient involvement in preeclampsia. _Journal of_
_Nutrition_ **133**, 1684S–1692S.
Roberts JM, Bodnar LM, Lain KY _et al_ . (2005) Uric acid is as
important as proteinuria in identifying fetal risk in women with
gestational hypertension. _Hypertension_ **46**, 1263–1269.
Roberts JM and Gammill HS (2005) Preeclampsia: recent insights.
_Hypertension_ **46**, 1243–1249.
Sanders TA (1999) Essential fatty acid requirements of vegetarians
in pregnancy, lactation, and infancy. _American Journal of Clinical_
_Nutrition_ **70**, 555S–559S.
Scholl TO and Reilly T (2000) Anemia, iron and pregnancy outcome. _Journal of Nutrition_ **130**, 443S–447S.
Sculley DV and Langley-Evans SC (2003) Periodontal disease is
associated with lower antioxidant capacity in whole saliva and
evidence of increased protein oxidation. _Clinical Science_ **105**,
167–172.
Sebire NJ, Jolly M, Harris J, Regan L, and Robinson S (2001) Is
maternal underweight really a risk factor for adverse pregnancy
outcome? A population-based study in London. _British Journal_
_of Obstetrics and Gynaecology_ **108**, 61–66.
Spohr HL, Willms J, and Steinhausen HC (2007) Fetal alcohol
spectrum disorders in young adulthood. _Journal of Pediatrics_
**150**, 175–179.
Steinhausen HC and Spohr HL (1998) Long-term outcome of children with fetal alcohol syndrome: psychopathology, behavior,
and intelligence. _Alcoholism, Clinical and Experimental Research_
**22**, 334–338.
Stokes T (2006) The earth eaters. Nature **444**, 543–544.
Tan PC, Jacob R, Quek KF, and Omar SZ (2007) Pregnancy outcome in hyperemesis gravidarum and the effect of laboratory
clinical indicators of hyperemesis severity. _Journal of Obstetrics_
_and Gynaecology Research_ **33**, 457–464.
Trogstad LI, Stoltenberg C, Magnus P, Skjaerven R, and Irgens
LM (2005) Recurrence risk in hyperemesis gravidarum. _British_
_Journal of Obstetrics and Gynaecology_ **112**, 1641–1645.
Verberg MF, Gillott DJ, Al-Fardan N, and Grudzinskas JG (2005)
Hyperemesis gravidarum, a literature review. _Human Reproduc-_
_tion Update_ **11**, 527–539.
Wainwright PE (2002) Dietary essential fatty acids and brain function: a developmental perspective on mechanisms. _Proceedings of_
_the Nutrition Society_ **61**, 61–69.
Walsh SW (2007) Obesity: a risk factor for preeclampsia. _Trends in_
_Endocrinology and Metabolism_ **18**, 365–370.
Wang JX, Davies MJ, and Norman RJ (2002) Obesity increases the
riskofspontaneousabortionduringinfertilitytreatment. _Obesity_
_Research_ **10**, 551–554.
Weng X, Odouli R, and Li DK (2008) Maternal caffeine consumption during pregnancy and the risk of miscarriage: a prospective
cohort study. _American Journal of Obstetrics and Gynecology_ **198**,
e1–e8.
Whittaker PG, Lind T, and Williams JG (1991) Iron absorption
during normal human pregnancy: a study using stable isotopes.
_British Journal of Nutrition_ **65**, 457–463.



**74** **Nutrition: A Lifespan Approach**


Yeh J and Shelton JA (2007) Association of pre-pregnancy maternal
body mass and maternal weight gain to newborn outcomes in
twin pregnancies. _Acta Obstetrica et Gynecologica Scandinavica_
**86**, 1051–1057.
Young SL, Goodman D, Farag TH _et al_ . (2007) Geophagia is not
associatedwithTrichurisorhookwormtransmissioninZanzibar,
Tanzania. _Transactions of the Royal Society of Tropical Medicine_
**101**, 766–772.


**Self-Assessment Questions**


Assess your understanding of the concepts outlined in
this chapter using the following questions:


~~1 Describe how the physiological adaptations associated~~
with pregnancy impact upon nutritional status.
2 How do energy and nutrient requirements alter with
pregnancy?
3 Which nutrition-related factors are predictive of adverse pregnancy outcomes?



Yu CKH, Teoh TG, and Robinson S (2006) Obesity in pregnancy.
_British Journal of Obstetrics and Gynaecology_ **113**, 1117–1125.
Zagr´e NM, Desplats G, Adou P, Mamadoultaibou A, and Aguayo
VM (2007) Prenatal multiple micronutrient supplementation
has greater impact on birthweight than supplementation with
iron and folic acid: a cluster-randomized, double-blind, controlled programmatic study in rural Niger. _Food and Nutrition_
_Bulletin_ **28**, 317–327.


4 PE is an inflammatory disorder. Describe the symptoms
of PE and the role of nutrition in determining risk.
5 What impact does NVP have upon nutritional status
~~and pregnancy outcomes?~~
6 Compare and contrast the nutritional requirements of
women carrying multiple compared to singleton pregnancies.



# **4**

### **Fetal Nutrition and Disease in Later Life**

**Learning objectives**



By the end of this chapter the reader should be able to:


r Understand the adaptive nature of fetal development
and the capacity of the fetal organs and tissues to respond to changes in the maternal environment.
r Define what is meant by the terms fetal or nutritional
~~programming.~~
r Describe the association between risk factors operating
in fetal life and disease during adulthood.
r Discuss the epidemiological evidence that suggests
that maternal nutrition during pregnancy may program
the risk of major disease later in life.
r Demonstrate an awareness of the limitations of epidemiology as a tool for exploring nutritional programming of disease.


**4.1 Introduction**


The previous chapter outlined the importance of
nutrition during pregnancy from the perspective of
maintaining the health of the pregnant woman and
ensuring the safe delivery of her infant. It is now clear
that nutrition during pregnancy is important in determining the long-term health and well-being of the developing fetus. This concept lies at the core of the idea
that health and disease at all stages of life are the product of cumulative experiences across the lifespan. The
present chapter will focus upon the evidence that early
life under- or overnutrition can exert powerful effects,
termed “programming,” upon the development of organs and systems, and that these programming effects
are an important risk factor for disease. Although research in this area is still at a relatively early stage, the
chapter will review some of the proposed mechanisms
that link nutrition during fetal life to diseases such
as coronary heart disease and diabetes in the older
adult.



r Give an overview of the evidence obtained from experimental models that shows the biological plausibility of
the nutritional programming concept.
r Discuss the candidate mechanisms that have been proposed to explain how maternal undernutrition might
program disease in the developing fetus.
~~r~~ ~~Show~~ ~~awareness~~ ~~of~~ ~~the~~ ~~epigenetic~~ ~~mechanisms~~
through which gene expression is regulated and describe how these processes might define the functions
of cells, tissues, and organs.
r Discuss the potential application of understanding of
nutritional programming in designing future public
health interventions to prevent coronary heart disease,
obesity, and type 2 diabetes.


**4.2 The developmental origins of adult**
**disease**


_**4.2.1 The concept of programming**_


The term programming describes the process through
which exposure to environmental stimuli or insults,
during critical phases of development brings about
permanent changes to the physiology or metabolism
of the organism. A dramatic example of programming at work is provided by the mechanisms that determine sex in crocodilians. Alligators and crocodiles
lack sex chromosomes. Their eggs are laid into heaped
mounds within which exists a temperature gradient.
At most temperatures within the nest the embryos will
developintofemales,whilewithinaveryspecificrange
of 4–5 [◦] C the embryos are programmed to become
males. These effects are seen because the temperature
of the egg determines the expression of genes responsible for synthesis of the sex steroids, which then govern the physiological development of these reptiles.
This is clearly a programming response under the



**76** **Nutrition: A Lifespan Approach**


definition provided above, since the stimulus is temperature, the critical phase of development lies within
the embryonic period and the effect of the exposure is
permanent.
Within mammalian systems, programming is a feature of the plasticity of cell lines during embryonic
and fetal life. Plasticity refers to the ability of cells
and tissues to develop in response to their current
environment. In some types of cell, this adaptive capacity remains present throughout life. For example,
the human immune system can respond to infection
by a previously unencountered pathogen. The lines
of B-lymphocytes that differentiate during that response will then remain available, in order to more
effectively combat any subsequent infection by that
organism. However, for most types of cell, plasticity is
a short-lived characteristic and is only a feature of the
embryonic and fetal stages. These are the critical developmental phases that are of greatest interest in the
context of nutrition and human health and disease.
The capacity to program mammalian systems
through early life stimuli can be demonstrated just
as dramatically as the example of temperaturedependent sex determination in reptiles. Treatment
of newborn female rats with testosterone in the

first few days of life impacts upon their lifelong reproductive function. Regions of the hypothalamus
that control the reproductive axis and archetypal female reproductive behaviors are remodeled to resemble the male brain and the female rats are ren
dered sterile (Arai and Gorski, 1968). The critical period in which this androgenizing treatment
is effective is relatively short, but the effects are
permanent.
There is also evidence that programming by the environment is a normal feature of human physiology.
The Japanese military made the discovery during the
Second World War that the number of sweat glands
in humans is set soon after birth and cannot then be
further adjusted. Individuals born in cooler climates
activate a smaller number of sweat glands than individualsborninwarmerclimates.Thus,theresponseto
the prevailing environment during the early postnatal
period brings about permanent changes to physiology
that allow the individual born in a warm climate to
be optimally adapted for life in that climate, while the
individual from a cold climate will cope less well with
the heat.



_**4.2.2 Fetal programming and human**_
_**disease**_
The capacity of the developing mammal to respond
to environmental cues or physiological insults in the
manner described above, suggests something profound and unexpected about the nature of development. For decades we have believed that development
is essentially a gene-led process and that activation
and switching off of the expression of genes, in wellordered sequences, brings about the normal growth
and development of organisms, from the fertilized egg
through to the adult offspring. The concepts of developmental plasticity and programming would suggest
that the environment can change the profile of genes
that are expressed at any given stage of development.
In other words, the genes do not necessarily lead the
process of development and instead follow the signals
from the mother that indicate the availability of nutrients, the presence of stressors, and the need to adapt
accordingly.
The impact of the environment upon apparently
genetically determined processes could be simply observed by looking at the effects of maternal factors
upon fetal growth. The growth trajectory of a fetus is determined by the genes inherited from both
the mother and the father, but evolution has provided mechanisms through which the genetically determined growth rate can be constrained. Classic experiments using embryo transfers in horses and cattle
show that the size of the mother is a primary factor
governing fetal growth. Shetland ponies are a small
breed of horses, standing at no more than 10 hands
(approximately 107 cm), while the Shire horse stands
at an impressive 18 hands (180 cm). The foals of these
horses are of a size commensurate with their breed.
When Shetland mares carry the foals resulting from
Shire horse x Shetland pony crosses, the genetically
large offspring are born at a size similar to the pure
Shetland. This form of constraint is in the interest of
maternal survival, as carrying a fetus that will become
too large to pass through the birth canal is likely to
prove fatal to mother and offspring.
Constraint of growth also occurs in response to
other characteristics of mothers. A whole range of factors that signal underprivilege or other indicators of
a less than optimal environment, are associated with
lower weights at birth among human babies. One of
the strongest predictors of the weight of a baby at birth



**4.0**


**3.5**


**3.0**


**2.5**


**2.0**
**I** **II** **III** **IV** **V**


**Social class of baby's mother**


**Figure 4.1** Effect of socioeconomic status on birth weight in humans.
Social class I- professionals, class II- clerical workers, class III- skilled
manual or nonmanual workers, class IV- unskilled workers, class Vunemployed.


is the socioeconomic class of the mother. In a study of
300 pregnant women from Northampton, UK (Figure 4.1), average weights at birth were 400 g lower in
babies of women from social class V (unemployed)
than in babies of women from social class I (professionals, Langley-Evans and Langley-Evans, 2003). Social class is a crude indicator of many different factors,
that will include family income, nutritional status, access to healthcare services, smoking, and other health
behaviors.Severaloftheseareknowntoinfluencefetal
growth in their own right. Maternal smoking during
pregnancy restricts fetal growth and increases risk of
low birth weight and premature birth. The same risks
are associated with maternal infection and severe maternal distress during pregnancy. Smits and colleagues
(2006)studied1885Dutchwomenwhowerepregnant
at the time of the 9/11 terrorist attacks on the World
Trade Center. Compared to women giving birth a year
later,babiesofthiscohortweresmaller,supportingthe
hypothesis that psychological stress can impact upon
growth and development.
The ability of maternal nutrition-related factors to
constrain fetal growth is an area of some controversy.
In populations exposed to famine it is simple to
demonstrate that there is a detrimental impact on fetal growth. The effects are, however, often remarkably
small. In the winter of 1944–1945, an area of western
Holland was subject to a famine of approximately
6 months duration as the occupying Nazi forces
blocked delivery of rations in reprisal for strike action
among Dutch railworkers. At the height of the famine,
the adult ration delivered only 500–600 kcal/day. Due



**Fetal Nutrition and Disease in Later Life** **77**


to the duration of the famine some pregnant women
were affected over the final stages of pregnancy, while
others were undernourished in early pregnancy. Birth
weights among babies affected by famine in late gestation were approximately 250 g lower than those of
babies born before or conceived after the famine
(Roseboom _et al_ ., 2001). Surprisingly, the babies
caught by famine in the first trimester of gestation
were heavier at birth than the Dutch norm for that

period.
Women living in rural areas of the Gambia are subject to seasonal variation in nutritional status, which
reflects variation in climate. During the dry season,
agriculture is relatively easy as the soil is light and easy
to work. Crop growth is good and conditions for food
storage are favorable. Thus, at this time women are
relatively well-nourished. During the lengthy wet season, however, the women lose 4–5 kg of weight and
this is due to a relative scarcity of food, occurring due
to inability to keep food stores dry and the difficulty of
working the fields and growing viable crops (Moore
_et al_ ., 1999). The variation in maternal nutritional status between these seasons is reflected in infant birth
weights, which are on average 200 g lighter in the wet
season that in the dry. Providing women with modest supplements of protein and energy during the wet
season has been shown to abolish this difference in
birth weight.
Among well-nourished populations of women,
simple measures of maternal intake tend to be only
weakly related to babies’ birth weights or other markers of fetal growth. Mathews and colleagues (1999)
studied pregnant women living in Portsmouth, UK,
and found that there were no significant associations
between babies’ weights at birth and maternal intakes
of any nutrient. Godfrey and colleagues (1996), on
the other hand, reported that birth weights of babies
in nearby Southampton, were related to maternal intakes of protein in late gestation (low-protein diets
were associated with lower birth weights) and maternal sucrose intakes in early gestation (high sucrose intakes were associated with lower birth weights). Wynn
and colleagues (1991) demonstrated that the influence of maternal nutrition may be greater in women
of lower socioeconomic status, finding that among
impoverished women in Hackney, London, intakes of
B vitamins were related to birth weight.
The lack of clear effects of maternal nutrient in
takes upon babies’ birth weights is unsurprising, as



**78** **Nutrition: A Lifespan Approach**







**Figure 4.2** Influences upon fetal growth. The growth
trajectory of the fetus is determined by the genotype.
Genetically determined growth rates may be constrained
by influences from the mother or placenta. These can act directly on the fetal tissues, for example, maternal hormones
crossing the placenta, or indirectly by modifying the range
or concentration of nutrients reaching the fetal tissues.









the delivery of nutrients to the fetus in order to drive
growth depends upon more than just maternal intakes of those nutrients (Figure 4.2). Well-nourished
women will generally have adequate reserves of nutrients and can therefore maintain delivery of most
substrates to the fetal tissues even if their intakes are

compromised in the short to medium term. Fetal nutrition will also depend upon the ability of the placenta to supply substrates, and this in turn may be
influenced by maternal adaptations to pregnancy, nutritional factors, and hormonal signals.
Constraintoffetalgrowth,leadingtoalowerweight
at birth, is an indicator that the developing fetus
is adapting to aspects of the maternal environment.
Given the evidence presented so far, showing that fetal
growth can respond to maternal nutritional signals,
and that events in early life can program developing
organs and tissues, it is reasonable to assert that maternal nutrition can also affect how mature organs
subsequently function and therefore program aspects
of physiology and metabolism, which ultimately determine risk of major disease.
The rate of fetal growth is likely to be set at a very
earlystageingestationandcouldbepartlydetermined
by the nutrition of the mother before pregnancy. The
availability of plentiful maternal stores may allow the
geneticallylargefetustogetofftoarapidinitialgrowth
(Harding, 2004). The rapidly growing fetus may be
more vulnerable to undernutrition later on in pregnancy, while a fetus that has been following a slower
growth trajectory throughout earlier gestation may be
able to maintain this rate of growth even in the face
of a nutrient shortage.
Some of the first evidence of a possible association between early life nutrition and disease came



from simple studies that set out to explore the North–
South divide in health noted in England and Wales. In
the 1980s, there was a profound difference in risk of
coronary heart disease death between the southeastern corner of England and the industrialized regions
of northern England and South Wales. David Barker
andcolleagueswereabletodemonstratethattherewas
a robust association between 1970s coronary mortality rates in the different regions and infant death rates
some 60 years earlier (Barker and Osmond, 1986).
Those parts of the country with high infant mortality early in the twentieth century were the same regions with high coronary death rates. Further investigationofthedeathcertificatesofover2millionBritons
showed that place of birth was a strong predictor of
death from coronary heart disease, with greatest risk
associated with birth in the industrial north (Bradford, Halifax, Huddersfield, Preston), and lowest risk
associated with birth in the south and southeast (East
Sussex, West Sussex, Isle of Wight). Most importantly,
this risk was independent of subsequent migration,
so individuals born in Bradford would retain their
greater likelihood of coronary heart disease death later
in life, even if they lived out their adult years in Sussex
(Osmond _et al_ ., 1990). The simplest interpretation of
these studies is that adverse factors, such as poor maternal nutrition, during fetal development either led
to the death of the infant, or prompted physiological
adaptations that allowed survival, but led to greater
risk of cardiovascular disease (CVD) later in life.
Such observations were the main spark for Barker’s
proposal of the Developmental Origins of Adult Disease hypothesis (Barker, 1998).
The Developmental Origins of Adult Disease hypothesis explicitly advances the idea that any form



**Figure 4.3** The Developmental Origins of Health and Disease hypothesis. Maternal undernutrition promotes fetal undernutrition, which in
turn will slow fetal growth rates. The relationship between fetal undernutrition and disease in later life may be directly the result of fetal
adaptations to undernutrition, or may be related to the restriction of
fetal growth and organ development.


of adverse environment encountered in early life can
elicit adaptive responses that modify the future health
of the individual. While a range of adverse factors
could be responsible for the developmental programming of health and disease, maternal nutrition was
proposed as the main factor that would determine
the nature of fetal development (Figure 4.3). The proposal of nutrition as the primary driver of programming stemmed from the fact that the epidemiological
evidence suggesting programming of human disease
highlighted impaired fetal growth as a predictor of
heart disease and diabetes. As will be seen below, this
evidence mostly came from studies of groups of people born in Britain, early in the twentieth century, a
period where undernutrition was rife among young
adult women.


**4.3 Evidence linking maternal nutrition to**
**disease in later life**


_**4.3.1 Epidemiology**_

A full exploration of the possible programming relationship between maternal diet and disease in later



**Fetal Nutrition and Disease in Later Life** **79**


life would require detailed records of many aspects
of maternal diet and lifestyle during pregnancy and
long-term follow-up of children into late adulthood.
This is not a realistic possibility for most researchers.
The alternative approach involves locating adults for
whom some indicator of prenatal exposure to putative risk factors is available, and then relating these
exposure indicators to disease patterns. This is called
aretrospectivecohortstudy.Historically,theonlydata
that was reliably recorded about pregnancy outcomes
was some anthropometric measure of infants, such
as birth weight, length at birth, and head circumference. These measurements give only a crude indicator of nutritional influences. As described above,
undernutritioncanconstraingrowthandreducebirth
weight. It is also suggested that the nutritional constraint of birth weight may be greater than that of
linear growth, leading to the birth of a baby who is
relatively thin (lightweight in relation to body length;
Godfrey, 2001).
A unique set of records from the county of Hertfordshire in England provided the basis of the first
major epidemiological study to consider relationships
between birth anthropometry and disease in later life.
Records from 16 000 men and women born in Hert
fordshire between 1911 and 1930 were traced. It was
found that while mortality rates for all causes were unrelated to size at birth or in infancy, both lower birth
weight and lower body weight at 1 year were predictive
of increased CVD mortality (Barker _et al_ ., 1989). By
following-up individuals from this cohort who were
still living in the county, researchers showed that low
weight at birth also predicted risk factors for CVD,
including blood pressure (Barker _et al_ ., 1990), type
2 diabetes (Hales _et al_ ., 1991), and the insulin resistance syndrome (Syndrome X) (Barker _et al_ ., 1993a).
Infants who weighed less than 5.5 lbs at birth (2.5 kg)
were twice as likely to die from coronary heart disease,
six and a half times more likely to develop type 2 diabetes and 18 times more likely to develop syndrome
X than individuals who weighed greater than 9.5 lbs
(4.3 kg). The Hertfordshire study and many similar studies from all over the world, showed that low
weight at birth was a significant predictor of disease
60–70 years later and supported the concept that maternal undernutrition may program disease processes
(Figure 4.3).
It became clear from a study of a cohort of
men and women born in Sheffield, UK, that body



**80** **Nutrition: A Lifespan Approach**


proportions at birth were also significant predictors
of CVD risk. Among 1586 men born in Sheffield between 1907 and 1923, CVD death rates were not only
related to birth weight, they also rose significantly
with decreasing ponderal index (Barker _et al_ ., 1993b).
The latter (weight/height, kg/m [3] ) is a marker of relative thinness (low ponderal index) or fatness (high
ponderal index) at birth. Ponderal index at birth was
also a significant predictor of blood pressure. This
data therefore showed that babies who were born

small and thin were at greater risk of disease in later
life. The US Nurses Health Study collected data on
birth weight by self-report from 70 297 women and
found that among full-term singletons, after adjustment for adult BMI, risk of coronary heart disease and
stroke were both related to weight at birth (Curhan
_et al_ ., 1996). A lower weight at birth increased risk
of coronary heart disease (relative risk estimate 0.85
per kg increase in birth weight) and stroke (relative
risk estimate 0.85 per kg increase in birth weight) and
was associated with higher blood pressure in adult
life.

Evidence of associations between characteristics at
birth and risk factors for major disease can also be
shown in studies of children. Bavdekar _et al_ . (1999)
studied 8-year-old children in India and found that
lower weight at birth was associated with lower sensitivity to insulin and impaired glucose tolerance. In
effect, these lower birth weight young children were
already on the road to type 2 diabetes. This suggests
that the programming effects of fetal life impact upon
metabolism and physiology immediately after birth,
and do not depend upon aging to be expressed.
The most powerful cohort studies to assess possible
programming of CVD and diabetes in humans have
emerged from investigations of two populations born
in Helsinki, Finland (1924–1933 and 1933–1944).
Eriksson _et al_ . (1999) found that birth weight was
inversely associated with risk of both coronary heart
disease and stroke-related mortality. Among men, a
low ponderal index at birth was also related to risk
of coronary heart disease death, if BMI was high in
childhood. The most important aspect of the Helsinki
1933–1944 cohort was that the babies had been sub
ject to serial measures of weight and height until age
12. Studies of this cohort showed low birth weight
to predict coronary heart disease events, type 2 diabetes, and metabolic syndrome, and again demonstrated that relative thinness at birth (low ponderal



index) and relative fatness in childhood (greater BMI)
were associated with risk of these conditions.

An increasing body of evidence from large cohorts
has begun to consider whether there is any interaction
between factors that influence fetal growth rates and
influences on postnatal growth. For example, it is of
interest to know if the fate of the low birth weight
baby differs depending on how he or she is fed during
childhood. Where studies were able to look at postnatal as well as prenatal growth, it is apparent that a rapid
gain from birth to adulthood was a risk in addition
to prenatal growth restriction. This could be an indicator that the two observations (pre- and postnatal
growth) represented independent risk factors that the
mostseverelyconstrainedbabiesaresubjecttopostnatal catch-up growth and this is a marker of CVD risk,
or that there is a genuine interaction of pre- and early
postnatal factors in programming. The Helsinki data
suggest the latter, as the fate of individuals with the
most rapid rates of infant growth differed depending
on their size at birth. Those born small and growing
most rapidly in infancy had highest risk of CVD, while
those who were larger at birth had lower CVD risk if
weight gain was rapid in infancy. The fact that the
small infant at birth who remained small throughout
infancyhadnoincreasedriskofadultCVDarguesthat
the pre-postnatal interaction is of prime importance
in cardiovascular programming.
The above studies are limited in that they are only
able to report associations between disease states and
anthropometric measurements at birth. The latter are
only weak markers of the nutritional environment
encountered by the fetus during critical periods of development. The Dutch famine, described in Section
4.2.2, has been useful in extending the developmental
origins hypothesis since it provides an easily accessible population whose mothers were subject to a brief
period of food restriction. Follow-up of the Dutch
famine babies showed that their health status was

poor relative to their contemporaries whose mothers had not been affected by the famine. Exposure to
famine in early gestation was associated with greater
prevalence of coronary heart disease, with raised circulating lipids, with raised concentrations of blood
clotting factors, and with more obesity compared to
those not exposed to the famine (Roseboom _et al_ .,
2001). Exposure to the famine during mid-gestation
wasassociatedwithmicroalbuminuria,anindicatorof
impaired kidney function. Exposure to famine during



late gestation was associated with disorders of glucose
metabolism that lead to type 2 diabetes. Similar support for there being an association between maternal
nutritional status and disease in later life has been

provided by studies of children in Jamaica and the
US. A small-scale study of Jamaican boys aged 10–11
years demonstrated that their blood pressures were
related to markers of undernutrition in their mothers during pregnancy (Godfrey _et al_ ., 1994). The boys
whose mothers had the lowest circulating hemoglobin
concentrations (indicating low iron status) and lowest
triceps skinfold thicknesses (indicating low body fat
reserves) had the highest blood pressures. Blood pressurewasalsoanoutcomeinProjectViva,aprospective
cohort study that aims to follow-up the children of
women whose nutritional status had been measured

in detail in the period prior to and during pregnancy.
Gillman and colleagues (2004) reported that maternal
calcium supplementation during pregnancy reduced
blood pressure in 6-month-old infants.


_**4.3.2 Criticisms of the programming**_
_**hypothesis**_


The compelling epidemiological findings described
above have major implications for our understanding
of how disease processes are initiated and for public health policy across the world. If nutritional programming has a genuine influence on human disease
then interventions designed to prevent disease must
be targeted at pregnant women, for the benefit of their
children, as well as being aimed at the adults whose
lifestyles may increase risk of obesity and related disorders. The developmental origins hypothesis would
suggest that altering patterns of disease in populations
may be the equivalent of trying to turn around an oil
tanker, as effective public health strategies could take
decades to come to fruition.
Through associations with such profound implications, it is right that the developmental origins hypothesis should be subjected to close scrutiny and critique. The epidemiology underpinning the hypothesis
hasbeencriticizedonseveraldifferentlevels.Mostimportantly, most of the epidemiology in this area has
focused on measuring disease outcomes in adults aged
50–80 and then attempting to relate these outcomes
retrospectively to proxy markers of maternal nutrition
from many decades previously. The quality of the data
on exposure is therefore very poor and it is relatively
easy to invoke the influences of confounding factors



**Fetal Nutrition and Disease in Later Life** **81**


that are either not adjusted for (e.g., maternal physical activity, maternal infection, childhood infection,
quality of the infant diet in the postnatal period, adult
lifestyle factors), or only crudely adjusted for (e.g., social class). Bartley and colleagues (1994) showed how
important social class could be in confounding the
birth-weight–disease association. Their study showed
that individuals born into a poor family tended to be
of lower weight at birth. Most individuals born into a
family of lower socioeconomic class tended to remain
in that lower class when they were adults. It is wellestablished that being of lower socioeconomic status
is a risk factor for CVD, and thus the birth-weight–
cardiovascular disease association could be purely an
influence of poverty.
There are also studies that do not fit with the hypothesis. For example, Matthes _et al_ . (1994) studied
330 adolescents and found that there was no difference in blood pressure between those who were lighter
than 3 kg at birth and those who were 3 kg, or heavier, at birth. Similarly, Falkner _et al_ . (1998) found no
elevation in blood pressure in young adults who were
of low birth weight.
Most epidemiological studies that have examined
the maternal diet–later disease association have relied
upon birth weight or other proportions at birth as a
proxy for maternal nutritional status. This is problematic since, as described above, maternal nutrient
intakes have only minor influences on fetal growth
rates, compared to some other factors. Studies of
the wartime famines in Holland or the Soviet Union
have been widely reported as providing evidence from
“naturalexperiments”inwhichwecanbesurethatthe
babies born at those times were subject to undernutrition. While they have yielded interesting findings,
these studies are subject to important criticisms. During wartime, birth rates can fall dramatically and so it
may be that the women having children at these times
were in some way not representative of the whole population.Wartimeisstressful,notleastintheLeningrad
siege where the population were exposed to vicious
street fighting. Maternal stress could program longterm effects independently of nutrition. It is also apparent that there were ways around rationing and a
black market in foodstuffs may have relieved some of
the hardships of pregnant women in at least the Dutch
famine.

The most potent criticism of the epidemiological studies showing associations between infant



**82** **Nutrition: A Lifespan Approach**


birth weights and disease risk indicators in later life
has come from the work of Huxley and colleagues
(2002). This group performed a meta-analysis of all
studies that had considered the association between

birth weight and blood pressure in adulthood. Generally, in epidemiology it is expected that studies with
the most subjects give the most reliable and robust
findings. Huxley _et al_ . (2002) found that the strongest
influences of birth weight on blood pressure were reported in small-scale studies, while large cohort studies found the weakest associations. It was concluded
that the birth-weight–blood pressure association was
partly a product of publication bias (in which small
studies showing an effect are prioritized by journal
editors over small studies showing no effect) and reflected random error, selective emphasis of particular results, methodological flaws, and confounding
factors.

Such criticisms are inevitable products of the complexity of any likely relationship between nutritional
exposures in fetal life and disease outcomes that
may not manifest for 60–70 years. It is questionable
whether epidemiological approaches have the capacity to investigate these questions at all. Studies such
as the Hertfordshire study, which was so influential in
promoting interest in developmental programming as
a risk factor in human disease, were already no longer
representative of influences at work in the modern
population, at the time at which they were published.
The nutritional and social influences on fetal development operative in the period 1910–1930 were clearly
vastly different to those operative in 1990 and it is
possible that the disease consequences that will be observed in 2050, will differ from those noted by Barker
and colleagues in the elderly Hertfordshire men and
women. It is critical, therefore, that there are studies
in this field that can establish the biological plausibility of programming as a risk factor for disease. It
is very important to identify the influences of different patterns of diet (e.g., overnutrition as well as
undernutrition) upon development and disease and
to begin to describe the mechanisms through which
programming occurs.


_**4.3.3 Experimental studies**_


To perform a study in humans that could adequately
test the developmental origins of health and disease
hypothesis would require prospective study of women
before and during pregnancy, with follow-ups of their



children for 50–60 years. This is clearly not practical in terms of either cost or manpower. Neither is it
ethically acceptable to manipulate the diets of pregnant women to attempt to influence the future health
of their offspring, potentially inducing major disease
states. There is, therefore, little alternative to using appropriate animal models to explore the relationship
between maternal diet and disease.
Many different animal models have been developed
forthispurpose,andthesewillbedescribedbelow.Researchers have focused primarily on rodents (rats and
mice)forsuchstudies.Thisisbecausethesespeciesare
simple to breed, it is straightforward to modify their
diets in pregnancy, gestation is short (rat 22 days,
mouse 18 days), and their offspring grow to adulthood very quickly (overall lifespan is around 2 years).
There are disadvantages associated with these species,
however. The main difference between rodents and
humans is that rodents deliver litters of offspring (typically 10–15 pups in the rat) and these offspring are
born very immature. Guinea pigs provide an alternative. Although these still produce litters of offspring
(3–6 pups), gestation is long (68 days), the placenta is
more similar to that of the human and the offspring
are born at a similar level of maturity to the human
infant. The sheep is a broadly favored species of fetal
physiologists, primarily because of the long gestation
(147 days) and the fact that the fetus is of similar size
to a human (3.5–4 kg). However, as the sheep is a ruminant, the ability to manipulate diet in pregnancy is
very limited.
Using these varied species, researchers have attempted to model the developmental origins hypothesis in different ways. Many have sought to simply
replicate the relationship between fetal growth retardation and later outcomes. Poore and colleagues
(2002) exploited the natural variability in birth weight
among litters of piglets and showed that birth weight
was inversely associated with blood pressure, just as
in humans. This approach is unusual and the relationship is more generally explored by limiting food
intake of the pregnant mother and therefore restricting intakes of all macro- and micronutrients (global
undernutrition). Some groups take a more drastic approach and retard fetal growth by surgically placing a
ligature around the uterine artery to limit the supply
of blood and nutrients. Persson and Jansson (1992)
showed, using this approach, that growth retardation
of the guinea pig fetus resulted in hypertension later



in life. Other researchers have chosen to look beyond
the birth-weight–disease association and model the
effects of specific nutrients in the diet. This allows investigation of the long-term consequences of either
nutritional deficit or excess.


**4.3.3.1 Global undernutrition**

Restriction of overall food intake during pregnancy
has a range of different effects that are dependent
upon the severity of the restriction imposed and upon
the animal species. Woodall and colleagues (1996) reported that feeding pregnant rats only 30% of their
normal daily rations led to major retardation of the
growth of their fetuses. As adults, these low birth
weight offspring exhibited high blood pressure and
profound obesity. The latter seemed to be caused by
an increase in the appetite of the animals and a reduction in their levels of physical activity. Holemans
and colleagues (1999a) also worked with pregnant
rats and fed 50% of normal rations, but only in the
second half of pregnancy. Under these conditions the
offspring did not develop high blood pressure but,
as adults, did display abnormalities of cardiovascular
function. In the sheep, feeding 50% of nutrient requirements during pregnancy has a number of effects
upon the cardiovascular function and metabolic state
of the adult lambs. The prenatally nutrient restricted
lamb is generally fatter and has higher blood pressure
than a lamb from a well-fed mother, by the age of 3
years (Gardner _et al_ ., 2007).
Even mild restriction of maternal food intake in
pregnancy can program the offspring. In the rat, feeding 70% of ad libitum intake produced pups that became hypertensive as adults (Ozaki _et al_ ., 2001). Similarly in guinea pigs, reducing maternal food intake
by just 15% was sufficient to program hypertension
and raised blood lipids in the adult offspring (Kind
_et al_ ., 2002). When pregnant sheep were fed 85% of
requirements over the first 70 days of gestation, their
fetuses showed altered cardiovascular function at the
end of gestation (Hawkins _et al_ ., 2000).


**4.3.3.2 Micronutrients**

Iron deficiency anemia is the most common nutrient deficiency disorder in the world, and particularly
impacts upon women during pregnancy. The normal physiological adaptation to pregnancy involves a
major expansion of blood volume, and typically the
plasma volume expansion outstrips the production



**Fetal Nutrition and Disease in Later Life** **83**


of new red cells and hemoglobin. As a result, blood
hemoglobin concentrations fall. Although this sign
of iron deficiency may be regarded as a normal part
of pregnancy, more severe anemia is associated with
poor pregnancy outcomes. It is estimated that twothirds of pregnant women will develop some degree
of iron deficiency in the course of their pregnancy. In
the pregnant rat, iron deficiency anemia can be shown
to program fetal development (Gambling _et al_ ., 2003).
The iron deficient rat embryo has an abnormally enlarged heart and as an adult will have high blood
pressure, suggesting that iron plays a key role in the
normal development of the cardiovascular system.
Maternal intakes of calcium are of considerable interest in the programming context. Suboptimal intakesofcalciumarerelativelycommonamongwomen
of childbearing age, particularly younger women and
adolescents.Gillman _etal_ .(2004)showedthatincreasing intakes of calcium from supplements during pregnancy could lower blood pressure in young children.
In rats, the relationship between maternal calcium intake and offspring blood pressure is complex. Rats,
whose mothers were fed a calcium deficient diet, had
blood pressures that were 12 mmHg higher than seen
in the offspring of rats fed a control diet (Bergel and
Belizan, 2002). However, high consumption of calciuminthematernaldietalsoelevatedbloodpressures
in the offspring, suggesting a U-shaped relationship
between calcium intake and later outcomes.
Sodium intake is a major determinant of blood
pressure in adults and there is major concern at the
high levels of intake seen within the modern western diet (see Chapter 8, Section “Sodium and blood
pressure”). There have been few studies that have considered the potential for variation in the sodium content of the diet to exert programming effects in utero.
Battista _et al_ . (2002) interestingly showed that a lowsodium diet fed to rats in the last week of their pregnancies, induced fetal growth retardation and high
blood pressure in their offspring.


**4.3.3.3 Macronutrients**

Protein restriction is one of the mostly widely studied manipulations of the maternal diet in animals.
Although protein deficiency _per se_ is relatively rare in
most populations of the world, the degree of variation
in protein intake both within and between populations is substantial. In the UK, for example, intakes
in pregnancy tend to be lower in women of lower



**84** **Nutrition: A Lifespan Approach**


**140**


**120**


**100**


**80**


**60**


**40**


**20**


**0**


**Developed** **Transition** **Developing**
**countries** **countries** **countries**


socioeconomic status and in younger mothers. Five to
ten percent of the population may consume protein
at less than the 51 g/day RNI for pregnancy (LangleyEvans _et al_ ., 2003). On a global scale, access to protein is a significant issue for almost two-thirds of the
population, with women in developing countries often subsisting on lower quality plant protein sources
(Figure 4.4).
There is an extensive literature reporting the programming effects of feeding a low-protein diet during
rat pregnancy. Relatively mild manipulation of protein intake produces subtle variations in the growth
of the offspring, which undergo a late gestation retardation of growth, particularly affecting the development of the truncal organs such as the lungs and
kidneys(Langley-Evans _etal_ .,1996a).Althoughoflow
tonormalbirthweight,ratsexposedtoproteinrestriction in fetal life develop raised blood pressure by 3–4
weeks of age and this hypertension persists into adult
life (Langley-Evans _et al_ ., 1994; Langley-Evans and
Jackson, 1995). In the postnatal period, these animals
have an accelerated progression toward renal failure
and their lifespan is significantly shorter than that of
rats exposed to a protein-replete diet in fetal life (Aihie
Sayer _et al_ ., 2001).
The offspring of rats fed low-protein diets in pregnancy exhibit a number of age-related disorders that
make this an interesting model to study in the context
of the metabolic syndrome in humans. Typically, humans become more insulin resistant as they age and
develop type 2 diabetes as a consequence. Rats exposed to protein restriction in fetal life are relatively
lean in early adult life and show increased sensitiv


ity to insulin. As they age, however, insulin resistance
begins to appear and with this the animals develop
raised blood lipid profiles and deposit large amounts
of fat in their livers (Erhuma _et al_ ., 2007).
An excess of protein in the diet is also a major issue
in the diets of populations living in the westernized
nations. In parts of Europe and the US, it is not uncommon for women to consume 120 g protein per
day, which is more than double the UK RNI. Daenzer
and colleagues (2002) considered the potential programming effects of high-protein diets in pregnant
rats. Offspring of rats fed a 40% protein diet were
shown to be more prone to obesity, due to reduced
total energy expenditure.
In human populations throughout the world, one
of the major nutritional concerns is the consumption
of diets containing excessive amounts of energy derived from fat, and in particular, saturated fat. Rodent
studies suggest that such a dietary pattern in pregnancy may program the later blood pressure of the
resulting offspring. The offspring from rats fed a lardrich diet had systolic blood pressures that were elevated by between 8 and 13 mmHg and showed general
dysfunction of vascular functions (Khan _et al_ ., 2003).
Bayol and colleagues (2007) showed that feeding
rats a diet containing highly palatable human “junk
foods” during pregnancy produced obesity in their
offspring.
Within human populations, it is difficult to dissociate the effects of a high-fat diet in pregnancy from
the effects of maternal obesity. Obesity in women of
childbearing age is increasing at a dramatic rate and
is associated with major complications in pregnancy.







**Figure 4.4** Global protein availability statistics.
Data extracted from 2004 FAO Food balance

sheets. Food balance methods only determine the
protein available (i.e., produced through agriculture or imported) per head of population. Actual
consumption will be below the figures shown and
highly variable within each region (e.g., affluent
versus poor, urban versus rural). Sixty-five percent
of the world population are likely to consume protein at less than the UK Reference Nutrient Intake,
and are therefore at risk of low protein intake during pregnancy. Many in developing countries rely
on lower quality plant protein sources.



One such complication is gestational diabetes, a condition in which glucose spills across the placenta from
mother to fetus, leading to abnormally increased fetal
growth. In rodents, maternal diabetes in pregnancy
is associated with vascular dysfunction in the adult
offspring (Holemans _et al_ ., 1999b). Overnutrition in
the postnatal period is also responsible for major programming effects in rodents. Rat pups can be overfed
by reducing the number of animals in the litter once
thefulllactationisestablished.Usingthisprotocol,the
offspring can be programmed to develop profound
obesity related to abnormalities of the hypothalamic
centers that regulate food intake (Plagemann _et al_ .,
1992).
The most remarkable aspect of all of the animal studies described above is the fact that very diverse nutritional manipulations in pregnancy (ranging from severe global undernutrition through to an
energy-rich, junk-food diet), in a diverse range of
species (including rodents and ruminants) can produce very similar effects in the offspring (typically
high blood pressure, glucose intolerance, and obesity). The commonality of the responses to diverse
dietary insults suggests that programming is driven
by a small number of common mechanisms, any of
which might be initiated by a maternal signal that the
nutritional environment is not optimal. Understanding of those mechanisms is of major importance if
the Developmental Origins hypothesis is ever to have
any significant impact upon the way in which public health problems related to nutrition are treated or
prevented.


**4.4 Mechanistic basis of fetal**
**programming**


_**4.4.1 Thrifty phenotypes and genotypes**_


Metabolic “thrift” is defined as the possession of
metabolic and physiological characteristics that ensure the most efficient and effective utilization of substrates. Neel (1962) first proposed this concept, suggesting that in the early development of the human
species, regular exposure to food shortages would favor the survival of those that carried thrifty genes
and that the population would therefore have evolved
to store fat during times of plenty, and utilize that
resource during periods of famine. Clearly, a thrifty
genotype would no longer be an advantage in mod


**Fetal Nutrition and Disease in Later Life** **85**


ern society and the mismatch between our current
westernized lifestyle and the environment that humans have experienced through 99.9% of their history, could be invoked as an explanation for modern
trends in obesity, CVD, and diabetes.
Thrifty genes could influence many aspects of the
acquisition and processing of nutrients, and many
different candidate genes that confer thrift have been
proposed (Breier _et al_ ., 2004). These include genes
that control feeding behavior, such as leptin and the
melanocortin receptor, genes that are involved in
metabolic regulation, such as peroxisome proliferator activated receptor _γ_, and genes that play a role in
insulin signaling and other signal transduction pathways. Hattersley and Tooke (1999) have proposed that
thrifty genotypes could entirely explain the observed
association between weight at birth and diabetes in
later life. Insulin is an important driver of fetal growth
and so genetic defects of the insulin axis, which would
ultimately promote diabetes, might also be associated
with fetal growth retardation. Mutations of the glucokinase gene are associated with both maturity-onset
diabetes, and low birth weight in this way. Arguments
in favor of a thrifty genotype driving the development of disease are weakened by the fact that while
the metabolic diseases (obesity, type 2 diabetes) are
very common in westernized society, mutations of
the candidate genes that are proven to be associated
with disease are extremely rare.
Thrift, however, remains an important consideration in the diet–disease relationship and comes to the
fore in the nutritional programming area. In 1992,
Hales and Barker first proposed the thrifty phenotype hypothesis (Figure 4.5). This suggests that the
developing fetus, exposed to suboptimal nutrition,
undergoes adaptions to key metabolic tissues such as
the liver and pancreas. Primarily, these enable the fetus to maximize the resources that are available during
that phase of development. However, as programming
events are permanent, the thrift that is acquired at the
time of undernutrition will remain through to adult
life. For our hunter-gatherer ancestors this would provide the same survival advantage as the thrifty genotype proposed by Neel. In the modern world, some
thriftyindividualswouldbebornintoanenvironment
where food shortages still occur and hence would benefit from their fetal experience. However, should the
individual programmed to be thrifty, be born into an
environment where food is plentiful, the thrift would



**86** **Nutrition: A Lifespan Approach**











**Figure 4.5** The thrifty phenotype hypothesis. ( _Source_ : Adapted
from Hales and Barker (2001).)


population of the Pacific island of Naurua is among
the highest in the world. Prior to the Second World
War this population was habitually undernourished,
but industrial development since the 1940s sparked
an epidemic of diabetes. A further example is provided by the Falasha immigrants in Israel (Research
highlight 4).


to the Israeli pattern of diet, however, brought out the negative
consequences of that thrift.
On initial inspection this example appears to support the Hales
and Barker hypothesis. However, the Cohen _et al_ . (1988) paper
did not define whether the Falasha they studied, had developed
type 1 or type 2 diabetes. While the thrifty phenotype concept
would apply well to type 2 diabetes in which insulin resistance develops alongside obesity and other products of a thrifty metabolism,
type 1 diabetes is due to destruction of the pancreatic ß-cells and
a failure to produce insulin. Zung _et al_ . (2004) examined Ethiopian
Jews in Israel and noted that they exhibited a very high occurrence
of a haplotype (DRB1*0301) of the human leukocyte antigen (HLA)
genes that is associated with ß-cell destruction and type 1 diabetes.
Importantly, the age at which subjects with this haplotype developed
their diabetes was dependent on the length of time their families had
lived in Israel. This suggested that rather than being programmed
for thrift, perhaps the Falasha carry a genotype that promotes diabetes, but only when individuals are exposed to a diabetogenic
environment.
The example of the Falasha shows how initial assumptions made
about the outcome of epidemiological studies should always be subject to rigorous questioning. While these papers clearly show that
the factors in the environment, including diet, can trigger metabolic
disease, the question of whether a thrifty phenotype or a thrifty
genotype drives the disease process cannot be addressed in this
simplistic manner.



drive excessive fat gain and the development of the
associated disease states.

Hales and Barker (1992) proposed several examples of the thrifty phenotype in action. Most of these
focused upon populations where it has been shown
that rapid changes from a traditional to a westernized
diet have been accompanied by soaring rates of diabetes. The prevalence rate for type 2 diabetes in the


~~**Research Highlight 4**~~ ~~Thrifty phenotype or thrifty genotype?~~


A number of populations around the world are often cited as examples that support the “Thrifty Phenotype” hypothesis of Hales and
Barker (2001). One such population is the group of Ethiopian Jews
(Falasha) who migrated from the Gondar region of Ethiopia to Israel
in the 1980s. This migration of Falasha was significant in terms of
size, as it took the Falasha population of Israel from just 500 in 1980
to over 62 000 by 2001. This large population provides a useful
opportunity to examine the changes in health and disease profiles
that occurred as a result of moving from rural Africa to the urbanized
areas of a westernized country. The Falasha in Israel tend not to
intermarry and so have retained their original genetic background.
This makes them an attractive population for the examination of the
relative influences of genes and the environment.
Cohen and colleagues (1988) first reported that among young
Ethiopian-born men who had been living in Israel for less than 4
years, there had been a major shift in dietary habits. Rather that
consuming a diet based upon the Ethiopian injura bread and spicy
stews, the Falasha migrants took on a westernized diet rich in refined
carbohydrate sources. Remarkably the prevalence rates for diabetes
in this population soared to 18%, some 30-fold higher than among
the original Ethiopian population and twofold higher than among
other ethnic groups in Israel. It has been argued (Barker, 1998) that
this shift demonstrates the thrifty phenotype in action. The Falasha
migrants while in utero would have developed in an environment
of scarce resource, and while remaining in their environment their
acquired metabolic thrift would have been advantageous. The shift



Observations of twins tend to support the thrifty
phenotype hypothesis rather than the concept of a
thrifty genotype. Studies of twin pairs (mono- and
dizygotic) in which one twin but not the other suffered from diabetes (Poulsen _et al_ ., 1997; Bo _et al_ .,
2000) showed that insulin resistance, raised circulating triglycerides, and cholesterol were more common
in the twin with the lower birth weight. Given that
in each case the twins would have very similar genotypes, these findings suggest that fetal growth constraint, perhaps driven by unequal distribution of nutritional resources from the mother, programmed the
diabetes.

Asmanycountriesaroundtheworldacquiregreater
economic stability and wealth, their populations generally undergo a nutritional transition, moving from a
diet rich in complex carbohydrates and low in animal
fats and meat to an energy-dense, westernized diet.
The thrifty phenotype hypothesis would predict that
in such countries, for example, India, China, Brazil,
generations of undernutrition impacting upon pregnant women and their offspring, would drive high
rates of obesity and diabetes that exceed those seen in
the West, where affluent lifestyles have been the norm
for several generations.


_**4.4.2 Predictive adaptive responses**_


Gluckman and Hanson (2004) have proposed that
the thrifty phenotype is just one aspect of a broader
phenomenon, which they describe as the “predictive
adaptive response” (PAR). The concept of thrift is
clearly applicable to metabolic disorders, but does
not cover the full gamut of conditions that are programmed by undernutrition. For example, there is
a body of evidence that suggests that humans who
were of lower weight at birth have a lower complement of nephrons in their kidneys (Hinchliffe _et al_ .,
1992). The nephrons are the functional units of the
kidney and are responsible for the filtration of the
blood and production of urine. Individuals with fewer
nephrons are more prone to kidney disease and high
blood pressure in later life. If nephron number is programmed in fetal development, this does not indicate
a thrifty phenotype. This is more suggestive of an
adaptation related to immediate survival of hostile
environments.

When the supply of nutrients to the fetus is restricted or when the passage of hormones from



**Fetal Nutrition and Disease in Later Life** **87**


mother to fetus is indicative of stress, the pregnancy
may be aborted or the fetus may undergo adaptations
to its physiology that ensure immediate survival. Often these adaptations will relate to a prioritizing of
valuable nutrients and resources away from systems
that are less critical for fetal survival (e.g., the lungs
andkidneys,whosefunctionsaremetbytheplacenta),
toward more critical systems such as the brain and
circulatory system. This ability to adapt, due to the
plasticity of fetal tissues, is clearly advantageous. Disease will only stem from this adaptive response if the
new physiological make-up is inappropriate for the
environment subsequently encountered by the individual. In the case of the kidney with fewer nephrons,
there would be no adverse consequences unless the individual habitually consumed a diet rich in protein or
sodium necessitating greater renal function to process
the load.
The PAR hypothesis stretches these concepts to suggest that environmental signals from the mother, such
as nutrient availability, provide an indicator of the
likely postnatal environment to the fetal tissues, and
that adaptations take place that optimize fitness for
that _future_ environment, in addition to the current
environment. Gluckman and Hanson (2004) argue
that a mismatch between this predicted environment
and the actual postnatal environment will promote
disease. The suggestion that there are these PARs,
equipping the individual for maximum survival fitness in postnatal life has not been accepted by many
in the scientific community, as it suggests that evolution is somehow forward-looking and that the fetus
is “planning” for a future that it cannot possibly be
aware of (Altimiras and Milberg, 2005). Much of this
argument is, however, about semantics and it seems
entirely reasonable to suggest that disease in later life is
the product of a mismatch between adaptations made
to ensure survival in early life and the subsequent
nature of the environment encountered. This clearly
goes some way beyond the original thrifty phenotype
hypothesis described in Section 4.4.1.


_**4.4.3 Tissue remodeling**_


The thrifty phenotype and PAR hypotheses are merely
conceptual frameworks and do not actually explain
the biological processes that link maternal undernutrition, fetal physiology, and later disease. One
of the simplest mechanisms that can explain these



**88** **Nutrition: A Lifespan Approach**


Tissue development
comprises proliferative
and differentiation phases


Undernutrition

Proliferation



**Figure 4.6** The principle of tissue remodeling. During embryonic and fetal life,
progenitor cells undergo rounds of proliferative cell division. Following this proliferative phase, the cells undergo differentiation to form diverse cell types that will
perform the physiological functions of the
mature organ. Adverse environments during either phase will modify the cell numbers or types that appear in the mature

organ.



A smaller organ with
fewer cells and

functional units


An organ of normal
size with an altered cell
profile and fewer
functional units



Differentiation



Undernutrition



phenomena invokes the process of tissue remodeling.
Changes to the numbers of cells or the type of cells
present within a tissue would reshape the morphology
of that tissue and could have profound effects upon
organ function.
The remodeling of organ structure could occur due
to disruption of cell proliferation or differentiation at
different developmental stages (Figure 4.6). In simple
terms, all tissues and organs are derived from small
populations of embryonic progenitor cell lines. During early embryonic development these cell lines proliferate, increasing the size of the embryo and early
structures. In later fetal periods they differentiate into
specialized cell types, bringing about the maturation
of the organs. A lack of nutrients or a disruption of
normal endocrine signals during these developmental stages can alter tissue structure, leaving irreversible

consequences.
The kidney, as described above (Section 4.4.2), provides an example of tissue programming that appears
to involve some remodeling of structure. In humans,
the number of nephrons is determined before birth
(Mackenzie _et al_ ., 1996). Factors that limit nephron
formation will impair renal function, raise local and
systemic blood pressure, and ultimately promote earlier renal failure. In rats exposed to low-protein diets
during fetal development kidney size is largely unaffected by prenatal nutritional insult, but nephron
number is reduced by as much as 30% (Langley-Evans



_et al_ ., 1999). The decrease in functional units alongside a normal tissue mass indicates that specialized cell
types comprising the nephron have been replaced by
nonspecialized lineages. This suggests that the vulnerable period for programming of renal development
lies in the differentiation phase.
Modifying the numbers and types of cells present
within a tissue will have a range of consequences. It is
easy to envisage how such changes might impact upon
specialized functions that are dependent upon certain
structures, as in the case of the kidney. Alterations to
the profile of cell types present within a tissue may also
modify the capacity of a tissue to produce or respond
to hormones, up- or down-regulate essential genes expressed within a tissue, or interfere with cell–cell signaling pathways. Some of these changes may have very
localized effects, simply impacting upon the function
of a particular tissue, but others could disrupt wholebody physiology and metabolic regulation. Studies
of rats exposed to maternal low-protein diets during
fetal development show that this dietary manipulation results in the offspring developing a pancreas
with reduced numbers of islets, which are smaller and
less effectively vascularized than in control animals
(Snoeck _et al_ ., 1990). This has a major impact upon
insulin production and hence glucose homeostasis at
the whole-body level (Dahri _et al_ ., 1991). Similarly,
fetal and neonatal undernutrition in the rat alters the

size, neuronal density, and types of neurone present



**Fetal Nutrition and Disease in Later Life** **89**













**Figure 4.7** Placental 11ß-hydroxysteroid
dehydrogenase (11ßHSD2) acts as a barrier to the movement of active glucocorticoids between mother and fetus.
(a) Normal gatekeeper functions of
11ßHSD2 convert active cortisol to inactive cortisone and hence protect fetal
tissues from hormones of maternal ori
gin. Only synthetic glucocorticoids such
as dexamethasone may pass across the
placenta unchanged. (b) In the undernourished mother, expression of 11ßHSD2
in placenta is diminished and hence the
fetal tissues are overexposed to active







products between mother and fetus. It should also
be appreciated that there are critical endocrine signals that pass between placenta and fetus, and between mother and placenta. These regulate aspects
of fetal development and also control the partitioning of nutrients to deliver the balance between maternal, placental, and fetal requirements (Power and
Tardif, 2005). There are hormones of placental origin,
which are involved in the maintenance of pregnancy
(e.g., progesterone), the preparation of the breasts
for lactation (e.g., human chorionic somatomammotropin), and determining the timing of labor (e.g.,
corticotrophin-releasing hormone). Other hormones
may move from mother to fetus and these exchanges
require tight regulation in order to avoid inappropriate fetal responses.
The glucocorticoids are steroid hormones that have
a wide range of different functions. Classically they act
to maintain blood glucose concentrations, generally
opposing the effects of insulin. They are also important stress hormones and have immunosuppressive
effects. Many, though not all, of the functions of glu


thereforeabletocrosscellmembranesthroughpassive
diffusion. In the context of maternal–fetal exchange
across the placenta, this is potentially problematic
as without any protective mechanism the hormones
should be able to move freely between the mother and
the fetus and could therefore up-regulate fetal gene
expression at inappropriate stages of development.
There is, however, a protective mechanism that
should prevent this from occurring. Placental
tissue expresses the enzyme 11ß-hydroxysteroid
dehydrogenase-2 (11ßHSD2), which converts active
glucocorticoids (e.g., cortisol in humans, corticosterone in rats) to forms that lack physiological activity
(e.g., cortisone in humans, 11-dehydrocorticosterone
in rats). 11ßHSD2, therefore, acts as a “gatekeeper”
enzyme that limits the movement of active glucocorticoids into the fetal circulation (Figure 4.7). Indeed,
there is a major gradient of glucocorticoids across the
placenta, with maternal concentrations maintained at
100–1000-fold greater than in the fetus. This allows
the fetal hypothalamic-pituitary-adrenal axis to developfreeofmaternalinfluences,andalsoensuresthat
maternal hormones do not interfere with the normal



**90** **Nutrition: A Lifespan Approach**


developmentallyregulatedpatternsofgeneexpression
within fetal tissues.

The consequences of excessive fetal glucocorticoid
exposure are well-documented. Glucocorticoids have
the effect of retarding growth but promoting cellular
differentiation, producing a smaller fetus with more
mature organs. Synthetic glucocorticoids, which are
only weakly metabolized by 11ßHSD2, such as dexamethasone are used clinically to enhance the maturation of the lungs of babies whose mothers are
going into premature labor. Benediktsson and colleagues (1993) administered dexamethasone to pregnant rats throughout gestation and then assessed the
impact of this treatment on their offspring. The rats
exposed to prenatal steroids were smaller at birth,
as expected, and as adults had elevated blood pressure. This suggested that glucocorticoids, like maternal undernutrition, could program long-term health
and well-being. The involvement of 11ßHSD2 in this
glucocorticoid programming was confirmed by treating pregnant rats with carbenoxolone, which is an
inhibitor of 11ßHSD2 activity. Offspring from such
pregnancies also had raised blood pressure as adults
(Langley-Evans, 1997).
While this glucocorticoid-driven mechanism of
programming may seem unrelated to nutritional programming, the two processes may be linked. In humans, lower expression or activity of 11ßHSD2 is
associated with lower birth weight and greater degrees of illness in premature infants (Kajantie _et al_ .,
2006). McTernan and colleagues (2001) reported that
11ßHSD2 mRNA expression in the placenta was lower
in pregnancies complicated by intrauterine growth
retardation. Most importantly however, in rats, maternal protein restriction results in a lower activity
of placental 11ßHSD2, and this suggests that nutritional factors can alter the capacity of the placenta
to protect the fetal tissues from maternal hormone
signals (Langley-Evans _et al_ ., 1996b). These hormone
signals may provide the mechanistic link between undernutrition and long-term ill health. Indeed, treating
pregnant rats fed a low-protein diet with a drug that
inhibits synthesis of corticosterone prevented their
offspring from developing high blood pressure.
There is, therefore, a body of evidence to suggest
that undernutrition reduces the capacity of the placenta to maintain the maternal-fetal gradient of glucocorticoid concentrations. Overexposure to steroids
of maternal origin will impact on tissue development



and program disease. It is relatively simple to see how
this mechanism could trigger tissue remodeling, as
the glucocorticoids would curtail proliferation of cells
andpromotedifferentiation.Thisisjustonematernalfetal hormone exchange that has been examined in the
context of fetal programming. There are likely to be
other such influences that are, as yet, unidentified.


_**4.4.5 Nutrient–gene interactions**_


It is clear from epidemiological studies that the developmental programming phenomenon involves interactions of early life factors with the genome. Peroxisome proliferator-activated receptor _γ_ 2 (PPAR- _γ_ 2)
is a ligand-dependent transcription factor that is predominantly expressed in adipose tissue where it regulates fat and energy metabolism. The PPAR- _γ_ 2 gene
has a polymorphic region within exon B and individuals may carry either an alanine coding or proline
coding allele of the gene depending on their pro12ala
genotype. Eriksson and colleagues (2002b) studied
the relationship between this polymorphism, birth
anthropometry, and risk of type 2 diabetes in cohorts
of men and women born in Helsinki between 1924

and 1933. The Ala12 allele was shown to be associated

with markers of lower diabetes risk in these individuals, but the beneficial effect of the polymorphism was
seen only in individuals who had been of lower weight
at birth. Low birth weight individuals with the Pro12
gene variant were at greater risk of diabetes, hypertension, and raised blood lipids, suggesting that a single
genotype can give rise to different phenotypes due to
variation in early life experience and variation in the
quality of early life nutrition.
Osteoporosis is one of the major preventable diseases of adult life that is known to be related to diet
and lifestyle factors earlier in the life course. A number
of genes that may be involved in determining osteoporosis risk have been mapped, including the vitamin
D receptor (VDR) and the type 1 collagen A1 gene
(Walker-Bone _et al_ ., 2002). For VDR, there are 22known polymorphisms that in isolation explain only
a very small proportion of variation in bone mass. For
example, it is estimated that the BB variant of the Bsm
I restriction site in VDR can reduce site-specific bone
mineral density (a powerful marker of osteoporotic
fracture risk) by, at most, 2%. The lack of stronger associations is explained by the fact that the influence of
genotype on bone health is modulated by lifestyle and
environmental factors. A number of epidemiological



**Fetal Nutrition and Disease in Later Life** **91**



**Figure 4.8** Programming of hepatic lipid
metabolism by a maternal low-protein diet in
the rat. Pregnant rats were fed a low-protein
diet throughout pregnancy. (a) At 18 months
of age their offspring showed histological evidence of hepatic steatosis (arrow shows white
lipid deposits within the liver tissue). (b) The
mRNA expression of fatty acid synthase, a
key enzyme in the synthesis of lipid was suppressed in the low protein exposed offspring
at 1 month of age, but (c) was elevated in
the older animals. ( _Source_ : Data from Erhuma
_et al_ . (2007).)



(a) Histological sections of liver
from aged rats


Maternal control diet


Maternal low-protein diet



(b) Expression of fatty acid synthase
mRNA in liver of 1-month-old rats


**1.0**


**0.8**


**0.6**


**0.4**


**0.2**


**0.0**
**Control** **Low protein**


**Maternal diet**

(c) Expression of fatty acid synthase
mRNA in liver of 18-month-old rats


**1.5**


**1.0**


**0.5**


**0.0**
**Control** **Low protein**


**Maternal diet**



studies have suggested that growth in utero and in the
first year of infancy determine risk of osteoporosis. In
a study of the Bsm 1 polymorphism of VDR, Jordan
and colleagues (2005) reported that, in men, the B
allele increased severity of degenerative bone disease
in the lumbar region of the spine and that the impact
of the allele was greatest in individuals of lower birth
weight. Thus, fetal factors modified the risk associated
with this particular VDR genotype.
In animal studies of maternal undernutrition, relatively brief periods of under- or overnutrition during
critical phases of development can influence the expression of genes in the adult animal. Such changes
have been shown in kidney, liver, brain, and heart
and can be related to the disease processes and abnormalities that are present within those organs. Many
of these changes in gene expression may simply reflect the metabolic and endocrine consequences of
the disease phenotype that has been programmed by
manipulation of the maternal diet, rather than being
the primary drivers of the disease process. For example, in aged rats exposed to low-protein diets during
fetal life the expression of the genes and transcription
factors that regulate the synthesis of lipids within the
liver are greatly increased. This goes hand-in-hand
with the observation that these animals have excess



lipid deposits within the tissue. It is likely that the
gene expression changes are a result of the nonalcoholic fatty liver disease that the rats have developed,
rather than the cause, as the expression of the same
genes is suppressed earlier in adulthood (Figure 4.8).
The finding that nutritional interventions in pregnancy can impact upon the expression of genes long
after the removal of the original stimulus is fascinating
and studies of this nature are certainly helping with
the identification of the mechanisms that link early
life nutrition to later disease. However, many of these
changes could be misleading and distract attention
from the most important nutrient–gene interactions,
that is, the interactions that occur at the actual time

of the maternal nutrient restriction. Under- or overnutrition during embryonic and fetal development
could set in train a series of events, such as tissue remodeling, or less effective regulation of hormone exchange across the placental barrier, that in turn have
the long-term programming effect on fetal physiology. These primary nutrient–gene interactions may
be difficult to observe as they may be transient. During the embryonic stage, even a few hours of up- or
down-regulation of key genes could have critical effectsondevelopment.Kwong _etal_ .(2007)showedthat
in newly implanted embryos of rats fed low-protein



**92** **Nutrition: A Lifespan Approach**


NH 2


N



N



NH 2
CH 3


N



O



N



O



5’-CpG-3’

3’-GpC-5’



5’-CpG-3’

3’-GpC-5’



DNA
methyltransferase

**Unmethylated DNA** **Methylated DNA**


Transcription

Methylated CpG islands groups on the
DNA prevent transcription


Acetylated groups on the histones
promote transcription



**Figure 4.9** DNA methylation and histone acetylation are epigenetic mechanisms that regulate gene transcription.
CpG islands in DNA may be methylated or
unmethylated. In the unmethylated state,
the histone proteins associated with the
DNA tend to be acetylated and the DNA
is less tightly coiled. Transcription factors
and transcription machinery can access
gene promoters and hence the unmethylated genes can be expressed. Methylation leads to deacetylation of histones and
prevents transcription.



diets, the expression of mRNA for the insulin-like
growth factor 2 and the closely related H19 gene,
were down-regulated. However, in low-protein exposed fetuses, close to full-term gestation, expression
of these genes was similar to levels seen in control
pregnancies. There may, therefore, be a short window
of time in which gene expression changes occur and
other programming effects will be secondary to those
events. Culturing mouse embryos in vitro for 96 h,
using a medium lacking a protein source, reduced the
number of cells present at the blastocyst stage and
programmed raised blood pressure in adult offspring
developed from embryos transferred back to a mouse
mother (Watkins _et al_ ., 2007). This further shows that
transient influences at a very early stage have the potentialtoexertprofoundlong-termeffects.Eventsthat
happenearlyoncandetermineremodelingoftissueor
the ability of the animal to respond to the conditions
that it encounters later in life.


_**4.4.6 Epigenetic regulation**_


The gene expression patterns described above are often found to represent permanent changes in the level
oftranscriptionofspecificgenesinspecifictissues.For
such patterns to persist throughout the lifespan of an
animal, there must be mechanisms that preserve the
cellular memory of the events that occurred in early
life. These stable changes in the expression of genes



can reasonably be attributed to programmed changes
in DNA methylation. DNA methylation is a potent
suppressor of gene expression, either through blocking access of transcriptional machinery to the chromatin structure surrounding specific gene promoters
or through interference with the binding of transcription factors to DNA (Figure 4.9). Around the time of
embryo implantation, the majority of the genome is
unmethylated, and this na¨ıve state is remodeled as a
normal element of development. The differentiation
of tissues is accompanied by the methylation and silencing of unrequired genes. A series of DNA methyltransferases (DNMT) are responsible for establishing
and maintaining the patterns of DNA methylation
within cells (Bird, 2002). DNMT1 is important during development, as it maintains the DNA methylation pattern when DNA replicates during cell division.
This is essential for normal development and mice
deficient for this gene die in utero. The other DNMT
(DNMT3L, DNMT3a, and DNMT3b), which are only
expressed in the embryo, are responsible for _de novo_
DNA methylation.
DNA methylation patterns have been shown to be
stably inherited and may therefore allow phenotypic
traits,acquiredasaresultofnutritionalprogramming,
to be passed on to subsequent offspring. Thus, a brief
period of undernutrition during embryonic, fetal, or
even early postnatal development may irreversibly



modify DNA methylation in a manner that compromises normal physiology and metabolism. These arguments are strongly supported by recent demonstrations that nutritional factors in fetal life can modify
expression of genes. Waterland and Jirtle (2003) studied the Agouti mouse in which a yellow coat color is
determined by the overexpression of a single gene
locus ( _A_ _[v][y]_ ), which changes the normal black coat
color to yellow. The overexpression of this gene is due
to hypomethylation of CpG islands in the _A_ _[v][y]_ locus.
When yellow mice were supplemented with methyl
donors (folic acid, vitamin B 12, choline chloride, and
betaine), the methylation was increased in the offspring and there were more mice with an intermediate
brown coat color born to the supplemented mothers.


**4.5 Implications of the programming**
**hypothesis**


_**4.5.1 Public health interventions**_


The importance of developmental programming as
a risk factor for human disease is currently difficult
to estimate. There are, however, some interesting indicators that suggest it may be appropriate to target
pregnancy for major health interventions. Depending
on age, blood pressure differences between individuals weighing 2.5 kg at birth might be expected to be up
to 5 mmHg higher than those who were a kilogram
heavier (Barker, 1998). This is a negligible blood pressuredifferenceforanindividual,butifbloodpressures
were to decline by 5 mmHg across the whole population of the UK, there would be 50 000 fewer deaths
from CVD. Developing public health interventions
that can prevent adverse nutritional programming, or
offset some of the effects of prenatal nutrition, may
therefore be worthy of consideration.



**Fetal Nutrition and Disease in Later Life** **93**


For achievement of such goals, there are many possible options that could be considered. The simplest
might be to improve the general advice given to pregnant women regarding the quality of their diets. However, more research would be required to determine
what might constitute the optimal diet for fetal development. The alternative approach might be to develop personalized nutrition advice that is aimed at
pregnant women or at individuals who can be recognized as being at risk of major disease on the basis of their characteristics at birth (e.g., birth weight,
markers of maternal diet). Further investigation of
the nutritional programming mechanism may allow
us to develop means of identifying individuals at risk
of cardiovascular or metabolic disease at a very early
age and then to prevent those diseases either through
targeted lifestyle advice or drug treatment. The possibility of using drugs in early life to counteract programming effects of undernutrition was explored by
Sherman and Langley-Evans (2000). Pregnant rats
were fed control or low-protein diets. Their offspring
were then either untreated or administered losartan,
an antihypertensive drug, while still being suckled by
their mothers. When blood pressure was determined
in the adult offspring, while untreated offspring of
low-protein fed mothers had raised blood pressure,
as expected, those treated with losartan had normal
blood pressure (Figure 4.10). This suggests that postnatal interventions could be designed to overcome the
intrauterine effects of nutrition.


_**4.5.2 Trans-generational transmission of**_
_**disease risk**_


It is suggested that the programming influences of
the fetal period upon disease in later life become
apparent when there is a mismatch between the



**200**
Control

LP

**150**


**100**


**50**


**0**
**Vehicle** **Losartan**


**Postnatal treatment**



**Figure 4.10** Postnatal treatment with antihypertensive
drugs reverse programming effects of maternal undernutrition. Pregnant rats were fed control or low-protein (LP) diets
in pregnancy. On giving birth all animals were fed the same
diet, but half of the litters from each group were treated with
losartan, an antagonist of the angiotensin II AT1 receptor
for 2 weeks. Blood pressure was measured 8 weeks later.
Blood pressure of offspring from untreated LP-fed rats was elevated compared to controls, but the LP-exposed rats treated
with losartan had normal blood pressure. ( _Source_ : Data from
Sherman and Langley-Evans (2000).)



**94** **Nutrition: A Lifespan Approach**


prenatal and postnatal environment. This is essentially the basis of the thrifty phenotype hypothesis.
Babies whose growth was restricted by adverse factors during their fetal growth tend to exhibit catchup growth in the postnatal period, that is, they grow
more rapidly to achieve their genetic potential once
the influence of maternal factors is withdrawn. There
is good evidence to demonstrate that this rapid catchupgrowth following prenatal growth restrictionis one
of the strongest predictors of the metabolic syndrome
(Eriksson _et al_ ., 2002a).
In populations that are undergoing economic and
nutritional transition from poor to relatively affluent status (e.g., India, China, South Africa), the mismatch of early life influences and the adult diet and
lifestyle might therefore be expected to drive an explosion of obesity, type 2 diabetes, and CVD. The
rapid improvements in maternal nutrition and health
that will accompany the nutritional transition in such
countries might be expected to lessen the importance
of nutritional programming as a contributor to the
overall disease burden. However, it is argued that programmingcouldhaveeffectsthatextendacrossseveral
generations. The consequences of deficits in maternal nutrition in pregnancy might ultimately be transmitted to grandchildren. This means that across the
globe, nutritional/economic transition may represent
a sharp decline in malnutrition-related disease to be
followed by half a century of unavoidable metabolic
disease.
Pembrey (1996) proposed that such an intergenerational feed-forward control loop exists, linking the
growth and health of an individual with the nutrition
of their grandparents. This form of control would be
likely to involve some epigenetic marking of genes,
with these markers then passed on to subsequent generations. The outcome of such imprinting would be
very long-term health consequences for populations
that are exposed to either undernutrition or overnutrition at some stage in their history. The complexity of the epidemiological studies that would be necessary to investigate intergenerational programming
in human populations largely precludes such work.
However, there are some examples that do appear to
support the hypothesis advanced by Pembrey. Studies
of individuals exposed to the acute but severe famine
in wartime Holland, indicate that undernutrition of
women during pregnancy influenced the nutrition of
their daughters, and this subsequently had an impact



upon the birth weight of their grandchildren. Intergenerational effects are not necessarily the product
of disturbances in maternal nutrition. Bygren _et al_ .
(2001) reported that the grandchildren of men who
were overfed in the prepubertal growth period had a
significantly shorter lifespan.
Intergenerational programming by nutritional insults in fetal life has been noted in studies of animals.

Beach _et al_ . (1982) assessed immune function in the
offspring of mice fed a zinc-deficient diet in pregnancy. This nutritional manipulation in fetal life led
to severe immunosuppression in the adult offspring.
Surprisingly, even though zinc status was normalized
at the end of the original pregnancies, the impact
on the immune system persisted into a third generation before resolving. As shown in Figure 4.11,
the feeding of a low-protein diet in rat pregnancy
produced high blood pressure in the adult offspring.
When these adults were mated in all possible combinations of males and females from different dietary
backgrounds,thenextgenerationofadultswerefound
to have higher blood pressure if they had at least one
parent exposed to undernutrition as a fetus (Harrison and Langley-Evans, 2009). Drake _et al_ . (2005)
reported that the treatment of pregnant rats with


**160**


**140**


**120**


**100**


**Figure 4.11** Programmingofbloodpressureacrossgenerations.Pregnant rats were fed control or low-protein (LP) diets in pregnancy. On
giving birth, all animals were fed the same diet and when adult the
offspring were mated to produce four separate crosses (control male
x control female, control male x LP female, LP male x control female, LP male x LP female). Blood pressures of first-generation and
second-generation offspring were measured at 8 weeks of age. F1:
first generation. F2: second generation. ( _Source_ : Data from Harrison
and Langley-Evans (2009).)



dexamethasone in pregnancy, an intervention known
to retard fetal growth and program hypertension and
glucose intolerance in the offspring, produced effects
on glucose homeostasis that persisted for two generations.

The main explanation of how programmed traits
can be passed on to second or third generation is that
the original nutritional insult initiates heritable epigeneticchangestoDNAatspecificgeneloci,asdescribed
above(Section4.4.6).Thereare,however,othermechanisms that could explain intergenerational programming effects of undernutrition that are specifically
transmitted via the maternal line. Rather than genomic imprinting playing a critical role, physiological
or endocrine disturbances in mothers, particularly in
the response to the challenge of pregnancy may lead to
programming responses in their offspring. For example,undernutritionduringfetallifewillinduceinsulin
resistance and eventually type 2 diabetes in the resultant adult individual. In women, this will make gestational diabetes more likely to occur, which generally
produces an overgrown baby. These babies are more
likely to gain excess weight in childhood and adolescence and will themselves be more likely to become
diabetic. Studies of rats fed low-protein diets in pregnancy and lactation show that this is in fact the case
and that modification of pancreatic function during
fetal life has effects that persist for several generations
(Reusens and Remacle, 2001).


~~**Summary Box 4**~~


Programming is the process through which exposure of the developing fetus to an insult or stimulus, at a critical stage of development, can permanently alter physiology and metabolism.
Exposure to undernutrition or overnutrition in early life is a risk
factor for major disease states in adulthood.
Epidemiological studies show that anthropometric measures
associated with poor nutrition in fetal life, such as lower birth
weight or thinness at birth, predict later risk of coronary heart
disease and type 2 diabetes.
Rapid catch-up growth in infancy, following fetal growth restriction, increases the disease risk associated with a poor maternal diet
in pregnancy.
Animal studies show that restricted intakes or excessive intakes
of a variety of macro- and micronutrients in pregnancy program
obesity, glucose intolerance, and high blood pressure in the developing fetus.
Discovery of the mechanisms through which programming occurs will be an important first step in planning future public health



**Fetal Nutrition and Disease in Later Life** **95**


interventions that may target pregnancy as a period for preventing
major diseases of adulthood.
Candidate mechanisms that have been proposed to explain
the association between maternal nutrition and disease in the
offspring include disturbance of materno-fetal hormone exchange
across the placenta, specific nutrient–gene interactions that impact
on tissue development, and disruption of epigenetic regulation of
gene expression.


**References**


Aihie Sayer A, Dunn R, Langley-Evans S, and Cooper C (2001)
Prenatal exposure to a maternal low protein diet shortens life
span in rats. _Gerontology_ **47**, 9–14.
Altimiras J and Milberg P (2005) Letter regarding article by Khan
_et al_ ., “predictive adaptive responses to maternal high-fat diet
prevent endothelial dysfunction but not hypertension in adult
rat offspring.” _Circulation_ **111**, e166.
Arai Y and Gorski RA (1968) Critical exposure time for androgenization of the developing hypothalamus in the female rat.
_Endocrinology_ **82**, 1010–1014.
Barker DJ, Bull AR, Osmond C, and Simmonds SJ (1990) Fetal
and placental size and risk of hypertension in adult life. _British_
_Medical Journal_ **301**, 259–262.
Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, and Clark
PM (1993a) Type 2 (non-insulin-dependent) diabetes mellitus,
hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. _Diabetologia_ **36**, 62–67.
Barker DJ and Osmond C (1986) Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. _Lancet_
**1**, 1077–1081.
Barker DJ, Osmond C, Simmonds SJ, and Wield GA (1993b) The
relation of small head circumference and thinness at birth to

death from cardiovascular disease in adult life. _British Medical_
_Journal_ **306**, 422–426.
Barker DJ, Winter PD, Osmond C, Margetts B, and Simmonds SJ
(1989) Weight in infancy and death from ischaemic heart disease.
_Lancet_ **2**, 577–580.
Barker DJP (1998) _Mothers, Babies and Health in Later Life._
Churchill Livingstone, Edinburgh.
Bartley M, Power C, Blane D, Smith GD, and Shipley M (1994)
Birth weight and later socioeconomic disadvantage: evidence
from the 1958 British cohort study. _British Medical Journal_ **309**,
1475–1478.
Battista MC, Oligny LL, St-Louis J, and Brochu M (2002) Intrauterine growth restriction in rats is associated with hypertension and
renal dysfunction in adulthood. _American Journal of Physiology_
**283**, E124–E131.
Bavdekar A, Yajnik CS, Fall CH _et al_ . (1999) Insulin resistance
syndrome in 8-year-old Indian children: small at birth, big at 8
years, or both? _Diabetes_ **48**, 2422–2429.
Bayol SA, Farrington SJ, and Stickland NC (2007) A maternal ‘junk
food’ diet in pregnancy and lactation promotes an exacerbated
taste for ‘junk food’ and a greater propensity for obesity in rat
offspring. _British Journal of Nutrition_ **98**, 843–851.
Beach RS, Gershwin ME, and Hurley LS (1982) Gestational zinc
deprivation in mice: persistence of immunodeficiency for three
generations. _Science_ **218**, 469–471.
Benediktsson R, Lindsay RS, Noble J, Seckl JR, and Edwards CR
(1993) Glucocorticoid exposure in utero: new model for adult
hypertension. _Lancet_ **341**, 339–341.



**96** **Nutrition: A Lifespan Approach**


Bergel E and Belizan JM (2002) A deficient maternal calcium intake
during pregnancy increases blood pressure of the offspring in
adult rats. _British Journal of Obstetrics and Gynaecology_ **109**, 540–
545.
Bird A (2002) DNA methylation patterns and epigenetic memory.
_Genes and Development_ **16**, 6–21.
Bo S, Cavallo-Perin P, Scaglione L, Ciccone G, and Pagano G
(2000) Low birthweight and metabolic abnormalities in twins
with increased susceptibility to Type 2 diabetes mellitus. _Dia-_
_betic Medicine_ **17**, 365–370.
Breier BH, Krechowec SO, and Vickers MH (2004) Maternal nutrition in pregnancy and adiposity in offspring. In: _Fetal Nutrition_
_and Adult Disease_ (ed. SC Langley-Evans), pp. 211–234. CABI
Publishing, Wallingford, UK.
Bygren LO, Kaati G, and Edvinsson S (2001) Longevity determined
by paternal ancestors’ nutrition during their slow growth period.
_Acta Biotheoretica_ **49**, 53–59.
Cohen MP, Stern E, Rusecki Y, and Zeidler A (1988) High prevalence of diabetes in young adult Ethiopian immigrants to Israel.
_Diabetes_ **37**, 824–828.
Curhan GC, Chertow GM, Willett WC _et al_ . (1996) Birth weight
and adult hypertension and obesity in women. _Circulation_ **94**,
1310–1315.
Daenzer M, Ortmann S, Klaus S, and Metges CC (2002) Prenatal high protein exposure decreases energy expenditure and
increases adiposity in young rats. _Journal of Nutrition_ **132**,
142–144.
Dahri S, Snoeck A, Reusens-Billen B, Remacle C, and Hoet JJ (1991)
Islet function in offspring of mothers on low-protein diet during
gestation. _Diabetes_ **40** (Suppl 2), 115–120.
Drake AJ, Walker BR, and Seckl JR (2005) Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats. _American Journal of Physiology_ **288**, R34–R38.
Erhuma A, Salter AM, Sculley DV, Langley-Evans SC, and Bennett
AJ (2007) Prenatal exposure to a low-protein diet programs disordered regulation of lipid metabolism in the aging rat. _American_
_Journal of Physiology_ **292**, E1702–E1714.
Eriksson JG, Forsen T, Tuomilehto J, Jaddoe VW, Osmond C, and
Barker DJ (2002a) Effects of size at birth and childhood growth
on the insulin resistance syndrome in elderly individuals. _Dia-_
_betologia_ **45**, 342–348.
Eriksson JG, Forsen T, Tuomilehto J, Winter PD, Osmond C, and
Barker DJ (1999) Catch-up growth in childhood and death from
coronary heart disease: longitudinal study. _British Medical Jour-_
_nal_ **318**, 427–431.
Eriksson JG, Lindi V, Uusitupa M _et al_ . (2002b) The effects of
the Pro12Ala polymorphism of the peroxisome proliferatoractivated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth. _Diabetes_ **51**, 2321–

2324.
Falkner B, Hulman S, and Kushner H (1998) Birth weight versus childhood growth as determinants of adult blood pressure.
_Hypertension_ **31**, 145–150.
Gambling L, Dunford S, Wallace DI _et al_ . (2003) Iron deficiency
during pregnancy affects postnatal blood pressure in the rat.
_Journal of Physiology_ **552**, 603–610.
Gardner DS, Bell RC, and Symonds ME (2007) Fetal mechanisms
that lead to later hypertension. _Current Drug Targets_ **8**, 894–905.
Gillman MW, Rifas-Shiman SL, Kleinman KP, Rich-Edwards JW,
and Lipshultz SE (2004) Maternal calcium intake and offspring
blood pressure. _Circulation_ **110**, 1990–1995.
Gluckman PD and Hanson MA (2004) Living with the past: evolution, development, and patterns of disease. _Science_ **305**, 1733–
1736.



Godfrey K, Robinson S, Barker DJ, Osmond C, and Cox V (1996)
Maternal nutrition in early and late pregnancy in relation to
placental and fetal growth. _British Medical Journal_ **312**, 410–414.
GodfreyKM(2001)The‘goldstandard’foroptimalfetalgrowthand
development. _Journal of Pediatric Endocrinology and Metabolism_
**14(** Suppl 6), 1507–1513.
Godfrey KM, Forrester T, Barker DJ _et al_ . (1994) Maternal nutritional status in pregnancy and blood pressure in childhood.
_British Journal of Obstetrics and Gynaecology_ **101**, 398–403.
Hales CN and Barker DJ (1992) Type 2 (non-insulin-dependent)
diabetes mellitus: the thrifty phenotype hypothesis. _Diabetologia_
**35**, 595–601.
Hales CN and Barker DJ (2001) The thrifty phenotype hypothesis.
_British Medical Bulletin_ **60**, 5–20.
Hales CN, Barker DJ, Clark PM _et al_ . (1991) Fetal and infant growth
and impaired glucose tolerance at age 64. _British Medical Journal_
**303**, 1019–1022.
Harding J (2004) Nutritional basis for the fetal origins of adult
disease. In: _Fetal Nutrition and Adult Disease_ . (ed. SC LangleyEvans), pp. 21–54. Cabi, Wallingford, UK.
Harrison M and Langley-Evans SC (2009) Intergenerational programming of impaired nephrogenesis and hypertension in rats
following maternal protein restriction during pregnancy. _British_
_Journal of Nutrition_ **In Press** .
Hattersley AT and Tooke JE (1999) The fetal insulin hypothesis: an
alternative explanation of the association of low birthweight with
diabetes and vascular disease. _Lancet_ **353**, 1789–1792.
Hawkins P, Steyn C, Ozaki T, Saito T, Noakes DE, and Hanson MA
(2000) Effect of maternal undernutrition in early gestation on
ovine fetal blood pressure and cardiovascular reflexes. _American_
_Journal of Physiology_ **279**, R340–R348.
Hinchliffe SA, Lynch MR, Sargent PH, Howard CV, and van Velzen
D (1992) The effect of intrauterine growth retardation on the
development of renal nephrons. _British Journal of Obstetrics and_
_Gynaecology_ **99**, 296–301.
Holemans K, Gerber R, Meurrens K, De Clerck F, Poston L, and van
Assche FA (1999a) Maternal food restriction in the second half
of pregnancy affects vascular function but not blood pressure of
rat female offspring. _British Journal of Nutrition_ **81**, 73–79.
Holemans K, Gerber RT, Meurrens K, De Clerck F, Poston L and
van Assche FA (1999b) Streptozotocin diabetes in the pregnant
rat induces cardiovascular dysfunction in adult offspring. _Dia-_
_betologia_ **42**, 81–89.
Huxley R, Neil A, and Collins R (2002) Unravelling the fetal origins
hypothesis: is there really an inverse association between birthweight and subsequent blood pressure? _Lancet_ **360**, 659–665.
Jordan KM, Syddall H, Dennison EM, Cooper C, and Arden NK
(2005) Birthweight, vitamin D receptor gene polymorphism, and
risk of lumbar spine osteoarthritis. _Journal of Rheumatology_ **32**,
678–683.
Kajantie E, Dunkel L, Turpeinen U, Stenman UH, and Andersson
S (2006) Placental 11beta-HSD2 activity, early postnatal clinical course, and adrenal function in extremely low birth weight
infants. _Pediatric Research_ **59**, 575–578.
Khan IY, Taylor PD, Dekou V _et al_ . (2003) Gender-linked hypertension in offspring of lard-fed pregnant rats. _Hypertension_ **41**,
168–175.
Kind KL, Simonetta G, Clifton PM, Robinson JS, Owens JA (2002)
Effect of maternal feed restriction on blood pressure in the adult
guinea pig. _Experimental Physiology_ **87**, 469–477.
Kwong WY, Miller DJ, Wilkins AP _et al_ . (2007) Maternal low protein
diet restricted to the preimplantation period induces a genderspecific change on hepatic gene expression in rat fetuses. _Molec-_
_ular Reproduction and Development_ **74**, 48–56.



Langley-Evans AJ and Langley-Evans SC (2003) Relationship between maternal nutrient intakes in early and late pregnancy and
infantsweightandproportionsatbirth:prospectivecohortstudy.
_Journal of the Royal Society for the Promotion of Health_ **123**, 210–
216.
Langley-Evans SC (1997) Maternal carbenoxolone treatment
lowers birthweight and induces hypertension in the offspring
of rats fed a protein-replete diet. _Clinical Science_ **93**, 423–429.
Langley-Evans SC, Gardner DS, and Jackson AA (1996a) Association of disproportionate growth of fetal rats in late gestation with
raised systolic blood pressure in later life. _Journal of Reproduction_
_and Fertility_ **106**, 307–312.
Langley-Evans SC and Jackson AA (1995) Captopril normalises systolic blood pressure in rats with hypertension induced by fetal
exposure to maternal low protein diets. _Comparative Biochem-_
_istry and Physiology_ **110**, 223–228.
Langley-Evans SC, Langley-Evans AJ, and Marchand MC (2003)
Nutritional programming of blood pressure and renal morphology. _Archives of Physiology and Biochemistry_ **111**, 8–16.
Langley-Evans SC, Phillips GJ, Benediktsson R _et al_ . (1996b) Protein intake in pregnancy, placental glucocorticoid metabolism
and the programming of hypertension in the rat. _Placenta_ **17**,
169–72.
Langley-Evans SC, Phillips GJ, and Jackson AA (1994) _In utero_
exposure to maternal low protein diets induces hypertension in
weanlingrats,independentlyofmaternalbloodpressurechanges.
_Clinical Nutrition_ **13**, 319–324.
Langley-Evans SC, Welham SJ, and Jackson AA (1999) Fetal exposure to a maternal low protein diet impairs nephrogenesis and
promotes hypertension in the rat. _Life Science_ **64**, 965–974.
Mackenzie HS, Lawler EV, and Brenner BM (1996) Congenital
oligonephropathy:thefetalflawinessentialhypertension? _Kidney_
_International Supplements_ **55**, S30–S34.
Mathews F, Yudkin P, and Neil A (1999) Influence of maternal
nutrition on outcome of pregnancy: prospective cohort study.
_British Medical Journal_ **319**, 339–343.
Matthes JW, Lewis PA, Davies DP, and Bethel JA (1994) Relation
between birth weight at term and systolic blood pressure in adolescence. _British Medical Journal_ **308**, 1074–1077.
McTernan CL, Draper N, Nicholson H _et al_ . (2001) Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels
in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. _Journal of Clinical_
_Endocrinology and Metabolism_ **86**, 4979–4983.
Moore SE, Cole TJ, Collinson AC, Poskitt EM, McGregor IA, and
Prentice AM (1999) Prenatal or early postnatal events predict infectious deaths in young adulthood in rural Africa. _International_
_Journal of Epidemiology_ **28**, 1088–1095.
Neel JV (1962) Diabetes mellitus: a “thrifty” genotype rendered
detrimental by “progress”? _American Journal of Human Genetics_
**14**, 353–362.
Osmond C, Barker DJ, and Slattery JM (1990) Risk of death from
cardiovascular disease and chronic bronchitis determined by
place of birth in England and Wales. _Journal of Epidemiology_
_and Community Health_ **44**, 139–141.
Ozaki T, Nishina H, Hanson MA, and Poston L (2001) Dietary
restriction in pregnant rats causes gender-related hypertension
and vascular dysfunction in offspring. _Journal of Physiology_ **530**,
141–52.
Pembrey M (1996) Imprinting and transgenerational modulation
of gene expression; human growth as a model. _Acta Geneticae_
_Medicae et Gemellologiae_ **45**, 111–125.



**Fetal Nutrition and Disease in Later Life** **97**


Persson E and Jansson T (1992) Low birth weight is associated
with elevated adult blood pressure in the chronically catheterized
guinea-pig. _Acta Physiology Scandinavia_ **145**, 195–196.
Plagemann A, Harder T, Rake A, Melchior K, Rohde W, and Dorner
G (2001) Hypothalamic nuclei are malformed in weanling offspringoflowproteinmalnourishedratdams. _JournalofNutrition_
**130**, 2582–2589.
Plagemann A, Heidrich I, Gotz F, Rohde W, and Dorner G (1992)
Obesity and enhanced diabetes and cardiovascular risk in adult
rats due to early postnatal overfeeding. _Experimental and Clinical_
_Endocrinology_ **99**, 154–158.
Poore KR, Forhead AJ, Gardner DS, Giussani DA, and Fowden
AL (2002) The effects of birth weight on basal cardiovascular
function in pigs at 3 months of age. _Journal of Physiology_ **539**,
969–978.
Poulsen P, Vaag AA, Kyvik KO, Moller Jensen D, and Beck-Nielsen
H (1997) Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs. _Diabetologia_ **40**,
439–446.
Power ML and Tardif SD (2005) Maternal nutrition and metabolic
control of pregnancy. In: _Birth, Distress and Disease_ (eds ML
Power and J Schulkin), pp. 88–113. Cambridge University Press,
New York.
Reusens B and Remacle C (2001) Intergenerational effect of an
adverse intrauterine environment on perturbation of glucose
metabolism. _Twin Research_ **4**, 406–11.
Roseboom TJ, Van Der Meulen JH, Ravelli AC, Osmond C, Barker
DJ, and Bleker OP (2001) Effects of prenatal exposure to the
Dutch famine on adult disease in later life: an overview. _Molecular_
_and Cellular Endocrinology_ **185**, 93–98.
Sherman RC and Langley-Evans SC (2000) Antihypertensive treatment in early postnatal life modulates prenatal dietary influences upon blood pressure in the rat. _Clinical Science_ **98**,
269–275.
Smits L, Krabbendam L, de Bie R, Essed G, and van Os J (2006)
Lower birth weight of Dutch neonates who were in utero at the
time of the 9/11 attacks. _Journal of Psychosomatic Research_ **61**,
715–717.
Snoeck A, Remacle C, Reusens B, and Hoet JJ (1990) Effect of a
low protein diet during pregnancy on the fetal rat endocrine
pancreas. _Biology of the Neonate_ **57**, 107–118.
Walker-Bone K, Walter G, and Cooper C (2002) Recent developments in the epidemiology of osteoporosis. _Current Opinions in_
_Rheumatology_ **14**, 411–415.
Waterland RA and Jirtle RL (2003) Transposable elements: targets
for early nutritional effects on epigenetic gene regulation. _Molec-_
_ular Cell Biology_ **23**, 5293–5300.
Watkins AJ, Platt D, Papenbrock T _et al_ . (2007) Mouse embryo
culture induces changes in postnatal phenotype including raised
systolic blood pressure. _Proceedings of the National Academy of_
_Sciences, USA_ **104**, 5449–5554.
Woodall SM, Johnston BM, Breier BH, and Gluckman PD (1996)
Chronic maternal undernutrition in the rat leads to delayed postnatal growth and elevated blood pressure of offspring. _Pediatric_
_Research_ **40**, 438–443.
WynnAH,CrawfordMA,DoyleW,andWynnSW(1991)Nutrition
of women in anticipation of pregnancy. _Nutrition and Health_ **7**,
69–88.
Zung A, Elizur M, Weintrob N _et al_ . (2004) Type 1 diabetes in Jewish
Ethiopian immigrants in Israel: HLA class II immunogenetics
and contribution of new environment. _Human Immunology_ **65**,
1463–1468.



**98** **Nutrition: A Lifespan Approach**


**Self-Assessment Questions**


Assess your understanding of the concepts outlined in
this chapter using the following questions:


1 Define the term “fetal programming.”
2 Review the epidemiological evidence that suggests
human disease states may be programmed in early
life. What are the main criticisms leveled at this

evidence?

3 Describe experimental studies that support the developmental origins of adult disease hypothesis.



4 How might nutritional status impact upon endocrine
control of fetal growth and development and hence
program risk of disease?
5 What is the thrifty phenotype hypothesis? How does
it explain associations between early life nutrition and
diseases of adulthood?

6 Describe the processes that result in epigenetic regulation of gene expression. How might these processes
contribute to fetal programming in response to underor overnutrition?



# **5**
### **Lactation and Infant Feeding**

**Learning objectives**



By the end of this chapter, the reader should be able to:


r Describe the anatomy of the human breast and the
~~synthesis of milk within mammary alveolar tissue.~~
r Demonstrate an understanding of the endocrine control of lactation.

r Discuss the extra nutrient demands that are imposed
by lactation and the maternal dietary changes that may
be required to meet those demands.


**5.1 Introduction**


The period of early infancy and the provision of nutrients in an optimal balance, are critical for the immediate health and well-being of the child. It is also becoming clear that events that occur during this phase
of development can also have a major impact upon
the long-term physiology, metabolism, and disease
risk of the individual (Chapter 4). There are different strategies available for feeding infants in the first
4–6 months of life and these include breast-feeding,
bottle-feeding a formula, and a mixed approach utilizing both breast and formula milks. The health of
both the infant and the mother is best served by exclusive breast-feeding. This chapter will review the
processes through which human milk is produced and
why breast-feeding is optimal for health and development. The chapter will also describe the composition
of formula milks and how these can be shaped to meet
the varying demands of life stage and special clinical
circumstances.


**5.2 The physiology of lactation**


_**5.2.1 Anatomy of the breast**_


The anatomy of the human mammary gland is shown
in Figure 5.1. The breast is a major site of fat deposition, particularly during pregnancy when high levels



r Critically review the evidence that breast-feeding is
beneficial for the health and well-being of mothers and
their infants.
~~r~~ ~~Describe trends in infant feeding behaviors seen in de-~~
veloped countries and discuss the global strategies that
have been developed to promote breast-feeding.
r Discuss the composition of infant formula milks and describe the need for specialized formulas for premature
babies and infants with food allergies and intolerances.


of estrogen promote storage in preparation for later
lactation. This fat underlies the skin of the breast and

provides protection for the ducts and alveolar structures that are required for milk production. There are
four key structures within the breast to be aware of in
the context of lactation.


**5.2.1.1 The nipple and areola**
The nipples are surrounded by a dark pigmented
region termed the areola. Both structures contain
smooth muscle cells that will contract when mechan
ically stimulated, allowing the nipple to stiffen. This is
essential to allow the suckling baby to grip the nipple
and to take the whole of the area into its mouth (see
rooting reflex, below). The nipple and areola also have
structures called Montgomery’s tubercules, which
are sebaceous glands that produce lubricants during
suckling.


**5.2.1.2 The lactiferous ducts**

Each breast has 15–20 lobes in which the machinery
for production of milk develops. Within each lobe lies
a lactiferous duct that links the milk producing tissues
to the nipple where milk is released.


**5.2.1.3 The lactiferous sinuses**

The lactiferous sinuses lie at the nipple end of each
duct. These sinuses provide some limited capacity for
storage of milk between feeds, but more importantly



**100** **Nutrition: A Lifespan Approach**









**Figure 5.1** The anatomy of the human breast. The breast comprises 10–12 lobules, each containing mammary alveolar tissue with associated
lactiferous ducts. The ducts terminate at the lactiferous sinuses that discharge via the nipple.



are lined with contractile myoepithelial cells that have
the role of ejecting milk from the nipple when the
baby suckles.


**5.2.1.4 The alveolar cells**

The mammary alveoli are the site of milk synthesis.
The key cells in these structures are the epithelial cells,
which form a single layer around the alveolar lumen
that drains into the lactiferous duct. Alveolar epithelial cells are polar in nature, meaning that there are
specialized organelles on the basal side (the side of the
cell in contact with the vascular system) and on the
apical side (the side of the cell in contact with the alveolar lumen). This reflects the function of these cells,
which requires uptake of nutrients from the blood
and secretion of milk. The apical side of the cells is



therefore packed with secretory structures (Golgi apparatus, secretory vesicles, and fat droplets).


**5.2.1.5 The rooting reflex**
Successful suckling requires that the baby correctly
takes the nipple into the mouth and stimulates the
nerve endings that lie beneath the areola. To achieve
this, correct “latching-on,” the human infant is born
with an innate response called the rooting reflex. All
newborn babies will turn their heads toward anything that strokes their cheek or mouth and open
the mouth. Thus, brushing the cheek with the nipple
will cause the baby to take it into the mouth and initiate suckling. The nipple is drawn up to the palate,
and the tongue and palate then squeeze together to
draw milk from the sinuses. The baby then starts
the actual milking action, which involves a tongue



**Lactation and Infant Feeding** **101**


**Table 5.1** The composition of human milk [a]


Units per 100 g milk


Colostrum Transitional milk Mature milk


Energy (kcal) 56.0 67.0 69.0
Protein (g) 2.0 1.5 1.3
Protein (% energy) 14.0 9.0 8.0
Fat (total, g) 2.6 3.7 4.1
Fat (% energy) 42.0 51.0 53.0
Carbohydrate (g) 6.6 6.9 7.2
Carbohydrate (% energy) 44.0 40.0 39.0
Calcium (mg) 28.0 25.0 34.0
Phosphorus (mg) 14.0 16.0 15.0
Sodium (mg) 47.0 30.0 15.0
Zinc (mg) 0.6 0.3 0.3
Riboflavin (mg) 0.03 0.03 0.03
Nicotinic acid (mg) 0.8 0.6 0.7
Vitamin B6 (µg) Trace Trace 0.01
Folate (µg) 2.0 3.0 5.0
Vitamin C (mg) 7.0 6.0 4.0
Vitamin A (µg) 177.5 91.2 62.0


Source: Data from Holland et al. (1991).
a Selected nutrients.



movement from areola to nipple. These movements
are instinctively coordinated with breathing and
swallowing.


_**5.2.2 Synthesis of milk**_


The average composition of mature human milk is
shown in Table 5.1. Generally speaking, women will
produce 750–800 mL of milk per day at the peak of
lactation, and within this milk, approximately 50% of
the energy will be delivered as fat and 40% as carbohydrate. Carbohydrate is primarily delivered in the form
of lactose and fats as triacylglycerols. Protein comprises casein and the whey proteins (α-lactalbumin,
lactoferrin).
Thetruecompositionofhumanmilkishighlycomplex as there are a number of nonnutritional componentsinadditiontothebasicnutritionalrequirements
of the infant. There is also wide variation in composition between women and between breasts within the

same woman. Some of this variation may be explained
by the differences in quality of maternal diet and maternal body composition and stores. Human milk also
changes in composition at different stages across the
full lactation period, with time of day and within the
course of a feed.



**5.2.2.1 Foremilk and hindmilk**

The first milk to be released during a feed is called the
foremilk. Once the full letdown of milk occurs (see
below), hindmilk is released. Foremilk tends to be
more watery than hindmilk and may serve primarily
to meet the thirst of the infant and provide some
instant satisfaction of the desire to feed. The foremilk

is lower in fat content and richer in lactose than the
hindmilk and is therefore less energy and nutrient
dense. As the hindmilk provides more of the energy
requirements of the infant, it is important for the
breast to be fully drained at each feed, rather than
adopt the strategy of allowing the infant to suckle for
a few minutes on each breast at each feed.


**5.2.2.2 Time of day**
Several studies have documented that the composition of human milk varies during the course of the
day. Lubetzky _et al._ (2006) reported that in mothers of
premature infants who were expressing milk for their
babies, the fat content of the milk was greater in the
evening than in the morning. Similarly, Mitoulas and
colleagues (2003) found that the fatty acid composition of milk from mothers of full-term infants varied
over the day, with generally more fat produced in the
evenings. The dynamic quality of milk composition



**102** **Nutrition: A Lifespan Approach**


may be explained by the diurnal variation in nutrient reserves of the mother, or possibly by endocrine
factors.


**5.2.2.3 Course of lactation**

The greatest variation in milk composition is associated with the developmental stage of the infant
(Table 5.1). Mothers of premature babies produce
milk that differs in composition to mothers of fullterm babies. Preterm milk contains greater concentrations of protein, nonprotein nitrogen, arachidonic
and docosahexaenoic acids (Kovacs _et al._, 2005).
The first secretions of the mammary gland following the birth of the baby are called colostrum.
Colostrum is a thick, sticky, yellowish fluid produced
in small quantities (around 100 mL/day). Due to the
low quantity produced, it has long been believed that
colostrum has little nutritive function and that it is

instead a protective secretion that minimizes the infants’ risk of infection and promotes maturation of
the gut. Colostrum has a low content of lactose and
fat and has a protein concentration that is considerably greater than in mature milk. Most of the proteins
in colostrum are protective factors, the principal elements being the secretory immunoglobulin IgA and
lactoferrin. Colostrum is also rich in vitamin A.
Between 3 and 7 days postpartum, the mammary
gland switches from production of colostrum to the
synthesis of _transitional milk_ . This milk is produced in
a larger volume and has a lower protein and sodium
content than colostrum. Lactose and fat concentra
tions are more similar to mature milk. Mature milk

will be secreted from around 14 days postpartum.


**5.2.2.4 Synthesis of carbohydrates**
The primary carbohydrate within milk is lactose,
which comprises approximately 80% of the total carbohydrate load. The remaining carbohydrate is in the
form of oligosaccharides that are believed to have an
immunoprotective role. Oligosaccharides escape digestion within the small intestine and pass to the
colon where they act as prebiotics. Prebiotic compounds provide substrates for the growth of bacteria
within the colon. Maintaining a healthy population
of _Lactobacillus_ and _Bifidobacteria_ species appears to
reduce risk of infection with diarrhea-causing species.
Lactose is synthesized from glucose in the polar
alveolar epithelial cells (Figure 5.2). Galactose is primarily synthesized de novo from glucose, although



some galactose will be taken up from the maternal
diet. Lactose is synthesized from glucose and galactose through the action of lactose synthetase, which is
a multienzyme complex comprising galactosyl transferase and α-lactalbumin. Galactosyl transferase is expressedinthemammaryglandsduringpregnancy,but
as there is little α-lactalbumin, the mature complex
cannot be formed.
Lactose synthesis occurs within the Golgi apparatus
on the apical side of the alveolar epithelial cell. Lactose
is packaged into secretory vesicles and due to the high
osmolality of the disaccharide, the vesicles take up
water and electrolytes such as potassium and sodium.
Lactose synthesis is therefore responsible for generatingthefluidportionofthemilk.Secretoryvesiclesand
their contents are discharged into the alveolar lumen
by exocytosis.


**5.2.2.5 Origins of milk fats**
Milk contains fat in the form of emulsified droplets
that consist of a mixture of triacylglycerides, diacylglycerides, monoacylglycerides, free fatty acids,
cholesterol, and phospholipids. Ninety-eight percent
of the fat is in the form of triacylglycerides. Lipid
droplets are formed within the alveolar epithelial cells
as lipids that are derived from maternal circulation or
from de novo synthesis coalesce and migrate toward
the apical side of the cell. The droplets are eliminated
fromthecellsbyexocytosis,andinthisprocess,asmall
portion of the apical cell membrane is lost. This will
therefore deliver some maternal phospholipids and
cell membrane proteins into the milk (Figure 5.2).
Glycerol for synthesis of triacylglycerides is derived
from the maternal circulation. This along with the
longer chain fatty acids (16 or more carbon chain) is
cleavedfromtriacylglyceridesbytheactionoflipoprotein lipase in the mammary capillaries. As these fatty
acids are derived from the maternal diet, the composition of breast milk will therefore reflect the composition of the fats consumed by the mother. Shorter
chain fatty acids are synthesized within the cytosol of
the alveolar cells. Acetyl-coA, which is generated from
thecitricacidcycleinthemitochondria,istransported
to the cytosol via the acetyl-group shuttle. Carboxylation generates malonyl-coA, which is the substrate
for the fatty acid synthetase complex, which progressively conjugates two carbon units up to C16 palmitic
acid. Fatty acids of C10–C16 length synthesized in this
manner will be incorporated into milk fat.



**Lactation and Infant Feeding** **103**



















Lipids released **Lumen**
as emulsion


**Figure 5.2** Synthesis of human milk. Milk synthesis occurs in the polar alveolar cells of the mammary tissue. Substrates for milk production are
either synthesized de novo within the cytoplasm and Golgi complexes of the alveolar cell, or are imported from the maternal circulation through
endocytotic uptake on the basal side of the cell. Lipid droplets and maternal circulation-derived proteins are discharged to the alveolar lumen by
exocytosis. Lactose, casein micelles, water, and micronutrients are secreted to the lumen from the Golgi apparatus.



**5.2.2.6 Milk proteins**
Human milk contains a broad array of proteins, many
of which have nonnutritive functions. In addition to
the major milk proteins, casein, α-lactalbumin, and
β-lactoglobin, which are synthesized de novo within
the mammary epithelial cells, there are proteins that
are derived from the maternal circulation. These include secretory IgA, lactoferrin, antiviral agents, enzymes, and growth factors (insulin-like growth factor 1, mammary-derived growth factor, insulin, and
nerve growth factor). Immunoglobulin A that is secreted into milk will reflect the antigen exposures
of the mother and serves to protect the infant from
gastrointestinal infection and to prime the neonatal
immune system. Lactoferrin is an iron-binding protein that minimizes risk of infection of the infant gut
by removing iron that could be used as a bacterial
substrate.



Blood-borne proteins, including IgA, generally enter the alveolar cells from the basal side through passive mechanisms (Figure 5.2). Endocytotic vesicles
will either deliver the proteins to the Golgi complex
for packaging into the same secretory vesicles that
deliver lactose and water to the lumen, or will move
across to the apical side of the cell and discharge the
proteins through exocytosis. Proteins that are synthesized de novo within the alveolar cells are transported
to the Golgi complex for posttranslational modification and secretion. Casein (of which there are α s1, α s2,
β, and κ forms), for example, is combined with calcium and phosphate to form a complex micelle structure. Hydrophobic α and β caseins form the core of
these spherical structures with hydrophilic κ casein on
the external surface (Phadungath, 2005). These casein
micelles not only give milk many of its physical characteristics, for example, the white color, but also have



**104** **Nutrition: A Lifespan Approach**


an important biological function. Micelles carry large
amounts of highly insoluble calcium phosphate in a
liquid form. They then form a clot in the neonatal
stomach, which increases the efficiency of absorption
of these minerals. Micelles also deliver citrate, electrolytes, and digestive enzymes such as lipase.


_**5.2.3 Endocrine control of lactation**_


Once established, lactation is under the control of a
cascade of hormones of hypothalamic and pituitary
origin. However, the actions of sex steroids produced
during pregnancy and endocrine factors produced
from the placenta are also critical in stimulating the
maturation of the breast tissue and ensuring that milk
production does not occur until after the birth of the
infant.


**5.2.3.1 The breast during pregnancy**
The mammary glands are extremely sensitive to the
actions of the sex steroids, estrogen and progesterone.
Development of the breast is primarily driven by these
hormones and occurs in a number of distinct stages.
The early stages occur during puberty in direct response to the rising concentrations of estrogen and
progesterone that occur at this time. The actions of
these hormones produce the structures shown in Figure 5.1. However, the full functional differentiation
of the breast tissue does not occur until pregnancy.
With the establishment of pregnancy, the breast undergoes extensive changes that are an essential preparation for feeding the baby after delivery. Estrogen
acts, along with growth hormone, to stimulate elongation of the lactiferous ducts. Progesterone and prolactin trigger alveologenesis where, essentially, new
ducts are formed branching off from the ducts formed
during pubertal breast development, and new alveolar
tissue is laid down around these ducts. While estrogen
and progesterone will be produced from the placenta,
prolactin is a product of the anterior pituitary.
The main function of prolactin is to stimulate
secretion of milk, but during pregnancy, the high
circulating concentrations of progesterone and estrogen inhibit this process. However, prolactin and the
placentally derived human chorionic somatomammotropin are still able to act on alveolar cells to stimulate the maturation of the enzyme systems that will
be required for milk production. Genes that encode
human milk proteins have been shown to be expressed



**Figure 5.3** The neuroendocrine control of lactation. Milk letdown is
stimulated by activation of mechanoreceptors in the nipple. The hypothalamus coordinates the response to stimulation, involving oxytocin
and prolactin, thereby ensuring that milk synthesis and release occur
simultaneously.


from mid-gestation and this expression is under the
control of prolactin.


**5.2.3.2 Established lactation**

After delivery of the baby, concentrations of progesterone and estrogen fall rapidly and inhibition of the
effect of prolactin on alveolar cells is lifted. Lactation is
now principally governed by prolactin and the posterior pituitary hormone oxytocin. These are produced
in a coordinated manner that ensures that milk synthesis and release are coupled together (Figure 5.3).
Thesucklingofthebabyprovidesstimulationtothe
mechanoreceptors that are located in the nipple. This
sends nerve signals to the hypothalamus, which then
coordinates the response. The hypothalamus releases
prolactin releasing hormone (PRH), which stimulates
secretion of prolactin. Prolactin acts on the alvelolar
epithelial cells of the breast and milk is released into
the alveolar lumen. Simultaneously, the synthesis of















more milk is activated. Secretion of oxytocin by the
posterior pituitary is stimulated by nerve impulses
from the hypothalamus. Oxytocin acts on the myoepithelial cells surrounding the alveolar lumen and
contractions move milk into the ducts, where further
contractions forcibly eject the milk from the nipple
(Figure 5.3). The ejection of milk should, in a correctly latched on baby, lead to transfer of milk directly to the throat of the baby. As a result, the baby
does not need to suck, but simply stimulate the nipple
through action of its gums. This suckling “technique”
is markedly different from that required by a bottlefed baby, which has to suck the teat to access the milk.
The coordinated secretion of prolactin and oxytocin is called the letdown reflex. In new mothers,
letdown will be triggered solely by the mechanical
stimulation of the nipples, but in women who have
a well-established lactation or who have previously
breast-fed a baby, letdown can be triggered by other
cues such as the sound of their baby crying. The coupling of milk synthesis and release means that lactation is a demand-led process. Essentially, the more
a baby suckles at the breast, the greater the stimulation of prolactin secretion and the more milk will be
produced. This important principle lies at the heart
of the advice to breast-feeding women to do so on
demand. While bottle-fed babies are usually fed to a
strict (usually 4 hourly) schedule, breast-fed babies
need to control the feeding schedule to ensure that
the supply is sufficient to meet their requirements.
In the very early stages of lactation, the baby will
receive only small amounts of colostrum, which will
not satisfy hunger. As a result, the baby may suckle 12–
18 times in a 24-h period. This grueling period for the
new mother serves to establish a good supply of milk
once inhibition of prolactin effects is lifted. Within
a few weeks, a more predictable pattern of feeding
(6–10 feeds per day) will develop and the breasts will
produce sufficient milk to satiate the baby, which in
the process develops the capacity to regulate its own
food intake. During phases of more rapid growth, the
baby will suckle more to obtain the extra energy and
nutrients required, and the stimulus to the breasts will
increase milk production accordingly.


**5.2.3.3 The breast after weaning**
Once lactation is ended, the stimulation of mammary
tissue by prolactin comes to an end. Remarkably, the
remodeling of the breast tissue that occurred dur


**Lactation and Infant Feeding** **105**


ing pregnancy is then largely reversed, as the milk
production apparatus is essentially dismantled and
reconstructed for any subsequent pregnancies. This
process, termed involution, involves apoptosis of the
epithelial cells of the mammary alveoli and recruitment of inflammatory cells to the breast tissue. Most
of the new ducts and alveolar tissue are removed in

this process and the breasts enter a resting phase. Only
the myoepithelial cells of the ducts and some secretory
cells are retained, with the bulk of the alveolar tissue
laid down in pregnancy replaced by fibrous tissue. At
the end of reproductive life, complete involution occurs and the breast structure returns to the virgin-like

state.

During involution, the composition of human milk
undergoes a change (Table 5.1). If weaning is gradual
rather than abrupt, then this will impact upon the
delivery of nutrients to the infant. Involutional milk
is lower in lactose content but is richer in protein, fat
and sodium. The composition changes occur because
retention of unused milk in the breast forces apart
tight cell junctions allowing flow of extracellular fluids
containing nonmilk proteins and electrolytes into the
ducts.


_**5.2.4 Maintenance of lactation**_


The demand-led nature of lactation means that it can
be maintained for as long as the baby is suckled. In
most westernized countries, breast-feeding beyond 9–
12 months is an unusual behavior, but in many other
societies, prolonged breast-feeding (sometimes up to
3 years) is relatively commonplace. In such circumstances, the demand-led nature of the process means
that women can maintain production of around
500 mL milk per day. Similarly, women who are feeding twins will produce twice as much milk as women
feeding a singleton baby, as milk production matches
demand. Lactation will come to an end only when the
stimulus of suckling is withdrawn for 7–14 days. This
results in a cessation of prolactin secretion and subsequently the cessation of milk production and breast
involution.

Lactation is remarkably robust and even malnourished women appear able to maintain successful
breast-feeding. Prentice _et al._ (1994) noted that extreme malnutrition (famine or near-famine conditions) is the only state in which milk production will
be significantly impaired. There is no detectable relationship between the body mass index (BMI) of the



**106** **Nutrition: A Lifespan Approach**


motherandthevolumeorcompositionofthemilkshe
produces. Very thin women (BMI _<_ 18.5) appear capable of maintaining normal lactational performance.
There are circumstances where it may be necessary to temporarily avoid suckling the baby but maintain the lactation. Such a situation may arise if the
woman requires a short period of medical treatment
with drugs that are excreted into breast milk. This can
be achieved through artificial withdrawal of milk from
the breast using a breast pump. This process is termed
expressing. In circumstances where the milk may be a
hazard to the infant, an artificial formula can be used
and the expressed breast milk discarded until safe to
resume feeding. In circumstances where the baby is
unable to feed, for example, due to prematurity, ill
health, or surgery, expressed milk can be safely stored
and given from a bottle or mixed with solids at a later
date.


_**5.2.5 Nutritional demands of lactation**_


Lactation is a highly demanding state for the mother
and there are undoubted increases in requirements for
a broad range of nutrients while breast-feeding continues. However, with the exception of protein and
energy, the exact nature of the altered requirements
is generally poorly understood and it is difficult to
conclude whether lactating women need to make significant changes to the quality of their diet. Table 5.2
shows the increments for lactation that are added to
UK Reference Nutrient Intakes. For many nutrients,



these levels of intake are likely to be met within the
normal diets of women in westernized countries.

The micronutrient composition of human milk is
relatively constant. Studies of women in developing
countries where micronutrient deficiencies are relatively common show that milk composition is most
affected by maternal deficiencies of the water soluble vitamins, thiamin, riboflavin, vitamin C, vitamin
B6, and vitamin B12. Marginal maternal deficiency
of these factors will limit milk concentrations, and
supplementation restores milk vitamin content. The
fat-soluble vitamins are less influential on milk composition, although maternal vitamin A status is to
some extent reflected in milk. With respect to folic
acid and all of the minerals, very severe maternal deficiency has to occur before any appreciable decline
in milk concentrations is observed. This protection
of milk composition against variation in maternal intake is achieved through mobilization of maternal reserves. For example, if intakes are less than optimal,
calcium will be released from the skeleton in order
to maintain milk calcium concentrations. Dijkhuizen
and colleagues (2001) studied mother–infant pairs in
Java and found that the micronutrient deficiencies
(vitamin A deficiency, iron deficiency anemia) observed in the mothers tended also to occur in their
children. However, this was not well explained by the
micronutrient composition of breast milk. Only 13%
of variation in milk retinol and 24% of variation in
milk β-carotene was explained by variation in maternal plasma concentrations. Accumulation of infant



**Table 5.2** UK reference nutrient intakes for lactating women


UK RNI for lactation _[a]_ Estimated intake for UK women _[b]_


Nutrient (lactation increment) Mean (standard deviation)


Protein (g/day) 56.0 (+11) 63.7 (16.6)
Riboflavin (mg/day) 1.6 (+0.5) 1.6 (0.6)
Vitamin B12 (µg/day) 2.0 (+0.5) 4.8 (2.7)
Folate (µg/day) 260 (+60) 251 (90)
Vitamin C (mg/day) 70 (+30) 109 (63–160)
Vitamin A (µg/day) 950 (+350) 671 (633)
Calcium (mg/day) 1350 (+550) 777 (268)
Magnesium (mg/day) 320 (+50) 229 (70)
Zinc (mg/day) 13.0 (+6.0) 7.4 (2.1)
Copper (mg/day) 1.5 (+0.3) 1.03 (0.38)


Sources: Department of Health (1991); Henderson et al. (2002).
_a_ For first 4–6 months of lactation.
_b_ Nonpregnant, nonlactating women.



reserves during fetal development, or use of weaning
diets low in these nutrients would be a greater risk
factor for infant deficiency.
Theenergyrequirementsforlactationareextremely
high, andoverthe first6months of lactation, a woman
will need to mobilize approximately 115 000 kcal
(481 MJ) for milk production. These figures are calculated on the basis that human milk has an energy
content of around 0.67 kcal/g, that the conversion of
maternal energy to milk energy is around 80% and
that women will secrete around 750 mL milk per day.
Thus, the energy cost of lactation is around 640 kcal
(2.7 MJ) per day in the first 6 months of lactation,
declining to around 510 kcal (2.1 MJ) per day beyond
6 months.

Most of the extra energy requirement will need to
be derived from increasing energy intake within the
maternal diet. Although some studies have suggested
that there are metabolic adaptations to conserve energy, the balance of opinion is that resting metabolic
rate and thermogenesis do not change in lactation.
Physical activity levels tend to be lower in women in
the first 4–6 weeks after childbirth, but energy savings
achieved through a sedentary lifestyle are unlikely to
have much impact on availability of energy for lactation. Most women will lose around 2 kg body weight
per month during lactation and this provides around
150 kcal/day for milk production. It is suggested
therefore that women require approximately 500 kcal
(2.1 MJ) per day extra within the diet to meet requirements during lactation.
The protein content of milk varies with the stage
of lactation (colostrum contains 30 g protein per liter,
while mature milk is 8–9 g per liter). It is estimated
that women require an extra 11 g protein per day
over the first 6 months lactation, falling to 8 g/day
for more prolonged breast-feeding in order to meet
this demand. In developed countries, most women
consume protein well in excess of this requirement
and would not need to alter diet during lactation
(Table 5.2). Studies of animals suggest that the protein
content of the maternal diet has an influence upon the
quantity and quality of milk produced, but it is not
clear whether this is also true of humans. Generally, a
higher protein intake is believed to increase milk volume, but variation in protein intake within normal
ranges does not appear to alter milk composition.
Some studies have shown that short-term reductions

in maternal protein intake decrease milk protein and



**Lactation and Infant Feeding** **107**


nonprotein nitrogen content, but it is unclear whether
longertermreductionsinproteinintakehavethesame
effect.


**5.3 The advantages of breast-feeding**


_**5.3.1 Advantages for the mother**_


Breast-feeding an infant carries a number of advantages for the mother, which encompass both the ease
of child rearing and her short- and long-term health.
The most obvious advantage is the convenience of
being able to feed the baby on demand, at any time
and in any place without need for special preparation.
Moreover, breast-feeding costs nothing, in contrast to
bottle-feeding that carries the cost of bottles, teats,
sterilizing equipment, and of course the infant formula itself. A typical infant milk formula in the UK
is likely to cost a family £6 per week, which for a
lower income family is a significant investment. Milk
voucher schemes exist to assist with this cost, but are
often unclaimed by parents.
Breast-feeding helps to develop the emotional bond
between mother and baby. The act of feeding involves
close physical contact and eye contact (termed mutual gazing), which is suggested to increase the quality of the mother–child relationship. Oxytocin secretion associated with the letdown reflex has the effect of reducing anxiety through increasing activity of
the parasympathetic nervous system. This helps the
mother to develop the emotional bond with her child
and promotes her sensitivity to the needs of the infant.
Breast-feeding aids the maternal recovery from
pregnancy in a number of ways. Primarily, the early
initiation of feeding promotes the involution of the
uterus and reduces the risk that the mother will suffer a postpartum hemorrhage, as the uterus is a target
for actions of oxytocin. Endocrine factors that control
lactation also delay the onset of reproductive cycling
and this means that women who breast-feed will have
a longer delay before resumption of their normal periods. Suckling inhibits the production of follicle stimulating hormone and luteinizing hormone from the
anterior pituitary. This lactational amenorrhea confers two benefits. Firstly, reduced blood losses help to
preserve iron stores and hence leads to a more rapidly
recovery of normal iron status after pregnancy. Secondly, lactational amenorrhea acts as a natural form
of contraception. In populations where other forms of



**108** **Nutrition: A Lifespan Approach**


contraception are not readily available, this approach
(which is estimated to be 90% effective in women fully
breast-feeding for 6 months) helps to space out pregnancies. This has a number of benefits for maternal
health, allowing full recovery between successive pregnancies, and in turn reduces the likelihood of children
being of low birth weight and hence at greater risk of
neonatal mortality.
Pregnancyisassociatedwithextensivedepositionof
fat reserves that are primarily intended for mobilization during lactation to meet the energy requirements
of milk production. It is generally assumed therefore
that breast-feeding will promote a more rapid loss of
weight gained during pregnancy. However, the data in
this area are far from clear. Most studies suggest that
there are only small weight changes during lactation.
Breast-feeding does appear enhance the rate of weight
loss postpartum, but the effect is relatively small and
depends on the duration of breast-feeding. Dewey
and colleagues (1993) reported that breast-feeding for
at least 6 months was required to promote significantly greater loss of weight than seen in women who
bottle-fed.
Evidence is emerging to suggest that risk of cancer is lower in women who breast-feed their infants.
Danforthandcolleagues(2007)carriedoutananalysis
of the two US Nurses Health Studies, which included
approximately150 000womenwhohadchildren.Risk
of ovarian cancer in these women was reduced by 14%
(not statistically significant) when comparing “ever
breast-fed” with “never breast-fed” groups. However,
risk of ovarian cancer was shown to decrease by 2%
for every month of breast-feeding and was 34% lower
in women who had breast-fed their children for more

than 18 months.

Risk of breast cancer is significantly reduced simply
by having a child. As childbearing and breast-feeding
are closely related activities, it can be difficult to independently evaluate the extent to which breast-feeding
impactsuponcancerrisk.TheCollaborativeGroupon
Hormonal Factors in Breast Cancer (2002) examined
data from 47 epidemiological studies encompassing
50 302 women with breast cancer and 96 973 controls

across 30 different countries. The data confirmed the
protective effect of childbearing and showed that having a larger family (three or more children) was most
protective.Riskofbreastcancerwasreducedby7%for
every birth. On top of this, each year of breast-feeding
reduced risk by 4.3%. These benefits appear small but



applying these data to breast-feeding prevalence and
duration rates in developed countries suggests that
a high proportion of the difference in breast cancer
prevalence between developed and developing countries might be explained by infant feeding practices.
For example, in Germany where only 10% of women
breast-feedtheirinfantsto6monthsofage,breastcancerprevalenceratesare1030casesper100 000populationcomparedtoaround75per100 000populationin
most African countries, where long-duration breastfeeding is commonplace. The Collaborative Group on
Hormonal Factors in Breast Cancer study (2002) suggested that if children in developed countries were
breast-fed for 6 months longer than at present, 5% of
breast cancers (25 000 cases) would be prevented.
A number of studies have evaluated the impact of
lactation upon maternal bone health. Milk production places heavy demands for calcium and it is estimated that 200–225 mg calcium per day is transferred
from mother to infant via breast milk. Over a period
of 6 months lactation, this equates to an additional
calcium requirement of between 35 and 40 g. Bone
is a dynamic tissue and acts as a reserve for calcium
that can be readily released in order to support the
lactation. A number of studies have shown that this
results in changes in the level of bone mineral present
within the skeleton. This can be measured using the
technique of dual x-ray absorptiometry, which determines the amount of bone mineral present per unit
area of skeleton (bone mineral density, BMD). Typically, lactation for a period of 6 months results in loss
of around 4–6% of BMD, with most losses coming
from the spine and hip (Karlsson _et al._, 2005). This
loss of bone mineral occurs despite the fact that most
lactating women reduce their intakes of alcohol and
caffeine, which are known to exert negative influences
on BMD. It is probably driven by low levels of estrogen, resulting from suppression of the hypothalamic–
pituitary–ovarian axis.
With these negative influences of lactation upon the
skeleton, it is clearly important to evaluate whether
breast-feeding is associated with long-term risk of osteoporosis, a disease associated with increased risk of
bone fracture in the elderly. As with cancer, it is difficult to dissociate the influences of breast-feeding and
childbearing upon osteoporosis risk. It is clear though
that in women who have had children, BMD is typically 3–5% _higher_ than in women who have never
had children and that women who have breast-fed for



extended periods (2 years or more) show no difference
in risk of later osteoporotic fracture.
The lack of osteoporosis risk associated with lactation is explained by the fact that BMD is fully recovered once the infant is weaned and lactation ends.
Most studies show that all bone mineral lost during
lactation is replaced within 12–18 months of giving
birth. A number of adaptive mechanisms appear to
conserve calcium and promote remineralization, of
which the most important is an increase in the capacity to absorb calcium from the diet. Bioavailability
of calcium, that is, the proportion of dietary intake
that is taken up across the gut, in nonlactating women
is approximately 25–30%. This increases with lactation to between 32% and 52%, but to an extent that
reflects habitual intake. In a study of well-nourished
US women, using radioisotope tracers, Ritchie and
colleagues (1998) showed that early lactation was not
associated with a significant increase in calcium absorption, but that renal losses of calcium were reduced to around half of pre-pregnancy levels. This
renal conservation was maintained at 5 months past
the resumption of reproductive cycling.


_**5.3.2 Advantages for the infant**_


As described earlier in this chapter, the composition
of human milk changes with stage of infant development, across the day and across the course of a feed.
These compositional changes, and the robust nature
of milk production, which ensures nutrient content is
maintained even if relatively poorly nourished mothers, guarantee that the nutrient availability for the
infant is optimal. This aspect of breast-feeding can
clearly be viewed from a teleological perspective, as
ensuring that there are health advantages for the infant in the short term. Similarly, from what is known
about early life influences on long-term health and
well-being (Chapter 4), it is reasonable to propose
that breast-feeding will confer lifelong benefits.
In the short term, one of the most important advantages for the infant is derived from the immunoprotective factors that are present in milk and that
are indirectly associated with the process of breastfeeding. Among the developing countries in particular, where hygiene and sanitation standards may be
poor, the major hazards to infants are diarrheal infections and infections of the respiratory tract. Breastfeedingprovidesclearprotectionagainstboth.Arifeen
and colleagues (2001) reported on the prevalence of



**Lactation and Infant Feeding** **109**


infection-related deaths from in the slums of Dhaka,
Bangladesh. In this population, 11% of infants died
within the first 12 months of life and 45% of these
deaths were attributable to either acute respiratory
infection or diarrhea. Infants who were not breast-fed
or who were partially breast-fed were 2.40 times more
likely to die of respiratory infection than breast-fed,
and were 3.94 times more likely to die from diarrheal
infections.

A large proportion of this protective effect can
be attributed to the presence of immunoglobulins,
lactoferrin,Blymphocytes,complementproteins,and
macrophages in human milk. These factors provide
the capacity to actively combat infection and also
bind out substrates that may be beneficial for bacterial growth. Breast-feeding is also protective against
gastrointestinal infection as provision of human milk
ensures that fluids consumed by the infant are clean
and free of contaminating factors. Poor sterilization of
bottle-feeding equipment, or the use of infected water supplies for formula preparation, is an avoidable
cause of infection.

Sudden Infant Death Syndrome (SIDS) describes
the sudden unexplained death of an infant under
1 year of age. Risk of SIDS is increased by parental
smoking and alcohol use and by placing infants to
sleep on their stomachs. Some studies have suggested
that SIDS is more prevalent in formula-fed infants
than breast-fed infants. Alm and colleagues (2002)
examined 244 cases of SIDS from Scandinavia. After
careful adjustment for potential confounding factors,
it was found that short-duration breast-feeding (less
than 4 weeks) increased risk of SIDS by 5.1-fold, compared to breast-feeding for longer than 15 weeks. The
possible explanation for the reduction in risk associated with breast-feeding could be a reduction in
occurrence of respiratory infections. Risk of SIDS has
been shown to be increased by the practice of bed
sharing (in which the baby sleeps with the parents).
As bed sharing facilitates the establishment of breastfeeding,thereissomeconcernthatparentsmayreceive
mixed messages relating to SIDS that will ultimately
discourage breast-feeding.
The rising prevalence of overweight and obesity
among children across the globe has prompted interest in the possible contribution of early life nutrition
to this problem. In many developed countries, the beginning of upward trend in childhood overweight coincided with widespread rejection of breast-feeding.



**110** **Nutrition: A Lifespan Approach**


Although difficult to demonstrate in single studies,
large-scale analyses of available data sets indicate that
risk of obesity in childhood is reduced by around 22%
by breast-feeding compared to bottle-feeding with an
infant formula (Research highlight 5).
The last trimester of pregnancy and the first 2 years
of life are the most rapid stage of brain development
in humans. The brain increases in size from around
350 g at birth to 1100 g at 12 months of age. This
rapid growth makes the brain vulnerable to adverse
environments during this time, including undernutrition. Grantham-McGregor and colleagues (1991)
showed in a group of stunted Jamaican infants that
a combination of nutritional supplements and stimulation through play increased developmental scores.
This, like most other studies of this kind, indicated
that the main effects of nutrition upon brain development were on development of locomotor abilities.
This is in keeping with the idea that rather than overall
brain growth being vulnerable to undernutrition, it is
specific brain functions that may suffer if nutrition is
less than optimal.



There are a number of studies that have demonstrated that the manner of infant feeding can impact
upon the cognitive development of infants. Some of
the best documented are those of Lucas and Morley
who have considered several cohorts of preterm or
low birth weight infants. These have shown that in
low birth weight infants, feeding of the mothers own
milk via an enteral tube produced an 8-point difference in the Bayley Score compared to feeding of an
infant formula. The Bayley score measures the mental
and motor development of infants, and the observed
differences persisted until at least 7.5–8 years of age
(Morley, 1988).
Several studies have suggested that breast-feeding
has a positive effect on the development of intelligence. However, the literature in this area is very variable in terms of the conclusions that can be drawn
and is invariably confounded by the fact that it is
generally considered neither ethical nor feasible to
perform a randomized control trial of breast-feeding
compared to formula feeding. As a result, maternal
characteristics and environment will have a strong



~~**Research Highlight 5**~~ ~~Breast-feeding reduces the risk of childhood obesity~~



It was first suggested that breast-feeding might provide protection
against the development of later obesity in the early 1980s. However, definitive exploration of this hypothesis was problematic due
to inconsistencies in the methods used for breast-feeding data collection, definitions of breast-feeding, and due to the confounding
factors that inevitably arise in such research. For example, women
who are better educated and wealthier are more likely to breast-feed
their infants, and are more likely to have children that consume a
healthy diet and exercise, hence avoiding obesity.


_Systematic review and meta-analysis_
A literature review is an attempt to synthesize the results and conclusions of two or more publications on a given topic. Most reviews are
inherently biased and will reflect the opinions of their authors. A _sys-_
_tematic review_ is a review that strives to comprehensively identify
and synthesize all the literature on a given topic in an unbiased
manner, and thereby test a stated hypothesis.
Arenz and colleagues (2004) performed a systematic review of
the literature published between 1966 and 2003 to address the possible association between breast-feeding and childhood obesity. The
meta-analysis associated with this review incorporated data from
nine studies including 69 000 participants, aged 3–26 years. Breastfeeding was found to significantly reduce risk of childhood obesity
with an adjusted odds ratio of 0.78 (95% confidence intervals 0.71–
0.85). In four out of the nine studies, duration of breast-feeding was
shown to be an important factor. Von Kries _et al._ (1999) reported



that while 4.5% of 6-year-olds who were never breast-fed were
obese, only 3.8% of those breast-fed for 3–5 months and 0.8% of
those breast-fed for 12 months were obese.


_Protective mechanism_
A number of putative mechanisms have been suggested to explain
the protective effect of breast-feeding:


r Bottle-feeding leads to an earlier _adiposity rebound_ . BMI in
children normally increases rapidly in the first year of life and
then declines reaching a minimum point around age 5–6, before
rising again. The point of minimum BMI (maximum leanness) is
termed the adiposity rebound point. Early adiposity rebound is
predictive of obesity later in life.
r Breast-feeding is demand led and the infant controls energy
intake. With bottle-feeding, loss of infant control over intake
causes the normal hypothalamic regulators of appetite to
develop in a way that favors excess intake in the longer

term.
r Bottle-fed infants have higher plasma insulin concentrations than
breast-fed infants. This favors early deposition of fat and an
increase in fat cell number.
r Human milk contains bioactive factors that maintain a pattern of
growth that favors a leaner body mass.
r The lower ratio of n-3 to n-6 fatty acids in formula milk compared
to human milk promotes adipose tissue development.



bearing on any studies that attempt to related measures of childhood intelligence (IQ: intelligence quotient) to infant feeding methods. Jain and colleagues
(2002) performed a systematic review of the literature
and found that most studies conclude that breastfeeding does improve later IQ scores. However, few
studies have specifically studied full-term rather than
preterm infants and higher quality studies suggest no
clear effect. Zhou _et al._ (2007) reported that in a study
of 300 Australian children aged 4 years, there was no
difference in IQ score between children breast-fed for
6 months and children who were never breast-fed.
It is also suggested that behavior of children may
be influenced by breast-feeding. Julvez and colleagues
(2007) studied two populations of Spanish 4–5-yearolds and found that breast-feeding for more than
20 weeks resulted in better scores on tests designed
to examine puzzle solving and numeracy skills, ability to respond to routine, ability to share and help
others, and to cope with frustration. Most interestingly, the study suggested that breast-feeding for more
than 12 weeks significantly reduced the occurrence of
symptoms of attention deficit hyperactivity disorder.
Breast-feeding is therefore generally associated with
better developmental outcomes in children. The relationship is almost certainly not linear with duration
of feeding and while exclusive breast-feeding for 6–
8 months carries benefits, prolonged exclusive breastfeeding will lead to impaired development.
It is argued that many of the observed differences
in behavioral and developmental outcomes noted between infants fed human milk compared to formula
milk are explained by the provision of particular fatty
acids. In terms of composition, the brain is around
60% lipid and, in particular, it is rich in the longchain polyunsaturated fatty acids, arachidonic acid,
and docosahexaenoic acid (DHA). Both become concentrated in the cell membranes of nonmyelinated
cells of the brain and in the retina and accumulate
during the rapid phase of brain growth. DHA has been
shown to be critical for the normal development of a
number of visual and mental functions (Carlson _et al._,
1994). Extrapolation from animal studies suggests
that over the first 6 months of life, infants accumulate
high quantities of DHA of which approximately 50%
will be incorporated into brain (Cunnane _et al._, 2000).
DHA is not widely found in the diet and is chiefly
derived from fish oils. It can be synthesized from
α-linolenic acid via a series of desaturase- and



**Lactation and Infant Feeding** **111**


elongase-catalyzed reactions, but it is generally considered that this pathway cannot support the high demand of the infant brain for this fatty acid. Thus, the
delivery of DHA in a pre-synthesized form in breast
milk may represent a significant advantage during the
brain growth spurt. The DHA content of human milk
varies considerably and generally reflects the maternal diet. Studies have shown that supplementation
of women with fish oils can boost DHA excretion in
their milk. Typically, DHA constitutes between 0.3%
and 0.4% of the fatty acids present in human milk. In
the past, infant formula used in bottle-feeding contained negligible amounts of DHA, but some formula
manufacturers now include long-chain fatty acids derived from egg and these milks contain DHA at a level
around 0.2% of total fatty acids.
It has been suggested that breast-feeding may have
an influence on the development of allergies in children, which will most commonly manifest as either
atopic dermatitis (allergic eczema) or asthma. The
main reasoning here is that formula feeding generally
involves exposure of the infant to cow’s milk proteins
at an early stage of development. Allergies to cow’s
milk proteins are among the most common food allergiesnotedinchildren. Clearly, breast-feeding prevents
this early exposure and sensitization but could also
be beneficial since human milk provides passive immunity and promotes the development of the infant
immune system. However, it is also clear that proteins
and peptides can cross from the maternal circulation
into milk and so some argue that breast-feeding could
increase risk of allergic sensitization by exposing the
infant to allergens consumed by the mother. Some
groups have argued that women who show allergic
tendencies themselves should restrict intakes of dairy
products, nuts, and other common food allergens
while breast-feeding to lower risk in their children.
Atopy, a tendency to develop allergies, is strongly
associated with genetic components and the impact
of breast-feeding on risk of atopic dermatitis varies
between children that have a family history of atopy
and those that do not. In children with no atopic
heredity, there is no clear evidence that breast-feeding
has either a beneficial or detrimental effect on risk
of atopic dermatitis. However, Kramer and colleagues
(2001), who are to date the only group to carry out
a randomized controlled trial of breast-feeding versus formula feeding (in Belarus), reported a 46% decrease in risk of atopic dermatitis when children were



**112** **Nutrition: A Lifespan Approach**


exclusively breast-fed for 3 months. In children with
a family history of atopy, the benefits of breastfeeding are clear, with significant reductions in childhood eczema associated with breast-feeding for up to
4 months. Kerkhof _et al._ (2003) reported that in the
children of women with a history of allergic asthma,
breast-feeding for 13 weeks or more reduced prevalence of atopic dermatitis by 40%.


_**5.3.3 Recommendation to feed to**_

_**6 months**_


In 1990, participants at a World Health Organization
(WHO)/UNICEF policymakers meeting on breastfeeding produced the Innocenti Declaration. This was
in recognition of the fact that breast-feeding provides
optimal infant nutrition and carries significant benefits for the health of infants and their mothers. The
Declaration set out a number of global goals and operational targets. The central aims were as follows:


r
To ensure optimal maternal and child health, all
women should be enabled to practice exclusive
breast-feeding for 4–6 months.

r
Toreinforceabreast-feedingcultureanddefendthis
against development of a bottle-feeding culture.

r
To increase confidence of women in their ability to
breast-feed.

r
To ensure that women are adequately nourished.


The Declaration called upon all governments to
take effective steps to centrally coordinate breastfeeding promotion and enact legislation to protect
the rights of women to breast-feed. International
organizations were called upon to develop action
plans to promote and support breast-feeding and to
support national governments in delivering breastfeeding policies.
The main outcome of the Innocenti Declaration

was the establishment of a global policy for the promotion of breast-feeding. At the heart of this is the
WHO/UNICEF recommendation that infants should
be exclusively breast-fed for the first 6 months of life.
The benefits of such a policy for infant and maternal
health are clear, particularly in the developing countries. The most important advantage is the reduction
in the risk of gastrointestinal infection, which is a major killer of infants. Globally, diarrheal disease is a
cause of up to 2 million deaths among under 5’s each

year.
While any public health nutrition policy will clearly
focus on the potential benefits to the population, it is



important to also consider potential hazards. Some
studies have suggested that exclusive breast-feeding
can lead to poor iron status in infants if maternal
iron status is suboptimal (a commonplace scenario
throughout the developing countries). It is unclear
whether the same risk applies to other micronutrients.
While the overwhelming benefits of exclusive breastfeeding for 6 months outweigh potential hazards in
most developing countries, there are some indications
that 4–6 months might be a more appropriate guideline in developed countries where infection is less of a
hazard. For some rapidly growing babies in developed
countries, exclusive breast-feeding for 6 months may
result in faltering of growth. In this case, it may be
appropriate to introduce complementary feeds at an
earlier age.


**5.4 Trends in breast-feeding behavior**


Despite the clear evidence that breast-feeding is the
best infant feeding option for the health of both the
mother and her infant, the majority of babies in westernized countries are bottle-fed with artificial formula
preparations. The WHO recommends that all babies
are _exclusively_ breast-fed until 6 months of age in order to maximize the benefits for the infant. However,
in the US and most European countries, exclusive
breast-feeding is an activity pursued by a very small
minority of women, and bottle-feeding or a mixed
feeding regime is the norm.
Understanding the literature on breast-feeding
trends and breast-feeding in relation to health can
often be confusing due to the different terms used
to describe and define approaches to infant feeding. Table 5.3 provides an overview of some of these
terms. Looking at trends over time, or making comparisonsbetweencountriesisparticularlydifficultdue
to variation in these definitions. In general, rates of
breast-feeding have been increasing across the western
world over the last two to three decades, as increasingly women become aware of the positive impact
this has on the development of their babies. However, in some countries, the significant increase has
come from a very low base and so breast-feeding rates
remain troublingly low. In the US, for example, a
mere 25% of babies born in 1970 were _ever breast-_
_fed_ . By 1994, this had risen to 57.4%, and in 2003, the
figure was around 70% with huge variation related to
ethnicity and social class.



**Lactation and Infant Feeding** **113**


**Table 5.3** Definitions of breast-feeding behavior


_Breast-feeding_ _[a]_ Process of feeding baby human milk either directly from the breast or in expressed _[b]_ form


_Ever breast-fed_ Infant has been breast-fed on at least one occasion


_Exclusive breast-feeding_ Infant has only ever been fed with breast milk. No other liquids or solids have been introduced, with the
exception of vitamin and mineral supplements


_Predominant breast-feeding_ Infant has mainly been breast-fed but may have consumed water, fruit juices, tea, or oral rehydration
fluids


_Full breast-feeding_ Includes both exclusive and predominant breast-feeding behavior


_Bottle-feeding_ _[c]_ Process of feeding baby liquid or semisolid foods via a bottle with a teat. Generally, this refers to
feeding a cows-milk-derived substitute to human milk


_Mixed feeding_ Process through which an infant is nourished through a combination of breast-feeding and
bottle-feeding


_Complementary feeding_ The infant is nourished through a combination of breast-feeding and solid or semisolid foods


_a_ Successful breast-feeding is generally baby-led. Baby is fed on demand rather than to a timed schedule.
_b_ Expressing refers to the technique of manually drawing milk off the breast for administration via a bottle, or through
mixing with solid foods.
_c_ Bottle-fed babies are generally fed to a timed schedule, for example, a bottle every 4 h.



In the UK, increases in rates of breast-feeding were
noted between the mid-1970s and the 1980s, taking
overall numbers of babies who were _ever_ breast-fed
to around 65% of the population (Figure 5.4). Since
then, these figures have remained relatively stable and
the 2000 Office for National Statistics Infant Feeding
Survey (Hamlyn _et al._, 2002) found 69% of British babies were _ever_ breast-fed. As can be seen in Figure 5.4,
there is tremendous regional variation, and despite
large increases in breast-feeding rates in Scotland and
Northern Ireland in recent years, these two countries
within the UK lag behind England and Wales in terms
of uptake of breast-feeding. The relatively low rates
of breast-feeding seen in the UK (bearing in mind
that the 69% figure reported above really only represents the percentage of women who initiate breastfeeding) are typical of much of Europe and are also
seen in France, Italy, Netherlands, Spain, and Switzer


land. Norway and Sweden have the highest rates of
breast-feeding of any of the westernized countries,
and in Sweden, 98% of women initiate breast-feeding
(Yngve and Sj¨ostr¨om, 2001).
While across Europe, breast-feeding is initiated by
between 60% and 98% of women, the dropout rate is
very high and numbers of infants who are exclusively
breast-fed to 6 months of age have been found to
vary from just 10% in Germany up to 42% in Sweden
(Yngve and Sj¨ostr¨om, 2001). Figure 5.5 shows the
falloff in the number of breast-fed infants in the UK
(Foster, 1997). It can be clearly seen that of the women
who initiate breast-feeding at birth of their babies, a
quarter will give up within the first 2 weeks, 40%
will switch to bottle-feeding within 6 weeks, and only
40% will maintain breast-feeding out to 4 months.
These trends apply across all European states and
the dropout rate is similar even in Sweden, where



**80**
~~England and Wales~~


~~Scotland~~



**70**


**60**


**50**


**40**
**1970** **1980** **1990** **2000**


**Year of survey**



~~Northern Ireland~~


~~UK Total~~



**Figure 5.4** Breast-feeding trends in the UK from
1975 to 2000.



**114** **Nutrition: A Lifespan Approach**


**80**


**60**


**40**


**20**


**0**
**0** **10** **20** **30**


**Weeks postpartum**


**Figure 5.5** Decline in breast-feeding rates over the first 6 months of
life. ( _Source_ : Data from Foster (1997).)


breast-feeding is most actively promoted and supported (Yngve and Sj¨ostr¨om, 2001). The observation
that large numbers of women initiate breast-feeding
but soon switch to bottle-feeding or mixed-feeding
approaches provides a major clue to the fact that
breast-feeding can be very difficult for many women
to sustain.


_**5.4.1 Reasons why women do not**_
_**breast-feed**_


In considering why bottle-feeding is the preferred infantfeedingmethodformostwomeninwesterncountries, we need to consider two sets of factors. The first
are the factors that prevent women from initiating
breast-feeding in the first place, and the second group
of factors are those that lead women to give up breastfeeding at some stage in the first 6 months.
Most of the factors that women cite as important in
leading them to choose bottle-feeding in preference
to breast-feeding are socially and culturally related.
For example, in the US, the 2005 Women’s Health
Survey found that Hispanic women were most likely
to breast-feed while non-Hispanic blacks were least
likely. As shown in European studies, the women who
are least likely to breast-feed are younger mothers,
women with low educational attainment, and women
from a lower income family. Figure 5.6 shows data
from a survey of 300 women from Northampton, UK,
who were surveyed in the final trimester of pregnancy.
The data show that among higher social classes, the
intention to breast-feed was indicated by a number
of women that was well above the national average,
while only 50–60% of single mothers and women of



**100**


**80**


**60**


**40**


**20**


**0**


**Social class of baby's father**


**Figure 5.6** Socioeconomic factors are a strong determinant of breastfeeding behavior. Three hundred pregnant women from Northampton,
UK, were interviewed regarding their breast-feeding intentions in the
32nd week of pregnancy (Langley-Evans and Langley-Evans, 2003).
The dotted line shows the proportion of women in the UK who would
be expected to breast-feed (Hamlyn _et al._, 2002). Social class I: professionals, II: clerical workers, IIINM: skilled nonmanual workers, IIIM:
skilled manual workers, IV: partly skilled workers, V: unskilled workers.


lower socioeconomic class indicated that they would
breast-feed their babies.
These behaviors almost certainly arise from
women’s perception of the social acceptability of
breast-feeding. Women who choose not to breast-feed
maydosobecauseofembarrassmentatbreast-feeding
in public, as in the western world the breast is perceived as a sexual object. Women may also need to
return to work early after delivery. In the UK, for
example, statutory maternity leave is relatively short
(14 weeks) and women of lower socioeconomic class,
for example, may not be able to afford an extended
period of leave after having their babies. Women who
have previously breast-fed and had a negative experience are also disinclined to repeat the process. Some
women also report that they would like to share feeding of their baby with other family members and
thereby spread the burden of childcare. The experienceofmembersoftheextendedfamilyisofmajorimportance and women will often take advice from and
mirror the behaviors of their mothers. In some cul
tures,thisinfluencecanproducequiteextremefeeding
practices. In some parts of Canada, including Newfoundland, breast-feeding rates are very low (around
40% initiate breast-feeding) and there is a tradition of feeding babies evaporated or condensed cow’s
milk, that is passed on from mothers to daughters



and through social networks (Matthews _et al._, 1998).
Although this practice, based on saving money, has
been suggested to cause harm to infants due to the
high associated protein and solute loads, it remains
prevalent among aboriginal groups and low-income
families.

It has also been suggested that the media contributes to the negative stereotypes that women may
develop in relation to breast-feeding. Henderson and
colleagues (2000) extensively studied UK newspaper, television, and radio coverage of infant feeding
during the month of March, 1999. It was apparent from this study that not only was bottle-feeding
more commonly portrayed (82% of all references to
feeding), it was also presented as simpler and more
socially integrated. Breast-feeding tended to be presented as “problematic, funny, embarrassing, and activelyassociatedwithwomenwhoweremiddleclassor
celebrities”.

Successful breast-feeding requires a good technique
and problems with establishing this technique and in
overcoming the difficulties of the first few days of lactation account for the very high dropout in the first
weeks after birth. Latching the baby on to the nipple correctly is something that has to be learned by all
women. Incorrect latching-on such that the baby grips
solely the nipple, rather than taking the whole of the
areola into the mouth, will lead to soreness and in the
worstcasesblistering andbleeding of thenippletissue.
Even with correct technique and with experience of
previous breast-feeding, the early days of feeding are
likely to be uncomfortable and hence some women
will look for alternatives. Breast engorgement may
also lead women to give up breast-feeding. After 2–3
days beyond birth, the decline in production of the
sex steroids lifts the inhibitory effect upon prolactin
stimulus of milk synthesis. The breasts begin to produce mature milk in large quantities due to the high
level of stimulation from the baby over the preceding days. The breasts become large, hard, and painful,
and it can be difficult to continue feeding. As this engorgement generally coincides with an emotional low
that is also associated with falling progesterone and
estrogen concentrations, women are liable to give up
feeding at this point.
Breast engorgement and sore or bleeding nipples do
not preclude maintaining breast-feeding for women
who are prepared to work through the difficult early
days. With an engorged breast, the solution is to man


**Lactation and Infant Feeding** **115**


ually express milk to soften the breast tissue sufficiently for baby to be able to suckle and drain off the
engorgement, which will pass within a few days. Sore
nipples can be treated with ointments and by exposing
to the air between feeds to promote healing.
Other problems that can arise with breast-feeding,
at any time, can also be debilitating and discourage
further maintenance of feeding. These include infection of the nipple with _Candida albicans_ and mastitis.
The latter arises either through infection of damaged
nipples, or due to breast engorgement or blockage of
ducts.Mastitisduetoinfectioncanproducesevereflulike symptoms and requires treatment with a suitable
antibiotic to resolve it. Mastitis due to noninfective
causes is generally a consequence of the breast not being fully drained at each feed. This can promote localized infections and so the breast needs to be manually
drained through massage, and relief from symptoms
can be gained through cooling with wet towels, ice
packs, or even cabbage leaves.
While these physical problems account for much of
the early drop-off in breast-feeding rates, the decision
to stop feeding after the first few weeks is generally
because women perceive that they are producing insufficient milk (Colin and Scott, 2002). Due to lactation being a demand-led process, it is highly unlikely
that the capacity to produce milk will be genuinely
outstripped by infant requirements in the first 4–6
months of life. Agostoni _et al._ (1999) clearly showed
that in fact over the first 6 months of life, exclusively
breast-fed babies grew faster than formula-fed babies.
However, many women perceive unsettled behavior in
their children as a sign of hunger and may start to introduce solid foods, formula top-up feeds in addition
to breast-feeding or cease breast-feeding completely
in response. Stress related to feeding the infant, or
the inevitable fatigue associated with a 24-h demandfeeding schedule, can inhibit the letdown reflex and
hence interfere with successful lactation.


_**5.4.2 Promoting breast-feeding**_


Across Europe and North America, there is active support for the aims of the Innocenti Declaration and
there are a number of organizations and initiatives
that aim to promote breast-feeding and provide support for breast-feeding mothers. The most important
development on a global scale is the UNICEF Baby
Friendly Initiative (BFI). This worldwide program
of the WHO and UNICEF was launched in 1992 to



**116** **Nutrition: A Lifespan Approach**


**Table 5.4** Ten steps to successful breast-feeding


Facilities providing maternity services and care for newborn infants should:


1 have a written breast-feeding policy that is routinely communicated to all health care staff;
2 train all health care staff in skills necessary to implement this policy;
3 inform all pregnant women about the benefits and management of breast-feeding;
4 help mothers initiating breast-feeding within half an hour of birth;
5 show mothers how to breast-feed and how to maintain lactation if separated from their infants;
6 give newborn infants no food or drink other than breast milk, unless medically indicated;
7 practice rooming-in. Mothers and infants to remain together at all times;
8 encourage breast-feeding on demand;
9 give no artificial teats or pacifiers to breast-feeding infants;
10 foster the establishment of breast-feeding support groups and refer mothers to them on discharge from hospital.


Source: WHO/UNICEF (1989).



encourage maternity hospitals to implement the ten
steps to successful breast-feeding (Table 5.4) and to
practice in accordance with the International Code of
Marketing of Breastmilk Substitutes, which seeks to
limit the promotion of formula milks to mothers.
The BFI is coordinated in individual countries by
local organizations. Attainment of sufficiently high
standards to gain Baby Friendly status is variable
withincountriesandsoSweden,forexample,reported
57 out of 57 hospitals were designated Baby Friendly
in 1998, while for the UK, accreditation has been given
to a much lower number of maternity units and these
are spread unevenly around the country. For example,
in the northeast of England around 40% of babies are
born in Baby Friendly hospitals, while in other areas
in the southeast no hospitals have accredited status.
BFI standards provide a clear benefit in terms of
increasing uptake of advice to breast-feed. Broadfoot and colleagues (2005) considered the impact of
BFI in Scotland, where breast-feeding rates are below the UK average. Babies born in BFI-accredited
hospitals were 28% more likely to be still breastfed at 7 days of age than those born elsewhere, and
rates of breast-feeding initiation had increased more
rapidlyinBFI-accreditedhospitalsthaninnonaccredited hospitals. Scotland leads the way in the UK in
terms of gaining BFI accreditation for maternity units
(Figure 5.7). Similarly, studies from Switzerland
(Merten _et al._, 2005) have shown that babies born in
BabyFriendlyhospitalsaremorelikelytobebreast-fed
for longer duration.
BFI promotes and supports breast-feeding through
national health services and may therefore be effective only in the first few days of breast-feeding.
Other organizations exist to provide support and



encouragement outside the health care setting. The
La Leche League (international) and National Childbirth Trust (UK) are charitable organizations that can
be easily accessed by women requiring support. La
Leche League, in particular, are involved in training
of health professionals and providing peer counselors
who can give practical advice and moral support to
breast-feeding mothers in difficulty. Just as social networks can strongly influence the initial decision on
whether to breast-feed or bottle-feed, peer support
groups can be very important in helping women to
continue breast-feeding. Vari and colleagues (2000)
reported that women were more able to maintain exclusive breast-feeding for longer if they were
given professional advice about breast-feeding as a
groupduringpregnancy,withfollow-upsessionsfrom


**80**


**60**


**40**


**20**



**0**


**Figure 5.7** Regional variation in the success of the BFI in the UK.
The accreditation of hospitals with Baby Friendly status in the UK has
tended to prioritize areas of the country with lower rates of breastfeeding. ( _Source_ : Data from Baby Friendly Initiative report, spring
2007.)



women who were currently breast-feeding to demonstrate the technique and provide later breast-feeding
support.


**5.5 Situations in which breast-feeding**
**is not advised**


There may be circumstances in which breast-feeding
is not advised, as to do so would put the infant at
risk. This may occur due to maternal exposure to toxins that are excreted in the milk, for example, heavy
metals, or through maternal usage of prescription or
nonprescription drugs that might have a negative impactontheinfant.Drugsandotherexogenousorganic
chemicals, perhaps encountered in the workplace, undergo a two-phase metabolism in the liver. Phase I
metabolism comprises oxidation, reduction, or hydrolytic reactions catalyzed by the cytochrome P450s,
yielding stable products that are targets for phase II
metabolism. This consists of conjugation with either
glucuronide, sulfonate, or amino acids. The conjugated products are then excreted, and in lactating
women, excretion into breast milk is one route of disposal. The pharmacokinetics of all prescription drugs
are well characterized and women will be advised accordingly if it is necessary to administer a drug likely
to appear in the milk in this way.
There are also a number of inborn errors of

metabolism that may make breast-feeding inadvisable, or difficult to pursue. Galactosemia is an inherited disorder in which individuals lack the enzyme
galactose-1-phosphate uridyl transferease. This occurs in approximately 1 in 45 000 live births in the UK.
In the absence of this enzyme, galactose will accumulate and this leads to extensive damage in liver and
kidney. Individuals with galactosemia therefore have
to restrict galactose consumption throughout life, but
even with restrictive diets, there are many long-term
complications that cannot be avoided. Clearly, as
lactose is metabolized to glucose and galactose,
consumption of human or normal formula milk is
impossible and infants with galactosemia cannot be
breast-fed. There are a number of galactose-free formulas available for use in this situation.

Ithasbeenwidelysupposedthatmostinbornerrors
of metabolism may preclude breast-feeding, but this
need not be the case if mothers want to confer some of

the health benefits of human milk upon their children.



**Lactation and Infant Feeding** **117**


There are two approaches that can be taken to achieve
this. Firstly, expressed milk mixed with other required
ingredients can be fed via a bottle. Secondly, infants
canbebreast-fedondemand,butpre-fedwithspecializedformula.Phenylketonuria(PKU)providesagood
example of the possibilities of the latter approach.
Infants with PKU lack the enzyme phenylalanine
hydroxylase, and as a result have to restrict intake of
phenylalanine. Human milk has a relatively low content of phenylalanine. Some mothers feed their infants
weighed quantities of expressed milk in order to regulate phenylalanine intake. More commonly, women
will breast-feed but begin each feed by giving a measured amount of a phenylalanine formula, following
up with breast-feeding until the infant is satiated. Another possible approach is to adopt a mixed feeding
schedule in which infants are alternately breast-fed
and bottle-fed with low-phenylalanine formula.
There are situations where breast-feeding can increase the risk of transmission of disease from mother
to infant, either through direct passage of infective
organisms via the milk (e.g., HIV) or through the
close contact between baby and infected mother (e.g.,
tuberculosis). The ideal protocols for dealing with
these situations will depend upon other factors in the
maternal–infant environment, but could involve the
use of an alternative to breast-feeding.
There is a significant risk of direct transmission of
HIV from mother to infant during breast-feeding, and
indevelopedcountries,maternalHIVinfectionwould
normally be regarded as a contraindication for breastfeeding. However, in most developing countries, it is
generally neither safe nor feasible for HIV positive
women to find an alternative to breast-feeding. A lack
of resources to purchase milk powder and a lack of
clean water for making up milk formula largely removes the option to bottle-feed. As described above,
breast-feeding in such countries will significantly reduce risk of infant mortality due to other infections.
HIV infection of the infant during breast-feeding
is believed to occur due to movement of virus in ma
ternal milk into the infant circulation through uptake
at points in the mouth, throat, or intestine where
the integrity of the mucosal cells lining the digestive tract is compromised (e.g., due to ulcers or inflammation). The most likely cause of a breakdown
in the mucosal integrity is the introduction of solid
foods. Consequently, the WHO and United Nations
currently advise that HIV positive women breast-feed



**118** **Nutrition: A Lifespan Approach**


theirinfantsexclusivelyuntil6monthsofage,atwhich
pointbreast-feedingshouldceaseabruptlyratherthan
the normally gradual introduction of complementary
feeding. Keeping the transition from breast-feeding
only to a diet comprising solids and formula milk
as short as possible will minimize risk of mother–
child transmission of HIV. Taha _et al._ (2007) studied
Malawian mother–infant pairs in which the women
were HIV positive, but infants were uninfected at
6 weeks of age. Mother-to-child transmission of HIV
during infancy occurred in 9.7% of the mother–infant
pairsovertheensuing2years,withmostinfectionsoccurring after the critical 6-month point. Although this
supports the proposal for abrupt cessation of breastfeeding at 6 months, there is concern that this will
increase vulnerability to diarrheal infections.
Tuberculosis is becoming increasingly common on
a global scale, and in many areas occurs alongside
HIV infection. In the past, it was common practice to
separate women with tuberculosis from their infants
in order to prevent cross-infection, but in developing countries, this would tend to increase infant death
rates due to loss of the immunoprotective effects of
breast milk. It is now recognized that the best way to
prevent tuberculosis infection of infants is to immunize the infant, treat the disease in the mother, and to
maintain exclusive breast-feeding for 6 months, as for
HIV. In the absence of HIV, women with tuberculosis
should continue breast-feeding with complementary
foods for up to 2 years.


**5.6 Alternatives to breast-feeding**


The evidence that breast-feeding carries both shortand long-term health benefits for both mother and infant is overwhelming. However, for the vast majority
of infants born in westernized countries, feeding will
be largely based upon the use of artificial milk formulas, fed via a bottle. The main benefit of this approach
to feeding is that it reduces the dependency of the
infant upon the mother as the main carer and allows
closer bonding with other family members. Bottlefeeding is also clearly advantageous to women who
need to return to work early after the delivery of their
baby.
As described above, there are some hazards and
drawbacks associated with formula feeding that may
make it an inappropriate choice for families on low



incomes and for women in developing countries
where a clean water supply cannot be guaranteed.
It should also be appreciated that formula feeding
can increase the risk of allergic sensitization to cow’s
milk protein, and can be hazardous if feeds are not
prepared according to manufacturers instructions.
Under-concentratingmilkformula,thatis,addingless
milk powder per unit volume, is a strategy that may
be adopted by families on low incomes to make the
formula last longer, and can lead to infant malnutrition. Over-concentration of the formula, that is,
adding too much milk powder per unit volume, can
lead to dehydration of the infant, as more water will
have to be excreted to deal with the ingested protein
and electrolytes.
There is a huge array of different milk formulas
available to consumers. These vary little in their compositionastherearestrictregulationsthatlimitthecapacity of manufacturers to alter formula constituents.
As will be described below, however, there are formulas designed for specific situations, and formulas may
vary in composition in order to deliver an optimal
balance of nutrients according to the developmental
stage of the infant.


_**5.6.1 Cow’s milk formulas**_


Mostinfantformulasarebaseduponcow’smilk,modified to produce a composition that is more similar to
the average composition of human milk. Unmodified
cow’s milk should not be given to infants below the age
of 12 months, although it can be mixed with solids as
part of complementary feeding before this time. Unmodified cow’s milk would promote the development
of nutrient deficiencies in infants as it is low in vitamin C, vitamin E, essential fatty acids, and iron. Iron
deficiency would also be promoted as adverse reactions to components of cow’s milk would promote
blood loss in the digestive tract. Importantly, the high
nitrogen, calcium, phosphorus, sodium, potassium,
and chloride content of cow’s milk would promote
dehydration as water would be required to excrete the
excess solute load.
Figure 5.8 shows a comparison of the macronutrient and micronutrient composition of human, cow,
and a typical formula milk. Cow’s milk contains almostthreefoldmoreproteinthanhumanmilkandhas
a lower sugar content and so the main modifications
made during formula production include processing
to remove protein and the addition of lactose. Many



**Energy and macronutrients**


**8**
Human


Formula



**150**


**100**


**50**


**0**



**Lactation and Infant Feeding** **119**


**Selected micronutrients**


Human


Formula


Cow



**6**


**4**


**2**


**0**



Cow



**Figure 5.8** Comparison of the compositions of milks from humans and cows, alongside a typical infant formula. ( _Source_ : Data from Holland
_et al._ (1991).)



of the raw materials used in the production of infant
formulas are actually waste products from other areas
of the dairy industry, and generally the starting material for formula production is not whole, unmodified
milk. The processing to remove protein may involve a
variety of steps including evaporation, condensation,
and hydrolysis, and other components of the cow’s
milk will be lost along the way. Much of the whey protein that is included in formula milks is discarded during cheese manufacture and when added to formula
mixes will consist of demineralized, fat-free whey protein (Jost _et al._, 1999). All infant formulas will contain
vegetable oils added to attain the required total fat
content. Between 25% and 75% of fats in formulas
may be of vegetable origin and this will clearly impact upon the overall fatty acid composition of the
formula.

It is a relatively simple process for manufacturers
to add vitamins and minerals to achieve optimal concentrations and indeed this is necessary if processing
demineralizes the raw materials that comprise the basis of the formula. For many micronutrients, this additionwillneedtotakeintoaccountthebioavailability
of the nutrient from the formula milk matrix. This is

exemplifiedbyiron,whichinhumanmilkispresentin
the highly absorbed haem form, but in formula milk,
it is in the non-haem form. It is therefore necessary
to add iron to cow’s milk formula at a concentra


tion tenfold greater than seen in either human milk
or the cow’s milk from which the formula is derived
(Figure 5.8).


**5.6.1.1 Milk stages and follow-on milk**
In the processing of cow’s milk to produce formula, it
becomes possible to manipulate the casein:whey ratio
of the proteins in the milk. Unmodified cow’s milk
has a casein:whey ratio of 80:20, which is markedly
different to human milk where the ratio is 40:60. Some
manufacturers take advantage of the ability to alter
this ratio to market separate _first stage_ and _second stage_
milks. First stage milks are whey-rich products and
have a casein:whey ratio that mimics mature human
milk. Second stage milks provide the 80:20 ratio seen
in cow’s milk and are proposed to be more difficult
to digest within the infant gut, but to have a more
satiating effect on infant appetite.
Itissuggestedthatfeedingawhey-richformulamay
have a number of benefits for the infant. The predominant whey proteins in infant formulas derived from
cow’s milk are β-lactoglobulin and α-lactalbumin.
β-lactoglobulin is not found in human milk, but
α-lactalbumin is the dominant whey protein consumed by breast-fed infants. Some formulas are manufactured to contain a level of α-lactalbumin that
is similar to human milk. It is suggested that these
enriched formulas may aid the neurodevelopment



**120** **Nutrition: A Lifespan Approach**


of infants as they increase circulating concentrations
of tryptophan, an amino acid that plays an important role in brain development (Lien 2003). Other
whey proteins that are present in whey-rich formulas may provide some antimicrobial protection for
infants. Lactoferrin, for example, has been shown in
animal studies to have immune system priming actions, and may therefore help the maturation of the
cellular immunity of infants. The lactoferricin B fragment of bovine lactoferrin, which is generated during
digestion within the stomach (Kuwata _et al._, 1998),
has been shown to have the capacity to damage cell
membranes and inhibit growth of a number of foodborne pathogens, including _Salmonella_, _Listeria_, and
_Campylobacter_ species.
The progression from whey-rich to casein-rich formulas is not an absolute necessity. Feeding casein-rich
formula at an earlier age would do no harm and the
whey-rich formulation can sustain the nutritional requirements of an infant up to 6 months of age. At
6 months, however, it is advisable for parents to switch
formula and introduce a follow-on milk to their in
fant. Follow-on milks derived from cow’s milk are less
modified than the milks targeted at younger intervals and therefore contain more protein and minerals
to meet the increasing demands of the infant past
6 months. Follow-on milks are used as a mixer during
weaning,orasadrinkduringcomplementaryfeeding.


_**5.6.2 Preterm formulas**_


Approximately 6% of all infants born in the UK are
born prematurely (less than 38 weeks gestation). The
infants at greatest risk of significant morbidity are
those born before 32 weeks gestation, which make up
around one-third of all preterm deliveries. This latter
group of preterm infants pose a number of problems
from a nutritional point of view, as they have high
demands for nutrients and yet cannot be fed by conventional means.

As seen in earlier chapters of this book, organs
develop and mature at differing rates. Organs and
systems that mature relatively late in gestation are
those which will be least mature in a preterm infant.
Lung immaturity leads to life-threatening complications that significantly raise nutrient demands due
to the need for mechanical ventilation. Immaturity
of the digestive system poses considerable problems
in terms of feeding strategies. Before 32 weeks gestation, the infant lacks the rooting reflex and so is unable



to breast-feed. The digestive system is so underdeveloped that stomach capacity is only around 3 mL for
a 1.5 kg infant, and this clearly limits the quantity of
food that can be taken via the enteral route. The gut
is also functionally immature and lacks effective peristalsis and the key enzymes and other factors required
for digestion.
The last stages of gestation are normally a time
when the fetus acquires nutrients for storage, from
the mother. In terms of energy, for example, the fullterm 40-week-gestation infant has fat reserves of approximately 450 g (4530 kcal, 18.98 MJ), whereas
a 26-week-gestation infant has a meager 20 g fat
(320 kcal, 1.34 MJ). The nutritional status of preterm
infants is therefore often poor at earlier stages of their
clinical management, as they have low intakes of nutrients, low reserves, and high demands associated
with trauma and their high growth rate (human body
weight normally doubles between 28 and 40 weeks
gestation).
Strategies for feeding preterm infants will depend
upon their size and their gestational age. For infants born prior to 34 weeks, normal bottle-feeding
or breast-feeding is not possible and the infant will
need artificial feeding using a tube via the enteral
route (a nasogastric tube carries milk directly to the
stomach) or using a parenteral feeding (intravenous
feeding of nutrients in the simplest form, e.g., free
fatty acids, glucose, and amino acids) protocol. Human milk may be fed to older preterm babies via a
tube. Ideally, this is milk expressed by the babies own
mother, which will have a composition suited to the
stage of development. Mothers of preterm infants are
reported to produce a more energy-dense milk with a
greater protein, fat, and sodium content than mothers
of full-term infants. Feeding human milk conveys the
immunological benefits to the infant, but does carry
some risk. Osteopenia of prematurity is a condition of
bone in which bone mineralization is compromised.
This can arise due to the low calcium and phosphate
content of human milk. Thus, when human milk is
used as the basis of enteral feeding for premature babies, it is mixed with fortifiers to increase the vitamin
and mineral content (Schanler, 1995).
Where preterm infants are fed with formula milk,
it is inappropriate to use a normal full-term formula
as the nutrient density is insufficient to meet demands. Given the lower capacity of the premature
gut and raised nutrient demands, most constituents



**Table 5.5** Comparison of full-term and preterm infant formula
composition (selected nutrients)


Formula content/100 mL reconstituted milk


Nutrient Term formula Preterm formula


Energy (kcal) 70.0 70.0


Protein (g) 1.5 1.9


Calcium (mg) 48.0 120.0


Phosphate (mg) 35.0 59.0


Iron (mg) 1.2 1.2


Sodium (mg) 20.0 30.0


Vitamin A (µg 100.0 350.0
retinol equivalents)


Vitamin D (µg) 1.0 3.0


Vitamin C (mg) 5.8 24.0


are needed at greater concentrations than in term

                             formula. Preterm formulas are based upon β
lactoglobulin as the protein source and are hence
whey-rich. Due to the functional immaturity of the
gut, the fat and sugar components are delivered as
mixtures that are more easily digested and which do
not overwhelm the existing enzyme systems. Sugars are provided as a mixture of lactose and glucose polymers, while fats are provided as a mixture of long-chain and medium-chain triglycerides.
Table 5.5 shows a comparison of the nutrient composition of preterm and full-term formulas, highlighting
their differing nutrient density.


_**5.6.3 Soy formulas**_


Some infants are intolerant of cows-milk-derived formulas, which is usually because of lactose intolerance
and may therefore require a lactose-free alternative.
Soy formulas are produced from isolated soy protein
and provide sugar as glucose rather than lactose. Originally, soy-based formulas were developed for infants
with cow’s milk protein allergy, but as the proteins in
these formulas cross-react with cow’s milk protein to
a large extent, infants allergic to cow’s milk are highly
likely to respond to soy formulas in the same way.
Soy formulas should not be confused with standard
soy milk. They should only be used on medical advice
and there are some concerns that there are implications for the development of the reproductive tract
and fertility in male babies exposed to phytoestrogens
in soy formulas.



**Lactation and Infant Feeding** **121**


_**5.6.4 Hydrolyzed protein and**_
_**amino-acid-based formulas**_


Cow’s milk protein allergy is the most common food
allergy seen in children. The only effective treatment
is the exclusion of all dairy produce from the diet
and this means that for formula-fed infants specialized products have to be introduced. Soy formula is
generally inappropriate as described above, and approximately 50% of all children who are allergic to
cow’s milk will be allergic to soy formula. Osborn _et_
_al._ (2004) performed a systematic review of the literature and found that in children with a family history of
atopy, feeding a soy formula also increased risk of soy
protein allergy by twofold compared to feeding standard formula. This suggests that soy formulas would
not be the ideal choice of feed for infants at risk of
allergies.
The alternative is to feed infants with either hydrolyzed protein or amino-acid-based formulas. Hydrolyzed protein formulas are based upon the whey
fraction of cow’s milk, with the major proteins hydrolyzed to smaller peptides that are less allergenic
than the native proteins. Hydrolyzed protein formulas
do not prevent the development of allergies, but are an
effective treatment for managing children with established cow’s milk protein allergy. Amino-acid-based
formulas play the same role and are formulations that
are free of intact proteins and peptides, instead providing all nitrogen in the form of isolated amino acids.
Not all infants are able to tolerate hydrolyzed protein
formulas and the study of Niggemann _et al_ . (2001)
suggested that children with intolerance or allergy to
cow’s milk had better growth rates when fed aminoacid-based formula compared to hydrolyzed proteins.


_**5.6.5 Other formulas**_


Formula milks based upon sheep or goat’s milk may
be marketed as an alternative to cow’s milk formula,
the argument being that consumption of such milks
would reduce risk of allergy to cow’s milk protein. The
milk proteins of sheep and goats are very similar to
those of cows and so this argument is fatuous. Milk
from sheep or goats provides an inadequate supply
of folic acid, iron, and vitamins A, D, and C, and so
formulas from these sources should not be given to
infants.Infantformulasandfollow-onformulasbased
on sheep or goat milk have not been approved for use
inEurope,butfull-fatsheeporgoat’smilkscanbeused



**122** **Nutrition: A Lifespan Approach**


for preparing sauces that are used in complementary
feeds from 6 months of age.


~~**Summary Box 5**~~


Mammary alveoli are the sites of milk synthesis. This process involves de novo synthesis of lactose, fatty acids, and proteins.
Human milk production is under endocrine control through
actions of prolactin and oxytocin. Hypothalamic integration of the
secretion of these hormones ensures that milk supply meets infant
demand.
Lactation increases maternal demand for energy, protein, and
micronutrients.
Breast-feeding confers health benefits upon lactating women,
including a more rapid recovery from childbirth, suppression of
reproductive cycling, and protection against breast and ovarian

cancers.
Breast-feeding delivers immunoprotective factors to the infant,
in addition to nutrients in an optimal formulation. Immunoprotective cells and proteins reduce the risk of gastrointestinal and
respiratory tract infections.
Breast-feeding is associated with lower risk of SIDS, childhood
obesity, and allergies in susceptible infants. The delivery of DHA in
human milk is believed to enhance infant brain development.
Despite the advantages of breast-feeding for mothers and infants, the majority of infants in developed countries do not experience the recommended 6 months of exclusive breast-feeding. The
decision to use alternative feeding methods is largely shaped by
social and cultural factors.
Formulas designed for bottle-fed babies are generally manufactured using modified by-products of the dairy industry. Their
composition mimics average human milk and must comply with
strict legislation.
Specialized infant formulas are used for the feeding of preterm
infants and infants with confirmed allergies or intolerance to cow’s
milk.


**References**


Agostoni C, Grandi F, Gianni ML _et al_ . (1999) Growth patterns of
breast fed and formula fed infants in the first 12 months of life:
an Italian study. _Archives of Disease in Childhood_ **81**, 395–399.
Alm B, Wennergren G, Norvenius SG _et al_ . (2002) Breast feeding
and the sudden infant death syndrome in Scandinavia 1992–
1995. _Archives Disease in Childhood_ **86**, 400–402.
Arenz S, Ruckerl R, Koletzko B, and von Kries R (2004) Breastfeeding and childhood obesity – a systematic review. _Interna-_
_tional Journal of Obesity_ **28**, 1247–1256.
Arifeen S, Black RE, Antelman G, Baqui A, Caulfield L, and Becker
S (2001) Exclusive breastfeeding reduces acute respiratory infection and diarrhea deaths among infants in Dhaka slums. _Pedi-_
_atrics_ **108**, E67.
Broadfoot M, Britten J, Tappin D, and MacKenzie J (2005) The Baby
Friendly Hospital initiative and breastfeeding rates in Scotland.
_Archives of Disease in Childhood_ **90**, F114–F116.
Carlson SE, Werkman SH, Peeples JM, and Wilson WM (1994)
Long-chain fatty acids and early visual and cognitive develop


ment of preterm infants. _European Journal of Clinical Nutrition_
**48** (Suppl 2), S27–S30.
Colin WB and Scott JA (2002) Breastfeeding: reasons for starting,
reasons for stopping and problems along the way. _Breastfeeding_
_Reviews_ **10**, 13–19.
Collaborative Group on Hormonal Factors in Breast Cancer (2002)
Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries,
including 50 302 women with breast cancer and 96 973 women
without the disease. _Lancet_ **360**, 187–195.
Cunnane SC, Francescutti V, Brenna JT, and Crawford MA (2000)
Breast-fed infants achieve a higher rate of brain and whole body
docosahexaenoate accumulation than formula-fed infants not
consuming dietary docosahexaenoate. _Lipids_ **35**, 105–111.
Danforth KN, Tworoger SS, Hecht JL, Rosner BA, Colditz GA, and
Hankinson SE (2007) Breastfeeding and risk of ovarian cancer in
two prospective cohorts. _Cancer Causes and Control_ **18**, 517–523.
Department of Health (1991) _Dietary Reference Values for Food_
_Energy and Nutrients for the United Kingdom_ . The Stationery
Office, Norwich.
Dewey KG, Heinig MJ, and Nommsen LA (1993) Maternal weightloss patterns during prolonged lactation. _American Journal of_
_Clinical Nutrition_ **58**, 162–166.
Dijkhuizen MA, Wieringa FT, West CE, and Muherdiyaniningsih M
(2001) Concurrent micronutrient deficiencies in lactating mothers and their infants in Indonesia. _American Journal of Clinical_
_Nutrition_ **73**, 786–791.
Foster K (1997) _Infant Feeding 1995: A Survey of Infant Feeding_
_Practices in the United Kingdom_ . The Stationery Office, London.
Grantham-McGregor SM, Powell CA, Walker SP, and Himes JH
(1991) Nutritional supplementation, psychosocial stimulation,
andmentaldevelopmentofstuntedchildren:theJamaicanStudy.
_Lancet_ **338**, 1–5.
Hamlyn B, Brooker S, Oleinikova K, and Wands S (2002) _Infant_
_Feeding 2000_ . The Stationery Office, London.
Henderson L, Gregory J, and Swan G (2002) _National Diet and_
_Nutrition Survey: Adults Aged 19–64 Years_ . Office of National
Statistics, London.
Henderson L, Kitzinger J, and Green J (2000) Representing infant
feeding: content analysis of British media portrayals of bottle
feeding and breast feeding. _British Medical Journal_ **321**, 1196–
1198.
Holland B, Welch AA, Unwin ID, Buss DH, Paul AA, and Southgate
DAT (1991) _McCance and Widdowson’s The Composition of Foods_,
5th edn. Royal Society of Chemistry, Cambridge.
Jain A, Concato J, and Leventhal JM (2002) How good is the
evidence linking breastfeeding and intelligence. _Pediatrics_ **109**,
1044–1053.
Jost R, Maire J-C, Maynard F, and Secretin M-C (1999) Aspects of
whey protein usage in infant nutrition, a brief review. _Interna-_
_tional Journal of Food Science and Technology_ **34**, 533–542.
Julvez J, Ribas-Fito N, Forns M, Garcia-Esteban R, Torrent M, and
Sunyer J (2007) Attention behaviour and hyperactivity at age 4
and duration of breast-feeding. _Acta Paediatrica_ **96**, 842–847.
Karlsson MK, Ahlborg HG, and Karlsson C (2005) Maternity and
bone density. _Acta Orthopaedica_ **76**, 2–13.
Kerkhof M, Koopman LP, van Strien RT _et al_ . (2003) Risk factors
for atopic dermatitis in infants at high risk of allergy: the PIAMA
study. _Clinical and Experimental Allergy_ **33**, 1336–1341.
Kovacs A, Funke S, Marosvolgyi T, Burus I, and Decsi T (2005) Fatty
acids in early human milk after preterm and full-term delivery.
_Journal of Pediatric Gastroenterology and Nutrition_ **41**, 454–459.
Kramer MS, Chalmers B, Hodnett ED _et al_ .; PROBIT Study Group
(Promotion of Breastfeeding Intervention Trial) (2001) Promotion of breastfeeding intervention trial (PROBIT): a randomized



trial in the Republic of Belarus. _Journal of the American Medical_
_Association_ **285**, 413–420.
Kuwata H, Yip TT, Yamauchi K _et al_ . (1998) The survival of ingested
lactoferrin in the gastrointestinal tract of adult mice. _Biochemical_
_Journal_ **334**, 321–323.
Langley-Evans AJ and Langley-Evans SC (2003) Relationship between maternal nutrient intakes in early and late pregnancy and
infantsweightandproportionsatbirth:prospectivecohortstudy.
_Journal of the Royal Society for the Promotion of Health_ **123**, 210–
216.
Lien EL (2003) Infant formulas with increased concentrations of
α-lactalbumin. _American Journal of Clinical Nutrition_ **77** (Suppl),
1555S–1558S.
Lubetzky R, Littner Y, Mimouni FB, Dollberg S, and Mandel D
(2006) Circadian variations in fat content of expressed breast
milk from mothers of preterm infants. _Journal of the American_
_College of Nutrition_ **25**, 151–154.
Matthews K, Webber K, McKim E, Banoub-Baddour S, and Laryea
M (1998) Maternal infant-feeding decisions: reasons and influences. _Canadian Journal of Nursing Research_ **30**, 177–198.
Merten S, Dratva J, and Ackermann-Liebrich U (2005) Do babyfriendly hospitals influence breastfeeding duration on a national
level? _Pediatrics_ **116**, E702–E708.
Mitoulas LR, Gurrin LC, Doherty DA, Sherriff JL, and Hartmann
PE (2003) Infant intake of fatty acids from human milk over the
first year of lactation. _British Journal of Nutrition_ **90**, 979–986.
Morley R, Cole TJ, Powell R, and Lucas A (1988) Mothers choice
to provide breast milk and developmental outcome. _Archives of_
_Disease in Childhood_ **63**, 1382–1385.
Niggemann B, Binder C, Dupont C, Hadji S, Arvola T, and Isolauri
E (2001) Prospective, controlled, multi-center study on the effect of an amino-acid-based formula in infants with cow’s milk
allergy/intolerance and atopic dermatitis. _Pediatric Allergy and_
_Immunology_ **12**, 78–82.


**Self-Assessment Questions**


Assess your understanding of the concepts outlined in
this chapter using the following questions:


1 Describe the synthesis of human milk within the mammary gland.
2 Explain how lactation is a self-regulating process, detailing how the hypothalamus integrates maternal supply and infant demand.



**Lactation and Infant Feeding** **123**


Osborn DA and Sinn J (2004) Soy formula for prevention of allergy
and food intolerance in infants. _Cochrane Database of Systematic_
_Reviews_ CD003741.
Phadungath C (2005) Casein micelle structure: a concise review. _Songklanakarin Journal of Science and Technology_ **27**, 201–
212.
Prentice AM, Goldberg GR, and Prentice A (1994) Body mass index
andlactationperformance. _EuropeanJournalofClinicalNutrition_
**48** (Suppl 3), S78–S86.
Ritchie LD, Fung EB, Halloran BP _et al_ . (1998) A longitudinal study
of calcium homeostasis during human pregnancy and lactation
and after resumption of menses. _American Journal of Clinical_
_Nutrition_ **67**, 693–701.
Schanler RJ (1995) Suitability of human milk for the lowbirthweight infant. _Clinics in Perinatology_ **22**, 207–222.
Taha TE, Hoover DR, and Kumwenda NI (2007) Late postnatal
transmissionofHIV-1andassociatedfactors. _JournalofInfectious_
_Disease_ **196**, 10–14.
Vari PM, Camburn J, and Henly SJ (2000) Professionally mediated
peer support and early breastfeeding success. _Journal of Perinatal_
_Education_ **9**, 22–30.
von Kries R, Koletzko B, Sauerwald T _et al_ . (1999) Breast feeding
and obesity: cross sectional study. _British Medical Journal_ **319**,
147–150.
WHO/UNICEF (1989) _Protecting, Promoting and Supporting_
_Breastfeeding: The Special Role of Maternity Services_ . WHO,
Geneva, Switzerland.
Yngve A and Sj¨ostr¨om M (2001) Breastfeeding in countries of the
European Union and EFTA: current and proposed recommendations, rationale, prevalence, duration and trends. _Public Health_
_Nutrition_ **4**, 631–645.
Zhou SJ, Baghurst P, Gibson RA, and Makrides M (2007) Home
environment, not duration of breast-feeding predicts intelligence
quotient of children at four years. _Nutrition_ **23**, 236–241.


3 Discuss trends in breast-feeding behavior. What strategies could be employed to promote breast-feeding over
alternatives?
4 What advantages does breast-feeding confer upon
mother and baby?
5 Describe the various types of formula milk that may be
fed to infants under the age of 6 months. How does
the composition of formula compare to human milk?



# **6**

### **Nutrition and Childhood**

**Learning objectives**



By the end of this chapter the reader should be able to:


r Explain that growth is the most important physiological
process determining the nutrient and energy requirements of children.
r Show an appreciation of why the requirements of children must be delivered through a nutrient-dense dietary pattern.
r Describe how infectious disease and catch-up growth
can promote micronutrient deficiencies among children in developing countries.
r Discuss the importance of nutrition during infancy in
establishing lifelong food preferences and the opportunities for health promotion that arise during this life
stage.
r Demonstrate understanding of the key issues surrounding the weaning process, with particular emphasis
on the timing of the introduction of complementary
foods.


**6.1 Introduction**


The human is almost unique among mammalian
species in that there is an extended period of growth
and development between birth and adulthood. Even
among our closest relatives, the great apes, where lifespan is typically 30–50 years, full maturity is achieved
after just 7–13 years. Human childhood represents an
important physiological and psychosocial stage of the
lifespan. During this time the individual attains full
adult stature, full functional capacity of organs and
systems, achieves a mature view of the world, and
develops independence from parents. Childhood is
the phase of maximum growth, enlargement of the
skeleton, and remodeling of body composition. These
changes are driven by surges in, and maturation of,
the activities of key endocrine systems, including the
somatotropic, hypothalamic–pituitary–gonadal, and
hypothalamic–pituitary–adrenalaxes.Nutritionplays
a paramount role during this time as the provision of



r Discuss the contribution of child poverty to both malnutrition and occurrence of overweight in the population.
r Describe the susceptibility of children to advertising of
energy-dense, nutrient-poor foods and beverages, and
highlight the importance of regulation of such marketing to ongoing health promotion strategies.
r Show an awareness of how schools contribute to

health promotion among school-age children.
~~r~~ Describe global trends in childhood obesity prevalence.
r Discuss the significant contribution that genetic factors
make to early onset obesity.
r Demonstrate understanding of the contribution that
the modern environment makes to obesity and overweight among children.
r Critically evaluate the evidence that suggests that childhood obesity is predictive of obesity and related disorders in adult life.
r Describe optimal strategies for the prevention and
treatment of obesity in children.


an adequate and balanced supply of energy and nutrients is essential to maintain a normal developmental
profile, provide resistance against infectious disease,
and to ensure good health at later stages of life. Within
this book the childhood years have been divided into
three stages: infancy, childhood, and adolescence. The
latter will be discussed in the next chapter.


**6.2 Infancy (birth to five)**


_**6.2.1 The key developmental milestones**_


Nutritional demands over the first 5 years of life
are very much shaped by the physiological and developmental processes associated with this life stage.
Achieving the physical milestones sets a relatively high
demand for energy and nutrients, but the psychosocial and behavioral milestones should not be ignored,
as these impact upon how nutrient demands are



**Nutrition and Childhood** **125**



**8**


**6**


**4**


**2**


**0**



**30**


**20**


**10**


**0**



Weight gain


Height gain



**Age**


delivered and upon the development of attitudes and
behaviors that help to shape long-term health and
well-being. Alongside the development of the physicalsystemsofthebodyandtheabilitytocommunicate
and learn about the world around them, children at
this preschool stage are undergoing a radical reshaping of their dietary pattern. The infant must make
the transition from the milk-only diet of the first 4–
6 months of life to a diet that comprises solids, but
which remains energy dense, and then to a pattern of
food intake that more resembles that which they will
follow in their adult years.
Growthisthemostimportantphysiologicalprocess
for the preschool child and largely explains the high
nutrient requirements of infancy. The first year of life
has the most rapid growth rate of any life stage, and
during this period the infant will triple body weight
and increase height by approximately 75%. Growth
rates slow thereafter, but growth continues to be a
major demand process (Figure 6.1). Growth rates for
boys and girls are similar over the first 5 years.
In addition to growth, the body is undergoing a
series of changes in terms of composition and proportions, along with maturation of organ systems.
For example, the lungs continue to undergo the process of branching off new alveoli until the age of 7–8
years. At birth, the human head is disproportionately
large in relation to the trunk and the limbs are relatively short. Over the first 5 years truncal and limb
growth is prioritized. Between birth and 1 year of age
there is considerable deposition of fat reserves, taking the proportion of the body that is fat from 14%
to around 25%. Over years 1–4 the absolute fat mass
in the body stays relatively stable, but increasing lean



**Figure 6.1** Rates of growth in preschool children. Data
compiled from Freeman _et al_ . (1995).


body mass (increases from 14% of body mass at birth
to 20% by age 5 years) results in fat proportions declining to around 20%. Body water is repartitioned in
infancy. Initially, a greater proportion of water is held
in the extracellular compartment making the infant
more vulnerable to dehydration. Shifting of fluid to
the intracellular compartment reduces this risk in the
older child.
While growth of the trunk and limbs is greatest
during infancy, the brain still grows at a rapid rate
at this time. Brain size doubles over the first year of
life, which can be observed as an increase in head
circumference. Average head circumference at birth is
around 34 cm, and the first year sees an increase of 12
cm. Over the next year (1–2) this slows to a gain of
just 2 cm, but despite this the brain increases in size
by around 50% between the ages of 1 and 5 years and
by the end of this period is around 90% of adult size.
Changes in brain size are accompanied by profound
changes in the abilities of the child. At birth the infant
is relatively helpless, and while it has well-developed
sensory neurones, the motor neurones are extremely
immature. Over the early years, rapid development
is seen in terms of these motor systems and their integration with sensory inputs. As a result, the infant
years see the acquisition of key skills such as speech,
walking, and the ability to interact with family members and other children. Table 6.1 summarizes some
of the key developmental milestones achieved by infants. The acquisition of these new physical and social
skills impacts upon the nutrition of the child, who
is effectively developing a physical and psychosocial
independence from his/her mother. Considering the
supply and demand model outlined in Chapter 1, on



**126** **Nutrition: A Lifespan Approach**


**Table 6.1** Developmental milestones for infants


Age (years) Physical changes and abilities Psychosocial changes and food-related behavior


0–1 Rapid growth Dependent on parent
Hand-eye coordination Good appetite
Sitting Enjoys food
Crawling
Convey food to mouth
Eruption of teeth


1–2 Walking Good appetite
Chewing Enjoys food but less experimental
Use of baby cup Developing verbal communication skills
Manipulation of food items


2–3 Running and jumping Appetite slows
Fine motor skills Fluent speech
Use of cup Uses tantrums to influence the behavior of others
Use of cutlery


3–4 Hopping Picky/faddy eating
Balancing Develops independent food preferences
Self-feeding


4–5 Adult range of dexterity Receptive to attitudes of others
Develops a circle of peers



the demand side growth and maturation increase requirements for nutrients in relation to body size. On
the supply side, there are factors such as attaining the
ability to self-feed or snack, the development of preferences and attitudes about food, and the interaction
with adults and peers, which will all determine the
quality and possibly quantity of nutrient inputs.


_**6.2.2 Nutrient requirements**_


Over the first 5 years of life there is a need for a pattern
of dietary intake that is both energy- and nutrientdense in order to meet high metabolic demands. With
their short stature, preschool children are unable to
consume and process sufficient bulk of food to meet
their needs. While in absolute terms the nutrient requirements of young children are well below those of
older children and adults, on a per body weight basis
they can be many times higher than at the later life
stages. Table 6.2 shows how energy requirements are
threefold higher in infancy than in adulthood and requirements for many micronutrients are elevated to a
similar extent.

One of the major challenges for delivery of nutrient
requirements to this age group is to provide an appropriate balance of all nutrients, within the restrictions
placed by the fact that children often have a limited



range of preferred foods. Snacks are extremely important for the nutrition of younger children as they allow
the supply of nutrients to be maintained throughout
the day and compensate for the limited quantity of
food that can be consumed at mealtimes. Selection of
snacks needs to remain focused upon nutrient density.
During this period of life, children move through
the major transitions of weaning and from a childhood dietary pattern to an adult diet. This latter transition is substantial as the infant diet essentially delivers around 50% of energy as fat and 40% as simple
sugars, with very little dietary fiber. In contrast, the
adult diet should deliver no more than 35% of energy
of fat and is mostly based upon bulky complex carbohydrates. Throughout this period, children need to be
encouraged to experiment with a wide range of different foods, flavors, and textures in order to establish
healthy food preferences later in life.


**6.2.2.1 Macronutrients and energy**
As in adults, total energy expenditure (TEE) in childhood is defined in terms of the resting energy expenditure (REE) plus energy expended in diet-induced
thermogenesis and physical activity. For children,
however, overall energy requirement is not solely
defined by TEE, as there are also considerations in



**Nutrition and Childhood** **127**


**Table 6.2** A comparison of nutrient requirements _[a]_ between adults and children under the age of 5 years


Age


Nutrient 1–3 4–6 19–50 (male) 19–50 (female)


Energy (kcal/kg/d) 95.8 91.6 34.5 32.3
Protein (g/kg/d) 0.94 0.83 0.60 0.62
Folate (µg/kg/d) 4.0 4.21 2.02 2.50
Ascorbate (mg/kg/d) 1.6 1.12 0.29 0.36
Cobalamin (µg/kg/d) 0.032 0.039 0.017 0.021
Iron (mg/kg/d) 0.42 0.26 0.09 0.19
Zinc (mg/kg/d) 0.30 0.28 0.10 0.09
Calcium (mg/kg/d) 22.0 19.7 7.1 8.8


Source: Data derived from UK, Estimated Average Requirements (Department of Health, 1998) and assuming
body weights of 12.5 kg (1–3 years), 17.8 (4–6 years), 74 kg (adult male), and 60 kg (adult female).
Note: All figures are shown adjusted for body weight.
_a_ Selected nutrients.



relation to growth and losses through urine and feces.
The latter are minor components, but compared to
adults, in children constitute a significant element of
energy expenditure. Growth impacts upon energy requirementsasthefatandproteindepositedingrowing
tissuehasanenergyvalue,andbecauseenergymustbe
expended in order to carry out the synthetic processes
that yield new tissues (Torun, 2005).
Over the first year of life energy requirements are
exceptionally high and can be between 3 and 4 times
greater (on a per body weight basis) than in adulthood. This high demand is only partly explained by
the energy requirements of growth. Torun (2005) estimated the energy cost of growth for infants at around
4 kcal (17 kJ) per gram of weight gain. In a 2-yearold, this would equate to around 26.4 kcal (112.2
kJ) per day, which is clearly a very minor component (around 2%) of Estimated Average Requirement
(EAR). In the neonate the energy demand for growth
is much greater, but at most amounts to a third of
overall energy requirement. TEE in infants is in fact
mostly related to REE, which increases steadily over
the first 5 years in proportion to body weight. The
smaller bodies of children compared to adults have a
greater surface area to volume ratio, and as a result
more energy must be expended to maintain normal
body temperature.
Children in developing countries are subject to a
number of specific factors that may elevate their dietary energy requirements to a greater extent than
thoseseeninmoreaffluentsettings.Micronutrientdeficiencies are commonplace in developing countries,



particularly in rural populations. If any micronutrient is limiting within the diet, then this will impact
upon the efficiency of utilization of energy substrates
and hence the capacity to meet demands for energy
(Prentice and Paul, 2000). Moreover, infectious diseases are common in these communities and this promotes negative energy balance by increasing demand
and reducing intakes. Fever has an anorectic influence
and gastrointestinal infection, or the presence of gastrointestinal parasites, increases losses of energy and
nutrients.Periodsofacuteinfectionareoftenfollowed
bycatch-upgrowth,effectivelymaintainingenergyrequirements at a higher level over a longer period of
time (Prentice and Paul, 2000). Such requirements are
likely to outstrip the supply of energy from the diet
and as a result growth will falter. Children in this age
group are the most vulnerable to protein–energy malnutrition and associated morbidities, mortality, and
long-term deficits of stature, cognitive function, and
health.

The requirements of preschool children for protein
that are shown in Table 6.2 and considered in more

detail in the various dietary reference value systems
produced by the World Health Organization and nationalgovernments,areestimatesthatarecontestedby
some researchers in the field. Protein requirements for
children have been estimated using nitrogen balance
studies, usually performed on older individuals, integratedwithestimatesof thenitrogencontentof tissues
and rates of tissue accretion. It has been noted that the

actual protein intakes of breast-fed infants are below
these estimates and yet growth and development are



**128** **Nutrition: A Lifespan Approach**


maintained. It may therefore be inferred that the estimated requirements are in excess of true values. As
amino acids regulate growth and development, it is
possible that consumption in excess could have negative consequences. Garlick (2006) reported the findings of potassium balance studies in young children.
Potassium balance is closely correlated with nitrogen
balance, and using relevant regression models it was
suggested that the average protein requirement of a
6-month-old would be 1.12 g/kg body weight/day,
declining to 0.74 g/kg/day by 10 years.
Provision of fat is an important consideration in
the diets of preschool children as fat plays an important role in the provision of energy, maturation
of organ systems, and maintenance of immune function (Butte, 2005). There are no recommendations
regarding the fat intakes of children before the age
of 2, but it is estimated that, at this stage, fat should
be providing around 50% of total energy. It is suggested that between 2 and 5 years of age, fat should
provide a minimum of 15% of dietary energy, and
ideally between 30% and 40%. Including fat in the
diet is important as it is the most effective means of
delivering the required energy density of the infant
diet. There is good evidence that restricting fat intake can impact adversely upon rates of growth. Fat
may be of greater importance in some populations
than in others. Children in developing countries generally expend more energy through physical activity
and therefore become dependent on fat oxidation as
glycogen reserves are rapidly depleted (Prentice and
Paul, 2000). Immune cells preferentially use fat oxidation to provide energy for their function; so again,
children in developing countries may require more
lipid for this purpose, in the face of regular infection. Essential fatty acids give rise to inflammatory
mediators and therefore also make a contribution to
this role. Long-chain fatty acids such as arachidonic
acid and docosahexaenoic acid are required for the
growth and maturation of the brain and visual apparatus. Given the rapid growth of the infant brain over
the first 5 years, provision of sufficient essential fatty
acids of the n-3 and n-6 series is a critical element of
a healthy diet for infants.


**6.2.2.2 Micronutrients**

All of the vitamins and minerals are essential for the
growth and well-being of children at this age. Infants
are especially vulnerable to the development of de


ficiency diseases and subclinical deficiencies as they
have high nutrient demands and generally low stores
of micronutrients. Micronutrients can be limiting
factors in the diet, causing growth faltering. Classical studies of children being treated for malnutrition
in the Caribbean showed that growth of infants receiving supplemental protein and energy was heavily dependent upon adequate provision of zinc, for
example.
Given the high demand for all micronutrients, this
text will not focus upon specific requirements in any
detail and the reader is advised to consult relevant
texts listing dietary reference values for more detailed
information(e.g.,DepartmentofHealth,1998).However, some nutrients are noteworthy as there are either
special guidelines in place or major concerns about
the adequacy of their provision to infants. Calcium
and vitamin D, for example, are considered important at this time as early growth and mineralization of
the skeleton may boost the peak bone mass attained
in early adulthood and reduce risk of osteoporosis
in later life. Infants should therefore consume good
sources of calcium, such as milk, and fortified sources
of vitamin D.

Fluoride is important for the formation of the teeth
andasadefenseagainstdentalcaries.Cariesarecaused
by demineralization of apatite in tooth enamel, an effect of organic acid production by bacterial species
such as _Streptococcus mutans_ . Apatite can exist in a
variety of forms. Carbonated apatite is most soluble,
while fluoridated forms are less soluble and more resistant to acid demineralization. Intakes of fluoride
depend largely on whether the water supply is fluoridated. Where fluoride is present in the water below 0.7
ppm, then infants should receive supplements (0.25
mg/day for under 1-year-olds, 0.5 mg/day for older
infants). Most fluoride supplements are provided via
toothpastes. Fluoride is safe for infants but may cause
mottling of the teeth. This fluorosis may be seen in up
to half of children in areas with fluoridated water, but
this is rarely more than a mild cosmetic issue.
Salt should be restricted in the diet of infants and
young children need to be taught the importance of
selecting low-salt foods and not adding salt to meals,
either during cooking or at the table. The Scientific
Advisory Committee on Nutrition (SACN, 2003) in
the UK issued guidelines for salt intake in the underfives. Their recommendation was for children under
1 year to consume no more than 1 g salt (400 mg



sodium) per day, with this rising to 2 g salt (800 mg
sodium) between 2 and 6 years.


_**6.2.3 Nutrient intakes and infants**_


The diets of young children are often quite limited in
their range and can exclude foods that would actually
be ideal for the delivery of the required nutrient and
energy density. This limitation may be a product of
children’s responses to newly introduced foods, a lack
of parental knowledge, or the use of a limited variety
of food items during weaning. The National Diet and
Nutrition Surveys in the UK have included two large
studiesofthedietsofchildren.The1995surveyspecifically considered infants (18–54 months) and the 2002
survey looked at diets of 4–18-year-olds. In the survey
of infants (Gregory _et al._, 1995), the foods that were
consumed by most children ( _>_ 70%) at least once during the 4-day study were biscuits, white bread, soft
drinks, whole milk, crisps, cereals, potatoes (boiled,
mashed, or baked), chocolate, and chips. Infants had
low intakes of cheese and fish and the most commonly consumed vegetables were peas and carrots.
Analyses of responses from parents of 4–5-year-olds
in the later survey showed a similar pattern of food
intakes (Henderson _et al._, 2002) and highlighted low
intakes of green leafy vegetables, citrus fruits, eggs,
and raw tomatoes.
Studies of toddlers (0–2-year-olds) in the US have
also indicated a relatively narrow range of foods as
the main staples. Fox _et al_ . (2006) found that cereals
and milk were the major sources of micronutrients
in the diet and that for 1–2-year-olds milk, cheese,
bread, chicken and turkey, eggs, and fruit juices were
the major sources of energy and protein. In developing countries, the range of foods available to infants is
often considerably lower than noted for the developed
countries, particularly in impoverished communities
and rural areas. Even where choice is limited by overall availability, food-related behaviors of children may
limit their preferences even further. Lutter and Rivera
(2003) noted that among children who were undernourished and growth retarded, up to 25% of food
offered was not consumed. Often foods in these situations are low in fat and lack nutrient density. Fat
is important in stimulating the appetite by virtue of
its contribution to aroma, flavor, and texture of food.
Palatability is a particularly important determinant of
food intake and choice in children.



**Nutrition and Childhood** **129**


Observations that milk is a major nutrient source
of nutrients in these studies are encouraging. It is generally considered that milk should be a major staple in
the diets of infants by virtue of its capacity to deliver
a high proportion of required nutrients and energy,
either as a drink, as a component of sauces used in
cooking,oraddedtobreakfastcereals.Consuming440
mL/day of whole milk will deliver 25–32% of daily energy requirements for a 1–4-year-old, and up to 60%
of protein requirement and all of the requirements
for vitamin A, calcium, and several B vitamins (e.g.,
riboflavin). To maintain energy density and intakes
of fat-soluble vitamins it is suggested that under-fives
should consume whole milk, but that semi-skimmed
milk is acceptable for children over the age of 2 years.
Vitamin and mineral supplements are often provided to infants by their parents, and in the past have
been recommended for infants who were breast-fed.
In a study from the US, Briefel and colleagues (2006)
noted that 16% of children aged 4 months to 2 years
were given supplements, with a much greater proportion (31%) between the ages of 1 and 2. Leaf (2007)
highlights UK recommendations that younger children should be supplemented with vitamin D, unless
consumingfortifiedsources.TheHealthyStartService
operated in this country ensures that supplements are
freely available, along with milk, for infants from poor
families. There are some concerns that supplements
may be more likely to be provided by better educated
and more affluent parents to children who do not
really need them. Briefel _et al_ . (2006) found that nutrient intakes were not compromised in infants who
did not receive supplements and found excessive intakes of folate, zinc, and vitamin A in supplemented
children due to the additive effects of supplements on
top of fortified food sources.


_**6.2.4 Transition to an adult pattern of**_
_**food intake**_


The infant years are a time of major physical and
psychological development and represent an intense
period of change to the diet. There are two key changes
that occur between 6 months and the age of five. The
first is the process of weaning, which generally results
inthechildmovingfromacompletedependenceupon
milk for all nutrition to a diet that provides most
nutrients from nonmilk sources by the age of 1 year.
The second is a decrease in the energy and nutrient
density of the diet as the pattern of intake shifts to



**130** **Nutrition: A Lifespan Approach**


include foods that are lower in fat content and richer
in complex carbohydrates. Accomplishing the dietary
transitions of infancy should be done in such a way
that the child learns dietary behaviors that will reduce
risk of obesity and related disorders later in his/her
life.


**6.2.4.1 Weaning**
Weaning is the process through which the infant
makes the transition from a milk-only diet, whether
breast or formula-fed, to a diet that contains solid
foods and nonmilk drinks (complementary foods).
This is a key developmental milestone that exerts
powerful changes in terms of functional changes to
the gastrointestinal tract, the immune system, and
metabolic processes. From a nutritional perspective,
the diversification of the diet that accompanies the introduction of complementary foods has profound effects. The weaned infant becomes exposed to a greater
range of fatty acids and proteins and these, and associated micronutrients, must be absorbed from a more
varied food matrix. While in early infancy feeding
occurs throughout the day and night, with no mealbased pattern, with the introduction of complementaryfoodstheinfantmovestohaving2–3setmealsper
day, with snacks in-between and often ceases nightfeeding.Thischangesmetabolicparametersmarkedly,
producing bigger fluctuations in glucose and insulin
concentrations between the fasted and fed states.
Weaning is critical for a number of reasons. First
of all, it is essential to ensure that the requirements of
the infant for nutrients are met by the dietary supply.
Milk is a poor source of certain nutrients, particularly
iron, zinc, vitamin D, and vitamin A, all of which are
essential for the maintenance of normal growth and
function. Prior to weaning, the infant, particularly if
breast-fed,isreliantuponstoresofthesenutrientsthat
were accrued in the last trimester of pregnancy. These
stores are largely depleted by the age of 6 months. The
introduction of solid foods also serves to stimulate the

development of the reflexes that coordinate biting and
chewing with swallowing of food. Weaning is also the
transition to a dietary pattern that includes most of
the normal range of foods consumed by the mature
individual. This process provides a useful opportunity to promote development of food preferences and
feeding behaviors that will be associated with good
health later in life.



Weaning can be seen as a hazardous process. In developing countries, it greatly increases vulnerability of
infants to food- and water-borne infection. It can also

promote malnutrition, as children from poor communities may be weaned onto low-quality foods that
lack essential nutrients, or which cannot provide the
necessary energy and nutrient densities. It is this latter
point that has prompted the World Health Organization to issue advice relating to weaning, which should
ideally be adopted on a global scale. Essentially, parents are advised that all babies should be exclusively
breast-fed for the first 6 months of life, with no introduction of complementary foods prior to this time.
Thispolicyislikelytobehighlyeffectiveinruralpopulations in developing countries, where access to clean
water and uncontaminated foods is difficult. Later
weaning reduces the likelihood of diarrheal disease
and associated mortality and has been shown to have
no detriment in terms of the growth of children. In
developed countries, however, many have questioned
the appropriateness of this advice, which represents
a significant shift away from the long-held view that
weaning after 4 months, but no later than 6 months
should be normal practice. The current view is that
the timing of weaning should ideally correspond with
the World Health Organization advice, but that health
professionals should give flexible advice to parents, on
a case-by-case basis (Foote and Marriott, 2003). This
affirms the view of Lanigan _et al._ (2001) who suggested that delaying weaning until 6 months had no
clear detrimental effect on infant growth, but that
there were subgroups in the population that would
benefit from earlier introduction of complementary
foods. Essentially, larger, more rapidly growing babies
are likely to need weaning at an earlier stage than their
smaller counterparts.
In most developed countries, weaning earlier than
6 months of age is the norm. Certainly in the UK, it is
noted that almost all infants are weaned at 30 weeks,
with 65% weaned prior to 20 weeks. Between 10%
and 20% of infants are weaned as early as 10 weeks, a
practice most commonly seen in low-income families.
Early weaning is even noted in children where there
may have been more intense medical advice and care.
Norris and colleagues (2002) reported that although
the recommendation is that premature babies should
not be weaned until they achieve a weight of 5 kg, the
average age at weaning was 17 weeks, with 95% being
weaned before 4 months of age.



Weaning prior to 4 months of age is not advisable
and may be detrimental to the health of the child.
Prior to this age, most babies are unable to masticate and swallow solids safely and are therefore at risk
of choking. Moreover, the immaturity of the kidneys
andgastrointestinaltractpresentsasignificanthazard.
The introduction of solid foods increases the quantity
of nitrogen and solutes delivered to the body. This
can overwhelm the excretory capacity of the kidneys,
promoting dehydration. The immature gut does not
produce the full range of pancreatic and intestinal secretions, so solid food may remain undigested in the
gut for longer periods. This can promote gastroenteritis and damage to the lining of the tract. Moreover,
the immature gut is more permeable and will allow
larger proteins to cross into systemic circulation. This
can promote allergic sensitization.
Late weaning (i.e., beyond 6 months of age) may
also be a cause for concern. This is more likely to be
associated with certain ethnic subgroups in the population. In the UK Infant Feeding Survey, 2000 (Hamlyn _et al_ ., 2002) it was noted that mothers from Asian
backgrounds were most likely to delay weaning and in
some Muslim communities the first stage of weaning
involved a switch to whole cow’s milk, accompanied
by lengthy use of convenience weaning foods. In developing countries, later weaning reduces morbidity
and mortality among infants, but where infectious
disease is not a major issue, it is of greater concern
that late-weaned infants may become malnourished
due to depletion of nutrient stores.
The introduction of complementary foods should
be accomplished gradually and the full process of
weaning will typically take 6 months. Throughout
that time milk should remain a key part of the diet.
Feeds of breast milk or appropriate follow-on formula
should continue, with both later being used for drinks
and mixing with solid foods. Weaning foods must be
prepared to a consistency that is appropriate to the
neuromuscular development of the child. This means
that initially foods need to be pureed and should contain no lumps that may cause choking. Over time
this should give way to mashed and finely chopped
food and eventually to normal family foods. To help
children become familiar with biting and chewing
and the conveyance of food from hand to mouth,
it is suggested that children of around 6 months of
age should be given “finger foods,” which might be
pieces of bread, rusks, biscuits, fruit, or raw vegeta


**Nutrition and Childhood** **131**


bles. The first foods during weaning have more to do
with giving the baby the experience of food and portion sizes and meal frequency are not a consideration.
To aid acceptance of food and to avoid these early
experiences displacing nutrients from milk, solids
should be offered to the child immediately after a milk
feed.

The foods that should be used in weaning can generally be normal family foods that have been prepared
to suit the stage of the child, as described above. A
key part of the process is providing the child with a
varied range of flavors, textures, and aromas as this
should help with acceptance of a broad range of foods
later in life. Most parents introduce new foods one at
a time in order to check whether any might produce
an adverse reaction. The energy density of the food
needs to be high (more than 4.2 kJ/g food) and the
salt content should be low. If the diet does not include
meat, then an alternative source of iron (generally
fortified cereals) should be included. Infants require
a diet that is low in phytate to maximize the absorption of micronutrients. Foods that are at risk of being
infected with pathogens, for example unpasteurized
soft cheeses, raw or only lightly cooked eggs, pate,
should be avoided. Given the greater risk of allergic
sensitization at this time, it is also suggested that the
introduction of gluten-containing cereals, cow’s milk,
eggs, fish, soybeans, and nuts is delayed until late in
the first year (Foote and Marriott, 2003).
There is a vast range of commercially available
weaning foods. These certainly do not disadvantage infant growth and development and their major
downside is their expense. As these foods are formulated in a way that ensures they meet with regulations
on salt and provision of a balanced nutrient content,
they may to some extent be superior to homemade
foods used in early weaning. For example, many babies’ first experience of food may be pureed fruit.
This has inadequate energy and nutrient density and
a better choice would be a milk-based nonwheat porridge or baby cereal. In many developing countries,
the move of populations from rural to urban areas is
increasing the proportion of food that is purchased
rather than grown, particularly in Latin America and
the Caribbean. This provides an opportunity to address some of the problems of malnutrition that are
associated with weaning onto inadequate diets. Lutter and Dewey (2003) proposed the development of
a low-cost fortified processed complementary food



**132** **Nutrition: A Lifespan Approach**


OH OH





















OH


that could be introduced into such areas and ensure
an adequate energy and nutrient intake.


**6.2.4.2 Nutrition-related problems**
Infants are vulnerable to micronutrient deficiencies,
which are often not detected until at an advanced
stage. This vulnerability arises in part due to a lack of
extensive reserves of nutrients, but also due to factors
that impact upon nutrient intakes, nutrient losses,
and the bioavailability of nutrients. Nutrient intake
is most often compromised due to poverty, but may
also arise because children are provided with an insufficiently varied diet. For example, in many parts of
the world children will live on rice as a staple food,
which is often not adequately complemented by other
nutrient sources. Rice is a poor source of vitamin A,
and as a consequence vitamin A deficiency becomes
rife among children in these regions. Cooking methods or food processing that leaches nutrients from raw
food ingredients may also limit the nutrient supply to
children. Losses of nutrients via the kidneys or digestive tract may be a consequence of infectious disease.
Infection and chronic disease processes can lead to
malabsorption of micronutrients. For example, children with cystic fibrosis are vulnerable to deficiencies
of fat-soluble vitamins due to the accumulation of
mucous in the digestive tract. Foods that are rich in
phytates, as are commonly used in weaning in some
cultures, limit the bioavailability of micronutrients.



**Figure 6.2** The structure of phytic acid. Phytates are found
in many cereals and legumes, where they occur bound to
proteins and starches. The phosphate groups of phytic acid
are able to chelate cations and as a result phytate in the gut
will reduce bioavailability of minerals such as zinc, calcium,
and magnesium.


In addition, short-term periods of malnutrition, for
example following repeated episodes of infection, will
stimulate catch-up growth. This rapid growth may
increase demands for micronutrients beyond the capacity of the diet to supply them.


_Zinc deficiency_
Zinc deficiency is difficult to detect as it has few clinical signs and biochemical assessment of zinc status
is far from straightforward. It is estimated that zinc
deficiency may occur in one-third of the world population(ShamahandVillalpando,2006)andinchildren
it will impair growth, immune function, and brain development. Zinc deficiency is most commonly seen in
children who do not eat meat, either by virtue of culturalbackgroundorduetopoverty,andwherethediet
is rich in cereal fiber (containing phytic acid; Figure
6.2). Zinc deficiency can also arise as a consequence
of diarrheal disease, which increases losses. Zinc is a
major component of digestive enzymes secreted into
the small intestine. Reuptake of zinc is impaired by
gastrointestinal infection. Although clinically relevant
zinc deficiency is mostly seen in developing countries,
low intakes of zinc during childhood are also a cause
for concern in more affluent populations (Cowin and
Emmett, 2007).
Zinc is a prerequisite for growth as it is required for
the synthesis of DNA during cell replication. Growth
faltering is therefore the main clinical indicator of



deficiency. Zinc is also essential for brain development
during infancy, partly due to the need for cell division
during brain growth, but also because zinc is required
for neurotransmitter release. There are reports that
zinc deficiency may be associated with poor cognitive development, but the balance of evidence suggests
that it mostly limits the motor skills of infants. Supplementation of children with zinc deficiency increases
their activity and ability to explore the world, possibly
increasing their ability to exploit learning opportunities in their environment (Black, 2003). Animal studies indicate that zinc deficiency impairs development
of the frontal lobes of the brain and the cerebellum.

These are important areas in determining memory
(Georgieff, 2007).
The immune function of zinc-deficient children is
impaired, increasing their vulnerability to infectious
diseases. In some parts of the world, diarrheal infection is considered to be a symptom of deficiency
(Calder and Jackson, 2000). Osendarp _et al_ . (2002)
reported that supplementation of Bangladeshi infants
with 5 mg/day zinc between 4 and 24 weeks of age
produced better weight gains and reduced the risk of
respiratoryinfectionby70%.Thesebenefitswereconfined to the children who were zinc-deficient at baseline. Ten mg/day zinc supplements given to Indian
under-fives over a 4-month period were shown by
Bhandari and colleagues (2002) to reduce the occurrenceofdiarrhea,thedurationofepisodesofdiarrhea,
and recurrence of diarrhea. As diarrheal infection is a
major cause of infant death in such populations, this
has important public health implications.


_Vitamin D deficiency_
Vitamin D deficiency manifests as rickets in children
who are undergoing rapid growth. Rickets is characterized by soft, malleable bones that in weightbearing locations become deformed. This gives
deficient children a characteristic bow-leggedness.
Rickets also causes swelling of joints and of the skull.
Although easily avoided through supplementation, or
consumption of fortified sources, rickets continues to
occur in children in Northern latitudes with low lev
els of sunlight during the winter months. Gordon and
colleagues (2008) reported vitamin D deficiency in
12% of a population of American toddlers. In the UK
and northern Europe, deficiency is most common in
the Asian population (Shaw and Pal, 2002) where it is
a product of low synthesis within the skin due to dark
pigmentation, low skin exposure to sunlight due to



**Nutrition and Childhood** **133**


wearing of traditional clothing, and the consumption
of foods rich in phytate. This limits calcium absorption and hence the response to vitamin D. Infants
may also be prone to vitamin D due to limited transfer from their mothers. Poor vitamin D status is near

universal among Asian adults in northern countries
during the winter months, and for many women this
is not fully redressed in the summer. During pregnancy, competition for vitamin D between mother
and fetus may limit transfer to fetal tissues and this
may be exacerbated postnatally through low vitamin
D concentrations in breast milk.


_Iron deficiency_
Iron deficiency is the most common micronutrient
deficiency in children. It is rarely seen in infants under
the age of 4 months due to accrual of iron of maternal origin in the fetal period. Beyond 4 months, the
rapid growth of infants means that requirements for
iron can often outstrip supply from breast milk and
foods used in weaning. The introduction of unmodified cow’s milk to the diet between 6 and 12 months of
age increases the risk of iron deficiency in infants, and
this may stem from gastrointestinal blood losses triggered by the presence of cow’s milk proteins (Booth
and Aukett, 1997).
Iron deficiency anemia in young children has a
number of adverse consequences. It is more common
in children from poor families and in the developed
countries is most often seen in children from ethnic

minorities. In the UK, for example, Asian children
are most at risk as they are more likely to be weaned
onto vegetarian diets (providing iron in the less well
absorbed nonheme form), or to be breast-fed for an
extended period. Iron deficiency slows the growth of
children and increases their susceptibility to infectious disease. The mechanisms through which iron
deficiency suppresses immune function are unclear
and may involve effects on the metabolism of other
nutrientssuchasvitaminA(Mu˜noz _etal_ .,2000).Irondeficient children have impaired capacity to produce
T cells and their phagocytes are less active. Although
iron supplements can reverse these impairments of
immunity, care needs to be taken in any intervention
program to support populations where deficiency is
common. Iron is utilized by pathogens as well as host
tissues. Although some studies show that treating iron
deficiency can reduce infant morbidity and mortality,
othersshowincreasedinfectionfollowingsupplementation of children (Calder and Jackson, 2000). The



**134** **Nutrition: A Lifespan Approach**


parasite responsible for malaria, for example, depends
on erythrocytes to complete its lifecycle. In malarial
areas, iron deficiency anemia has a protective effect
and supplementation of children has to be targeted
outside the malarial season.
Iron deficiency anemia is associated with developmental delay in preschool children, as it interferes
withgrowthofthebrain.Incontrasttozincdeficiency,
which impacts mainly upon motor development, iron
deficiency has a detrimental effect upon the capacity
to learn (Booth and Aukett, 1997). Children with iron
deficiency have low developmental scores, poor ability to process information, are less happy, more wary,
and more dependent upon their mothers for social
support (Lozoff _et al_ ., 2006). While long-term iron
supplementation can overcome many of the developmental problems associated with deficiency, some
consequences may be longer lasting. Animal studies
suggest that during periods of brain development and
maturation, iron deficiency impacts upon expression
of tyrosine hydroxylase and tryptophan hydroxylase.
These are enzymes involved in the synthesis of the
neurotransmitters dopamine and serotonin respectively (Lozoff _et al_ ., 2006). Reduced expression during
critical developmental stages appears to change densities of dopaminergic and serotonergic neurones in
brain regions such as the substantia nigra. Changes
during development may not be corrected later in life
so any functional deficits may be irreversible. A range
ofstudiessuggestthatlowhemoglobinconcentrations
between 6 and 9 months of age may be predictive of
lower IQ at ages up to 9 years.


_Food additives and hyperactivity_
While micronutrient deficiencies present a significant
threat to the health and development of very young
children, there is also concern that the use of food colorings, preservatives, and flavorings may also impact
upon well-being. These agents are commonly used
in processed foods and especially those that are marketed at children, for example fizzy drinks, sweets, and
frozen ready meals. There has been concern since the
1970s that artificial colorings, in particular, may be
associated with hyperactive behavior (i.e., impulsiveness, overactivity, poor attention span).
There is now little doubt that in children who have

a confirmed diagnosis of Attention Deficit Hyperactivity Disorder (ADHD), restriction of the diet to exclude artificial colorings and other additives can im


prove behavior (Kemp, 2008). Whether the additives
have a causal role in the development of hyperactive
disorders in otherwise normally behaved children is
unclear. Meta-analyses show that almost all effects of
additives on behavior are restricted to children with
ADHD and there is little robust evidence to suggest
any impact upon the broader population (Schab and
Trinh, 2004). However, debate in this area was fuelled by the findings of a double-blind randomized
placebo trial in two groups of children aged 3 and 9
years (McCann _et al_ ., 2007). When 3-year-olds were
given either a placebo or one of two mixtures of additives, it was shown that children receiving a mixture
of sodium benzoate, sunset yellow, camoisine, tartrazine, and Ponceau 4R, exhibited more hyperactive
behaviors over the subsequent week.


**6.2.4.3 Barriers to healthy nutrition**
Asdescribedabove,infantsarevulnerabletoanumber
of nutrition-related problems. These often arise due
to a lack of parental knowledge and understanding
of what constitutes a balanced diet, or due to disease and other organic causes. While these nutritionrelated problems are relatively uncommon in developed countries, the majority of parents express the
concern that the diets their very young children consume are not healthy. This may be a misperception
arising because parents do not understand that the
diet that is optimal for an infant is very different to
that which would be recommended for an adult. The

snacks that infants depend upon are perceived as a
negative element of the diet and fussy eating behaviors, which are common in infants, also cause parents
a lot of concern. Although many parental worries are
unfounded, modern society does impose genuine barriers to developing healthy nutrition and food-related
behaviors in young children.


_Faddy eating_
In developed countries, most parents of children below the age of 5 will readily voice concerns about the
quality and quantity of nutrients in their children’s diets. These are often only perceived problems and are
generally not backed up by hard evidence of growth
faltering or other manifestations of undernutrition.
The negative perceptions of parents are explained by
two common food-related behaviors in young children: food neophobia and faddy (picky) eating.



Food neophobia is an inherent trait seen in most
childrenthatmaywellhaveevolvedinordertoprevent
poisoning.Essentially,itinvolvestherejectionoffoods
that have not been previously encountered (Dovey
_et al_ ., 2008). Neophobic behavior is at a low level
around the time of weaning, when children are very
opentoexperimentationwithflavorsandtextures,but
steadily increases thereafter, reaching a peak between
the ages of 2 and 6 years. It has been suggested that
neophobia occurs, as children are especially averse to
bitter tastes. Most of the foods rejected by neophobic
children are fruits and vegetables, and these often contain chemicals that have a bitter tang that is no longer
perceived by the more mature adult palate. However,
much of the food neophobia response appears to be
based in the visual domain. In other words, children
appear to reject foods that do not look right and cannot be persuaded to taste the items and confirm their
negative assessment. It may well be that this rejection
is based upon previous taste experience. For example,
a green food (e.g., Brussels sprouts) might be tasted
in early infancy and found unpleasant, and thereafter
all green foods are rejected on the basis that they will
be similarly unpalatable.
Most food neophobia disappears by the time the
child reaches early adolescence and repeated exposures to food items will generally result in their acceptance. Social influences are important. Acceptance of
novel food items is more likely to occur if the child is
in the company of a group of other people who are
also consuming that foodstuff (Dovey _et al_ ., 2008). At
this age this is most likely to be other family members,
but as the circle of friends of the same age begins to
grow, “peer-pressure” may help to bring an end to
neophobic behaviors.
Food neophobia, when combined with the growing
independence of the preschool child, can be a trigger
for faddy eating behaviors and make mealtimes an
area of tension within families. Faddy or picky eating
is best defined as a behavior pattern in which a child
either refuses to eat or will only eat a limited range of
foods. It is perhaps best regarded as a flexing of muscle
and a testing of developing powers of communication
and control of the behavior of other family members.
Young children crave attention of any sort from their
parents and other caregivers and mealtimes provide
anidealopportunitytogainthatattention.Byrefusing
to eat, children can gain a response from an adult and
become the center of attention.



**Nutrition and Childhood** **135**


Faddy eating behaviors are highly unpredictable
and variable. Some children demonstrate a good appetite but only for a limited range of foods, while
others may consume a broad range of foods, but only
intermittently. A food that appears to be the favorite
of a child on one day may be rejected out of hand
the next. Even within a mealtime, a display of temper
and refusal to eat may give way to normal eating of a
full portion if the child is somehow distracted. Wright
and colleagues (2007) found that 8% of parents of
30-month-old children reported faddy eating behaviors. The responses of the parents were often to try
and mollify children by providing rewards for eating
their meals, offering alternatives to the rejected food
items, or distract the children by providing television
during mealtimes. These are generally considered inappropriate responses to faddy eating, as in effect they
reward and reinforce the behavior. An angry response
accompanied by punishment is also inappropriate.
The best response to faddy eating is to ignore the
behavior and to try and encourage eating by making mealtimes into pleasant, social occasions in which
normal eating is praised.
It has generally been assumed that faddy eating,
except in extreme forms, has little impact upon the
nutritional status of infants. Children will often put
on a “performance” to gain attention at one meal per
day and then compensate for any lost intake through
other meals and snacks throughout the rest of the
day. Indeed, there is little evidence that faddy eaters
are more prone to growth faltering despite their apparently limited range of preferred foods (Wright
_et al_ ., 2007). Recently, however, Galloway and colleagues (2003) reported that the altered patterns of
food intake that are associated with faddy eating can
impact upon nutrient intakes. Girls who were faddy
eaters tended to consume less fruits and vegetables
and hence have lower intakes of fiber, folate, ascorbate, and vitamin E and compensated for lower food
intakes by consuming more fat.
The role of parents in managing both food neophobia and faddy eating is critical and, as in many
aspects of promoting healthy eating to children, the
simplest approach is to lead through positive examples. The study of Galloway _et al_ . (2003) noted that
girls were more likely to consume fruits and vegetables if they observed their mothers doing so. This
agrees with the findings of Cooke _et al_ . (2004) who reported that among nursery school children, parental



**136** **Nutrition: A Lifespan Approach**


**25**


**20**


**15**


**10**


**5**


**0**


**Figure 6.3** Social deprivation in children. Within developed countries,
poverty is defined as a family income below 50% of the population
median wage. Levels of poverty experienced by children are variable
throughout the developed countries, generally being highest in Eastern
and Southern Europe. Data shown represents figures for the period
2002–2007.


consumption of fruits and vegetables was the major
predictor of fruit and vegetable intakes.


_Poverty_
Child poverty is the major cause of malnutrition and
associated disease and death among the under-fives.
It is rife on a global scale and at least half a billion
children live in conditions that are unacceptable, with
poor housing, limited sanitation, and chronic food
insecurity. The alleviation of child poverty is one of
the key Millennium Development Goals set out by
the United Nations in 2005. Poverty is not limited to
the developing countries of the world. High rates are
noted in developed regions and in some of the most
affluent countries of the world (Figure 6.3) and this
poverty has a significant impact upon the nutrition of
infants and older children.
Poverty is defined using a variety of different measures. The UN Millennium project uses an income of
less than $ 1 per day to define unacceptable poverty.
Even on this basis, there are estimated to be 50 million
European children living in poverty, mostly centered
in Russia, the former republics of the Soviet Union,
and in the Balkan states (Bulgaria, Romania). This
definition is clearly unrealistic as a tool for measuring poverty in richer countries, and instead poverty
tends to be defined as living on an income that is
less than half of the median income for the national
population. As can be seen in Figure 6.3, using this



definition poverty rates among families are very high
and more than one in ten children are likely to be
affected in the developed nations. There are major
variations in poverty levels depending on ethnicity
and regions within countries. In the US, for example, the highest rates of child poverty are seen in rural counties of the southern states (28% of children,
compared to 17% in urban areas), with some communities in South Dakota and Mississippi having child
poverty rates between 60% and 70%. US children are
more likely to live in poverty if they are Black Americans or American Indians. Similarly, poverty rates are
highest in immigrant populations and among indigenous peoples of Canada. In the UK, it is estimated
that 1.4 million children are raised in poverty, with
highest rates seen in London, Wales, and Northern
Ireland. Again, ethnic minorities, particularly Asians,
are most affected (Save the Children, 2007). For many
oftheseaffectedfamilies,povertymaybeborderlineor
short term, but significant numbers of children live in
households where substantial meals may not be provided on at least one day each fortnight, and where
meat or suitable vegetarian alternatives are available
only on every other day (EU-SILC, 2007).
The impact of poverty on the nutrition and health
and young children is well documented. Nelson
(2000) reported important differences in the pattern
of diet consumed by 1–5-year-olds from socially deprived families compared to other children. The children from poor backgrounds consumed more white
bread and sugar-coated cereals, more fatty food (pies,
pastries, fried food, chips) and less fruit, vegetables,
meat, and poultry. Their diets contained more salt,
more fat and less iron, calcium, iodine, β-carotene,
and vitamin C. Sausenthaler _et al_ . (2007) reported
similar trends in 2-year-olds, with children whose
parents were on low incomes and who had lower educational achievement, consuming more hydrogenated
vegetable fats and less milk, less fresh fruit, and cooked
vegetables. Children from poor backgrounds suffer
fromagreaternumberofdentalcariesandhaveslower
rates of recovery from infection (Nelson, 2000). They
are more likely to be obese (Freedman _et al_ ., 2007)
and to suffer from specific nutrient deficiencies, such
as iron deficiency anemia (Booth and Aukett, 1997).
Attempts to combat child poverty on a global scale
have had limited success. The Millennium Development Goal to halve world hunger by 2015 is unlikely to succeed. Although child hunger has been



reduced in China and other countries of East Asia,
it has at best leveled off in Africa and in some areas

has increased (UN, 2007). Achieving improvements
in developing countries depends upon cooperation
between national governments, nongovernmental organizations, and aid agencies. In the developed countries, tackling child poverty and the impact this has
on nutrition in the short and long term is a matter for
national governments. A number of strategies can be
considered (Nelson, 2000). One approach would be
to provide more food directly to children. While this
is feasible with school-age children (e.g., by providing
free school milk and meals), it is more problematic for
the preschool infant. Establishing breakfast clubs and
the provision of milk and healthy snacks in nurseries
and playgroups are approaches that can provide poor
children with at least one nutritious meal per day.
Alternatively, governments can increase the money
available to poor families by increasing benefits and
reducing taxation. Kukrety (2007) advocates direct
transfers of cash from governments to families as a
means of helping households cope with either shortterm financial crises or chronic poverty. This is an
approach often used in humanitarian aid, and experience in Asia and Africa shows that families spend a
highproportionofsuchmoneyonfood.Insomestates
this approach is done in a way that ensures money can
only be spent on food, for example by issuing food
vouchers (Nelson, 2000). Implicit in this is a lack of
trust in families and the view that they will waste the
money on nonessential items. All the evidence suggests that making provision of money conditional is
unnecessary and that most poor families are very efficient in budgeting and targeting funds at essential
items such as food (Kukrety, 2007).


_The impact of advertising_
The advertisement of unhealthy foods and beverages
to children is a significant negative influence that
works against the efforts of parents, health professionals, and educators to promote the establishment
of healthy eating and behaviors in children. Preschool
children are avid watchers of television and are in
creasingly exposed to movies in cinemas and unregulated media such as the Internet. For children under
theageoffive,thereislittleperceptionofthedifference
between advertisements and the actual program content they are watching. This makes them an ideal and
particularly receptive audience for the advertising of



**Nutrition and Childhood** **137**


a range of items, including food and drink. Although
these infants are not in direct control of food purchasing in a household, they can very effectively influence
parental choices through demanding behavior.
The budgets available to spend on advertising of
food and drink are staggering and make the sums allocated for health education and health promotion pale
into insignificance. In the US alone, food and drink
companies spend $ 10 billion per year on advertising
of products aimed specifically at children (Robinson
_et al_ ., 2007). In contrast, the annual budget of the
World Health Organization for all of its varied activities is $ 4.5 billion. Neville and colleagues (2005)
monitored Australian television networks and found

that there were 8.2 advertisements for food and drink
per hour of broadcasting, of which 55% were for foods
that were high in fat and sugar. Half of these advertisements were placed during programming aimed at
children. In contrast, only 0.1% of food advertising
was for fruit and vegetables. Food and beverage advertising is also appearing on the Internet and sites that
allow children access to free games and cartoons generally advertise confectionary and fast-food restaurants such as McDonalds (Alvy and Calvert, 2008).
Much of the literature that evaluates the impact this
has on children’s food choices and health is focused
upon older children and generally shows a detrimental influence. Dixon _et al_ . (2007) found that among
children aged between 10 and 12, television advertising produced more positive attitudes toward junk
foods and was associated with greater consumption
of such items. Kopelman _et al_ . (2007) noted very high
recognition of brands in 9–11-year-olds.
It is becoming clear that the preschool child is also
susceptible to advertising messages and this may be
more insidious due to the critical impact that this
stage of life has upon future health behaviors. Advertisers use branding of products to increase recognition. Associating positive messages with a brand is
designed to gain lifelong customers (Connor, 2006).
By the age of two, children are already able to recognize well-advertised food brands and have certain value-beliefs attached to those brands (Robinson
_et al_ ., 2007). Two- to –six-year-olds are aware of brand
names and have strong recognition of logos and packaging. Advertisement of brands and logos is a widely
used tactic in the battle to gain very young children as
customers. Connor (2006) found that on commercial
children’s channels in the US, 96 half-hour blocks of



**138** **Nutrition: A Lifespan Approach**


programming contained 130 advertisements for food
and drink, of which half were for fast-food outlets and
sugar-coated cereals and aimed directly at the children. Advertisers frequently associate cartoon characters,sportspersonalities,andsuperheroeswithbrands
and children in this age group are adept at linking the
characters to the brands. In an experiment with children aged between 2 and 6 years, Borzekowski and
Robinson (2001) showed that when exposed to just
30 s of brand advertising within a 30 min session of
watching cartoons, children were up to 3 times more
likely to choose a branded item when it was offered
alongside an identical product presented in similar,
but unbranded packaging. Similarly, when 3–5-yearolds were offered a choice of identical foods but with
one item packaged plainly and the other in McDonalds branded materials, they were up to 6 times more
likely to choose the branded item (Robinson _et al_ .,
2007).
Finding solutions to this problem will not be easy,
particularly with the growth of the Internet, which
crosses national borders and therefore largely escapes robust legislation. Given the ready acceptance of
branding and logos by very young children, it may be
opportune to use this in a positive manner, for example branding fruit and vegetables or healthier cereals.
There are some examples of this, but generally food
producers and supermarkets are reluctant to interfere
with their very successful marketing of less healthy
foods. In the UK, legislation introduced in 2007 effectively banned the advertising of foods high in sugar
and fat during television programs aimed at the under 9s. This policy was extended to include programs
for under 15s and programs for adults, which may
also attract large numbers of children. This policy has
been heavily criticized by some as draconian and an
infringement of consumers’ rights. Some researchers
believe it will be ineffective as food advertising does
not markedly influence the actual eating behaviors
of older children (Kopelman _et al_ ., 2007). In contrast,
others feel the ban does not go far enough and that access to and display of sweets and similar items should
be restricted in the same way as seen with cigarettes.


_Restrictive dietary practices_
Some infants may be fed diets that restrict specific
foods or food groups. This is often due to religious,
ethical,orhealth-relatedbeliefsheldbyparents,which
are imposed upon the children. In most cases these



practices do not have any detrimental impact upon
nutritional status or health, but careful management
may be necessary to avoid problems. Hindu and Buddhist families, for example, may follow vegetarian diets and although there are reports that infants weaned
onto such diets suffer a greater incidence of iron deficiency anemia, growth is generally maintained at a
rate equivalent to omnivores. Children following vegetarian diets have been shown to maintain normal
prepubertal growth patterns, but only if the diet is
managed to include an appropriate diversity of nutrient sources (Hackett _et al_ ., 1998). Vegan diets provide
a greater challenge as they are of low energy density. To maintain growth, careful planning of diets for
vegan children to include varied sources of protein
(tofu, beans, and meat analogs), and more energydense items such as avocados and vegetable oils is essential (Mangels and Messina 2001). There are many
reports of vitamin B12 deficiency in vegan children,
so supplements should be provided to such infants.
Thereareothercircumstancesinwhichparentsmay
restrict the foods that are provided for young children,
withnegativeoutcomesforgrowth.Therearereported
cases of failure to thrive in children whose parents
have, in good faith, introduced a low-fat, high-fiber
diet that accords with guidelines for healthy eating in
adults. This is inappropriate for young children as the
bulk of food required to deliver nutrient requirements
is not feasible. The introduction of adult healthy eating recommendations should be delayed until the end
of the infant stage, but applied flexibly. While, on average, the age of 5 years would be appropriate to adopt a
high-fiber, low-fat diet, for slow-growing children this
may be too soon and for children on a more rapid trajectory it should come earlier, but certainly not before
the age of 2 years.
Fear of food allergies and intolerances may also
prompt restrictions in children’s diets. The true prevalence of adverse reactions to food is estimated at be
tween 4% and 8% of the childhood populations. Parents often mistakenly believe that their child has an
allergy to food, and the parental report of adverse
reactions is at a level 3–4 times above the true prevalence (Noimark and Cox, 2008). Where adverse reactions are suspected, parents may act unilaterally to
remove the suspect food from the diet and in so doing
exclude important sources of nutrients. Even where
expert advice is given and allergy confirmed, parents
may be overzealous in the interpretation of that advice



**Nutrition and Childhood** **139**


**Table 6.3** Energy requirements of children


UK estimated average requirement (kcal/day) Energy requirement (kcal/kg body weight/day)


Age (years) Boys Girls Boys Girls


3 1490 1370 97 92

5 1720 1550 88 82

7 1890 1680 78 71

9 2040 1790 69 61


Source: Data from Department of Health (1998).



and take actions to restrict the diet without providing
suitable alternative sources of nutrients and energy.
This can contribute to growth faltering.


**6.3 Childhood (five to thirteen)**


_**6.3.1 Nutrient requirements of the**_
_**older child**_


In contrast to the earlier stages of childhood, the
period between the age of five and puberty is characterized by a relative absence of nutritional problems and rapidly declining nutrient demands. Growth
continues to keep nutrient requirements above those
of adults, but it is striking that despite demands of
growth and their larger body size, children of this
age have requirements for energy and nutrients that
are not grossly dissimilar to those of under-fives. As
shown in Table 6.3, energy requirements on a per kg
body weight basis fall sharply throughout this period.
While still a problem in many regions, the impact of
micronutrient deficiencies upon older children is less
severe. Although stunting of growth remains a significant issue, the high rates of morbidity and mortality
associated with undernutrition in younger children
are not seen in the older age groups. This stems from
more robust immune function, less vulnerability to
dehydration associated with diarrheal disease, and a
longer period of time in which to accrue viable nutrient reserves. In the developed countries the major
nutritional concerns at this stage of life are overweight
and obesity, which will be discussed in greater detail
later in this chapter.
Children at this stage are increasing their independence from their parents and begin to hold their own
strong views about food, physical activity, and health.
They take a greater role in the acquisition of the food



thattheywillconsume,andastheybegintoexperience
more life outside the home through going to school,
become more likely to purchase meals and snacks for
their own consumption. Education about food, nutrition, and health, therefore, becomes an important
priority in the development of these children. By this
stage of life, it is important for them to begin to follow
a model along the lines of the Balance of Good Health
(Eatwell) plate or similar schemes such as the US Food
Pyramid in order to develop eating habits that lower
fat intake and promote consumption of starchy foods
and fruits and vegetables.


_**6.3.2 School meals and the promotion of**_
_**healthy eating**_


All over the world, schools provide meals for children.
These are generally optional, giving children the opportunity to either bring in their own lunches from
home or to purchase a cooked meal in school. While
lunches brought in from home are the responsibility
of parents, it is now common for schools and government agencies to provide information and advice to
ensure that these meals are based upon basic principles of healthy eating.
The meals that are provided within schools are increasingly subject to formal regulation to ensure their
quality, particularly in the light of concern about rising levels of childhood obesity. These meals may be
provided free of charge to children from poor backgrounds as a means of combating undernutrition.
The UK provides a useful example of how legislation
can be introduced to ensure that school meals fulfill
nutritional standards. In 2006, in response to public
concerns at the levels of fat in school meals and the

widespread use of low grade, mechanically reclaimed
meat and fish, new regulations were introduced to
ensure that caterers were properly trained and used



**140** **Nutrition: A Lifespan Approach**


higher quality ingredients, included at least two portions of fruit or vegetables and provided sources of
complex carbohydrate (bread, cereals, or potatoes)
in every meal. The provision of fried foods was limited to no more than once per week and fizzy drinks,
crisps, and confectionary were banned from school
vending machines and meal provision. Under these
guidelines, school lunches must provide 30% of the
EAR for energy, at least 30% of the RNI for protein,
and at least 40% of the RNI for iron, zinc, calcium, vitamin A, vitamin C, and folate. Meals should contain
no more than 30% of the SACN guidelines for salt
(no more than 1.8 g salt for this age group). School
meal provision is now an element of the inspection
program that ensures overall quality standards of UK
education. This emphasizes the growing importance
of food, nutrition, and health in the overall curriculum, which encourages children to engage more with
food production and increase their knowledge of how
diet impacts upon health and well-being.
School meals are often just one element of a wider
range of health interventions in schools, which also
target physical activity and health education. Again
in the UK, the government introduced the National
SchoolFruitSchemein2004withtheaimofproviding
one portion of fruit per day to school children aged
between 4 and 6 years. The aim was to improve nutrient intakes and promote the five-a-day message to
children. Evaluations of this program have shown that
while the scheme improved intakes of fruit while children were in the age group covered by the scheme,
once they moved out of the targeted provision,
their intakes declined to where they were at baseline
(Fogarty _et al_ ., 2007; Ransley _et al_ ., 2007). This is unsurprising as the scheme merely adds to what children
may consume at home and does not change family
behaviors outside school. Longer and more sustained
interventions would be required to obtain any lasting
benefits.


_**6.3.3 The importance of breakfast**_

Breakfast is an important contributor to the overall
dietary quality of children. It has been estimated that
it provides between 275 and 670 kcal energy, which is
delivered mostly from carbohydrate (50–72% of energy) and fat (14–40% of energy). The major breakfast foods consumed by children in developed countries are milk, fruit juices, breads, and fortified cereals
(Rampersaud _et al_ ., 2005). Generally, breakfast will be



delivering approximately 20% of daily energy intake
and a greater proportion of micronutrients if based
upon fortified cereals. It has an important metabolic
role in that it ends the overnight period of fasting during which glycogen stores become depleted. Breakfast
induces a rise in blood glucose concentrations, which
will be sustained over a longer period if the meal contains a high proportion of complex carbohydrates.
Despite its importance, breakfast is the most likely
meal of the day to be missed by children. Utter
_et al_ . (2007) found that 3.7% of New Zealand children missed breakfast on most days and that 12.8%
failed to eat it every day. These figures are similar to reports from other countries. Children who skip breakfast have been shown to have greater intakes of less
healthy snack foods at other points in the day and to
often have irregular meal patterns. Typically, their intakesoffruitsandvegetablestendtobelowerthanseen
in regular breakfast consumers. Breakfast skipping is
therefore a good indicator of unhealthy food choices
in children. In the study of Utter and colleagues, skipping breakfast was also associated with greater BMI,
consistent with other reports that although they consume less energy during the day, children who skip
breakfast are more likely to be overweight (Rampersaud _et al_ ., 2005).
There are many reports that breakfast benefits cognitive processes and boosts performance in school.
Observational studies based in school and home settings and experimental studies generally show that
consumption of a breakfast that is rich in complex carbohydrate improves school attendance rates, boosts
academic attainment, and improves both short- and
long-term memory. It has been argued that this stems
from the effect of breakfast upon blood glucose concentrations, or possibly through modulation of neurotransmitter functions. However, Ells _et al_ . (2008)
suggest that these reports should be treated with caution as they are mostly performed in small cohorts
of children and over short periods of time. Studies
that are based in school breakfast clubs may be confounded by the social benefits of eating breakfast with

peers.
The provision of breakfast in schools is seen as an
important tool for dietary intervention to improve
the quality of children’s diets. As missing breakfast
is a behavior that is more common in socially deprived children from low-income families, this may
be a useful approach to target this population group



BMI centile
**32**


98th

**28**

**24**

**20**

**16**

**14**

**12**

**10**

|Col1|Col2|Col3|Col4|Col5|Col6|Col7|Col8|Col9|
|---|---|---|---|---|---|---|---|---|
||||||||||
||||||||||
|||||||||**B**|
||||||||||
||||||||||
||||||||||
||||||||||
||||||||||
||||||||||
||||||||||



**0** **2** **4** **6** **8** **10** **12** **14** **16** **18** **20**



**Nutrition and Childhood** **141**


**Figure 6.4** Body Mass Index Centiles. The most robust definitions of overweight and obesity are based upon tracking the
current BMI centile of any child under the age of 18 through to
the BMI value for that centile at age 18. Standard BMI cutoffs of
25 kg/m [2] and 30 kg/m [2] for overweight and obesity respectively,
can then be applied. On this basis a child following the centile
marked A on the chart would be defined as obese, while a child
following the centile marked B, would be defined as overweight.
Data compiled from Cole _et al_ . (1995). This chart is shown for
illustrative purposes only and is not for clinical use.





98th


91st





50th



2nd



**Age (years)**


(Moore _et al_ ., 2007). In the US, the Department of
Agriculture (USDA) oversees the School Breakfast
Program, which is a major initiative reaching out
to many millions of children across the nation. The
program provides breakfast to children of all backgrounds, but is subsidized so that the price paid depends upon family income. Children from the poorest
families receive breakfast free of charge. The program
provides a breakfast based upon 240 mL milk, 120 mL
fruit or vegetable juice, 1 slice of bread or an alternative, and 28 g of meat or an alternative (Kennedy and
Davis, 1998). This provides one-quarter of the RDA
for energy and a significant proportion of requirements for other nutrients. Evaluations of this scheme

have shown that it improves the nutrient intakes of
participants and has benefits for school attendance
and performance.
In schools where breakfast clubs and other schemes
along the lines of the USDA School Breakfast Program
are operating, there is a major opportunity for health
promotion and to make improvements to the quality
of diets consumed by children. Children participating
in breakfast schemes may also consume lunch within
school. A high proportion of daily food intake can
therefore be managed and planned to fit well with
health priorities. The importance of effective school
based interventions will be further explored in Section
6.4.5 below.


**6.4 Obesity in children**


_**6.4.1 The rising prevalence of obesity**_

Obesity and overweight are a major health concern at
all points across the lifespan. Chapter 8 will set out in



detail the evidence that the prevalence of overweight
and obesity in adults increased by twofold between
1990 and 2000 in the developed countries and is increasing at an alarming rate all across the world. The
prevalence of obesity in childhood is also increasing
rapidly in all parts of the world and this may be of
greatersignificanceintermsofthefuturepublichealth
burden.
One of the challenges in following trends in childhood obesity over time is the often very different definitions that have been used in surveys and research
papers over recent decades. In adults, body mass index
(BMI) cutoff values can be simply applied 25 kg/m [2]

for overweight, 30 kg/m [2] for obesity), and although
there are many concerns about the accuracy of BMI
in predicting body fatness and the suitability of these
standard cutoffs for all ethnic groups, this gives a reasonable estimate of population-wide overweight and
obesity rates. In children, as shown in Figure 6.4, BMI
varies with age and in a nonlinear manner, so simple
cutoff values are inappropriate. Instead, clinicians and
researchers make reference to centile charts for BMI

to define obesity. Typically, clinical reports are more
stringent and define obesity as having BMI above the
98th centile (i.e., the BMI of the child is in the top
2% for the population at that age). Research reports
using data collected prior to 2002 tended to define
overweight as BMI above the 90th centile, and obesity above the 95th centile. In an attempt to provide a
standard classification to be applied globally, the International Obesity Taskforce (IOTF), have suggested
that the centile value at any given age should be projected forward to age 18 and then the cutoffs of 25
kg/m [2] for overweight and 30 kg/m [2] for obesity applied. On this basis, obese children lie just above the



**142** **Nutrition: A Lifespan Approach**


98th centile for BMI, and overweight is defined as just
above the 90th centile.

There is a wealth of evidence to suggest that the
prevalence of obesity has increased at a similar rate
to that seen in adults over recent decades. Global estimates suggest that 155 million children (1 in 10)
are overweight and 30–45 million are obese. For the
first time in history this figure is similar to the numbers of children who are underweight and malnourished. de Onis and Bl¨ossner (2000) found that, although in Asia and Africa the prevalence of wasting
was around 3 times greater than the prevalence of
overweight among the under-fives, even in the developing countries, overweight was a significant issue.
Among these nations, those in North Africa had the
highest prevalence (8.1%), while Southeast Asia had
thelowest(2.4%).WangandLobstein(2006)reported
that between 1980 and 2005, the prevalence of obesity in school-age children had increased in almost all
countries for which data was available.
In the UK, Bundred and colleagues (2001) reported
that between 1989 and 1998 overweight (defined as
BMI over the 85th centile) and obesity (BMI over 95th
centile) increased by 1.7- and 1.6-fold, respectively,
in the under-fives. Using the more robust IOTF definitions, Chinn and Rona (2001) found that the
prevalence of obesity in 4–11-year-olds had risen by
two- to threefold among British children. Rudolf and
colleagues (2001) showed that in 9–11-year-olds, obesity prevalence had increased by fourfold over a 25year period. In this study, 47.7% of 11-year-old boys,
and 45% of 11-year-old girls were defined as overweight or obese.
Such trends are typical of all of the developed
countries. Analysis of the 1976–1980 and 2003–2004
NHANES studies from the US indicates that among
2–5-year-olds obesity prevalence increased from 5 to
13.9%,whilefor5–11-year-olds,theincreasewasfrom
6.5 to 18%. In the European region, the prevalence of
overweight was found to be 24% in 2002. The greatest
prevalence of childhood obesity in Europe is noted
in the Mediterranean countries, with Malta and Sicily
exhibiting the highest rates.


_**6.4.2 The causes of obesity in childhood**_


On a simplistic level the causes of obesity at any age are
obvious. Obesity represents the excess accumulation
of body fat as a consequence of positive energy balance. In other words, the amount of energy consumed



is in excess of requirement for metabolic and physiological processes. To put this another way, childhood
obesity is the product of excess food intake and insufficient energy expenditure through physical activity.
This explanation, is however, a superficial viewpoint
and is unhelpful as it serves to perpetuate the false
idea that all obese children are greedy and lazy.
Obesity is multifactorial in origin and represents an
interaction between a genetic predisposition and the
environment. Obesity can be generated without gross
imbalances of energy supply and demand. A habitual positive energy balance of just 10–20 kcal/day can
result in a significant accumulation of excess body
fat over a period of a few years. It is generally argued that the modern obesity “epidemic” that afflicts
children is a consequence of the mismatch between
the biological evolution of humans and the technological revolution of recent times. This “discordance
hypothesis” suggests that early humans evolved for
subsistence on a food supply that was insecure and
where considerable amounts of energy had to be expended in order to gain access to food, either through
hunting or foraging. As a result, the human genome
evolved to favor efficient energy storage. The modern environment is at odds with this biological background and daily consumption of energy-rich foods,
with low energy expenditure through activity (Eaton
_et al_ ., 1988; Hill and Peters, 1998). It is proposed that
obesity genes carried by many humans achieve their
expression in the “obesogenic” environment that has
been constructed through social and technological
changes.
Obesity-promoting genes may play an important
role in determining risk of childhood obesity. It is
estimated that between 33% and 50% of the risk to
anyindividualisderivedfromgeneticinheritance.Ina
powerful analysis, Wardle and colleagues (2008) studied twins aged between 8 and 11, a study therefore free
of many confounding influences seen in earlier studies
of adult twins, and noted that 77% of the variation in
BMI and waist circumference could be explained by
genetic factors. Given that many monogenic causes of
obesity are likely to be of early onset, they may contribute significantly to observed levels of childhood
obesity. Despite the major influence of genetic factors, it has to be recognized that the modern obesity
crisis has developed over the last 20–30 years and that
the human gene pool will have been relatively stable
for tens of thousands of years. The overwhelming view



of researchers in the field is that environmental factors
explain current trends.


**6.4.2.1 Physical activity**
Physical activity is seen as an important element of
normal healthy development and provides protection
against weight gain and related disorders later in life,
while promoting bone mineralization and optimal
growth. Some points in childhood appear to be more
important than others in terms of the health gain associated with activity, for example the preschool years
and the later stages of adolescence. This may be because these are stages at which attitudes to exercise are
shaped, therefore influencing activity levels at future
life stages. Physical activity levels often decline with
age, reflecting patterns of play in children, which often change from free, unstructured, and active games
(e.g., spontaneous games of chase and tag) to a more
regimented sports-based pattern in early adolescence
(Must and Tybor, 2005).
Declining levels of physical activity are seen as a
major contributor to obesity in children. The modern
environment encourages low levels of physical activity
in children for a number of reasons. Firstly, modern
transport networks discourage walking or cycling and
many parents will choose to drive their children to
school and other activities, by car even over relatively
short distances. This may be due to concerns about
children’s safety when out and about, but may also be
a product of the fact that driving is easier and faster
and a simpler way to integrate children’s activities
into busy family life. Within schools the prioritization of academic subjects and testing over time spent
in physical education, sport, dance, and other more
active subjects, has led to a progressive fall in levels of
physical activity within the working week. Alternative
activities outside school can be difficult for some children to access due to cost, location, or a general lack
of availability.
The flip side of the coin in consideration of declining physical activity is the increase in the amount
of time spent on sedentary activities. These are generally leisure activities that involve little more than
the resting level of energy expenditure. In developed
countries, children spend 4–6 h per day either watching television or using computers and games consoles.
These are now the preferred leisure activities of most
children and are favored by many parents as they keep
the child in a safe and controlled environment.



**Nutrition and Childhood** **143**


Although physical activity is seen as a key contributor to obesity risk in children, it is difficult to quantify the extent of that risk with any certainty. Within
populations, levels of physical activity are extremely
variable and it is highly problematic to quantify actual
energy expenditure through activity, using validated
methods (Rennie _et al_ ., 2006). Most of the literature
is therefore based upon indirect and subjective measurements (e.g., self-report of the hours spent watching television). Moreover, cross-sectional studies that
attempt to examine relationships between activity and
obesity are confounded by the fact that causality cannot be shown. In general, overweight and obese children _will_ be less active than their lean counterparts
as they find physical activity and sport more difficult
and less enjoyable (Must and Tybor, 2005).
Despitethesemethodologicalissues,fromtheavailable information, it seems likely that leisure inactivity
is a critical component of the modern obesogenic environment that is driving childhood obesity. Prospective studies that have considered how childhood BMI
changes over time are related to activity levels consistently show strong negative associations between
the two variables. Sedentary behaviors are strongly
predictive of greater BMI (Must and Tybor, 2005).
The degree of risk of obesity associated with sedentary activity is truly shocking. Stettler and colleagues
(2004) reported that even an hour a day spent playing
videogamesincreasedriskofobesitybytwofold,while
Burke _et al_ . (2005) found that each hour of television
watched on a daily basis increased risk of obesity by
40% among 6-year-olds. A key step in the reduction
of obesity risk may therefore be to promote the avoidance of sedentary behavior rather than participation
in high-impact physical activities. Television watching
may be doubly insidious in that not only is it a sedentary activity, it also changes dietary behaviors, promoting consumption of soft drinks, snack foods, and
conveniencefoods.Thismaybearesponsetoadvertisingofsuchitems.LobsteinandDibb(2005)foundthat
in the US, Australia, and a number of European countries, there was a positive association between children’s exposure to advertisements for energy-dense,
micronutrient poor foods and levels of overweight
and obesity in the population.


**6.4.2.2 Food intake**

From the above discussion it should be clear that
energy expenditure through physical activity among



**144** **Nutrition: A Lifespan Approach**


children has declined markedly over recent decades.
James (2008a) highlighted the fact that this has impacted particularly heavily on the rapidly developing
countries such as China and India. In China changes
in technology and increasing use of motorized transport mean that energy requirements for children are
markedly lower than they were 40 years ago. Whereas,
in the past, children were engaged in work-related
activities for much of their time, modernization and
urbanization may have reduced energy requirements
by 200 kcal/day. Alongside these shifts in activity levels, the nature of the diet has undergone a revolution
in almost all parts of the world, producing an increase
in energy intakes and energy density of foodstuffs.
Again in China, Popkin and Duo (2003) reported that
among young adults, intakes of fat increased from
just 14% of dietary energy to 32.8% between 1981
and 2003. It can therefore be strongly asserted that
the modern environment simultaneously promotes
reduced energy expenditure and increased consumption.

Studies that have sought to establish the links between dietary intakes and obesity in children have
generally produced inconclusive results and at best indicate weak relationships between specific dietary factorsandobesityinchildhood.Forexample,Guillaume
_et al_ . (1998) found no association between energy intake from fat and body fatness in 6–12-year-olds. Similarly, Maffeis _et al_ . (1998) could find no association
between body fatness and intakes of macronutrients
in children. Robertson and colleagues (1999) considered fatness using a comprehensive series of skinfold
measurements and showed that children with more
body fat had higher intakes of energy, but not of any
specific macronutrient. Reilly _et al_ . (2005) found no
contribution of dietary factors to difference in risk
of overweight among 7-year-old children, even when
comparing children with an established preference for
a diet rich in chocolate, crisps, sugar-sweetened beverages,tothosewithdietsrichincomplexcarbohydrates
and protein.
Therearemajorchallengesinattemptingsuchstudies, and this may be responsible for the lack of consistency in the literature. Firstly, confounding factors
need to be taken into account, including body weight
at birth and parental BMI. Moreover, as individuals of greater weight require more energy to maintain that weight, studies are best performed using a



longitudinal design to monitor the associations between dietary factors and weight or fat gain over a
period of time. Obtaining accurate measurements of
dietary intake is difficult at any stage of life, but is particularly difficult in children and their parents, who
may fail to recall and fully record their intakes. As
described in Section 6.4.1, even the anthropometric
classification of overweight and obesity is far from
straightforward.
Magarey _et al_ . (2001) used robust methods in order to avoid the pitfalls identified above, in a study of
2–15-year-old Australian children. However, no clear
influence of macronutrient intake upon BMI or body
fatness measured using skinfolds could be identified.
In contrast, Skinner and colleagues (2004) found associations between macronutrient intakes and change
in BMI between 2 months and 8 years of age. Regular assessment of dietary intake using weighed records
and 24-h maternal recall allowed determination of
longitudinal patterns of protein, carbohydrate, and
fat consumption, alongside changes in BMI. Protein
and fat intakes were positively associated with BMI,
while carbohydrate intake was negatively associated.
Surprisingly, total energy intake was not predictive
of BMI. BMI at 8 years was most strongly related to
BMI at age 2 and the timing of the adiposity rebound
(Figure 6.5), indicating that factors in early infancy
may be critical in setting the risk of overweight and
obesity and reinforcing the importance of infant feeding methods in this context.
While the macronutrient composition of the diet
cannot be strongly related to body fatness in children,
there is clear evidence that meal patterns, portion
sizes, and the energy density of foods consumed plays
an important role in determining risk of overweight
and obesity. Dubois and colleagues (2008), for example, considered energy and macronutrient intakes in
a cohort of Canadian children. These children were
divided into a group who consumed breakfast on a
daily basis (90% of the study population) and those
who missed breakfast on at least one day each week
(10% of population). Those who skipped breakfast
had different overall dietary patterns to the breakfast
consumers.Theyconsumedmoreenergyintotal,consumed less protein and energy from protein, and ate
a greater number of carbohydrate-rich snacks. Risk
of overweight among the breakfast-skipping children
was increased by 2.27-fold (95% CI 1.33–3.88). The



BMI centile
**25**

98th


**20**

50th



**15**



9th



**10**

**0** **2** **4** **6** **8** **10** **12**


**Age (years)**


**Figure 6.5** The adiposity rebound. In early childhood the weight gain
of children outstrips their height gain and as a result BMI rises rapidly.
Beyond the first year of life height gain tends to exceed weight gain
and so BMI declines. Between the age of 4 and 8 the BMI begins to
increase again and this point is termed the adiposity rebound. Having
an earlier adiposity rebound appears to be predictive of obesity in
childhood, and it can be clearly seen on the graph that for children on
a higher BMI centile, the rebound (marked by the stars) occurs at an
earlier age. Earlier adiposity rebound is noted in formula-fed compared
to breast-fed infants.


study could not discount the fact that breakfast skipping could be a marker for other confounding factors,
such as sedentary behavior, but nonetheless showed
how patterns of intake within the day could influence
body fatness. While in the reference group BMI was
unrelated to intakes at specific points in the day, in
children who skipped breakfast, consumption of over
700 kcal at lunchtime was a predictor of overweight.
This suggests that meal frequency could impact on
energy balance or appetite regulation.
Increased energy density of foodstuffs has also been
proposed as a factor driving the increase in childhood
obesity. Changes in family lifestyle, where the need for
both parents to be out of the house in paid employment, have increased the consumption of preprepared
convenience foods. These are generally rich in fats and
sugars and have a higher energy density than meals
prepared at home, from fresh ingredients. Moreover,
children are consuming increasing amounts of snack
foods, in addition to meals, and these also increase the
energy density of the overall diet. It is logical to assume that this change in food consumption has an impact upon overall energy intake in children, but once
again methodological issues have made it difficult to
demonstrate a relationship between energy density
and obesity risk. McCaffrey _et al_ . (2008) investigated



**Nutrition and Childhood** **145**


this potential association using a 7-year follow-up to
a study initially conducted in primary school children
(aged 6–8). No relationship was noted between energy
density of the childrens diets and the gain in fat mass
over this period. In contrast, Johnson and colleagues
(2008) found that fat mass in 9-year-old children was
related to energy density of the diet, dietary fat intake,
and inversely related to intakes of dietary fiber.
Regular consumption of “fast-food” is recognized
as a behavior that increases energy density of the diet,
and hence overall energy intake. Fast-food can be
defined as foodstuffs that are mass-produced convenience foods, generally purchased from self-service
or takeaway outlets. There is a huge market for these
foods, and in the US this represents the most rapidly
expanding sector of the food industry. Fifty percent
of food expenditure in the US is on fast-food (Rosenheck,2008).Bowman _etal_ .(2004)exploredthedietary
patternsofUSchildrenandfoundthat30%consumed
fast-food on a typical day. Among these children, this
increasedenergydensityby0.29kcal/gfood,increased
intakes of fat, carbohydrate, sugar-sweetened beverages was associated with lower intakes of milk, fruit,
and vegetables. Fast-food consumers on average consumed an extra 187 kcal/day.
A review of experimental and cohort studies of fastfoodconsumptionandobesityrisk(Rosenheck,2008)
concluded that, in children, although fast-food consumption increases energy intake, there is no clear
effect upon BMI and weight gain. However, Thompson and colleagues (2006) found that after 4–10 years
of follow-up, girls who consumed fast-food twice or
more per week at a baseline survey, exhibited a greater
increase in BMI than those who did not. Although
the evidence is equivocal, it is suggested that fast-food
consumption in childhood helps to establish a pattern
of behavior and food preferences that may increase
risk later in life.

Sugar-sweetened beverages are an important element of the energy-dense diet that is associated with
fast-food consumption. These drinks can contribute
significantly to energy intake in children. Pure fruit
juices are also considered in this category, even though
parents widely perceive these to be a healthy alternative to other drinks, including water. A 100 mL
serving of apple juice, for example, can deliver 11.8
g of sugar (a nearly identical quantity to a similar
serving of cola) and consumption may displace less



**146** **Nutrition: A Lifespan Approach**


**Table 6.4** Energy and sugar content of beverages commonly consumed by children


Per 100 mL serving


Beverage Energy (kcal) Energy (kJ) Sugars (g)


Cow’s milk (whole) 66 277 5.6
Apple juice (unsweetened) 49 205 11.8
Orange juice (unsweetened) 49 205 11.1
Fruit squash 55 230 12.8
Lemonade 63 264 15.9

Cola 43 180 11.9



energy dense, more nutrient-dense drinks such as
milk (Table 6.4). Wang _et al_ . (2008) reported that
in the US energy intakes in children from sugarsweetened beverages and fruit juices accounted for
10–15% of total energy intakes. A wide range of observational studies shows that higher consumption of
sugar-sweetened beverages is associated with greater
body weight, more rapid weight gain, and increased
risk of obesity (Malik _et al_ ., 2006). A study of US
12-year-olds suggested that such beverages were delivering 36–58 g/day sugar to girls and boys, respectively, and that children who consumed more than
265 mL/day had energy intakes that were 200 kcal/day
more than those who did not (Ludwig _et al_ ., 2001).
Each extra serving of sugar-sweetened drinks increasedriskofobesityby1.6-fold(95%CI,1.14–2.24).
These drinks may be particularly important in promoting weight gain, as the hypothalamic systems that
regulate appetite and energy balance do not compen

**Table 6.5** Genetic disorders associated with early onset obesity



sate for liquid food sources as efficiently as they do for
solids.


**6.4.2.3 Genetic disorders**

There are a number of single-gene mutations that are
known to promote early onset obesity (Table 6.5). Until recently, it has always been assumed that these are
extremely rare and account for only a small proportion of childhood and adult obesity cases. The use of
modern molecular techniques for population screening and the discovery of new gene targets is starting
to change this perception and it appears that up to
10% of all obese children may have an underlying
genetic disorder. For example, confirmed deficiency
of the leptin receptor had only been observed in a
single family, but a screen of 300 individuals with
early onset obesity revealed LepR defects in 3% of
cases (Farooqi _et al_ ., 2007). The _FTO_ gene has been



Condition Gene defect(s) Contribution to obesity


Melanocortin receptor defects MC1R, MC2R, MC3R, MC4R, MC5R MC4R defects may explain 5% of
all childhood obesity cases


_FTO_ polymorphisms _FTO_ Explains1% of variation in
population BMI. 16% of
population homozygous for
obesity-related allele


Prader–Willi syndrome Abnormalities of Chromosome 15 1 in 12 000–15 000 births


Leptin receptor defects LepR Up to 3% of cases of childhood
obesity


Bardet–Biedl syndrome Abnormalities of Chromosomes 11 and 16 1 in 125 000 births


MOMO Unknown Only 5 confirmed cases


Congenital leptin deficiency Leptin Only 12 confirmed cases


Note: MOMO- Macrosomia, Obesity, Macrocephaly and Ocular abnormalities.



highlighted as a novel gene target for obesity research.
Single nucleotide polymorphisms in _FTO_ are common in the population (between 14% and 52%) and
are associated with greater BMI. Individuals who are
homozygousfortheat-riskformofthe _FTO_ allelehave
1.67-fold greater risk of obesity (Loos and Bouchard,
2008).
Many of the genetic disorders linked to obesity are
associated with other abnormalities. In Bardet–Biedl
syndrome, for example, obesity is just one outcome
amidstamyriadofabnormalitiesofgrowthanddevelopment, affecting the eyes, the gastrointestinal tract,
and cardiovascular system. Other disorders induce
obesity through effects upon the neuroendocrine control of appetite. Defects of MC4R (the melanocortin
4 receptor, Research highlight 6) are associated
with binge-eating disorders (Loos _et al._, 2008). In
Prader–Willi syndrome (PWS), there are defects of
the chromosome 15q11–13 region that stem from
either deletion of paternally derived alleles, or epigenetic silencing (DNA methylation) of paternal


~~**Research Highlight 6**~~ ~~Melanocortin and obesity~~


_Melanocortin_

The human hypothalamus, anterior pituitary, and brain stem express
the 241 amino acid peptide, pro-opiomelanocortin. This peptide is
relatively inert but is cleaved to produce a series of biologically active
peptide hormones including β-endorphin, adrenocorticotrophin, and
the melanocortins, _α_ -MSH, β-MSH, and _γ_ -MSH. Melanocortins have
varied functions. In the periphery, _α_ -MSH (12 amino acid residues)
is an inflammatory mediator and promotes skin pigmentation, but
within the central nervous system is an important regulator of energy
balance and food intake. β-MSH (22 amino acid residues) has similar
functions. The functions of _γ_ -MSH are poorly defined.


_The melanocortin receptors_
There are five melanocortin receptors (MC1R, MC2R, MC3R, MC4R,
and MC5R), which are expressed in many tissues. MC3R and MC4R
are expressed in the regions of the hypothalamus that are involved
in the regulation of appetite and energy balance (Coll, 2007). Both
may contribute to this process, but MC4R is known to play the more
important role. MC4R is a G-protein coupled receptor and binds both
_α_ - and β-MSH. Following consumption of food, or in an energyrich situation, production of leptin from adipose tissue simultaneously stimulates synthesis of melanocortins and suppresses production of Agouti Related Protein (AgRP). Binding of _α_ -MSH to MC4R
suppresses food intake. As AgRP is an antagonist of the receptor
this aspect of leptin signaling optimizes melanocortin binding (Coll,
2007).



**Nutrition and Childhood** **147**


alleles (Goldstone, 2004). PWS affected children have
a number of neurological defects and generally have
learning difficulties. In infancy they often fail-tothrive as they are unable to feed normally, but between 1 and 6 years gain weight at a prodigious
rate due to extreme hyperphagia. Some adolescents
with PWS will consume in excess of 5000 kcal/day
if given free access to food. Management of the
condition therefore requires strict control over portion sizes and the availability of food. This can involve extreme measures such as locking fridges and
larders.


_**6.4.3 The consequences of childhood**_
_**obesity**_


Soaring rates of childhood overweight and obesity
have prompted fears about the impact of these
trends upon the health of populations. Clearly,
these concerns must focus upon the immediate
health of the affected children, but it is also of
importance to consider whether obesity in childhood


_Melanocortin and control of appetite_
Studies of rodents have shown that MC4R plays a critical role in
controlling food intake and weight gain. Animals with MC4R deficiency become hyperphagic, obese, and insulin resistant. Selective knockout of MC4R in the paraventricular nucleus duplicates
this effect (Garza _et al_ ., 2008). In humans, mutations of MC4R
are relatively common and are noted in 0.1% of the UK population (O’Rahilly, 2007). Although there may be marked differences
in prevalence in different ethnic groups (Lee _et al_ ., 2008), MC4R
mutations represent the major monogenic forms of obesity. In some
populations, 5% of early onset obesity appears related to MC4R defects. The interaction of leptin receptor and MC4R mutations may
also be important in determining risk of obesity (Hart Sailors _et al_ .,
~~2007). Interestingly, MC4R mutations also promote increases in lean~~
mass, so affected children are often taller as well as fatter (Coll,
2007).


_Future therapeutics_
MC4R may be an important target for the development of future
therapies for obesity. Possibilities include transgenic approaches to
increase expression of melanocortins. In obese rodents overproduction of _α_ - and β-MSH reduces weight gain and body fatness.
Melanocortin agonists have been developed for use as antiobesity
drugs but to date have proved unsuitable as they impact upon skin
pigmentation and sexual function as well as food intake and energy
homeostasis (Coll, 2007).



**148** **Nutrition: A Lifespan Approach**


increases risk of obesity and related disorders later in
life.


**6.4.3.1 Immediate health consequences**
Obesity and overweight have important physical and
psychological effects upon children and adolescents.
Overweight children tend to grow and mature more
rapidly and so attain a greater height than their leaner
peers. In girls, the greater level of body fat drives
earlier menarche (see Chapter 2). Overweight has
important metabolic consequences and, as a result,
disease states that were once extremely rare among
children are increasing in prevalence. The metabolic
syndrome, also referred to as the insulin resistance
syndrome, is defined as the combined presence of
hyperinsulinemia, hypertriglyceridemia, and cardiovascular disorders (hypertension). It is primarily a
condition of adulthood, with a prevalence of just
4% in children. There are reports that in overweight
children and adolescents, this may increase to 30–
50% (Daniels _et al_ ., 2005). Individual components
of the syndrome are also noted in a high proportion of overweight children, who are more likely to
have a profile of circulating lipids that is associated
with greater risk of cardiovascular disease (elevated
low density lipoprotein–cholesterol and triglycerides,
lower concentrations of high-density lipoprotein–
cholesterol). Glucose intolerance is also more likely,
leading to a marked increase in the prevalence of noninsulin-dependent diabetes in children (Dietz, 1998).
Pinhas-Hamiel and colleagues (1996) reported a tenfold increase in the number of US adolescents diagnosed with diabetes between 1982 and 1995. Although type 1 diabetes is generally regarded as the
early onset form of diabetes, among US children the
prevalence of type 1 diabetes is now markedly lower
(1.7 cases per 1000 children) than that of type 2 diabetes (4.1 cases per 1000 children) (Daniels _et al_ .,
2005).
Overweight impacts upon liver function and obese
children are more prone to hepatic steatosis and gallstones. High blood pressure is reported to be on the
increase among obese children (Dietz, 1998). Cerebral
hypertension can manifest as pseudotumor cerebri.
Carrying excess weight puts strain upon the growing skeleton. Two-thirds of patients diagnosed with
Blounts disease, a bone-deformation condition of
childhood, are obese. Thirty to fifty percent of children with slipped capital femoral epiphysis, a defect



of the growth plate in the thigh bone are overweight
or obese.

From a psychological perspective, overweight in the
childhood years can be extremely destructive, lowering self-esteem, promoting depression, and preventing happy social interactions. Children who are overweight are more likely to be bullied at school and
are often discriminated against by their peers. Even
very young children show a preference for thinner
children as playmates and will equate obesity with
laziness and other undesirable descriptions (Dietz,
1998).


**6.4.3.2 Tracking of obesity: consequences for**
**the future**
In the context of obesity, “tracking” is the term used
to describe the situation where body fatness at one
stage of life correlates strongly with a later stage. For
example, if underweight children grow up to become
underweight adults, their body fatness will be said to
have tracked from one stage to another. Similarly, if
overweight infants remain overweight in adolescence,
their body fatness will be described as having tracked
throughout childhood. Identification of tracking of
overweight and obesity from childhood to adulthood,
and of risk factors for such tracking is important for
two reasons. Firstly, strong evidence of tracking would
indicate that high levels of childhood obesity will exert effects upon adult body fatness and related health
problems for many decades to come. In other words,
if obese children grow up to be obese adults then the
current generation of children may grow up with a
major burden of type 2 diabetes and cardiovascular
disease. Secondly, if overweight and obesity really do
track to adulthood, then it may be possible to identify
individuals at greatest risk of obesity and related disorders at an early phase of life and intervene at that
stage.
In general, the literature in relation to obesity tracking shows only a moderate, weak association between
BMI in childhood and adulthood, but stronger associations between BMI in adolescence and later life
(Figure 6.6). Studies that consider tracking are often
limited by the span of time that can be reasonably
covered by a follow-up study and by the confounding influences of parental BMI and genetic factors.
Wang and colleagues (2000) considered the tracking
of BMI from childhood to adolescence in a cohort
of Chinese children aged 6–13. Children who were



**60**


**40**


**20**


**0**


**Figure 6.6** Tracking of overweight. This chart summarizes the data
from 4 studies that evaluated the tracking of overweight (OW) from
early childhood to adolescence and adulthood and from childhood to
adulthood. Wang _et al_ . (2000) and Johannsson _et al_ . (2006) considered tracking from childhood to adolescence. Deshmukh-Taskar _et al_ .
(2006) and Wright _et al_ . (2001) were powered to assess tracking
from childhood or adolescence to adulthood. The strongest evidence
of tracking of overweight is seen in the studies that evaluated tracking
from adolescence to adulthood.


overweight between 6–9 years of age were 2.8 times
more likely to be overweight adolescents. Children
with one or more obese parents were more likely to
track in this way, but in general the evidence of tracking from childhood to adolescence was much weaker
for overweight than it was for underweight children.
In contrast, Johannsson _et al_ . (2006) suggested that
tracking from infancy to adolescence meant that BMI
in childhood was a strong predictor of overweight or
obesity at age 15. Being overweight at age 6 or 9 was
found to increase risk of overweight at 15 by 10.4- and
18.6-fold respectively. Fifty-one percent of overweight
6-year-olds remained overweight after puberty.
The Thousand Families cohort, a study of children born in the city of Newcastle between May and
June, 1947, provided a useful opportunity to consider
tracking of body fatness from childhood through to
middle age. BMI at age 9 was weakly correlated with
adult BMI, but this relationship was explained by lean,
rather than fat, mass (Wright _et al_ ., 2001). There was
evidenceoftrackingfromage13toage50andchildren
whose BMI was in the top quartile for the population
were twice as likely to be in the top quartile for body
fatnessatage50.However,asobesitywasrelativelyuncommon in the 1950s and as the drivers of childhood



**Nutrition and Childhood** **149**


obesity at that time may well be different to contemporary populations, the generalizability of these data
may be questioned. Moreover, this study reported that
most obese 50-year-olds had not been overweight as
children. The Bogalusa Heart Study was a prospective
cohort study from the US, with adults who were initially studied at ages 9–11 followed up to 19–35 years
of age. Given the span of time covered, this may give a
more reliable picture of how likely tracking of obesity
is, within contemporary population groups. Within
this study, overall tracking of overweight from childhood to adulthood was found to be around 22.5%,
compared to 40% tracking of normal weight. There
were sex and ethnic group differences in rates of tracking, which was most prominent in African-American
women (Deshmukh-Taskar _et al_ ., 2006).
The evidence to support the view that overweight
in childhood predisposes the individual to overweight
and obesity in adulthood is, therefore, rather modest.
While it is clear that there is some influence of childhood body fatness on later weight classification, this
is just one component of a more complex etiology for
adult obesity. However, it is important to also consider
whether childhood overweight and obesity might be
an independent risk factor for adult disease states.
Few studies have the power to consider this question
in detail. The Thousand Families study surprisingly
found that after adjusting for adult body fat, there
was an inverse relationship between BMI at 9 years
and adult total cholesterol and triglyceride concentrations, but only for women. Other cardiovascular risk
factors were unrelated to childhood BMI, and BMI at
age 13 was completely unrelated to adult risk profile
(Wright _et al_ ., 2001). The greatest risk for adult disease
appearedtobepredictedbythecombinationofunderweight during childhood and obesity in adulthood.
Juonala _etal_ .(2005)foundstrongevidenceoftracking of overweight from early childhood to adulthood.
Individuals with BMI over the 80th centile between 3
and 9 years had triple the risk of obesity between
24 and 39 years, and this risk increased to fourfold in those who were overweight in adolescence.
Measurements of carotid intima-media thickness as
a proxy for early stages of atherosclerosis, however,
showed no risk of cardiovascular disease associated
with childhood or adolescent obesity. All disease risk
was related to adult obesity. Freedman and colleagues
(2001) examined relationships between risk factors
for cardiovascular disease and BMI in childhood.



**150** **Nutrition: A Lifespan Approach**









**Figure 6.7** Risk factors for coronary heart disease in relation
to childhood or adult overweight. Adult obesity is associated with raised circulating LDL cholesterol and lower HDL
cholesterol concentrations. These are established risk factors
for coronary heart disease. In adult individuals who were
overweight during childhood the risk profile associated with
obesity is no different to that seen in adults who were of normal weight in childhood. These data suggest that adult risk of
coronary heart disease is not directly influenced by childhood
weight status. NW- normal weight. OW- overweight. Data
drawn from Freedman _et al_ ., 2001.



**100**


**50**



**0**
**LDL-cholesterol** **HDL-cholesterol**


Although individuals who had been obese in childhood tended to have high circulating total cholesterol,
LDL cholesterol, insulin and triglyceride concentrations, and higher blood pressure, these effects were
all explained by their greater body fatness in adulthood (Figure 6.7). In contrast to these findings that
suggest that childhood body fatness has no impact
upon adult disease risk, further studies of the Bogalusa Heart cohort found that carotid intima-media
thickness was weakly related to childhood obesity, after adjusting for adult body fatness (Freedman _et al_ .,
2008). Garnett and colleagues (2007) reported that
children who were overweight at age 8, were more
likely (OR 6.9, 95% CI 2.5–19.0) to display 3 or more
risk factors for cardiovascular disease (out of elevated
blood glucose, insulin, triglycerides, blood pressure,
and lowered HDL cholesterol) at age 15 years.
Although there is a lack of strong evidence to suggest that the obese child is at greater risk of disease
in adulthood by virtue of his/her childhood adiposity,
the balance of opinion appears to be that the obese
child is more likely to be an obese adult and hence
develop a high-risk metabolic profile. The treatment
and prevention of pediatric obesity is therefore considered to be a very high priority for public health and
clinical practice.


_**6.4.4 Treatment of childhood obesity**_


Once identified as being overweight or obese, children require rapid and well thought-out intervention
to limit the risk of health problems and of becoming
an obese adult with related metabolic and cardio
vascular disorders. However, the treatment of obese



children poses special problems, as there is a need to
maintain normal rates of growth, while simultaneously promoting loss of excess weight and reduction
of fat mass. The strategy to be employed will depend
upon the age of the child, partly because his/her capacity for autonomous decision making will change
markedly between childhood and later adolescence,
but also because of the influence of normal growth.
For very young children, for example, reducing rates
of weight gain may be sufficient to correct overweight
and obesity as the child will normalize body weight
and fat mass through the growth process.
The overriding aim in treating childhood obesity is
to promote only slow and gradual reductions in fat
mass and loss of excess weight. Slower rates of fat loss
are easier to sustain and the gradual approach can
be advantageous as children and their parents can be
set simply achieved goals. With achievement of those
goals comes the self-esteem and confidence that is
necessary to achieve longer term aims. However, the
absence of an obvious and rapid change can also be
disheartening. In some cases fat loss may occur without any change, or even an increase in body weight
due to growth. Obese children and their parents therefore require close supervision and encouragement in
order to sustain successful treatment.
Treating pediatric obesity requires a close integration of multiple approaches that include changes in
nutrition, physical activity levels, sedentary time, and
wholesale lifestyle modifications that ideally impact
upon whole families. The physical activity component can be particularly difficult to introduce as many
overweight and obese children find exercise difficult
and embarrassing. To promote fat loss, children need



to engage in around 60 min per day of aerobic exercise, such as cycling, swimming, dancing, or walking.
To ensure compliance with any exercise program, it
is essential that the activities increase in intensity at a
gradual rate and that the activities are tailored to the
individual children. If the exercise is enjoyable then
the children will maintain their involvement, whereas
humiliating boot camp experiences will achieve no
more than a short-term gain in energy expenditure.
When children can be encouraged to take part in activities where they can succeed and show some mastery, self-esteem is increased, boosting motivation and
the desire to stay active even at the end of treatment
(Craig _et al._, 1996). Alongside increased levels of exercise, parents should remove or limit access to elements
of the environment that promote sedentary activity,
for example televisions and computer games. Many
of these changes are perhaps most effective if they are
incorporated in to whole lifestyle changes in which
activity becomes a part of everyday life, for example
walking or cycling to school and other activities.
Dietary modifications to treat obesity must be introduced as long-term changes. It is obvious that any
short-term dietary change that ceases as soon as an
acceptable BMI is achieved will fail, as the individual
will simply revert to his/her old eating habits and regain weight at the end of the treatment. With children,
dietary changes should not be referred to as dieting
and must be treated as a wholly positive experience.
Rather than labeling certain foods as forbidden and
to be wholly excluded, children should be encouraged
to consume a pattern of diet that is healthier overall,
but which still includes their preferred options such as
sweets and chocolate (Grace, 2001). The overweight
child requires a diet that delivers sufficient energy and
nutrients to support growth that is based upon foods
that are acceptable to children and that are easy to
acquire and prepare. Epstein and colleagues (2008)
compared the approaches of promoting healthy eating against restricting energy-dense foods in a group
of children aged between 8 and 12. All children and
their parents were given the goal of keeping energy
intake to between 1000 and 1500 kcal/day and taught
a traffic light classification of foodstuffs. One group
were instructed to limit intakes of red light foods (high
in sugar and fat), while the other were instructed to
consume greater amounts of green light foods (mostly
fruits and vegetables). At follow-ups 12–24 months
after the intervention both groups of children had



**Nutrition and Childhood** **151**


improved their BMI, but the healthy eating group had
fared significantly better. This study highlights the importance of promoting a healthy lifestyle rather than
simply dictating a restrictive diet. When given greater
access to healthier foods, children find it easier to consume these as alternatives for energy-dense choices.
Formostoverweightandobesechildrensmallgradual changes are sufficient to manage weight gain. For
those with more severe or morbid obesity the strategy
is different as more rapid weight loss is necessary to
avoid ill health. In these cases, low-calorie or very low
calorie diets (800 kcal/day or less) may be merited,
but only under strict medical supervision (Caroli and
Burniat, 2002).
Parents play a central role in the treatment of obese
children. With younger children (under 11), at least,
parents will generally have full control over food purchase and preparation, access to exercise opportunities and leisure activities and as such need to be the
main targets for education and advice during periods
of treatment (Golan _et al_ ., 1998). Where at least one
parent is actively participating in a weight loss program alongside their children, the chances of success
are increased (McLean _et al_ ., 2003). Children enjoy
monitoring the progress of their parents, and setting
their goals and rewards. This stimulates active engagement with treatment programs. The influence of
parents should ideally be applied to all children in
a family. It is clearly unreasonable to expect an obese
childtochangehis/herdietandincreaseactivitylevels,
if other family members do not.
With parents at the heart of treatment strategies,
it is alarming to note that many parents of obese
children do not recognize that their children have a
problem. Carnell _et al_ . (2005) surveyed parents of
3–5-year-old children through nursery and primary
schools in London and found that only 1.9% of parents with overweight children and 17.1% of parents
with obese children described their children as overweight. None of the parents described their children
as “very overweight,” even though the prevalence of
obesity among the children was actually 7.3%. However, although they were unable to correctly classify
their children’s body weights, the parents of overweightandobeseinfantsweremorethantwiceaslikely
than other parents to express concerns that their children may become obese later in life. Successful treatment of pediatric obesity can only begin once parents
are ready to recognize the issue and engage with the



**152** **Nutrition: A Lifespan Approach**


relevant professionals. Parents are more likely to do
this if their overweight child is older, if the parents are
themselves overweight or obese, and if there is a belief
that the health of the child may be at risk (Rhee _et al_ .,
2005).


_**6.4.5 Prevention of childhood obesity**_


In the UK, the government’s chief scientist published
the Foresight Report in 2007. This report highlighted
obesity as a major public health problem, which by
2050 would be expected to cost the country £45 billion
per year. Within this report, obesity was regarded as
the normal passive physiological response to the modern obesogenic environment. To tackle the problem
there has to be massive societal change that changes
the environment, as the epidemic cannot be prevented
through individual action alone. These conclusions
echo the statement made by the World Health Or


ganization in 1997, “Obesity cannot be prevented or
managed solely at the individual level. Committees,
governments, the media and the food industry need
to work together to modify the environment so that it
is less conducive to weight gain.”
Prevention of obesity is a far more effective public
health strategy than treatment at any stage of life. Targeting prevention strategies at children is considered
to be of primary importance, partly due to the evidence that suggests that obesity may track from childhood to adulthood, but primarily because sweeping
lifestyle changes at this stage of life are more likely
to be sustained by individuals over the longer term.
While prevention strategies require a multiagency approach that involves families, schools, the food industry, and governments (Figure 6.8), they may be more
effective if tailored to suit the specific targets in the
population. For example, interventions that promote













**Figure 6.8** The prevention of childhood obesity depends upon the involvement of parents and families, food producers, schools and government
agencies. None of these stakeholders have sufficient influence to be able to tackle the obesity problem in isolation.



breast-feeding may be the most effective way of prevention obesity in infants, while targeting schools to
increase physical activity, include more health-related
subjects in the curriculum, and limit access to energydense snacks would be an effective strategy for older
school-age children (Daniels _et al_ ., 2005).
The influence of parents and family upon the food
choices and lifestyle behaviors of children is immense. Implementation of population-wide strategies
for prevention of childhood obesity requires all members of the community to recognize the benefits of a
healthy diet and greater level of physical activity. The
food choices, attitudes, and levels of activity adopted
by parents will tend to be copied by their children.
Parents undoubtedly shape the food choices of young
children and even their ability to regulate their own
intake and appetite (Birch and Davison, 2001; Cooke
_et al_ ., 2004). Campaigns to promote awareness of key
issues are essential and the constant coverage of the
obesity epidemic and its causes through the printed
and broadcast media should play a positive role.
Aside from parents and siblings, schools are the
most important influence upon the health behaviors and knowledge of children. Schools are therefore
seen as an ideal environment to set obesity prevention strategies and interventions. Schools can change
behavior in a number of different ways:


r
Inclusion of healthy eating messages in the curriculum.

r
Promotion of healthy living to both children and
their parents.

r
Inclusion of physical activity sessions across the
whole curriculum on all days of the school week.

r
Provision of open spaces and active play equipment.

r
Limiting access to energy-dense snack foods
through appropriate policies and removal of vending machines.

r
Provision of healthy school meals.


There have been a number of published reports
of school-based interventions and these have yielded
rather patchy results. Stone and colleagues (1998) reviewed the outcomes of 14 school-based interventions that were aimed at boosting physical activity between 1980 and 1997. Although there were some successes, many interventions used limited methodology
for assessing outcome and it was unclear whether observed benefits were maintained once interventions
ended. It was noted that girls may be less recep


**Nutrition and Childhood** **153**


tive than boys to physical activity-based intervention

programs.
Sahota and colleagues (2001) attempted a very
broad school-based intervention in primary schools
in Leeds, UK. A group of five schools serving 5–11year-olds were subjected to a 1-year multidisciplinary
program designed to influence diet, physical activity,
and knowledge. Teachers underwent relevant training, school meals quality was reviewed and improved,
dietitians went into schools to teach sessions to chil
dren, physical education classes were altered to emphasize physical fitness, school health resources were
improved, playground equipment renewed, and parents encouraged to provide healthier packed lunches.
At the end of the intervention period, the schools
were compared to five similar schools where no intervention had taken place. Within the intervention
schools the overall ethos had changed considerably
and children showed much greater knowledge and
understanding of how to change their own behavior
in relation to health. However, despite this there was
no difference in levels of obesity and overweight. In
the intervention schools, while consumption of vegetables increased, fruit consumption decreased. Physical activity patterns were unchanged by the intervention. This study highlights the need for engagement with obesity prevention from more than just
one agency. Schools alone cannot succeed in reversing
obesity trends, if influences and opportunities outside
school hours are operating in the opposite direction.
The food industry, supermarkets, and all elements
of the food distribution network have a powerful influence upon the eating habits of the population and
must therefore play a critical role in any obesity prevention strategy. To achieve societal change the industry needs to be persuaded, or forced by government to
make changes to pricing, availability, and marketing
of energy-dense, high-fat, and high-sugar foodstuffs
in order to discourage their consumption (Dehghan
_et al_ ., 2005; James, 2008b). In some parts of the US
and Canada, taxes have been introduced in order to
increase the price of unhealthy foods and snacks, but
this might be seen by consumers as heavy-handed and
an infringement of their right to choice. It might be
more appropriate to lead consumers to make healthier choices through other means, such as improved
labeling of foods. James (2008b) points out that the
food industry has responded well to other health concerns and should be in a position to do so again.



**154** **Nutrition: A Lifespan Approach**


Effective marketing, pricing, and control of availability has manipulated population-wide consumption
of saturated fats such that intakes have declined and
intakes of polyunsaturated fats have increased, with
clear benefits in cardiovascular health across Northern Europe and America.
Governments at national and local level can have a

majorimpactuponthefightagainstchildhoodobesity
through the influence that they have upon all of the
other agencies and individuals described above. Introducing policies, taxes, or incentives that can influence
food purchasing and consumer choices is one tool that
could be applied. Similarly, governments can shape
education policy and the priorities within school curricula. Changes to the built environment to encourage
more leisure facilities, safe open spaces, and the introduction of walking and cycling networks can help to
promote physical activity.


~~**Summary Box 6**~~


Compared to adults, the energy and nutrient requirements of children are high. Increased demands are a product of growth and
maturation. A nutrient- and energy-dense diet is essential to meet
these demands as the small size of children means that they are
unable to process a bulky diet.
Children are vulnerable to micronutrient deficiencies and
protein–energy malnutrition. Growth faltering is a common sign of
these problems. Poverty, infectious disease, or restrictive dietary
practices are the major factors that drive undernutrition.
Weaning is the introduction of complementary foods to the
infant diet. The overall transition from a milk-based diet to a diet
comprising an adult pattern of eating is an opportunity to teach
children to follow a healthy lifestyle and comply with guidelines
for healthy eating. The range of preferred foods that is actually
consumed by children is rather narrow, but strongly influenced by
parental choices.
Schools provide suitable environments for the promotion of
health in children. This can be achieved through placing health
and nutrition in a prominent position in the curriculum, by encouraging daily physical activity, and through introduction of
high-quality school meals, breakfast clubs, and other food-based
initiatives.
The prevalence of overweight and obesity in children has more
than doubled in the first decade of the twenty-first century. This
increase is primarily driven by increased consumption of energydense foodstuffs and declining energy expenditure associated with
sedentary leisure activities.
Successful strategies for the prevention of childhood obesity at
the population level are dependent upon integrated activities of
all stakeholders, including parents and children, schools, the food
industry, and local and national governments.



**References**


Alvy LM and Calvert SL (2008) Food marketing on popular children’s web sites: a content analysis. _Journal of the American Di-_
_etetic Association_ **108**, 710–713.
Bhandari N, Bahl R, Taneja S _et al._ (2002) Substantial reduction
in severe diarrheal morbidity by daily zinc supplementation in
young north Indian children. _Pediatrics_ **109**, e86.
Birch LL and Davison KK (2001) Family environmental factors
influencing the developing behavioral controls of food intake
and childhood overweight. _Pediatric Clinics North America_ **48**,
893–907.
Black MM (2003) The evidence linking zinc deficiency with children’s cognitive and motor functioning. _Journal of Nutrition_ **133**,
1473S–1476S.
BoothIWandAukettMA(1997)Irondeficiencyanaemiaininfancy
and early childhood. _Archives of Disease in Childhood_ **76**, 549–
553.
Borzekowski DL and Robinson TN (2001) The 30-second effect:
an experiment revealing the impact of television commercials on
food preferences of preschoolers. _Journal of the American Dietetic_
_Association_ **101**, 42–46.
Bowman SA, Gortmaker SL, Ebbeling CB, Pereira MA, and Ludwig
DS (2004) Effects of fast-food consumption on energy intake
and diet quality among children in a national household survey.
_Pediatrics_ **113**, 112–118.
BriefelR,HansonC,FoxMK,NovakT,andZieglerP(2006)Feeding
Infants and Toddlers Study: do vitamin and mineral supplements
contribute to nutrient adequacy or excess among US infants and
toddlers? _Journal of the American Dietetic Association_ **106**, S52–
S65.
Bundred P, Kitchiner D, and Buchan I (2001) Prevalence of overweight and obese children between 1989 and 1998: population
based series of cross sectional studies. _British Medical Journal_
**322**, 326–328.
Burke V, Beilin LJ, Simmer K _et al._ (2005) Predictors of body mass
index and associations with cardiovascular risk factors in Australian children: a prospective cohort study. _International Journal_
_of Obesity_ **29**, 5–23.
ButteNF(2005)Energyrequirementsofinfantsandchildren. _Nestle_
_Nutrition Workshop Series Pediatric Programme_ **58**, 19–32.
Calder PC and Jackson AA (2000) Undernutrition, infection and
immune function. _Nutrition Research Reviews_ **13**, 3–29.
Carnell S, Edwards C, Croker H, Boniface D, and Wardle J (2005)
Parental perceptions of overweight in 3–5 y olds. _International_
_Journal of Obesity_ **29**, 353–355.
Caroli M and Burniat W (2002) Dietary management. In: _Child_
_and Adolescent Obesity. Causes, Consequences and Management_
(eds W Burniat, T Cole, I Lissau, and E Poskitt), pp. 282–306.
Cambridge University Press, New York.
Chinn S and Rona RJ (2001) Prevalence and trends in overweight
and obesity in three cross sectional studies of British children,
1974–94. _British Medical Journal_ **322**, 24–26.
Cole TJ, Freeman JV, and Preece MA (1995) Body mass index
referencecurvesfortheUK,1990. _ArchivesofDiseaseinChildhood_
**73**, 25–29.
Coll AP (2007) Effects of pro-opiomelanocortin (POMC) on food
intake and body weight: mechanisms and therapeutic potential?
_Clinical Science_ **113**, 171–182.
Connor SM (2006) Food-related advertising on preschool television:buildingbrandrecognitioninyoungviewers. _Pediatrics_ **118**,
1478–1485.
Cooke LJ, Wardle J, Gibson EL, Sapochnik M, Sheiham A, and
Lawson M (2004) Demographic, familial and trait predictors of



fruit and vegetable consumption by pre-school children. _Public_
_Health Nutrition_ **7**, 295–302.
Cowin I and Emmett P (2007) ALSPAC Study Team. Diet in a group
of 18-month-old children in South West England, and comparison with the results of a national survey. _Journal of Human_
_Nutrition and Dietetics_ **20**, 254–267.
Craig S, Goldberg J, and Dietz WH (1996) Psychosocial correlates
of physical activity among fifth and eighth graders. _Preventive_
_Medicine_ **25**, 506–513.
Daniels SR, Arnett DK, Eckel RH _et al._ (2005) Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. _Circulation_ **111**, 1999–2012.
Dehghan M, Akhtar-Danesh N, and Merchant AT (2005) Childhood obesity, prevalence and prevention. _Nutrition Journal_ **2**,
4–24.
de Onis M and Bl¨ossner M (2000) Prevalence and trends of overweight among preschool children in developing countries. _Amer-_
_ican Journal of Clinical Nutrition_ **72**, 1032–1039.
Department of Health (1998) _Dietary Reference Values for Energy_
_and Nutrients for the United Kingdom_ . Stationary Office, London.
Deshmukh-Taskar P, Nicklas TA, Morales M, Yang SJ, Zakeri I, and
Berenson GS (2006) Tracking of overweight status from childhood to young adulthood: the Bogalusa Heart Study. _European_
_Journal of Clinical Nutrition_ **60**, 48–57.
Dietz WH (1998) Childhood weight affects adult morbidity and
mortality. _Journal of Nutrition_ **128**, 411S–414S.
Dixon HG, Scully ML, Wakefield MA, White VM, and Crawford DA
(2007) The effects of television advertisements for junk food versus nutritious food on children’s food attitudes and preferences.
_Social Science and Medicine_ **65**, 1311–1323.
Dovey TM, Staples PA, Gibson EL, and Halford JC (2008) Food
neophobia and ‘picky/fussy’ eating in children: a review. _Appetite_
**50**, 181–193.
Dubois L, Farmer A, Girard M, and Peterson K (2008) Social factors
and television use during meals and snacks is associated with
higher BMI among pre-school children. _Public Health Nutrition_
**12**, 1–13.
Eaton SB, Konner M, and Shostak M (1988) Stone agers in the fast
lane: chronic degenerative diseases in evolutionary perspective.
_American Journal of Medicine_ **84**, 739–749.
Ells LJ, Hillier FC, Shucksmith J _et al._ (2008) A systematic review of
the effect of dietary exposure that could be achieved through normal dietary intake on learning and performance of school-aged
children of relevance to UK schools. _British Journal of Nutrition_
**100**, 927–936.
Epstein LH, Paluch RA, Beecher MD, and Roemmich JN (2008)
Increasing healthy eating vs. reducing high energy-dense foods
to treat pediatric obesity. _Obesity_ **16**, 318–326.
(EU-SILC) (2007) EU Survey on Income and Living Conditions.
The Stationery Office, Dublin, Ireland.
Farooqi IS, Wangensteen T, Collins S _et al._ (2007) Clinical
and molecular genetic spectrum of congenital deficiency of
the leptin receptor. _New England Journal of Medicine_ **356**,
237–247.
Fogarty AW, Antoniak M, Venn AJ _et al._ (2007) Does participation
in a population-based dietary intervention scheme have a lasting
impact on fruit intake in young children? _International Journal_
_of Epidemiology_ **36**, 1080–1085.
Foote KD and Marriott LD (2003) Weaning of infants. _Archives of_
_Disease in Childhood_ **88**, 488–492.
Fox MK, Reidy K, Novak T, and Ziegler P (2006) Sources of energy
and nutrients in the diets of infants and toddlers. _Journal of the_
_American Dietetic Association_ **106**, S28–S42.
Freedman DS, Khan LK, Dietz WH, Srinivasan SR, and Berenson
GS (2001) Relationship of childhood obesity to coronary heart



**Nutrition and Childhood** **155**


disease risk factors in adulthood: the Bogalusa Heart Study. _Pe-_
_diatrics_ **108**, 712–718.
Freedman DS, Ogden CL, Flegal KM, Khan LK, Serdula MK, and
Dietz WH (2007) Childhood overweight and family income.
_Medscape General Medicine_ **9**, 26.
Freedman DS, Patel DA, Srinivasan SR _et al._ (2008) The contribution of childhood obesity to adult carotid intima-media thickness: the Bogalusa Heart Study. _International Journal of Obesity_
**32**, 749–756.
Freeman JV, Cole TJ, Chinn S, Jones PR, White EM, and Preece
MA (1995) Cross sectional stature and weight reference curves
for the UK, 1990. _Archives of Disease in Childhood_ **73**, 17–24.
Galloway AT, Lee Y, and Birch LL (2003) Predictors and consequences of food neophobia and pickiness in young girls. _Journal_
_of the American Dietetic Association_ **103**, 692–698.
Garlick PJ (2006) Protein requirements of infants and children.
_Nestle Nutrition Workshop Series Pediatric Programme_ **58**, 39–47.
Garnett SP, Baur LA, Srinivasan S, Lee JW, and Cowell CT (2007)
Body mass index and waist circumference in midchildhood and
adverse cardiovascular disease risk clustering in adolescence.
_American Journal of Clinical Nutrition_ **86**, 549–555.
Garza JC, Kim CS, Liu J, Zhang W, and Lu XY (2008) Adenoassociated virus-mediated knockdown of melanocortin-4 receptor in the paraventricular nucleus of the hypothalamus promotes
high-fat diet-induced hyperphagia and obesity. _Journal of En-_
_docrinology_ **197**, 471–482.
Georgieff MK (2007) Nutrition and the developing brain: nutrient
priorities and measurement. _American Journal of Clinical Nutri-_
_tion_ **85**, 614S–620S.
Golan M, Weizman A, Apter A, and Fainaru M (1998) Parents as the
exclusive agents of change in the treatment of childhood obesity.
_American Journal of Clinical Nutrition_ **67**, 1130–1135.
Goldstone AP (2004) Prader-Willi syndrome: advances in genetics, pathophysiology and treatment. _Trends in Endocrinology and_
_Metabolism_ **15**, 12–20.
Gordon CM, Feldman HA, Sinclair L _et al._ (2008) Prevalence of vitamin D deficiency among healthy infants and toddlers. _Archives_
_of Pediatric and Adolescent Medicine_ **162**, 505–512.
Grace CM (2001) Dietary management of obesity. In: _Management_
_ofObesityandRelatedDisorders_ (ed.PGKopelman),pp.129–164.
Martin Dunitz, London.
Gregory JR, Collins DL, Davies PSW, Hughes JM, and Clarke PM
(1995) _National Diet and Nutrition Survey: Children Aged 1 1/2_
_to 4 1/2 Years_, Vol. 1, Report of the diet and nutrition survey.
HMSO, London.
Guillaume M, Lapidus L, and Lambert A (1998) Obesity and nutrition in children. The Belgian Luxembourg Child Study IV.
_European Journal of Clinical Nutrition_ **52**, 323–328.
Hackett A, Nathan I, and Burgess L (1998) Is a vegetarian diet
adequate for children. _Nutrition and Health_ **12**, 189–195.
Hamlyn B, Brooker S, Oleinikova K, and Wands S (2002) _Infant_
_Feeding 2000_ . The Stationery Office, London.
Hart Sailors ML, Folsom AR, Ballantyne CM _et al._ (2007) Genetic
variation and decreased risk for obesity in the Atherosclerosis
Risk in Communities Study. _Diabetes Obesity and Metabolism_ **9**,
548–557.
Henderson L, Gregory J, and Swan G (2002) _National Diet and_
_Nutrition Survey: Adults Aged 19–64 Years_ . Office of National
Statistics, London.
Hill JO and Peters JC (1998) Environmental contributions to the
obesity epidemic. _Science_ **280**, 1371–1374.
JamesWP(2008a)Thefundamentaldriversoftheobesityepidemic.
_Obesity Reviews_ **9**, 6–13.
James WP (2008b) The epidemiology of obesity: the size of the
problem. _Journal of Internal Medicine_ **263**, 336–352.



**156** **Nutrition: A Lifespan Approach**


Johannsson E, Arngrimsson SA, Thorsdottir I, and Sveinsson T
(2006) Tracking of overweight from early childhood to adolescence in cohorts born 1988 and 1994: overweight in a high birth
weight population. _International Journal of Obesity_ **30**, 1265–
1271.
Johnson L, Mander AP, Jones LR, Emmett PM, and Jebb SA (2008)
Energy-dense, low-fiber, high-fat dietary pattern is associated
with increased fatness in childhood. _American Journal of Clinical_
_Nutrition_ **87**, 846–854.
Juonala M, Raitakari MSA, Viikari J, and Raitakari OT (2005) Obesity in youth is not an independent predictor of carotid IMT
in adulthood. The cardiovascular risk in Young Finns Study.
_Atherosclerosis_ **185**, 388–393.
Kemp A (2008) Food additives and hyperactivity. _British Medical_
_Journal_ **336**, 1144.
Kennedy E and Davis C (1998) US department of agriculture school
breakfast program. _American Journal of Clinical Nutrition_ **67**,
798S–803S.
Kopelman CA, Roberts LM, and Adab P (2007) Advertising of
food to children: is brand logo recognition related to their food
knowledge, eating behaviours and food preferences? _Journal of_
_Public Health_ **29**, 358–367.
KukretyN(2007) _InvestingintheFuture_ .SavetheChildren,London.
Lanigan JA, Bishop J, Kimber AC, and Morgan J (2001) Systematic
review concerning the age of introduction of complementary
foods to the healthy full-term infant. _European Journal of Clinical_
_Nutrition_ **55**, 309–320.
Leaf AA (2007) RCPCH standing committee on nutrition. Vitamins
for babies and young children. _Archives of Disease in Childhood_
**92**, 160–164.
Lee YS, Poh LK, Kek BL, and Loke KY (2008) Novel melanocortin
4 receptor gene mutations in severely obese children. _Clinical_
_Endocrinology_ **68**, 529–535.
Lobstein T and Dibb S (2005) Evidence of a possible link between
obesogenic food advertising and child overweight. _Obesity Re-_
_views_ **6**, 203–208.
Loos RJ and Bouchard C (2008) FTO: the first gene contributing to
common forms of human obesity. _Obesity Reviews_ **9**, 246–250.
Loos RJ, Lindgren CM, Li S _et al._ (2008) Common variants near
MC4R are associated with fat mass, weight and risk of obesity.
_Nature Genetics_ **40**, 768–775.
Lozoff B, Beard J, Connor J, Barbara F, Georgieff M, and Schallert
T (2006) Long-lasting neural and behavioral effects of iron deficiency in infancy. _Nutrition Reviews_ **64**, S34–S43.
Ludwig DS, Peterson KE, and Gortmaker SL (2001) Relation between consumption of sugar-sweetened drinks and childhood
obesity: a prospective, observational analysis. _Lancet_ **357**, 505–
508.
LutterCKandDeweyKG(2003)Proposednutrientcompositionfor
fortified complementary foods. _Journal of Nutrition_ **133**, 3011S–
3020S.
Lutter CK and Rivera JA (2003) Nutritional status of infants and
young children and characteristics of their diets. _Journal of Nu-_
_trition_ **133**, 2941S–2949S.
Maffeis C, Talamini G, and Tat`o L (1998) Influence of diet, physical
activity and parents’ obesity on children’s adiposity: a four-year
longitudinal study. _International Journal of Obesity_ **22**, 758–764.
Magarey AM, Daniels LA, Boulton TJ, and Cockington RA (2001)
Does fat intake predict adiposity in healthy children and adolescents aged 2–15 y? A longitudinal analysis. _European Journal of_
_Clinical Nutrition_ **55**, 471–481.
Malik VS, Schulze MB, and Hu FB (2006) Intake of sugar-sweetened
beverages and weight gain: a systematic review. _American Journal_
_of Clinical Nutrition_ **84**, 274–288.



Mangels AR and Messina V (2001) Considerations in planning
vegan diets: infants. _Journal of the American Dietetic Association_
**101**, 670–677.
McCaffrey TA, Rennie KL, Kerr MA _et al._ (2008) Energy density of
the diet and change in body fatness from childhood to adolescence; is there a relation? _American Journal of Clinical Nutrition_
**87**, 1230–1237.
McCann D, Barrett A, Cooper A _et al._ (2007) Food additives
and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebocontrolled trial. _Lancet_ **370**, 1560–1567.
McLean N, Griffin S, Toney K, and Hardeman W (2003) Family
involvement in weight control, weight maintenance and weightloss interventions: a systematic review of randomised trials. _In-_
_ternational Journal of Obesity_ **27**, 987–1005.
Moore GF, Tapper K, Murphy S, _et al._ (2007) Associations between
deprivation, attitudes towards eating breakfast and breakfast eating behaviours in 9–11-year-olds. _Public Health Nutrition_ **10**,
582–589.
Mu˜noz EC, Rosado JL, L´opez P, Furr HC, and Allen LH (2000)
Iron and zinc supplementation improves indicators of vitamin
A status of Mexican preschoolers. _American Journal of Clinical_
_Nutrition_ **71**, 789–794.
Must A and Tybor DJ (2005) Physical activity and sedentary behavior: a review of longitudinal studies of weight and adiposity in
youth. _International Journal of Obesity_ **29**, S84–S96.
Nelson M (2000) Childhood nutrition and poverty. _Proceedings of_
_the Nutrition Society_ **59**, 307–315.
Neville L, Thomas M, and Bauman A (2005) Food advertising on
Australian television: the extent of children’s exposure. _Health_
_Promotion International_ **20**, 105–112.
Noimark L and Cox HE (2008) Nutritional problems related to
food allergy in childhood. _Pediatric Allergy and Immunology_ **19**,
188–195.
Norris FJ, Larkin MS, Williams CM, Hampton SM, and Morgan
JB (2002) Factors affecting the introduction of complementary
foodsinthepreterminfant. _EuropeanJournalofClinicalNutrition_
**56**, 448–454.
O’Rahilly S (2007) Human obesity and insulin resistance: lessons
from experiments of nature. _Biochemical Society Transactions_ **35**,
33–36.
Osendarp SJ, Santosham M, Black RE, Wahed MA, van Raaij JM,
and Fuchs GJ (2002) Effect of zinc supplementation between 1
and 6 mo of life on growth and morbidity of Bangladeshi infants
in urban slums. _American Journal of Clinical Nutrition_ **76**, 1401–
1408.
Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury
PR, and Zeitler P (1996) Increased incidence of non-insulindependent diabetes mellitus among adolescents. _Journal of Pedi-_
_atrics_ **128**, 608–615.
Popkin BM and Duo S (2003) Dynamics of the nutrition transition
toward the animal foods sector in China and its implications: a
worried perspective. _Journal of Nutrition_ **133**, S3898–S3906.
Prentice AM and Paul AA (2000) Fat and energy needs of children
in developing countries. _American Journal of Clinical Nutrition_
**72**, 1253S–1265S.
Rampersaud GC, Pereira MA, Girard BL, Adams J, and Metzl JD
(2005) Breakfast habits, nutritional status, body weight, and academic performance in children and adolescents. _Journal of the_
_American Dietetic Association_ **105**, 743–760.
Ransley JK, Greenwood DC, Cade JE _et al._ (2007) Does the school
fruit and vegetable scheme improve children’s diet? A nonrandomised controlled trial. _Journal of Epidemiology and Com-_
_munity Health_ **61**, 699–703.



Reilly JJ, Armstrong J, Dorosty AR _et al._ (2005) Avon longitudinal
study of parents and children study team. Early life risk factors
for obesity in childhood: cohort study. _British Medical Journal_
**330**, 1357.
Rennie KL, Wells JC, McCaffrey TA, and Livingstone MB
(2006) The effect of physical activity on body fatness in children and adolescents. _Proceedings of the Nutrition Society_ **65**,
393–402.
Rhee KE, De Lago CW, Arscott-Mills T, Mehta SD, and Davis
RK (2005) Factors associated with parental readiness to
make changes for overweight children. _Pediatrics_ **116**, e94–
e101.
Robertson SM, Cullen KW, Baranowski J, Baranowski T, Hu S, and
de Moor C (1999) Factors related to adiposity among children
aged 3 to 7 years. _Journal of the American Dietetic Association_ **99**,
938–943.
Robinson TN, Borzekowski DL, Matheson DM, and Kraemer HC
(2007) Effects of fast food branding on young children’s taste
preferences. _Archives of Pediatric and Adolescent Medicine_ **161**,
792–797.
Rosenheck R (2008) Fast food consumption and increased caloric
intake: a systematic review of a trajectory towards weight gain
and obesity risk. _Obesity Reviews_ **9**, 518–521.
Rudolf MC, Sahota P, Barth JH, and Walker J (2001) Increasing
prevalence of obesity in primary school children: cohort study.
_British Medical Journal_ **322**, 1094–1095.
SACN (2003) _Salt and Health_ . The Stationery Office, London.
Sahota P, Rudolf MC, Dixey R, Hill AJ, Barth JH, and Cade J (2001)
Randomised controlled trial of primary school based intervention to reduce risk factors for obesity. _British Medical Journal_ **323**,
1029–1032.
Sausenthaler S, Kompauer I, Mielck A _et al._ (2007) Impact of
parental education and income inequality on children’s food
intake. _Public Health Nutrition_ **10**, 24–33.
Save the Children (2007) Living below the radar. Severe child
poverty in the UK. Save the Children, London.
Schab DW and Trinh NH (2004) Do artificial food colors promote hyperactivity in children with hyperactive syndromes? A
meta-analysis of double-blind placebo-controlled trials. _Jour-_
_nal of Developmental and Behavioural Pediatrics_ **25**, 423–
434.
Shamah T and Villalpando S (2006) The role of enriched foods
in infant and child nutrition. _British Journal of Nutrition_ **96**,
S73–S77.


**Self-Assessment Questions**


Assess your understanding of the concepts outlined in
this chapter using the following questions:


1 What are the causes of obesity in childhood?
2 What public health strategies might be employed to
prevent overweight and obesity in children?
3 Critically review whether childhood obesity might be a
risk factor for metabolic disease in adult life.
4 Describe the nutrient requirements of preschool children.



**Nutrition and Childhood** **157**


Shaw NJ and Pal BR (2002) Vitamin D deficiency in UK Asian families: activating a new concern. _Archives of Disease in Childhood_
**86**, 147–149.
Skinner JD, Bounds W, Carruth BR, Morris M, and Ziegler P (2004)
Predictors of children’s body mass index: a longitudinal study of
diet and growth in children aged 2–8 y. _International Journal of_
_Obesity_ **28**, 476–482.
Stettler N, Signer TM, and Suter PM (2004) Electronic games
and environmental factors associated with childhood obesity in
Switzerland. _Obesity Research_ **12**, 896–903.
Stone EJ, McKenzie TL, Welk GJ, and Booth ML (1998) Effects of
physical activity interventions in youth. Review and synthesis.
_American Journal of Preventive Medicine_ **15**, 298–315.
Thompson OM, Ballew C, Resnicow K _et al._ (2006) Dietary pattern
as a predictor of change in BMI z-score among girls. _International_
_Journal of Obesity_ **30**, 176–182.
Torun B (2005) Energy requirements of children and adolescents.
_Public Health Nutrition_ **8**, 968–993.
United Nations (2007) _The Millennium Development Goals Report_ .
United Nations, New York.
Utter J, Scragg R, Mhurchu CN, and Schaaf D (2007) At-home
breakfast consumption among New Zealand children: associations with body mass index and related nutrition behaviors.
_Journal of the American Dietetic Association_ **107**, 570–576.
Wang Y, Ge K, and Popkin BM (2000) Tracking of body mass index
from childhood to adolescence: a 6-y follow-up study in China.
_American Journal of Clinical Nutrition_ **72**, 1018–1024.
Wang Y and Lobstein T (2006) Worldwide trends in childhood
overweight and obesity. _International Journal of Pediatric Obesity_
**1**, 11–25.
Wang YC, Bleich SN, and Gortmaker SL (2008) Increasing caloric
contribution from sugar-sweetened beverages and 100% fruit
juices among US children and adolescents, 1988–2004. _Pediatrics_
**121**, e1604–e1614.
Wardle J, Carnell S, Haworth CM, and Plomin R (2008) Evidence
for a strong genetic influence on childhood adiposity despite
the force of the obesogenic environment. _American Journal of_
_Clinical Nutrition_ **87**, 398–404.
Wright CM, Parker L, Lamont D, and Craft AW (2001) Implications
of childhood obesity for adult health: findings from thousand
families cohort study. _British Medical Journal_ **323**, 1280–1284.
Wright CM, Parkinson KN, Shipton D, and Drewett RF (2007) How
do toddler eating problems relate to their eating behavior, food
preferences, and growth? _Pediatrics_ **120**, e1069–e1075.


5 What is the current advice on the timing and approach
to be taken in introducing complementary foods to infants?

6 Discuss the main barriers to healthy eating in children
under the age of 11 years.
7 How might school-based interventions influence the
establishment of healthy eating preferences in children?



# **7**

### **Nutrition and Adolescence**

**Learning objectives**



By the end of this chapter, the reader should be able to:


r Describe the patterns of growth that are seen during
the adolescent period.
r Discuss the changes in body composition that are as~~sociated with the pubertal phase of growth.~~
r Show an appreciation of the relationship between endocrine factors and nutritional status as determinants
of bone growth and sexual maturation.
r Describe the processes that allow the growth of bone.
r Discuss the physiological processes that determine requirements for energy, macronutrients, and micronutrients during adolescence.


**7.1 Introduction**


Adolescence is the transitional stage that lies between
childhood and adulthood. This stage of life is dominated by the physiological processes that surround
puberty, which are accompanied by rapid growth
and maturation. Alongside these biological processes,
there are psychological changes as the child attains
an adult capacity for cognitive processes and acquires
the ability to take on adult responsibilities. The impact that the adolescent period has upon nutritional
status is not only influenced by these biological and
psychological changes, but is also strongly modulated
by the sociocultural aspects of adolescence. In many
of the developing countries, the transition from child
to adult is mostly a physiological issue and culturally the child becomes an adult by passing through a
coming-of-age ceremony. Thereafter, the boys take on
the roles of adult men, and the girls marry and have
children. In industrialized countries, the social construct of the “teenager” is the dominant cultural pattern. This serves to extend the transition from child
to adult, and in effect, the young adult lives for a
longer period under the guidance of their parents.
The teenager is culturally expected to undergo emotional trauma, erratic, and occasionally rebellious be


r Describe how the increasing independence that is associated with adolescence is a major factor that determines food choices during this life stage.
r Identify behaviors that may promote problems with nutritional status among adolescents. These will include
~~restrictive dietary practices, excessive physical activity,~~
disordered eating, and the use of alcohol and tobacco
products.
r Discuss the main features of anorexia nervosa and bulimia nervosa and identify key risk factors for the development of these eating disorders in adolescence.
r Describe the particular nutritional concerns that are associated with pregnancy during adolescence.


havior. This chapter will consider how these issues
and behaviors, coupled with the biological demands
of adolescence, impact upon nutritional requirements
and status.


**7.2 Physical development**


_**7.2.1 Growth rate**_


During childhood, growth occurs at a rate of 5–6 cm
per year, with a steady decline in growth velocity from
infancy through to the onset of puberty. With puberty,
both girls and boys go through a “growth spurt” that
lasts for approximately 2–3 years. In terms of height,
the gain associated with the growth spurt is a significant proportion of final adult stature (15–20%).
During this growth phase, girls gain approximately
20 cm (range 5–25 cm), while in boys the gain is
slightly greater at 23 cm (10–30 cm). Peak height velocities achieved during the growth spurt are 9 and
10.5 cm/year for girls and boys, respectively (Tanner,
1989). Timing of the growth spurt is earlier in girls
than in boys, occurring at around the time the breasts
begin to grow (thelarche; one of the earliest indicators of female puberty). In boys, sexual maturation



has generally advanced to a relatively late stage before
the onset of the growth spurt. The increase in rates of
height gain is matched by increases in weight. In boys,
height and weight gain occur together, but in girls
weight gain lags behind height gain by 3–6 months. In
both sexes, weight gain is proportionally greater than
height gain (e.g., girls gain 20% of adult height and
50% of adult weight during the growth spurt), leading
to an increased body mass index.
Although the pubertal growth spurt is a phase of
major height and weight gain, it is not the main determinant of final adult height. Indeed, it is estimated
that only 30% of the variation in adult height is explainedbytherateofgrowthduringitsmaximalphase
during puberty (Tanner, 1989). Growth before puberty is in fact the main determinant of adult stature,
and the height and weight gained during the growth
spurt are simply superimposed upon the prepubertal
growth rate. Boys tend to grow taller than girls because they enter puberty at a later stage. Indeed, prior
to puberty, boys and girls tend to be of similar stature
(average height of Europeans at age 9, boys 132 cm,
girls 131 cm) but by adulthood males are typically 12–
13 cm taller. Similarly, girls who are “late developers”
and enter puberty at an older age will generally attain
a greater than average height due to their extended
prepubertal growth phase.
The growth spurt impacts upon all parts of the
body, but the timing of regional growth is uneven.
Limb growth precedes the growth of the trunk by 6–9
months, for example. Thickening of the skull and remodeling of tissues of the scalp, widening of the jaws,
and growth of the facial musculature are all events
associated with the growth spurt, and are more pronounced in boys than in girls, particularly later in
puberty. Growth ceases in males between the ages of
18 and 20, which is usually 2–3 years after the end of
the growth spurt. In females, growth usually ceases
within 2–3 years of menarche, and on average, girls
attain final adult height by the age of 16.5 years. In
some cases, later sexual maturation allows growth to
continue until 19 years.
Growth is sexually dimorphic, in terms of the timing and final achieved heights and the distribution of
increasing mass. Males exhibit characteristic increases
in size across the shoulders during puberty, while in
females there is greater growth at the hips. These differences in skeletal growth occur due to hormone sensitivity of cartilage cells at these sites. At the hip, cells



**Nutrition and Adolescence** **159**


respond to estrogen and this leads to greater pelvic
girth to accommodate reproductive functions. Androgen sensitivity at the shoulders produces the characteristic male body shape and upper body strength.


_**7.2.2 Body composition**_


The rapid growth of adolescence is accompanied by
remodeling of body composition in both sexes. In
boys and girls, the larger body mass associated with
greater stature is associated with an increase in muscle mass and hence the fat-free mass of the body
(Figure 7.1). The growth spurt for muscle lags slightly
behind the peak in linear growth, and as it is triggered
by the events of puberty, it tends to occur earlier in
females than in males. In fact for a period between 12
and 14 years of age, girls will tend to be more muscular than boys (Tanner, 1989). However, there are
significant differences between the sexes in terms of
fat deposition, which is greater in girls than in boys.
As a result, while fat-free mass as a proportion of body
weight increases from 80% to 90% in boys across the
period of adolescence, this declines from 80% to 75%
in girls.
As shown in Figure 7.1, the absolute mass of body
fat in boys increases slightly between the ages of 8
and the onset of the pubertal growth spurt and then
declines. As a proportion of body mass, body fat increases from 15% at age 8 to 17.5% at 12–14 years, but
by the end of puberty, it is only 11% (Guo _et al_ ., 1997).
In girls, puberty is associated with a steady increase in
the amount of adipose tissue, as fat is deposited in the
pelvic region, breasts, upper back, arms, and subcutaneously. As a proportion of body mass, fat increases
from 20% to 25% in females over the adolescent years.


_**7.2.3 Puberty and sexual maturation**_


It should be clear from the sections above that sexual
maturation and the events surrounding puberty are
the principal processes that determine many of the
requirements for nutrients and changes in body composition that are associated with the adolescent period. Puberty has its onset earlier in girls (8–13 years
of age) than in boys (9.5–13.5 years of age) and is typically of 3–4 years duration. There are wide variations
in timing and speed of maturation between individuals. In boys, the growth of the penis, for example, on
average begins at the age of 12.5 years. However, in
some boys, this will occur much earlier (10.5 years),
and in others as late as 14.5 years. Thus, among a



**160** **Nutrition: A Lifespan Approach**


**60**
Males

Females


**40**


**20**


**0**





**20**
Males

Females

**15**



**10**


**5**


**0**


**8–10** **10–12** **12–14** **14–16** **16–18**


**Age (years)**


population of boys aged 13–15 years, the level of sexualmaturationwillshowhugevariation.Althoughthe
timings are variable, in boys the sequence of maturational events is well conserved. Testicular enlargement
is always the first event, and with the ensuing increase
in hormone secretion, this drives penile growth, the
appearance of pubic hair, and the pubertal growth
spurt.
As a result of the variability in timing of pubertal
growth and maturation, it is more practical to consider adolescents in terms of their pubertal milestones
than in terms of chronological age when reviewing
influences of nutrition upon physiology. For this purpose, it is common to consider either skeletal age (see
Section 7.2.4) or the sexual maturation rating (SMR,
Tanner stage of development, Table 7.1). In girls, there
is variability in terms of timing and sequencing of
these stages. Breast stage 2 is often the first indicator
of puberty and occurs on average at 10.8 years (range
8.8–12.8 years). In two-thirds of girls, this will precede
other events, but a significant proportion of girls will
develop pubic hair ahead of breast budding (Tanner,
1989). Timing of menarche also varies and while most



**Figure 7.1** Accrual of lean and fat mass during the prepubertal and pubertal periods. During adolescence, there
is a rapid increase in the lean body mass of males and
females, coinciding with the pubertal growth spurt. Fat
mass also increases, but to a greater extent in females.
Data redrawn from Guo _et al_ . (1997) represents Caucasian children.


girls have their first menstrual period at breast stage
4, around 25% will do so at stage 3. The SMR ratings
generally map well against growth rates. In girls, the
pubertal growth spurt begins at around stage 2. In
boys, the growth spurt is delayed and coincides with
SMR4 (Figure 7.2).
The major changes in body composition that are
described in Section 7.2.2 are partly features of
growth during adolescence. They are also driven by
the actions of sex steroids that are secreted as the
hypothalamic–pituitary–gonadal and hypothalamic–
pituitary–adrenal axes mature. The independent and
parallel processes of puberty and adrenarche result
in the development of the secondary sexual characteristics and produce endocrine changes that remodel body composition in a gender-specific manner
(Figure 7.3).
Adrenarche usually occurs between the ages of 6
and 10 years. In boys, it is therefore a forerunner of
puberty, but in girls may occur alongside pubertal
changes. During adrenarche, the adrenal cortex expands and completes differentiation into three separate zones, the zona glomerulosa, the zona fasciculata,



**Nutrition and Adolescence** **161**


**Table 7.1** Sexual maturation ratings (Tanner stages)


Both sexes


Pubic hair

Stage 1 None
Stage 2 Small amounts of long downy hair with little pigment
Stage 3 Coarse and curly extending across pubis
Stage 4 Adult-like features but not yet spreading to thighs
Stage 5 Adult pattern and features
Males


Genitals _[a]_


Stage 1 Prepubertal appearance
Stage 2 Testes enlarging and scrotum reddening and thinning
Stage 3 Further enlargement of scrotum and testes. Penis lengthening
Stage 4 Penis increasing in length, scrotum darkening further
Stage 5 Adult characteristics


Breasts

Stage 1 Prepubertal appearance
Stage 2 Breast bud formation and growth of areola
Stage 3 Areola continuing expansion. Breast elevating and extending beyond areola
Stage 4 Breast size and elevation increasing. Nipple and areola extending as a secondary mound
Stage 5 Adult characteristics


_a_ In males, staging based upon genital growth may be referred to as stages G1–G5.





Menarche


Breast SMR


Pubic hair SMR


Genitals



10.5–16.0 13.5–17.5


10.0–16.5


2  3  4      5

8.0–13.0

2      3 4      5


8.0–14.0


2  3    4        5



9.5–13.5 13.5–17.0

Pubic hair SMR 2    3    4          5


8.0–14.0 13.5–17.0


**8** **9** **10** **11** **12** **13** **14** **15** **16** **17** **18**

**Age (years)**


**Figure 7.2** The relationship of growth velocity to pubertal staging in boys and girls. Average timings of pubertal (Tanner) staging are shown in
the lower half of the figure. Age ranges beneath the pubertal staging boxes indicate the spread of values over which sexual maturation begins and
ends. Height velocity curves at the top of the figure show the timings of the pubertal growth spurt in girls ( ) and boys (- - - -) and the average
age of maximal growth velocity. It is clear from the figure that in girls, acceleration of growth precedes pubertal development, while in boys, this
acceleration occurs at a more advanced stage. ( _Source_ : Adapted from Tanner (1989).)



**162** **Nutrition: A Lifespan Approach**

















**Figure 7.3** The key endocrine events of adolescence. Adrenarche and puberty are separate processes that promote endocrine maturation.
Development of the adrenal gland increases secretion of androgens in both males and females. The adrenal androgens stimulate development
of secondary sexual characteristics. Puberty begins with the maturation of the hypothalamus and the stable rhythm of production of GnRH. FSH,
follicle stimulating hormone; LH, luteinising hormone.



and the zona reticularis. The zona reticularis synthesizes androgens, including androstendione and dihydroepiandrosterone sulfate. These initiate the appearanceofthesecondarysexualcharacteristicsandsymptoms that are associated with puberty, including acne,
body odor, changes to the vocal cords and deepening
of the voice, appearance of pubic hair, and axillary
hair.

The appearance of pubic hair is termed pubarche
andisalsodrivenbytheendocrinesignalsthatdevelop
with the onset of puberty (Figure 7.3). True puberty
beginswiththehypothalamusachievingaregularpulsatile pattern of gonadotrophin releasing hormone
(GnRH) release. This is not only partly achieved as a
response to leptin signaling of body fatness in both
girls and boys (see Chapter 2), but is also driven by
the maturation of glutaminergic neurones within the
hypothalamus. Stimulation of the gonads by luteinising hormone and follicle stimulating hormone has
characteristic effects in boys and girls. In boys, the



testes enlarge and produce testosterone and androstendione. These further stimulate the appearance of
the secondary sexual characteristics and the growth
of the penis and testes. Production of androgens promotes both linear growth and the growth of muscular tissue. The greater activity of these hormones in
males results in the development of a larger body with
a greater proportion of lean body mass. In girls, ovarian synthesis of estrogen and progesterone also contributes to the secondary sexual characteristics, but
more importantly leads to the establishment of reproductive cycling and thelarche. Estrogens stimulate
the deposition of body fat, and hence with advancing pubertal stages, the female body contains a greater
proportion of fat than that of the male. Menarche is an
indicator that the uterus and ovaries are fully mature,
but this does not mark the end of the events of puberty. In girls, growth will continue for a short period,
allowing a further increase in height of approximately
6 cm, beyond menarche.



_**7.2.4 Bone growth**_


The mature skeleton is a complex tissue that comprises two main forms of bone, spongy trabecular
bone and more dense cortical bone. Bones in differentsitesaroundthebodydifferintherelativeamounts
of the two forms that are present, and within bones,
there are different layers of cortical and trabecular
bone, with the latter being more prominent in and
around joints. During adolescent growth, all of the
boneswithintheskeletonareincreasinginsize,butfor
the purposes of this text, the process will be described
for the long bones (e.g., the femur or humerus).
Bones initially form from cartilaginous structures
during the fetal period. The process of endochondrial
ossification converts these structures into mineralized
(ossified) bone structures that are innervated and invaded by the cardiovascular system. Endochondrial
ossification ends in the first few years of life, and bone
is then able to increase in size by virtue of the distribution of different zones of bone. As shown in Figure 7.4,
the long bones in childhood comprise three regions.
The shaft of the bone is called the diaphysis. This is
mostly cortical bone surrounded by an external layer


Epiphyseal plate



**Nutrition and Adolescence** **163**


of connective tissue (the periosteum). This tissue is
important in the growth process, as it allows an increase in bone girth. In mature bone, it is the point of
connection for tendons and ligaments. There is also
an internal layer of connective tissue (the endosteum),
which surrounds the central medullary cavity, where
the bone marrow is located. The end of the bone is

called the epiphysis, which is mostly trabecular bone,
with thin layers of cortical bone. In the growing bone,
there is a layer between these two zones called the
epiphyseal plate, which is composed of cartilage and
partially calcified cartilage. It is this that allows linear
growth to take place.
Within the epiphyseal plate, there are four layers
of cells. Closest to the epiphysis lies a layer of resting chondrocytes (cartilage cells). The function of
these cells is to anchor the epiphyseal bone to the
growth zone. Beneath this layer, the chondrocytes are
in a state of active multiplication by mitosis. Moving
closer to the diaphysis, the cartilage of the plate begins to calcify. Within this zone are chondrocytes that
are maturing and enlarging, and along the border of
the epiphyseal plate and the diaphysis lies the fourth







Resting cell layer


Proliferating
chondrocyte layer



Layer of maturing
and enlarging
chondrocytes


Layer of dying and
calcifying
chondrocytes


Osteoblast activity



**Figure 7.4** The growth of long bones. Long bones expand through activity within the epiphyseal growth plate, which lies at the interface of the
bone shaft (diaphysis) and end (epiphysis). New cartilage cells (chondrocytes) are formed at the epiphyseal end of the growth plate, while mature
cells on the diaphyseal end die and become calcified. The bone extends by virtue of this zone pushing the epiphysis away from the diaphysis.



**164** **Nutrition: A Lifespan Approach**


cell layer, comprising chondrocytes that are dying and
becoming calcified. In effect, the process pushes the
epiphysis out from the diaphysis by depositing strips
of bone over the top of the diaphysis and new cartilage cells just below the epiphysis, hence elongating
the bone. The newly formed bone may be remodeled
through action of osteoblasts, and other cells, and will
be invaded by blood vessels. At the point of skeletal maturation, the cartilage is fully calcified and the
epiphysis and diaphysis fuse together.
The same process occurs in all growing bones.
While in the long bones, the process relies on growth
plates at the ends of the shaft, in other bones, the
growth plates exist as concentric rings, with growth
progressing from the outside, in toward the center.
Bone maturity can be assessed by x-ray and is often
used as a marker of pubertal development to supplement Tanner staging based on breast or genital maturation. In bones that are still growing, the epiphyses
are imaged as less radiographically dense than the ossified bone, while in mature bones, the fused epiphyses show as clear epiphyseal lines. Staging of maturity
through skeletal aging usually employs x-rays of the
wrist or hand. These are then compared to atlases of
images that consider size and shape of bones, along
with degree of ossification (Tanner, 1989). Bone age is
thengradedusingtheTanner-WhitehouseorGreulich
and Pyle scales.
Bone growth occurs throughout childhood, but is
most rapid during adolescence, when approximately
half of the eventual mass of the skeleton is laid down.



As shown in Figure 7.5, there is a short continuation
of the accrual of bone mass beyond the attainment of
final height. In girls, the most rapid period of bone
mineralization is between 12 and 15 years, while in
boys, the peak lies between 14 and 17. Peak bone mass,
the point where bone mineral content and density is
at its greatest, occurs between 25 and 35 years of age
(Davies _et al_ ., 2004).
Bone growth is strongly under the influence of genetic factors, which are believed to determine around
80% of the variation in adult bone mass. Many genes
are important in formation, growth, and maintenance
of the skeleton, but those that appear to be of greatest
importance during childhood and adolescent growth
include the vitamin D receptor, type 1 collagen, the estrogen receptor (ERβ), leptin, insulin-like growth factor 1, interleukin-6, low-density lipoprotein receptorrelated protein 5, and osteocalcin (Davies _et al_ ., 2004).
Endocrine signals are also the major factors that
drive bone growth. Growth hormone and insulin-like
growthfactor1,forexample,stimulateaccrualofbone
mass by promoting the proliferation of osteoblasts.
The secretion of these hormones is increased during
puberty through the actions of the sex steroids. The
sex steroids exert direct effects on bone also. Adrenalderived androgens increase the overall strength of
bone, while estradiol increases bone thickness.
While genetics determine most of the variation in
rates of bone growth and accrual of mineral, diet and
lifestyle factors are also of importance. Physical activity stimulates bone mineralization, particularly if







**0** **10** **20** **30** **40**


**Age (Years)**



**Figure 7.5** The accrual of bone mass. Much of
the mass of the adult skeleton is deposited during
the adolescent growth phase. The most rapid rate
of bone mineralization coincides with the pubertal
growth spurt. Deposition of bone continues beyond
the cessation of growth, and peak bone mass is
achieved in the third decade of life.



comprising high-impact sports (e.g., basketball, volleyball, rugby, and gymnastics) or weight-bearing activities. This bone growth is greatest at the skeletal
sites that bear the greatest load (Daly, 2007). In other
words, bone tends to accrue at the greatest rate along
lines of stress. This structural response to exercise
is seen in both boys and girls, but once puberty is
initiated, it differs slightly. In boys, exercise stimulates bone thickening by expansion of the periosteum,
while in girls, there is a contraction of the endosteum
layer. The benefits of activity in terms of bone mineral accrual are greatest in children who are active
in the prepubertal and early pubertal stages (Davies
_et al_ ., 2004). Welten and colleagues (1994) performed
a longitudinal study of 13-year-old boys and girls with
a follow-up to 27 years of age. Levels of physical activity in adolescence explained 17% of the variation in
adult bone mineral density and was the main predictor of adult bone mass.

Nutrition-related factors are known to be of importance in determining adolescent bone growth. Girls
who have suffered from anorexia nervosa generally
have reduced bone mineral density into adulthood
and are therefore at risk of bone disorders such as osteoporosis later in life. Eating disorders or excessive
underweight are associated with reduced production
of sex steroids and expression of insulin-like growth
factor 1, hence limiting bone growth. Interestingly,
overweight may also limit bone growth. Ducy _et al_ .
(2000)usedmutantmousestrainstodemonstratethat
leptin is a negative regulator of skeletal growth. The
_ob/ob_ mouse, which lacks a functional leptin gene,
and the _db/db_ mouse, which does not express leptin receptors, have almost threefold greater bone volume than wild-type mice. Skeletal development can
be normalized by administration of exogenous leptin.
Overweight children will secrete more leptin and this
may therefore reduce bone mineralization. As obese
individuals tend to be leptin resistant, it might be argued that obesity in adolescence could provide some
benefits for skeletal growth. However, as discussed in
Chapter 6, excessive obesity in childhood can lead to
deformation of the skeleton or damage to the epiphyses of the hip, associated with the need to bear a
heavier load.
The major nutrient associated with skeletal growth
is calcium, with increased intakes promoting accrual
of bone mass, provided that vitamin D status is adequate. Most but not all studies of adolescents and



**Nutrition and Adolescence** **165**


prepubescent children show positive associations betweenbonemineralizationandcalciumintake(Davies
_et al_ ., 2004). Fiorito _et al_ . (2006), for example, showed
that the habitual calcium intakes of 9-year-olds were
predictive of bone mineral content at age 11. A number of studies in boys (Prentice _et al_ ., 2005) and girls
(Stear _et al_ ., 2003) have shown that provision of calcium supplements to adolescents can increase whole
body bone mineral density, and have specific benefits at the hip, spine, and wrist. The prepubertal period may be a key time for boosting calcium intake.
Johnston _et al_ . (1992) reported that supplements were
effective in boosting bone mineral density prior to puberty, but had no significant benefits when initiated
during puberty.
It is unclear whether the benefits associated with
increased calcium intake in adolescence are carried
through to the adult years. Certainly, the study of
Welten _et al_ . (1994) found no relationship between
bone mineral density at 27 years and habitual calcium
intake at 13. Lambert and colleagues (2008) reported
that 18 months of calcium supplements (792 mg/d)
to 12-year-old girls with low habitual calcium intakes
boosted whole body bone mineral density in the short
term, but had no lasting effect when followed-up
2 years beyond the end of the supplementation period.


**7.3 Psychosocial development**


Adolescence is a period of intense cognitive, emotional, and social development. Over the period from
11 to 21 years of age, the individual undergoes a transition from a childlike way of thinking and interacting
with others to a mature, adult level of functioning
(Story _et al_ ., 2002). These changes can impact significantly upon nutrition, as the transition process
generates attitudes, beliefs, and ways of thinking that
can strongly influence food choices.
In the earliest stages of adolescence, children find
it difficult to think in abstract terms. The average 11–
14-year-old is able to only focus upon present realities
and thinks in concrete terms. The ability to process
abstract concepts and make associations between current actions and later consequences is poorly developed. This can make health promotion at this stage
very challenging, as these adolescents are unable to
perceive that their current eating behaviors might impact upon their health three or more decades into the



**166** **Nutrition: A Lifespan Approach**


future.Onasocialandemotionallevel,theyoungadolescent increasingly strives to establish independence
from parents and family. The peer group becomes
overwhelmingly important and influential and this
can be a cause of conflict in the home as acceptance
by peers often dictates a degree of rebellion against
authority.
Between 15 and 17 years, the adolescent acquires
a more advanced range of cognitive skills and begins to be able to think about abstract scenarios and
consider the possibilities and intangible consequences
that may stem from their actions. At this age, the individual can begin to grasp multiple viewpoints of a
given situation or argument and as a result conflicts
within families will reduce. The peer group remains
hugely important, and the desire to be accepted by
peers and to conform with the expectations of the
social network can lead to the adolescent being very
self-conscious about their appearance, behaviors, and
how they might be perceived by others. By the age of
18–21, the individual is capable of all advanced cognitive processes and will have established a firm view of
their personal identity and their overall place within
society and local culture. These young adults may still
show immature behavior and decision making, particularly under pressure, and will retain strong links
with a wide social group of like-minded individuals of
similar age.



**7.4 Nutritional requirements in**
**adolescence**


The high rates of growth during adolescence carry significant increments in nutritional requirements over
and above those seen in earlier childhood. Indeed,
this stage of life has requirements for energy and nutrients that are greater than seen in adulthood, both in
absolute terms and when expressed per body weight
(Table 7.2). It is recognized that adolescence increases
nutrient requirements, mostly due to growth. The remodeling of body shape, body composition, and the
maturationoforgansystemsalsocontributetoadolescence being a peak time in terms of nutrient requirements. Precise guidelines and recommendations for
nutrient intakes in adolescence are, however, largely
undefined. This is due to a lack of relevant research
and due to the difficulties of reconciling chronological
age and physiological stage of development. For some
nutrients, it is more useful to set dietary reference values based upon height, body weight, or energy intake,
rather than age.


_**7.4.1 Macronutrients and energy**_


Estimating the energy requirements of adolescents
represents a particular challenge, as the true energy
requirement is more closely related to body size and
the growth velocity than to age. The pubertal period



**Table 7.2** A comparison of nutrient requirements _[a]_ between adults and children aged 11–18 years


Age
11–14 15–18 19–50 19–50

Nutrient Male Female Male Female Male Female


Energy (kcal/d) 2220 1845 2755 2110 2550 1940
Protein (g/d) 42.1 41.2 55.2 45.4 55.5 45.0
Riboflavin (mg/d) 1.2 1.1 1.3 1.1 1.3 1.1
Thiamin (mg/1000 kcal) 0.4 0.4 0.4 0.4 0.4 0.4
Folate (µg/d) 200 200 200 200 200 200
Ascorbate (mg/d) 35 35 40 40 40 40
Cobalamin (µg/d) 1.2 1.2 1.5 1.5 1.5 1.5
Iron (mg/d) 11.3 14.8 11.3 14.8 8.7 14.8
Zinc (mg/d) 9.0 9.0 9.5 7.0 9.5 7.0
Calcium (g/d) 1.0 0.8 1.0 0.8 0.7 0.7
Magnesium (mg/d) 280 280 300 300 300 270


All figures are shown adjusted for body weight.
Data shown are from UK; Estimated Average Requirements for energy, and Reference Nutrient
Intakes for protein and micronutrients (Department of Health, 1998).
_a_ Selected nutrients.



**Nutrition and Adolescence** **167**


**Table 7.3** Energy requirements of adolescents are dependent upon physiological development and physical activity level (PAL)


Estimated average requirement (kcal/d)
Physical activity level
Body weight Basal metabolic

(kg) rate (kcal/day) 1.4 1.5 1.6 1.8 2.0


Boys
30 1186 1670 1789 1909 2148 2363

40 1362 1909 2052 2172 2458 2720

50 1539 2148 2315 2458 2768 3078

60 1715 2410 2578 2744 3078 3437


Girls

30 1093 1527 1646 1742 1957 2195

40 1227 1718 1837 1957 2195 2458

50 1360 1909 2028 2172 2458 2720

60 1494 2100 2243 2386 2697 2983


Source: Data from Department of Health (1998).
PAL of 1.0 corresponds to sleeping (basal rate); 1.2–1.4, lying or sitting at rest, reading, eating, and watching
television; 1.5–1.8, moderately active seated, for example, driving, playing piano or operative computer, and
moderate standing activities; 1.9–2.4, walking at 3–4 km/h, low-intensity sports. High-intensity sports and exercise
will have PAL of 4.5–7.9. Average PAL for boys aged 10–18 years is 1.56. For girls, it is 1.48 as calculated from
estimates of time spent sleeping, at school, and engaged in light, moderate, or high-intensity activities.



sees an increase in height of 15–20% and a gain in
weightthatcorrespondstoapproximately50%offinal
attained adult weight. The bulk of the height gain and
weight gain is through accrual of skeletal mass and
lean body mass, and therefore requires an anabolic
state and hence a high demand for energy (Giovannini _et al_ ., 2000). As shown in Table 7.3, the energy
requirements of boys are greater than for girls at any
given body weight, by virtue of their larger bulk of
metabolically active tissue (lean body mass). With the
onset of puberty, therefore, the difference in energy
requirements of males and females begin to diverge
sharply. Adolescents often have higher levels of physical activity than seen in adults, and these can contribute significantly to energy requirements.
To deliver the energy needs of growth, the appetite
of adolescents increases markedly. One of the challenges of this period is to manage intake such that
optimal growth can be sustained, without excessive
weight gain. As described in Chapter 6, the emergence of overweight and obesity during the adolescent years is an indicator of increased risk of obesity
duringadulthood.Themajorsourcesofenergywithin
thedietarecarbohydrate,whichinadolescenceshould
provide up to 55% of daily energy, and fat (no more
than35%of energy). Therearenospecific recommendations for these macronutrients in adolescence, but



intakes need to be sufficient in order to spare protein
for growth.
There are major requirements for protein in order
to sustain growth. Protein demands reach their peak
during the pubertal growth spurt (11–14 years in girls,
15–18 years in boys). In addition to growth, protein
is required for the maintenance of existing tissues and
the deposition of new lean mass. To maintain nitrogen
balance in the face of growth and deposition of lean
body mass, protein intake should be at a level corresponding to 12–14% of energy intake (Table 7.2).
Most adolescents in the developed countries consume
protein at a level beyond requirements. Excessive intakes have been suggested as potentially detrimental
to calcium homeostasis and bone growth.


_**7.4.2 Micronutrients**_


Micronutrients are essential during adolescence in order to ensure that the major physiological processes
and functions can be maintained during the period
of maximal growth (Olmedilla and Granado, 2000).
Generally speaking, the demands for vitamins and
minerals increase in proportion to energy requirements. For vitamins, there are little available data on
which to base specific recommendations for adolescents.Itisassumedthatgrowthandtheincreasedrates
of energy utilization will increase requirements for



**168** **Nutrition: A Lifespan Approach**


riboflavin, thiamin, and niacin. Protein metabolism
and the synthesis of DNA and RNA will increase the
demand for vitamin B6 and cobalamin. Folate is also
required for these important synthetic processes, and
it is a key nutrient in the synthesis of red blood cells.
Thepubertalgrowthspurtseesamajor(25%)increase
in blood volume.

Most minerals and trace elements accumulate
within the body in large amounts during adolescence
due to increasing body mass and stature. For most
of these, there are physiological adaptations in place
to maximize absorption and bioavailability. Among
the minerals, those of particular significance during
the adolescent years are calcium, iron, and zinc. Zinc
is an essential nutrient for protein and nucleic acid
synthesis and is a cofactor for many metabolically
important enzymes. In adults, most zinc within the
body is locked into muscle and bone. As these tissues gain in mass during adolescence, the accrual of
zinc is at a maximal rate, and biochemical measurements of zinc status in body fluids or hair often show
declines as it is redistributed to bone and muscle.

Poor zinc status can have important consequences, as
zinc deficiency is associated with impaired growth,
reduced appetite, and delayed skeletal and sexual
maturation.

The absorption of calcium from the diet (approximately 35–40%) during adolescence does not appear
to be markedly greater than that at other stages of
life. As described earlier in this chapter, bone mineralization is at a maximal rate during puberty and
hence this is a peak period in terms of calcium requirements. The high RNI set for the adolescent years
(Table 7.2) reflects this accrual of bone mineral. Optimal utilization of calcium obtained within the diet
is dependent upon the supply of other nutrients, including vitamin D, phosphorus, protein, magnesium,
and ascorbate. Magnesium and phosphorus are also
important skeletal minerals. The ratio of calcium to
phosphorus in the diet becomes important at low intakes of calcium, when excessive intake of phosphorus
leads to oversecretion of parathyroid hormone. This
promotes release of calcium from bone. Ascorbate is
an essential cofactor for the action of prolyl hydroxylase, which converts proline to hydroxyproline. This
uncommon amino acid is incorporated into collagen,
which is the major protein within bone, providing the
basic fibrous structure into which calcium and other
minerals are deposited.



Adolescence sees an increase in requirements for
iron. This is driven partly by the increase in blood
volume, but mainly by the increase in lean body mass
and the synthesis of the muscle protein, myoglobin.
The increase in lean mass is greater in boys than in
girls, but the iron requirements of girls increase to a
greater extent (Table 7.2) in order to compensate for
blood losses associated with the onset of menstruation. Poor iron status is associated with iron deficiency
anemia, reduced ability to exercise, and impaired cognitive abilities. Iron status is influenced by a variety
of other nutrients and components of food. Phenolic
compounds and phytates reduce absorption of nonhaem iron, while ascorbate enhances absorption. It is
desirable for adolescents to maintain high intakes of
dairy products as a rich source of calcium, but as calcium inhibits uptake of iron, this can have a negative
impact upon iron status. Individuals with poor vitamin A intakes will tend to develop problems with iron
status. Vitamin A deficiency increases the occurrence
of infectious disease and the acute phase response
results in the sequestration of iron within the liver,
reducing availability for the physiological processes
associated with puberty.


**7.5 Nutritional intakes in adolescence**


Adolescents are frequently identified as being at risk
of undernutrition, largely because their very high nutrient demands often appear incompatible with their
range of preferred foods and patterns of eating. Surveys from all over the developed world identify high
levels of potential nutrient deficiency, as will be described below. Interpretation of such surveys should,
however, be very cautious. Nutritional surveys carried out at a national level often use estimates of
intakes carried out over just a 24- or 48-h period.
These will rarely provide an accurate picture of nutritional status in the population and will be particularly
misleading if the intention is to estimate the prevalence of low micronutrient intakes (Mackerras and
Rutishauser, 2005). Even the well-designed National
Diet and Nutrition Surveys carried out periodically
in the UK may have problems with the validity and
reliability of the data that are generated, due to issues
of underreporting. The disparity between estimates
of intake and actual prevalence of nutrient deficiency
disease perhaps best illustrates the perils and pitfalls



of such survey data. Forty-five percent of British girls
aged 11–14 and 50% of girls aged 15–18 years were
shown to consume iron at a level below the Lower

Reference Nutrient Intake (LRNI; Henderson _et al_ .,
2002). However, assessment of iron status from blood
samples showed the prevalence of iron deficiency anemia to be only 9%.
In most of the developed countries, surveys indicate that adolescents consume adequate amounts of
energy, but that this is generally delivered through excessive consumption of fat and sugar. Among Western
European adolescents, fat delivers 37–41% of energy
for boys and 39–42% for girls (Rolland-Cachera _et al_ .,
2000). Saturated fat consumption is higher than recommended. Adolescents in Spain, Portugal, Italy, and
Greece also consume more than the recommended

35% of energy as fat, but tend to have high intakes
of monounsaturated fatty acids (Cruz, 2000). Only in
the Scandinavian countries does there seem to be a
trend toward adolescents following guidelines for fat
consumption (Samuelson, 2000).
Micronutrient intakes of adolescents are most frequentlyidentifiedasbeingbelowdietaryreferencevalues or population guidelines. Surveys across the European nations identify calcium as one of the micronutrients for which there may be cause for concern. Onethird of Spanish, Italian, Greek, and Portuguese girls
consume calcium below recommended levels (Cruz,
2000), a pattern that is also noted in France and the
UK (Rolland-Cachera _et al_ ., 2000). The National Diet
and Nutrition Survey of British children aged 4–18
(Henderson _et al_ ., 2002) reported that 10% of adolescent boys and 25% of girls consumed calcium at
below the LRNI (480 mg/day).
Iron is a nutrient that gives particular cause for
concern in most European countries. For example,
in France, it has been estimated that 50% of adolescent boys and 80% of adolescent girls consume
this nutrient at below recommended levels (Preziosi
_et al_ ., 1994). In the UK, significant proportions (6–
28% boys, 20–50% girls) of adolescents with intakes
of nutrients below the LRNI have been reported for
vitamin A, riboflavin, zinc, and magnesium (Henderson _et al_ ., 2002). In the US, folate intakes have been
reported to fall below the estimated average requirement in 20% of adolescents (Cleveland _et al_ ., 2000).
Up to 13% of adolescent girls in the US may consume inadequate amounts of zinc. Poor iron status
has been reported in 10% of adolescent boys, 16% of



**Nutrition and Adolescence** **169**


9–13-year-old girls, and 26% of 14–18-year-old girls
(Cleveland _et al_ ., 2000).


_**7.5.1 Factors that influence food choice**_


Although reliable estimates of the prevalence of undernutrition with respect to specific micronutrients
may be difficult to establish, it is clear that the diet of
thetypicaladolescentdoesnotcomplywithguidelines
for healthy eating and may not deliver the full profile
of nutrient requirements. This is of concern at a life
stage when optimal nutrition is necessary for optimal
growth and development. The reasons contributing
to poor nutrition need to be explored. Suboptimal
nutrition partly stems from the preferred range of
foods that are consumed by adolescents and by the,
sometimes erratic, meal patterns that are followed
by this increasingly independent group of young
people.
The range of influences upon adolescents’ food
choicesisbroadandvaried(Figure7.6).Whilecurrent
health status and other health behaviors are influential, food choices and eating behaviors are also determined by environmental factors and personal factors.
Environmental factors include the influences of parents and family, socioeconomic factors, the influence
of peers and exposure to media, and sociocultural
expectations. Personal factors include the values and
beliefs of the individual (e.g., religious or ethical viewpoints), emotional and physiological needs, and perceptions of body image. Several of these factors may
interact with each other to influence behavior. For
example, dissatisfaction with appearance and body
weight is common among adolescents (50% of girls
and 20% of boys; Hill, 2002). Part of this dissatisfaction comes from the exposure of adolescents to images in magazines and television programs that depict
thinness as the epitome of beauty and a state to aspire to. Girls in their mid-teens are particularly influenced by reported material depicting celebrities who
are praised for weight loss and thinness and ridiculed
for overweight or physical flaws. Thus, society shapes
adolescents views of their own body size and shape
and may prompt engagement in restrictive dietary
practices (Hill, 2006).
Adolescence is in all ways a period of transition,
both physically and emotionally. Food becomes an element of the developing autonomy of adolescents and
young people increasingly take control over the purchasing and preparation of meals. This can become



**170** **Nutrition: A Lifespan Approach**









disorders **Figure 7.6** Factors that influence the food choices
and eating behaviors of adolescents.



embroiled in the general rebellion associated with
the adolescent years, and poor food choices (fastconvenience foods) may be particularly pleasurable
because of their labeling as “bad” foods by parents
and other authorities (Hill, 2002). The main influences on the food choices of adolescents are, however,
obvious ones. With appetite drives high in order to
meet physiological demands, adolescents are strongly
influenced by feelings of hunger and select foods that
are taste good, have favorable aroma and appearance,
and that are familiar to them from earlier childhood

exposures (Neumark-Sztainer _et al_ ., 1999).
Adolescents tend to feel constrained in terms of
time, as they have to integrate their strong desire
to sleep in late in the mornings with heavy workloads at school, busy social programs, part-time jobs,
and sporting activities. This promotes preferences for
foods that are readily available and that are easy and
fast to prepare (Neumark-Sztainer _et al_ ., 1999). Adolescents who are taking responsibility for finding their
own food for at least part of the day often find it hard
to access more healthful alternatives (O’Dea, 2003).
Outlets that sell high-fat, high-sugar, fast foods can
act as focal points for adolescents to meet with friends.
There are some claims that poor food selections may
be an element of achieving integration with the peer



group and fulfilling social expectations, but the evidence to support this is not strong. Correlations of
adolescents’ food choices with parental preferences
are considerably stronger than correlations with preferences of best friends (Hill, 2002).
While convenience and hedonistic factors are
strong factors that determine food choices, there
are other factors that are of low importance to
adolescents as a population group, but those may
be major influences for some individuals with the
population. These include the desire to enhance
health or sporting performance, compliance with
religious or family rules pertaining to food and issues
relating to body image and influences of the media
(Neumark-Sztainer _et al_ ., 1999).


_**7.5.2 Food consumed out of the home**_


While younger children will predominantly consume
food in a supervised environment such as home or
school, where food is purchased and prepared by
adults, adolescents increasingly take responsibility for
this themselves. Generally speaking, adolescents have
some income that they can spend on food, and they
begin to consume a considerable proportion of their
daily energy and nutrient intakes in school or college, from vending machines, in snack bars, fast-food



restaurants, sandwich shops, or in the homes of their
friends. Although school meals are increasingly being
formulated to comply with nationally set standards,
foods purchased from the other sources tend to be of
lower nutritional quality and of higher energy density.
The autonomy of adolescents in selection and preparation of foods may therefore be a determining factor
leading to low micronutrient intakes.
Fast-food restaurants aim much of their marketing at adolescents, and indeed a high proportion of
their workforces tend to be within this age group.
Sometimes these workers receive some of their re
muneration in the form of free food (French _et al_ .,
2001). Intakes of foods from fast-food restaurants increased rapidly over the last decades of the twentieth
century and remain high in the early twenty-first century despite growing awareness of the importance of
nutrition for health. Estimates of access to such es
tablishments by adolescents vary. Among teenagers in
the US, estimates of the proportion who purchase fast
food several times a week vary between 39% and 50%
(Paeratakul _et al_ ., 2003; Bowman _et al_ ., 2004). This
greatly increases the energy density of the diet and
intakes of fat, sugar, and sodium. Good sources of micronutrients such as grains, fruit, vegetables, legumes,
seeds, milk, and dairy products are displaced from the
diet by fast foods (Paeratakul _et al_ ., 2003). Although
having a high personal income is strongly related
to consuming less healthy foods outside the home
(Bowman _et al_ ., 2004), the main predictors of external food sources displacing home-prepared foods are
low socioeconomic status, having a part-time job, and
being active in sport (French _et al_ ., 2001). The convenience and time-saving attributes of snack foods and
items from fast-food restaurants is a major attraction
to busy adolescents.


_**7.5.3 Meal skipping and snacking**_


In keeping with their increasing income and access to
food outside the home, adolescents are the population
group who are most likely to have erratic eating habits,
with missed meals and high intakes of snack foods.
Adolescents have strong appetites and tend to eat outsidemealtimesinordertofulfillfeelingsofhungerand
cravings for specific snack items (Neumark-Sztainer
_et al_ ., 1999). Skipping meals can impact significantly
upon nutrient intakes, particularly as the meal that is
mostfrequentlymissedisbreakfast.Wherethenormal
breakfast foods are fortified cereals with milk, this can



**Nutrition and Adolescence** **171**


produce marked reductions in micronutrient intakes.
Some studies have estimated that up to one-third of
adolescents regularly miss breakfast. The major reason underpinning this behavior appears to be a lack of
time and low levels of hunger on rising in the morning
(Shaw, 1998).
Breakfast is not the only meal that may be missed.
In some families, adolescents either opt out of family
meals, or, if in the position of providing their own
meals for at least some part of the day, will choose to
adopt a “grazing” pattern of snacking throughout the
day. van Den Bulck and Eggermont (2006) reported
that this kind of behavior is more prevalent among
adolescentswhowatchtelevisionformorethan5hper
day and who play computer games four times a week
or more. They postulated that in these children, these
activities were displacing time that would otherwise
be spent on meals.
Skipping of meals is more common among adolescents who are high consumers of snacks (Savige
_et al_ ., 2007). Adolescents generally consume two to
three snacks per day, with greatest frequency in those
who are sedentary. Snacks are consumed in a variety
of settings and at all times of the day, including in
front of the television, while doing homework, with
friends, and in transit to school or other activities.
Snacks provide between a quarter and a third of total
daily energy intake for adolescents (Kerr _et al_ ., 2009).
The selection of snack foods is usually reported to be
biased toward foods that are rich in salty or sweet taste
rather than healthy foods.
Foods of high-energy density have been linked to
overweight and obesity and would displace micronutrients from the diet. However, the literature suggests
that not all aspects of adolescent snacking are negative. Sebastian and colleagues (2008) reported that
among US adolescents, snacking contributed 35% of
daily energy intake and 43% of added sugar intake
and was associated with greater total energy intake
and higher intakes of carbohydrate. However, high
snack consumers also consumed more ascorbate and

less protein and fat than adolescents with lower snack
consumption. Intakes of milk and fruit were actually
increased by snacking, suggesting that awareness of
healthy eating messages may influence some aspects
of snacking behavior. This agrees with the findings
of Kerr _et al_ . (2009), who reported that though the
favored snack foods of British adolescents included

chocolate, carbonated drinks and cakes, and biscuits,



**172** **Nutrition: A Lifespan Approach**


bread, fruit, and breakfast cereals were also widely
consumed as snack items.


**7.6 Potential problems with nutrition**


_**7.6.1 Dieting and weight control**_


Restriction of dietary intake or other actions that
can promote weight loss are commonplace behaviors among some groups of adolescents. Most surveys show that girls are more likely to indulge in
such behaviors than boys, but that between 20% and
50% of adolescents of either sex will attempt some
sort of weight loss behavior (Neumark-Sztainer and
Hannan, 2000). This high prevalence of dieting behavior is believed to be chiefly a response to the major
changes in body size and shape associated with adolescence. Other influences include exposure to media
items about body weight and dieting, parental concerns about weight gain, teasing from other children
about weight, and aspiration to share the dieting experiences of peers.
Some restrictive practices may improve the quality
of the diet, for example increasing intakes of fruits
and vegetables in place of energy-dense snacks. These
behaviors are more the norm for younger adolescents. Later in puberty, girls, in particular, develop
increased concerns about their body image and become more likely to restrict weight gain in an unhealthy manner (Abraham, 2003). Unhealthy practices related to weight loss include meal skipping, use
of dieting drugs, fasting, consumption of food substitutes (e.g., slimming shakes), and smoking. These
can impact in a negative way upon nutritional status, particularly with respect to calcium and other
micronutrients, and are associated with slower rates
of growth, psychological disorders, and poor physical health (Neumark-Sztainer and Hannan, 2000).
Longer term health may also be compromised. Reduced bone mineralization and lower attained peak
bone mass may, for example, increase risk of osteoporosis later in life. Interestingly, adolescents who
dieted were shown by Neumark-Sztainer and colleagues (2006) to have threefold greater risk of overweight at a 5-year follow-up. Adolescents who indulge in dieting behaviors may be eight times more
likely to go on to develop eating disorders than those
who do not diet (Neumark-Sztainer and Hannan,
2000).



Dissatisfaction with body size, shape, or fatness
is believed to be a major driver of dieting behavior
in adolescents. Many researchers report lower levels of self-esteem and greater prevalence of depression among adolescents who attempt to lose weight.
Strategies adopted to try to improve body image vary
between boys and girls. While girls are more likely to
restrict food intake in order to reduce weight, boys are
more likely to attempt to remodel their bodies to more
muscular forms through changes in diet and exercise
(Lawrie _et al_ ., 2007). The body image of both sexes
is unquestionably influenced by media images, as described in Section 7.5.1 above. Utter and colleagues
(2003) reported that girls who often read magazine
articles about weight loss and dieting were 6.2 times
(95% CI 3.0–12.7) to indulge in healthy dieting behaviors and 7.3 times more likely (95% CI 4.7–11.4)
to indulge in unhealthy dieting behaviors than those
who never read such materials. Similar relationships
werenotedforboys,buttheeffectsizewaslessmarked.


_**7.6.2 The vegetarian teenager**_


Vegetarianism is a pattern of diet that has increased
in popularity in most developed countries since the
1960s. There are many forms of vegetarian diet ranging from the semi-vegetarian (consumes meat infrequently) and pollo-vegetarian (avoids red meat
but consumes poultry) through to the lacto-ovovegetarian (consumes eggs and milk, but not meat)
and the vegan (consumes no animal produce at all).
Adolescents are the population group most likely to
make the switch from a mixed diet to a vegetarian
diet. Girls are significantly more likely than boys to become vegetarians and estimates from the UK, Canada,
and Australia suggest that while veganism is extremely
rare, around 8–10% of adolescent girls and 1–2% of
boys (15–18 years) follow a lacto-ovo-vegetarian diet.
Pollo-vegetarianism and semi-vegetarianism may be
considerably more common. Worsley and Skrzypiec
(1998) noted that up to 37% of Australian girls and
11–17% of boys reported a semi-vegetarian pattern
of diet.
As with all forms of restrictive dietary practice in
adolescence, there are concerns that vegetarianism
could have a negative impact upon nutritional status
and the capacity to maintain optimal rates of growth
and development. Adolescents are likely to experiment with diets and to make unplanned and abrupt
shifts from a diet including meat to some form of



**Nutrition and Adolescence** **173**



~~**Research Highlight 7**~~ ~~Concerns surrounding nutrition and health in vegetarian adolescents~~



_Nutritional status_
Vegetarian adolescents appear to be at greater risk of having inadequate intakes of a number of nutrients, including protein, iron,
calcium, zinc, and riboflavin (Donovan and Gibson, 1996). This is of
major concern at a time of rapid growth. Plant foods are rich in phytic
acid that inhibits absorption of iron and calcium, and oxalates that
inhibit calcium uptake. The bioavailability of iron from a vegetarian
diet is only 10% compared to 18% from a mixed diet (Hunt, 2003).
An 80% increase in intake is required to meet requirements, which
is challenging without supplementation or careful dietary planning.
~~Vegetarian girls are six times more likely than omnivores to have~~
low hemoglobin concentrations and three times more likely to have
reduced iron stores (Thane _et al_ ., 2003). Calcium uptake is poor
from many plant sources, but some such as soybeans, broccoli, and
kale have very high bioavailability (Weaver _et al_ ., 1999). Inclusion
of dairy products alongside such foods in the vegetarian diet should
maintain healthy calcium status.


_Overall health and health behaviors_

In adolescence, vegetarianism may be associated with a number
of negative health behaviors. Vegetarians are less likely than om

vegetarianism, without any informed guidance. This
can increase the risk that the dietary pattern adopted
will fail to deliver an adequate balance of nutrients
(Research highlight 7).
Studies of adult vegetarians indicate that they are
generally motivated to abandon meat eating in order
to improve their health. This is a response to reports
that vegetarian diets are associated with low risks of
cancer (Willett, 2003; Taylor _et al_ ., 2007). Adult vegetarians usually exhibit a number of positive health
behaviors such as reduced alcohol consumption, not
smoking, and higher levels of physical activity. The
motives for becoming vegetarian in adolescence are
not usually related to health concerns. Many studies
report that adolescent girls, in particular, are motivated by the desire to lose or control body weight and
by philosophical and ethical concerns about animal
welfare (Greene-Finestone _et al_ ., 2008). Adolescent
girls who follow a vegetarian diet often also express
profound disgust at the thought of consuming blood
and body parts of animals and object to the smell,
flavor, and chewy fibrous texture of red meat (Kenyon
and Barker, 1998; Kubberd _et al_ ., 2002).


_**7.6.3 Sport and physical activity**_


The impact of physical activity upon health and wellbeing is overwhelmingly positive at any stage of life.



nivores to be smokers, consume less alcohol, and are less likely to
be overweight and obese. However, there is a greater prevalence of
underweight, and vegetarian girls are more likely to suffer mental
health disturbances and require medication for depression (Baines
_et al_ ., 2007). A vegetarian diet can be used as a cover to hide more
serious restriction of the diet and disordered eating by both girls and
boys (Martins _et al_ ., 1999).


_Fertility and reproductive function_
Vegetarian girls may exhibit a number of problems with reproduc~~tive function. Vegetarianism is associated with longer cycle length,~~
greater prevalence of amenorrhea, anovulation, and luteal phase defects. This may not only be partly explained by reduced body fatness
and leptin secretion, but may also relate to hypothalamic control
over sex hormone secretion (Griffith and Omar, 2003). Vegetarians
secrete lower levels of luteinizing hormone, even if cycles are regular.
Diets rich in fiber and low in fat alter the profile of sex steroids that
are synthesized within the ovary and increase cycle length (Goldin
_et al_ ., 1994). Baines _et al_ . (2007) also noted that vegetarians
were less likely than omnivorous teenagers to use the contraceptive
pill.


Adolescence is no exception to this and adolescents
who are more active will be protected against overweight and obesity and will have enhanced skeletal
growth. Exercise benefits bone mineralization, for example, with particularly strong effects in trabecular
regions (Specker, 2006). Often the diets of adolescents who are involved in sports are of higher quality
than those of less active peers (D’Alessandro _et al_ .,
2007). However, where levels of physical activity become more intense over longer and more frequent
periods, such as in adolescents who become involved
in organized sports or dance activities, this can impact
upon energy balance, nutritional status, growth, and
development in an adverse manner.
Intense physical activity will, by definition, increase
demands for energy and the sporting teenager will
need to consume more energy sources than a sedentary individual, in order to maintain growth and
sustain their performance. Requirements for protein
may also be increased as physical activity will promote the deposition of muscle mass over and above
that, which normally occurs in growth. This is most
marked in adolescents who partake in events that
are weight-class dependent, that is, where the optimal performance is associated with a highly muscular
but lightweight body (e.g., martial arts and gymnastics) and endurance sports (swimming, long-distance



**174** **Nutrition: A Lifespan Approach**


running). Swimmers, for example, may increase their
protein requirements from 0.73 (girls) to between 1.2
and 2.32 g/kg body weight per day (Petrie _et al_ ., 2004).
High-levelphysicalactivityalsoincreasesdemandsfor
micronutrients. Demand for most vitamins follows
energy intake and utilization. Mineral requirements
will increase as calcium, iron, magnesium, sodium,
phosphorus, and trace elements are incorporated into
lean tissues and the skeleton as they grow under the
influence of activity. Electrolyte and fluid status may
also be perturbed by participation in sports.
Where physical activity is at a level that does not
exert consistently high nutritional demands, there is
unlikely to be any adverse impact upon physiological processes. Certain sports, however, particularly
gymnastics, dance, and the weight-class sports, can
lead to delayed maturation. These activities often result in negative energy balance as individuals attempt
to develop a lighter physique with greater muscular
strength (Roemmich _et al_ ., 2001). Energy deficit, poor
nutritional status, and reduced body fatness are particularly associated with amenorrhea and menstrual
cycle abnormalities in adolescent girls involved in intense sport, with up to 25% of US high school athletes
being affected (Misra, 2008). The loss of the permissive effects of leptin on the hypothalamic–pituitary–
ovarian axis as body fat declines may largely explain
these problems. Hormones such as cortisol, which is
secreted at higher levels during activity, may also suppress hypothalamic production of GnRH. Failure to
produce estrogen can impact upon growth, particularly of the skeleton, as estrogen normally increases
secretion of growth hormone and IGF-1. Only regular, intense activity will produce these effects. Lower
levels of activity actually promote growth by stimulating growth hormone production (Borer, 1995).
The worst-case scenario associated with high-level
sport in adolescence has become known as the “female
athletetriad”.Thisisnotedwhereinvolvementinsport
and exercise is at a high or elite level, particularly if
the activity is associated with having a strictly controlled body weight that stems predominantly from
a high proportion of lean body mass (Brunet, 2005).
This physique is generally achieved and maintained
through the combination of activity itself and controlled eating. When the control over diet tips into
disordered eating (see below), the first element of the
triad is in place. The second element is amenorrhea,
whichisadirectconsequenceofthebodyfat.Thethird



element is osteoporosis or osteopenia, which stems
from inadequate bone mineralization. This will not
only be mainly a result of the endocrine immaturity
and suppressed reproductive cycling of the individual,
but can also be related to calcium intake. Avoidance
of dairy products as a means of weight control is a
common feature of this condition.


_**7.6.4 Eating disorders**_


Eating disorders are psychiatric conditions that manifest as extremely abnormal patterns of food intake and
weight control. A number of such conditions have
been identified, of which the best characterized are
anorexia nervosa (AN) and bulimia nervosa (BN).
These conditions, along with binge eating disorder
and the spectrum of conditions that fail to meet the
diagnostic criteria for AN and BN (partial eating disorders, or eating disorders not otherwise specified),
are believed to lie on a broad continuum of eating
behaviors extending from normal eating to behaviors promoting underweight (including normal dieting), and to behaviors promoting severe overweight
(Chamay-Weber _et al_ ., 2005). All of the eating disorders are most common in young women, and often first manifest during the adolescent years. Eating disorders, particularly AN, are among the major causes of death among adolescents in developed
countries.


**7.6.4.1 Anorexia nervosa**

ANischaracterizedbytheadoptionofapatternofeating and physical activity that promotes severe weight
loss. Individuals with AN generally have a highly distorted image of their own body size and shape and an
intense fear of becoming fat or gaining weight. As a
consequence, they impose a starvation regime upon
themselves. The full diagnostic criteria used for assessment of AN are shown in Table 7.4. Individuals with

ANmayadoptapurelyrestrictivedietarypattern,with
minimal food intake, or may be of a bingeing/purging
type whereby occasional episodes of excessive food
intake are compensated through the use of laxatives,
diuretics, extreme exercise, or techniques to induce
vomiting. All of these behaviors surrounding food are
often compounded by the presence of obsessions with
food, ritualistic calorie counting, food hoarding, and
collection of food recipes (Abraham, 2003).
Individuals with AN undergo extreme weight loss
and, if in adolescence, a failure of growth and delay



**Nutrition and Adolescence** **175**


**Table 7.4** Diagnostic criteria for eating disorders


Anorexia nervosa


1. Refusal to maintain body weight at or above minimally normal for age and height (less than 85% of expected weight)
2. Intense fear of gaining weight or becoming fat, even though underweight
3. Disturbance of the perception of body weight or shape. Denial of seriousness of current underweight
4. Amenorrhea (absence of three consecutive menstrual periods)


Bulimia nervosa


1. Recurrent episodes of binge eating characterized by both of the following:
(a) Eating an amount of food in a discrete period of time that is larger than most people would achieve in the same time, under similar
circumstances
(b) A sense of lack of control over eating during the bingeing episode
2. Recurrent inappropriate behavior to compensate for eating in order to control weight gain (e.g., use of laxatives, enemas, diuretics, or
excessive exercise)
3. Binge eating and compensatory behavior occurring at least twice a week for 3 months
4. No undue influence of body shape and weight on behavior
5. The disturbance does not occur excessively during periods of AN


Source: From American Psychiatric Association (2000).



of sexual maturation. Muscle wasting occurs, along
with loss of subcutaneous fat. The body often grows
a layer of downy hair (lanugo) and the individual develops gastrointestinal and renal disturbances. Electrolyte imbalances are common and result from dehydration and losses associated with purging behaviors.
Treatment of AN involves hospitalization and nutritional support to promote weight gain and metabolic
stabilization. Psychotherapy is necessary to resolve the
underlying condition. Getting individuals to treatment is problematic as AN sufferers will often deny
that they have a problem. As a result, mortality rates
can be as high as 20%.
AN is most common in women, and is generally
seen between the ages of 15 and 23 years. The average age of onset is around 17 years. AN is also seen
in males, who account for around 10% of cases. Estimates of the prevalence of the condition vary considerably, but between 0.3% and 0.5% of the young
female population are likely to be affected (Hoek and
van Hoeken, 2003). The incidence of AN has not varied significantly since the 1930s in the US, but in
European countries, it appeared to increase between
1935 and the early 1980s.
The causes of AN are complex and not fully understood. The condition has always been more common
in girls, particularly white Caucasians from middle or
high socioeconomic status. The key features of AN are
very low self-esteem and a poor view of body image
and these psychological traits often stem from unhap


piness in the home life of the individual. Common
indicators of risk include having conflicts in the home
(Felker and Stivers, 1994), a passive father and domineering mother, lack of independence for the adolescent, or sexual or physical abuse. AN may therefore
be perceived as a failure of the individual to respond
adequately to the growing emotional challenges of
adulthood (Baluch _et al_ ., 1997). It is also argued that
AN is a response to the pressures of a modern culture and society that idealizes a thin body shape and
equates dieting and thinness with beauty and success.
The marketing of this ideal to adolescent girls (and
boys) is known to be highly effective (Hill, 2006), but
is it reasonable to believe that adolescents and young
adults will be prepared to starve themselves to death
to match the cultural expectation?
The main driver for AN may, in fact, be a genetic
predisposition, which produces the eating disorder when coupled to sociocultural stimuli and/or
emotional and psychological disturbance. Studies
of extended families and twins have indicated that

an excess of the risk of AN is determined by genetic
factors (Klump and Gobrogge, 2005). The basis of
the genetic links is, as yet, poorly understood, but
there is considerable interest in the potential role of
the serotonin receptor 2a (5-HT2a) and the estrogen
receptor (ERβ). The neurotransmitter serotonin
plays a role in determining mood, and central defects
of serotonin action are a common cause of anxiety
and depression. Serotonin is also a component of the



**176** **Nutrition: A Lifespan Approach**


appetite regulation system, hence linking together
eating behavior and psychological states. A role for
estrogen is also attractive as AN often manifests
during puberty. ERβ mediates many of the effects
of estrogen and can regulate the expression of genes
with estrogen-response elements. 5-HT2a is one such

gene.


**7.6.4.2 Bulimia nervosa**

BN shares the same basic psychopathology as AN,
namely, a distorted view of body size and shape, but
despite this, it manifests in a different way and impacts upon a slightly different population (Fairburn
and Harrison, 2003). While AN can begin to appear
as early as 8 years of age, and reaches a peak of incidence in adolescence, development of BN prior to
13 years of age is unusual, and most sufferers are
young adults (Gowers, 2008). BN is estimated to affect approximately 1% of young women, although
claims of prevalence rates of up to 3.2% in schoolgirls have been reported. The prevalence is ten times
higher in women than in men (Hoek and van Hoeken,
2003).
BN is more challenging to identify than AN if working purely from physical symptoms. It is characterized
by episodes of binge eating that occur on a frequent
basis (Table 7.4). Usually, these binges involve the ingestion of between 1000 and 2000 kcal in a single 2-h
session (Fairburn and Harrison, 2003), but there are
reports that bulimics can take in 15 000 kcal during a
binge. Sufferers sometimes report that during a binge,
they lose all control and will eat raw food and food
straight from tins and packets, stopping only when
they are overcome by pain, fatigue, or vomiting. The
ability to take in larger binges is likely to develop over
time as the normal signals from the gut that indicate
satiety become suppressed.
Following binge sessions, the BN sufferer will take
compensatory action to prevent weight gain. This can
involve excessive exercising, but more commonly utilizes techniques to purge the food from the body.
Laxative substances or emetics are widely abused for
this purpose. In between binges, there may be periods of intense food restriction to maintain control
over body weight, but physically the BN sufferer will
often appear to be of normal, or even slightly above
average weight. Physiologically, however, there is an
accrual of damage related to bingeing–purging cycles including loss of gut peristalsis and associated



colonic problems, electrolyte imbalances and dehydration, damage to the salivary glands, malabsorption
of fat soluble vitamins leading to deficiency of vitamin A and vitamin D, esophagitis, and erosion of dental enamel due to contact with stomach acid during
vomiting.
As with AN, the development of BN is strongly
linked to genetic factors and probably involves disturbances of the serotoninergic system. The profile of
sufferers is similar to AN, with girls from home situations that create anxiety and depression being at
greatest risk. Early menarche is also seen as a risk factor for BN in adolescent girls (Fairburn and Harrison,
2003). In the case of BN, the means of coping with
emotional problems is to binge, which either provides
a feeling of taking control over matters in an otherwise
out of control life, or a means of temporarily escaping from negative thoughts and feelings (Abraham,
2003). However, as shown in Figure 7.7, the bulimic
individual falls into a negative cycle as the process of
bingeing and purging creates feelings of shame, selfloathing, and revulsion that exacerbate the initiating
negative feelings.
Treatment for BN involves similar approaches to
those used for AN sufferers. Hospitalization and the
need for intense nutritional support are less likely as
BN sufferers become malnourished less frequently.
In adults, the prescribing of antidepressant medication can serve to reduce the frequency of bingeing and purging, but this benefit is often short lived
and has not been reported in adolescents (Gowers,
2008).


_**7.6.5 The pregnant teenager**_


Adolescent pregnancies account for up to 20% of all
births on a global scale. While in developed countries,
they are unusual and are generally considered socially
unacceptable, in the developing countries where early
marriage is the norm, pregnancy under the age of
20 is commonplace. Indeed, 90% of all such births
are seen in the poorer nations and adolescent pregnancyratesrangebetween140and240birthsper1000
women aged 15–19 in Africa, 110–120 births per 1000
women in the Indian subcontinent, and 73 births per
1000 women in Brazil. The highest rates of adolescent
pregnancy in developed nations are seen in the US. Although rates here have declined considerably from the
107 per 1000 women aged 15–19 in the late 1980s, the
US adolescent pregnancy rate remains at over 50 per



**Nutrition and Adolescence** **177**


**Figure 7.7** BN as a cycle of behavior driven by
poor self-esteem. Individuals with BN go through
frequent episodes of binge eating followed by use
of laxatives, emetics, or excessive exercise to compensate for ingested energy. The bingeing is seen
as a way of dealing with anxiety and depression
linked to poor self-esteem and feelings of low selfworth. Feelings of shame that follow the bingepurge episode actually serve to reinforce the initial
problem and hence maintain the bulimic behavior.





1000 women. In Europe, adolescent pregnancy rates
are low due to high standards of sex education and
are typically between 3 and 10 pregnancies per 1000
women aged 15–19. The UK is the exception to this
(20 adolescent pregnancies per 1000 women), and in
England and Wales, the adolescent pregnancy rate is
40 per 1000 women and has not changed appreciably
in over a decade.
In developed countries, adolescent pregnancies are
more likely among girls of lower socioeconomic status. In the UK, for example, more than half of adolescent pregnancies are seen in girls from socially deprived backgrounds and pregnancy rates are six times
more likely in socially deprived areas (Wallace _et al_ .,
2006). Most adolescent pregnancies are unplanned
and are the consequence of either poor knowledge of,
or restricted access to contraception. Among the developing countries, pregnancy rates among teenagers
are highest in the poorest nations, for example, those
of sub-Saharan Africa. Pregnancy rates are higher in
the rural populations of such countries than in the
urban areas.

The risks associated with pregnancy that were described in Chapter 3, for example, miscarriage, fetal
death, and maternal death, are considerably greater in
adolescents than in older mothers. Adolescents have a
fourfold greater risk of death during pregnancy than
women over the age of 20 years. Maternal mortality
due to postpartum hemorrhage (often related to iron
deficiency anemia), or obstructive labor due to the
pelvis being too narrow for the passage of the baby, is
the major cause of death among 15–19-year-old girls
in developing countries.



Adolescent pregnancies, particularly where the
mother is under the age of 16 years, are significantly
more likely to end in miscarriage, premature labor,
or low birth weight (Wallace _et al_ ., 2006). Fraser and
colleagues (1995) found that all women aged under
20 were at increased risk of such outcomes. For those
aged 13–17, the risk of premature delivery was almost
doubled compared to 20–24-year-olds (OR 1.9, 95%
CI 1.7–2.1). The risk of low birth weight was 70%
greater (OR 1.7, 95% CI 1.5–2.0). These observations
were made in a population with good antenatal care
suggesting that factors related to biological immaturity drive many of the observed outcomes. Indeed,
for adolescents in the developing world, antenatal
care and medical supervision are likely to be poor.
Teenagers in developed countries will often conceal
their pregnancies until later in gestation due to the
associated social stigma. This makes antenatal care,
particularly strategies aimed at optimizing nutrition,
extremely challenging. In addition to these immediate threats to health associated with pregnancy, the
offspring of adolescent mothers are at risk in the long
term. Low birth weight is associated with increased
risk of cardiovascular disease and the metabolic syndrome (Barker, 1998). Children of adolescent mothers
tend to remain socially disadvantaged, are less likely
to succeed educationally, and are more likely to have
behavioral problems (Wallace _et al_ ., 2006).
Nutritional status may be a critical element of the
greater risk associated with adolescent pregnancy. The
relationship between the nutritional status of adolescents and pregnancy outcomes is complex and poorly
understood. It is clear however that there is major



**178** **Nutrition: A Lifespan Approach**


competitionbetweenmaternalgrowthandthegrowth
of the fetus and placenta. Growth generally continues during pregnancy and produces the apparently
paradoxicalsituationofgreaterpregnancyweightgain
thanthatseeninadultwomen,butwithlowereventual
birth weights (Wallace _et al_ ., 2006). Growth of adolescent girls continues for up to 4 years after menarche
and is maximal between 13 and 15 years. The energy
utilization to sustain growth appears to have priority over requirements for pregnancy, and as a result
adolescent mothers fail to deposit reserves of fat in
early pregnancy and cannot sustain rapid rates of fetal
growth in the second and third trimesters.
Adolescent mothers are more likely to consume alcohol, smoke tobacco, and engage in other high-risk
behaviors than older women. These factors may also
contribute to the greater prevalence of adverse outcomes. These women are less likely to optimize nutritional status prior to conception, for example, they are
unlikely to take folate supplements in the periconceptualperiod(Langley-EvansandLangley-Evans,2002),
and often enter pregnancy with low micronutrient reserves. Adolescent mothers are more likely to have
low intakes of calcium, iron, zinc, riboflavin, and
folate than adults during pregnancy (Moran, 2007).
Biochemical evidence of iron deficiency has been reported to have a high prevalence in adolescent pregnancies, reaching 70–80% in some populations. Allen
(1993) reported that likelihood of iron deficiency anemia increased with advancing pregnancy. Eleven percent of pregnant teenagers were anemic in the first
trimester of pregnancy, but this rose to 37% by the
third trimester.

In developed countries, it is often assumed that
poor nutritional status in pregnant adolescents is a
product of poor dietary habits (e.g., missed meals
and snacking) both prior to and during pregnancy
(Gutierrez and King, 1993). This may be an overly
simplistic view as this does not explain the greater
risks associated with pregnancy in adolescence, which
are seen in developing countries. Nor do all surveys
of nutrition in pregnancy indicate problems with dietary intake. Giddens _et al_ . (2000) found no differences in nutrient intakes between pregnant teenagers
and adults in a US population. Competition for nutrients between the pregnancy and maternal growth,
and poorly understood issues related to how the placenta partitions nutrients between mother and fetus,
are likely to play the major role in determining the



relationship between maternal nutritional status and

pregnancy outcomes.


_**7.6.6 Alcohol**_


Adolescence is a time when individuals attempt to
assert their individuality and independence from parentsandfamily.Thistransitiontoadulthoodcanmanifest in a variety of ways, but in many cultures, the
rebellion of adolescence is heavily focused upon the
misuse of alcohol. In the countries of northern Eu
rope (UK, Scandinavia, Ireland, and the Netherlands),
teenagers are the population group that is most likely
drink excessively, focusing mostly on the intoxicating properties of alcoholic beverages, rather than on
drinking as one aspect of social interaction. Among
these countries, 17–32% of 16-year-olds report being intoxicated more than ten times in a given year
(Engels and Knibbe, 2000), and binge drinking (more
than five alcoholic drinks in a session) is widespread,
particularly among girls (McArdle, 2008). In contrast, in the countries of southern Europe (France,
Spain, Italy, and Portugal), alcohol is mostly consumed with meals and drunkenness among adolescents is uncommon (Engels and Knibbe, 2000). However, even in these countries, alcohol is consumed
in large quantities by teenagers, and this may impact upon development, disease risk, and nutritional

status.

The metabolism of alcohol (Figure 7.8) occurs primarily within the liver, where it can be cleared by
several pathways. Most metabolism is mediated by
the cytosolic pathway in which alcohol dehydrogenase converts ethanol to acetaldehyde. This can then
be cleared to acetate through the action of aldehyde
dehydrogenases in the cytosol (ALDH1) or mitochondria (ALDH2). If alcohol consumption is excessive,
these processes will have a number of effects upon
nutritional status, primarily through increases in demand for thiamine, riboflavin, and nicotinic acid. Alcohol dehydrogenase is also responsible for the conversion of retinol to retinaldehyde. Regular consumption of excessive alcohol will competitively inhibit
retinol metabolism and hence impact upon vitamin
A status.

If the capacity of the alcohol dehydrogenase pathway is exceeded, either due to the quantity of alcohol consumed, or due to B vitamins being limiting
nutrients, then detoxification follows the microsomal ethanol oxidation pathway. Cytochrome P450



**Nutrition and Adolescence** **179**



NAD [+] NADH + H [+] NAD [+] NADH + H [+]







































H 2 O 2 H 2 O


**Figure 7.8** The metabolism of alcohol. Alcohol (ethanol) can be metabolized through cytosolic, microsomal, or peroxisomal pathways. Cytosolic
metabolism involves the enzymes alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase 1 (ALDH1). Where the cytosolic capacity is
exceeded, microsomal metabolism utilizes the cytochrome P450 enzymes (CYP2E1 and CYP4A1). Acetaldehyde products of microsomal ethanol
metabolism are cleared by acetaldehyde dehydrogenase 2 (ALDH2). Peroxisomal catalase (CAT) can also contribute to alcohol clearance.



enzymes catalyze the conversion of ethanol to acetaldehyde. As the expression of these enzymes is induced by ethanol, metabolism via this pathway has
different consequences in individuals who consume
frequently to those seen in irregular drinkers. Regular
consumption increases the formation of free radical
and carcinogenic intermediates. Clearance of xenobiotics, retinoids, and steroids is more rapid and, as
a consequence, hepatic vitamin D metabolism is disrupted. Damage to cells within the liver promotes cirrhosis. Specific damage to hepatic stellate cells further
impacts on vitamin A status as these are the sites of
liverstorage. Acetaldehydeisitself a toxic intermediate
and can cause injury to the liver and form adducts that
promote cell death or carcinogenesis. Accumulation
of lipid within the liver is commonly seen in alcohol abusers and this stems from excess production of
NADH from the alcohol dehydrogenase pathway and
also from the actions of CYP4A1.



The effects of alcohol upon physiology and
metabolism depend upon the nature and frequency of
the exposure. In the short-term, alcohol is associated
with stimulation of the appetite and the consumption
of energy-dense snacks. Berkey and colleagues (2008)
reported that even moderate consumption (two or
more servings per week) of alcohol by teenaged girls
was associated with greater increases in body mass index over a 12-month follow-up. More frequent and
excessive consumption has contrasting effects and
may be extremely harmful to health and social development. While alcohol dependency (alcoholism) may
be rare among adolescents, alcohol abuse (a pattern of
alcohol use in which the individual drinks in a manner that is hazardous to physical well-being and likely
to suffer problems with meeting obligations at home
and at school) is increasingly a cause for concern.
Alcoholics and alcohol abusers are often malnour
ished. This can stem from reduced nutrient intakes



**180** **Nutrition: A Lifespan Approach**


(alcoholic beverages displacing food intake), hyperexcretion of nutrients, or reductions in bioavailabilty.
Given the often marginal micronutrient intakes of
adolescents, even moderate alcohol consumption may
impact significantly upon nutritional status (AlonsoAperte and Varela-Moreiras, 2000). Individuals who
abuse alcohol are more likely to self-harm, suffer from
attention deficit hyperactivity disorder, have learning difficulties, and problems with their behavior and
conduct. Adolescence is a critical period of development for the brain, during which regions in the hippocampus are rewired. These are centers that are responsible for memory. The adolescent brain appears
more sensitive to alcohol than the adult, so excessive
consumption during this stage may be particularly
damaging (White and Swarzwelder, 2005).


_**7.6.7 Tobacco smoking**_


Among adult populations, the prevalence of smoking
is in decline as awareness of the links between smokingandcancer,cardiovasculardisease,andpulmonary
disease grows. The age group of 20–34-year-olds is the
group in the population that is most likely to be smokers, but adolescence represents the life stage at which
smoking is most likely to be initiated. Up to 75%
of adolescents will experiment with cigarette smoking
and over 90% of adult smokers begin smoking in their
teenage years (Hampl and Betts, 1999). Although the
numbers of adults who smoke are in decline, among
adolescents, in most countries, the figures are relatively stable. In the UK, the proportion of 16–19-yearolds who smoke has remained at around 30% over a
period of 30 years and 20% of 11–16-year-olds are reported to smoke (Lenney and Enderby, 2008). These
figures are similar across Western Europe and in the
US. Smoking rates among adolescent girls are slightly
higher than in boys.
As with alcohol consumption, cigarette smoking is
often an act of rebellion among adolescents and the
habit is most commonly initiated in order to achieve
social acceptance among peers. There are suggestions
that adolescents may also begin smoking as a means
of addressing concerns about body weight or body
image. Smoking is known to suppress weight gain,
and typically, smoking males weigh 5 kg less than
nonsmokers (Hampl and Betts, 1999). Jensen and
colleagues (1995) reported that hip circumference in
young men was inversely correlated with excretion of
cotinine (a breakdown product of nicotine). Aware


ness of the association between smoking and body
weight appears to be greater among girls than boys,
and there is evidence that this is an important influence on smoking behavior in girls and young women
(Potter _et al_ ., 2004). French and colleagues (1994)
noted that among teenaged girls, the odds of initiating smoking during a 12-month period were 1.44–
2.15 times greater if individuals had expressed fear of
weight gain, the desire to lose weight, or indulged in
restrictive dietary practices.
The effects of smoking upon the nutritional status of adults are well documented, but there have
been few studies that have specifically addressed the
issue in adolescents. As adolescent smokers are highly
likely to have parents who smoke, it may be that
their diets differ from nonsmokers in the same re
spects as noted with adults. Indeed, Crawley and
While (1996) reported that nonsmoking teenagers’
dietary intakes were similar to those of smokers if
their parents were smokers. Typically, smokers have
low circulating concentrations of folate, vitamin C,
vitamin E, and carotenoids, which may be explained
by greater turnover due to oxidative stress (Tappia
_et al_ ., 1995). Dietary patterns also differ and smokers
consume more meat, processed meat, eggs, and fried
foods. Adolescent boys who smoke tend to consume
less fruit and fruit juices, while girls consume less
fruit and vegetables (Hampl and Betts, 1999). Smoking among adolescents is associated with lower intakes
of fiber, vitamin C, selenium, calcium, and thiamine
and greater intakes of fat, sugar, and alcohol (Crawley
and While, 1996).
Smoking clearly impacts upon eating behaviors and
a number of explanations for this have been advanced.
Primarily, the fact that an individual is a smoker indicates that they make less healthy choices in general.
Poor dietary habits are therefore unsurprising. Indeed, individuals who cease smoking often also adopt
very healthy dietary habits as an element of wholesale
lifestyle changes. It is also proposed that food intake
may be displaced by smoking and that cigarette smoking dulls the sense of taste, particularly for sweet foods
(Hampl and Betts, 1999). The act of smoking may also
determine meal frequency and duration. This might
beparticularlyinfluentialinadolescents,whosesmoking habit is usually an illicit and furtive activity.
The health consequences of cigarette smoking are
well established and clearly the initiation of smoking
in adolescence will be a risk factor for disease at later



stages of life. Diseases of bone, such as osteoporosis,
have their origins in adolescence as this is the major phase of skeletal growth and deposition of bone
mineral. Smoking may interfere with these processes
through alterations in endocrine control of mineralization. It is established that in cigarette smokers,
serum 1,25 dihydroxycholecalciferol concentrations
are reduced, and this will inhibit intestinal uptake
of calcium. V¨alim¨aki and colleagues (1994) reported
thatmenaged20–29hadlowerbonemineraldensityif
they had smoked in adolescence. Similar findings were
noted in a comparison of 18–19-year-old men who
smoked with nonsmokers (Lorentzon _et al_ ., 2007).
In adolescent girls, the relationship between smoking
and bone mineralization appears to be absent (Harel
_et al_ ., 2007). However, although adolescent girls who
smoke do not manifest this radiological evidence of
disordered skeletal growth, there are reports that they
are at significantly greater risk of bone fractures than
nonsmokers (Jones _et al_ ., 2004).


_**7.6.8 Drug abuse**_


Whilethemajorityofadolescentsdonotuseillicitsubstances,thisagegroupisthepopulationsubgroupthat
is most likely to experiment with abuse of hallucinogenic solvents, intravenous drugs, inhaled drugs, and
prescription drugs. Statistics from developed countries suggest that the numbers of adolescents using
drugs increased significantly between the 1980s and
the early part of the twenty-first century. In the US,
cannabis use was reported by 6.5% of 13–14-year-olds
(8th grade at school) and 18.3% of 17–18-year-olds
(12th grade). Cocaine use was reported by 2.5% of the
older adolescents (Centers for Disease Control, 2005).
In the UK, cannabis is the most commonly used drug
among teenagers. Thirteen percent of girls and 15% of
boys aged 11–15 years reported use of cannabis, with
these figures rising to 24% and 31%, respectively, for
16–19-year-olds (Office of National Statistics, 2008).
Among Australian adolescents, cannabis is also the
main drug of choice, being used by up to 35% of
14–19-year-olds.
Abuse of drugs and other substances is often associated with undernutrition. This effect can be direct,
by virtue of effects of drugs upon food intake, absorption of nutrients, urinary and fecal losses of nutrients,
and metabolic rate. The latter will often be elevated
by substance abuse due to requirements to metabolize
xenobiotics in the liver. In adolescents, there may be



**Nutrition and Adolescence** **181**


problems with micronutrient status that can potentiate the effects of drugs (both illicit and those administered for therapeutic purposes), and the enzyme systems needed for xenobiotic detoxification are not fully
matured (Alonso-Aperte and Varela-Moreiras, 2000).
Indirect effects on nutritional status may be more important. For example, substance addiction will lead
to crime and social exclusion and this limits normal
access to a healthy diet. Disordered eating is also often
linked to drug abuse. Herzog and colleagues (2006)
reported that 20% of women with AN or BN had a
history of drug use, with amphetamines, cocaine, and
cannabis most frequently used. Pisetsky _et al_ . (2008)
also noted strong associations between abuse of anabolic steroids, or cannabis and extreme dieting, and
the use of vomiting and laxatives for weight control
among male high school students.
Drug use is also associated with other unhealthy behaviors and factors that can impact upon nutritional
status. Cannabis use is positively correlated with alcohol consumption and tobacco smoking (Rodondi
_et al_ ., 2006). Consumption of snack foods tends to be
greater and drug users are more frequently from lower
income families or ethnic minority groups. Overall,
drug use is one manifestation of a wider spectrum
of behaviors and influences that promote undernutrition. There are few studies that have been able to
quantify the impact upon nutritional status, mainly
because drug users are an unreliable group to survey
accurately. Knight _et al_ . (1994) were able to relate drug
use to biochemical measures of nutritional status, in
a group of socially deprived, pregnant women. Use
of cannabis, cocaine, or phencyclidine was associated
with reduced serum ferritin, and poor ascorbate, folate, and vitamin B12 status. This would be consistent
with the imbalanced meals, erratic eating patterns,
and increased alcohol consumption that are associated with substance abuse.


~~**Summary Box 7**~~


Adolescence is a life stage that is dominated by rapid rates of
growth, remodeling of body shape and composition, and sexual
maturation. These physiological processes may be vulnerable if
nutritional status is compromised.
Puberty is associated with gains in lean body mass, rising fat
mass in girls, and rapid increases in bone mineralization.
Requirements for energy and nutrients are higher during adolescence than at any other stage of life.



**182** **Nutrition: A Lifespan Approach**


Intakes of nutrients may be compromised by poor food choices
that are related to the growing emotional and social independence
of adolescents. Low iron, zinc, calcium, and folate status are all of
concern in this subpopulation.
Nutrient status in adolescents may be impaired by experimentation with restrictive dietary practices such as vegetarianism or
weight loss diets.
Adolescents are a high-risk group for eating disorders. These
~~conditions have a strong genetic component, but risk is increased~~
by emotional disturbance, anxiety, and depression.
Adolescent pregnancy is a major challenge from a nutritional
perspective. The competition for nutrients between fetal and ongoing maternal growth increases the risk of poor pregnancy out
comes.
Use of tobacco, alcohol, and drugs can negatively impact upon
nutritional status and normal growth and development in adoles
cents.


**References**


Abraham SF (2003) Dieting, body weight, body image and selfesteem in young women: doctors’ dilemmas. _Medical Journal of_
_Australia_ **178**, 607–611.
Allen LH (1993) Iron-deficiency anemia increases risk of preterm
delivery. _Nutrition Reviews_ **51**, 49–52.
Alonso-Aperte E and Varela-Moreiras G (2000) Drugs-nutrient interactions: a potential problem during adolescence. _European_
_Journal of Clinical Nutrition_ **54** (Suppl.), S69–S74.
American Psychiatric Association (2000) _Diagnostic and Statistical_
_Manual of Mental Disorders_, 4th edn, APA, Washington DC.
Baines S, Powers J, and Brown WJ (2007) How does the health and
well-being of young Australian vegetarian and semi-vegetarian
women compare with non-vegetarians? _Public Health Nutrition_
**10**, 436–442.
Baluch B, Furnham A, and Huszcza A (1997) Perception of body
shapes by anorexics and mature and teenage females. _Journal of_
_Clinical Psychology_ **53**, 167–175.
Barker DJP (1998) _Mothers, Babies and Health in Later Life._
Churchill Livingstone, Edinburgh.
Berkey CS, Rockett HR, and Colditz GA (2008) Weight gain in
older adolescent females: the internet, sleep, coffee, and alcohol.
_Journal of Pediatrics_ **153**, 635–639.
Borer KT (1995) The effects of exercise on growth. _Sports Medicine_
**20**, 375–397.
Bowman SA, Gortmaker SL, Ebbeling CB, Pereira MA, and Ludwig
DS (2004) Effects of fast-food consumption on energy intake
and diet quality among children in a national household survey.
_Pediatrics_ **113**, 112–118.
Brunet M (2005) Female athlete triad. _Clinical Sports Medicine_ **24**,
623–636.
Centers for Disease Control and Prevention (2005) YRBSS:
Youth Risk Behavior Surveillance System. Available from
http://www.cdc.gov/HealthyYouth/yrbs/ (last accessed August
2008).
Chamay-Weber C, Narring F, and Michaud PA (2005) Partial eating disorders among adolescents: a review. _Journal of Adolescent_
_Health_ **37**, 417–427.
ClevelandLE,MoshfeghAJ,AlbertsonAM,andGoldmanJD(2000)
Dietary intake of whole grains. _Journal of the American College of_
_Nutrition_ **19**, 331S–338S.



Crawley HF and While D (1996) Parental smoking and the nutrient
intake and food choice of British teenagers aged 16–17 years.
_Journal of Epidemiology and Community Health_ **50**, 306–312.
Cruz JA (2000) Dietary habits and nutritional status in adolescents
over Europe–Southern Europe. _European Journal of Clinical Nu-_
_trition_ 54 (Suppl 1), S29–S35.
D’Alessandro C, Morelli E, Evangelisti I _et al_ . (2007) Profiling the
diet and body composition of subelite adolescent rhythmic gymnasts. _Pediatric Exercise Science_ **19**, 215–227.
Daly RM (2007) The effect of exercise on bone mass and structural
geometry during growth. _Medicine and Sport Science_ **51**, 33–49.
DaviesJH,EvansBA,andGregoryJW(2004)Bonemassacquisition
in healthy children. _Archives of Disease in Childhood_ **90**, 373–378.
Department of Health (1998) _Dietary Reference Values for Energy_
_and Nutrients for the United Kingdom_ . Stationery Office, London.
Donovan UM and Gibson RS (1996) Dietary intakes of adolescent
femalesconsumingvegetarian,semi-vegetarian,andomnivorous
diets. _Journal of Adolescent Health_ **18**, 292–300.
Ducy P, Amling M, Takeda S _et al_ . (2000) Leptin inhibits bone
formation through a hypothalamic relay: a central control of
bone mass. _Cell_ **100**, 197–207.
Engels RC and Knibbe RA (2000) Young people’s alcohol consumption from a European perspective: risks and benefits. _European_
_Journal of Clinical Nutrition_ **54** (Suppl. 1), S52–S55.
Fairburn CG and Harrison PJ (2003) Eating disorders. _Lancet_ **361**,
407–416.
Felker KR and Stivers C (1994) The relationship of gender and familyenvironmenttoeatingdisorderriskinadolescents. _Adolescence_
**29**, 821–834.
Fiorito LM, Mitchell DC, Smiciklas-Wright H, and Birch LL (2006)
Girls’ calcium intake is associated with bone mineral content
during middle childhood. _Journal of Nutrition_ **136**, 1281–1286.
Fraser AM, Brockert JE, and Ward RH (1995) Association of young
maternal age with adverse reproductive outcomes. _New England_
_Journal of Medicine_ **332**, 1113–1117.
French SA, Perry CL, Leon GR, and Fulkerson JA (1994) Weight
concerns, dieting behavior, and smoking initiation among adolescents: a prospective study. _American Journal of Public Health_
**84**, 1818–1820.
French SA, Story M, Neumark-Sztainer D, Fulkerson JA, and Hannan P (2001) Fast food restaurant use among adolescents: associations with nutrient intake, food choices and behavioral and
psychosocial variables. _International Journal of Obesity_ **25**, 1823–
1833.
Giddens JB, Krug SK, Tsang RC, Guo S, Miodovnik M, and Prada
JA (2000) Pregnant adolescent and adult women have similarly
low intakes of selected nutrients. _Journal of the American Dietetic_
_Association_ **100**, 1334–1340.
Giovannini M, Agostoni C, Giann´ı M, Bernardo L, and Riva E
(2000) Adolescence: macronutrient needs. _European Journal of_
_Clinical Nutrition_ **54** (Suppl. 1), S7–S10.
Goldin BR, Woods MN, Spiegelman DL _et al_ . (1994) The effect of
dietary fat and fiber on serum estrogen concentrations in premenopausal women under controlled dietary conditions. _Cancer_
**74**, 1125–1131.
Gowers SG (2008) Management of eating disorders in children and
adolescents. _Archives of Disease in Childhood_ **93**, 331–334.
Greene-Finestone LS, Campbell MK, Evers SE, and Gutmanis IA
(2008) Attitudes and health behaviours of young adolescent omnivores and vegetarians: a school-based study. _Appetite_ **51**, 104–
110.
Griffith J and Omar H (2003) Association between vegetarian diet
and menstrual problems in young women: a case presentation
and brief review. _Journal of Pediatric and Adolescent Gynecology_
**16**, 319–323.



GuoSS,ChumleaWC,RocheAF,andSiervogelRM(1997)Age-and
maturity-related changes in body composition during adolescence into adulthood: the Fels Longitudinal Study. _International_
_Journal of Obesity_ **21**, 1167–1175.
Gutierrez Y and King JC (1993) Nutrition during teenage pregnancy. _Pediatric Annals_ **22**, 99–108.
Hampl JS and Betts NM (1999) Cigarette use during adolescence: effects on nutritional status. _Nutrition Reviews_ **57**, 215–

221.
Harel Z, Gold M, Cromer B _et al_ . (2007) Bone mineral density in
postmenarchal adolescent girls in the United States: associated
biopsychosocial variables and bone turnover markers. _Journal of_
_Adolescent Health_ **40**, 44–53.
Henderson L, Gregory J, and Swan G (2002) _National Diet and_
_Nutrition Survey: Adults Aged 19–64 Years_ . Office of National
Statistics, London.
Herzog DB, Franko DL, Dorer DJ, Keel PK, Jackson S, and Manzo
MP (2006) Drug abuse in women with eating disorders. _Interna-_
_tional Journal of Eating Disorders_ **39**, 364–368.
Hill AJ (2002) Developmental issues in attitudes to food and diet.
_Proceedings of the Nutrition Society_ **61**, 259–266.
Hill AJ (2006) Motivation for eating behaviour in adolescent girls:
the body beautiful. _Proceedings of the Nutrition Society_ **65**, 376–
384.
Hoek HW and van Hoeken D (2003) Review of the prevalence
and incidence of eating disorders. _International Journal of Eating_
_Disorders_ **34**, 383–396.
HuntJR(2003)Bioavailabilityofiron,zinc,andothertraceminerals
from vegetarian diets. _American Journal of Clinical Nutrition_ **78**,
633S–639S.
Jensen EX, Fusch C, Jaeger P, Peheim E, and Horber FF (1995) Impact of chronic cigarette smoking on body composition and fuel
metabolism. _Journal of Clinical Endocrinology and Metabolism_
**80**, 2181–2185.
Johnston CC Jr, Miller JZ, Slemenda CW _et al_ . (1992) Calcium supplementation and increases in bone mineral density in children.
_New England Journal of Medicine_ **327**, 82–87.
Jones IE, Williams SM, and Goulding A (2004) Associations of
birth weight and length, childhood size, and smoking with bone
fractures during growth: evidence from a birth cohort study.
_American Journal of Epidemiology_ **159**, 343–350.
Kenyon PM and Barker ME (1998) Attitudes towards meat-eating
in vegetarian and non-vegetarian teenage girls in England–an
ethnographic approach. _Appetite_ **30**, 185–198.
Kerr MA, Rennie KL, McCaffrey TA, Wallace JM, Hannon-Fletcher
MP, and Livingstone MB (2009) Snacking patterns among adolescents: a comparison of type, frequency and portion size between Britain in 1997 and Northern Ireland in 2005. _British_
_Journal of Nutrition_ **101**, 122–131.
Klump KL and Gobrogge KL (2005) A review and primer of molecular genetic studies of anorexia nervosa. _International Journal of_
_Eating Disorders_ **37**, S43–S48.
Knight EM, James H, Edwards CH _et al_ . (1994) Relationships of
serum illicit drug concentrations during pregnancy to maternal
nutritional status. _Journal of Nutrition_ **124**, 973S–980S.
Kubberød E, Ueland Ø, Tronstad A, and Risvik E (2002) Attitudes
towards meat and meat-eating among adolescents in Norway: a
qualitative study. _Appetite_ **38**, 53–62.
Lambert HL, Eastell R, Karnik K, Russell JM, and Barker ME (2008)
Calcium supplementation and bone mineral accretion in adolescent girls: an 18-mo randomized controlled trial with 2-y followup. _American Journal Clinical Nutrition_ **87**, 455–462.
Langley-Evans SC and Langley-Evans AJ (2002) Use of folic acid
supplements in the first trimester of pregnancy. _Journal of the_
_Royal Society of Health_ **122**, 181–186.



**Nutrition and Adolescence** **183**


Lawrie Z, Sullivan EA, Davies PS, and Hill RJ (2007) Body change
strategies in children: relationship to age and gender. _Eating Be-_
_haviour_ **8**, 357–363.
Lenney W and Enderby B (2008) “Blowing in the wind”: a review
of teenage smoking. _Archives of Disease in Childhood_ **93**, 72–75.
Lorentzon M, Mellstr¨om D, Haug E, and Ohlsson C (2007) Smoking is associated with lower bone mineral density and reduced
cortical thickness in young men. _Journal of Clinical Endocrinology_
_and Metabolism_ **92**, 497–503.
Mackerras D and Rutishauser I (2005) 24-Hour national dietary
survey data: how do we interpret them most effectively? _Public_
_Health Nutrition_ **8**, 657–665.
Martins Y, Pliner P, and O’Connor R (1999) Restrained eating
among vegetarians: does a vegetarian eating style mask concerns
about weight? _Appetite_ **32**, 145–154.
McArdle P (2008) Alcohol abuse in adolescents. _Archives Disease in_
_Childhood_ **93**, 524–527.
Misra M (2008) Bone density in the adolescent athlete. _Reviews in_
_Endocrine and Metabolic Disorders_ **9**, 139–144.
Moran VH (2007) Nutritional status in pregnant adolescents: a
systematic review of biochemical markers. _Maternal and Child_
_Nutrition_ **3**, 74–93.
Neumark-Sztainer D and Hannan PJ (2000) Weight-related behaviors among adolescent girls and boys: results from a national
survey. _Archives of Pediatric and Adolescent Medicine_ **154**, 569–
577.
Neumark-Sztainer D, Story M, Perry C, and Casey MA (1999)
Factors influencing food choices of adolescents: findings from
focus-groupdiscussionswithadolescents. _JournaloftheAmerican_
_Dietetic Association_ **99**, 929–937.
Neumark-Sztainer D, Wall M, Guo J, Story M, Haines J, and Eisenberg M (2006) Obesity, disordered eating, and eating disorders
in a longitudinal study of adolescents: how do dieters fare 5 years
later? _Journal of the American Dietetic Association_ **106**, 559–568.
O’Dea JA (2003) Why do kids eat healthful food? Perceived benefits
of and barriers to healthful eating and physical activity among
children and adolescents. _Journal of the American Dietetic Asso-_
_ciation_ **103**, 497–501.
Office for National Statistics (2008) The health of children and
young people. Available from http://www.statistics.gov.uk/cci/
nugget.asp?id=719 (last accessed August 2008).
Olmedilla B and Granado F (2000) Growth and micronutrient
needs of adolescents. _European Journal of Clinical Nutrition_
**54** (Suppl. 1), S11–S15.
Paeratakul S, Ferdinand DP, Champagne CM, Ryan DH, and Bray
GA (2003) Fast-food consumption among US adults and children: dietary and nutrient intake profile. _Journal of the American_
_Dietetic Association_ **103**, 1332–1338.
Petrie HJ, Stover EA, and Horswill CA (2004) Nutritional concerns
for the child and adolescent competitor. _Nutrition_ **20**, 620–631.
Pisetsky EM, Chao YM, Dierker LC, May AM, and Striegel-Moore
RH (2008) Disordered eating and substance use in high-school
students: results from the Youth Risk Behavior Surveillance System. _International Journal of Eating Disorders_ **41**, 464–470.
Potter BK, Pederson LL, Chan SS, Aubut JA, and Koval JJ (2004)
Does a relationship exist between body weight, concerns about
weight, and smoking among adolescents? An integration of the
literature with an emphasis on gender. _Nicotine and Tobacco Re-_
_search_ **6**, 397–425.
Prentice A, Ginty F, Stear SJ, Jones SC, Laskey MA, and Cole TJ
(2005) Calcium supplementation increases stature and bone
mineral mass of 16- to 18-year-old boys. _Journal of Clinical En-_
_docrinology and Metabolism_ **90**, 3153–3161.
Preziosi P, Hercberg S, Galan P, Devanlay M, Cherouvrier F, and
Dupin H (1994) Iron status of a healthy French population:



**184** **Nutrition: A Lifespan Approach**


factors determining biochemical markers. _Annals of Nutrition_
_and Metabolism_ **38**, 192–202.
Rodondi N, Pletcher MJ, Liu K, Hulley SB, and Sidney S (2006)
Coronary artery risk development in young adults (CARDIA)
study. Marijuana use, diet, body mass index, and cardiovascular risk factors (from the CARDIA study). _American Journal of_
_Cardiology_ **98**, 478–484.
Roemmich JN, Richmond RJ, and Rogol AD (2001) Consequences
of sport training during puberty. _Journal of Endocrinological In-_
_vestigation_ **24**, 708–715.
Rolland-Cachera MF, Bellisle F, and Deheeger M (2000) Nutritional
status and food intake in adolescents living in Western Europe.
_European Journal of Clinical Nutrition_ **54** (Suppl. 1), S41–S46.
Samuelson G (2000) Dietary habits and nutritional status in adolescents over Europe. An overview of current studies in the Nordic
countries. _European Journal of Clinical Nutrition_ **54** (Suppl. 1),
S21–S28.
Savige G, Macfarlane A, Ball K, Worsley A, and Crawford D (2007)
Snacking behaviours of adolescents and their association with
skipping meals. _International Journal of Behavioural Nutrition_
_and Physical Activity_ **4**, 36.
Sebastian RS, Cleveland LE, and Goldman JD (2008) Effect of
snacking frequency on adolescents’ dietary intakes and meeting national recommendations. _Journal of Adolescent Health_ **42**,
503–511.
ShawME(1998)Adolescentbreakfastskipping:anAustralianstudy.
_Adolescence_ **33**, 851–861.
Specker BL (2006) Influence of rapid growth on skeletal adaptation
to exercise. _Journal of Musculoskeletal and Neuronal Interactions_
**6**, 147–153.
Stear SJ, Prentice A, Jones SC, and Cole TJ (2003) Effect of a calcium
and exercise intervention on the bone mineral status of 16–18y-old adolescent girls. _American Journal of Clinical Nutrition_ **77**,
985–992.
Story M, Holt K, and Softka A (2002) _Bright Futures in Practice:_
_Nutrition._ National Center for Education in Maternal and Child
Health, Arlington, VA.
Tanner JM (1989) _Foetus into Man._ Castlemead Publications,
Ware.


**Self-Assessment Questions**


Assess your understanding of the concepts outlined in
this chapter using the following questions:


1 Describe the impact of puberty upon growth and body
composition in adolescence.
2 What are the main factors influencing food choice
among adolescents? To what extent are these compatible with requirements for nutrients?



Tappia PS, Troughton KL, Langley-Evans SC, and Grimble RF
(1995) Cigarette smoking influences cytokine production and
antioxidant defences. _Clinical Science_ **88**, 485–489.
Taylor EF, Burley VJ, Greenwood DC, and Cade JE (2007) Meat consumption and risk of breast cancer in the UK Women’s Cohort
Study. _British Journal of Cancer_ **96**, 1139–1146.
Thane CW, Bates CJ, and Prentice A (2003) Risk factors for low iron
intake and poor iron status in a national sample of British young
people aged 4–18 years. _Public Health Nutrition_ **6**, 485–496.
Utter J, Neumark-Sztainer D, Wall M, and Story M (2003) Reading
magazine articles about dieting and associated weight control
behaviors among adolescents. _Journal of Adolescent Health_ **32**,
78–82.
V¨alim¨aki MJ, K¨arkk¨ainen M, Lamberg-Allardt C _et al_ . (1994) Exercise, smoking, and calcium intake during adolescence and early
adulthood as determinants of peak bone mass. Cardiovascular
risk in young finns study group. _British Medical Journal_ **309**,
230–235.
van Den Bulck J, and Eggermont S (2006) Media use as a reason
for meal skipping and fast eating in secondary school children.
_Journal of Human Nutrition and Dietetics_ **19**, 91–100.
WallaceJM,LutherJS,MilneJS _etal_ .(2006)Nutritionalmodulation
of adolescent pregnancy outcome – a review. _Placenta_ **27**, S61–
S68.
WeaverCM,ProulxWR,andHeaneyR(1999)Choicesforachieving
adequatedietarycalciumwithavegetariandiet. _AmericanJournal_
_of Clinical Nutrition_ **70**, 543S–548S.
Welten DC, Kemper HC, Post GB _et al_ . (1994) Weight-bearing
activity during youth is a more important factor for peak bone
mass than calcium intake. _Journal of Bone and Mineral Research_
**9**, 1089–1096.
White AM and Swartzwelder HS (2005) Age-related effects of alcohol on memory and memory-related brain function in adolescents and adults. _Recent Developments in Alcohol_ **17**, 161–176.
Willett WC (2003) Lessons from dietary studies in Adventists and
questions for the future. _American Journal of Clinical Nutrition_
**78**, 539S–543S.
Worsley A and Skrzypiec G (1998) Teenage vegetarianism: prevalence, social and cognitive contexts. _Appetite_ **30**, 151–170.


3 Describe the process of bone growth. What should be
the main diet and lifestyle priorities for promotion of
skeletal growth in adolescence?
4 Discuss the main barriers to healthy nutrition in adolescence.
5 What are the main characteristics of the eating disorders, AN, and BN? Describe the main risk factors for
these conditions.



# **8**

### **The Adult Years**

**Learning objectives**


By the end of this chapter the reader should be able to:


r Show an awareness of the need to adjust diet and
lifestyle during the adult years in order to promote
maintenance of a healthy weight and avoid major disease states including cardiovascular disease, cancer,
~~and type 2 diabetes.~~
r Describe some of the different approaches taken by
governments to promote healthy diet and lifestyle in
populations.
r Describe the global trends in the prevalence of overweight and obesity.
r Demonstrate an understanding of the relationship between obesity, insulin resistance, and risk of cardiovascular disease and diabetes.


**8.1 Introduction**


All of the preceding chapters in this book have considered the relationships between diet and health during periods of major physiological change. Demanding life stages and processes, such as development,
growth, maturation, and reproduction, all increase
requirements for nutrients. Failure to deliver those
nutrient demands can result in rapid onset of potentially disastrous outcomes for the individual, or
may set in place an increased risk of disease later in
life. In contrast to this, the adult years from 19–65
are therefore relatively “quiet” from a nutritional perspective, but do represent the stage of life at which
most of the adverse consequences of poor nutrition
and acquisition of unhealthy lifestyle behaviors at
earlier life stages begin to manifest as major disease
states. The main focus of this chapter will be on these
nutrition-related diseases of adulthood and how diet

and lifestyle change might offset risk of ill health and
mortality.



r Describe optimal strategies for the management and
treatment of obesity and related disorders.
r Discuss the diet-related risk factors for cardiovascular
disease, including the classical risk factors (e.g., highsodium and high-fat diets) and emerging risk factors
(e.g., hyperhomocysteinemia).
~~r~~ ~~Critically review different approaches to nutritional epi-~~
demiology, showing an understanding of the limitations of observational and intervention studies.

r Describe the relationship between diet and cancer,
showing an awareness of the elements of human diets that may drive the processes of carcinogenesis and
metastasis, and the factors that may play a role in cancer prevention.


**8.2 Changing needs for nutrients**


With the completion of growth at the end of the adolescentyears,adultphysiologybecomesstable,withno
further changes of a major nature until the degenerative processes associated with aging begin to impact
on organ functions (see Chapter 9). The peak of performance for most systems is achieved at around the
age of 30 years, but with demand for most nutrients
simply meeting the need for maintenance of function
and repair processes there is little variation in the need
for nutrients across the earlier adult years. As there is
no longer a demand associated with growth and maturation, requirements for most nutrients is lower in
adulthood than was seen in adolescence.
Beyond the change in demands associated with attainment of mature physique, protein and micronutrient requirements are unchanging across the earlier
adult years. Requirements for protein are stable at
0.8 g/day/kg protein and the requirements for vitamins and minerals are essentially similar at age 19



**186** **Nutrition: A Lifespan Approach**


**8**


**6**


**4**


**2**


**0**

**19-29** **30-59** **19-29** **30-59**


**Age (years)**


**Figure 8.1** Basal metabolic rate declines with age in men and women.
Data show basal metabolic rate (BMR) estimates for men and women
of average weight, derived from the Schofield equations.
Males aged 18–29 yr: BMR = 0.063 × body weight + 2.869.
Males aged 30–59 yr: BMR = 0.048 × body weight + 3.653.
Females aged 18–29 yr: BMR = 0.062 × body weight + 2.036.
Females aged 30–59 yr: BMR = 0.034 × body weight + 3.538.


and age 60. However, this lack of change in demands
masksthemajorchangethatisrequiredintermsofthe
quality of diet across this time span. With aging comes
a need for the diet to become more nutrient-dense

(i.e., for the concentration of protein and micronutrients per unit of energy to increase). This reflects a
downward shift in energy requirements with aging.
Energy requirements of adults are lower than those
of adolescents partly due to the loss of requirement
for growth, but mainly due to typically lower levels of expenditure through physical activity. Actual
energy requirements of individual adults will vary
widely with gender, activity level, state of health, and
body size, all contributing to this variation. For most
adults, engaged in sedentary occupations, energy requirements will fall not only relative to the adolescent
years, but across the middle years of adulthood also.
This is due to a decline in the resting metabolic rate
(Figure 8.1).
Making adjustments to this protracted change in
nutrient requirements can often be problematic and
overnutrition leading to overweight and obesity is
commonplace among adults in westernized and, increasingly, the developing countries. Most of the
major disease states, diabetes, cardiovascular disease
(CVD), and cancer, which are reviewed later in this
chapter are the consequence of this overnutrition.
However, it is important to bear in mind that the



undernutrition described earlier in this book in relation to children remains a significant problem among
adult populations. Adult undernutrition will be observed in developing countries and in the developed
countries of the world among particular subgroups in
the population. Those at risk of malnutrition include
the homeless, alcoholics, intravenous drug users, institutionalized individuals, the chronically ill, the elderly (see Chapter 9), and those infected with HIV.
Whereas in children malnutrition rapidly becomes a
life-threatening factor, among adults undernutrition
in these circumstances will generally be present over
a longer term. Malnutrition in adults reduces the capacity to do physical work, which in many countries
will impact on the ability to provide food and care
for whole families. Undernutrition will also reduce

the capacity of individuals to respond to metabolic
trauma, triggered by infection, injury, or surgery.
Ultimately, the undernourished adult is as much at
risk of premature death as the overweight or obese
adult.


**8.3 Guidelines for healthy nutrition**


Decades of research that has considered the relation
ships between diet and disease have left no doubt
that defining the optimal diet for a population is a
complex process. Individuals respond metabolically
to variation in the composition of the diet in different
ways and this variation will depend upon often poorly
understoodgeneticfactors,earlylifeprogramminginfluences, and lifestyle factors. However, it is clear that
in general terms a healthier diet should be a varied diet
in which carbohydrate provides the basic staple, with
energy intakes from fat and protein providing lesser
components of intake (Table 8.1). In most circumstances healthy adults are advised to base meals on
starchy foods, to consume five portions of fruit and
vegetables per day, to consume two portions of fish
per week (including one of oily fish), and to have low
intakes of fats and sugars. Food intakes should be well
spaced throughout the day, and breakfast remains an
essential meal of the day, as in childhood.
Highly successful health promotion campaigns
across the westernized countries, such as the Five-aday campaign (National Health Service, 2007), mean
that these general messages are now widely recognized, but are not necessarily fully understood.



**Table 8.1** General guidelines for intake of sugars, fats, and salt by
adults


Nutrient Maximum recommended intake _[a]_


**Fats**
Saturated fatty acids 10% of daily energy
Polyunsaturated fatty acids 10% of daily energy
Monounsaturated fatty acids 12% of daily energy
Total fats 35% of daily energy
**Sugars**
Milk sugars and starch 39% of daily energy
Nonmilk extrinsic sugars 11% of daily energy
Total carbohydrate 50% of daily energy
**Salt** 6 g/day


Source: Department of Health (1999).
_a_ Also referred to as population averages.


Communicating information such as that shown in
Table 8.1 to the population presents a sizeable problem. Concepts such as percentage of daily energy intakearecomplexandmeannothingwithinthecontext
of individuals’ daily dietary choices. Even with successful campaigns such as Five-a-day, understanding
of the detail behind the generalized message is often



**The Adult Years** **187**


weak. The need to consume five portions of fruit and
vegetables per day is simple to remember, but defining a “portion” (actually 80 g of fresh, frozen, canned
or dried fruit, vegetables, salad, fruit juice) is beyond
most people. As a result, most governments in the
westernized nations have sought to develop simple
pictorial models to act as a guide to healthy adults,
showing what comprises a healthy and well-balanced
diet. In the UK, the Balance of Good Health plate
model (Figure 8.2) was introduced in the mid-1990s
for this purpose (Health Education Authority, 1995).
The Food Standards Agency redesigned this model in
2007, producing the new Eatwell plate, which renames
some food groups, for example, “breads, cereals and
potatoes” became “bread, rice, potatoes, pasta and
other starchy foods.”
The Balance of Good Health/Eatwell model works
on a principle that is common to similar models that
are used in other countries, for example the US Food
Pyramid (USDA, 2005). Foods are divided into food
groups. Within the Balance of Good Health model
there are fruits and vegetables, breads, cereals and
potatoes, milk and dairy, meat, fish and alternatives,



**The Balance of Good Health**



**Fruit and vegetables**



**Bread, other cereals, and potatoes**



**Meat, fish, and alternatives** **Foods containing fat** **Milk and diary foods**
**Foods and drinks containing sugar**


**There are five main groups of valuable foods**


**Figure 8.2** The balance of good health. This pictorial representation of the relative proportions of foods from each of five groups that should be
included in a healthy diet was used as one of the key aids in health education in the UK. Health Education Authority (1995).



**188** **Nutrition: A Lifespan Approach**


**(a) UK FSA Traffic light label**



**(b) Swedish National Food**
**Administration, keyhole symbol**











and foods containing fat and sugar. The sectors on the
plate (Figure 8.2) are supposed to reflect the relative
amount of food intake that should come from each
group, hence breads, cereals and potatoes, fruits and
vegetables should provide approximately two-thirds
of intake. There are variations on this model (e.g.,
Japanese Spinning Top Food Guide, Swedish Food
Circle), and within the US Food Pyramid, for example,fruitsandvegetablesareintheirownseparatefood
groups, and it is suggested that intakes of foods from
the breads, cereals, pasta, and rice group outweigh intakes of the fruit and vegetable groups. The Swedish
Food Circle is similar in design to the Balance of Good
Health Plate, but crucially lacks the foods containing
fat and sugar food group (hence discouraging their
intake altogether), and separates vegetables into “root
vegetables” (starchy roots such as carrots and potatoes) and “essential vegetables” (green leafy vegetables that are important micronutrient sources). The
United States Food Pyramid was first introduced in
1992 and was widely taken up by other countries in
Europe, Australasia, Africa, and Asia. An updated version of the pyramid model, My Pyramid, was introduced in the US in 2005 to reflect some of the factors,
including age, weight, and ethnicity that shape nutrient demands. This provides a more personalized
format for nutrition advice, but requires positive engagement with users who should ideally input data to
the My Pyramid web pages.
This latter point emphasizes the major problem
with all such pictorial guidance schemes, as they can



R **Figure 8.3** Symbolsusedinfoodlabeling.(a)The
traffic light scheme (FSA; Food Standards Agency,
UK). The content of fat, saturated fat, sugar, and
salt in foods are rated as high, medium, or low,
providing a simple visual representation for consumers. (b) The Swedish National Food Administration Keyhole symbol. Only foods that are low
in fat, sugar, and salt can carry this logo, which
allows consumers to identify the foods that comprise a healthy diet, both in shops and when eating out.


educate but are of little practical use to individuals in
daily life. When confronted with the infinite variety of
food products in supermarkets, individuals either forget or become confused by healthy eating messages.
This has prompted many countries to promote improved food labeling schemes that provide clear and
simple nutritional messages at the point of sale. In
the UK, the Food Standards Agency has promoted the
use of a Food Traffic Light scheme. Foodstuffs labeled
with the traffic lights would bear a label as shown in
Figure 8.3, which shows content of fat, saturated fat,
sugar, and salt highlighted as red for high, amber for
medium, and green for low. This would allow consumers to make informed decisions on brands or varieties. However, the introduction of traffic lights has
not been wholly welcomed by major supermarkets,
some of which have brought in similar, but less informative, labeling systems based on “Guideline Daily
Allowances.” The existence of multiple versions of the
traffic light system, with differences in labeling style
between supermarkets and food producers is sure
to confuse consumers and dilute the power of this
initiative.

Swedish consumers have a similar but greatly simplified guide to healthy options when buying food in
shops or eating out. The Livsmedelsverket Keyhole
(Figure 8.3) symbol, like the FSA traffic light, is a voluntary label and food producers take responsibility
for ensuring that foods bearing the symbol conform
to regulations and are low in fat, sugar, salt and high
in dietary fiber.



**8.4 Disease states associated with**
**unhealthy nutrition and lifestyle**


_**8.4.1 Obesity**_


**8.4.1.1 Classification of overweight and**
**obesity**
Obesity is normally defined on the basis of body mass
index (BMI) as shown in Table 8.2. This anthropometric measurement based on height and weight is
actually a poor indicator of body fatness, so its usefulness in studying or managing obesity (which is
essentially the presence of excess body fat) has been
questioned. BMI cannot discriminate between lean
tissue mass and fat mass and so will often misclassify
individuals who are particularly muscular. However,
for most clinical purposes and for epidemiological
studies at the population level, BMI is a measurement that is fit for purpose. The BMI classifications
shown in Table 8.2 are a generalization and many obesity researchers argue that specific cutoffs should be
used for different ethnic groups and should be agespecific. South Asians, for example, have more body
fat than Caucasians at any given level of BMI, when
this is measured using robust methods such as computed tomography. A BMI of 27.0 may therefore be
a more appropriate cutoff to define obesity in this
ethnic group (Weisell, 2002).
Fat is distributed in different regions of the body
and will be found in a subcutaneous layer, in depots


**Table 8.2** Classifying obesity using body mass index or waist
circumference


Body mass index (kg/m [2] )


Underweight _<_ 18.5
Desirable weight 18.5–24.9
Overweight 25.0–29.9
Obese _>_ 30.0


Waist circumference (cm)


Men Women


Action level _[a]_ 1 94 80

Action level 2 102 88


_a_ From Lean et al. (1995). Action levels 1 and 2 correspond to
overweight and obese classifications and indicate the waist
circumferences at which action to reduce weight would be
beneficial to health.



**The Adult Years** **189**


with the abdomen, in depots around organs such as
the heart and kidneys, and present within tissues such
as the liver and skeletal muscle. The fat stored in locations other than subcutaneously is termed visceral
fat. The patterns of fat deposition within an individual may be critical determinants of their disease risk
(see Cardiovascular Disease and Cancer sections below) and will vary between the sexes. Males typically
store fat in an _android_ pattern, where most visceral fat
accumulates in the abdomen. Women store fat in a

_gynoid_ pattern, with the buttocks and hips providing
the main depots. In obesity, however, women will tend
to adopt an android shape, as fat is stored centrally.
BMI cannot determine the patterns of fat distribution within the body, so other anthropometric tools
are necessary. Historically the waist–hip ratio, which
simply required measurements of the circumference
of the body around the waist and the hips, was viewed
as a measure of abdominal fat deposition. Lean _et al_ .
(1995), however, suggested that waist circumference
alone serves as a robust marker of central obesity, and
this measure is now widely accepted (Table 8.2).


**8.4.1.2 Prevalence and trends in obesity**
The rise in the prevalence of obesity across the globe is
well documented and widely reported. In most countries of the world, the proportion of obese adults increased by 40–50% between the mid-1990s and the
first few years of the twenty-first century. In westernized countries, this increase in prevalence coincided with a decrease in overall energy intake, which
strongly suggests that the rising trend was related to
sedentary lifestyle.
On a global scale, the World Health Organization
(2000) estimated that there were as many overweight
people as underweight people in the world, for the
first time in history, in the year 2000. Eight percent
of the world population were estimated to be overweight or obese, with lowest prevalence in the least
developed countries and highest prevalence in the developed market economies. In developing countries
prevalence was increasing, and in nations undergoing
economic transition, with the associated changes in
diet and lifestyle, rates of obesity and overweight were
increasing most rapidly. Table 8.3 shows data from
the International Obesity Task Force (2007), which
highlights the countries with the greatest adult obesity problems, in different regions of the world.



**190** **Nutrition: A Lifespan Approach**


**Table 8.3** Global distribution of obesity in adults


Region Obesity in men Obesity in women


Europe Croatia 31%. Albania 36%.
Cyprus 27% Malta 35%
Czech Republic 25% Turkey 29%


Eastern Mediterranean Lebanon 36% Jordan 60%

Qatar 35% Qatar 45%
Jordan 33% Saudi Arabia 44%


North America USA 31% USA 33%

Mexico 19% Barbados 31%

Canada 17% Mexico 29%


South and Central Panama 28% Panama 36%


America Paraguay 23% Paraguay 36%
Argentina 20% Peru 23%


Africa South Africa 10% Seychelles 28%
Seychelles 9% South Africa 28%
Ghana 5% Ghana 20%


Southeast Asia and Pacific Nauru 80% Nauru 78%
Tonga 47% Tonga 70%
Cook Islands 41% Samoa 63%


Source: Data from IOTF (2007).
Note: The table shows three countries within each region with the highest prevalence of
obesity, with prevalence figures for the period 2001–2006.



The UK and US are among the most closely
studied countries with regard to increasing obesity
prevalence in both adults and children. In England
(Department of Health, 2002), the prevalence of obesity (BMI greater than 30 kg/m [2] ) increased from 6%
in men and 8% in women in 1980, to 22% in men
and 23% in women by 2002. This represents an overall increase of 221% over 22 years. In the US similar
increases have been noted. Kim _et al._ (2007) reported
thatamongwomenofchildbearingage,theprevalence
of obesity rose by 69% between 1993 (13% of women
obese) and 2003 (22% of women obese). Flegal _et al_ .
(2002) noted that 70% of men and 66.1% of women
in the US (aged 40–59) were overweight, with 28.8%
of men and 34.2% of women classified as obese. The
prevalence of obesity had risen by 33% between 1994
and 2000 and the prevalence of severe obesity (BMI
_>_ 40 kg/m [2] ) had increased by 62%.


**8.4.1.3 Causes of obesity in adulthood**
While some associations between body fatness in
childhood and early life experience may explain the
developmentofobesityinadulthood(seeearlierchap


ters), the adult lifestyle is the primary driver of weight
gain and body fatness.
The combination of an excessive nutrient intake

and a sedentary lifestyle promote positive energy balance and adiposity. Positive energy balance will also
be driven by genetic factors and polymorphisms in
genes that contribute to the regulation of appetite,
energy metabolism, and adipokine release may well
predispose individuals to obesity. However, single locus mutations that contribute to obesity are extremely
rare and most obesity-promoting genotypes are dependent on lifestyle factors to be fully expressed.
The rising prevalence of obesity across the globe
over the last decades of the twentieth and first decade
ofthetwenty-firstcenturiesisalmostwhollyexplained
by changes in lifestyle over the same period. The availability and consumption of energy increased hugely
relative to the 1970s and 1980s, and while intakes of
sugars tended to decrease, fat consumption increased
markedly (Prentice and Jebb, 1995). Food processing technology generated an infinite variety of inexpensive and attractive products. The low cost of this
food contributed to increased portion sizes and, with
changing patterns of family life, greater proportions



of people chose to consume prepackaged foods that
were energy dense and nutrient poor. The increased
use of cars in preference to walking and cycling, even
over relatively short distances, contributed to a slump
in physical activity and associated energy expenditure.
Occupationsthatinvolvedmanuallaborandheavyindustry were replaced with desk-based jobs, and leisure
activities reinforced the sedentary way of living, by becoming focused on television and the Internet.


**8.4.1.4 Treatment of obesity**
Obesity is associated with significantly greater risk of
major illness and premature death due to a variety
of causes. Greenberg and colleagues (2007) estimated
that BMI greater than 30 kg/m [2] increased risk of death
from any cause by 170% in a US population aged between 51 and 70 years. Banegas _et al_ . (2003) estimated
that in European countries 7.7% of all deaths were
related to obesity, of which 70% were CVD deaths
and 20% cancer-related. The association of obesity
with diabetes, CVD, and certain cancers is discussed
in greater depth later in this chapter.
Given the importance of obesity and overweight as
risk factors for life-threatening disease, the treatment
and management of obesity is a major priority.
Weight loss can be achieved through a wide variety
of different approaches that utilize dietary change,
increases in physical activity, pharmacological agents,
and bariatric surgery. Short-term weight loss carries
no real health benefits, and there are some suggestions
that weight cycling, in which individuals continually
lose and then regain body weight, may actually
increase risk of major disease. If the goal for obese
individuals in the population is to lose weight for a
sustained period, none of the approaches indicated
above will be successful in isolation. Sustained weight
loss depends upon wholesale lifestyle and behavioral
changes that incorporate strategies for reducing
energy intake, while increasing expenditure through
activity.
Dietary approaches to losing weight are legion and
a massive multi-billion pound industry has grown up
aroundtheglobalobesitypandemic.Most,ifnotall,of
the restrictive diet practices that are advocated will be
effective in the short term but are unlikely to produce
sustained weight loss. The more bizarre and difficult it
is to follow the commercial diet programs, the harder
the users will find the process. This reduces the likeli


**The Adult Years** **191**


hood that the new eating pattern will be successfully
incorporated into a permanent lifestyle change. The
most effective strategies for reducing energy intake
will be those that require less willpower to follow. In
this respect, reducing energy intake by limiting snacking (which may contribute in excess of 300 kcal/day
to the typical diet) or reducing portion sizes may be
a helpful strategy (Jebb, 2005). Reductions of energy
intake of approximately 500 kcal/day would be expected to produce weight loss of around 0.25 kg per
week. This slow gradual weight loss is more likely to
be successful in the longer term.
Manyweightlossdietshavebeendesignedtoreduce
fat intake, working on the assumption that if obesity
is increased body fatness, then consuming less fat will
promote weight loss. This is of course overly simplistic
and most studies show that decreasing fat intake has
only short-term effects on body weight and that these
are almost certainly the result of reducing the energy
density of the diet (Jebb, 2005).
There is major interest in diets that limit carbohydrate intake. The Atkins diet, for example, reduces
intake of carbohydrates to just 10–30% of daily energy intake and allows unlimited consumption of protein and fat. Weight loss is supposed to occur as the
lower blood sugar resulting from carbohydrate restriction promotes ketosis and lowers insulin concentrations. This is proposed to stimulate lipolysis and
inhibit lipogenesis. However, it is more likely that the
greater protein intakes associated with such diets promote satiety and simply reduce overall energy intake
(Malik and Hu, 2007).
Another approach to modifying the diet is to restrict intake of carbohydrates to those with a lower
glycemic index (GI). GI is a ranking system that rates
different carbohydrate sources according to their impact upon blood glucose and insulin concentrations.
Simple sugars that are rapidly absorbed, producing
a large spike in blood glucose have high GI, while
complex carbohydrates that require greater digestion
and release glucose into the blood in a slow sustained
fashion have low GI. True GI will vary between individuals due to variation in the response to different
foodstuffs. Low GI diets appear to promote weight
loss in animal studies, but data from human trials
remains controversial. Although some studies suggest
low GI diets promote weight loss of 5% or more over a
12-month period, this may occur simply because subjects seeking lower GI foods consume more fruits and



**192** **Nutrition: A Lifespan Approach**


vegetables and less processed, refined foods, which
tend to be more energy-dense (Jebb, 2005).
Many individuals with higher grade obesity (BMI
over 35 kg/m [2] ) may be advised to follow a very
low calorie diet (VLCD). This type of diet focuses
on severely reducing energy intake to approximately
800–1200 kcal/day. This often promotes rapid weight
loss of around 1 kg per week. However, VLCD are
largely ineffective as a tool for achieving longer term
weight loss. Vogels and Westerterp-Plantenga (2007)
reported that in a group that followed a VLCD for 6
weeks, achieving an average weight loss of 7.2 kg, 87%
of the individuals regained the lost weight within 2

years.
Mild-to-moderate exercise such as walking or
housework are sufficient to increase energy expenditure and even with no change in dietary intakes sedentaryindividualstakingonsuchactivitiesinadditionto
normal activity should experience some weight loss.
However, weight loss associated with physical activity
alone will be minor and exercise is most effective when
coupled to a change in diet (Shaw _et al_ ., 2006). Higher
intensity exercise produces greater improvements in
weight profile than mild–moderate activity, but for
any individual to succeed it is important that exercise
and weight loss goals are realistic and achievable.
Pharmacological agents are considered appropriate
for patients who either cannot, or do not, lose weight
usingconventionalapproaches.Theyareasuitableadjunct to lifestyle advice and change, but should only be
usedfortheshorttermsinceallcarrysomeformofundesirable side effects. Typically, antiobesity drugs have
their maximum effect over a period of 7–8 months,
beyond which users will tend to start regaining weight
unless adequate lifestyle changes have also been implemented.
Orlistat is a widely used antiobesity drug that works
by inhibiting lipase activities and hence reducing the
absorption of fat across the gut. On a diet that provides 30% of energy in the form of fat, approximately
one-third of the fat will be lost in the feces (Bray
and Ryan, 2007). Orlistat has been shown to promote
loss of approximately 7% of body weight in obese
individuals over a 2-year period. Similar effects are
noted with sibutramine, which is a central inhibitor
of serotonin, noradrenaline, and dopamine reuptake.
This drug inhibits appetite and also promotes energy
expenditure by activating thermogenesis. Apfelbaum
and colleagues (1999) showed that sibutramine was



highly effective alongside VLCD, allowing patients to
maintain weight loss associated with their initial dietary change, for at least 1 year. The most recently licensedantiobesitydrugisrimonabant,whichisanantagonist of the CB1 cannabinoid receptor. This receptor, which binds the active constituents of marijuana,
promotes appetite for sweet and high-fat foods. Rimonabant selectively reduces appetite for these foods
and is capable of producing a 9% weight loss in obese
patients over a 2-year period (Pi-Sunyer _et al._, 2006).
Bariatric surgery is an extreme approach to treating obesity and would normally be reserved only for
the morbidly obese (BMI over 40 kg/m [2] ). There are
a number of different surgical approaches, which include gastric banding or surgery to form a gastric
pouch. These procedures restrict the amount of food
that can be ingested in a single meal and hence reduce overall intake. A similar effect is achieved by
gastric resection (where the stomach is made smaller
or removed altogether) or gastric bypass. These interventions promote major weight loss, with maximal
effects over the first 12–24 months after surgery (up
to 70% of excess weight lost). Although the impact on
satiety may be reduced over time as the gastric bands
stretch or pouch capacity increases, studies considering follow-up of patients for 10 years or more, suggest
that around 60% of excess weight will be permanently
lost (Kral and Naslund, 2007).


_**8.4.2 Type 2 diabetes**_


Diabetes mellitus is a condition in which control over
bloodglucosehomeostasisislostthroughimpairment
of either the production of insulin by the pancreas
or through impairment of the actions of insulin in
the main target tissues (liver, skeletal muscle). Type
1 diabetes mellitus (formerly described as insulindependent diabetes) is the result of destruction of
the β-cells of the pancreas, leading to either an absence of or low production of insulin. Type 1 diabetes is generally of early onset and most sufferers will
be diagnosed in childhood. Type 2 diabetes mellitus
(T2DM, noninsulin dependent diabetes) is characterized by either blunted insulin production in response
to ingestion of carbohydrates or, more commonly,
extremely high plasma insulin concentrations with a
blunted response to insulin (insulin resistance, see below). T2DM generally first appears in the middle years
of adulthood.



**250**
~~Healthy~~



**The Adult Years** **193**


**Figure 8.4** The glucose tolerance test. Subjects consume an oral load of 75 g glucose.
This promotes a rise in blood glucose concentrations. Blood samples at 2 h into the test can
discriminate between healthy subjects (glucose should have returned to the baseline,
normal range of below 110 mg/dL), subjects
who are glucose intolerant (glucose will remain above 140 mg/dL), and subjects with
frank diabetes (glucose will remain above
200 mg/dL).



**200**


**150**


**100**


**50**


**0**

**0** **2** **4** **6**


**Time (hours)**


The simplest diagnostic tools used to identify individualswithT2DMarethepresenceofsymptomssuch
as thirst and polyuria, or the observation of a raised
fasting plasma glucose concentration (greater than
126 mg/dL glucose in venous blood). However, the
fasting plasma glucose method is less reliable and will
tend to underdiagnose T2DM in the population. The
oral glucose tolerance test is a more robust method,
which should always be used to confirm any provisional diagnosis. In an oral glucose tolerance test, the
patient is fasted overnight and then provided with a
solution of glucose (usually a 75 g load) to drink. As
shown in Figure 8.4, this promotes a rapid increase in
blood glucose concentrations. In healthy individuals
this promotes a release of insulin, which drives the
excess blood glucose into the liver and skeletal muscle
and brings blood glucose back to the baseline concentration within 2 h of loading. Among individuals with
glucose intolerance (a prediabetic state), the peak in
plasma glucose will tend to be greater than in healthy
individuals, and concentrations will remain elevated
(greater than 140 mg/dL) after 2 h. In individuals
with T2DM, the peak in blood glucose will be over
200 mg/dL and the return to baseline concentrations
greatly delayed (Figure 8.4).
The risk of developing T2DM is strongly influenced
by genetic factors. Individuals with a sibling with
T2DM are 4 times more likely to develop T2DM than
individuals with no family history (Rich, 1990). There
are some rare forms of T2DM that are attributable to

defects of specific genes. These Maturity Onset Diabetes of the Young (MODY) variants of T2DM are
associated with defects of hepatocyte nuclear factor
4α (MODY1), glucokinase (MODY2), hepatocyte nuclear factor 1α (MODY3), insulin promoter factor-1
(MODY4), hepatocyte nuclear factor 1β (MODY5),



~~Glucose intolera~~ nce


~~Type 2 diabetes~~



and neurogenic differentiation factor-1 (MODY6). It
has proven difficult however to firmly identify genes
that drive T2DM risk in the rest of the population, as it
is clear that several genes or polymorphisms of genes
are likely to play a role and, more importantly, that
these genetic influences are modified by environmental factors (McIntyre and Walker, 2002). Candidate
genes that may contribute to risk of T2DM include
the insulin gene itself, SUR-1 (sulfonylurea receptor), IRS-1 (insulin receptor substrate- 1), peroxisome
proliferator-activated receptor gamma, and glycogen
synthase. All of these show polymorphisms in humans
that have variants that appear to predispose to T2DM.
Obesity is the main diet and lifestyle related risk factor
for T2DM. Storage of fat in adipose tissue impairs insulin sensitivity in target tissues by promoting the delivery of fat in the form of triacylglycerides to peripheral tissues, and by direct production of antagonists of
insulin action by the adipocytes (Roche _et al._, 2005).
The prevalence of T2DM is rapidly increasing all
over the world, in line with the increasing levels of
obesity and overweight. It is estimated by the World
Health Organization that global prevalence will be
45% greater in 2025 than in 1995 (Alberti and Zimmet, 1998), with most of the increase accounted for
by soaring prevalence rates in China, India, and other
developing countries. While much of this increase will
be occurring in the adult population, there is growing
concern in the westernized countries that T2DM is increasingly manifesting in childhood and adolescents.
The migration of certain ethnic minorities to the
westernized countries has resulted in greater prevalence of T2DM in those migrant populations. As reported by Patel _et al_ . (2006), Asian Indians in the UK
exhibit greater prevalence of obesity and T2DM than
the Caucasian population of the UK and considerably



**194** **Nutrition: A Lifespan Approach**


higher prevalence than nonmigrant Indians. Similar
observations are noted in migrant Indians living in
South Africa, where the association between migrant
status and T2DM is more marked if the migrants
retain their traditional diet and lifestyle (Misra and
Ganda, 2007). The finding that migration promotes
an increase in prevalence rates, adds weight to the argument that T2DM risk is strongly associated with
a thrifty genotype (Neel, 1962) or thrifty phenotype
(Hales and Barker, 2001). Generations of undernutrition and regular famine will either program traits,
or select for genetic traits, that promote the most efficient use of metabolic substrates. On encountering
an environment where energy is widely available, this
metabolic thrift will drive development of obesity and
associated disorders.

The concept of thrift, whether acquired through
programming or through genetic selection, is also
supported by studies of the two populations with the
highest global prevalence of T2DM. The Pima Indians
of Arizona and the Nauruan islanders exhibit T2DM

rates of 40–50%, and in both populations the shift
to endemic diabetes was associated with a rapid shift
in availability of high-energy foods and adoption of
sedentary patterns of work and physical activity. However, the situation with migrant populations may be
less clear-cut, as migration brings social inequalities,
stress, and greater prevalence of unhealthy behaviors
such as smoking and alcohol consumption in addition
to a nutritional transition (Misra and Ganda, 2007).
T2DM is a major risk factor for CVD (see below),
but is also associated with a range of other complications that arise due to the damaging effects of chronically high blood glucose concentrations upon the vasculature and nerves. Within the eye, glucose causes
damage to the vessels that supply the retina (nonproliferative diabetic retinopathy) and this causes leakage
of plasma into the retina, blurring vision. In more severe diabetes, abnormal blood vessels develop on the
face of the retina (proliferative diabetic retinopathy).
This reduces normal blood flow to the tissue and can
causeblindness.Withinthekidneys,highglucoseconcentrations cause loss of nephrons and this can lead to
chronic renal failure in diabetic subjects. The legs and
feet of diabetic subjects are vulnerable as nerve damage (diabetic neuropathy) numbs sensation and leads
to greater risk of physical injury. With lower blood
flow to the limbs (a further consequence of diabetes),
these injuries are prone to infection and ulceration.



Amputation of feet and lower limbs can be a consequence of failure to heal these ulcers successfully.
The treatment and management of T2DM relies
upon a mixture of dietary and lifestyle change and
medication. Monitoring of blood glucose concentrations by diabetic patients is an essential element of
management of the condition, as this allows carbohydrate intakes to be tailored to fluctuations in blood
glucose, that may be influenced by the time since
the last food consumption or by levels of physical
activity. Clinical monitoring is also recommended
(NICE, 2008), with regular screening of the glycosylated hemoglobin (HbA1c) concentration providing
a good indicator of the quality of glycemic control
(target HbA1c concentration is 6.5–7.5%).
Patients with T2DM who are of optimal body
weight may be able to maintain good control over
blood glucose concentrations through relatively simple management of the carbohydrate content of their
diet. In overweight or obese individuals, the priorities will shift so as to couple weight loss to glycemic
control. There is no “diabetic diet” as such, and the
guidelines given to diabetic patients are broadly in line
with the healthy eating guidelines for adults that were
outlined earlier in this chapter. T2DM patients are
advised to increase intakes of complex carbohydrates
and reduce intakes of simple sugars, in effect taking
on a low GI diet. Intakes of dietary fiber should be
high, and it is suggested that complex carbohydrates
should be consumed with every meal or snack to delay absorption of glucose into the circulation. Meals
should be regular and low-fat options should be the
mainstay of intake. Special foods aimed at diabetics
are not necessary and often have a high-fat content to
maintain palatability, so should be avoided. Diabetic
patients should be given individualized advice and
health education from an appropriate specialist, such
as a dietitian, so that a lifestyle change incorporating
both diet modification and increased physical activity can be tailored to the individuals’ needs (NICE,
2007). Surprisingly, while T2DM is a common condition and dietary change is the main element used
in the management of the condition, Nield and colleagues (2007) found that there was no high-quality
data available to allow assessment of the efficacy of
diet in management of T2DM.
Where T2DM patients are overweight or obese, and
have difficulties in maintaining satisfactory glycemic
control, pharmacological agents are widely used.



These include metformin, sulfonylurea derivatives,
and the glitazones (thiazolidenediones). Metformin
increases sensitivity to insulin and also helps to control blood glucose by inhibiting the absorption of glucose across the gut and inhibiting hepatic gluconeogenesis. Sulfonylureas promote uptake of calcium by
the pancreas and this elicits increased secretion of
insulin, hence promoting reduction of blood glucose
concentrations. Glitazones are agonists of peroxisome
proliferator-activated receptor gamma, and work by
increasing sensitivity to insulin in peripheral tissues.
Often, the glitazones are used in combination with
metformin.


_**8.4.3 The metabolic syndrome**_


The metabolic syndrome, also called the insulin resistance syndrome or syndrome X, is a cluster of
metabolic and physiological disturbances that all stem
from the occurrence of insulin resistance in an in
dividual. Insulin resistance is the state in which the

response to insulin is blunted, and hence insulin resistant individuals need to produce more insulin to
regulate their blood glucose concentrations. Insulin
is a powerful metabolic regulator and has effects in
skeletal muscle, the liver, the brain, kidney, and vascular tissues. As a result insulin resistance will impact



**The Adult Years** **195**


uponmultipleorgansystems,producingabroadspectrum of effects (Figure 8.5). The metabolic syndrome
is strongly linked to CVD as most of the functional
defects that accompany insulin resistance are all independent risk factors for coronary heart disease (CHD)
and stroke (see later sections in this chapter). Lakka
and colleagues (2002) estimated that metabolic syndrome increases risk of CVD mortality by threefold.
Insulin resistance can be measured in individuals
using a variety of different techniques, but mostly
the Homeostasis Model Assessment-insulin resistance

(HOMA-IR)scaleisapplied.HOMA-IRisdetermined
using the calculation (plasma insulin concentration x
plasma glucose concentration)/22.5. This result can
then be used alongside other diagnostic criteria to
confirm the presence of the metabolic syndrome. A
number of diagnostic definitions are in use, and that
used by the World Health Organization is shown in
Table 8.4.

The basic actions of insulin are to stimulate glucose uptake by muscle and liver and to inhibit lipolysis. In insulin-resistant individuals, these functions
will be impaired and hence blood glucose clearance
is reduced and circulating lipid concentrations rise.
However, some other functions of insulin are not impaired and the high circulating insulin concentrations

















**Figure** **8.5** Schematic representation of the consequences of insulin
resistance.



**196** **Nutrition: A Lifespan Approach**


**Table 8.4** World Health Organization diagnostic criteria for the metabolic syndrome (Alberti and Zimmet, 1998)


Criteria Defined by:


Insulin resistance Measure of resistance in top 25% for population
Impaired glucose tolerance Raised fasting glucose, impaired glucose tolerance test or type 2 diabetes
Hypertension Systolic pressure _>_ 159, diastolic pressure _>_ 89
Central obesity BMI _>_ 30 kg/m [2] . Waist–hip ratio _>_ 0.9 men or 0.8 women
Raised triglycerides Serum triglycerides _>_ 2.o mmol/L
Reduced HDL-cholesterol HDL cholesterol _<_ 1.0 mmol/L
Microalbuminuria Urinary albumin excretion _>_ 30 mg/day


Note: Individuals manifesting one of the first two criteria and two of the remaining criteria
should receive a diagnosis of metabolic syndrome.



that are associated with insulin resistance will increase

these. For example, insulin promotes elevations of
blood pressure, and this function is not lost in the
insulin-resistant individual.
The origins of metabolic syndrome may vary considerably between individuals. Certainly obesity promotes insulin resistance, possibly because factors such
as cytokines produced from adipose tissue act as antagonists of insulin action. Insulin resistance itself
will promote deposition of lipid in adipose tissue,
as adipocytes often retain greater sensitivity to insulin
than other tissues. This promotes storage of energy
in the adipose tissue in preference to liver or muscle. Obesity should therefore be regarded as both a
cause and a consequence of insulin resistance. Concentrations of hormones such as cortisol also become

elevated in obese individuals, and these may oppose
the actions of insulin. There are a number of genetic
defects that may also contribute to risk. Loss or impairment of insulin responsive elements in a number
of different pathways that control lipid or carbohydrate metabolism would be expected to promote the
development of an insulin-resistant phenotype.


_**8.4.4 Cardiovascular disease**_


**8.4.4.1 What is cardiovascular disease?**

Cardiovascular disease (CVD) is a term that collectively describes a number of different conditions,
which include CHD, cerebrovascular disease, and peripheral artery disease. All of these conditions stem
from the same basic pathology, which is the development of atherosclerosis within major arteries.


_Atherosclerosis_

Atherosclerosis is the process through which deposits of cholesterol, collagen, and calcium accumu


late within the intimal layer of arteries, resulting in
occlusion of the arterial lumen and a focus for the for
mation of clots (thrombosis). Atherosclerotic plaques
can form in any of the arterial vessels of the body
and each individual may potentially have tens or hundreds of plaques. The main feature of plaques is the
accumulated mass of cholesterol-bearing foam cells
and vascular smooth muscle cells (VSMC) (see Figure
8.6). Most plaques are stable as they are covered in a
fibrous crust. Should this crust split, then the resultant
release of collagen and other material will provide the
focus for thrombosis, which can trigger potentially
fatal consequences.
There are two prerequisites for the initiation of
plaque formation. The first requires the accumulation of oxidized LDL-cholesterol within the arterial
intima. LDL (low-density lipoprotein) is responsible
for the transport of cholesterol away from the liver
to deliver it to sites that require it for metabolism,
for example the adrenal glands where it is used to
manufacture steroid hormones. Some of this circulating LDL-cholesterol can be deposited in the arterial wall. Cholesterol may be transferred from LDL to
HDL (high-density lipoprotein), which carries it back
to the liver. However, the conditions within the intimal layer will also tend to favor the oxidation of
LDL cholesterol by reactive oxygen species (ROS).
The LDL-cholesterol complex is vulnerable to ROS
attack, despite having antioxidant defenses, due to the
high polyunsaturated fatty acid density present within
the phospholipid shell. Oxidative damage will spread
from the lipids to the key apolipoprotein B100, which
is required to recognize the LDL receptor on target
tissues.

The second key event in atherosclerosis is damage to the endothelial lining of the intima. This is



**The Adult Years** **197**



Monocyte







VSMC



































**Figure 8.6** Events leading to the formation of the fatty streak and atherosclerotic plaque. VCAM-vascular cell adhesion molecule. ROS-reactive
oxygen species.



generally due to inflammation, which can be triggered
by local injury, infection, or raised circulating concentrations of inflammatory cytokines, as is seen in
obese individuals. Endothelial inflammation attracts
monocytes,aclassofundifferentiatedwhitebloodcell.
Monocytes bind to vascular cell adhesion molecule
(VCAM) on the endothelial surface, allowing movement through to the underlying intimal zone. Here,
the presence of cytokines associated with endothelial
inflammation drive differentiation of the monocytes
to macrophages.
Macrophages bear a scavenger receptor that is
able to recognize and bind oxidized LDL-cholesterol.
Macrophages that have taken up oxidized LDL will
remain in the intima and steadily accumulate this oxidized material, eventually becoming foam cells. The
first sign of atherosclerosis in blood vessels is the appearance of a yellowish spot, termed a fatty streak. The
accumulated foam cells promote the proliferation of



VSMC in the intima and thus the plaque becomes
established. VSMC secrete collagen into the plaque,
providing the associated protein accumulation. Established plaques will also accrue calcium and this
causes stiffening of the arteries.


_Coronary heart disease_
Coronary heart disease (CHD) is also referred to as
ischemic heart disease. It is the result of atherosclerotic plaque formation within the coronary arteries, which supply the heart muscle with oxygen and
nutrients. Formation of plaques will occlude these
arteries causing chest pain, termed angina pectoris.
The potentially life-threatening aspect of atherosclerosis in the coronary arteries results from thrombosis, causing full occlusion of the vessels. The heart
muscle, starved of oxygen, will then begin to die,
forming a damaged area called an infarct. In individuals surviving this injury (myocardial infarction



**198** **Nutrition: A Lifespan Approach**



**1000**


**800**


**600**


**400**


**200**


**0**



**Men**



**400**


**300**


**200**


**100**


**0**



**Country**


**Figure 8.7** Coronary heart disease mortality in men and women in selected countries.



**Women**


**Country**



(MI)), future heart function will be impaired and
they may suffer from arrhythmias and other cardiac
problems.
Although deaths from CHD have generally been
in decline in the westernized countries throughout
the 1990s and early twenty-first century, CHD remains the leading cause of death in the western hemisphere. Alongside this, the disease has increased in
prevalence in the developing countries, as they enter economic and nutritional transition. Figure 8.7
shows the prevalence rates for CHD in selected
countries and highlights the fact that the disease is
most prevalent in countries of the former Soviet
Union (e.g., Ukraine and Belarus) and has lowest
prevalence in southern Europe (e.g., Spain, Portugal,
Greece, France). There can be considerable variation
within countries. For example, in the UK the lowest
rates of CHD are seen among men and women in
the south and eastern parts of England. CHD rates
among the male population of Scotland are at a level
60% above those in southern England. This variation largely reflects regional differences in diet and
lifestyle.


_Cerebrovascular disease_

Cerebrovascular disease manifests itself when indi
viduals suffer a cerebrovascular accident, or stroke.
Strokes occur when the blood supply to the brain is interrupted, which can lead to reversible or irreversible
damage. Strokes may be hemorrhagic, in which case
blood leaks from vessels into the brain tissue. These



strokes are unrelated to atherosclerosis and are the

product of raised blood pressure. Ischemic strokes are
caused by blockage of the arterial supply to the brain
due to atherosclerosis and thrombosis. Strokes are the

second most common cause of death in the UK and

other European countries.


_Peripheral artery disease_
Peripheral artery disease stems from the formation
of atherosclerotic plaques in arteries other than those
supplying the heart or brain. Typically, these problems affect the legs. Often peripheral artery disease
will manifest as pain during exercise, which is termed
claudication. In severe cases these plaques will lead
to ischemic injury to the limbs, resulting in amputation.


_Hypertension_
Hypertension, or raised blood pressure, is often included as one of the CVDs. However, raised blood
pressure is not truly a disease state and should instead
be regarded as a risk factor or clinical indicator for
other CVDs. High blood pressure is associated with
increased risk of both CHD and stroke. In the case of
CHD, it may be that atherosclerosis impairs the ability of the major vessels to contract or dilate to maintain normal pressure, but it is also the case that raised
pressure causes a form of arterial damage, called shear
stress, that can act as the focus for plaque formation.
Higher blood pressures will also make atherosclerotic
plaques less stable.



**8.4.4.2 Risk factors for cardiovascular disease**

The classical risk factors for CVD are generally defined as modifiable or nonmodifiable characteristics.
Nonmodifiable risk factors include age, gender, and
ethnicity. The strong association of risk with gender
can be clearly seen in Figure 8.7, which shows death
rates from CHD to be lower in women than men in all

countries. Much of the protection associated with female gender disappears after the menopause and it is
suggested that this is due to postmenopausal women
adopting an android pattern of abdominal fat deposition. Risk of CHD and stroke both increase with
increasing age and this may, at least in part, be explained by rising blood pressure that typically occurs
with aging.
CertainethnicgroupsexhibitincreasedriskofCVD
withinwesternizednations.IndividualsofsouthAsian
descent (i.e., populations from India, Bangladesh, and
Pakistan) have increased risk of CHD, which appears
toberelatedtoagreaterpropensitytodevelopabdominal obesity. Patel _et al_ . (2006) compared a population
of Gujarati migrants in the UK with a nonmigrant
Gujarati population in India. The UK population had
considerably greater BMI, raised circulating lipids,
and other CVD risk factors compared to the Indian
group. Thus, the combination of a south Asian heritage with a westernized lifestyle appeared to increase
CVD risk. Afro-Caribbean populations are at greater
risk of stroke-related death than other ethnic groups
and this appears to be due to a genetic predisposition
to hypertension.
Aspects of lifestyle that increase CVD risk are generally considered to be modifiable risk factors. Lower
socioeconomic status (SES) can be included in this
category. Lower SES is an indicator of a number of different factors that include lower income, poor health
behaviors such as smoking, and a diet of lower quality.
Ramsay _et al_ . (2007) reported that lower SES in adulthood was a risk factor for CHD in men aged 52–74.
Men who had manual occupations were significantly
more likely to suffer from fatal or nonfatal CHD and
were more likely to be smokers, to be overweight, and
to be physically inactive, when compared to those in
nonmanual occupations.
Smoking increases risk of CVD through a number of mechanisms, including increasing concentrations of clotting factors and thereby increasing risk of
thrombosis, by promoting endothelial dysfunction,
and by increasing oxidative stress. Obesity and related



**The Adult Years** **199**


disorders, including type 2 diabetes are major risk
factors for CHD and other cardiovascular conditions.

Abdominalobesityinparticularwillincreaserisk.Factors that contribute to development of obesity, such as
physical inactivity, are independently associated with
greater risk of CVD. The nutrition-related risk factors
for CVD, including obesity, will be described in more
detail in the next section.


**8.4.4.3 Nutrition-related factors and risk of**

**cardiovascular disease**


_Obesity_
The major lifestyle related risk factors for CVD are
cigarette smoking and obesity. At a time when the
prevalence of smoking is declining in most westernized populations, the secular trend for increasing
prevalence of obesity is reducing the beneficial impact
of smoking reduction (Hu _et al_ ., 2000) and is rapidly
becoming the main contributor to CHD and strokerelated death. Bender and colleagues (2006) reported
that obesity increased risk of CVD death by 2.2-fold
in men and 1.6-fold in women (comparing BMI of
over 30 kg/m [2] to BMI in the ideal range).
Determining the influence of obesity upon CVD
risk, independent of all other risk factors, is almost
impossible. Obese individuals will also tend to be
the individuals who are least physically active, who
have raised blood pressure, type 2 diabetes, insulin
resistance, and dyslipidemia, all of which are associated with greater risk of atherosclerosis. However,
it is clear that all anthropometric measures of overweight and obesity, whether considering BMI, waist–
hip ratio, or total percentage body fat, determined by
bioimpedance, are powerful indicators of increased
CVD risk. Abdominal fat deposition is most strongly
related to risk, presumably because fat stored centrally
either triggers, or is a marker of, metabolic events that
impact upon mechanisms that drive atherosclerotic
plaque formation. Leander _et al_ . (2007) reported that
the presence of excess central fat was also strongly
predictive of risk of a further nonfatal or fatal MI
in individuals who had undergone treatment for a
first MI.
Obesity clearly increases CVD risk via a number
of different routes. Blood pressure becomes elevated
in obesity, as the blood volume increases in proportion to the greater body size. Obese individuals
also become hypertensive because the homeostatic



**200** **Nutrition: A Lifespan Approach**


regulation of blood pressure is abnormal. Factors produced from the adipose tissue, including leptin will
also contribute to elevated blood pressure. Obesity is
associated with increased circulating concentrations
of a number of clotting factors including fibrinogen, Factor VII, and Factor VIII. This increases the
likelihood of thrombosis in subjects with established
atherosclerosis. Morbid obesity is a major risk factor
for death from acute pulmonary thromboembolism
(Blaszyk _et al_ ., 1999).
Adipose tissue is a source of a wide range of
adipokines,cytokines,andotherfactorsthatcanmodulate the process of atherosclerosis. Adiponectin, for
example, suppresses inflammation and tends to accumulate in the vascular wall following local trauma.
Adiponectin will block atherosclerosis as it prevents
the transformation of macrophages to foam cells at
an early stage in the formation of the fatty streak.
However, in obesity, concentrations of adiponectin
tend to be low and so this protective mechanism is
less effective. The pro-inflammatory cytokines tumor
necrosis factor-α (TNFα) and interleukin 6 (IL-6) are
also produced by adipose tissue and with obesity their
secretion is increased. IL-6, in particular, appears to
drive atherosclerosis and thrombosis as it induces the
production of C-reactive protein and fibrinogen, increasing blood viscosity. IL-6 suppresses the activity
of lipoprotein lipase in macrophages and this promotes the uptake of lipids by the fatty streak. IL-6 has
also been linked to development of hypertension and
promotes endothelial cell dysfunction.
Interventionsthatpromoteweightlossandincrease
physical activity produce clear benefits in terms of
CVD risk. Reducing adiposity will reverse the insulin
resistance associated with obesity, and hence reduce
risk of diabetes. The Look Ahead Research Group
(2007) reported that an intensive lifestyle intervention over a 12-month period, in over 5000 obese or
overweight adults with type-2 diabetes reduced body
weight by an average of 8.9%. This weight loss was
associated with lowered blood pressure, reduced use
of diabetes and hypertension medication, increased
physical fitness, raised HDL cholesterol, and lowered
LDL cholesterol concentrations. Randomized con
trol trials of physical activity promoting interventions
have shown that lifestyle changes that incorporate relatively moderate changes can reduce blood pressure
independently of changes in body fat (Dunn _et al_ .,
1999).



_Diabetes_

Type2diabeticsareatsignificantlygreaterriskofCVD
and of fatal outcomes associated with CVD events

than the nondiabetic population. Men with diabetes
have two-to-threefold greater CVD mortality, and in
women the risk is even greater (three- to fourfold,
Goff _et al._, 2007). Twice as many type 2 diabetics as
nondiabetics show clinical evidence of atherosclerosis, and death rates following MI are 2–3 times higher
where diabetes is present. Diabetes tends to be associated with other classical risk factors for CVD, including obesity, hypertension, and dyslipidemia and
this undoubtedly explains some of the increased risk.
However, insulin resistance is the main driver of CVD
risk in type 2 diabetes.
Insulin resistance impacts upon atherosclerosis and
the associated disease outcomes (MI and stroke) at
several different levels (Bansilal _et al_ ., 2007). The
processes that drive endothelial cell dysfunction, the
uptake of oxidized lipid by macrophages to form
foam cells, and the development of a chronic inflammatory state that favors plaque formation, are
all consequences of insulin resistance and the associated hyperglycemia and dyslipidemia. The cytokines
and adipokines that are the products of adipocytes
are major players in mediating these effects, as described above, in the context of obesity. Insulin resistance is associated with elevated leptin, IL-6, TNFα,
and lower concentrations of adiponectin, all of which
will contribute to the development of atherosclerosis
and a hypercoagulant state that promotes thrombosis.
In addition to these factors, insulin resistance favors
the production of angiotensinogen by the adipocytes.
This is the precursor of angiotensin II, which promotes vasoconstriction and elevated blood pressure
and also increases the vascular expression of monocyte chemoattractant protein 1 (MCP-1), vascular cell
adhesion molecule 1 (VCAM-1), and intracellular adhesion molecule 1 (ICAM-1), all of which drive the recruitment and binding of monocytes to the intima in
theearlystagesofatherosclerosis.Plasminogenactivationinhibitor-1isalsooverexpressedbytheadipocytes
in insulin resistance and this promotes the formation of clots around existing, unstable, atherosclerotic
plaques.
Interventions that target diabetes, either through
improved control over blood glucose or through
improving other associated metabolic abnormalities
(e.g., dyslipidemia in diabetic subjects), generally



**Table 8.5** Reference ranges for plasma lipids in adults


Reference range Healthy range
(mmol/L) (mmol/L)


Triglycerides 0.70–1.80 0.70–1.70
Total cholesterol 3.50–7.80 _<_ 5.20

HDL-cholesterol 0.80–1.70 _>_ 1.15

LDL-cholesterol 2.30–6.10 _<_ 4.0


Note: The reference range is the range of values that
would be within the normal distribution for the population. There are sex differences in these ranges, with triglyceride concentrations tending to be higher in men and HDLcholesterol higher in women.


show that cardiovascular risk declines with successful

management. An intensive program to manage
glycemia,bloodpressure,microalbuminuria,anddyslipidemia in the Steno-2 Study (Gaede _et al._, 2003)
showed that over an 8-year period CVD risk was
reduced by 53% in patients with type 2 diabetes.
The United Kingdom Prospective Diabetes Study
(UKPDS,1998)showedthatintensivecontrolofblood
glucose using oral drugs or insulin reduced risk of MI
by 39%.


_Dietary fat and cholesterol transport_
Risk of CVD is strongly related to circulating concentrations of total cholesterol, lipoproteins, and triglycerides. Reference ranges for these lipids are shown
in Table 8.5. High total cholesterol, hypertriglyceridemia, raised LDL-cholesterol, and low HDL
cholesterol are all risk factors for atherosclerosis. The

main basis for this risk stems from the fact that choles
terol uptake by macrophages as they become foam
cells,isanessentialprocessinplaqueformation.HDLcholesterol reduces risk as it is responsible for carrying excess cholesterol away from the arterial wall to
the liver. Concentrations of triglycerides tend to be
negatively correlated with HDL-cholesterol.
The strong association between dyslipidemia (an
abnormal lipid profile) and CVD risk has made manipulation of cholesterol and triglycerides a primary
target for interventions designed to prevent disease,
both in individuals and at the population level. Statins
are a class of drug that are designed specifically to
lower LDL-cholesterol concentrations. These agents,
such as lovastatin, are inhibitors of 3-hydroxy-3methyl-glutaryl-CoA reductase (HMG-CoA reductase), which is the rate-limiting step in the pathway



**The Adult Years** **201**


of cholesterol biosynthesis. Statins effectively lower
cholesterol concentrations and this in turn leads to

up-regulation of LDL receptors in the liver, which
causes LDL to be more rapidly cleared from circulation. Gould and colleagues (2007) analyses of interventions using statins found that they reduced total cholesterol concentrations by between 4–34% and
LDL-cholesterol concentrations by up to 52%, with
no effect on HDL-cholesterol. 1 mmol/L reductions
intotalcholesterolwereshowntoreduceprevalenceof
CHD events by 29.5% and CHD death rates by 24.5%.
1 mmol/L reductions in serum LDL-cholesterol produced similar changes in risk.
Dietary change provides the alternative strategy for
minimizing the prevalence of dyslipidemia and the
associated burden of CVD. For several decades the

public health message has been to reduce total intakes
of fat, to consume less saturated fat, and to consume
more starchy carbohydrates as an alternative energy
source (see Section 8.3). This is a message familiar to
most people in westernized countries, but it is now
becoming clear that this may not be the most effective
strategy.
Saturated fats increase total cholesterol concen
trations in circulation and elevate LDL-cholesterol.
Polyunsaturated fatty acids (PUFA) have the opposite
effect. HDL-cholesterol concentrations are increased
by all classes of fatty acids (saturates, PUFA, and monounsaturated fatty acids; MUFA), if these fats replace
carbohydrate in the diet. Interestingly, saturated fatty
acids may be more effective than PUFA and MUFA
in this respect. Replacing fats in the diet with carbohydrates actually increases serum triglyceride concentrations. This means that following advice to replace
saturated fats in the diet with carbohydrate is likely
to have little cardiovascular benefit, since this will effectively lower both LDL, and HDL-cholesterol and
increase triglyceride concentrations (Hu and Willett,
2002). A more effective strategy may be to replace the
saturated fats in the diet with alternative fats. MUFA

and PUFA in place of saturates would lower LDLcholesterol and, although there would be no increase
in HDL-cholesterol, the HDL–LDL ratio would be
improved. Substitution of saturated fatty acids with
MUFA and PUFA would carry additional benefits as
the unsaturated fatty acids improve insulin sensitivity
and risk of diabetes, which effectively reduces CVD
risk independently of direct effects on the process of
atherosclerosis.



**202** **Nutrition: A Lifespan Approach**


There has been considerable concern over the high
levels of trans-fatty acids present in the processed
foods consumed in the westernized nations. Transfatty acids are derived from both MUFA and PUFA
and are formed during the processing of vegetable
oils to convert them to solids. The majority of transfatty acids in the human food chain are associated
with the hydrogenation of vegetable oils and they are
primarily consumed in margarines and in deep-fried
foods. Trans-fatty acids formed in food processing
generally have similar effects to saturated fatty acids
and will increase LDL-cholesterol concentrations (Hu
and Willett, 2002). The trans-fatty acids inhibit the
enzyme delta 6 desaturase and therefore disrupt the
metabolism of essential fatty acids and the generation of prostaglandins and inflammatory mediators.
This contributes to endothelial cell dysfunction. Naturally occurring trans-fatty acids are found in dairy
products and include vaccenic acid and conjugated
linoleic acid. Some isomers of these fatty acids have
beenshowntoprotectagainstatherosclerosisandeven
cause regression of existing atherosclerotic lesions in
mice (Toomey _et al._, 2003), but beneficial effects in
humans have not been convincingly demonstrated.
A number of intervention trials have suggested that
greater intakes of n-3 fatty acids are protective against
CVD.Bucher _etal_ .(2002)notedthateicosapentaenoic
acid and docosahexaenoic acid were associated with
significantlylowerCVDmortality,whetherconsumed
as part of the normal diet or if taken as supplements.
The greatest benefits were noted in individuals with
established CVD. The n-3 fatty acids may work by a
number of mechanisms as they have been shown to
lower serum triglyceride concentrations, improve endothial cell function, and inhibit platelet aggregation.
A number of food products have been developed to
reduce total cholesterol through the inclusion of plant
stanols and stanol esters. There is a large global market
for margarines containing these agents, which block
the absorption of exogenous dietary cholesterol and
endogenous biliary cholesterol in the small intestine.
This has the effect of reducing circulating cholesterol
and increasing expression of hepatic LDL receptors.
Raitakari and colleagues (2007) showed that regular
consumption of margarine containing stanol esters
over a 2-year period significantly improved carotid
artery compliance (reduced stiffness) in healthy nonsmokers with normal blood lipid profiles. Castro
Cabezas _et al_ . (2006) demonstrated that combining



stanol–ester margarine with statin treatment in patients with primary hyperlipidemia enhanced the impact of the statin treatment, producing declines in
serum cholesterol and LDL-cholesterol that were dou
ble those observed with statins alone.


_Folic acid and plasma homocysteine_
Elevated plasma homocysteine is one of the emerging risk factors for CVD. Homocysteine is a sulfurcontaining amino acid, which is found in circulation
bound to proteins (70%), other sulfates (5%), or as
homocysteine dimers (25%). Risk associated with elevated concentrations of homocysteine is independent
of all other CVD risk factors and appears to be graded
and linear, that is, as plasma homocysteine concentration increases, the increase in CVD risk is directly
proportional.
The normal range of homocysteine concentrations
in human plasma is considered to be 5–15 µmol/L.
The range 16–100 µmol/L represents mild-tomoderate hyperhomocysteinemia, and concentrations over 100 µmol/L represent severe hyperhomocysteinemia. Hyperhomocysteinemia is reported in
up to half of patients with atherosclerosis. Concentrations of homocysteine are determined by the flux
through two biochemical pathways, both of which are
subject to regulation by micronutrients (Figure 8.8).
The methionine cycle involves reactions that either
demethylate or remethylate methionine and homocysteine, respectively. This cycling is critical in determining the availability of methyl groups for a variety of processes, including synthesis of phosphatidyl
choline and the methylation of DNA in epigenetic
gene silencing. When methionine is in excess, concentrations of homocysteine will increase unless it can be
converted to cysteine via the trans-sulfuration pathway. The rate limiting step in this pathway, catalysed
by cystathionine β-synthase requires vitamin B6 as a
cofactor. If methionine is limiting then homocysteine
will be remethylated by methionine synthase. This
step requires vitamin B12 and an adequate supply of
methyl tetrahydrofolate, which is derived from folate
in the folate cycle. Thus, the metabolism and circulating concentration of homocysteine is controlled by
the B vitamins, of which folic acid appears to be the
most important.
There are well-described inborn errors of
metabolism that impact upon the three key enzyme
stepsinthemethionine–homocysteinecycleidentified



**The Adult Years** **203**


Serine Glycine





















Cystathionine



Cysteine


**Figure 8.8** The methionine and folate cycles. THF-tetrahydrofolate, MTHFR-methyltetrahydrofolate reductase, CBS-cystathionine β-synthetase,
MS-methionine synthase, SAM-S-adenosylmethionine, SAH-S-adenosylhomocysteine.



in Figure 8.8. Individuals with these inherited disorders share the characteristics of having severe hyperhomocysteinemia and premature atherosclerotic
disease. This emphasizes the potential importance of
homocysteine as a risk factor for CVD. In addition to
these inborn errors of metabolism, a relatively commonpolymorphismofmethyltetrahydrofolatereductase (MTHFR C677T) is associated with increased
CVD risk. The TT variant of MTHFR C677T leads
to enzyme activity being two-thirds lower than in individuals with the CC variant. Individuals with TT
are therefore predisposed to a higher circulating homocysteine concentration as their capacity to form
methyl-THF for the methionine synthase step of the
methionine cycle is impaired.
The Homocysteine Studies Collaboration (2002)
reviewedevidencefrom30studiesthathadconsidered
homocysteine in relation to CVD, following on from
some smaller meta-analyses that suggested hyperhomocysteinemia increased CHD risk by 70%. The
aim of the Homocysteine Studies Collaboration was
to assess the likely impact of a 25% reduction in populations’ plasma homocysteine concentrations. It was
suggested that such a reduction would reduce risk of
both CHD (OR 0.73, 95% confidence intervals 0.64–
0.83) and stroke (OR 0.77, 0.66–0.90). For CHD, at



least, this reduction in risk would be dependent on the
MTHFR genotype of individuals. Klerk _et al_ . (2002)
also noted that MTHFR genotype modified CHD risk,
but found that other factors could modify this risk. In
European populations, carrying the TT genotype increased CHD risk (OR 1.16, 1.05–1.28) but in North
America, where folate status is better, there was no
evidence that TT impacted significantly on CHD risk.
A variety of mechanisms have been proposed to explain the association of hyperhomocysteinemia with
CVD risk. Homocysteine may initiate atherosclerosis
through both oxidative processes and by causing endothelial cell injury. In the presence of ferric or cupric
ions, homocysteine will autooxidize and the ensuing
production of hydrogen peroxide could be an early
step in LDL-cholesterol oxidation. In particular, this
process inhibits the formation of nitric oxide, which
normally serves to protect LDL-cholesterol from oxidation within the vessel wall. Animal studies indicate
that experimentally induced hyperhomocysteinemia
promotes changes in the arterial wall that are early
stages in the process of atherosclerosis, including endothelial cell dysfunction, activation of thrombosis,
and increased adhesion of monocytes.
Given the epidemiological findings that hyperhomocysteinemia increases CVD risk and the presence



**204** **Nutrition: A Lifespan Approach**


of apparently robust biological mechanisms to explain the association, there is considerable interest
in the use of B vitamins, and particularly folate, to
modify this risk factor. A number of studies have
shown that supplements of folate, vitamin B12, and
vitamin B6 at doses up to 20 times normal intakes
could reduce plasma homocysteine by up to 32%,
with folate providing the strongest effect. Malinow
and colleagues (1998) studied the impact of supplementing breakfast cereals with folate at doses ranging
from 127–665 µg/day. All doses were effective in reducing plasma homocysteine, and the effect of folate
was dose-dependent. Since 1998, staple foods in the
US have been fortified with folic acid. In that time,
there has been a 50% decrease in the prevalence of
hyperhomocysteinemia and a significant decrease in
stroke-related death rates.

The Hope 2 (Lonn _et al._, 2006) trial was a prospective cohort study that aimed to investigate whether
folate and other B vitamins might be effective in preventing CVD. Over 5500 patients with established
CVD or diabetes were randomly assigned to either
placebo or a supplement containing 2.5 mg folate,
50 mg vitamin B6, and 1 mg vitamin B12 over a
5-year period. This supplement regimen decreased
the homocysteine concentration of the population by
2.4 µmol/L, but had no effect on overall CVD death
rates or the prevalence of MIs. However, significant
benefit was seen with respect to stroke risk, with a reduction in the number of strokes in the patients taking
supplements (OR 0.75, 0.59–0.97).
The available evidence therefore strongly supports
the view that folate status determines homocysteine
concentrations and risk of CVD. However, the evidence that reduction in CVD is associated with folate
does not always fit the hypothesis that the mechanism of action is related to homocysteine. Durga _et al_ .
(2005) reported that in 820 subjects with normal homocysteine concentrations, folate status was associated with arterial stiffness (a marker of atherosclerosis), independently of homocysteine. Folate may
therefore be protective in other ways. For example,
it lowers production of superoxide radicals in the vessel wall preventing oxidative damage, and has also
been shown to protect LDL-cholesterol from oxidation by increasing production of nitric oxide. Interventions that aim to prevent CVD by targeting homocysteine may therefore be ineffective (Moat _et al_ .,
2004).



_Antioxidant nutrients_

Given the importance of LDL-oxidation and uptake
of the oxidized complex by macrophages in the etiology of atherosclerosis, it is suggested that antioxidant nutrients present within the diet may be protective against CVD. LDL is a rich target for ROS attack
as each LDL complex comprises a spherical arrangement of approximately 2700 phospholipids around a
hydrophobic core of cholesterol and cholesterol esters. Around 50% of the fatty acids in the phospholipid shell are polyunsaturated and the presence of a
high density of double bonds serves to increase the
likelihood of reaction with free radicals. Oxidation

of these fatty acids can establish chain reactions that
will spread through the phospholipid shell, eventually
leading to oxidation of apoprotein B100. Antioxidant
protection within LDL is provided primarily by vitamin E (α-tocopherol), with between 5–9 molecules
inserted into the phospholipid shell of each LDL complex. In addition to vitamin E, the core of the LDL will

                             contain other fat-soluble antioxidants, including β
carotene, lycopene, ubiquinone, and polyphenolics.
Increased consumption of foods that are rich in antioxidants has been shown in epidemiological studies
to provide protection against CVD. Law and Morris
(1998) showed that higher levels of consumption of
fruits and vegetables could significantly reduce CHD
risk. In general, studies that have considered the impact of specific antioxidant nutrients upon risk provide results that are consistent with the hypothesis
that consumption of antioxidants will oppose LDLoxidation and protect against atherosclerosis. Abbey
(1995) and colleagues performed a series of studies
that showed that vitamin E could inhibit LDL oxi
dation in vitro and that LDL obtained from volun
teers who had taken vitamin E supplements was also
protected from copper-induced oxidation. The EURAMIC study (Kardinaal _et al_ ., 1993) compared fatsoluble antioxidant status in fat biopsies from men
whohadsufferedanMIeventandhealthycontrols.No
difference in vitamin E status was reported but there
was evidence that the MI patients had consumed less
β-carotene and less fat-soluble antioxidants in total.
The CHAOS intervention study (Stephens _et al._, 1996)
evaluated the impact of supplementing patients with
established atherosclerosis with vitamin E at doses of
400 or 800 IU/day, over a period of over 500 days. The
study found that supplements led to a 47% reduction
in risk of nonfatal MI.



~~**Research Highlight 8**~~ ~~Tea and cardiovascular disease~~


Tea is the most commonly consumed beverage, other than water, on
a global scale. In the eastern countries green tea is favored, and is
prepared by infusion of dried leaves of _Camellia sinensis_ . Black tea,
favored in western countries, is prepared from leaves that have been
macerated prior to drying. Both teas are rich sources of polyphenolic
compounds, providing a significant proportion of daily intakes in the
populations where they are consumed. The oxidation that accompanies the production of black tea alters the profile of polyphenolics
present, effectively reducing the quantity of catechins in the drink
and introducing more complex theafavins and thearubigins.l
Tea is regarded as a potential source of antioxidants in the diet
and consumption of both green (Leenen _et al_ ., 2000) and black tea
(Langley-Evans, 2000) increases plasma antioxidant status in healthy
volunteers. Both drinks are associated with lower CVD risk. There is

a graded and linear relationship between black tea consumption
and CHD risk, with every 3 cup (711 mL) increment in consumption reducing risk of MI by 11% (Peters _et al._, 2001). Some studies
suggesting that high levels of consumption could reduce risk by up
to 70% (Gardner _et al._, 2007). Risk of stroke is also reduced by


The overall effectiveness of vitamin E and other antioxidant nutrients in lowering CVD risk appears to
depend upon their source. Knekt _et al_ . (2004) performed a meta-analysis of nine major cohort studies,
comprising over 290 000 people that had considered
the impact of dietary sources of vitamin E, vitamin C,
and the carotenoids, and the impact of supplements
of these nutrients, upon risk of CHD. Within the normal diet, comparing the highest quintile of vitamin E
intake, with the lowest quintile of intake, showed a reduced risk of CHD (OR 0.77, 0.64–0.92). Carotenoids
had a similar protective effect (OR 0.83, 0.73–0.95),
with α-carotene, β-carotene, β-cryptoxanthin, and
lutein, but not lycopene all contributing to this effect.
In contrast, vitamin C within the normal diet had
no significant impact upon CHD risk. This evidence
argues in favor of supplementation as a strategy for
CVD prevention. To attain the doses of fat-soluble
antioxidant vitamins required to obtain significant
cardiovascular protection through diet alone, would
necessitate sizeable increases in consumption of fats
and oils that would probably offset any benefit. However, the Knekt analysis also evaluated the impact of
antioxidant supplements and concluded that while
supplemental vitamin C produced a dose-dependent
reductioninCHDrisk(500mg/dayascorbatereduced
risk by 25%), vitamin E supplements were ineffective.
It is likely therefore that the benefits associated with



**The Adult Years** **205**


higher consumption of black tea (Keli _et al_ ., 1996) and green tea
(Fraser _et al_ ., 2007). A Chinese study that compared habitual green
tea drinkers with nonconsumers showed OR of 0.6 (95% confidence
intervals 0.42–0.85) for stroke-related death.
A variety of plausible biological mechanisms have been proposed
to explain the protective effects of tea drinking:

r The polyphenolics in green and black tea are potent fat-soluble
antioxidants that are readily incorporated into the LDL complex
and prevent oxidation. Experimental studies show that tea

l

~~consumption by healthy volunteers increases the concentration of~~
tea flavonoids present in LDL and inhibits LDL oxidation in vitro.
r Tea-derived flavonoids are vasodilators that are capable of
lowering blood pressure.
r The polyphenolic compounds in tea inhibit clotting by
suppressing platelet aggregation.
r Polyphenolic compounds may down-regulate genes and
transcription factors that are involved in the inflammatory
process and thereby reduce the impact of pro-inflammatory
cytokines upon endothelial cell function.


increased intakes of vitamin E and carotenoids may
be, at least in part, explained by other components
present in the foods that are their richest sources.
Tea is regarded as a major source of dietary antioxidants, with some studies estimating that 40–50% of
the daily intake of scavenging antioxidants is derived
from this source. There is an extensive literature on

tea in relation to both CHD and stroke risk, which
is briefly reviewed in Research highlight 8. The general balance of opinion is that green and black teas
both confer cardiovascular benefits. Although their
mode of action is generally regarded as involving antioxidant protection of LDL, anti-inflammatory, and
other properties of tea polyphenols may also be of
importance.


_Sodium and blood pressure_
Blood pressure is the pressure generated within the
vascular tree when blood pushes against the arterial
walls. In measurement of blood pressure two components are determined. The systolic pressure is the
pressure generated when blood is ejected from the
left ventricle of the heart, whist the diastolic pressure
is the pressure between heart beats. Table 8.6 shows
the normal ranges of values for systolic and diastolic
pressures and the different classifications of prehypertension and hypertension. From a clinical perspective the cutoff points generally used in treatment of



**206** **Nutrition: A Lifespan Approach**


**Table 8.6** Normal and hypertensive blood pressure references


Systolic blood Diastolic blood
Category pressure (mmHg) pressure (mmHg)


Normotensive _<_ 120 _<_ 80

Prehypertensive 120–139 80–89
Hypertensive
Stage 1 140–159 90–99
Stage 2 160+ 100+


hypertension are systolic blood pressure (SBP) of 140
mmHg and diastolic blood pressure (DBP) 90 mmHg.
In westernized countries blood pressure will generally increase with age in both men and women, and
systolic pressure is 20–30 mmHg higher at age 75
than at age 24. Men have higher blood pressure than
women. Rising blood pressure is associated with increased risk of stroke death in both sexes. In men,
comparing the highest decile of the blood pressure
distribution (SBP _>_ 151, DBP _>_ 98 mmHg) with the
lowest decile (SBP _<_ 112, DBP _<_ 71 mmHg) indicates
aneightfoldgreaterriskofstrokedeathwiththehigher
pressure. In women a fourfold greater risk is noted.
The association between stroke risk and blood pressure applies across the whole of the population distribution of blood pressures and so men who may not be
considered for antihypertensive treatment (SBP 137–
142, DBP 89–92 mmHg) have fourfold greater risk of
stroke death than those in the population who have
the lowest blood pressures.
High blood pressure is driven by a number of nonmodifiable risk factors, which in addition to increasing age, includes male gender, ethnicity, and a number
of genetically determined disorders of renal and vascular function. For example, the syndrome of apparent mineralocorticoid excess is a genetic disorder of
the renal form of 11β-hydroxysteroid dehydrogenase,
which allows cortisol to bind to the aldosterone receptor. This leads to sodium retention and hypertension.
Modifiable factors that increase blood pressure include lower SES, physical inactivity, high intakes of
alcohol, and dietary factors.
Within diet, sodium intake is the major concern
in relation to blood pressure. On a low-salt (sodium
chloride) diet, homeostatic mechanisms ensure that
the kidneys will excrete any excess sodium via the
urine.Acuteandmodestchangesinsodiumintakewill
be comfortably accommodated by these mechanisms.



In salt-sensitive individuals and with age-related declines in renal function, the capacity of the kidneys
to clear excess sodium may be exceeded with high
intakes of salt. As a result, sodium will be retained
necessitating a movement of water from the intracellular compartment to the extracellular compartment.
Effectively,therequireddilutionofcirculatingsodium
will produce an increase in blood volume. With more
blood to be pumped by the heart, blood pressure increases. Over a relatively short period of time these
blood pressure changes can become fixed as the vessels accommodate to the raised pressure by reducing
their elasticity. Greater resistance to flow will push
blood pressure still higher.
Animal studies clearly show the relationship between sodium intake and blood pressure. Rats, for example, provided with a solution of 1.5% sodium chloride instead of water to drink, show increases of SBP
of around 40 mmHg within 3–5 days of treatment.
Experiments with chimpanzees showed that increasing salt intake from 5 to 15 g/day led to a rise in blood
pressure of 30 mmHg SBP and 10 mmHg DBP, over
a period of 16 months. As in the rodent studies this
effect was reversible.

Epidemiological studies of the association between
sodium and blood pressure in humans have been
rather controversial due to concerns regarding the analytic methods used and potential confounding factors. However that such a relationship exists is irrefutable. One of the first major studies to consider
this issue was INTERSALT (Elliott _et al_ ., 1989), which
considered 10 000 people in 52 populations across
32 different countries. The full analysis showed that
blood pressure was related to sodium excretion, which
provides the most robust marker of intake. Every
100 mmol sodium greater excretion predicted an 11.3
mmHg rise in SBP and 6.4 mmHg rise in DBP. Moreover when considering 4 rural populations in INTERSALT, with the lowest salt intakes, blood pressure was
lower than in westernized populations and there was
no age-related rise in blood pressure, unlike all other
populations in the study.
The findings of INTERSALT were reproduced by
the more recent EPIC-Norfolk study (Khaw _et al_ .,
2004), which studied 23 104 men and women aged
45–79. Comparing the lowest to the highest quintile
of sodium excretion there was a 7.2 mmHg SBP difference in men, and 3.0 mmHg difference in women.
Thesedifferencesappeartobeverysmallinthecontext



of Table 8.6, but at the whole population level would
be highly significant. In the UK, a 5 mmHg reduction
ofSBPforthewholepopulationwouldhalvethenumber of hypertensive individuals, reduce stroke-related
deaths by 14% and CHD deaths by 9%.
Given this potentially very powerful impact of minor shifts in the population blood pressure profile, it
is of major importance to develop and evaluate interventions that could reduce sodium intake. The Trials
of Hypertension Prevention study (Cook _et al_ ., 1998),
which included 2382 participants, evaluated the effectiveness of counseling to reduce sodium intake and
promote weight loss over a 4-year period. At the end
of the trial, sodium reduction alone had reduced the
prevalence of hypertension by 18%. Similarly, the
Dietary Approaches to Stop Hypertension (DASH)
study showed that a diet low in fat, high in fiber, low
in sodium, and rich in magnesium and potassium
could reduce SBP and DBP in hypertensive individuals, by 11 and 5.5 mmHg, respectively, over just an
8-week period (Sacks _et al_ ., 2001). He and MacGregor
(2003) performed a meta-analysis of the largest and
longest intervention trials that have applied sodium
reduction in human populations. Reducing sodium
intakes were shown to provide proportionate changes
in populations’ blood pressure, with the greatest effects noted in hypertensives. For example, a 9.0 g/day
reduction in salt intake would be expected to reduce
SBP by 5.4 mmHg in normotensive subjects and by
10.7 mmHg in hypertensive subjects. Reductions of
this magnitude would be sufficient to prevent 150 000
cardiovascular events and 50 000 deaths per year in
the UK alone. Average intakes of salt in the UK are
estimated to be 11.0 g/day in men and 8.1 g/day in
women. Current advice is to consume no more than
6.0 g/day.
Other minerals may play a role in determining
blood pressure. Calcium, for example, is believed
to lower blood pressure, but studies with supplements show that even megadoses (twice normal
daily intake) produce only minor changes. Similarly,
magnesium is believed to be of importance as hypertensives often manifest low serum magnesium concentrations. However, supplemental magnesium has
no significant effect upon blood pressure in humans.
Increasing potassium intakes will lower blood pressure. INTERSALT suggested that a 50 mmol/day increase in potassium excretion would be associated
with 3 mmHg lower SBP and 2 mmHg lower DBP.



**The Adult Years** **207**


_**8.4.5 Cancer**_


**8.4.5.1 What is cancer?**

Cancers, or tumors, can arise in any of the tissues
of the body. They develop through a process termed
carcinogenesis and are essentially the products of uncontrolled cell division. All mammalian cells have a
limited capacity for cell division, termed the Hayflick
limit. In humans differentiated cells can divide only
52 times before undergoing apoptosis (programmed
cell death), but in cancer the processes that control
cell division are lost through genetic mutation. Prevention of cell division beyond the Hayflick limit is
achieved by action of the products of genes called
proto-oncogenes and antioncogenes.
Proto-oncogenes are genes whose protein products
participate in cell–cell signaling and signal transduction pathways. Under normal circumstances, these
proteins are expressed at levels that do not allow
cell division to occur and are represented as the cforms of the gene, for example c-ras or c-myc. Mutations of the proto-oncogenes render them oncogenes
(cancer genes), which actively drive unregulated mitotic cell division. The oncogenic forms are given the
“v-” prefix, for example, v-ras. A large number of
proto-oncogenes have now been identified, and all are
known components of signal transduction pathways.
Ras, for example, is a membrane associated G-protein,
and in the mutated form is frequently found in colorectal tumors. The Trk genes are tyrosine kinases and
Raf is a threonine kinase.

Antioncogenes are also called tumor suppressor
genes. Most of their protein products are factors that
prevent cell division. For example, the p53 protein is
a transcription factor that promotes the expression of
other genes that suppress mitosis. Mutations of p53
will therefore allow unregulated cell division to occur.
p53 mutations are among the most common found in
human tumors. Some other tumor suppressors have
roles in repairing DNA damage that might lead to
mutations of antioncogenes or proto-oncogenes. For
example, mutations of BRCA1 are known to greatly
increase risk of breast cancer. BRCA1 and the related

BRCA2 gene encode enzymes that have a role in repairing double stranded DNA breaks.
The process of developing cancer follows three defined stages, as shown in Figure 8.9. Carcinogenesis
is _initiated_ with damage to either proto-oncogenes
or antioncogenes, resulting in cells that are actively



**208** **Nutrition: A Lifespan Approach**


**Carcinogen**


Untransformed cell Transformed

cell


**Invasion phase**



Dedifferentiated

cell



**Figure 8.9** Schematic representation of the three stages of tumorigenesis: initiation, proliferation, and invasion.



expressing oncogenes. Such mutations are commonplacewithincellsandtissuesandaregenerallyrepaired
without any adverse consequences. However, should
a mutated oncogene not undergo repair and should
the cell be stable and able to survive in the mutated

form, then it becomes transformed. A transformed
cell dedifferentiates, essentially losing all of its specialized structures and functions. In many cases the
transformed cell will be identified as a tumor cell by
the immune system and will be eliminated, but if this
does not occur then the cell will _proliferate_ through
mitotic divisions to form a primary tumor. Many tumors are benign and grow only slowly, but others are
more aggressive and will _invade_ tissues rapidly. Often, these aggressive tumors will shed cells into the
circulation, which then act as the focus for development of secondary tumors (metastases) in other

organs.
The initiation phase of carcinogenesis depends
upon contact between cells and carcinogenic agents.
These include all factors that are capable of inducing
genetic mutations through DNA damage. Thus, ionizing radiation, ultraviolet radiation, chemical agents,
and certain viruses are all carcinogenic. Most car


cinogen exposures are either lifestyle or occupationrelated. Occupations that involve exposure to hazardous chemicals, for example, asbestos or pesticides,
are associated with elevated cancer risk. Carcinogenic
exposures also occur due to tobacco smoking, exposure to environmental pollution, excessive sunlight
exposure, and due to the presence of carcinogenic
chemicals in the food chain.


**8.4.5.2 Diet is the main determinant**

**of cancer risk**

While tobacco smoking and environmental or occupational exposures are most obviously viewed as
risk factors for cancer, it is becoming clear that components of the diet are the major determinants of
risk of cancer in all organs and tissues. Some estimates suggest that up to 70% of all cancer deaths
may be attributable to diet-related factors, although
it is more generally accepted that 35–40% of risk is
diet related. Components of the diet, including alcohol are able to modify cancer risk in many different ways, and some nutrients have been identified
as potentially increasing risk, while others are cancer
preventive.



The most obvious way in which the diet can increase the risk of cancer is by directly delivering carcinogenic chemicals to the body. Later in this chapter,
agents such as safrole will be discussed as carcinogens
that are normally present within certain foodstuffs.
Intakes of such agents at levels that are hazardous
are unusual and so they are not generally considered
as a major threat to human health. Most carcinogens that are ingested as components of food will
be present either as contaminants or as products of
cooking. Nitrosamines are a good example of the latter. The nitrosamines are derived from nitrites combined with secondary amino groups on certain amino
acids or proteins. The most commonly occurring dietary nitrosamine is N-nitrosodimethylamine. Such
compounds are present in high quantities in cooked,
processed meats and in salted foods and pickles and
are formed as by-products of food processing. Nitrosamines can also be inhaled as components of tobaccosmoke.Nitrosaminesareassociatedwitharange
of different cancers, particularly within the digestive
tract. Larsson _et al_ . (2006) reported that stomach cancer risk was elevated twofold in women consuming
high levels of N-nitrosodimethylamine derived from
salami, ham, and sausages. Similarly, high intakes of
nitrosamines and foods rich in nitrosamines are associated with risk of rectal and esophageal cancers (Le
Marchand _et al_ ., 2002).
Some foods may also deliver compounds to the
body that themselves may be only weakly carcinogenic, but which when processed through Phase I
metabolism in the liver generate potent carcinogenic
forms. A good example of this is benzo(a)pyrene
(B(a)P), which is a polycyclic aromatic hydrocarbon
formed during combustion. B(a)P can be present on
grains and cereals as a environmental pollutant, but
is more likely to enter the body during the cooking
of meats, particularly if the meat is charred on the
outside. B(a)P is metabolized by aryl hydrocarbon
hydroxylase (cytochrome P450 1B1) to form a series
of hydroxyl and diol intermediates. These products,
and most notably the B(a)P diol epoxides, are able
to form adducts with DNA, leading to damage and
mutation.

The metabolism of nitrosamines may also determine their ultimate carcinogenicity. Nitrosamines are
metabolized by the cytochrome P450, CYP2E1. This
can exist in different forms as there is a polymorphism
of the CYP2E1 gene, with some individuals having a



**The Adult Years** **209**


gene with 96 bp 5 [′] insert. In a study of a Hawaiian population, individuals with the 5 [′] insert had 60% greater
risk of rectal cancer (Le Marchand _et al._, 2002). This
increased risk may be further elevated by consumption of a nitrosamine-rich diet. Individuals carrying
the gene with the 5 [′] insert were noted to have up to
threefold greater risk of rectal cancer if consuming a
diet rich in processed meats.
Components of the diet may also interact with each
other or with other cancer risk factors to modify risk
of cancer. Stomach cancer is generally preceded by
inflammatory disorders of the stomach lining, which
permit infection with bacteria that promote carcinogenesis, for example _Helicobacter pylori_, or which increase the likelihood of cell transformation occurring
in the presence of carcinogens. A high-sodium diet is
proposed to irritate the stomach mucosa and promote
localized inflammation (gastritis). In addition to promoting infection, high salt concentrations appear to
alter expression of certain _H. pylori_ genes and this may
contribute to tumor initiation (Loh _et al_ ., 2007). Nitrosamines may also promote development of gastric
carcinomas once gastritis is established.
Once within the body the ability of carcinogens to
drive the formation of tumors, or for tumors to become established, may be modulated by other componentsofthediet.Nutrientsthatpromotehealthyfunctioning of the immune system, for example vitamin
A, will make it more likely that transformed cells will
be eliminated and therefore inhibit carcinogenesis at
theinitiationphase.Antioxidantnutrientsshouldalso
have an anticarcinogenic function as they have the capacity to neutralize free radicals such as the hydroxyl
radical, which unquenched can cause DNA strand
scission, or modify base sequences. It is also proposed
that some components of the diet can modulate the
access of carcinogens to their sites of action. For example, certain nonnutrient components of plant food
stuffs may bind carcinogenic compounds and prevent
their absorption across the gut, and therefore have antitumor properties. Other antitumor agents are active
postabsorption and bind carcinogens to prevent their
interaction with DNA.


**8.4.5.3 Nutritional epidemiology and cancer**
The study of the relationship between diet and cancer
has been one of the main areas of focus for nutritional

epidemiologists over the last four decades. A wide
range of different methodological approaches have



**210** **Nutrition: A Lifespan Approach**


been adopted, each yielding data that is suggestive
of associations between particular components of the
diet and either increased or decreased risk of cancers
at different sites of the body.


_Ecological studies_
Ecological studies involve comparing prevalence rates
for specific diseases between different regions of a
country or between different countries. They can also
look at changes in prevalence rates within a population over an extended period of time. To uncover the
underlying reasons between temporal or geographical variation in disease rates, the ecological studies
explore variation in putative exposures that might explain the patterns of disease. For example, it is widely
reported that there is a strong correlation between
risk of breast cancer in women and total fat intake.

This assertion is based on the observation that on
a global scale, the nations with the highest breast
cancer death rates (e.g., the UK, Netherlands, New
Zealand, Canada, Denmark, and the US) are those
with the highest per capita fat intakes. The nations
with the lowest death rates from breast cancer (Thailand, Japan, Taiwan, El Salvador) are those with the
lowestfatintakes.Thisexampletypifiesthelimitations
of ecological studies, which at best can only be suggestive of a diet–cancer relationship. In the example
described above, it is not possible to establish whether
the women dying of breast cancer are the same women
who were exposed to high-fat intake, nor is it possible to exclude important confounding factors that are
knowntoimpactuponbreastcancerriskandthatvary
between these nations (for example, age at menarche
and menopause, age at first pregnancy, number of
pregnancies, use of oral contraceptives). All ecological studies must be followed up with studies using
more reliable methodologies. In the case of the putative relationship between fat and breast cancer, there is
little reliable evidence to suggest a major risk (Hunter
_et al_ ., 1996; Mazhar and Waxman, 2006).


_Migrant studies_
Migrant populations, that is, groups of people who
have moved from a country where they have been
established for many generations to a new country,
were widely used in early studies of diet and cancer.
Migrant populations provide the ability to discriminate between influences of genetics and influences of



the environment in the etiology of disease. Genetic
changes in migrant populations occur slowly as they
often require three or more generations to mix significantly with the indigenous peoples of their new
homeland. Environmental changes such as exposure
to pollutants or background radiation will exert effects immediately. Dietary changes often occur within
two generations as younger people, in particular, will
take on the dietary patterns of the new country very
readily.
Studies of Japanese migrants to the US in the period following the Second World War provided some
of the first clues to the dietary basis of cancers of the
stomach and colon. Over three generations the US
Japanese developed colon cancer rates fivefold above
those seen in Japan, while stomach cancer rates fell
by 80%. These observations were taken as evidence
that high-salt intake was a risk factor for stomach
cancer, while a high-red meat, low-fiber diet could
increase risk of colon cancer. More recently, Lee _et al._
(2007) have reported on changes in prevalence of cancers among Korean migrants to the US. In South Korea, rates of certain cancers are very high and this has
been attributed to high intakes of salted foods and
foods rich in nitrosamines. As shown in Figure 8.10,
among the male population of US Koreans, migration decreased prevalence rates of stomach, liver, and
gallbladder cancers, while risk of cancers of the colon
and prostate appeared to increase. This illustrates that
the shift to a more westernized lifestyle produces profound changes in cancer risk and investigation of the
nature of those lifestyle changes could inform understanding of the diet–cancer relationship.


_Studies of populations with unique characteristics_
Therearesomegroupsofindividualslivingamongnational or continental populations, whose beliefs and
lifestylessetthemapart.Throughcomparisonsofsuch
groups with the broader population it may be possible to elucidate nutritional factors that could explain
variance in cancer risk. For example, some orders of
English nuns who follow a vegetarian diet have been
useful in exploring relationships between meat consumption and breast cancer risk. The nuns are celibate
and therefore not reproductively active, so they represent a high-risk group for these tumors. As they also
abstain from alcohol and tobacco smoking, the influence of diet can be studied in the absence of these

other risk factors (Willett, 1990).



**10**
US Korean


**6**


**4**


**2**


US White males



**The Adult Years** **211**


**Figure 8.10** Cancer rates in male Korean migrants
to the US, compared to the native South Korean population. Migration is associated with significantly decreased prevalence of cancers of the stomach, liver,
and gallbladder, but these cancers still remain more
common than in the full US population. Migration increased risk of colon and prostate cancers. ( _Source_ :
Data taken from Lee _et al_ . (2007).)



**0**


**Cancer site**


One group that has been extensively studied in this
context is the Seventh Day Adventist population in
the US. This religious group is notable in that dietary practices are very varied. While some Adventists are omnivores, a high proportion are vegetarians,
with many following a vegan lifestyle. The very wide
range of intakes of many different nutrients, coupled
to low rates of smoking and other risk exposures,
makes the Adventists an attractive group to consider
the dietary determinants of cancer (Willett, 2003).
Adventists have low rates of colon and lung cancers,
but higher rates of breast and prostate cancers than
the broader US population and this has promoted interest in the contribution of red meat consumption to
tumors at these sites. Some Adventists are prodigious
consumers of milk and dairy products and so are a
useful group to study when considering relationships
between these foods and cancer risk.


_Case-control studies_

Case-controlstudieshavebeenavaluableinvestigative
tool for considering relationships between diet and
cancer. Essentially, in a case-control study, researchers
will recruit subjects who have been diagnosed with
the disease of interest. These cases will then be com
pared to a suitably matched control group without the
disease to ascertain the factors that could explain why
the cases but not the controls developed the disease.
For example, Taylor and colleagues (2007) studied
35 372 women, of whom 1750 developed malignant
breast cancers. Using a case-control analysis it was
shown that after adjustment for known confounding
factors, postmenopausal women who consumed the



highest amounts of meat had significantly greater risk
of breast cancer than those who consumed no meat at

all (Hazard ratio 1.10, 95%CI 1.01–1.20).
There are a number of important problems with
this approach that can undermine confidence in any
findings. Firstly, the recruiting of suitable control
populations is often fraught with difficulty and casecontrol studies are highly vulnerable to influences of
confounding factors. It is impossible to exclude the
possibilitythatcontrolsubjectsareundiagnosedcases,
or cases waiting to happen. Finally, all exposure data
(i.e., data relating to diet) is either collected well after
the period during which carcinogenesis was initiated
or has to be collected retrospectively. Asking subjects
to recall their typical diet from a decade previously is
bound to introduce considerable bias to a study.


_Cohort studies_

Prospective cohort studies that are able to follow a
population over an extended period of time provide
a very powerful tool for examining relationships between diet and cancer. Prospective cohorts require
very large populations (tens of thousands of people)
to be recruited to allow for the fact that specific cancers are actually uncommon events. Baseline data on
diet and other exposures can be collected at the start
of the study and at intervals thereafter. These data
can then be related to the occurrence of disease over
the duration of the study. Although many prospective
studies are plagued by inaccurate estimation of the
exposure data in the initial stages, there are several
major prospective cohorts that have informed much
of what we know about diet–cancer relationships.



**212** **Nutrition: A Lifespan Approach**


The US Nurses Health Study (Colditz and
Hankinson, 2005) began to collect data on diet and
alcohol consumption among US women in 1980 and
has included over 80 000 subjects. By sustaining the
follow-up of these women over three decades it has
proved possible to investigate the role of diet in the
etiology of many cancers and other disease states. The
Nurses Health Study is one of the key studies that
has shown the proposed relationship between fat intake and risk of breast cancer to be fallacious. The

European Prospective Investigation into Cancer and
Nutrition (EPIC) was established in 1992, and by 2006
had recruited over 520 000 individuals across 23 cen
ters in 10 European countries (Gonzalez, 2006). The
chief advantage of such a large study is that the actual
number of cancer cases will be high, which greatly
increases the chances of observing diet–cancer relationships. EPIC used a range of dietary assessment
methods to obtain baseline data from participants
and was designed to follow-up for at least 20 years.


_Intervention studies_

Intervention studies are arguably the most effective
tool for studying the relationship between any dietary
component and cancer risk. Typically, an intervention will seek to provide volunteers with a diet that
is either supplemented with a putative protective factor or which has a reduced content of a suspected
harmful agent. The volunteers can then be followed
up over a period of time to assess the impact on cancer risk. Many of these very expensive intervention
trials have been performed to assess efficacy of antioxidants, dietary fiber, and other agents in cancer
prevention, but despite their power many of the trials have proven inconclusive or have yielded results
of an unexpected nature. For example, the CARET
trial was an intervention trial in which supplements
of β-carotene were provided to smokers and other
individuals at high risk of lung cancer. The trial was
abandoned at an early stage when it was noted that the
supplements actually increased rather than decreased
cancer mortality (Omenn _et al_ ., 1996). It is thought
that this occurred because although vitamin A may
block carcinogenesis at the initiation stage, it may accelerate the progression of tumors at the proliferation
and invasion stages.
TheCARETexperiencehighlightssomeofthemain
drawbacks of almost all diet–cancer intervention trials. Most trials, for reasons of good scientific method,



seek to only manipulate subjects intakes of a single nutrient. This instantly renders them unrepresentative
of a typical human diet. Moreover, selected doses are
often poorly thought out. As cancer will generally develop very slowly, perhaps taking decades to progress
from actual critical exposure to clinically significant
stages, most intervention studies will save time and
cost in following-up volunteers by recruiting participants who are at high risk. It is commonplace, for
example, to recruit individuals who have previously
been treated for a cancer and who are at high risk
of recurrence. Again, this is not representative of the
population and their risk in relation to diet.


_Cancer risk is a product of the whole diet_
All of the approaches to the study of diet–cancer relationships outlined above suffer from a common limitation in that they fail to take into account the ways
in which nutrients interact with each other, with the
genes carried by individuals, and with risk factors in
the environment. It is overly simplistic to assume that
intakes of a single nutrient are representative of the
whole range of dietary and environmental exposures
experienced by individuals. The CARET study described above typifies this and highlights the fact that
nutritional factors impact on cancer risk at all stages
of the development and progression of the disease.
The human diet comprises varied mixtures of
foods, each providing different combinations of nutrients, prepared in a variety of different ways. This
means that within each food and within each meal

there is considerable scope for interactions between
nutrients, and between nutrients and the nonnutrient
components of foodstuffs (Gerber, 2001). Having a
varied diet is desirable as it increases the chances that
a broad array of protective agents will be ingested and
minimizes the risk of repetitive exposure to harmful
factors. As such it will be the combinations of factors

in the habitual diet of any individual that confer cancer risk, rather than intakes of specific nutrients or
foods. For example, in relation to colon cancer risk, a
diet high in processed and red meats, high in refined
sugars, and high in fat carries significantly greater
risk than one high in fish, legumes, vegetables, and
fresh fruits (Gerber, 2001). These are complex dietary
patterns and it is challenging to ascertain where the
difference lies. Is the reduced risk associated with the

latter diet due to the lower intake of meat or saturated fats, or could it be explained by greater intakes



**The Adult Years** **213**



**40**
Women


Men



**30**


**20**


**10**


**0**


of antioxidants from plant materials? Almost certainly
it is a combination of these factors that provides the
observed benefit.
Despite these concerns about methodology and the
limitations of considering single nutrients as risk factors, it still remains tempting and desirable to pick
out the contributions of different components of the
overall diet to cancer risk. Clear identification of factors, or combinations of factors, that may increase
or decrease risk will help to refine dietary guidelines
given to populations and will inform the design of future dietary interventions. The following sections will
therefore review the evidence that specific macro- and
micronutrients in the human diet modulate risk of

cancer.


**8.4.5.4 Dietary factors that may promote**

**cancer**


_Obesity_
Excessive weight gain and body fatness, whether attributable to poor diet, low physical activity levels,
or both, is firmly associated with cancers at all sites
around the body. The 1997 World Cancer Research
Fund report on diet and cancer linked low levels of
exercise to premenopausal breast cancer, and obesity
to postmenopausal breast cancer, and cancers of the
colon, rectum, endometrium, esophagus, gallbladder,
kidney, and pancreas. The American Cancer Society
Prospective Cohort (Calle _et al._, 2003) showed, in a
population of 900 000 men and women, that risk of
death from cancer at all sites was increased by almost
twofold by obesity, with the greatest effects noted for
kidney and uterine cancers in women and for liver



**Figure 8.11** Contribution of obesity and overweight to
cancer risk in European men and women. ( _Source_ : Data
taken from Bergstrom _et al_ . (2001).)


cancer in men. As shown in Figure 8.11, Bergstrom _et_
_al_ . (2001) estimated that 6.4% of all female and 3.4%
of all male cancer cases in Europe were attributable to
overweight and obesity. Given the shifts in prevalence
of obesity occurring around the world as developing
countries take on westernized patterns of food intake,
leisure, and employment, there is likely to be a large
rise in the prevalence of these cancers on a global scale
(Popkin, 2007).
The mechanisms through which obesity increases
cancer risk are varied, largely unidentified, and may
be specific to each tumor site. Obese individuals
produce greater background concentrations of proinflammatory cytokines and in tissues such as the
colon the presence of a persistent, low level, inflammation will increase risk of tumor growth. Obesity is also associated with insulin resistance and
raised concentrations of sex steroids and insulin likegrowth factor 1. All of these factors will promote
the growth and metabolic activity of tumor cells and
hence drive the proliferative and invasion phases of

cancer.

Breast cancer risk is strongly related to the duration
of production of estrogens. As described in Chapter 2,
obesity in childhood is associated with an earlier
menarche and hence a longer phase of estrogen production, while obesity beyond the menopause will allow for estrogen production beyond the phase of normal ovarian function. The association between female

BMI and breast cancer risk is dependent on stage of
life. Premenopausal women of greater BMI are apparently protected against breast cancer (Willett, 2001),
with some studies suggesting that BMI of 30 or greater
may halve risk. However, in postmenopausal women



**214** **Nutrition: A Lifespan Approach**


there is a significant increase in risk, particularly with
central adiposity.
Estrogens are produced beyond the menopause
throughtheactionofaromatasesinadiposetissuethat
convert androgens to a range of estrogen metabolites.
Insulin resistance associated with obesity increases the
production of androgens and hence drives this process. All estrogens are mitogenic and will promote tumor growth. 17β-estradiol is an estrogen metabolite
that is known to be carcinogenic, and this may also explain some of the risk of breast cancer associated with
obesity. It is suggested that before the menopause the
actions of 17β-estradiol and other estrogens are opposed by progesterone, but following the menopause
this protective action of progesterone will be lost. The
association of obesity with breast cancer mortality
may also be explained by delays in recognizing symptoms and detecting breast lumps at an early stage of
cancer, due to the accumulation of fatty tissue in the
breasts.


_Fat intake_

Ecological studies generally show that in populations
with higher intakes of fat, there is greater prevalence
of cancers of the breast, colon, and lung. These studies typically support findings from animal studies that
consistently show that high-fat diets increase susceptibility to chemically induced carcinogenesis in the
colon and mammary glands. However, these experimental and ecological observations do not stand up to
robust analytical approaches in nutritional epidemiology and the balance of opinion is that dietary fat
has little impact on cancer risk in humans. There is
no basis for any advice to reduce fat intake in order
to prevent cancer, nor to modify the profile of fats
consumed. Avoidance of obesity should be a higher
priority (Kushi and Giovannucci, 2002).
The breast was one site at which possible links between cancer and fat intake were identified in early
studies (World Cancer Research Fund, 1997). To some
extent the meta-analysis of case-control studies performed by Howe and colleagues (1990) supported this
view, as it found that increasing intakes of total fat
by 100 g/day would increase risk of breast cancer by
approximately 40%. Given that typical daily intakes
among western populations are only of the order of
70–80 g/day the benefits of a modest reduction in fat
intake are likely to be minor. Willett (2001) reviewed
the findings of prospective cohort studies with follow


ups of up to 8 years duration. No evidence of risk was
observed in relation to either total fat or saturated

fat intakes. The 14-year follow-up of the US Nurses
Health Study (Holmes _et al._, 1999) found that there
was no evidence of any risk of breast cancer associated with four different measures of fat intake. Even
at very low intakes of fat (less than 20% of energy
intake), there was no evidence of benefit, and in fact a
slightly higher risk of breast cancer was noted in such

women.

Some animal studies have identified MUFA and
omega-3 fatty acids derived from fish oils as possibly
having a protective role in breast and colorectal cancers. Although some studies from southern Europe
support the concept that olive oils may reduce risk
of breast cancer, the evidence is insufficient to make
a definitive statement on this. Engeset _et al._ (2006)
considered the impact of fish consumption on breast
cancer risk in women from the EPIC cohort. Highest
intakes of fatty fish, that is, the fish with the greatest omega-3 content, were actually associated with an
increased risk of breast cancer.


_Protein_

Variation in the consumption of protein between developed and developing countries was originally one
of the factors emerging from ecological studies as a
possible explanation of the global variation in prevalence of colon and other cancers. Some plausible
mechanisms were advanced to explain any possible
association, including the formation of ammonia in
the colon due to bacterial utilization of urea derived

from amino acids. Influences of animal protein, in
particular, are difficult to dissociate from influences
of other nutrients and agents present in the richest
food sources. For example, the main sources of animal protein in the western diet are red meat and
dairy products, which are also sources of dietary fat.
Although the World Cancer Research Fund report of
1997 suggested that animal protein could possibly be
positively associated with risk of breast cancer, there
is no robust evidence from epidemiology to indicate
thathighproteinintakesareasignificantriskofcancer
at any other site.


_Meat_

There is strong evidence that consumption of meat
is associated with increased risk of cancers of the

stomach, colon and rectum, pancreas, and breast.



The initial interest in meat consumption as a risk
factor for cancer stemmed from observational stud
ies that suggested that high intakes of animal protein
and saturated fat increased risk. However, it is now

believed that formation of nitrosamines and heterocyclic amines during the cooking and preservation of
meats is the main vehicle through which meat products contribute to cancer risk.

Several cohort studies have shown an increased risk

of colorectal cancer (CRC) associated with meat consumption. A large study of male health professionals
in the US (Giovannucci _et al._, 2004) found that regular
consumption of meat increased risk (relative risk 3.6)
compared to rare or infrequent consumption of meat.
Processed meat and red meats are generally identified as the main contributor to risk, with white meat
(poultry) apparently having little or no impact. Gonzalez and colleagues (2006) examined 521 457 men
and women in the EPIC cohort over a 6-year period.
Risk of stomach cancer associated with infection by
_H. pylori_ was significantly increased by consumption
of meat of any kind, but the direct association between
cancer risk and processed meat was the strongest. A
50 g/day increase in consumption was associated with
a hazard ratio of 2.4 (95% confidence intervals 1.43–
4.21). There was no association of meat consumption
with esophageal adenocarcinoma in this study.
Data in relation to breast cancer and meat consumption is somewhat inconclusive, but many studies suggest increased risk. Taylor _et al._ (2007) studied the UK Womens Cohort (including over 35 000
women). Total meat intake was significantly related
to breast cancer risk, regardless of menopausal status.
Comparing the highest intakes (over 100 g/day) with
vegetarians the study reported a hazard ratio of 1.34
(95% confidence intervals 1.05–1.71). Only processed
or red meats increased risk, with no evidence of association with intakes of poultry or offal. Risk was
greater in postmenopausal women for whom high intakes of processed meat increased breast cancer risk
by 64% compared to vegetarians.
As stated above, red meat may directly deliver carcinogens formed during cooking, to the body. Heterocyclic amines are formed in the cooking of all
meats, including poultry, so the lack of evidence linking consumption of white meats to cancer is perplexing. Peptides derived from red, but not white,
meats undergo metabolism in the colon, greatly increasing their mutagenicity. N-nitrosation generates



**The Adult Years** **215**


**80**


**60**


**40**


**20**


**0**


**Diet**


**Figure 8.12** Healthy volunteers consumed vegetarian, high meat, or
high-meat/high-fiber diets for periods of 10 days. Exfoliated colonic
cells shed in fecal matter were stained for O [6] -carboxymethyl guanine.
Meat increased appearance of these positive cells and fiber partially
offset this effect. ( _Source_ : Data taken from Lewin _et al_ . (2007).)


N-methyl-N-nitroso compounds that form adducts
with DNA. Many of these adducts are excised during DNA repair processes and can be detected in the
colon as a marker of carcinogenic processes. Lewin
_et al_ . (2007) studied healthy volunteers who were allocated to consume either a vegetarian diet or a diet
rich in red meat. In a third element of the study the
high meat intake was supplemented with fiber. Shedding of cells containing the adduct O [6] -carboxymethyl
guanine was determined in fecal samples. As shown
in Figure 8.12, the high-meat diet greatly increased
this marker of carcinogenic processes, and high fiber
intake partially offset this effect. Thus, delivery of Nnitroso compounds to the colon may be an important
means through which red meat increases risk of CRC.


_Alcohol_

Levels of alcohol consumption are extremely varied
both across and within global populations. While
some groups never consume alcoholic beverages,
there are others where around 10% of energy is consumed as alcohol. Consumption is increasing steadily
in many westernized countries. In the UK, for example, overall alcohol consumption in women increased
by 16% between 1992 and 2005 (General Household
Survey, 2006), and the proportion of women consuming more than the recommended 14 units per week
increased by 50% over a similar period. These trends
are a major concern as alcohol has been positively
identified as a carcinogen in humans.



**216** **Nutrition: A Lifespan Approach**


There is convincing evidence that alcohol consumption is a risk factor for cancers of the liver, esophagus, mouth, and pharynx, and it is probably causally
associated with cancers of the breast, colon, and rectum. Lung cancer risk may also increase with high
consumption (World Cancer Research Fund, 1997).
The mechanisms of action proposed, include direct
DNA damage by ethanol and acetaldehyde, the main
product of alcohol degradation in the liver, activation
of microsomal Phase I metabolism, and delivery of
other carcinogens that may be present in alcoholic
beverages, such as nitrosamines. It is also suggested
that alcohol in drinks may increase the bioavailability of ethanol-soluble carcinogens across the digestive

tract.

Most epidemiological studies suggest that risk of
breast cancer increases with alcohol consumption.
Meta-analysis of well-designed cohort studies (SmithWarner _et al._, 1998) showed that for every 10 g/day
increase in alcohol consumption risk of breast cancer
rose by 9%. Risk of esophageal and other head and
neck cancers is increased by up to tenfold in heavy
drinkers (over 80 g alcohol per day), a hazard that is
further increased by cigarette smoking. Rehm _et al._
(2007) performed a systematic review of the literature that examined whether this risk could be ameliorated through cessation of drinking. As shown in
Figure 8.13, alcohol consumption increased risk of
esophageal cancer by 2.7-fold compared to subjects
who never consumed alcohol. Cessation of drinking
produced an initial increase in risk, which is also seen
in relation to breast cancer (Willett, 2001), but by 5
years postcessation of drinking significant health benefits became apparent.


_Specific carcinogens in food_
Foodstuffsdeliverahugerangeofchemicalagentsthat
are not normally regarded as nutrients to the body.
Some of these are present as contaminants, entering
the food chain during production and preparation;
others are generated during the process of cooking.
In addition, there is a vast array of agents that are
the products of the complex secondary metabolism
of plants. As will be described below, some of the
nonnutrient components of food may have anticancer
properties. It is also the case that some of these factors
are directly carcinogenic and if consumed in excess
may directly promote the development of primary

tumors.



**3**


**2**


**1**


**0**


**Period since drinking cessation**


**Figure 8.13** Risk of esophageal cancer associated with alcohol consumption is significantly higher when comparing current drinkers to
individuals who have never consumed alcohol. Cessation of alcohol
drinking initially increases risk of cancer, but over the longer term restores risk to the equivalent of never drinking. ( _Source_ : Data taken
from Rehm _et al_ . (2007).)


A simple test was developed by Bruce Ames and colleagues in the 1970s to screen potential carcinogenic
agents, from food or from other sources. The Ames
Test assesses the mutagenic capacity of compounds
and works on the assumption that any agent capable
of damaging DNA, will have the potential to have carcinogenic effects. The test involves growing mutant
strains of _Salmonella typhimurium_ that lack genes for
key enzymes involved in amino acid metabolism, on
media lacking those amino acids. Any colonies that
grow in the presence of a suspected carcinogen must
have undergone mutation to be able to utilize the
limiting medium and therefore signal that the test
chemical is a mutagen. The number of colonies that
grow will provide an index of how potent a mutagen,
the agent, is. Many compounds that are not carcinogens could produce a positive Ames Test result, and
some carcinogens that only become active when metabolized within the human body (e.g., B(a)P) give a
negative Ames Test result. The main disadvantage of
the Ames Test is that the test organism is a prokaryote, and thus it is a poor model for studying potential
harm to humans. The test can be improved by using eukaryotic yeast cells instead of bacteria, and by
adding extracts of rodent liver to the test medium
to introduce hepatic Phase I and Phase II xenobiotic
metabolism.



There are some important Ames Test-positive
agents that can regularly appear in the human food
chainandpromotecarcinogenesis.Severalsuchagents
are present in commonly consumed herbs. Basil and
tarragon, for example, deliver estragole, while comfrey contains carcinogenic alkaloids. Generally speaking, however, these agents are not consumed in significantly large amounts and risk is negligible. The
same is true of safrole—a compound found in cinnamon and nutmeg. In Taiwan, however, the habit
of chewing betel is associated with esophageal cancer. Betel is essentially ground areca nut mixed with
leaves and lime to form a chewable quid that has a
high safrole content. Safrole is also present in peppercorns, which are used to produce the pepper used in
cooking and as a condiment in most western cuisines.
Red peppers and chilli peppers have their characteristic flavor due to the presence of capsaicin. Capsaicin
is mutagenic when subjected to the Ames Test and
has been shown to be carcinogenic in animal studies. Archer and Jones (2002) studied different ethnic
groups in the US, where capsaicin-containing peppers are widely used in Mexican, Creole, and Cajun cooking. Evidence was found to relate high consumption of capsaicin to increased risk of stomach

cancer.

A variety of fungal toxins are known to be potent carcinogens, providing a concern over some
foods grown in the tropics. Peanuts, for example,
can be a source of aflatoxins, which are highly active
liver carcinogens. Ochratoxins are also fungal contaminants, arising through development of mildews
on cereal crops. While controls over the quality of
imported peanuts and other foods from at-risk areas minimize aflatoxin and ochratoxin exposures of
western populations, in the developing world contamination of staple foods is widespread. Most
contamination occurs after harvest due to storage in
unventilated, hot and humid conditions with poor
hygiene. Maize and groundnut crops are particularly at risk and consumption of these staples in
West Africa is associated with high circulating concentrations of aflatoxin–albumin adducts in both
children and adults (Egal _et al._, 2005). Simple procedures to reduce contamination such as sundrying of crops and storage in natural-fiber bags can
reduce exposure in affected areas (Turner _et al_ .,
2005).



**The Adult Years** **217**


**8.4.5.5 Dietary factors that may reduce**
**cancer risk**


_Complex carbohydrates_

Much of the literature that discusses the associations

between complex carbohydrates and risk of cancer
will refer to the influence of dietary fiber. Dietary
fiber is a term that is perhaps better replaced, as it is
moreappropriatetodiscusstheinfluenceofnonstarch
polysaccharides and insoluble starches. The complex
carbohydrates within the human diet are a diverse
group of materials that share the common property of
resisting digestion and hence are able to pass through
the digestive tract to the colon relatively unchanged.
The complex carbohydrates include cellulose from
plantmaterials,insolublestarches(largelyofvegetable
or cereal origin), lignans (of vegetable origin), phytoestrogens, and chitin (from fungal cell walls and shellfish). “Fiber” is therefore not a single substance, and
the effects of fiber reported in the literature should be
expected to vary according to the source of the material in the diet, as the composition of fruit, vegetable,
or cereal-derived fiber will differ considerably. There
is an extensive literature that links higher consumption of complex carbohydrates to lower risk of cancer
at several sites. It is difficult to isolate dietary fiber as a
beneficial component of the diet, as individuals who
have higher intakes of these complex carbohydrates
from plant materials will also tend to have lower intakes of meat and the associated putative carcinogenic
agents described above.
It is widely reported that complex carbohydrate
consumption reduces the risk of cancers of the breast
and ovary in women. These cancers are largely driven
by hormonal factors, which implies that complex carbohydrates may somehow modify the production of
estrogens beyond the menopause, which is the major
risk factor for these cancers. Certainly, feeding highfiber diets to rodents protects the animals against
development of chemically induced mammary tumors, and meta-analyses of case-control studies in
human populations suggests that a 20 g/day increase
infiberintakewouldreduceriskofbreastcancerbyapproximately 15% (Howe _et al._, 1990). However, large
prospective cohort studies, including the US Nurses
Health Study, have suggested that there is little benefit
associated with increased intakes of complex carbohydrates with respect to breast cancer (Willett, 2001).



**218** **Nutrition: A Lifespan Approach**


Interventions in which women have made lifestyle
changes favoring a low-fat–high-fiber diet have produced small reductions in risk of breast cancer over
follow-up periods of around 8–10 years, but these may
be attributed more to the associated weight and body
fat loss than to specific effects of complex carbohydrates (Forman, 2007).
There is a considerable level of controversy in relation to the proposed inverse association between
CRC risk and intakes of complex carbohydrates.
Denis Burkitt first proposed this association in the
1970s as a means of explaining the very low prevalence
of CRC in African countries compared to westernized
populations. This viewpoint was generally supported
by case-control studies that predominantly indicated
that risk of CRC was lowered by increasing intakes
of complex carbohydrates, particularly those of vegetable rather than cereal origin. However, these observations were not supported by large prospective
cohort studies performed in European and US settings. The Nurses Health Study, for example, found
that there was no difference in CRC risk between
groups with the highest compared to the lowest intakes of dietary fiber (Fuchs _et al._, 1999), and in fact
the highest intakes of vegetable fiber were actually
associated with a 35% increase in CRC risk. In addition to this apparent indication that the case-control
data were misleading, a number of intervention trials of dietary fiber supplementation found that administration of fiber to individuals with previous history of CRC failed to prevent either tumor recurrence or short–medium term-survival (Alberts _et al._,
2000).
Support for a protective effect of complex carbohydrates against CRC has been provided by the EPIC
study. With over half a million participants across 10
different countries, EPIC had unprecedented power
to consider any putative diet–cancer association. The
heterogeneity of diets between European countries
means that the range of nutrient intakes is extremely
broad, which enhances the prospects of detecting significant influences. As reviewed by Bingham (2006),
EPIC found that when comparing dietary fiber intakes in the highest quintile (mean 35 g/day) with
the lowest quintile (15 g/day) the relative risk for
CRC was 0.58 (95% CI 0.41–0.85), with beneficial effects of fiber becoming apparent at intakes of around
20 g/day. The main benefit in this study appeared to



be associated with intakes of cereal fiber. Risk of CRC
is obviously determined by complex interactions of
nutrients and other factors. The EPIC study was able
to assess some of these interactions and noted that

the greatest CRC risk was associated with the highest
intakes of meat and lowest intakes of fiber, when compared to the lowest intakes of meat and highest intakes
of fiber (Bingham, 2006). This appears to contradict
the findings of Key _et al_ . (1999) who reported that
there was no difference in risk between vegetarians
and nonvegetarians.
The mechanism through which complex carbohydrates are proposed to protect the colon from tumorigenesis is shown in Figure 8.14. Entry of complex
carbohydrates into the large intestine provides substratesforthegrowthofthebacterialspeciesthatmake
up the colonic microflora. Fermentation of complex
carbohydrates is associated with reproduction and
metabolism of these organisms and has several beneficial side effects for the human host. Firstly, the presence of fiber itself within the fecal material has the
effect of bulking up the stool, but this is further enhanced by accumulation of bacteria and retention of
water. The larger and softer stool that results is more
rapidly moved through the colon, and this reduced
transit time minimizes the length of time that potential carcinogens will be present within the colon.
The larger stool also has a reduced surface area to
volume ratio, which effectively means that any carcinogenic agents are more likely to be buried within
the fecal material rather than on an exterior surface

that might come into contact with the colonic mucosal cells. The fermentation of the complex carbohydrates by the microflora will also generate short chain
fatty acids (SCFA), which include butyrate, propionate, and acetate. This reduces the pH of the colon,
which reduces the likelihood of inflammation of the
mucosa. More importantly, butyrate is an inducer of
apoptosis and inhibits the transformation of cells in
the colonic epithelium (Chai _et al._, 2000). Thus, utilizationofcomplexcarbohydratebybacteriagenerates
potent antitumor agents within the human colon. The
nature of the carbohydrates reaching the colon may
determine the profile of bacterial species present, and
some of the more soluble complex carbohydrates have
been proposed to favor the growth of beneficial _Bifi-_
_dobacteria_ over other species such as _Escherichia coli_
or _Bacteriodes_ (Slavin, 2003).



**The Adult Years** **219**



**Complex CHO**









**Figure 8.14** Proposed mechanism to explain the protective influence of complex carbohydrate in colorectal cancer. CHO: carbohydrate.



The functional food industry exploits the fiber–
CRC relationship and markets two classes of product on the basis of their potential protective properties. Probiotic foods supply bacterial species such as
_Lactobacilli_ directly to the gut with the intention of
boosting fermentation by species that generate SCFA.
Prebiotics are complex carbohydrates such as inulin
or fructooligosaccharides that are intended to enter
the colon and selectively stimulate the reproduction
of _Lactobacilli_ and _Bifidobacteria_ .
Another explanation of the protective effects of
complex carbohydrates in the colon is that foods
that are rich in fiber will also deliver other cancerpreventive compounds. Folate, for example, will tend
to be consumed in greater quantities with fiber-rich
foods. There is also a wide range of nonnutrient compounds present in plants that have antitumor and
tumor-suppressing properties, and these could confound the apparent relationship between CRC and
fiber.
The data from EPIC and the identification of plausible mechanisms through which complex carbohydrates can reduce cancer risk makes it confusing
that interventions with fiber are wholly ineffective.
Goodlad (2001) suggests that the apparent failure of
intervention trials is due to the use of solely solu


ble forms in supplements. These are very rapidly fermented and greatly increase the metabolic activity of
the microflora. Once the substrate is exhausted, these
bacteria will switch to proteolytic metabolism and attack the colonic mucosa. Colon pH thus rises and any
benefit of the supplement is lost, or harm may even
be sustained.


_Antioxidant nutrients_

There is a very robust literature relating to the cancerpreventive properties of agents present in fruits and
vegetables, and in fact some of the most convincing
evidence in cancer epidemiology relates to the strong
inverse relationship between consuming diets rich in
fruits and vegetables and risk of cancers at all sites.
Ames and Wakimoto (2002) combined evidence from
two major reviews of the evidence and concluded that
75%ofallstudiesshowedclearprotectiveeffects.Generally, a higher intake of fruits and vegetables had the
potential to halve the risk of cancer, with most of the
convincing data relating to epithelial cell cancers (i.e.,
those of the digestive tract, lung, and liver). Greatest
benefits were noted for pancreatic and stomach cancers, while the only cancer showing little associated
benefit was prostate cancer.



**220** **Nutrition: A Lifespan Approach**


Fruits and vegetables are foodstuffs that deliver a
very broad range of putative cancer preventing nutrients and agents, including dietary fiber and folic acid.
Most attention has focused on the possible impact
of antioxidant nutrients, most notably the vitamins
A, C, and E and selenium. These are proposed to
primarily act through protection of DNA from oxidative damage mediated by ROS, but may also prevent
tumor formation and proliferation by other mechanisms. Quenching of ROS action will prevent some
conversion of inactive precursors to active carcinogens. Activation of the immune system may drive the
elimination of transformed cells. There is also some

evidence that vitamin C and retinol have the capacity
to induce apoptosis in tumor cells.
In considering the associations between the antioxidant nutrients and cancer risk it is necessary to dissociate the evidence from observational studies at the
population level and intervention trials using supplements, as these frequently yield widely contrasting
results. Vitamin E was first identified as potentially
beneficial when rodent studies showed that it could
prevent mammary tumor formation. However, in humans there is no evidence of protection against breast
cancer associated with normal ranges of intake. The
World Cancer Research Fund (1997) reported that like
vitamin C, dietary vitamin E possibly protects against
lung cancer via an antioxidant mechanism. However,
the overall evidence of associations between vitamin

E and cancer risk is somewhat tenuous.
Higher vitamin C intakes are strongly associated
with lower prevalence of stomach cancer, and there
is also evidence that they may reduce risk of cancers
of the mouth and esophagus (World Cancer Research
Fund, 1997). Graham _et al_ . (1991) carried out a casecontrol study of breast cancer and noted a 40% reduction in risk when comparing the highest quartile
of vitamin C intake with the lowest quartile. Metaanalyses show similar benefits (Howe _et al._, 1990), but
large prospective cohort trials fail to duplicate these
findings (Willett, 2001).
The most effective antioxidant nutrients in rela
                             tion to cancer risk are the carotenoids, notably β
carotene. Carotenoids appear to provide protection
against cancer at all sites of the body (World Cancer
Research Fund, 1997), but strongest evidence relates
to the lung, where a critical review found that all but 2
of 23 case-control and cohort studies showed reduced
risk associated with higher intakes. Higher intakes of



β-carotene have been suggested to reduce risk of CRC
by up to 40% (Johnson, 2004). Case-control studies of breast cancer also suggest reproducible protective effects of carotenoids, and the US Nurses Health
Study highlighted that this benefit was restricted to
premenopausal women (Willett, 2001). Selenium is
also a key element of antioxidant defenses, acting as
the catalytic center for the glutathione peroxidases.
Inverse associations between serum–selenium con
centrations and cancer risk have been reported for
prostate, lung, and CRCs in men (Johnson, 2004).
Followingonfromthewealthofstudiesthatsuggest
that the antioxidant components of fruit and vegetables account for at least some of the protective effects
that accompany consumption of these foods, there
have been a multitude of cancer intervention trials

designed around supplementation with vitamins A,
C, E and with selenium. The CARET trial mentioned
earlier in this chapter typifies the null or often negative outcomes of such trials, with unexpectedly increased cancer mortality associated with supplementation.Almostallstudiesthathaveadministeredsingle
antioxidant nutrients or combinations of antioxidant
nutrients have failed to show the benefits predicted by
case-control or other observational studies.
Bjelakovic _et al_ . (2004) performed a meta-analysis
of intervention trials performed to prevent gastrointestinal and liver cancers using antioxidants. Fourteen
large randomized trials of over 170 000 individuals
were considered and no benefits of vitamins A, C, E
or selenium were noted, regardless of whether they
were given alone or in combination. In fact, there was
evidence of an increase in death rates associated with

supplementation (RR of death 1.06, 95% CI 1.02–
1.10). This latter finding was supported by the work
of Lawson _et al_ . (2007) who considered risk of prostate
cancerinapopulationofalmost300 000USmen.Men
consuming 7 doses of multivitamin supplements per
week were at greater risk of fatal cancers (RR 1.98,
95% CI 1.07–3.66) than men who did not take supplements. Clearly, the benefits of fruit and vegetable
intake cannot be solely attributed to their antioxidant
content and the promise of antioxidant supplement
therapy in cancer prevention strategies cannot be realistically delivered.
One of the main reasons why antioxidant supplements fail to prevent cancer is most likely to be
an arbitrary dose selection that may be considerably
higher than required. At high concentrations some



antioxidants take on a pro-oxidant activity that would
promote oxidative processes. Providing supplements
of single nutrients shows a lack of consideration of
the interactions between antioxidant nutrients and

between the antioxidants and other components of
the diet such as fiber, which may be critical in mediatingtheprotectiveeffectsofplant-derivedfoodstuffs.It
is also important to appreciate that ROS play a normal
role in several processes, including the destruction of
precancerous or cancerous cells. Inhibiting these processes may allow tumors to progress beyond the initiation stage of carcinogenesis (Bjelakovic and Gluud,
2007).


_Folic acid_

As with complex carbohydrates, a large proportion of
theearlycancerepidemiologyliteratureidentifiedthat
poor dietary intakes of folic acid were associated with
increased risk of cancers at many sites, particularly
the colon, lung, cervix, and breast. Closer scrutiny
of the data is, however, less convincing. With respect
to cervical cancer, most of the evidence comes from
case-control studies that have inadequately adjusted
for other risk factors and so there is no consensus on
the role of folate (Powers, 2005). Meta-analyses suggest that while folate does not significantly impact on
breast cancer risk, it may ameliorate the risk associated with high alcohol consumption. However, the
mechanism for this effect is unclear as folate has been

shown to have no effect on development of benign
proliferative epithelial disorders of the breast, which
are precursors of cancer (Cui _et al_ ., 2007).
The epidemiological data appears more robust with
respect to CRC and there are inverse relationships between both intakes and red blood cell concentrations
of folate and CRC risk (Duthie _et al._, 2004). Konings
_etal_ .(2002)followedupover120 000menandwomen
in the Netherlands for 7 years and found that CRC risk
was 34% lower for the highest quintile of folic acid intake compared to the lowest quintile of intake, but in
men only. Porcelli _et al._ (1996) reported that the concentrations of plasma and red cell folate were lower in
patients with existing CRC compared to healthy controls. There have also been a number of small inter
vention trials using folate that have provided suggestive, if not convincing, evidence of protective effects.
Lashner _et al._ (1997), for example, studied a group of
98 individuals with ulcerative colitis, a condition that
increases risk of neoplastic changes in the colon and of



**The Adult Years** **221**


CRC. Folate supplements in this group reduced risk of
neoplasia in a dose-dependent manner and appeared
to reduce risk of CRC by 55%, although the effect was
not statistically significant.
Folate status is extensively determined by genotype
for a number of polymorphisms of genes in the folic
acid cycle, for example the MTHFR C677T polymorphism described earlier in this chapter. Surprisingly,
the TT variant of this polymorphism, which is associated with the lowest concentrations of folate in

circulation, actually appears to be protective against
CRC (Sharp and Little, 2004). The explanation for
this paradox lies in the fact that two mechanisms may
underlie the association between folate and cancer

risk.

Both of the putative mechanisms of protection involve folate increasing the stability of DNA. Folate is
critical in the synthesis of nucleotides, and poor folate
status is associated with limited synthesis of thymine
and so instead uracil is incorporated into DNA during cell replication, or DNA repair processes. Uracil
misincorporation promotes DNA strand breaks and
is associated with cell transformation. Some regions
of DNA may be more susceptible than others to uracil
misincorporation, and rodent studies have suggested
that the p53 tumor suppressor gene is especially sensitive to this misrepair (Kim _et al_ ., 1996).
The other protective mechanism depends upon the
role of folate in determining levels of DNA methylation. Methylation of DNA at CpG islands in promoter regions effectively silences the expression of
key genes. Low folate status results in hypomethylation and activation of gene expression, and it is
proposed that in susceptible individuals this will result in the expression of normally silenced, protooncogenes. While the TT polymorphism of MTHFR,
which is associated with lower folate concentrations,
may promote hypomethylation, individuals with this
gene variant appear to be more effective at synthesizing nucleotides for DNA repair and therefore have
lower levels of uracil misincorporation. This would
explain why there are lower rates of CRC among the
TT-carrying population (Duthie _et al_ ., 2004).


_Nonnutrient components of plant foodstuffs_
A wide range of putative cancer-preventive bioactive
compounds are present within the human diet, in
particular being derived from cereals, fruits, and vegetables. There is evidence from in vitro studies and



**222** **Nutrition: A Lifespan Approach**


animal models that these may be protective either
against specific cancers, or possibly all cancers, but as
yet little evidence exists to firmly support claims made
regarding human disease.
The strongest evidence from human trials relates
to the protective role of allium vegetables in stomach
cancer. The principal allium vegetables in the human
diet are onions, garlic, and chives. Higher consumption of these has been shown in many case-control
studies to be associated with lower risk of stomach

cancer. For example, De Stefani and colleagues (2001)
reported that allium consumption was beneficial in a
Uruguayan population (OR 0.56, 95% CI 0.34–0.92).
You _et al._ (2006), however, found no benefit associated with garlic extract supplementation over a 7-year
follow-up in China. The mode of action for allium extracts is proposed to be through antimicrobial activity
as the principal cause of stomach cancer is infection
with _H. pylori._
Phytoestrogens such as the soy isoflavones are proposed to confer protection against breast cancer by
modifying circulating estrogen concentrations after
the menopause. However, there is no convincing evidence of benefit seen in human populations (Willett,
2001). Glucosinolates and indoles from cruciferous
vegetables may be cancer preventive as they have been
shown in rodents to inhibit formation of tumors at all
sites. Similarly, the isothiocyanates in cruciferous vegetables appear to suppress tumorigenesis and this may
explain some of the protective potency of vegetables.
Polyphenolic compounds, terpenoids (such as
limonene), and the flavonoids (including quercetin,
myricetin)areverywidelyconsumedinfruitsandvegetables, in beverages such as tea, and may be added to
some processed foods as natural colorings and flavorings. Most of these bioactive compounds are potent
antioxidants and may therefore provide some protection by reducing oxidative damage to DNA. There are
other modes of action though and many of these compoundsareknowntoinhibitmutagenicityintheAmes
Test, although interestingly some of the flavonoids
such as quercetin appear to be mutagens according
to this test. Most of these compounds have the capacity to induce Phase II conjugation activities and
hence promote elimination of chemical carcinogens.
Quercetin can act as conjugator of carcinogens within
the digestive tract and hence reduce the bioavailability
of harmful agents. Some phenolics also have the capacity to inhibit angiogenesis, thereby restricting the



formation of new blood vessels around primary tumors and limiting the capacity for metastasis (Fresco
_et al_ ., 2006). Polyphenols have not been specifically
studied in relation to human cancer so the actual ef
ficacy of such agents in cancer prevention is largely
unknown.


~~**Summary Box 8**~~


The adult years (19–65) are associated with decreasing energy
requirements and therefore adjustment to a more nutrient-dense
pattern of dietary intake. Undernutrition remains a significant issue
among subpopulations, but for the majority of adults a healthy diet
and lifestyle aimed at preventing obesity and related metabolic
disorders is a high priority.
Obesity and overweight are increasing in prevalence all over
the world due to greater availability of food and declining physical
activity levels.
Risk of type 2 diabetes is the product of an interaction between
genetic factors and environmental influences. Obesity-related insulin resistance is the main feature of this condition.
The metabolic syndrome represents a complex cluster of disorders including hypertension, renal dysfunction, and disordered
lipid and glucose metabolism. All of these disorders are driven by
insulin resistance. The metabolic syndrome is a major risk factor
for development of CVD.
Atherosclerosis is the process through which deposits of cholesterol and collagen in the arterial wall promote occlusion of blood
flow and clot formation. This provides the fundamental basis of
CHD, cerebrovascular disease, and peripheral artery disease.
The major dietary risk factors for CVD are high intakes of
saturated fats, trans-fatty acids, sodium and obesity and related
metabolic disorders. Increasing intakes of monounsaturated fatty
acids, omega-3 fatty acids, folic acid, and antioxidant nutrients
from fruit and vegetables may reduce risk.
Cancer risk is strongly related to quality of the diet. Risk is
greatest with obesity and high intakes of red or processed meats
and low intakes of fruits and vegetables. Attempts to identify
specific dietary components that may be cancer preventive have
been largely unsuccessful and attention is currently focused on the
putative antitumor agents present in fruits and vegetables.


**References**


Abbey M (1995) The importance of vitamin E in reducing cardiovascular risk. _Nutrition Reviews_ **53**, S28–S32.
Alberti KGMM and Zimmet PZ (1998) Definition, diagnosis and
classification of diabetes mellitus and its complications. Part 1:
Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. _Diabetic Medicine_ **15**, 539–553.
Alberts DS, Martinez ME, Roe DJ _et al_ . (2000) Lack of effect of a
high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix colon cancer prevention physicians’ network.
_New England Journal of Medicine_ **342**, 1156–1162.



Ames BN and Wakimoto P (2002) Are vitamin and mineral deficiencies a major cancer risk? _Nature Reviews Cancer_ **2**, 694–704.
Apfelbaum M, Vague P, Ziegler O, Hanotin C, Thomas F, and
LeuteneggerE(1999)Long-termmaintenanceofweightlossafter
a very-low-calorie diet: a randomized blinded trial of the efficacy
and tolerability of sibutramine. _American Journal of Medicine_
**106**, 179–184.
Archer VE and Jones DW (2002) Capsaicin pepper, cancer and
ethnicity. _Medical Hypotheses_ **59**, 450–457.
BanegasJR,Lopez-GarciaE,Gutierrez-FisacJL,Guallar-CastillonP,
and Rodriguez-Artalejo F (2003) A simple estimate of mortality
attributable to excess weight in the European Union. _European_
_Journal of Clinical Nutrition_ **57**, 201–208.
Bansilal S, Farkouh ME, and Fuster V (2007) Role of insulin resistance and hyperglycemia in the development of atherosclerosis.
_American Journal of Cardiology_ **99**, 6B–14B.
Bender R, Zeeb H, Schwarz M, Jockel KH, and Berger M (2006)
Causes of death in obesity: relevant increase in cardiovascular
but not in all-cancer mortality. _Journal of Clinical Epidemiology_
**59**, 1064–1071.
Bergstrom A, Pisani P, Tenet V, Wolk A, and Adami HO (2001)
Overweight as an avoidable cause of cancer in Europe. _Interna-_
_tional Journal of Cancer_ **91**, 421–430.
Bingham S (2006) The fibre-folate debate in colo-rectal cancer.
_Proceedings of the Nutrition Society_ **65**, 19–23.
Bjelakovic G and Gluud C (2007) Surviving antioxidant supplements. _Journal of the National Cancer Institute_ **99**, 742–743.
Bjelakovic G, Nikolova D, Simonetti RG, and Gluud C (2004) Antioxidant supplements for prevention of gastrointestinal cancers:
a systematic review and meta-analysis. _Lancet_ **364**, 1219–1228.
Blaszyk H, Wollan PC, Witkiewicz AK, and Bjornsson J (1999)
Death from pulmonary thromboembolism in severe obesity: lack
of association with established genetic and clinical risk factors.
_Virchows Archives_ **434**, 529–532.
Bray GA and Ryan DH (2007) Drug treatment of the overweight
patient. _Gastroenterology_ **132**, 2239–2252.
Bucher HC, Hengstler P, Schindler C, and Meier G (2002) N-3
polyunsaturated fatty acids in coronary heart disease: a metaanalysis of randomized controlled trials. _American Journal of_
_Medicine_ **112**, 298–304.
Calle EE, Rodriguez C, Walker-Thurmond K, and Thun MJ (2003)
Overweight,obesity,andmortalityfromcancerinaprospectively
studied cohort of U.S. adults. _New England Journal of Medicine_
**348**, 1625–1638.
Castro Cabezas M, de Vries JH, van Oostrom AJ, Iestra J, and van
Staveren WA (2006) Effects of a stanol-enriched diet on plasma
cholesterol and triglycerides in patients treated with statins. _Jour-_
_nal of the American Dietetic Association_ **106**, 1564–1569.
Chai F, Evdokiou A, Young GP, and Zalewski PD (2000) Involvement of p21(Waf1/Cip1) and its cleavage by DEVD-caspase during apoptosis of colorectal cancer cells induced by butyrate. _Car-_
_cinogenesis_ **21**, 7–14.
Colditz GA and Hankinson SE (2005) The nurses’ health study:
lifestyle and health among women. _Nature Reviews Cancer_ **5**,
388–396.
Cook NR, Kumanyika SK, and Cutler JA (1998) Effect of change
in sodium excretion on change in blood pressure corrected for
measurement error. The trials of hypertension prevention, phase
I. _American Journal of Epidemiology_ **148**, 431–444.
Cui Y, Page DL, Chlebowski RT _et al_ . (2007) Alcohol and folate
consumption and risk of benign proliferative epithelial disorders
of the breast. _International Journal of Cancer_ **121**, 1346–1351.
De Stefani E, Correa P, Boffetta P _et al_ . (2001) Plant foods and
risk of gastric cancer: a case-control study in Uruguay. _European_
_Journal of Cancer Prevention_ **10**, 357–364.



**The Adult Years** **223**


Department of Health (1999) _Dietary Reference Values for Energy_
_and Nutrients for the United Kingdom_ . Stationary Office, London.
Department of Health (2002) _National Service Framework for Dia-_
_betes: Delivery Strategy_ . Stationery Office, London.
Dunn AL, Marcus BH, Kampert JB, Garcia ME, Kohl HW 3rd, and
Blair SN (1999) Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness:
a randomized trial. _Journal of the American Medical Association_
**281**, 327–334.
Durga J, Bots ML, Schouten EG, Kok FJ, and Verhoef P (2005)
Low concentrations of folate, not hyperhomocysteinemia, are
associated with carotid intima-media thickness. _Atherosclerosis_

**179**, 285–292.
Duthie SJ, Narayanan S, Sharp L, Little J, Basten G, and Powers H
(2004) Folate, DNA stability and colo-rectal neoplasia. _Proceed-_
_ings of the Nutrition Society_ **63**, 571–578.
Egal S, Hounsa A, Gong YY _et al_ . (2005) Dietary exposure to aflatoxin from maize and groundnut in young children from Benin
and Togo, West Africa. _International Journal of Food Microbiology_
**104**, 215–224.
Elliott P, Marmot M, Dyer A _et al_ . (1989) The INTERSALT study:
main results, conclusions and some implications. _Clinical and_
_Experimental Hypertension_ **11**, 1025–1034.
Engeset D, Alsaker E, Lund E _et al_ . (2006) Fish consumption and
breast cancer risk. The european prospective investigation into
cancer and nutrition (EPIC). _International Journal of Cancer_ **119**,
175–182.
Flegal KM, Carroll MD, Ogden CL, and Johnson CL (2002) Prevalence and trends in obesity among US adults, 1999–2000. _Journal_
_of the American Medical Association_ **288**, 1723–1727.
Forman MR (2007) Changes in dietary fat and fiber and serum
hormone concentrations: nutritional strategies for breast cancer
prevention over the life course. _Journal of Nutrition_ **137**, 170S–
174S.
Fraser ML, Mok GS, and Lee AH (2007) Green tea and stroke
prevention: emerging evidence. _Complementary Therapies in_
_Medicine_ **15**, 46–53.
Fresco P, Borges F, Diniz C, and Marques MP (2006) New insights
on the anticancer properties of dietary polyphenols. _Medical Re-_
_search Reviews_ **26**, 747–766.
Fuchs CS, Giovannucci EL, Colditz GA _et al_ . (1999) Dietary fiber
and the risk of colorectal cancer and adenoma in women. _New_
_England Journal of Medicine_ **340**, 169–176.
Gaede PH, Jepsen PV, Larsen JN, Jensen GV, Parving HH, and
Pedersen OB (2003) The Steno-2 study. Intensive multifactorial
intervention reduces the occurrence of cardiovascular disease in
patients with type 2 diabetes. _Ugeskrift for Laeger_ **165**, 2658–
2661.
Gardner EJ, Ruxton CHS, and Leeds AR (2007) Black tea- helpful or
harmful? A review of the evidence. _European Journal of Clinical_
_Nutrition_ **61**, 3–18.
General Household Survey (2006) General Household Survey. Office for National Statistics.
Gerber M (2001) The comprehensive approach to diet: a critical
review. _Journal of Nutrition_ **131**, 3051S–3055S.
Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A,
and Willett WC (2004) Intake of fat, meat, and fiber in relation
to risk of colon cancer in men. _Cancer Research_ **54**, 2390–2397.
Goff DC Jr, Gerstein HC, Ginsberg HN _et al_ . (2007) Prevention of
cardiovascular disease in persons with type 2 diabetes mellitus:
current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. _American Journal_
_of Cardiology_ **99**, 4i–20i.
Gonzalez CA (2006) The european prospective investigation into
cancer and nutrition (EPIC). _Public Health Nutrition_ **9**, 124–126.



**224** **Nutrition: A Lifespan Approach**


Gonzalez CA, Jakszyn P, Pera G _et al_ . (2006) Meat intake and risk
of stomach and esophageal adenocarcinoma within the European prospective investigation into cancer and nutrition (EPIC).
_Journal of the National Cancer Institute_ **98**, 345–354.
Goodlad RA (2001) Dietary fibre and the risk of colorectal cancer.
_Gut_ **48**, 587–589.
Gould AL, Davies GM, Alemao E, Yin DD, and Cook JR (2007)
Cholesterol reduction yields clinical benefits: meta-analysis including recent trials. _Clinical Therapeutics_ **29**, 778–794.
Graham S, Hellmann R, Marshall J _et al_ . (1991) Nutritional epidemiologyofpostmenopausalbreastcancerinwesternNewYork.
_American Journal of Epidemiology_ **134**, 552–566.
Greenberg JA, Fontaine K, and Allison DB (2007) Putative biases in
estimatingmortalityattributabletoobesityin theUS population.
_International Journal of Obesity_ **31**, 1449–1455.
Hales CN and Barker DJ (2001) The thrifty phenotype hypothesis.
_British Medical Bulletin_ **60**, 5–20.
He FJ and MacGregor GA (2003) How far should salt intake be
reduced? _Hypertension_ **42**, 1093–1099.
Health Education Authority (1995) _Enjoy Healthy Eating. The Bal-_
_ance of Good Health_ . HEA, London.
Holmes MD, Hunter DJ, Colditz GA _et al_ . (1999) Association of
dietary intake of fat and fatty acids with risk of breast cancer.
_Journal of the American Medical Association_ **281**, 914–920.
Homocysteine Studies Collaboration (2002) Homocysteine and
risk of ischemic heart disease and stroke: a meta-analysis. _Journal_
_of the American Medical Association_ **288**, 2015–2022.
Howe GR, Hirohata T, Hislop TG _et al_ . (1990) Dietary factors and risk of breast cancer: combined analysis of 12 casecontrol studies. _Journal of the National Cancer Institute_ **82**, 561–
569.
HuFB,StampferMJ,MansonJE _etal_ .(2000)Trendsintheincidence
of coronary heart disease and changes in diet and lifestyle in
women. _New England Journal of Medicine_ **343**, 530–537.
Hu FB and Willett WC (2002) Optimal diets for prevention of coronary heart disease. _Journal of the American Medical Association_
**288**, 2569–2578.
Hunter DJ, Spiegelman D, Adami HO _et al_ . (1996) Cohort studies
of fat intake and the risk of breast cancer–a pooled analysis. _New_
_England Journal of Medicine_ **334**, 356–361.
International Obesity Task Force (2007) http://www.iotf.org/
database/index.asp (accessed August 30, 2007).
Jebb SA (2005) Dietary strategies for the prevention of obesity.
_Proceedings of the Nutrition Society_ **64**, 217–227.
Johnson IT (2004) Micronutrients and cancer. _Proceedings of the_
_Nutrition Society_ **63**, 587–595.
Kardinaal AF, Kok FJ, Ringstad J _et al_ . (1993) Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC
Study. _Lancet_ **342**, 1379–1384.
Keli SO, Hertog MG, Feskens EJ, and Kromhout D (1996) Dietary
flavonoids, antioxidant vitamins, and incidence of stroke: the
Zutphen study. _Archives of Internal Medicine_ **156**, 637–642.
Key TJ, Fraser GE, Thorogood M _et al_ . (1999) Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative
analysis of 5 prospective studies. _American Journal of Clinical_
_Nutrition_ **70**, 516S–524S.
Khaw KT, Bingham S, Welch A _et al_ . (2004) Blood pressure and
urinary sodium in men and women: the Norfolk cohort of the
European prospective investigation into cancer (EPIC-Norfolk).
_American Journal of Clinical Nutrition_ **80**, 1397–1403.
Kim SY, Dietz PM, England L, Morrow B, and Callaghan WM
(2007) Trends in pre-pregnancy obesity in nine states, 1993–
2003. _Obesity_ **15**, 986–993.
Kim YI, Pogribny LP, Salomon RN _et al_ . (1996) Exon-specific
DNA hypomethylation of the _p53_ gene of rat colon induced



by dimethylhydrazine: modulation by dietary folate. _American_
_Journal of Pathology_ **149**, 1129–1137.
Klerk M, Verhoef P, Clarke R _et al_ . (2002) MTHFR 677C– _>_ T polymorphism and risk of coronary heart disease: a meta-analysis.
_Journal of the American Medical Association_ **288**, 2023–2031.
Knekt P, Ritz J, Pereira MA _et al_ . (2004) Antioxidant vitamins
and coronary heart disease risk: a pooled analysis of 9 cohorts.
_American Journal of Clinical Nutrition_ **80**, 1508–1520.
Konings EJ, Goldbohm RA, Brants HA, Saris WH, and Van Den
Brandt PA (2002) Intake of dietary folate vitamers and risk of colorectal carcinoma: results from The Netherlands Cohort Study.
_Cancer_ **95**, 1421–1433.
Kral JG and Naslund E (2007) Surgical treatment of obesity. _Nature_
_Clinical Practice Endocrinology and Metabolism_ **3**, 574–583.
Kushi L and Giovannucci E (2002) Dietary fat and cancer. _American_
_Journal of Medicine_ **113**, 63S–70S.
Lakka HM, Laaksonen DE, Lakka TA _et al_ . (2002) The metabolic
syndrome and total and cardiovascular disease mortality in
middle-aged men. _Journal of the American Medical Association_
**288**, 2709–2716.
Langley-Evans SC (2000) Consumption of black tea elicits an increase in plasma antioxidant potential in humans. _International_
_Journal of Food Science and Nutrition_ **51**, 309–315.
Larsson SC, Bergkvist L, and Wolk A (2006) Processed meat consumption, dietary nitrosamines and stomach cancer risk in a
cohort of Swedish women. _International Journal of Cancer_ **119**,
915–919.
Lashner BA, Provencher KS, Seidner DL, Knesebeck A, and Brzezinski A (1997) The effect of folic acid supplementation on the risk
for cancer or dysplasia in ulcerative colitis. _Gastroenterology_ **112**,
29–32.
Law MR and Morris JK (1998) By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease?
_European Journal of Clinical Nutrition_ **52**, 549–556.
Lawson KA, Wright ME, Subar A _et al_ . (2007) Multivitamin use and
risk of prostate cancer in the National Institutes of Health-AARP
Diet and Health Study. _Journal of the National Cancer Institute_
**99**, 754–764.
Lean ME, Han TS, and Morrison CE (1995) Waist circumference
as a measure for indicating need for weight management. _British_
_Medical Journal_ **311**, 158–161.
Leander K, Wiman B, Hallqvist J, Andersson T, Ahlbom A, and de
Faire U (2007) Primary risk factors influence risk of recurrent
myocardial infarction/death from coronary heart disease: results
from the Stockholm Heart Epidemiology Program (SHEEP). _Eu-_
_ropean Journal Cardiovascular Preventive Rehabilitation_ **14**, 532–
537.
Lee J, Demissie K, Lu SE, and Rhoads GG (2007) Cancer incidence
among Korean-American immigrants in the United States and
native Koreans in South Korea. _Cancer Control_ **14**, 78–85.
Leenen R, Roodenburg AJ, Tijburg LB, and Wiseman SA (2000) A
single dose of tea with or without milk increases plasma antioxidant activity in humans. _European Journal of Clinical Nutrition_
**54**, 87–92.
Le Marchand L, Donlon T, Seifried A, and Wilkens LR (2002)
Red meat intake, CYP2E1 genetic polymorphisms, and colorectal
cancer risk. _Cancer Epidemiology, Biomarkers and Prevention_ **11**,
1019–1024.
Lewin MH, Bailey N, Bandaletova T _et al_ . (2007) Red meat enhances
the colonic formation of the DNA adduct O6-carboxymethyl
guanine: implications for colorectal cancer risk. _Cancer Research_
**66**, 1859–1865.
Loh JT, Torres VJ, and Cover TL (2007) Regulation of Helicobacter
pylori cagA expression in response to salt. _Cancer Research_ **67**,
4709—4715.



Lonn E, Yusuf S, Arnold MJ _et al_ . (2006) Homocysteine lowering
with folic acid and B vitamins in vascular disease. _New England_
_Journal of Medicine_ **354**, 1567–1577.
Look AHEAD Research Group, Pi-Sunyer X, Blackburn G _et al_ .
(2007) Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the
look AHEAD trial. _Diabetes Care_ **30**, 1374–1383.
Malik VS and Hu FB (2007) Popular weight-loss diets: from
evidence to practice. _Nature Clinical Practice, Cardiovascular_
_Medicine_ **4**, 34–41.
Malinow MR, Duell PB, Hess DL _et al_ . (1998) Reduction of plasma
homocyst(e)ine levels by breakfast cereal fortified with folic acid
in patients with coronary heart disease. _New England Journal of_
_Medicine_ **338**, 1009–1015.
Mazhar D and Waxman J (2006) Dietary fat and breast cancer.
_Quarterly Journal of Medicine_ **99**, 469–473.
McIntyre EA and Walker M (2002) Genetics of type 2 diabetes
and insulin resistance: knowledge from human studies. _Clinical_
_Endocrinology_ **57**, 303–311.
Misra A and Ganda OP (2007) Migration and its impact on adiposity and type 2 diabetes. _Nutrition_ **23**, 696–708.
Moat SJ, Lang D, McDowell IF _et al_ . (2004) Folate, homocysteine,
endothelial function and cardiovascular disease. _Journal of Nu-_
_tritional Biochemistry_ **15**, 64–79.
National Health Service (2007) Five-a-day campaign. http://www.
5aday.nhs.uk/ (accessed September 2007).
Neel JV (1962) Diabetes mellitus: a “thrifty” genotype rendered
detrimental by “progress”? _American Journal of Human Genetics_
**14**, 353–362.
NICE (2008) Clinical Guideline 66. Type 2 diabetes: National clinical guideline for management in primary and secondary care
(update). http://www.nice.org.uk (accessed January 19, 2009).
NICE(2007)Clinicalguidelinesfortype2diabetes.http://guidance.
nice.org.uk/page.aspx?o=36881 (accessed September 2007).
Nield L, Moore H, Hooper L _et al_ . (2007) Dietary advice for treatment of type 2 diabetes mellitus in adults. _Cochrane Database of_
_Systematic Reviews_ CD004097.
OmennGS,GoodmanGE,ThornquistMD _etal_ .(1996)Riskfactors
for lung cancer and for intervention effects in CARET, the BetaCaroteneandRetinolEfficacyTrial. _JournaloftheNationalCancer_
_Institute_ **88**, 1550–1559.
Patel JV, Vyas A, Cruickshank JK _et al_ . (2006) Impact of migration
on coronary heart disease risk factors: comparison of Gujaratis
in Britain and their contemporaries in villages of origin in India.
_Atherosclerosis_ **185**, 297–306.
Peters U, Poole C, and Arab L (2001) Does tea affect cardiovascular
disease? A meta-analysis. _American Journal of Epidemiology_ **154**,
495–503.
Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J, and
RIO-North America Study Group (2006) Effect of rimonabant, a
cannabinoid-1 receptor blocker, on weight and cardiometabolic
risk factors in overweight or obese patients: RIO-North America:
a randomized controlled trial. _Journal of the American Medical_
_Association_ **295**, 761–775.
Popkin BM (2007) Understanding global nutrition dynamics as a
steptowardscontrollingcancerincidence. _NatureReviewsCancer_
**7**, 61–67.
Porcelli B, Frosi B, Rosi F _et al_ . (1996) Levels of folic acid in plasma
and in red blood cells of colorectal cancer patients. _Biomedical_
_Pharmacotherapeutics_ **50**, 303–305.
Powers HJ (2005) Interaction among folate, riboflavin, genotype,
and cancer, with reference to colorectal and cervical cancer. _Jour-_
_nal of Nutrition_ **135**, 2960S–2966S.
Prentice AM and Jebb SA (1995) Obesity in Britain: gluttony or
sloth? _British Medical Journal_ **311**, 437–439.



**The Adult Years** **225**


Raitakari OT, Salo P, and Ahotupa M (2007) Carotid artery compliance in users of plant stanol ester margarine. _European Journal_
_of Clinical Nutrition_ **62**, 218–224.
Ramsay SE, Whincup PH, Morris RW, Lennon LT, and Wannamethee S (2007) Are childhood socio-economic circumstances related to coronary heart disease risk? Findings from
a population-based study of older men. _International Journal of_
_Epidemiology_ **36**, 560–566.
Rehm J, Patra J, and Popova S (2007) Alcohol drinking cessation
and its effect on esophageal and head and neck cancers: a pooled
analysis. _International Journal of Cancer_ **121**, 1132–1137.
Rich SS (1990) Mapping genes in diabetes. Genetic epidemiological
perspective. _Diabetes_ **39**, 1315–1319.
Roche HM, Phillips C, and Gibney MJ (2005) The metabolic syndrome: the crossroads of diet and genetics. _Proceedings of the_
_Nutrition Society_ **64**, 371–377.
Sacks FM, Svetkey LP, Vollmer WM _et al_ . (2001) Effects on blood
pressure of reduced dietary sodium and the Dietary Approaches
to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. _New England Journal of Medicine_ **344**, 3–10.
Sharp L and Little J (2004) Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. _Amer-_
_ican Journal of Epidemiology_ **159**, 423–443.
Shaw K, Gennat H, O’Rourke P, and Del Mar C (2006) Exercise for
overweight or obesity. _Cochrane Database of Systematic Reviews_
CD003817.
Slavin J (2003) Why whole grains are protective: biological mechanisms. _Proceedings of the Nutrition Society_ **62**, 129–134.
Smith-Warner SA, Spiegelman D, Yaun F _et al_ . (1998) Alcohol and
breast cancer in women: a pooled analysis of cohort studies.
_Journal of the American Medical Association_ **279**, 535–540.
Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, and
Mitchinson MJ (1996) Randomised controlled trial of vitamin E
in patients with coronary disease: Cambridge Heart Antioxidant
Study (CHAOS) _Lancet_ **347**, 781–786.
Taylor EF, Burley VJ, Greenwood DC, and Cade JE (2007) Meat consumption and risk of breast cancer in the UK Women’s Cohort
Study. _British Journal of Cancer_ **96**, 1139–1146.
Toomey S, Roche H, Fitzgerald D, and Belton O (2003) Regression
of pre-established atherosclerosis in the apoE-/- mouse by conjugated linoleic acid. _Biochemical Society Transactions_ **31**, 1075–
1079.
Turner PC, Sylla A, Gong YY _et al_ . (2005) Reduction in exposure to
carcinogenic aflatoxins by postharvest intervention measures in
west Africa: a community-based intervention study. _Lancet_ **365**,
1950–1956.
UKPDS (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk
of complications in patients with type 2 diabetes (UKPDS 33).
UK Prospective Diabetes Study (UKPDS) Group. _Lancet_ **352**,
837–853.
USDA (2005) My Pyramid. http://www.mypyramid.gov/ (accessed
September 2007).
Vogels N and Westerterp-Plantenga MS (2007) Successful longterm weight maintenance: a 2-year follow-up. _Obesity_ **15**, 1258–
1266.
Weisell RC (2002) Body mass index as an indicator of obesity. _Asia_
_Pacific Journal of Clinical Nutrition_ **11**, S681–S684.
WillettWC(1990)Epidemiologicstudiesofdietandcancer. _Progress_
_in Clinical and Biological Research_ **346**, 159–168.
Willett WC (2001) Diet and breast cancer. _Journal of Internal_
_Medicine_ **249**, 395–411.
Willett WC (2003) Lessons from dietary studies in Adventists and
questions for the future. _American Journal of Clinical Nutrition_
**78**, 539S–543S.



**226** **Nutrition: A Lifespan Approach**


World Cancer Research Fund (1997) Food, nutrition and the
prevention of cancer: A global perspective. http://www.wcrf-uk.
org/report/index.lasso?-session=WCRFUK:80F3DC2A144a319223YxJ1857262 (accessed, August 31, 2007).
World Health Organization (2000) _Obesity: Preventing and Man-_
_aging the Global Epidemic_ . _Report of a WHO Consultation_ . WHO


**Self-Assessment Questions**


Assess your understanding of the concepts outlined in
this chapter using the following questions:


1 Describe basic guidelines for healthy eating in adults.
~~Explain different approaches that have been used to~~
communicate these guidelines to populations.
2 How might obesity be treated in adults?
3 Improving folic acid status in populations may reduce
the prevalence of cardiovascular disease. What is the
most likely mechanistic basis for this beneficial association?



Technical Report Series No. 894. World Health Organization,
Geneva.
You WC, Brown LM, Zhang L _et al_ . (2006) Randomized doubleblind factorial trial of three treatments to reduce the prevalence
of precancerous gastric lesions. _Journal of the National Cancer_
_Institute_ **98**, 974–983.


4 Dietary fats are important mediators of coronary heart
disease risk. Explain the influence that fat intake has
upon cholesterol transport and atherosclerosis.
5 What are the major nutrition-related factors that in~~crease risk of cancer?~~
6 In the context of preventing cancer and coronary heart
disease, which is more effective: consuming antioxidant supplements or increasing intakes of natural
sources of antioxidant nutrients?



# **9**
### **Nutrition, Aging, and the Elderly**

**Learning objectives**



By the end of this chapter, the reader should be able to:


r Show an awareness of the changing demographic profile of the population and the impact that the aging
population will have on global trends in health and
~~disease.~~
r Describe the process of cellular aging and how this
contributes to physiological decline.
r Appreciate the differing theories that explain the mechanistic basis of cellular senescence.

r Describe how changes in nutrition, particularly caloric
restriction, may impact upon aging and longevity.


**9.1 Introduction**


The elderly population are generally considered to be
those individuals who are aged 65 and over. As will
be described below, the elderly population is rapidly
growing in almost all parts of the world, and with the
increase in the numbers of elderly people, the specific
nutrition-related problems of the elderly years take on
greater significance in terms of health care and health
resources. It is important, however, to avoid stereotypes of elderly people as being frail, mentally incapable, dependent on others, and plagued by chronic
disease. Although elderly patients will make up a high
proportion of the population in hospital and receivinglong-termmedicalcare,thevastmajorityofelderly
peoplearehealthy,freeliving,andactive.However,the
elderly years are inevitably the years of decline and ultimately aging. The development of disease and the
loss of physiological functions will lead to death. This
chapter will discuss the biological processes that are
responsible for aging and the degeneration of physiological systems that is associated with the elderly years.
It will consider the particular nutrient requirements
that accompany this life stage and describe some of
the main nutrition-related problems of the elderly.



r Discuss the energy, macronutrient, and micronutrient
requirements of the elderly population, and how these
differ with the younger adult population.
r Show an appreciation of the fact that the elderly are
at significant risk of malnutrition and the factors that
~~contribute to this risk.~~
r Describe the nutrition-related disorders of the elderly
and the interrelationship between malnutrition and
chronic disease.
r Discuss the role of specific nutrients, including vitamin
D, calcium, folic acid, and vitamin B12 in the etiology
and prevention of conditions including osteoporosis,
anemia, and dementia.


**9.2 The aging population**


Average life expectancy varies considerably between
nations ranging from 33 years for men and 36 for
women in Swaziland through to 78 years for men and
85 for women in Japan (World Health Organization,
2007). In the UK, average life expectancy at birth for
men was 76 years in 2007 and 81 for women. This
represents a remarkable shift, typical of all developed
countries, as in 1900, life expectancy at birth was only
45.7 years for men and 49.6 years for women. Since
1840, life expectancy in the UK has increased by approximately 0.25 years every year.
As shown in Figure 9.1, the number of elderly people is increasing rapidly all over the world, and the
United Nations estimate that almost two billion people will be aged over 60 by 2050. These increases are
most marked in the developing regions, but even in
developed countries such as the UK significant demographic shifts are taking place. While the proportion
of the UK population aged 65–74 has not changed
markedly since the mid-1940s (approximately 7.5%
of the population), the overall proportion of elderly
people in the population has increased greatly, as increasing numbers are living on beyond 75 years. In



**228** **Nutrition: A Lifespan Approach**


~~World~~


~~More developed regions~~


~~Less developed regions~~


~~Less developed countrie~~ s


**2.5**


**2.0**


**1.5**


**1.0**


**0.5**


**0.0**

**1980** **2000** **2020** **2040** **2060**


**Year**


**Figure 9.1** Global demographic trends show that the elderly population is rising. Increases in the proportion of the population over the
age of 65 years in the developing world will drive a major demographic
shift over the next four decades.


1948, 8.5% of the UK population was over 65. By
2036, this figure is expected to have risen to 24.1%,
with almost 5% of the population being 85 years or
over. Shifts in the balance between younger and older
members of the population have important implications for health and health resources. While UK men
and women live for three decades longer than their
counterparts a hundred years ago, the extra life is not
necessarily healthy life, and for men, there are likely to
be 14 years, and for women, 17 years of chronic illness
in the final years of life.


**9.3 The aging process**


_**9.3.1 Impact on physiological systems**_


Aging brings about a progressive decline in the functioning of all organs and systems. The function of
the gastrointestinal tract is particularly vulnerable to
the negative effects of aging. Loss of teeth throughout
life means that many elderly people will rely on dentures, which provide reduced power to masticate food.
Periodontal disease afflicts many elderly people and
contributes to further tooth loss. Reductions in sali
vary flow reduce the sense of taste and make it more
difficult to swallow food. Production of stomach acid
is reduced and this impacts upon the bioavailability



of several nutrients including folic acid, vitamin B6,
vitamin B12, and iron. Lower down the tract, bacterial
overgrowth of the small intestine limits nutrient uptake, and losses of colon motility lead to constipation
and diverticular disease.
Some organs progressively lose function due to reductions in the numbers of functional units. For ex
ample, in the lungs, alveolar numbers fall with aging
and this reduces vital capacity and makes it harder
for the elderly to partake in vigorous exercise. In
the kidneys, loss of nephrons contributes to declining homeostatic functions, which can drive problems
with fluid balance and lead to higher blood pressure.
Skeletal mass is also lost with age, lean body mass declines, and fat mass tends to increase. These changes
in body composition can increase the propensity of
older people to fall and sustain injury, as the loss of
lean body mass is generally a product of sarcopenia.
Loss of skeletal muscle is not only partly driven by
physical inactivity and decreased use of muscles, but
may also be attributable to impairments of the central
nervous system innervation of muscles, to declining
concentrations of sex steroids and growth hormone,
and to reduction in muscle contractility.
Immune function also declines in the elderly, with
both cellular immunity and passive immunity (e.g.,
the skin barrier to infection) being compromised.
The general level of chronic illness is also at its greatest within this group in the population, who are the
most likely group in modern society to require longterm medication, or to be hospitalized. In addition
to these physical manifestations of aging, there may
also be psychological and cognitive changes, including
depression and dementia. Sensory impairments also
accumulate with aging, including loss of taste, smell,
sight, and hearing.


_**9.3.2 Mechanisms of cellular senescence**_


The decline in physiological function and general degeneration of organs and systems that occurs during
aging is the physical manifestation of processes taking place at the cellular level. It is erroneous to believe that aging is the product of programmed cell
death (apoptosis), as in fact most cells enter a phase
of senescence or quiescence and can remain in that
state for a considerable period of time before their destruction via apoptotic pathways. The accumulation
of senescent cells will impact upon the functions of
organs and tissues with aging, as generally these cells



M phase corresponds
to all stages of mitosis



**Nutrition, Aging, and the Elderly** **229**


G1 corresponds to the earliest
stages of interphase in mitosis.







G0 is a resting
or “gap” stage.
G0 cells are
not dividing
cells











**Figure 9.2** The mammalian cell cycle.


have altered phenotypes. Although they retain their
differentiated state they will tend to under- or overexpress the enzymes, receptors, cell-signaling proteins,
and adhesion molecules that are necessary for their
normal function (Campisi, 1997). All tissues contain
stem cells. These are undifferentiated cells that have
the capacity to divide and replenish cells that have
been destroyed or entered a state of senescence. With
aging, the capacity of the stem cells to regenerate tissues and restore tissue function becomes outstripped
by the number of cells entering the senescent stage,
and hence functional capacity declines.
All mammalian cell types, like those of lower organisms, have the capacity to divide through the process of mitosis. Indeed, all cells will be at one of the
stages in the cell cycle shown in Figure 9.2, and if
they have sufficient energy and nutrients, they will
continue to divide, at varying rates until they reach



the Hayflick limit. This limit is a set number of divisions, at which point the cell enters the senescent stage
and is permanently arrested in the G1 phase of the
cycle. With the exception of stem cells, tumor cells,
and the germ line cells that give rise to gametes, all
mammalian cells will undergo senescence once they
have completed their maximal number of cell divisions (Campisi, 1997). All eukaryotic cells, with the
exception of some single-celled organisms appear to
have this trait. It is now widely recognized that this
control over cell division is essentially a tumor suppressor function and in fact the processes that lead to
senescence and age-related degeneration are processes
that prevent cancer formation (Collado _et al_ ., 2007).
The precise mechanisms through which senescence is
induced are not fully understood, but it appears that
three basic processes are involved, as summarized in
Figure 9.3.



**230** **Nutrition: A Lifespan Approach**















**9.3.2.1 Oxidative senescence**

As described in Chapter 8, DNA is highly vulnerable
todamagethroughtheactionsoffreeradicals,reactive
oxygen species (ROS), ionizing radiation, and other
environmental factors. While mutation and cancer is
one possible outcome of this damage, aging may also
be driven by the same oxidative processes. The production of ROS is continuous throughout the lifespan
since the formation of superoxide radicals and subsequently hydrogen peroxide is a normal feature of
aerobic respiration. However, the rates of ROS formation appear to increase with aging and this results in
greater levels of damage to all macromolecules within
the cell, including DNA (Sohal _et al_ ., 2002). Increasing ROS formation may be a consequence of damage to the mitochondria, which are the main sources
of the ROS. Some researchers argue that mutations
of mitochondrial DNA may be mechanistically important in aging, but it is unlikely that this plays
more than a minor role in the process (Sohal _et al_ .,
2006).
A role for oxidative processes in driving aging has
been demonstrated using transgenic mammalian and
insect models. For example, _Drosophila_ carrying extra
copies of genes encoding antioxidant enzymes have
a longer lifespan (Sohal _et al_ ., 2002). Mice lacking
superoxide dismutase 1 have reduced lifespan and
mice that overexpress catalase specifically within mi


**Figure 9.3** The drivers of cellular aging. Accumulated DNA damage, including telomere shortening, activates senescence via the p53 tumor suppressor gene.
The INK4a/ARF axis also has the capacity to trigger

senescence.


tochondria have extended longevity (Muller _et al_ .,
2007). However, these animal studies do not correlate well with the normal in vivo situation, particularly in humans. Measurements of the levels of
antioxidant protection in tissues of different species
do not appear to relate to their lifespan, or other
markers of aging. Importantly, interventions that extend longevity, such as caloric restriction (see Section 9.2.3) have no impact upon tissue antioxidant

status.

Although antioxidant capacity is not a strong predictor of patterns of aging, the oxidative damage theory is still considered to be of importance. Any ROSmediateddamagetoDNAislikelytoberepairedunder
normal conditions, and it is only in the older organism, where the capacity for repair is declining, that
oxidative damage will begin to accumulate. It is clear
that genomic instability (a loss or corruption of information carried in DNA) is a feature of aging. There are
a number of premature aging syndromes, caused by
rare mutations, that are associated with genomic instability, including xeroderma pigmentosa and ataxia
telangiectasia. An imbalance between the level of oxidative damage to DNA and the capacity to repair
that DNA might contribute to this instability (Muller
_et al_ ., 2007). The importance of these processes in
individuals that do not have these rare mutations is

unclear.



**9.3.2.2 The role of p53 activation**
p53 is a transcription factor that regulates the cell
cycle. During normal cellular function, it is in an inactive state, being bound to the protein product of the
Hdm2 (human double minute 2) oncogene. Cell cycle
abnormalities, as seen in tumor cells, or DNA damage
will result in the activation of p53 and this activation
will result in one of two possible outcomes, senescence
or cell death. In younger organisms, levels of p53 activation tend to be lower than in older organisms and
p53 essentially functions as a mechanism that allows
damaged cells to be eliminated from healthy tissues
and replaced by stem cells. In older animals, high levels of p53 activation mean that the capacity to replace
and regenerate damaged tissue is insufficient to avoid
loss of physiological function (Collado _et al_ ., 2007).
Programmed cell death, or apoptosis, is driven by
p53 through influences on the Bcl2 and Bax proteins. Bcl2 is anti-apoptotic and is downregulated by
p53, while the pro-apoptotic Bcl2-associated X protein (Bax) is upregulated by p53. One of the actions of
Bax is to increase the permeability of mitochondrial
membranes. Leakage of material from the mitochondrial matrix results in the activation of the caspase
system, which brings about cell death.
Senescence is driven by the activation of p53, as this
protein is a key factor determining progress of the cell
from the G1 to the S phase of the cell cycle (Figure 9.2).
If cells become arrested at this G1/S checkpoint, then
division will not occur until the DNA damage that initially activated p53 is repaired. It appears reasonable
to suggest that in the aging organism, the capacity to
repair DNA damage may be outstripped by the level
of oxidative processes and hence the arrest of the cell
cycleispermanent.However,amoreimportantmechanism may ensure that p53-mediated cell cycle arrest
cannot be overcome once the Hayflick limit has been
reached. Cells have an inbuilt “counter” or “clock”

that measures divisions, in the form of telomeres.


**9.3.2.3 Telomere shortening**
Telomeres are the regions of DNA that lie at the ends
of the linear chromosomes in mammalian cells. They
consist of long repeats of the base sequence TTAGGG
and have important cellular functions, in that they
prevent fusions between chromosomes, translocation
of DNA from one chromosome to another, and other
harmful genetic defects. Telomere lengths vary widely
within tissues and may be between 1.5 and 160 kilo


**Nutrition, Aging, and the Elderly** **231**


bases. Many studies have shown that the length of
telomeres shortens with aging and there is a clear inverse association between age and telomere length in
human and animal tissues.

Telomeres provide the principal aging clock within
cells as they shorten each time the cell divides (Figure
9.4). This is because the DNA polymerases that replicateDNAduringtheSphaseofthecellcycleareunable
to faithfully copy the ends of linear DNA. The enzyme
telomerase can replace some of the lost length, but
as most mammalian cells have only low telomerase
activity, the 3‘ end of the telomeres is shortened with
each replication. (Collado _et al_ ., 2007). Shortening
of the telomeres to a critical length triggers p53 activation. This initiation of processes that result in cell
cycle arrest or apoptosis, most likely occurs as telomere shortening to critical levels, is recognized as a form
of DNA damage (Campisi, 1997).
In addition to providing the equivalent of a countdown of the number of possible cell divisions remaining, telomere shortening may be a component of oxidative senescence. Experiments with cultured cells
show that incubating them at low oxygen concentrations (3% O 2 instead of the usual atmospheric 21%
O 2 ) increases the Hayflick limit and suppresses senescence. This suggests that under normal conditions,
oxidative processes might cause damage to the telomeres and drive a more rapid shortening. There is some
evidence that telomeric DNA is more vulnerable to
oxidative damage than other regions of the chromosomes (Muller _et al_ ., 2007).


**9.3.2.4 The INK4a/ARF axis**
INK4a and ARF are tumor suppressor proteins that
are encoded by a single gene locus (p16INK4). Like
other tumor suppressors, these proteins are known
to have a pro-aging influence by virtue of their ability to prevent cell division. Studies of cells in culture
show that increased expression of the p16INK4 locus
will promote senescence, even if the cells have raised
activities of telomerase and long telomeres (Collado
_et al_ ., 2007). This indicates that the INK4a/ARF axis
can override the telomere clock, and it is suggested
that these proteins provide a second form of counter
that monitors the number of exposures a cell has to
mitogenic agents.
INK4a appears to contribute to the physiological signs of aging by promoting the accumulation
of senescent cells within tissues, and by opposing



**232** **Nutrition: A Lifespan Approach**











**Figure 9.4** Telomere shortening is a key controller of cell division. Each mitotic division leads to loss of telomeric DNA. At critical shortening,
this is recognized as DNA damage and leads to apoptosis or senescence through activation of p53.



regeneration of tissues by stem cells. Mice that lack
p16INK4 have been shown to possess an increased
capacity for regeneration (Janzen _et al_ ., 2006). In tissues from aged rodents and humans, the expression of
p16INK4 can be shown to be related to age, which is
in keeping with the suggestion that INK4a/ARF somehow drives the aging process. It is not clear why expression of p16INK4 increases with age, but it may be
that oxidative damage, or age-dependent expression
of transcriptional regulators, are responsible (Collado
_et al._, 2007).


_**9.3.3 Nutritional modulation of the aging**_

_**process**_


The long-lived nature of humans and the major difficulties of performing intervention studies that can go
on for decades in order to assess the impact of nutritional factors upon the aging process mean that most
studies of nutrition and aging have been performed
using animal models. A wide variety of model systems
are used including rats and mice and simpler organisms including the fruit fly _Drosophila melanogaster_
and the nematode _Caenorhabditis elegans_ .



**9.3.3.1 Caloric restriction and lifespan**
It was first reported in 1935 that feeding rats a diet
of reduced caloric content throughout their lives, significantly extended their lifespan. Generally speaking,
in mammalian models, protocols that reduce caloric
intake by 60% will increase lifespan by approximately
30–40%, although in extreme cases, the extension of
longevity is closer to 50%. The same effects on lifespan
are reported in yeast cells, _Drosophila_ and _C. elegans_ .
In rodents, in addition to the extension of lifespan,
the caloric restriction (CR) protocol reduces the occurrence and extent of age-related diseases, including
cancer, cardiovascular disease, diabetes, autoimmune
disorders, and neurodegenerative problems (Young
and Kirkland, 2007). Studies of nonhuman primates
suggest similar benefits are seen with CR in those
species and this raises the exciting possibility that human aging might be countered by CR.
The mechanism through which CR extends lifespan is not fully understood as animals that undergo
CR protocols exhibit a wide range of metabolic, endocrine, and physiological changes. In the early stages
of CR, animals are in a state of negative energy balance and, in response, reduce their metabolic rate.



Basal metabolic rates are rapidly reset and energy
balance is maintained largely through lower thermogenic capacity, resulting in a lower body temperature. Body mass is lost, and the animal maintained
on CR has lower lean and fat mass. Although potentially of importance, the prevention of obesity is
not, however, the sole mechanism through which
health benefits and increased longevity accrue (Speakman and Hambly, 2007). CR induces major changes
in endocrine axes, upregulating the hypothalamic–
pituitary–adrenal axis and suppressing production of
insulin, the thyroid hormones, sex hormones, and the
somatotropic hormones (Dirks and Leeuwenburgh,
2006). At the cellular level, CR suppresses inflammatory processes and oxidative stressors, while at the
same time upregulating systems involved in repair and
protein synthesis.
The extension of lifespan by CR in rodents is highly
dependent upon the level of restriction and upon the
timing of the introduction of the protocol. Maximal
extension of lifespan is noted when rodents are fed
only 35% of normal _ad libitum_ intakes and CR is most
effective when introduced immediately after weaning. Rodent studies show that introducing CR later
in life has a greatly attenuated effect, or may not alter longevity at all. Speakman and Hambly (2007)
used available data on rats and mice to model the
anticipated benefits of CR in humans, making the assumption that humans and rodents would respond in
a similar manner. On this basis, introducing a 30%
CR at 16 years of age would add 11 years to life, while
introducing CR at age 47 would extend life by less
than 3 years.
Estimates such as this provide almost all that is
known about the potential impact of CR in humans
as there are no robust studies of populations that practice this behavior. There are some groups that attempt
CR in the hope that it will extend life and the indications are that following a restricted diet for 3–15
years does improve markers of cardiovascular disease
risk (Fontana _et al_ ., 2004). The population of Okinawa in Japan is renowned for its longevity, having
remarkably low death rates among middle-aged men
and women and the highest density of centenarians
in the world. The Okinawan diet is believed to underlie this and is suggested to be similar to the CR diet
protocol used with rodents, being nutrient dense and
lower in energy than the diet consumed elsewhere in
Japan (Dirks and Leeuwenburgh, 2006).



**Nutrition, Aging, and the Elderly** **233**


Despite these observations that appear to lend support to the idea that human CR might be beneficial in
aging and avoidance of age-related disease, considerable caution is needed in translating the data from CR
studies in animals into humans. CR in humans would
certainly have a number of adverse health effects that
would offset many of the benefits. It is clear that CR
would promote weight loss and excessive weight loss,
andBMIoflessthan20isassociatedwithmenstrualirregularities and infertility, osteoporosis, poor wound
healing, and reduced capacity to metabolize drugs and
toxins. Underweight is also associated with impaired
immunity and hence excess levels of illness and reduced capacity for work. Mortality associated with
all causes and in particular cardiovascular disease has
been shown to increase when comparing BMI of less
than 20 with BMI in the optimal range (RomeroCorral _et al_ ., 2006). CR is also likely to result in depression and other psychological disorders (Dirks and
Leeuwenburgh, 2006).


**9.3.3.2 Fetal programming of lifespan**
In contrast to CR in postnatal life, manipulations of
the diet during early development appears to program shorter lifespan. The feeding of maternal lowprotein diets, without CR, during rat pregnancy significantly reduced the lifespan of the offspring (AihieSayer _et al_ ., 2001), and similar observations in mice
indicate that this programming of lifespan is exacerbated by feeding an obesity-inducing diet in postnatal life (Ozanne and Hales, 2004). The mechanism
through which this programming occurs has not been
fully elucidated but appears to involve both oxidative
processes and more rapid telomere shortening in key
tissues such as the liver (Langley-Evans and Sculley,
2006) and kidney (Jennings _et al_ ., 1999).


**9.3.3.3 Supplementary antioxidants**
Although it is well established that in cardiovascular
disease and cancer (see Chapter 8), supplemental intakes of antioxidants are ineffective or even harmful to

health, there is sufficient interest in the concept of oxidative senescence to merit experiments that consider
the impact of increasing intakes of antioxidants on aging processes. Much attention has focused on ascorbic
acid as a potential inhibitor of aging processes, given
that it is water soluble and that it is one of the most
potent scavenging antioxidants in vivo. Studies of the
effects of ascorbic acid upon longevity in rodents



**234** **Nutrition: A Lifespan Approach**


have proven inconclusive and while Massie and colleagues (1984) reported that lifelong supplementation
with ascorbic acid increased lifespan in mice, Selman
_et al_ . (2006) found no benefits associated with a similar protocol.
It is oversimplistic to assume that supplementing
with a single nutrient could have any real benefit in
extending lifespan, since cellular senescence and the
associated tissue degeneration occur through multiple mechanisms and are the products of the balance
between pro-aging and anti-aging processes, and between cellular damage and repair. Selman _et al_ . (2006)
noted that supplementing mice with ascorbate apparently had no impact upon levels of oxidative injury
within cells, but downregulated genes associated with
ROS scavenging and repair processes. It seems likely
that any benefit attained by providing greater antioxidant protection from the diet was offset by downregulation of endogenous systems. On this basis, antioxidant therapy to increase longevity appears unlikely to
succeed.


**9.4 Nutrient requirements of the elderly**


_**9.4.1 Macronutrients and energy**_


As shown in Table 9.1, the requirement for energy declineswithaging,reflectingtypicallylowerlevelsofenergy expenditure through physical activity and a fall in


**Table 9.1** Dietary reference values (UK) for energy and protein


EAR RNI

Energy (MJ/day) Protein (g/day)


Males 19–49 years 10.6
50–59 years 10.6
60–64 years 9.93
65–75 years 9.71
75+ years 8.77
19–50 years 55.5
50+ years 53.3


Females 19–49 years 8.1
50–59 years 8.0
60–64 years 7.99
65–75 years 7.96
75+ years 7.61
19–50 years 45.0
50+ years 46.5


EAR, Estimated Average Requirement; RNI, Reference
Nutrient Intake.



basal metabolic rate. The latter is largely attributable
to a loss of lean body tissue that is seen in most elderly
people. Generally, there are no other major changes
in the macro- or micronutrient requirements of this
population, and although protein requirements, for
men at least, fall slightly with age, the percentage of
energy derived from protein remains relatively unchanged with aging. With a lower energy requirement
and unchanged, or in some cases increased, requirements for other nutrients, the optimal diet for the
elderly needs to be nutrient dense.


_**9.4.2 Micronutrients**_


There are few micronutrients recognized within the
dietary reference values of westernized countries, as
being required by the elderly at greater levels of intake (Department of Health, 1999). This is surprising
given the high levels of malnutrition and nutrient
deficiency observed in this population and the high
prevalence of chronic disease states that lead to micronutrientmalabsorption.Theassignmentofdietary
reference values that are similar to those for younger
adults reflects the fact that dietary reference values are
derived for healthy populations and that they were
determined from relatively sparse data on the elderly.
There are a number of nutrients where, despite there
being no special requirement set for the elderly, special care to maintain intake at an optimal level may be
worthwhile. Vitamin B6, for example, has been set a
RNI value of 15 µg/g protein/day for both men and
women aged 19–50 and over 50 years. This reference
value reflects requirements extrapolated from studies
of younger people. However, in the elderly, vitamin
B6 may be of additional importance in maintaining
immune function, so demands may be greater than
the dietary reference values suggest. Vitamin C (RNI
40mg/day)intakesshouldbecomfortablymaintained
by most elderly individuals, and therefore positively
contribute to absorption of iron. However, in institutionalized settings where bulk food preparation and
delivery systems necessitate maintaining food at high
temperatures for long periods of time, actual intakes
of ascorbate may be suboptimal. Consideration of potential raw sources of this nutrient is therefore rele
vant.


_**9.4.3 Specific guidelines for the elderly**_

There are few specific guidelines for the nutrition
of elderly people, since in general this population is



advised to follow a healthy balanced diet, as at earlier
stages of adulthood. Mild–moderate physical activity
is considered to be an important element of a healthy
lifestyle for the elderly, since activities such as walking, climbing stairs, and gardening are sufficient to
increase appetite and contribute to maintenance of
bone health.

In the UK and the US, the few specific recommendations that have been made regarding intakes of elderly people relate to a narrow range of nutrients. In
both countries, it is recommended that the elderly
increase intakes of vitamin D either through supplementation (10 µg/day) or by increasing intakes of
fortified margarines and other sources. In the US, it
is recommended that the over-50s increase their intakes of vitamin B12 through supplementation with
2.4 µg/day to offset declining absorption of this micronutrient. Dehydration is considered to be an important issue for the elderly as fluid intakes are often
poor. This may not only be partly due to declining
physiological control of the thirst center and fluid
homeostasis, but can also come from concerns about
urinary incontinence. Dehydration can contribute to
mental confusion, headaches, and irritability. The elderly are recommended to consume 1.5 L of fluid per
day (excluding alcoholic beverages).
Maintaining the desired nutrient density for this
age group might best be achieved by encouraging a
diet that is rich in whole grain and nutrient-enriched
breads, pasta, and cereals. Using these foods to replace
refined grains helps to maintain intakes of B vitamins.
The elderly should favor deeply pigmented fruits and
vegetables to maximize intakes of folate and antioxidant nutrients. In keeping with guidelines to prevent
cardiovascular disease, choosing low-fat dairy options
also maximizes intakes of calcium. Fiber is an important element of the diet in order to optimize bowel
function. However, wheat bran should be avoided due
to the presence of phytates that impede the absorption
of iron, calcium, and zinc.
Older adults tend to consume less food overall

than the younger population. However, the burden of
chronic diseases such as cardiovascular disease, osteoporosis, and gastrointestinal disorders means that for
some in this population, energy and protein requirements are actually increased. As individuals with these
chronic diseases make up a high proportion of the
population within long-term institutional care (e.g.,
nursing homes), there are major challenges in pro


**Nutrition, Aging, and the Elderly** **235**


viding high-quality nutrition in these settings. As a
diet rich in complex carbohydrate is bulky, attaining
both the extra energy requirement and nutrient intake in frail elderly patients might best be achieved by
increasing intakes of fat-rich foods.


**9.5 Barriers to healthy nutrition in the**
**elderly**


_**9.5.1 Malnutrition and the elderly**_


In 2001, the Malnutrition Action Group carried out a
survey of nutritional status among the elderly population of the UK. They identified high levels of malnutrition, affecting 14% of the over-65s (potentially
1.26 million people), with marked regional differences. Up to 20% of the elderly population of the
northwest were malnourished, and people living in
the north of England were 71% more likely to be malnourished than those in the south. It was estimated

that this level of malnutrition would be associated
with major ill health, costing the National Health Service up to £ 4 billion every year. These are problems
seen in all developed countries and Brownie (2006)
estimated that while the prevalence of malnutrition
among the free-living elderly is between 5–10%, malnutrition is rife among the institutionalized elderly,
affecting 30–65% of those in old peoples’ homes or in
hospital and at least 85% of those in nursing homes.
Some of these figures appear rather high in the face
of other evidence from Stratton and Elia (2006), who
reported that protein–energy malnutrition was observed in 13.9% of a British elderly population, with
a prevalence of 12.5% in free-living individuals, and
20.8% in institutionalized people. Suominen and colleagues (2005) reported that among elderly people
living in Finnish nursing homes, 29% were malnourished, but two-thirds were at risk of malnutrition.
Despite discrepancies in prevalence figures, it is
clear that being dependent or institutionalized increases risk of malnutrition, and several lines of

evidence show the decline in nutritional status as elderlypeoplelosetheirindependence.Morganandcolleagues (1986) carried out a detailed study of elderly
women either living in their own homes, admitted
to psychogeriatric hospital, attending a day hospital
once or twice a week, living in a long-stay hospital,
or in situations where they were nursed for terminal
illness. Anthropometric indices of nutritional status



**236** **Nutrition: A Lifespan Approach**


**Financial problems** **Poor appetite**



**Difficulty chewing**











**Figure 9.5** Factors leading to protein–energy
malnutrition and its consequences in the elderly
population.


mission and that the majority went on to lose further
weight during their hospital stay due to a failure to
identify nutrition as an issue requiring support.
The consequences of malnutrition are severe as
malnutrition is a cause, as well as an outcome of major illness and trauma. As shown in Figure 9.6, poor
nutritional status resulting from a failure to balance
supply and demand establishes a vicious cycle in the
elderly. Malnutrition promotes infection, which itself
drives and maintains malnutrition. Undernutrition is
a predictor of morbidity and mortality among the elderly. It leads to longer stays in hospital, impaired ability to recover from infections, fractures and surgery,
and is ultimately a major contributor to death. SundLevander _et al_ . (2007) reported that among women
living in nursing homes, survival over a 3-year period
was very strongly related to nutritional status. Similarly, Gariballa and Forster (2007) found that lower
serumalbumin(abiochemicalindicatorofnutritional
status)andlowermid-armmusclecircumferencewere
predictors of increased risk of death over a year following admission to hospital for acute illness (e.g.,
stroke, falls and fractures, septicemia, and chest or
urinary tract infections).


_**9.5.2 Poverty**_


The elderly are a group in the population for whom
poverty is a major risk. The vast majority of elderly
people are retired from full- or part-time employment
and are therefore dependent upon any pension provision built up during the working years, or upon state
benefits. A survey of the 25 member countries of the



(body weight, triceps skinfold, and mid-arm muscle circumference) and biochemical indices (plasma
vitamin C and plasma albumin) all declined in the
dependent groups compared to the free-living individuals. Despite numerous campaigns to improve the
quality of nutrition-related care and support for the
elderly, these trends appear to have persisted over two
subsequent decades. Eastwood and colleagues (2002)
reported that institutionalized elderly had lower energy intakes than their free-living counterparts and
Hirani and Primatesta (2005) reported that elderly
people living in institutions had significantly lower
plasma vitamin D concentrations than those living in
their own homes.

The reasons why the elderly are so vulnerable
to malnutrition are discussed in more detail below,
and include poverty, social isolation, and ill health
(Figure 9.5). The very high prevalence of malnutrition
in institutionalized settings is both caused by, and is
a contributor to, ongoing health problems. Margetts
_etal_ .(2003)foundthatwhilehospitalizationincreased
risk of malnutrition (OR 1.83, 95% CI 1.03–3.16), the
poor health of elderly people was in itself a major
cause of their malnutrition (OR for malnutrition associated with ill health 2.34 men, 95% CI 1.20–4.58,
2.98 women, 95% CI 1.58–5.62). What is most concerning is the common failure of health professionals
and nursing home staff to adequately assess the nutritional status of elderly people in their care and to set in
place appropriate interventions. McWhirter and Pennington (1994) reported that in UK hospitals, 40% of
patients (mostly elderly) were malnourished on ad


poor wound
healing



**Nutrition, Aging, and the Elderly** **237**


**Figure 9.6** The vicious cycle of malnutrition and
disease.



EU (Zaidi, 2006) showed that one in six elderly people
were at risk of poverty (13 million people), with highest rates of poverty in Cyprus (52% of elderly population), Ireland (40%), and Spain (30%). Women may
be particularly at risk of poverty as they live for longer
and must therefore spread resources over a greater
period of time. Levels of poverty in countries such
as the US, where the lack of a welfare state means a
high proportion of pension income has to be allocated to housing costs and medical expenses, may be
considerably greater.
Poverty impacts upon nutritional status in a number of ways. Primarily, a lack of money will reduce the
quantity of food consumed, but importantly, it also
reduces the scope for choice and variety within the
diet. Modern shopping practices can also make it difficult to access food without transport, and so poverty
may disadvantage those unable to run a car or access
public transport for shopping.


_**9.5.3 Social isolation**_

As many as one in seven elderly people will live alone,
and a high proportion of these will be widowed. The
sense of grief, loneliness, and isolation that accompanies widowhood can be particularly great in relation
to food, as the purchase of food, the preparation of
food, and the sharing of food at mealtimes are especially important elements of a close relationship. As a
result, many people living alone are reluctant to invest



time in cooking and eating and as a result are vulnerable to malnutrition. Martin _et al_ . (2005) identified this
as a major factor leading to weight loss in the elderly.
Women are less vulnerable in this respect following
widowhood as, for the elderly generation, they tend
to have better domestic skills. Men of this generation
cook less and are more dependent upon others for
the acquisition and preparation of food. Hughes _et al_ .
(2004) studied 39 men, aged 62–94, living alone, and
noted that very few achieved recommended intakes
for energy, trace elements, and vitamins A and D. Energy intakes were highly correlated with the cooking
skills of the men.

For institutionalized elderly, the opportunities for
social interaction around mealtimes can be an advantage over living alone in the home setting. However,
there are still factors at work that are likely to reduce
intakes. In an institutional setting, individuals are no
longer preparing their own food or playing a role in
the purchase of food items. Regimented mealtimes
that may not correspond to peaks in appetite can detract from overall intakes.


_**9.5.4 Education**_

For many elderly people, the knowledge of food and
health and the cooking skills that they accrued in their
younger years may be not be helpful in providing the
balance of nutrients required to meet requirements.
Favored cooking and food preparation techniques



**238** **Nutrition: A Lifespan Approach**


may use excessive amounts of saturated fat, sugar,
and salt, and also reduce the bioavailability of nutrients (e.g., boiling rather than steaming vegetables will
reduce vitamin content). Contemporary foods (particularly foods from imported cuisines) may also be
unfamiliar to some elderly people and this reduces
the number of acceptable choices when out shopping
and can make the diet narrow in scope. Individuals
who are advised to make adjustments to their diet to
manage chronic health conditions may also struggle
to meet nutrient demands due to lack of education
and understanding.


_**9.5.5 Physical changes**_


Even in healthy individuals, physical changes associated with aging will have a deleterious effect upon
nutritional status. The reduced efficiency of the gastrointestinal tract leads to malabsorption and reduced
bioavailability of micronutrients. The elderly may also
develop a variety of conditions within the bowel that
lead to discomfort and the avoidance of certain types
of food. For example, the degeneration of the brushbordercellsofthesmallintestinecanlimittheproduction of lactase, promoting lactose intolerance. Given
the discomfort that will ensue with consumption of
dairyproducts,thesenutrient-richsourceswilltendto
be cut from the diet and not replaced with suitable alternatives. Within the mouth, periodontal disease and
poorly fitted dentures can also result in avoidance of
foods such as meat, which require longer mastication.
The senses of taste and smell decline with age and
this can reduce enjoyment of food and impair appetite.Thesenseoftastecanchangequiteabruptlyand
often it is the sensing of sweetness and saltiness that is
initially lost, effectively making food seem more bitter
(Omran and Morley, 2000). Around half of the 65–80year-old age group report reductions in the sense of
smell (Griep _et al_ ., 1995). These changes may be partly
age related, but are also brought on by medications
used to manage chronic disease (e.g., phenothiazines
used in treatment of mental disorders).
Physical infirmity, stemming from disability or
disease, will also contribute to the development of
malnutrition. Major disease states such as cancer, cardiovascular disease, renal disease, and diabetes are important comorbidities of malnutrition in the elderly.
Chronicdiseaseincreasesrequirementsforenergyand
protein and micronutrients such as zinc, and can promote nutrient losses via the bowel and urine. In addi


tion, these diseases and physical disability associated
with musculoskeletal disorders will contribute to im
mobility and increase dependence upon carers. The
ensuing impairment of the ability to shop, cook and
self-feed, and social isolation are obvious contributors

to malnutrition.


_**9.5.6 Combating malnutrition in the**_
_**elderly**_


The prevention and treatment of malnutrition among
the elderly has to be a major public health priority
in all nations. Malnutrition is clearly more prevalent
among individuals who are hospitalized or otherwise
institutionalized for long periods of time but is not
confined to that subgroup in the population. Malnutrition is also a problem for the free-living elderly, and
this group perhaps provides the greater challenge in
terms of intervention.

Most malnutrition goes unnoticed, particularly
among the elderly living in nursing homes (Abbassi
and Rudman, 1994). The basic first step in preventing
and treating malnutrition has to be the introduction
of suitable tools for screening and monitoring nutritional status. The MUST tool, developed in the UK, is
an example of such a tool (Stratton _et al_ ., 2004). It uses
measures of BMI, acute illness events, and unplanned
weight loss, to assign a score that then triggers appropriate specialist referrals and interventions for the
at-risk, or malnourished patient.
In nursing home or hospital settings, tools such
as MUST can be used for screening of the elderly
on admission and for monitoring in the longer term.
Having standardized measures in operation between
different institutions allows for tracking of nutritional
status over time and can trigger intervention at a range
of different levels, up to and including oral nutritional
support with fortifiers or supplements. Ideally, all staff
working with institutionalized elderly patients should
be trained in nutritional screening, in taking responsibility for initiating nutritional support, and in carrying out basic feeding and food-related support tasks.
In addition to this, there are a number of steps that can
be taken to promote food intake and boost nutritional
status without the need for supplemental products or
specialist intervention. It is important to target the
quality of the food itself, ensuring that it is nutritious,
varied, and attractive. Carrier and colleagues (2007)
found that among Canadian nursing home residents,
bulk-delivery food systems, repetitious menus, and



provision of meals in difficult-to-open packages and
dishes all decreased food intake. Large portion sizes
also suppress the appetite, so provision of smaller but
more frequent meals helps to increase overall intake.
The environment provided for mealtimes is also of
importance. All individuals involved with the feeding
of dependent elderly need to be aware of the fact that
malnutrition has a multifaceted etiology and stems
not only from reduced food intake, but also from all
of the social, pharmacological, and medical factors
that contribute to reducing appetite. Eating is a social activity, so providing meals in a social, friendly,
and pleasant environment encourages greater intake.
Mamhidir and colleagues (2007) showed that with
a group of demented, hospitalized patients, providing an intervention that made the ward seem more
homelike and encouraging staff and caregivers to be
more attentive and responsive at mealtimes prevented
weight loss over a 3-month period, and in many cases
promoted gains in weight. Assistance with feeding is
also an essential element in the elderly care setting.
This can range from physically feeding frail and dependent individuals to providing modified utensils
that enable self-feeding. In all circumstances, encouragement, warmth, and preservation of dignity are essential elements of maintaining a healthy intake.
Inthecommunity,thechallengesaredifferentasthe
level of support that can be provided is often limited.
There are schemes in place in many countries that are
designedtoprolongtheperiodoftimethatfrailelderly
canmaintainindependentlivingandreducetheriskof
malnutrition. Meals-on-wheels, or community meals,
is a widely used strategy. Meals are delivered directly
to the homes of recipients, in a ready-to-eat form that
requires no further preparation. However, there are
a number of concerns about this form of support.
Although meals-on-wheels certainly increase intakes
of energy, protein, fat, and micronutrients, they do
not reduce the prevalence of malnutrition among the
frail elderly (Roy and Payette, 2006). This presumably reflects the fact that simply providing food does
not address all of the other determinants of poor appetite and nutrient availability (e.g., social isolation or
underlying medical conditions). There are also concerns that meals-on-wheels may increase the risk of
food-borne disease (Roseman, 2007). Many recipients
of delivered meals do not eat them immediately and
then store the whole meal, or leftovers, in unsafe conditions (Almanza _et al_ ., 2007). As an alternative, the



**Nutrition, Aging, and the Elderly** **239**


elderly may be encouraged to visit day centers and
access lunch clubs, which provide the opportunity to
eat in a social setting. These, however, rarely operate
on a daily basis and there have been no studies that
have evaluated their effectiveness.


**9.6 Common nutrition-related health**
**problems**


_**9.6.1 Bone disorders**_


The degeneration of physiological function and physical well-being that is associated with aging means that
many chronic diseases first manifest in the later years
of adulthood. While cardiovascular diseases and can
cer are often first noted in the elderly, they are clearly
also a major problem in younger adults. In contrast,
there are a number of diseases of bone that are almost
exclusively seen in elderly people.


**9.6.1.1 Bone mineralization and remodeling**
Bone has a complex structure and is a highly vascularized and innervated tissue. It essentially comprisesaframeworkofcollagensubtypesintowhichare
deposited minerals to provide the hard, rigid structure. Most of the mineral in bone comprises calcium
and phosphate, but there are many other minerals
and trace elements present, including fluoride and
sodium. Seventy to eighty percent of the skeleton
comprises cortical bone, which in section appears as
concentric rings of bone in a bundled arrangement.
The remaining bone is termed trabecular bone, which
has a lattice structure, similar in nature to that of a
sponge. The trabecular bone is found at the ends of
the long bones, within the vertebrae, and at the hips
and wrist.
Bone mineralization is a process that essentially occurs during childhood and the pubertal growth spurt
(Figure 9.7). As the body grows, the mass of mineral
in the skeleton increases accordingly. At the end of the
growth phase, coinciding with sexual maturity, there
is no further net gain of mineral within the skeleton
and the individual is said to have achieved peak bone
mass. Although there is now no further net gain of
mineral, the skeleton is far from inert at this stage.
There is a constant cycle of mineral loss and replacement taking place. This is essential not only to allow the skeleton to be repaired in the event of injury,
but also to allow the skeleton to be remodeled and



**240** **Nutrition: A Lifespan Approach**


Childhood Adolescence Adulthood Menopause







Age (years)


maintained, and for the release of minerals from bone
to make up for any shortfall in supply for other critical

processes.
The skeleton completely remodels itself every 7–10
yearsandthatprocessisdrivenbytwocelltypeswithin
the bone. Osteoclasts are cells that remove mineral
from bone (Figure 9.8). They respond to hormonal



**Figure 9.7** Bone mass across the
lifespan. Bone mineral accrues in the
first three decades of life, but thereafter declines progressively. The rate
of bone loss accelerates after the

menopause.


signals including parathyroid hormone and vitamin
D3 to release calcium from bone, into the circulation.
When bone is injured or fractured, they move into
the damaged area to remove debris and begin the process of repair. In contrast, the osteoblasts bring about
the remineralization of bone. During childhood and
adolescence, osteoblast activity is in the ascendance



Parathyroid
Growth Sex steroids hormone



Vitamin D3


Calcitonin









Calcium uptake Bone mineral Calcium loss


Calcium Calcium





Calcium Vitamin D3


**Figure 9.8** The endocrine control of bone mineralization.



as high concentrations of growth hormone stimulate osteoblast activity, and during puberty, rising sex
steroid concentrations also promote bone mineralization. At the end of growth, the activities of osteoblasts
and osteoclasts are in equilibrium and the skeleton
is maintained in a stable state through the ongoing
remodeling process. With aging, however, osteoclast
activity tends to exceed the rates of remineralization
and hence the bone mineral content and density begin to decline (Figure 9.7). In women, the rate of
decline accelerates at the menopause as the loss of
estrogen production removes the stimulatory effect
upon osteoblasts. Rates of bone remodeling are not
even across the whole skeleton and trabecular bone
remodels around eight times faster than cortical bone.
This means that with aging, loss of bone density from
the trabecular regions is much faster, declining by up
to 2.5% every year.


**9.6.1.2 Osteoporosis pathology and prevalence**
Osteoporosis is one of the most common causes of
hospitalization among the elderly and is characterized
by an increased susceptibility to bone fracture due to
demineralization. In the EU, there are over a million
osteoporotic fractures every year, and this number is
steadily increasing. While at the present time, most
osteoporosis is noted in the developed countries, the
increasinglifespanofpopulationsindevelopingcountries means that the global prevalence of the condition
will increase dramatically, possibly doubling over 50

years.
Osteoporosis is a serious condition, and among the
elderly, a quarter of all individuals sustaining a fracture can be expected to die within 1 year. Often the
first indication of the condition comes when an elderly person has a fall and fractures a bone at one
of the main trabecular bone sites, such as the hip or
wrist. Fractures to the vertebrae can often go unnoticed and manifest as a loss of height or the development of a hump-backed posture. Osteoporosis is
generally diagnosed through x-ray, which shows the
loss of mineral from affected regions, and confirmed
using the dual x-ray absorptiometry technique. This
allows the determination of the total mineral present
within the skeleton, or specific bone regions (bone
mineral content), and from this, the bone mineral
density (BMD, g mineral/cm [2] bone) can be derived.
BMDistheprimarytoolfordiagnosisandmonitoring
of osteoporosis, with clearly characterized thresholds



**Nutrition, Aging, and the Elderly** **241**


for defining the progression of the disease. Markers of
bone degradation (e.g., _N_ -telopeptide), or formation
(e.g., alkaline phosphatase activity or procollagen 1
C-terminal peptide) can also be used to monitor the
disease. Although osteoporosis is seen in both men
and women, it is far more common in women due to
the impact of the menopause on rates of bone loss.
Kanis _et al_ . (2002) reported that significant risk of osteoporosis begins at around the age of 50–55 years,
when up to 10% of women meet the criteria for diagnosis. By the age of 80 years, osteoporosis was seen in
47% of women and 16% of men.


**9.6.1.3 Risk factors for osteoporosis**
The major nonmodifiable risk factors for osteoporosis include female gender, early menopause, and increasing age. There is believed to be a strong genetic
component underlying the risk of osteoporosis, and
some twin studies suggest that this may account for
as much as 50% of risk. There are a number of polymorphisms of the vitamin D receptor gene and the
collagen 1 _α_ 1 gene (Col1 _α_ 1) that contribute to individual risk. For example, BMD tends to be lower
in individuals with the ss variant of the Sp1 polymorphism of Col1 _α_ 1, compared to the SS variant
(Garnero _et al_ ., 1998). A number of disease states will
impact upon risk of osteoporosis, generally by virtue
of the effects they have upon the endocrine regulation
of bone turnover or the metabolism and transport
of vitamin D and calcium. These include hyperthyroidism, hyperparathyroidism, cancer, rheumatoid
arthritis, coeliac disease, inflammatory bowel disorders, renal failure, and anorexia nervosa. Therapies
that require administration of corticosteroids, or that
disrupt the normal production of sex steroids, will
promote osteoporosis.
The level of peak bone mass attained at the end of
the growth phase is considered to be an important determinant of the risk of osteoporosis later in life. Rates
of bone loss are relatively constant among the population, so risk of BMD falling below the thresholds
at which fractures become likely is increased in individuals for whom peak bone mass was lower (Figure
9.7). For this reason, the optimal periods for targeting
interventions to prevent osteoporosis may lie during
childhood and adolescence, rather than in the adult

years.
The main avoidable lifestyle risk factors for osteoporosis include smoking, physical inactivity and



**242** **Nutrition: A Lifespan Approach**


excessive consumption of alcohol, poor dietary intakes of calcium, and vitamin D. The latter two form
the main targets for nutritional interventions, as will
be discussed in the next section. Physical activity is
important as bone mineralization occurs at faster
rates around lines of stress within bone. Low-to
moderate intakes of alcohol appear to be protective
against osteoporosis, but with heavy use, any benefits
are lost. Alcoholics typically develop an osteopenic
skeleton and suffer high rates of falls and fractures.
This is because alcohol specifically blocks bone formation, while having no effect on rates of resorption
(Chakkalakal, 2005).


**9.6.1.4 Dietary interventions for osteoporosis**
**prevention**
Once diagnosed, osteoporosis is generally treated using pharmacological agents. Rates of bone loss can
be reduced by treating with bisphonates, which inhibit osteoclast activity. Calcitonin has a similar effect
and can be administered as a nasal spray. Bone deposition can be increased through administration of
drugs that boost hormone concentrations or mimic
their actions. Raloxifene, for example, is a selective
estrogen receptor modulator, which mimics estrogen
activity and helps maintain bone mass in women after
the menopause (Keen, 2007). Strontium ranelate is a
drug that promotes bone deposition. In addition to
these pharmacological approaches, older people with
osteoporosis are advised to increase intakes of calcium
and vitamin D in order to limit bone loss. However,
this nutritional strategy is considered to be more important in the context of osteoporosis prevention and
is the cornerstone of population-wide intervention
strategies.
Calcium has been shown to be effective in increasing bone mass in individuals at any stage of
life and most observational studies are supportive
of a role for calcium supplementation as a means of
preventing osteoporosis. Stear and colleagues (2003)
showed that in 17-year-old girls with good baseline calcium intakes, a 1000 mg/day calcium supplement increased whole-body BMD over a 2-year period, with particularly strong effects at the trochanter
(5% increase in BMD). Studies of children show
that initiating calcium supplementation during the
pubertal growth spurt is particularly effective. Although this stage of life is well ahead of the appearance of any disease, boosting BMD at this time



might enable the achievement of a greater peak bone

mass.

When considering the impact of calcium supplementation in older people, the effects are less impressive. Shea _et al_ . (2004) performed a systematic review
of the literature considering randomized clinical trials
ofcalciumsupplements(excludingcalciumcombined
with vitamin D or other nutrients). While calcium
supplementation was shown to be capable of boosting whole-body BMD by approximately 2%, with significant gains in hip and spine, there was no benefit
in terms of fracture risk. While increasing BMD is
desirable, fractures are the true disease outcome in
osteoporosis, and any preventive or therapeutic intervention should aim to reduce their occurrence.
Epidemiological studies are similarly equivocal regarding preventive strategies that use vitamin D alone.
Most vitamin D is synthesized endogenously through
the action of sunlight upon the skin, and as a result,
concentrations in circulation tend to vary with season, particularly among elderly people in the northern hemisphere. As vitamin D3 concentrations fall
in the winter months, the risk of fracture increases.
In contrast to calcium, where supplementing the elderly increases BMD, vitamin D supplements appear
to have no effect on bone mineralization, except in
individuals whose calcium status is poor. This is because the main function of vitamin D within bone

remodeling is to reverse calcium insufficiency. However, despite this lack of effect on BMD, vitamin D
supplementation of elderly women has a clear impact upon fracture risk, with doses of between 700
and 800 IU/day reducing risk of fractures of the
hip and vertebrae by 25% (Bischoff-Ferrari _et al._,
2004).
Most randomized control trials do not consider

effects of calcium and vitamin D in isolation and
instead administer these two nutrients together. Di
Daniele and colleagues (2004) studied 1200 women
over the age of 45 years for a 30-month period
and showed that combined supplements prevented
the decline in BMD following the menopause, and
indeed, actually increased bone mineralization. Although relatively low-dose supplements of calcium
(500mg/day)andvitaminD(700IU/day)areeffective
in preventing declines in BMD and fractures among
the elderly, supplementation must be maintained in
the long term to preserve the benefits (DawsonHughes _et al_ ., 2000). Boonen _et al._ (2007) performed a



meta-analysis that showed that the observed benefits
of vitamin D upon fracture risk were largely dependent upon the coadministration of calcium supplements. Comparing the relative risk of hip fracture
associated with combined supplements with that associated with vitamin D alone, they reported a 25%
decrease (RR 0.75, 95% CI 0.58–0.90). Falls are the
main cause of fractures among elderly people with
osteoporosis. There is a growing body of evidence to
suggest that calcium and vitamin D supplementation
may contribute to reduced risk of fracture by preventing falls, in addition to increasing BMD (Research
highlight 9). It is suggested that vitamin D3 supplements should be targeted at the elderly population,
either as a daily dose of 700–800 IU, or as a large
depot dose (100 000 IU) every 4 months, in order to
prevent falls and fractures. Optimal strategies for delivering this on a population-wide scale have yet to be
determined (Bischoff-Ferrari and Dawson-Hughes,
2007).
Othernutrientsanddietarycomponentsmaybeinfluential in determining risk of developing osteoporosis and fractures. Iron and magnesium have both been
shown to contribute to bone mineralization. Serum
magnesium concentrations are reported to be higher
among elderly individuals with greater BMD. Iron, on
the other hand, promotes bone loss, but only when
present in major excess, as is seen with the condition,


~~**Research Highlight 9**~~ ~~Vitamin D and falls in the elderly~~


Falls are commonplace in some groups of elderly people, and among
populations living in nursing homes, these may occur at least once
per year per individual. These falls are not trivial and are the major
cause of nonvertebral fractures among individuals with osteoporosis.
Vitamin D status is often poor in the elderly population, particularly
during the winter months and among those living in institutions.
Vitamin D supplements appear to counter vitamin D insufficiency
and reduce risk of fracture. As there appears to be no effect of vitamin D supplementation upon BMD, there is considerable interest
~~in whether it has any infuence upon risk of falling. There is evi-~~ l i
dence to suggest that individuals with higher circulating vitamin D3
concentrations suffer fewer falls (Stein _et al_ ., 1999).
Many studies suggest that supplementing with vitamin D or synthetic analogues is beneficial in the elderly. Bischoff _et al_ . (2003)
reported that administering 800 IU/day cholecalciferol (vitamin D3)
with 1200 mg/day calcium to a population of 63—99-year-olds reduced risk of falling by 49%, while calcium alone increased risk. In
contrast, Law _et al_ . (2006) found no benefit of administering 2.5 mg
of ergocalciferol (vitamin D2) every 2 months, in terms of either frac


**Nutrition, Aging, and the Elderly** **243**


hemochromatosis. Neither of these minerals is likely
to have a major influence on bone health within the
normal range of dietary intakes.
The influence of protein upon bone mineralization
appears to be complex and dependent upon intakes
of other nutrients. Availability of protein clearly plays
a role in the formation of bone, and supplements are
beneficial in the elderly following a fracture. Moreover, protein intake may be a determinant of muscle strength and may play a role in determining the
risk of falling. However, there are reports that excess
protein can promote calcium loss and hence reductions in BMD. Rapuri and colleagues (2003) studied
almost 500 elderly people (aged 65–79) with protein intakes varying between 53 and 74 g/day. Over
a 3-year period, protein intake had no influence over
rates of bone loss. A higher protein intake was associated with greater BMD at the spine and wrist,
but only in the subjects whose calcium intake was
adequate.
Phytoestrogens have been suggested as a safe alternative to hormone replacement therapy by virtue of
theircapacitytoreducebonelossafterthemenopause.
However, their efficacy has not been firmly established
and they may only be useful as an adjunct to other
therapies, such as the use of selective estrogen receptor
modulators. Atkinson _et al_ . (2004) randomized 200
postmenopausal women to receive either placebo or


ture or falls risk. The meta-analysis of Bischoff-Ferrari and colleagues
(2004) concluded that providing a supplement of vitamin D could
significantly reduce the risk of falling (OR 0.78, 95% CI 0.64–0.92).
This benefit might be dose dependent as Broe _et al_ . (2007) found
that benefits were only noted when 800 IU/day was administered to
elderly women at risk of falls. Lower doses appeared insufficient to
significantly improve vitamin D status.
The mechanism of action through which vitamin D supplements
prevent falls has not been fully defined. However, there are many

l ~~reports that suggest the benefts stem from improvements to muscu-~~ i

loskeletal function. Circulating concentrations of 25-hydroxy-vitamin
D are good predictors of quadriceps strength and balance in elderly people. Dhesi _et al_ . (2004) recruited a population of people
aged over 65 years who had previously suffered a fall. Injections of
600 000 IU ergocalciferol did not impact upon the subsequent rate of
falls in the ensuing 6 months, but did significantly improve balance
and reaction times. This suggests that vitamin D improves neuromuscular performance and that this mechanism could be protective
in those at risk of osteoporotic fracture.



**244** **Nutrition: A Lifespan Approach**


redcloverderivedisoflavones(genisteinanddaidzein)
for 12 months. Over this period, the degree of spinal
bone loss was slowed by the isoflavones, but there was
no benefit in terms of BMD at the hip. Markers of
bone formation, alkaline phosphatase and procollagen type I N-terminal propeptide, were increased by
the isoflavone treatment. To some extent, the response
to phytoestrogens may depend upon the composition
of the gut microflora. Intestinal bacterial metabolize
the soy isoflavone daidzein to _O_ -desmethylangolensin
( _O_ -DMA), or equol. In _O_ -DMA (80–90% of population) and equol producers (20–30% of population), the benefits for bone health associated with
isoflavone intake may be enhanced (Frankenfeld _et al_ .,
2005).
Avoidance of caffeine might be advocated as a strategy to prevent bone loss in certain individuals. Rapuri
_et al_ . (2001) reported that bone loss over a 3-year
period was markedly greater among postmenopausal
women consuming over 300 mg caffeine (10 cups of
tea, 3–5 cups of coffee) per day, compared to those
consuming less than 300 mg/day. However, these effects were confined to the women who expressed the
tt variant of the vitamin D receptor Taq1 polymorphism. This suggests that caffeine may interfere with
vitamin D metabolism via its receptor.


**9.6.1.5 Paget’s disease of bone**
Paget’s disease of bone (osteitis deformans) is a disorder that is more common among the elderly population than in younger adults. It is characterized by the
developmentofenlargedanddeformedbone,particularly in the spine and any areas adjacent to joints. This
is caused by excessive remodeling of bone, with high
rates of breakdown and remineralization, and leads
to malformations, including curvature of the spine,
and weakness of bone that increases the likelihood of
fracture. In contrast to osteoporosis, Paget’s disease is
more common in men than in women. It is treated
using bisphosphonates to inhibit osteoclast activity,
and patients taking these drugs are recommended to
consume calcium supplements (1000–1500 mg day)
with vitamin D (400 IU/day).


_**9.6.2 Immunity and infection**_


Nutrition, infection, and immunity are closely related
(Figure 9.6). Nutrient deficits, particularly protein–
energy malnutrition and deficits of the B vitamins,
vitamin A, and trace elements, impair both passive



immunity and cellular immunity and therefore reduce the capacity to resist infection. Infection promotes malnutrition by activating the acute phase response to trauma. This response is characterized by
an increase in demand for energy and protein, coupled with a decrease in appetite. Chronic or recurrent infections can therefore exacerbate the effects

of ongoing malnutrition. In the elderly, the relationship between nutritional status and immune function is of greater significance as the risk of malnutrition is heightened by other factors, and infection becomes more likely due to other medical conditions that either impair immune function, or increased exposure to sources of infection, for example, following surgery. In developed countries, the elderly population are at two- to tenfold greater risk of
death due to infectious diseases than younger adults
(High, 2001)). This population is also the major atrisk group for hospital-acquired infections such as
multiple resistant _Staphylococcus aureus_ or antibioticresistant strains of _Clostridium difficile_ (Castle _et al_ .,
2007).
While much of the increased infection risk seen
among the elderly might be attributed to nutritional
status or comorbidities, it is important to appreciate that the immune system undergoes age-related
changesinfunctionthatareprobablygreaterthanseen
in any other tissue. Immune senescence is accompanied by complex changes to both innate and adaptive
responses. Generally speaking, aging is accompanied
byachangeintheprofileofcytokinesproducedbyimmune cells, and increases in baseline levels of secretion
of interleukin-6 and interleukin-10 create an environment that is undergoing a chronic, low-grade inflammatory response (Castle _et al_, 2007). The lymphocyte types that are present in circulation also undergo
change with senescence and the elderly possess more
memory T cells. These cells are responsible for the
recognition of pathogens that the body has previously
encountered, and orchestrate a stronger immune response than that at the first infection. This would appeartobeafeatureofamorerobustimmuneresponse,
but it appears that the predominance of memory T
cells results in reduced numbers of other T cell types,
including CD4+ helper cells (which activate cytotoxic
T cells) and na¨ıve T cells. This means that there are less
effective responses to new pathogens. The senescent
immune system is generally less responsive to stimuli, for example, producing less interleukin-1 with an



antigen challenge. Vaccinations produce lower antibody responses and are therefore less helpful. Declining functions of phagocytic cells and the complement
system make the response to bacterial and viral infections less effective.

A number of studies have suggested that while nutritional status may not contribute appreciably to
immune senescence, availability of nutrient supplements might lessen some of the impact. Providing
nutritional support to patients in the postsurgical period can improve recovery rates, and without such
support, the elderly surgical patient might be expected to lose weight for around 2 months during
their convalescence (High, 2001). Multivitamin supplements are generally considered to be of greater
value than supplements of single nutrients and some
trials have shown that over long periods of administration (12 months) to free-living elderly subjects,
they can boost natural killer cell activity, increase expression of interleukin-2, and reduce the frequency
of infectious illness (High, 2001). Among the institutionalized elderly, supplementation with zinc (20
mg/day) and selenium (100 _µ_ g/day) has been highlighted as having the potential to reduce respiratory
tract and urinary tract infection rates (Girodon _et al_ .,
1997). Chandra (2004), however, urges caution with
interpreting such findings as many trials have been
poorly designed, and because some nutrients may
have harmful effects at higher doses. Zinc and vitamin E supplements, for example, may be effective in
boosting immune responses at low to moderate doses,
but both impair immune cell function when in excess.
Any individual who is immobilized for a long period is susceptible to the development of pressure
sores, or pressure ulcers. These are areas of deep damage to skin tissue that is caused by pressure and/or
friction. Such lesions are seen in up to two-thirds of
all hospital inpatients and are most likely to occur in
bed-bound elderly individuals, often following other
age-related injuries such as hip fracture, or as a consequence of prolonged sitting and lack of physical
activity (Stratton _et al_ ., 2005). Pressure ulcers carry
considerable risk of further complications, extend periods of hospitalization associated with other medical
problems, severely impair patients’ quality of life, and
increase risk of death by fivefold. Malnutrition is a
major risk factor for development of pressure ulcers.
This could be because there is reduced skin resistance
and cushioning by body fat at areas of likely pressure



**Nutrition, Aging, and the Elderly** **245**


in individuals of low BMI. In addition, malnutrition
is associated with reduced availability of key nutrients for maintenance, repair, and healing of the skin.
The most effective nutritional support for those with
pressure ulcers appears to be provision of oral supplements of protein and energy, which when given to atrisk patients without ulcers significantly reduce their
occurrence(RR0.75,95%CI0.62–0.89,Stratton _etal_ .,
2005). Among elderly patients, such supplements appear to reduce the stay in hospital associated with
hip fractures, presumably by lessening occurrence of
complications such as pressure ulcers (Delmi _et al.,_
1990). In addition to preventing pressure ulcers, nutritional status and nutritional support are important
factors in determining rates of healing (Donini _et al_ .,
2005).


_**9.6.3 Digestive tract disorders**_


As described earlier in this chapter, gastrointestinal
tract problems are an important contributor to undernutrition in the elderly population. There are a
wide variety of different disorders that impact upon
gastrointestinal function, and these affect the whole
length of the tract (D’Souza, 2007).


**9.6.3.1 Mouth and esophagus**
Soreness of the mouth is a common problem among
the elderly. This often stems from the reduced flow
of saliva, or poor fitting of dentures. Clearly, this will
detract from the desire to eat and can impact upon
nutritional status. However, factors impacting upon
esophageal function are of much greater significance
and lead to dysphagia and malnutrition. Problems
with swallowing fall into two categories. Inhibition of
the swallowing reflex is usually an issue in individuals
who are recovering from a stroke and therefore has a
clearcauseandgenerallyanacuteonset.Neuromuscular disorders affecting the esophagus and chronic conditions such as Parkinson’s disease can impact upon
swallowing over a much longer period and have a
greater impact of general health. These conditions,
and age-related declines in the peristaltic functions
of the esophagus, can induce the feeling that food
is becoming stuck in transit to the stomach and this
discourages swallowing. Swallowing can also become
painful due to reduced production of mucous in the
esophagus (D’Souza, 2007). Age-related loss of function in the lower esophageal sphincter can lead to



**246** **Nutrition: A Lifespan Approach**


gastric reflux, and over time, the exposure to gastric
secretions can promote esophagitis.


**9.6.3.2 Stomach**

Inflammationofthegastricmucosaandtheformation
of peptic ulcers are more common among the elderly
than in the younger population. There are believed to
be a number of physiological reasons for this, but it
should also be borne in mind that infection with _Heli-_
_cobacter pylori_ is also more common in the elderly. _H._
_pylori_ infests the mucous layer of the stomach wall and
generates ammonia from urea that would normally
buffer stomach acids. This ammonia causes damage
to the gastric epithelium. Approximately 80% of the
over-65s will have _H. pylori_ within the stomach, compared to 20–50% of younger adults (Marshall, 1994).
Another cause of peptic ulcers is irritation of the gastric mucosa by anti-inflammatory medications. In the
elderly, gastrointestinal transit times are slower, and
gastric emptying less frequent. Coupled to this, there
is reduced production of mucous and gastric juices. As
a result, irritants stay in the stomach for longer, and
undergo less dilution with stomach acid (D’Souza,
2007). With atrophy of the gastric mucosa, the capacity to repair any inflamed or damaged areas is reduced.


**9.6.3.3 Small intestine**

The functions of the small intestine are well preserved
within the aging gastrointestinal tract and most of
the small intestinal disorders reported in the elderly
are secondary to other disease states (Hoffmann and
Zeitz, 2002). Malabsorption of nutrients is a major
problem in elderly patients, and it is driven by conditions such as pancreatitis, parasitic infections, inflammatory bowel disease (Crohn’s disease), and coeliac
disease. Bacterial overgrowth of the small intestine
is another factor promoting malabsorption, which is
not usually seen in younger individuals. McEvoy and
colleagues (1983) reported that among a group of
patients in an elderly care setting, 31% of those with
malabsorptionproblemsleadingtomalnutritionwere
showing evidence of bacterial overgrowth syndrome.
Bacterial overgrowth is most likely to occur in the
elderly as a result of the other gastrointestinal and
health problems that they develop. Immunosuppressive drugs, for example, will allow bacteria to resist
the local immune system. The presence of blind loops
formed during surgery to the small intestine, or diverticulae (see below), provide a foothold for bacterial



colonization. As with all of the other causes of mal
absorption, the condition is likely to manifest as abdominal pain, diarrhea, bloating, and flatulence, but
should be readily treatable with antibiotics.


**9.6.3.4 Large intestine**
Constipation is a commonly reported condition
among the elderly population, with a prevalence of
between 25% and 35% among the free-living population. In nursing homes, around 50–65% of nursing home residents are reported to take laxatives on
a daily basis (Morley, 2007). Constipation is a serious issue and the associated pain and occasional incontinence are associated with a decline in quality of
life measures. Constipation can impact upon psychological health and is noted to cause aggression and
delirium in elderly people. There are many factors
that promote constipation in this group. Some are
related to drug treatments or nutrient supplementation for other conditions. Iron and calcium supplements, for example, lead to constipation, as do
diuretics, opiate-based painkillers, many antidepressant drugs, and antihypertensive agents. Lifestyle is
also a major issue, and gastrointestinal transit times
are lengthened by physical inactivity, poor hydration,
and a lack of dietary fiber. It is often suggested that
the latter is a major explanation of why the elderly
are more prone to constipation. It is argued that the
poor dentition of the elderly can discourage intakes
of fiber-rich foods. However, while the average intakes of nonstarch polysaccharides among UK elderly
(National Diet and Nutrition Survey, 1998) were well
below the dietary reference value (intakes were on average 10–11 g/day and the EAR is 18 g/day), there is
little evidence to suggest that the elderly are any different to younger adults in this respect. Indeed, the UK
National Food Survey 2000 (DEFRA, 2000) showed
that intakes of cereals, bread, vegetables, and fruits
were higher in the over-65s than in any other group
of adults.
Declining peristaltic function within the large intestine contributes to constipation in the elderly. With
this loss of function, the pressures generated within
the colon required to keep stools moving has to increase, and this is a cause of diverticular disease. Diverticulae are sacs and pouches that form within the
lining of the intestine. They are present in between
50% and 80% of elderly people and in most cases
are asymptomatic (in which case the condition is



termed diverticulosis). In around 15–20% of cases,
the condition progresses to diverticulitis in which the
pouches become blocked with fecal matter. Subsequent infection leads to abdominal pain, lower gastrointestinal bleeding, and alternating diarrhea and
constipation.Infecteddiverticulaecanulcerateorperforate and this can become life threatening. Diverticular disease is best avoided by following a lifestyle
that prevents constipation, including increased intake
of nonstarch polysaccharides, physical activity, and
maintaining adequate hydration (D’Souza, 2007).


_**9.6.4 Anemia**_


Anemia is a hematological condition characterized by
abnormalities of the red blood cells. It is most simply
defined on the basis of hemoglobin concentrations,
and the World Health Organization sets cutoff values
for adults at 13 g/dL hemoglobin for men and 12
g/dL for women. As will be explained below, there are
different forms of anemia and these require further
examination of the red blood cells for diagnosis.
Anemia, and in particular iron deficiency anemia,
is very common throughout the world, particularly
among the female population. The elderly are especially at risk of anemia and many of the anemias
that are unrelated to iron deficiency are almost solely
observed in older individuals. Steensma and Tefferi

(2007) reported that the prevalence of anemia in
the US population is approximately 8% in the 65–
74 age group (which is not significantly different to
the prevalence in younger populations), 12% in the
75–84 age group, and over 20% in the over-85s (26%
in men, 20% in women). These figures are similar to
those reported in other westernized countries, with
20.1% of elderly British men, and 13.7% of elderly
British women shown to be anemic (Mukhopadhyay
and Mohanaruban, 2002). Prevalence rates for anemia are considerably higher in the institutionalized
elderly than in the free-living population and some
estimates are as high as 50% for the elderly living in
nursing homes (Eisenstaedt _et al_ ., 2006).
Anemia in general is related to a number of poor
health outcomes and reduced quality of life among
the elderly. It is associated with reduced mobility,
greater risk of falls and osteoporotic fractures, greater
frailty, and reduced cognitive function (Eisenstaedt
_etal_ .,2006).Moreover,mortalityratesaresignificantly
greater among the anemic population, either due to
specific causes such as cardiovascular disease or can


**Nutrition, Aging, and the Elderly** **247**


**Table 9.2** Causes of anemia in the elderly population


Cause Estimated percentage of cases


Iron deficiency 5–10
Anemia of chronic disease 50–65

Acute hemorrhage 5–10
Vitamin B12 or folate deficiency 5–10
Myelodysplastic syndrome _[a]_ 5
Leukemia or lymphoma 5
Unknown causes 5–10


_a_ A condition in which the bone marrow produces reduced
numbers of red blood cells.


cer, or from all causes. The US Cardiovascular Health
Study showed greater mortality over a 12-year period
among elderly men and women in the lowest quintile
of hemoglobin at baseline (Zakai _et al_ ., 2005). Similarly, Izaks and colleagues (1999) reported that risk of
death over a 10-year period, in a population of people
aged over 85 years, was increased by 2.3-fold in men
and1.6-foldrelativetothosewithnormalhemoglobin
in women with hemoglobin concentrations below
6.3 g/dL.
There are a wide range of different anemias, with a
range of different causes (Table 9.2), but those that are
most commonly observed are iron deficiency anemia,
anemia of chronic disease, and the megaloblastic anemias. These can be diagnosed using flow cytometry
to determine the size of the red blood cells. Microcytic anemia is diagnosed when the mean cell volume
is low. This occurs when the hemoglobin concentration is low due to a failure to synthesize the protein,
either due to iron deficiency, or as a consequence of
disordered erythropoeisis. Microcytic signs may also
be noted with the anemia of chronic disease, but this
more usually manifests as a normocytic anemia, in
which the mean cell volume is in the normal range.
Normocytic anemia may also result from hemolytic
anemia in which the red cells are broken down at an
abnormally high rate.
The anemia of chronic disease is a product of inflammation and is seen commonly in patients with
congestive heart failure, rheumatoid arthritis, or after surgery. Approximately 65% of anemia observed
in the elderly is likely to be chronic disease related.
In these situations, there are high circulating concentrations of pro-inflammatory cytokines, such as tumor necrosis factor _α_, interleukin-1, and interleukin6, and these inhibit erythropoeisis. Moreover, the



**248** **Nutrition: A Lifespan Approach**


production of the iron transport inhibitor hepcidin
increases during chronic inflammation and this reduces the uptake of iron across the gut (Eisenstaedt
_etal_ .,2006).Inchronicrenaldisease,theabilitytoproduce erythropoietin is impaired and this can produce
a microcytic anemia of chronic disease.
The megaloblastic anemias are characterized by the
enlargement of red cells, which is related to the production of only immature and dysfunctional erythrocytes. The megaloblastic anemias are the products of
deficiencies of either vitamin B12 or folic acid. Megaloblastic anemia due to vitamin B12 deficiency is often
erroneously referred to as pernicious anemia. Pernicious anemia is a term that only applies to anemia
arising from B12 deficiency caused by atrophic gastritis, or due to loss of the cells of the stomach lining,
which secrete the intrinsic factor required for absorption of cobalamin. Pernicious anemia is associated
with severe neurological abnormalities that can result
in sensory impairments, loss of appetite, and cardiovascular and gastrointestinal problems.


**9.6.4.1 Iron deficiency anemia**
Irondeficiencyanemiaisrelativelyuncommonamong
the elderly populations of westernized countries, with
prevalence estimated at 3–5%. In elderly patients, iron
deficiency is most likely to be attributable to blood
loss, and deficiency due to poor dietary intakes is rare.
Villous atrophy within the intestine may be a cause of
iron malabsorption, but over 60% of iron deficiency is
aconsequenceofoccultbloodlosswithinthegastrointestinal tract (Rockey and Cello, 1993). Occult bleeding can be the result of treatment with nonsteroidal
anti-inflammatory drugs but it is more often the result
of underlying gastrointestinal pathologies, including
gastric cancers, peptic ulcers, colonic cancers, and
colonic polyps. Iron deficiency in the elderly, as with
youngergroups,ismosteffectivelytreatedthroughthe
administration of iron supplements, but given that it
may indicate more sinister pathologies, this treatment
should be accompanied by gastrointestinal investigations (Mukhopadhyay and Mohanaruban, 2002).


**9.6.4.2 Vitamin B12 deficiency**
Deficiency of vitamin B12 (cobalamin) is relatively
common among the elderly population. Most estimates (Andr`es _et al_ ., 2004) suggest that at least 20%
of the over-65s are cobalamin deficient, with greater
prevalence among institutionalized elderly (30–40%)



than in the community (12%). Measurements of
serum homocysteine and methylmalonate provide
good biomarkers of deficiency of cobalamin and folic
acid.Clarkeandcolleagues(2003)showedthatamong
an elderly UK population, these biomarkers indicated
that 10–20% of people were at risk of cobalamin deficiency and a similar number of people were folate
deficient, or borderline folate deficient. Ten percent
of the cobalamin-deficient population were also folate deficient. In some countries, the prevalence of
deficiency may well be greater. Olivares _et al_ . (2000)
studied a group of over-60s in Chile. Chile fortifies
wheat flour with iron at 30 mg/100 g flour and so iron
status was good in these elderly people. In the absence
of anemia, low-serum vitamin B12 and low-serum folate were noted in 50% of men and 33% of women.
Iron fortification, therefore, appeared to mask the potential deleterious effects of B vitamin deficiencies.
It is rare for vitamin B12 deficiency to arise through
inadequate dietary intakes, which would only be a
concern in individuals consuming a strict vegetarian
diet,orinveryseverelymalnourishedindividuals.The
major causes of deficiency relate to the function of the
digestive tract, which is why the elderly are a highrisk group. Cobalamin is absorbed through a complex
process involving actions of the stomach and the small
intestine (Andr`es _et al_ . 2004). Cobalamin in the diet
generallyentersthestomachboundtoanimalproteins
(Figure 9.9). Pepsin and the stomach acid release the
free cobalamin, which is then bound by haptocorrin, a
proteinreleasedinsaliva.Thehaptocorrin–cobalamin
complex passes into the duodenum where it is degraded, again releasing free cobalamin. This is then
bound by intrinsic factor, which is produced within
the stomach by the gastric parietal cells. The intrinsic
factor–cobalamin complex binds to cubilin receptors
in the ileum and the cobalamin is then taken up and
transported around the body by the three transcobalamin transporter proteins.
In the elderly, pernicious anemia associated with
loss of gastric parietal cells accounts for 15–20% of
cases of cobalamin deficiency, while most other cases
are the product of malabsorption due to atrophy of
cells within the gastric mucosa, atrophy of the ileum,
or bacterial overgrowth of the small intestine. Infection with _Helicobacter pylori_ can also contribute to
cobalamin malabsorption. Cobalamin deficiency can
be treated, with rapid improvements in associated
symptoms. Treatment protocols seek to build up and



**Nutrition, Aging, and the Elderly** **249**





































maintain cobalamin reserves through repeated highdose depot injections, as the underlying gastrointestinal causes of deficiency are unlikely to be resolved
(Reynolds, 2006).


**9.6.4.3 Folic acid deficiency**
Folic acid deficiency is generally considered to be uncommon in westernized countries, although in some
parts of the world, prevalence may be high and related to poverty (Olivares _et al_ ., 2000; Antony, 2001).
Flood and Mitchell (2007) found low-serum folate
in 2.3% of older Australians, which is in line with
estimates from elsewhere (Clarke, 2006). Unlike vitamin B12 deficiency in the elderly, folate deficiency will
arise purely through inadequate intakes. It is simply
treated through the administration of supplements
(1 mg folic acid per day).
Any intervention to increase folic acid intakes,
whether through supplementation or fortification of
staple foods, in the elderly must be handled with caution. Folic acid repletion can have important consequences for the individuals in the population who are
vitamin B12 deficient. B12 deficiency is often unrecognized as the clinical symptoms are often regarded
as normal features of aging. Most diagnosis is through
the identification of megaloblastic anemia in routine blood sampling, with follow-up measurements



**Figure 9.9** The absorption of vitamin B12 (cobalamin).


of methylmalonate, or cobalamin. Increased folic acid
intakes can mask the hematological signs of vitamin
B12 deficiency by resolving the megaloblastic anemia,
but do not remove the other consequences of B12
deficiency. Folic acid may also be toxic to individuals with B12 deficiency and accelerate neurological
damage. For this reason, many people have expressed
concerns about the general fortification of foods with
folic acid, aimed at preventing spina bifida and improving population’s cardiovascular health (Cuskelly
_et al_ ., 2007).


**9.6.4.4 Cognitive impairment and anemia**
A number of progressive disorders of the brain, including Alzheimer’s disease (AZD), lead to cognitive
impairments and dementia (loss of memory, reasoning, and capacity to carry out mental tasks) in the elderly. Approximately 6–8% of the elderly population
in westernized countries will suffer from AZD. High
circulating concentrations of homocysteine have been
noted in patients with AZD and appear to precede
the onset of any cognitive impairments (McCaddon
_et al_ ., 1998). As elevated homocysteine could be toxic
to neuronal tissue, through oxidative processes or disruption of neuronal metabolism, there has been a
major interest in the potential role of the B vitamins,
particularly folic acid and vitamin B12, which play a



**250** **Nutrition: A Lifespan Approach**


pivotal role in determining homocysteine metabolism
(see Section “Folic acid and plasma homocysteine” in
Chapter 8).
Vitamin B12 deficiency has long been associated
with cognitive problems. The deficiency manifests as
both hematological and neuronal abnormalities, and
a high prevalence of neuropsychiatric disorders and
memory impairment is seen in patients with B12
deficiency (Malouf _et al_ ., 2003a). Importantly lowcirculating B12 is noted in individuals with AZD and
other forms of dementia. Folate is also of major importance within the brain and individuals with low
folate status are at significantly greater risk of developing AZD. Other psychological disorders including
depression are linked to low-circulating folate, and
this may reflect the role of this vitamin as a cofactor
for the synthesis of certain neurotransmitters, including serotonin (Malouf _et al_ ., 2003b). Moreover, folate
is important in the repair of DNA damage, so a limiting supply may allow the accumulation of oxidative
damage associated with the amyloid beta peptide in
AZD.

The associations between the B vitamins, AZD,
and dementia may not be causal, despite the plausible mechanisms that have been advanced. Individuals
with dementia are highly likely to become malnourished and hence develop anemia as a result of their
psychological difficulties. Dementia impacts upon all
areasofself-careandtheabilitytoshop,cook,andfeed
declines. It is therefore difficult to determine whether
poor intakes or absorption of B vitamins associated
with anemia promote dementia, or vice versa. Trials
that have evaluated whether supplementation with
vitamin B12 (Malouf _et al_ ., 2003a), folate, or folate
plus vitamin B12 (Malouf _et al_ ., 2003b) have found
little evidence to suggest that such interventions can
improve the cognitive function of the demented or
cognitively impaired.


~~**Summary Box 9**~~


On a global scale, the numbers of elderly people in the population
are increasing rapidly. Greater lifespan means that nutrition-related
health problems associated with aging are set to become more
prevalent.
Aging-related declines in physiological functions are a product
of the accumulation of cells with a senescent phenotype within
tissues. Cellular senescence may be driven by oxidative processes,
but telomere shortening and activation of the INK4a pathway also



provide important mechanisms for limiting the normal lifespan of
cellular functions.
CR may provide a means for extension of lifespan. However,
this modulation of rates of aging may be effective only when
introduced early in life. The adverse impact of CR on human health
and well-being may offset any benefit of a longer lifespan.
The elderly have similar nutrient requirements to younger
adults, but declining energy expenditure means that the optimal
diet should be more nutrient dense.
The elderly population are the main at-risk group for malnutrition in developed countries. Risk is associated with physical decline
and chronic disease, with poverty, social isolation, institutionalization, and a lack of knowledge of food and nutrition.
Osteoporosis is a condition that primarily affects the elderly.
Optimal intakes of vitamin D and calcium may reduce the risk of
falls and fractures.
The elderly are at high risk of gastrointestinal diseases, some of
which will impact upon other aspects of health through impairment
of the absorption of key micronutrients.
There is a high prevalence of anemia among the elderly population, with macrocytic anemias associated with vitamin B12 and
folate deficiencies predominating. Anemia in the elderly is most
commonly a product of chronic disease, but risk is also driven by
malabsorption and other factors associated with malnutrition.


**References**


Abbassi AA and Rudman D (1994) Undernutrition in the nursing
home: prevalence, consequences, causes and prevention. _Nutri-_
_tion Reviews_ **52**, 113–122.
Aihie Sayer A, Dunn R, Langley-Evans S, and Cooper C (2001)
Prenatal exposure to a maternal low protein diet shortens life
span in rats. _Gerontology_ **47**, 9–14.
Almanza BA, Namkung Y, Ismail JA, and Nelson DC (2007) Clients’
safe food-handling knowledge and risk behavior in a homedelivered meal program. _Journal of the American Dietetic Associ-_
_ation_ **107**, 816–821.
Andr`esE, Loukili NH, NoelE _etal._ (2004)VitaminB12(cobalamin)
deficiency in elderly patients. _Canadian Medical Association Jour-_
_nal_ **171**, 251–259.
Antony AC (2001) Prevalence of cobalamin (vitamin B-12) and
folate deficiency in India–audi alteram partem. _American Journal_
_of Clinical Nutrition_ **74**, 157–159.
Atkinson C, Compston JE, Day NE, Dowsett M, and Bingham SA
(2004) The effects of phytoestrogen isoflavones on bone density
in women: a double-blind, randomized, placebo-controlled trial.
_American Journal of Clinical Nutrition_ **79**, 326–333.
Bischoff-Ferrari HA and Dawson-Hughes B (2007) Where do we
stand on vitamin D? _Bone_ **41** (1, Suppl. 1), S13–S19.
Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC _et al._ (2004)
Effect of vitamin D on falls: a meta-analysis. _Journal of the Amer-_
_ican Medical Association_ **291**, 1999–2006.
Bischoff-Ferrari HA, St¨ahelin HB, Dick W _et al._ (2003) Effects of
vitamin D and calcium supplementation on falls: a randomized
controlled trial. _Journal of Bone and Mineral Research_ **18**, 343–
351.
Boonen S, Lips P, Bouillon R, Bischoff-Ferrari HA, Vanderschueren
D, and Haentjens P (2007) Need for additional calcium to reduce
theriskofhipfracturewithvitaminDsupplementation:evidence



fromacomparativemetaanalysisofrandomizedcontrolledtrials.
_Journal of Clinical Endocrinology and Metabolism_ **92**, 1415–1423.
Broe KE, Chen TC, Weinberg F, Bischoff-Ferrari HA, Holick MF,
and Kiel DP (2007) A higher dose of vitamin D reduces the risk
of falls in nursing home residents: a randomized, multiple-dose
study. _Journal of the American Geriatric Society_ **55**, 234–239.
Brownie S (2006) Why are elderly individuals at risk of nutritional
deficiency? _International Journal of Nursing Practice_ **12**, 110–118.
Campisi J (1997) The biology of replicative senescence. _European_
_Journal of Cancer_ **33**, 703–709.
Carrier N, Ouellet D, and West GE (2007) Nursing home food
services linked with risk of malnutrition. _Canadian Journal of_
_Dietetic Practice and Research_ **68**, 14–20.
Castle SC, Uyemura K, Fulop T, and Makinodan T (2007) Host
resistance and immune responses in advanced age. _Clinics in_
_Geriatric Medicine_ **23**, 463–479.
Chakkalakal DA (2005) Alcohol-induced bone loss and deficient
bone repair. _Alcoholism, Clinical and Experimental Research_ **29**,
2077–2090.
Chandra RK (2004) Impact of nutritional status and nutrient supplements on immune responses and incidence of infection in
older individuals. _Ageing Research Reviews_ **3**, 91–104.
Clarke R (2006) Vitamin B12, folic acid, and the prevention of
dementia. _New England Journal of Medicine_ **354**, 2817–2819.
Clarke R, Refsum H, Birks J _et al._ (2003) Screening for vitamin
B-12 and folate deficiency in older persons. _American Journal of_
_Clinical Nutrition_ **77**, 1241–1247.
Collado M, Blasco MA, and Serrano M (2007) Cellular senescence
in cancer and aging. _Cell_ **130**, 223–233.
Cuskelly GJ, Mooney KM, and Young IS (2007) Folate and vitamin
B12: friendly or enemy nutrients for the elderly. _Proceedings of_
_the Nutrition Society_ **66**, 548–558.
D’SouzaAL(2007)Ageingandthegut. _PostgraduateMedicalJournal_
**83**, 44–53.
Dawson-Hughes B, Harris SS, Krall EA, and Dallal GE (2000) Effect
of withdrawal of calcium and vitamin D supplements on bone
mass in elderly men and women. _American Journal of Clinical_
_Nutrition_ **72**, 745–750.
DEFRA (2000) _National Food Survey: 2000: Annual Report on Food_
_Expenditure, Consumption and Nutrient Intakes_ . Department of
the Environment, Food and Rural Affairs, London.
Delmi M, Rapin CH, Bengoa JM, Delmas PD, Vasey H, and Bonjour JP (1990) Dietary supplementation in elderly patients with
fractured neck of the femur. _Lancet_ **335**, 1013–1016.
Department of Health (1999) _Dietary Reference Values for Food_
_Energy and Nutrients for the United Kingdom_ . The Stationery
Office, London.
Dhesi JK, Jackson SH, Bearne LM _et al._ (2004) Vitamin D supplementation improves neuromuscular function in older people
who fall. _Age and Ageing_ **33**, 589–595.
DiDanieleN,CarbonelliMG,CandeloroN,IacopinoL,DeLorenzo
A, and Andreoli A (2004) Effect of supplementation of calcium
andvitaminDonbonemineraldensityandbonemineralcontent
in peri- and post-menopause women: a double-blind, randomized, controlled trial. _Pharmacological Research_ **50**, 637–641.
Dirks AJ and Leeuwenburgh C (2006) Caloric restriction in humans: potential pitfalls and health concerns. _Mechanisms of Age-_
_ing and Development_ **127**, 1–7.
Donini LM, De Felice MR, Tagliaccica A, De Bernardini L, and
Cannella C (2005) Nutritional status and evolution of pressure
sores in geriatric patients. _Journal of Nutrition, Health and Ageing_
**9**, 446–454.
Eastwood C, Davies GJ, Gardiner FK, and Dettmar PW (2002)
Energy intakes of institutionalised and free-living older people.
_Journal of Nutrition, Health and Ageing_ **6**, 91–92.



**Nutrition, Aging, and the Elderly** **251**


Eisenstaedt R, Penninx BW, and Woodman RC (2006) Anemia in
the elderly: current understanding and emerging concepts. _Blood_
_Reviews_ **20**, 213–226.
Flood V and Mitchell P (2007) Folate and vitamin B12 in older
Australians. _Medical Journal of Australia_ **186**, 321–322.
Fontana L, Meyer TE, Klein S, and Holloszy JO (2004) Long-term
calorie restriction is highly effective in reducing the risk for
atherosclerosis in humans. _Proceedings of the National Academy_
_of Sciences of the United States of America_ **101**, 6659–6663.
Frankenfeld CL, Atkinson C, Thomas WK _et al._ (2005) High concordance of daidzein-metabolizing phenotypes in individuals
measured 1 to 3 years apart. _British Journal of Nutrition_ **94**, 873–
876.
Gariballa S and Forster S (2007) Malnutrition is an independent
predictor of 1-year mortality following acute illness. _British Jour-_
_nal of Nutrition_ **98**, 332–336.
Garnero P, Borel O, Grant SF, Ralston SH, and Delmas PD
(1998) Collagen Ialpha1 Sp1 polymorphism, bone mass, and
bone turnover in healthy French premenopausal women: the
OFELY study. _Journal of Bone and Mineral Research_ **13**, 813–
817.
Girodon F, Lombard M, Galan P _et al._ (1997) Effect of micronutrient supplementation on infection in institutionalized elderly
subjects: a controlled trial. _Annals of Nutrition and Metabolism_
**41**, 98–107.
Griep MI, Mets TF, Vercruysse A _et al._ (1995) Food odor thresholds in relation to age, nutritional, and health status. _Journal of_
_Gerontology Series A_ : _Biological Sciences and Medical Sciences_ **50**,
B407–B414.
High KP (2001) Nutritional strategies to boost immunity and prevent infection in elderly individuals. _Clinical Infectious Diseases_
**33**, 1892–1900.
Hirani V and Primatesta P (2005) Vitamin D concentrations among
people aged 65 years and over living in private households and
institutions in England: population survey. _Age and Ageing_ **34**,
485–491.
Hoffmann JC and Zeitz M (2002) Small bowel disease in the elderly:
diarrhoea and malabsorption. _Best Practice and Research. Clinical_
_Gastroenterology_ **16**, 17–36.
Hughes G, Bennett KM, and Hetherington MM (2004) Old and
alone: barriers to healthy eating in older men living on their
own. _Appetite_ **43**, 269–276.
Izaks GJ, Westendorp RG, and Knook DL (1999) The definition
of anemia in older persons. _Journal of the American Medical_
_Association_ **281**, 1714–1717.
Janzen V, Forkert R, Fleming HE _et al._ (2006) Stem-cell ageing
modified by the cyclin-dependent kinase inhibitor p16INK4a.
_Nature_ **443**, 421–426.
Jennings BJ, Ozanne SE, Dorling MW, and Hales CN (1999) Early
growth determines longevity in male rats and may be related to
telomere shortening in the kidney. _FEBS Letters_ **448**, 4–8.
Kanis JA, Johnell O, Oden A, De Laet C, Jonsson B, and Dawson
A (2002) Ten-year risk of osteoporotic fracture and the effect of
risk factors on screening strategies. _Bone_ **30**, 251–258.
Keen R (2007) Osteoporosis: strategies for prevention and management. _Best Practice and Research: Clinical Rheumatology_ **21**,
109–122.
Langley-Evans SC, and Sculley DV (2006) The association between
birthweight and longevity in the rat is complex and modulated
by maternal protein intake during fetal life. _FEBS Letters_ **580**,
4150–4153.
Law M, Withers H, Morris J, and Anderson F (2006) Vitamin D
supplementation and the prevention of fractures and falls: results
of a randomised trial in elderly people in residential accommodation. _Age and Ageing_ **35**, 482–486.



**252** **Nutrition: A Lifespan Approach**


Malouf R and Areosa Sastre A (2003a). Vitamin B12 for cognition.
_Cochrane Database of Systematic Reviews_ CD004326.
Malouf M, Grimley EJ, and Areosa SA (2003b). Folic acid with
or without vitamin B12 for cognition and dementia. _Cochrane_
_Database of Systematic Reviews_ CD004514.
Mamhidir AG, Karlsson I, Norberg A, and Mona K (2007) Weight
increase in patients with dementia, and alteration in meal routines and meal environment after integrity promoting care. _Jour-_
_nal of Clinical Nursing_ **16**, 987–996.
Margetts BM, Thompson RL, Elia M, and Jackson AA (2003) Prevalence of risk of undernutrition is associated with poor health
status in older people in the UK. _European Journal of Clinical_
_Nutrition_ **57**, 69–74.
Marshall BJ (1994) Helicobacter pylori. _American Journal of Gas-_
_troenterology_ **89** (8 Suppl.), S116–S128.
Martin CT, Kayser-Jones J, Stotts N, Porter C, and Froelicher ES
(2005) Factors contributing to low weight in community-living
older adults. _Journal of the American Academy of Nurse Practi-_
_tioners_ **17**, 425–431.
Massie HR, Aiello VR, and Doherty TJ (1984) Dietary vitamin C
improves the survival of mice. _Gerontology_ **30**, 371–375.
McCaddon A, Davies G, Hudson P, Tandy S, and Cattell H (1998)
Total serum homocysteine in senile dementia of Alzheimer
type. _International Journal of Geriatric Psychiatry_ **13**, 235–
239.
McEvoy A, Dutton J, and James OF (1983) Bacterial contamination
of the small intestine is an important cause of occult malabsorption in the elderly. _British Medical Journal_ **287**, 789–793.
McWhirter JP and Pennington CR (1994) Incidence and recognition of malnutrition in hospital. _British Medical Journal_ **308**,
945–948.
Morgan DB, Newton HM, Schorah CJ, Jewitt MA, Hancock MR,
and Hullin RP (1986) Abnormal indices of nutrition in the elderly: a study of different clinical groups. _Age and Ageing_ **15**,
65–76.
Morley JE (2007) Constipation and irritable bowel syndrome in the
elderly. _Clinics in Geriatric Medicine_ **23**, 823–832.
Mukhopadhyay D and Mohanaruban K (2002) Iron deficiency
anaemia in older people: investigation, management and treatment. _Age and Ageing_ **31**, 87–91.
Muller FL, Lustgarten MS, Jang Y, Richardson A, and Van Remmen
H (2007) Trends in oxidative aging theories. _Free Radical Biology_
_and Medicine_ **43**, 477–503.
National Diet and Nutrition Survey (1998) _National Diet and Nu-_
_trition Survey: People Aged 65 Years and Over_ . The Stationery
Office, London.
Olivares M, Hertrampf E, Capurro MT, and Wegner D (2000)
Prevalence of anemia in elderly subjects living at home: role
of micronutrient deficiency and inflammation. _European Journal_
_of Clinical Nutrition_ **54**, 834–839.
Omran ML and Morley JE (2000) Assessment of protein energy
malnutrition in older persons, Part I: history, examination, body
composition, and screening tools. _Nutrition_ **16**, 50–63.
Ozanne SE and Hales CN (2004) Lifespan: catch-up growth and
obesity in male mice. _Nature_ **427**, 411–412.
Rapuri PB, Gallagher JC, and Haynatzka V (2003) Protein intake:
effects on bone mineral density and the rate of bone loss in
elderly women. _American Journal of Clinical Nutrition_ **77**, 1517–
1525.
Rapuri PB, Gallagher JC, Kinyamu HK, and Ryschon KL (2001)
Caffeine intake increases the rate of bone loss in elderly women
and interacts with vitamin D receptor genotypes. _American Jour-_
_nal of Clinical Nutrition_ **74**, 694–700.
Reynolds E (2006) Vitamin B12, folic acid, and the nervous system.
_Lancet Neurology_ **5**, 949–960.



Rockey DC and Cello JP (1993) Evaluation of the gastrointestinal tract in patients with iron-deficiency anemia. _New England_
_Journal of Medicine_ **329**, 1691–1695.
Romero-Corral A, Montori VM, Somers VK _et al._ (2006) Association of bodyweight with total mortality and with cardiovascular
events in coronary artery disease: a systematic review of cohort
studies. _Lancet_ **368**, 666–678.
Roseman MG (2007) Food safety perceptions and behaviors of
participants in congregate-meal and home-delivered-meal programs. _Journal of Environmental Health_ **70**, 13–21.
Roy MA and Payette H (2006) Meals-on-wheels improves energy
and nutrient intake in a frail free-living elderly population. _Jour-_
_nal of Nutrition Health and Ageing_ **10**, 554–560.
Selman C, McLaren JS, Meyer C _et al._ (2006) Life-long vitamin C
supplementation in combination with cold exposure does not
affect oxidative damage or lifespan in mice, but decreases expression of antioxidant protection genes. _Mechanisms of Ageing and_
_Development_ **127**, 897–904.
Shea B, Wells G, Cranney A _et al._ ; Osteoporosis Methodology
Group; Osteoporosis Research Advisory Group (2004) Calcium supplementation on bone loss in postmenopausal women.
_Cochrane Database of Systematic Reviews_ CD004526.
Sohal RS, Kamzalov S, Sumien N _et al._ (2006) Effect of coenzyme
Q10 intake on endogenous coenzyme Q content, mitochondrial
electron transport chain, antioxidative defenses, and life span of
mice. _Free Radical Biology and Medicine_ **40**, 480–487.
Sohal RS, Mockett RJ, and Orr WC (2002) Mechanisms of aging: an
appraisal of the oxidative stress hypothesis. _Free Radical Biology_
_and Medicine_ **33**, 575–586.
Speakman JR and Hambly C (2007) Starving for life: what animal
studies can and cannot tell us about the use of caloric restriction to prolong human lifespan. _Journal of Nutrition_ **137**, 1078–
1086.
Stear SJ, Prentice A, Jones SC, and Cole TJ (2003) Effect of a calcium
and exercise intervention on the bone mineral status of 16-18y-old adolescent girls. _American Journal of Clinical Nutrition_ **77**,
985–992.
Steensma DP and Tefferi A (2007) Anemia in the elderly: how
should we define it, when does it matter, and what can be done?
_Mayo Clinic Proceedings_ **82**, 958–966.
Stein MS, Wark JD, Scherer SC _et al._ (1999) Falls relate to vitamin D and parathyroid hormone in an Australian nursing home
and hostel. _Journal of the American Geriatrics Society_ **47**, 1195–
1201.
Stratton RJ, Ek AC, Engfer M _et al._ (2005) Enteral nutritional support in prevention and treatment of pressure ulcers: a systematic
review and meta-analysis. _Ageing Research Reviews_ **4**, 422–450.
Stratton RJ and Elia M (2006) Deprivation linked to malnutrition
risk and mortality in hospital. _British Journal of Nutrition_ **96**,
870–876.
Stratton RJ, Hackston A, Longmore D _et al._ (2004) Malnutrition
in hospital outpatients and inpatients: prevalence, concurrent
validity and ease of use of the “malnutrition universal screening
tool” (“MUST”) for adults. _British Journal of Nutrition_ **92**, 799–
808.
Sund-Levander M, Grodzinsky E, and Wahren LK (2007) Gender
differences in predictors of survival in elderly nursing-home residents: a 3-year follow up. _Scandinavian Journal of Caring Sciences_
**21**, 18–24.
Suominen M, Muurinen S, Routasalo P _et al._ (2005) Malnutrition
and associated factors among aged residents in all nursing homes
in Helsinki. _European Journal of Clinical Nutrition_ **59**, 578–583.
World Health Organisation (2007) Dataand statisticsaccessed from
http://www.who.int/research/en/. Page last visited November 29,
2007.



Young GS and Kirkland JB (2007) Rat models of caloric intake and
activity: relationships to animal physiology and human health.
_Applied Physiology, Nutrition and Metabolism_ **32**, 161–176.
Zaidi A (2006) _Poverty of Elderly People in EU25_ . European Centre
for Social Welfare Policy and Research. Vienna.


**Self-Assessment Questions**


Assess your understanding of the concepts outlined in
this chapter using the following questions:


1 Describe the major theories that explain how cellular
and tissue functions decline with aging.
2 How does CR extend lifespan?
3 Discuss how the nutrient requirements of elderly people may differ from those of younger adults.



**Nutrition, Aging, and the Elderly** **253**


Zakai NA, Katz R, Hirsch C _et al._ (2005) A prospective study of
anemia status, hemoglobin concentration, and mortality in an
elderly cohort: the Cardiovascular Health Study. _Archives of In-_
_ternal Medicine_ **165**, 2214–2220.


4 What are the main factors that promote malnutrition
among elderly people?
5 Describe the pathology of osteoporosis. How might nutritional interventions be used to prevent this disease?
6 Anemia is common among elderly people. What are
the different forms of anemia and why are they so
prevalent in this age group?



# **10**

### **Personalized Nutrition**

**Learning objectives**


By the end of this chapter the reader should be able to:


r Describe the reasons why a personalized approach to
nutritional advice may be of benefit to the health of
individuals and populations.
~~r~~ ~~Discuss the basis of the variability in the individual re-~~
sponse to nutrition.
r Show an understanding of how genetic factors control
food intake and nutrient bioavailability.
r Describe how nutrients can directly regulate gene expression.
r Discuss the main techniques used in nutrigenomics,
proteomics, and metabolomics, showing an under

**10.1 Introduction**


The earlier chapters of this book have each dealt with
a particular life stage, considering the major nutritional demands and ongoing physiological processes
that accompany that point in the lifespan. These chapters have moved from the factors that promote fertility and hence conception, through stages of fetal life,
childhood, and adolescence and into the adult years
and how nutrition impacts upon aging. Throughout,
this work has addressed how nutrition-related factors

determinethebalancebetweenhealthanddiseaseand,
where appropriate, how nutrition could be used as a
tool for disease prevention in the wider population.
A range of disease-prevention strategies have been
discussed, moving from approaches that involve education and information-giving (e.g., the labeling of
foods to indicate fat, sugar, and sodium content)
through to population-based fortification interventions (e.g., the Universal Salt Iodization program).
These approaches are, with few exceptions, very
crude and inefficient. Information-giving through the
medium of food labels or health education leaflets will
onlyeverinfluencethebehaviorsoftheminorityofindividuals who are already motivated to make changes



standing of the limitations of these approaches in the
study of human nutrition and disease.
r Give an overview of some of the key polymorphisms
that have been linked to human obesity, cardiovascular disease, and cancer.
~~r~~ ~~Discuss how environmental factors, including nutrition,~~
at all points of the lifespan can shape the nature of
nutrient–gene interactions at any given point in time.
r Show an understanding of the limitations of modern
molecular methods as tools for the promotion of good
health and prevention of disease.


to their diet and lifestyle. Mass fortification and supplementation programs, on the other hand, can be
very effective in reaching the individuals in the population who require nutritional support. However, this
approach is hugely expensive and wasteful of resource,
as many people without nutritional deficiencies are
also included in the program.
Information-giving and similar health promotion
activities are elements of an approach to improving
public health that takes the view that all of the individuals in a population are responsible for their own
health. Inotherwords, governments provide guidance
and information on what constitutes a healthy diet
and lifestyle and each member of society makes the
decision on whether or how to respond to this advice.
This is a strategy that will always produce low success rates for obvious reasons relating to motivation,
understanding of the health messages, and conflicting
messages from the food industry and media.
Fortification typifies the opposite approach,
whereby governments can implement interventions
that impact on almost all people in a population without any requirement for individual decision making.
This will produce higher success rates, but such interventions carry potential risks. As well as wasting,



often scarce, health resources, there is the possibility
that the intervention may cause harm to some in the
population. This situation is best exemplified by debates surrounding proposed folic acid fortification of
grains in the UK. Fortification should drastically reduce the incidence of neural tube defects and would
bring cardiovascular benefits to millions of people.
However, balanced against this is the possibility of
causing some deaths from cancer and driving cobalamin deficiency-related disorders in the elderly.
This chapter will be exploring the concept of personalized nutrition. This is defined as a means of
health promotion and disease prevention that will
enhance the effectiveness of an individual-based approach to public health nutrition. Advances in the
techniques employed in molecular biology and understanding of nutrient–disease relationships theoretically allow us to screen the genotype of an individual
and consider how that genotype would be expressed
(phenotype) under different nutritional conditions.
Using such information it may become possible to tailor information and advice to individuals and hence

reduce risk of disease.


**10.2 The individual response to variation**
**in food intake**


Long-term disease states such as obesity, cancer, or
coronary heart disease are the products of a number of risk factors, working together, against a battery
of protective factors. Disease is promoted by a poor
diet, smoking, sedentary lifestyle, and adverse early
life programming and these factors all overlie the genetic background of the individual. The genotype will
comprise a complex set of traits that might be disease
promoting (susceptibility genes) or disease suppressing (protective genes). For most disease states more
than one gene will be driving the components of risk.
Due to the complexity of the genetic determinants
of physiological function, individuals will respond to
environmental challenges, including nutritional signals in different ways. For example, some individuals will have a genetic make-up that promotes highenergy expenditure. This enables them to maintain a
healthy weight at a level of energy intake that is sufficient to promote obesity in other individuals, who
may instead carry obesity-promoting genes. As described in Chapter 8, the cardiovascular benefits of a



**Personalized Nutrition** **255**


diet rich in folates may be restricted to those in the
population who carry specific variants of the methyltetrahydrofolate reductase (MTHFR) gene. This second example leads us to the key question of how and
why individuals vary in their response to the diet.
Some of the risk of chronic disease is determined
by single nucleotide polymorphisms (SNPs) that are
variants in the sequences of genes that control specific aspects of physiological and metabolic function
(Joost _et al_ ., 2007). SNPs are now well characterized as
having interactions with components of the diet and
some detailed examples will be discussed in Section
10.4. The aforementioned C677T SNP in MTHFR is

one of the best studied examples and illustrates some
key concepts around the variability of the individual response to diet and the implications this has for
developing personalized nutrition. Within the population there will be three distinct populations based
upon variants of C677T, namely, individuals carrying CC, CT, or TT genotypes. For those carrying TT,
circulating homocysteine concentrations will tend to
be higher and as a result risk of cardiovascular disease
(CVD)iselevated,unlessthedietdeliverssufficientfolate to offset this risk. At face value this gives a tool that
can be exploited for nutritional intervention. Genotyping the population and providing additional folate
in a targeted manner for those with the TT variant
would theoretically reduce the burden of CVD in the
population.
Such a strategy would be flawed for many reasons.
The contribution of a SNP to risk of disease should

not be overestimated. Often, the influence of SNPs is
miniscule compared to the impact of lifestyle factors.
For example, a variant of the calpain-10 gene is associated with a 20% increase in risk of type 2 diabetes,
which is dwarfed by the 4–30-fold risk that is associated with obesity (Joost _et al_ ., 2007). It should also
be borne in mind that other genetically determined
factors may modulate the influence of the SNP. In the
case of the C677T polymorphism of MTHFR, the influence on disease risk varies between ethnic groups
(Klerk _etal_ .,2002).SomeSNPsposeproblemsinterms
of designing nutritional interventions as they may increase risk of one chronic disease, yet protect against
another. CVD-prone TT MTHFR variant carrying individuals appear to have some protection against cancers of the large intestine (Joost _et al._, 2007).
The complexity of these scenarios will make developing workable strategies for personalized nutrition



**256** **Nutrition: A Lifespan Approach**

















**Figure 10.1** Physiological function is determined by the interplay of genome and diet. Nutrients determine how genes are expressed, namely,
the transcription and translation of the genome to produce the active proteome. Both genome and proteome, in turn, regulate the availability of
nutrients and the influence nutrition has upon the physiological determinants of health and disease.



extremely difficult unless suitable and robust markers
of disease risk can be identified. Moreover, the complexity grows (Figure 10.1), as not only do genes determine the physiological response to nutrients, they
also impact upon aspects of nutrient supply. Appetite
and food choice are under a high degree of genetic
control, and genes determine the functional capacity to absorb, process, and metabolize nutrients and
nonnutrient components of food. On top of this, nutrients themselves determine how genes are expressed
and effectively establish the phenotype of the individual under different states of metabolic challenge,
for example, fed versus fasted, high-fat versus low-fat
diet.
Understanding all of these processes is necessary
before personalized nutrition can move beyond the
realms of theoretical possibility toward a practical
health promotion strategy. Even where a diet–gene
interaction seems relatively straightforward, there are
always unforeseen consequences of hurried intervention. Ordovas _et al_ . (2002) reported a simple relationship between a SNP within the Apolipoprotein A1



gene (APOA1) and circulating HDL-cholesterol concentrations. Individuals carrying the AA variant of
the −75 G/A polymorphism of APOA1 exhibited increases in HDL-cholesterol when they increased their
intake of PUFA from 4% of dietary energy to 8%. In
contrast, individuals with the GG variant decreased
HDL-cholesterol concentrations in response to the
same dietary change. While tempting to screen populations for this SNP and advise individuals regarding
PUFA intake on the basis of the findings, it has to be
borne in mind that increases in PUFA intake for the
AA population would potentially displace other nutrients from the diet, would require increases in antioxidant intake to protect against lipid oxidation, and
could impact upon other unidentified gene–nutrient
interactions and hence have adverse consequences
(Ordovas, 2004).


_**10.2.1 Genes may determine food intake**_

Genes may influence the intake of food and hence nutrients at a variety of different levels. Firstly, the genotype may determine the overall appetite and drive



to consume food. Secondly, genes may exert a finer
control over intake and determine the preference of
an individual for macronutrients. Finally, it is becoming clear that there are genetic determinants of taste
and smell and as a result the genotype will govern the
perceived palatability of foodstuffs and shape food
preferences.


**10.2.1.1 Regulation of food intake**
Food intake is controlled by a complex interplay
of hunger and satiety signals involving gut-derived
polypeptides (e.g., ghrelin, peptide YY, and oxyntomodulin), metabolic parameters (e.g., the blood glucose concentration), neurotransmitters (serotonin,
dopamine), and neuropeptides (e.g., neuropeptide
Y, agouti-related protein, and leptin), all of which
are integrated within the hypothalamus. Although
much is known about this regulatory system, there
are surprisingly few reports of how variance in the
genes encoding these regulatory agents might impact
upon food intake. Those that do exist clearly show
the potential for genetic factors to modulate nutrient
supply through this route. For example, the 5-HT2a
(serotonin) receptor, which is linked to eating disorders, has a SNP that is associated with control of energy intake. Individuals with the minor allele of this
SNP consume approximately 10% less energy than
those with the more common variant (Aubert _et al_ .,
2000). Other genes that have been linked to hunger
and food intake include neuromedin B and proopiomelanocortin (Rankinen and Bouchard, 2006).
Many genes that are associated with monogenic obesity, for example, melanocortin 4 receptor and agoutirelated protein are also linked to hyperphagia, so it is
conceivable that more subtle variants could drive variation in eating behavior.


**10.2.1.2 Regulation of macronutrient intake**
Preferences for macronutrients are of particular relevanceifconsideringpersonalizednutrition.Achieving
a low-fat diet to reduce chronic disease risk would be

particularly difficult in individuals whose genotype
favors a fat-rich diet. Twin and family studies have
produced estimates that suggest between 10–40% of
preferences for fat, carbohydrate, and protein in humans, could be under genetic control (Rankinen and
Bouchard, 2006). Specific genes are yet to be identified, but a number of haplotypes (sets of alleles that
are closely clustered in loci on a chromosome and



**Personalized Nutrition** **257**


consequently tend to be inherited together) have been
highlighted as regions for further investigation. For
example, fat intake is associated with the 12q14.1 region on chromosome 12 and 1p22.1–1q22 on chromosome 1. The 1q43–44 locus region of chromosome
1 appears related to sucrose intake in humans (Tanaka
_et al_ ., 2008).


**10.2.1.3 Regulation of taste**
Humans are able to detect five basic tastes through the
presence of taste receptors on the tongue. These are
sweetness, bitterness, sourness, saltiness, and umami
(the ability to detect monosodium glutamate, Tanaka
_et al_ ., 2008). Perception of these tastes can influence
food choice, especially in children, as bitterness and
sourness prompt rejection, while sweetness, saltiness,
and umami are generally perceived as pleasant. These
tasteperceptionsarefurthermodulatedbythesenseof
smell and signals that indicate the texture of ingested
substances. Together, these signals determine whether
food is perceived as palatable or not.
Much of the work that relates to the genetics of
these processes has been focused upon the perception of bitterness. Bitter compounds in foodstuffs are
generally phytochemicals and many of these have potentially healthy effects within the human body, for
example, the isothiocyanates from cruciferous vegetables or polyphenols in tea and wine. Acceptance or
rejection of these compounds, under genetic control,
may therefore influence food intake and hence risk
of disease. An individual with low tolerance of bitter
compounds of cruciferous vegetables, for example,
may be seen as having a greater risk of bowel cancers.
Studies of the perception of bitterness have largely
focused upon testing for sensitivity for phenylthiocarbamide (PTC). As shown in Table 10.1, around a
quarter of the Caucasian population are unable to detect this bitter chemical unless at high concentrations
(nontasters), while a similar proportion are extremely
sensitive to low concentrations (supertasters; Reed
_et al_ ., 1995). Some of this variation appears related to
the structure of the taste buds of the tongue, but genes
that control taste perception are also involved. There
is a large family of bitter-taste receptor genes. Among
these, TAS2R38 seems to best explain most of the response to PTC. There are three SNPs in this gene and
combinations of alleles for each allow several overall

gene variants to exist (Tanaka _et al_ ., 2008). While the
genotype that gives rise to the supertaster phenotype



**258** **Nutrition: A Lifespan Approach**


**Table 10.1** Variants of the TAS2R38 gene and sensitivity to the bitter
taste of phenylthiocarbamide


Sensitivity Population (%) Gene variant


Nontaster 25 Alanine–valine–isoleucine

Taster 50 Proline–alanine–valine
Supertaster 25 Not identified


Note: Phenylthiocarbamide is a bitter tasting compound
used experimentally to determine sensitivity to bitterness.
Nontasters have a high tolerance of bitter tastes. Supertasters have a strong aversion to bitterness and avoid many
sources of bitter phytochemicals, such as cruciferous vegetables. There are three SNPs in the TAS2R38 gene: Proline
49 alanine, Alanine 262 valine, and Valine 296 isoleucine.


has not been identified and may involve other bitterness receptor genes, the variants linked to nontaster
and taster phenotypes have been characterized. However, there has beennoconvincing demonstrationthat
either the gene variants or taste phenotypes predict
population-wide variance in food choice or disease
risk.

Similar gene variants are likely to be related to other
components of taste and smell perception, and some
progress has been made in identifying these in relation to sweetness, sourness, and umami (Tanaka _et al_ .,
2008). Texture is the other determinant of palatability
and food choice. Fat is a highly desirable component
of food, contributing to a pleasant mouthfeel during mastication. Genes that govern how this is perceived could clearly be of great importance in determining food choice. As yet, no strong candidate genes
have been identified in humans, but in rodents the
CD36 gene appears to control this aspect of palatability and determines the innate preference for fatty
acid-enriched foods (Laugerette _et al_ ., 2005).


_**10.2.2 Genes may determine nutrient**_
_**bioavailability and utilization**_


Ingested micronutrients must be absorbed from the
food matrix, cross the barrier of the gastrointestinal
tract, and then enter the circulation. They are then
transported to the tissues where they are utilized or
stored. These processes involve a large number of specific carrier and transport proteins that are responsible for translocation across the enterocytes, transport
in circulation, and intracellular storage and trafficking. It is conceivable that genetic variability in the
expression of these proteins, at any of these stages of



utilization, may impact upon nutritional status and
hence physiological function.
The absorption of calcium involves a number of
proteins. Calcium is passively absorbed from the food
matrix into intestinal cells. Here, transport to the circulation is dependent upon binding of the Ca [2][+] ion
to calcium-binding protein (CBP). Expression of the
CBPs is regulated by vitamin D3 (calcitriol). Binding of calcitriol to the vitamin D receptor promotes
transcription of CBP and hence increases calcium
absorption. Abrams and colleagues (2005) demonstrated that polymorphisms of the vitamin D receptor,
which are known to determine bone mineralization,
do so by modifying calcium absorption. Adolescents
carrying the minor ff variant of the _Fok1_ genotype
of the vitamin D receptor, absorbed significantly less
calcium than those with the Ff or FF variants.

The distribution of nutrients within cells may also
be influenced by polymorphisms (Hesketh and Villette, 2002). SNPs for the metallothioneins are associated with disease states including diabetes. These
proteinsbindzincandheavymetalsandappearparticularly important in moving zinc between cytoplasm
and nucleus. Absorbed selenium becomes incorporated into the amino acid selenocysteine. This is then
used in the synthesis of selenoproteins, including glutathione peroxidase. When selenium supply is limiting there is a clear hierarchy of utilization of available
mineral, both between tissues and protein type. Selenocysteine is incorporated into proteins due to an
RNA sequence called SECIS (selenocysteine insertion
sequence). It is emerging that there are polymorphic
versions of SECIS and these may explain interindividual differences in how dietary selenium is utilized
(Hesketh and Villette, 2002).


_**10.2.3 Nutritional regulation of gene**_
_**expression**_

Theexpressionofthephenotypeencodedbyanygiven
genotype is dependent upon how the prevailing environment influences the transcription of genes to
mRNA, the subsequent translation to protein, and the
posttranslational modification (e.g., phosphorylation
or splicing) to produce the mature protein. Nutrients
are able to modulate these processes at all levels, but
perhaps have their greatest influence at the level of
gene transcription. In Chapter 4, some of this regulatory capacity was considered in the context of epigenetic modification of DNA. The other main influence



**Personalized Nutrition** **259**

















**Figure 10.2** The mode of action of nuclear receptors. Nuclear receptors (NR) are typically located in the cytosol associated with heat shock
proteins (Hsp). On binding ligand, the ligand–receptor complex forms dimers, which bind to hormone response elements (HRE) on DNA, where
they promote transcription. Coac- coactivator, RNAp-RNA polymerase.



comes through interaction with the proteins known
as transcription factors, which are direct modulators
of gene transcription.
Transcriptionfactorsareregulatoryproteins,which
form complexes centered around RNA polymerase
and hence either promote or repress gene expression.
A proportion of transcription factors are constitutively expressed while others are regulated by signals
that indicate cell cycle stage, or developmental stage.
Many hormones mediate their effects by binding to
transcription factors. The classic examples of this are
the nuclear receptors, a family of proteins including
thesteroidreceptors,thyroidreceptors,andvitaminD
receptor. Their mode of action is shown in Figure 10.2
and essentially involves the binding of receptor–ligand
complexes to specific hormone response elements on
DNA. This interaction is made possible through conformational changes in the receptor, which occur on
ligand binding. Binding to DNA facilitates binding of
coactivator proteins and RNA polymerase and brings
about mRNA synthesis.



When ligand–receptor complexes form, there is the
capacity to form homodimers (two proteins of the
same type) or heterodimers (complexing of different
receptors for two separate ligands), hence allowing
more complex gene-regulatory activities. Within the
nucleus other transcription factors act as coactivator
proteins, which promote transcription or corepressors, which suppress transcription. Most of the transcription factors that are able to sense the nutrient
status of a cell or tissue are of the nuclear receptor
family. These receptors and their ligands are listed in
Table 10.2. Many of the nutrient-sensitive nuclear receptors interact with one another. For example, the
effects of the PPARs are mediated through formation
of heterodimers with the retinoid X receptor within
the nucleus. The sterol-response element binding proteins (SREBPs) are another group of nutrient-sensing
transcription factors. These, however, do not bind a
ligand. Instead, they exist as proteins bound to the endoplasmic reticulum membrane. In response to low
levels of sterols in the membrane, mature SREBPs are



**260** **Nutrition: A Lifespan Approach**


**Table 10.2** Nutrient-sensing nuclear receptor proteins and their
ligands


Protein Ligands


Retinoic acid receptors All-trans retinoic acid
(RARα, RARβ, RARγ) 9- _cis_ -retinoic acid
Retinoid X receptor 9- _cis_ -retinoic acid
(RXR)
Liver X receptor Orphan (regulates cholesterol
and lipid metabolism)
(LXRα, LXRβ)
Peroxisome Free fatty acids
proliferator-activated
receptors

Prostaglandins
(PPARα, PPARγ, PPARδ)
Vitamin D receptor. Vitamin D3 (1, 25-dihydroxy
vitamin D3)
(VDR)
RAR-related orphan Orphan (regulates cholesterol
receptor metabolism)


Note: Orphan receptors are nuclear receptors of known
function, but with no known ligand.


cleaved off, enabling transcription of genes that upregulate cholesterol metabolism.


**10.3 Identifying disease risk biomarkers**


To be able to successfully apply a personalized nutrition strategy, either at an individual level or within
broader populations, it will be necessary to have
biomarkers that provide a reliable indicator of disease risk and the phenotype that arises in response
to a given nutritional or environmental challenge. A
range of modern molecular techniques may allow relevant biomarkers to be identified and utilized as the
basis for personalized advice. One approach is to use
genome-wide genotyping of individuals to profile the
SNPs that are likely to determine their disease-risk
phenotypes (Joost _et al_ ., 2007). Another is to apply
the “’omics” technologies. These comprise nutrigenomics (also called transcriptomics), which analyzes
the genome, proteomics, which analyzes the range of
proteins expressed by the genome and metabolomics,
which analyzes the metabolic profile that is generated
by the proteome in response to controlled nutritional
challenges. One of the difficulties of applying these
techniques to consideration of human health is to



identifyteststhatarerobust,sensitive,andreliableand
which can be performed noninvasively in free-living
individuals (Elliott _et al._, 2007). In all cases, the ideal
is to compare a baseline steady state of gene, protein,
or metabolomic expression with a challenge. Examples of comparisons might include fed versus fasted,
resting versus exercise, or the impact of a lipid-rich
meal compared to a low-fat meal.


_**10.3.1 Nutrigenomics**_


Nutrigenomics is the study of the relationship between nutritional factors and gene expression, and
how this relates to human health. This approach can,
theoretically, define the relationship between a dietary
pattern, or specific nutrient, and the expression of the
wholegenome.Thisisadesirableapproachthatwould
extend knowledge of such relationships well beyond
what is known about certain well-defined SNPs. For
example, while the TT variant of the C677T MTHFR
polymorphism is known to increase risk of coronary
heart disease, it is clear that possibly hundreds of
other polymorphisms will also influence nutritional
biochemistry, in sometimes subtle ways, and hence
modulate this risk. Transcriptomic technologies can
assess how the whole genome responds under specific
challenge situations.
DNA microarrays are the main tools used in transcriptomics.Microarraysallowthesimultaneousmeasurement of the expression of hundreds, thousands,
or tens of thousands of genes within a single sample (Figure 10.3). On an array, DNA oligonucleotides,
corresponding to specific gene sequences, are spotted
ontoasolidmatrix.MessengerRNA,expressedinatissue sample, can be converted to copy DNA by reverse
transcription and in the process labeled with a fluorescent probe. The labeled cDNA is then hybridized to
the sequences on the array, and the bound fluorescent
intensity will be proportional to the level of mRNA
expression in the tissue. Control and test samples can
be labeled using different fluorescent channels and expression in each compared on the same array (Figure
10.3a). Comparing a resting sample to a test (challenge) sample can therefore be used to assess how
the whole genome, or a targeted selection of genes
(e.g., genes involved in atherosclerosis, Figure 10.3b),
responds to the test.
Although of major use in studies involving animal models of nutrition and disease, nutrigenomics
has delivered scant reward in studies of human



(a) (b)


1


2



**Personalized Nutrition** **261**


3


4


Control Test



**Figure 10.3** Microarrays used in transcriptomics. (a) A whole genome array comprising 10 000 oligonucleotide sequences bound to a glass slide.
Test samples and control samples are labeled with fluorescent markers, which can be detected in different channels (e.g., green and red). The
intensity of fluorescence for each spot on the array is proportional to the expression of the gene. For gene 1, the intensity is high in the red channel
suggesting higher expression of that gene in one of the samples. For gene 2, the fluorescent is mostly green suggesting greater expression in the
other sample. (b) A targeted array, in this case, examining the expression of 130 genes involved in atherosclerosis. Here, signal detection is via
a biotin-induced chemiluminescence reaction. As this is detected only in one channel, test, and control samples are hybridized to separate array
chips. Spots are compared across the two chips. It can be seen that genes 3 and 4 are expressed at lower levels in the test than in the control.



nutrition and disease. There are a number of challenges that must be overcome before this technology
can be widely used. Firstly, the sensitivity of microarrays is often too low to be useful. Most effects of
nutrition upon gene expression are small (40–50%
changes), but most arrays can only reliably detect
changes in expression of twofold or greater. Changes
in expression that are detected by microarray need
to be confirmed using more robust techniques such
as quantitative real-time polymerase chain reaction,
which increases costs and the need for sample material. The latter is a major challenge to use of this technology in humans. The only readily available tissue
from human volunteers or patients is usually blood.
While useful for genotyping and characterizing SNPs,
blood is of little use in considering how gene expressionchangesinresponsetonutritionalchallenges.The
metabolically active tissues, liver, muscle, and adipose
tissue can be biopsied, but this is too unpleasant, de


manding, and potentially hazardous (in the case of
liver) for routine, mass screening.


_**10.3.2 Proteomics**_


Proteomics is an approach that is similar to transcriptomics, except that instead of considering gene expression, it allows simultaneous consideration of the
expression of all proteins present within a tissue or
body fluid. In this respect, it allows determination
of the expression of the molecular entities that are
responsible for cellular and tissue function and measurement of how they respond to nutritional or environmental challenges. Proteomic approaches can also
distinguish between immature proteins and those that
become functional only when subject to posttranslational modifications.
The usual technological approach used in proteomic studies involves subjecting a sample to
two-dimensional polyacrylamide gel electrophoresis



**262** **Nutrition: A Lifespan Approach**


Low pH











High pH









**Figure 10.4** Use of two-dimensional (2D) gel electrophoresis in proteomics. Many proteomics experiments use 2D gel electrophoresis to separate
the mixture of proteins in a sample on the basis of their charge and size. As shown in (a) two separating electrophoretic approaches are applied,
in different dimensions. This separation will give a characteristic profile of protein spots on the gel. In the example (b) it can be seen that the
proteins in spots 1 and 2 are expressed in both control and test situations, but spots 3 and 4 are underexpressed in the test. An appropriate mass
spectrometry method, for example, MALDI-TOF (matrix-assisted laser desorption/ionization-time of flight) can be used to identify which protein or
proteins make up these spots of interest.



(2D-PAGE). Initially, all protein is extracted from a
suitable sample. As with nutrigenomics, obtaining
metabolically relevant samples from humans is a major limitation of the technology. The proteins are then
subjected to 2D-PAGE, first separating on the basis of
charge (isoelectric focusing) and then separating on
the basis of molecular mass. This produces a gel with
a series of spots (Figure 10.4), with each spot corresponding to a single protein, or a cluster of proteins
of similar structure. The process can be simplified
(i.e., the number of spots reduced) by prepurifying
the sample to focus on cytosolic or membrane proteins, or proteins from specific organelles (e.g., nuclear or mitochondrial proteins). As shown in Figure
10.4, comparing the density of spots in a test sample
compared to a control (e.g., fasted vs fed) will high


light proteins that may be differentially regulated by
the challenge. Subjecting the material in the spot to a
techniquesuchasmassspectrometrycanthenidentify
the nature of the proteins affected.
The biological material that is most likely to be
sampled from humans, for proteomics, is blood. This
is of some interest as blood will contain proteins involved in signaling between organs, which may be
of some use as biomarkers of health and disease

or nutritional status. For example, there are several
blood-borne proteins (hemoglobin, transferrin, and
ferritin) that can indicate responses of the iron transport system to nutritional challenges. Working with
thebloodproteomeis,however,extremelychallenging
as 99% of blood protein is represented by just 22 proteins. Albumin is present in plasma at a concentration



10 [6] –10 [9] -fold greater than many metabolically interesting proteins and can swamp smaller spots on 2DPAGE gels.
Successes in human proteomics in relation to nutrition and health have been scarce. Much work to date
has been focused upon characterizing the proteome
in specific disease states in order to identify proteins
that may provide early warning of longer term disease outcomes. Meier _et al_ . (2005) used this approach
to screen the urinary proteome of diabetic individuals and identified some putative biomarkers of renal
complications. Comparison of protein expression in
adipose tissue biopsies from obese and lean individuals enabled Xu and colleagues (2006) to identify fatty
acid binding protein as a new biomarker for risk of
the metabolic syndrome.


_**10.3.3 Metabolomics**_


While nutrigenomics and proteomics concern themselves with screening the large biomolecules that
control metabolism, metabolomics relates to measurements of the myriad of small molecules that
participate in and regulate intermediary metabolism.
Isolation of relevant biofluids such as blood plasma,
saliva, or urine permits the simultaneous measurement of hundreds of metabolites using NMR spectroscopy or mass spectrometry. The resulting profile
of what is present in the sample (fatty acids, sterols,
amino acids, sugars, hormones, and cytokines) will
effectively produce a metabolic signature for the moment in time when the sample was collected. Thus,
comparing the profile for the same individual following two different dietary patterns will give a signature
for how that individual responds to a dietary change.
These signatures may prove to also be characteristic
of risk of specific disease states.
There are many technological challenges associated with a metabolomic approach. Firstly, there is
still considerable debate about the best analytical approach (e.g., gas chromatography–mass spectrometry
vs NMR spectroscopy). Secondly, and more importantly, the metabolome is a far more dynamic entity
than the genome or proteome. The profile of intermediates detected in a sample will reflect many factors
other than just the dietary pattern, and all of these
must be controlled for in any analysis. External factors that modulate the metabolic profile include diet,
stress, physical activity, and the colonic microflora



**Personalized Nutrition** **263**


(Gibney _et al_ ., 2005). Influences also come from intrinsic factors such as age, time of day at which the
sample was taken, genotype, reproductive status, and
ongoing disease.
To date, the practical applications of a metabolomic
approach have been limited. However, the future application of the study of metabolic signatures could be
commonplace. An aim of this technology is to build
databases of the average metabolic signatures that are
associated with specific dietary patterns in population
groups. Screening of individuals will allow comparison to these databases and flagging up of responses
that deviate from normality. This would then prompt
appropriate intervention to maintain health.


**10.4 Genetic influences on response to**
**nutrients and disease risk**


_**10.4.1 Obesity**_


Clearly, the etiology of obesity is complex and overall risk is determined by the processes that control
food intake, the metabolism of energy substrates, the
metabolism of lipids and energy expenditure. Risk is
strongly related to inherited factors and, as described
in Chapter 6, there are a number of well-defined
monogenic forms of obesity. For individuals who do
not carry mutations of genes such as _MC4R_, the leptin receptor, or _FTO,_ the overall obesity risk profile is
likely to relate to polymorphisms in a whole cluster
of genes related to food intake and adipocyte biology
and to how nutrition-related factors regulate the expression of those genes. In relation to the adipocyte
alone, there are over 30 candidate genes that may
influence development of adiposity and overweight
(Dahlman and Arner, 2007). These include genes involved in regulating the differentiation of adipocytes
(e.g., PPAR _γ_ ), genes that regulate lipid metabolism
(e.g.,perilipin),genesthatregulatemitochondrialrespiration (e.g., the uncoupling proteins), and the genes
encoding hormones and other signaling molecules
(the adipokines, e.g., tumor necrosis factor _α_ )
For some of these candidate genes there is clear evidence that genetic variation is associated with obese
phenotypes. Uncoupling proteins (UCP) are a class
of protein that are located within the inner mitochondrial membrane. They allow protons within the
intermembrane space to reenter the matrix without
participation in ATP synthesis and thereby uncouple



**264** **Nutrition: A Lifespan Approach**


mitochondrial respiration from ATP generation.
There are three UCPs, amongst which UCP2 is of
greatest interest as it is expressed in most tissues. Adipose tissue from obese subjects expresses UCP2 at
a lower level than is seen in lean individuals (Millet
_et al_ ., 1997), prompting the suggestion that variants
of UCP2 could contribute to obesity risk. Esterbauer
and colleagues (2001) found that the -866GA polymorphism of the UCP2 promoter was related to obesity in a middle-aged population. Individuals with
the GG variant (63% of the population studied) were
40% more likely to be obese than those carrying the
less common AA or GA forms. This SNP appeared to
explain 15% of obesity risk in the study population.
The same polymorphism was shown by Kovacs _et al_ .
(2005) to be associated with 24-h energy expenditure,
suggesting that UCP2 is an important determinant of
energy metabolism in humans.
There is no evidence that variants of UCP2 allow
for genotype-specific responses to dietary change. In
contrast, polymorphic variants in another gene linked
to obesity may explain responses to weight loss diets.
Perilipin(PLIN)isaproteinthatcoatslipiddropletsin
adipocytes. There is evidence that obese subjects overexpress this protein and as a result their lipid stores
areresistanttolipolysis(DahlmanandArner, 2007). A
number of polymorphisms of PLIN have been identified, of which two have been linked to lower BMI
(6209TC and 11482GA) and two linked to greater
obesity risk (13041AG and 14995AT, Qi _et al_ ., 2004).
Women who carry the G variant of 11482GA tend
to have increased rates of lipolysis and are less likely
to be obese. The A allele is associated with greater
obesity and with resistance to weight loss when following a caloric-restriction diet (Corella _et al_ ., 2005).
This suggests that this particular SNP could be a useful biomarker for whether traditional approaches to
weight loss are likely to be successful. However, use
of such a biomarker would be limited, as the associations between PLIN polymorphisms and obesity risk
appear to be confined to women. The relationship
with response to caloric restriction may also be specific to Caucasian populations, as Jang and colleagues
(2005) showed that weight loss was _enhanced_ by the A
allele of 11482GA among Korean subjects.


_**10.4.2 Cardiovascular disease**_


Cardiovascular disease, as described in Chapter 8,
is the product of disorders in a number of pro


cesses including inflammation, endothelial function,
oxidant/antioxidant balance, macrophage function,
lipid metabolism, and cholesterol transport. Genotype variants and adverse nutrient–gene interactions
related to any of these processes can therefore be regarded as candidates that may predispose an individual to atherosclerosis. Apolipoprotein E (ApoE) is one
of the most widely studied of these candidate genes in
thecontextofcoronaryheartdisease.ApoEisaprotein
predominantly secreted by the liver, which plays a role
in the overall regulation of lipoprotein metabolism. It
isakeyelementofthesystemthatclearschylomicrons,
VLDL,andLDLfromthecirculation.ApoEisalsoproducedbymacrophageswithinatherosclerotic plaques,
where it influences expression of adhesion molecules,
proliferation of vascular smooth muscle cells, and
platelet aggregation (Jofre-Monseny _et al_ ., 2008).
There are several well-described SNPs of the ApoE
gene, which give rise to different isoforms of the protein based around three basic alleles (E2, E3, and E4;
see Table 10.3). The E4 allele has been associated with
several disease outcomes. The strongest association is
with Alzheimer’s disease, where homozygous (E4/E4)
individuals are more than 15 times more likely to
develop the disease than those homozygous for the
majority E3 allele (Jofre-Monseny _et al_ ., 2008). Homozygosity for E4 increases risk of atherosclerosis by
42%. The reason for this greater risk is unclear, but
it may be attributable to defects of cholesterol transport, enhanced inflammatory responses, or reduced
antioxidant capacity.
ApoE is of interest as the association of the E4 allele
with disease risk appears to be modulated through
interaction with other, modifiable risk factors.


**Table 10.3** Frequency of apolipoprotein E genotypes in caucasian
populations


E2 E3 E4


E2 1–2% 15% 1–2%

E3 55% 25%

E4 1–2%


Note: The six possible E2, E3, and E4 genotypes for
apolipoprotein E are determined by the possible combinations of protein isoforms arising through two amino acid
substitutions at positions 112 and 158 in the polypeptide
chain. Figures in the table show the estimated percentage
frequency of each variant (E2E2, E2E3, E2E4, etc.) in the
population.



Individuals with the E4 genotype appear to derive
greater benefit from reductions in intakes of total fat,
saturated fats, and cholesterol than those with a low
genetic risk profile. Individuals who carry E4 exhibit
reductions in LDL-cholesterol concentrations with alcohol consumption, while those with the apparently
protective E2 show the opposite response. The same
is true for exercise, which increases HDL-cholesterol
concentrations in individuals with the E4 genotype
(Corella _et al_ ., 2001).
The development and progression of atherosclerosis is heavily determined by inflammatory processes
that drive the initiating endothelial cell dysfunction
andwhichareinvolvedinrecruitmentofmacrophages
to fatty streaks. This recruitment is dependent upon
production of pro-inflammatory cytokines in response to oxidative injury. Antioxidant/oxidant imbalance is sensed through the transcription factor,
NF _κ_ B, which is the main orchestrator of inflammatory responses related to disease. NF _κ_ B promotes
the expression of cytokines, adhesion molecules and
effectively initiates the acute phase response to injury. Expression of NF _κ_ B can be suppressed by
antioxidants.
Genetic variability in susceptibility to inflammatory processes and associated disease, including
atherosclerosis, can be attributed to variance in expression of either NF _κ_ B, the antioxidant system, or
the main pro-inflammatory cytokines (TNF _α_, IL-6,
IL-1 _β_ ). TNF _α_ polymorphisms have attracted particular interest and 9 polymorphisms in a haplotype that
includes TNF _α_, TNF _β_, and leukotriene _β_ have been
shown to determine the magnitude of inflammatory
responses under trauma conditions. Individuals with
a TNFB2 genotype (50% of the population) appear
to be at greater risk of sepsis following trauma than
those with a TNFB1 genotype (7.3% of population;
Majetschak _etal_ .,1999).TheTNFgenotypemaymodulate responses to dietary influences on inflammatory
processes (Paoloni-Giacobino _et al_ ., 2003). For example, individuals homozygous for TNFB2 exhibit elevated concentrations of pro-inflammatory cytokines
and do not exhibit the generally anti-inflammatory
response to consumption of fish oils.


_**10.4.3 Cancer**_


Risk of cancer is influenced by genetic factors in a variety of ways, and the proportion of overall risk for
particular tumor types that can be explained by heri


**Personalized Nutrition** **265**


table factors varies from around 20–25% for ovarian
and stomach cancers, up to 42% for prostate cancer (Lichtenstein _et al_ ., 2000). Some cancers in certain individuals and families may be a consequence
of powerful mutations that directly promote tumorigenesis, such as the breast cancer genes, BRCA1, and
BRCA2. Cancer will also be promoted by genotypes
that are related to specific polymorphisms or clusters
of polymorphisms. In the case of bowel cancer, for example, polymorphisms of the MTHFR gene, the APC
tumor suppressor gene (related to familial adenomatous polyposis), and the HRas1 gene, are robustly associated with disease risk (Houlston and Tomlinson,
2001). While the TT variant of C677T MTHFR lowers
risk by 25%, the tandem repeat polymorphism of the
oncogene HRas1 increases risk by 2.5-fold.
Nutrient–gene interactions and their influence
upon cancer risk have already been discussed in the
context of MTHFR in Chapter 8. There are other examples of major interest, however, which merit further discussion. Oxidative damage to DNA is a key
step in the development of some cancers. Genotyperelated variance in the profile of antioxidant enzyme
mediated protection may therefore explain some variability in cancer risk and also the variability in the individual response to antioxidant nutrients in the diet,
or administered through supplementation. Much interest has focused upon variants in the gene encoding manganese superoxide dismutase (MnSOD).
MnSOD is a mitochondrial enzyme that plays a
key role in quenching the superoxide radicals produced during respiration. It, therefore, limits damage to mitochondrial DNA and prevents leakage of
these radicals into other regions of the cell, including
the nucleus. A polymorphism resulting in a change
from a valine to an alanine at codon 9 alters the
intracellular trafficking of the MnSOD protein, effectively reducing the amount of enzyme reaching
the mitochondria. Ambrosone _et al_ . (1999) noted
thatamongbothpremenopausalandpostmenopausal
women, homozygosity for the alanine variant increased risk of breast cancer. In premenopausal
women, but not postmenopausal women, the risk
was greater, but modified by consumption of dietary antioxidants. Comparing AA genotype with the
VV or VA genotype, relative risk for breast cancer
was 6.0 if fruit and vegetable consumption was below 764 g/day, while with higher intake relative risk
was 3.2.



**266** **Nutrition: A Lifespan Approach**


The same polymorphism of MnSOD was investigated by Li and colleagues (2005) in the context
of prostate cancer. The AA genotype was noted in
25% of their study population and did not appear to
be associated with risk of prostate cancer until adjusted for plasma biomarkers of antioxidant status.
Risk of cancer was inversely associated with lycopene,
_α_ -tocopherol, and selenium status, with the strongest
associations noted in men with the AA genotype. Risk
ofaggressiveprostatecancerwasstronglyrelatedtoselenium status, but only in men with the AA genotype.
Most importantly, the study demonstrated that supplementation with _β_ -carotene (50 mg every second
day) reduced risk of prostate cancer by 40%, but only
in individuals with the AA genotype. The influence
of selenium status upon cancer risk may also operate through interaction with polymorphic variants of
glutathione peroxidase. A minor variant of the GPx-1
gene in which codon 198 encodes leucine instead of
proline has been associated with increased risk of lung
and bladder cancers (Hesketh, 2008).


**10.5 Nutrient–gene interactions—a**
**lifespan approach**


It is clear from the above discussions that the genotype
canbeanimportantdeterminantofdiseaserisk.However,theinstancesofwhereitisthesoleormajordriver



of risk are rare, and in most cases genetic inheritance
is one of many components that determine the overall
risk profile for chronic disease. For most of the disease
polymorphisms that have so far been identified, the
progression from gene variant to disease is far from
assured.IfwetaketheE4E4genotypeofApoEasanexample, then we see that risk of coronary heart disease
is only 40% above that seen with the majority E3E3
genotype. Even for Alzheimer’s disease it is apparent
that although E4E4 carriers are at very high risk, they
still have a 50% chance of avoiding the disease (Wang
_et al._, 2008). The reason for this is that the same genotype can give rise to multiple phenotypes, due to interaction with the environment, including nutrition.
Developing an understanding of how this phenotypemodulationworksisafundamentalissueinmodern nutrition research. It is already clear that stage in
the life course plays a big role in the process. The
way in which the genotype is expressed is not just the
product of gene–environment interactions ongoing at
any given moment in time. It reflects the cumulative
experience of the individual. Gene–environment interactions at every stage of life produce adaptations
to metabolism, physiology, and endocrine function
that will further shape the responses to the environment and expression of the genotype at later life
stages. Fetal programming (Chapter 4) provides the
primary example of this process in action and examples are emerging from the fields of diabetes (Research



~~**Research Highlight 10**~~ ~~Diabetes risk: Genotype, fetal programming, or an interaction of the two?~~



_Type 2 diabetes and birth anthropometry_
There are firmly established relationships between characteristics at
birth, growth in childhood, and risk of diabetes in adulthood (Barker,
1998). Individuals who are born of lower birth weight or who are
thin at birth (low ponderal index, Phillips _et al_ ., 1994) exhibit significantly greater disease risk, especially if they gain body fat rapidly
in adolescence (Eriksson _et al._, 2002a).


_Polymorphisms associated with type 2 diabetes_
A number of polymorphisms of genes involved in insulin signaling
and metabolic regulation have been identified as playing a causative
role in the etiology of type 2 diabetes. These include the Pro12Ala
polymorphism of PPAR _γ_ -2 (Buzzetti _et al_ ., 2004), the K121Q polymorphism of glycoprotein 1 (PC1, Pizzuti _et al_ ., 1999), and an
insertion/deletion (I/D) polymorphism of angiotensin converting enzyme (ACE).



_Interaction of programming influences_
_and genotype_
The relationship between birth anthropometry and diabetes can be
modified by genotype. The Ala12Ala variant of PPAR _γ_ -2 is beneficial to individuals of lower birth weight, and the association of
birth weight and diabetes may be confined to individuals with the
Pro12Pro genotype (Eriksson _et al_ ., 2002b). Similarly, the Q variant
of the K121Q polymorphism of PC1 is associated with insulin resis~~tance, but only in individuals who were of low weight and shorter~~
stature at birth (Kubaszek _et al_ ., 2004).
Single genotypes can, therefore, give rise to multiple adult phenotypes due to variation in early life experience. Care is needed in interpreting findings relating to both sides of the interaction. The ACE I/D
polymorphism exemplifies the fact that genotype may impact upon
both disease outcome and birth anthropometry. Individuals with the
DD variant are both small at birth and more likely as adults to exhibit
a blunted insulin response to glucose (Kajantie _et al_ ., 2004).



highlight 10), osteoporosis, and CVD to show that
birth anthropometry modulates the influences of
genotype on disease risk. In other words, the early
life experience of the individual determines how the
genotype will be expressed at later life stages.
Within this chapter, it has been stated that polymorphismsrelatedtodiseaserisksometimesappearto
haveinfluencesthatarespecifictogender,menopausal
status,orrace.Itisalsothecasethattheexpressedphenotype may be life stage-specific. This is important in
the context of personalized nutrition as it means that
there may be relatively narrow windows during which
we can screen for disease biomarkers or take preventive action based upon genotyping information.
Ferrari and colleagues (1998) studied the relationship
betweenbonemineraldensityandtheBsm1polymorphism of the vitamin D receptor in a mixed cohort of
adult women, prepubertal girls, and postpubertal girls
(11–18.5 years). It was found that in adults there was
no association between the polymorphism and bone
mineral density at any of the skeletal sites studied.
In the children, and particularly in the prepubertal
group the minority _BB_ genotype was strongly predictive of lower bone mineral density. Supplementation
of prepubertal girls with calcium produced changes in
bone mineral density that were genotype-dependent.
While mineralization was promoted by supplements
in girls with the _BB_ or _Bb_ genotypes, those with _bb_ did
not respond. This study suggested that nutritional intervention at the key life stage might overcome the
negative effects of an adverse genotype. Beyond a key
window in time the genotype becomes less useful as
a predictor of risk and the opportunity to exploit the
biomarker is lost.

For some conditions the relationship between
genotype and disease is hard to explain as the appearance of the condition is age related. For pathology that
appears only in the elderly years, it is problematic to
sift through the huge range of life experiences and environmental interactions that might be involved in the
etiology of the disease. It has been suggested that the
epigenome may play a key role in some of these cases.
Epigenetic regulation of gene expression involves the
tagging of DNA sequences through methylation of
CpG islands (which suppresses gene expression), or
acetylation of histone proteins (which promotes gene
expression). These epigenetic tags are set in early life
and at key stages of life may be modified by the prevailing nutritional environment, or through exposure



**Personalized Nutrition** **267**


to other factors such as tobacco smoking. Age is also
an important modifying factor due to a process called
epigenetic drift.
It is clear that in all mammalian species the level of
methylation across the whole genome declines with
aging (Poulsen _et al_ ., 2007). This can be inconsistent however, and in some cell types the decline may
be rapid, while in others the level of methylation is
stable, or even increases. Loss of methylation might
even be specific to particular gene promoters. The
changes in methylation patterns appear related to agerelated changes in the expression of the DNA methyltransferases that are responsible for maintenance of
the epigenome. Age-related drift in epigenetic control may drive concomitant shifts in gene expression.
Loss of methylation may result in increasing expression of genotypes that had been suppressed at earlier
life stages, hence producing late onset disease. Unless
personalized nutritional advice takes into account assessments of the state of the epigenome, it may be
difficult to effectively predict or target conditions of
this nature.

Alzheimer’s disease provides a key example of
epigenetic drift in relation to known nutritionrelated gene polymorphisms. Ninety-five percent of
Alzheimer’s patients develop their disease late in life.
Risk is related to particular genes and to dysregulation of the folate–methionine–homocysteine cycles.
ApoE is strongly linked to the disease and comparison of methylation patterns in this gene in brains from
affected individuals and healthy individuals revealed
oneregionthatwasstronglyhypermethylated,andanother that was strongly hypomethylated in the disease
cases (Wang _et al_ ., 2008). This suggests that epigenetic
modification may determine the extent to which an
adverse E4 genotype is expressed. Importantly, when
brainsfromyoungindividualswerecomparedtothose
of older patients, it was clear that in healthy people, methylation of ApoE and MTHFR increased over
time,whileinAlzheimer’sdisease,thesegenesreduced
their level of methylation. This is consistent with the
hypothesis that epigenetic drift with aging allows expression of the late onset disease genotype.
Stage of life therefore influences the extent to which
genes determine the risk of disease and the capacity
of the diet to modulate these effects. Understanding
of these processes is at an early stage and it remains
to be seen if and how other key life events such as
pregnancy might open up windows of opportunity



**268** **Nutrition: A Lifespan Approach**


for exploiting these interactions to promote health
and prevent disease.


**10.6 The future of nutritional advice?**


The potential health benefits of developing the necessary tools associated with a personalized nutrition
strategy are great. Personalized nutrition advice could
be used to target interventions that prevent disease,
ensuring greater efficacy of supplementation programs or diet restriction regimens, and limiting the
capacity of population-wide interventions to cause
harm. Furthermore, the same principle could be applied to the treatment and management of chronic
disease, in terms of either dietetic or medical intervention. For example, life expectancy of women with
ovarian cancer is already known to be greater if intakes
of fruits and vegetables are higher. Might this response
to diet be greater in women with particular genotypes
or earlier life experiences than in others? Similarly,
treatmentofbowelcancersusing5-fluorouracil,aninhibitor of pyrimidine nucleotide synthesis, appears to
be more effective in individuals with specific MTHFR
genotypes.
At the present time, the concept of personalized
nutrition remains little more than an ambitious sci
entific goal that may, or may, not be achieved over the
next 10–20 years. There are some significant barriers
to be overcome if the perceived potential benefits to
society are to be achieved. The greatest of these is the
lack of knowledge and understanding of the science
that underpins the nutrient–gene–disease interaction.
Research in this area is still very much in its infancy
and, for example, the extent to which the metabolome
reflectsthegenome,orthemannerinwhichclustersof
genepolymorphismsmightinteractwitheachotherto
shape risk, are poorly understood. While technologies
such as proteomics and DNA microarray are incredibly advanced compared to techniques in use a decade
ago, they are still crude and insensitive tools with major limitations. Until they can be refined and the problems associated with sampling and identifying robust
and reliable biomarkers of disease risk and nutrient–
gene interactions (discussed above) are resolved, then
their application to personalized nutrition advice is
limited.
Despite all of these concerns, there are already the
first signs of the potential exploitation of the personal


ized nutrition concept. The United States Food Pyramid was revamped by the US Department of Agriculture to reflect the fact that individual responses to
nutrients are highly variable. Although no biomarkers are sampled, visitors to the MyPyramid website(http://www.mypyramid.gov/)canobtaintailored
menu advice based upon age, gender, height, weight,
and reproductive stage (i.e., pregnancy or lactation).
More troublingly, commercial enterprises offer personalized nutrition advice based upon genotyping for
specific SNPs, such as C677T MTHFR or ApoE. Until
our knowledge of the nutrient–gene–disease interaction and how it might be modified by life stage, ethnicity, gender, age, and disease status is sufficiently
advanced, such commercial exploitation would seem
unwise and unethical.

Ethical issues represent the final challenge to the full
exploitation of modern molecular techniques as a cornerstone of nutritional advice or intervention. There
are few that would argue against the suggestion that
the goal of being able to offer precise and effective nutritional advice to prevent chronic disease represents
a noble endeavor. Similarly, developing technologies
that enable detection of early predictors of disease risk
sothataffectedindividualscanbeadvisedaccordingly,
is viewed as desirable. The full implications of ’omics
technologies in this context, however, may go beyond
the tolerance of society, leading to the rejection of
their potential.
One major objection of lay people, and of course
the media that inform their opinions, would be the
medicalization of food. There is already widespread
public disdain for the idea that the “food police” (i.e.,
nutritionists) aim to limit consumer choices based
upon health grounds, and for the “mass medication”
of populations through fortification. Blurring the distinction between foods and medicines is unlikely to be
popular and the importance of the hedonistic aspects
of eating and drinking as opposed to the health risks
and benefits should never be overlooked. After all, it
is well established that the average obese patient who
is trying to lose weight, will ignore all of the information and blandishments of a dietitian, simply because
less healthy food smells, looks, and tastes good and
provides a sense of emotional well-being.
Ethical concerns surrounding widespread population screening using ’omics approaches will be difficult to circumvent, even when the technologies have
been enhanced and are more reliable. For example,



there will be issues surrounding the privacy of results and implications for individuals faced with an
adverse nutrigenomic profile. Carrying SNPs that increase risk of premature death from cancer might, for
example,increasethecostoflifeinsurance,oremployers could conceivably discriminate against prospective
workers whose careers may be likely to be foreshortened by chronic disease linked to pro-inflammatory
genotypes. As the complexity of the personalized nutrition profile grows, incorporating larger numbers
of genes, and factoring in lifestyle and life stage elements, the adverse psychological impact of a poor
prognosis upon the recipient and their family could
becomeasdamagingasphysiologicaldisease.Furthermore, there needs to be consideration of who might
take responsibility for interpretation of such complex
data and communicating the true level of risk associated with a personalized nutrition profile to unqualified, untrained patients, and postprofile counseling
if required.


~~**Summary Box 10**~~


One of the goals for nutritionists in the twenty-first century is to be
able to provide reliable, targeted, and personalized nutritional advice to individuals. This would be based upon detailed assessment
of disease risk factors. Such an assessment would encompass analysis of genetic background and prediction of how that background
would determine the response to nutrients.
Genes are important regulators of food intake, nutrient
metabolism, and the influence of diet upon healthy physiology
and disease processes. In turn, gene expression is responsive to
nutritional status.

Gene expression can be controlled by nutritional signals
through nutrient-sensing transcription factors or modification of
the epigenome.
The important tools to be used in developing personalized
nutrition strategies are based around nutrigenomics, proteomics,
and metabolomics.
The interactions between genes and nutrients may be specific
to particular life stages.
The science of personalized nutrition is at an early stage. The
theoretical promise of the ’omics technologies for human health
may require several decades of further research before coming to
fruition.


**References**


Abrams SA, Griffin IJ, Hawthorne KM _et al_ . (2005) Vitamin D receptor Fok1 polymorphisms affect calcium absorption, kinetics,
and bone mineralization rates during puberty. _Journal of Bone_
_and Mineral Research_ **20**, 945–953.



**Personalized Nutrition** **269**


Ambrosone CB, Freudenheim JL, Thompson PA _et al_ . (1999) Manganese superoxide dismutase (MnSOD) genetic polymorphisms,
dietary antioxidants, and risk of breast cancer. _Cancer Research_
**59**, 602–606.
Aubert R, Betoulle D, Herbeth B, Siest G, and Fumeron F (2000) 5HT2A receptor gene polymorphism is associated with food and
alcohol intake in obese people. _International Journal of Obesity_
**24**, 920–924.
Barker DJP (1998) _Mothers, Babies and Health in Later Life._
Churchill Livingstone, Edinburgh
Buzzetti R, Petrone A, Ribaudo MC _et al_ . (2004) The common
PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity. _European Journal of Human Genetics_ **12**, 1050–
1054.
Corella D, Guill´en M, S´aiz C _et al_ . (2001) Environmental factors modulate the effect of the APOE genetic polymorphism
on plasma lipid concentrations: ecogenetic studies in a Mediterranean Spanish population. _Metabolism_ **50**, 936–944.
Corella D, Qi L, Sorl´ı JV _et al_ . (2005) Obese subjects carrying the
11482G _>_ A polymorphism at the perilipin locus are resistant to
weight loss after dietary energy restriction. _Journal of Clinical_
_Endocrinology and Metabolism_ **90**, 5121–5126.
Dahlman I and Arner P (2007) Obesity and polymorphisms in
genes regulating human adipose tissue. _International Journal of_
_Obesity_ **31**, 1629–1641.
Elliott R, Pico C, Dommels Y, Wybranska I, Hesketh J, and Keijer
J (2007) Nutrigenomic approaches for benefit-risk analysis of
foods and food components: defining markers of health. _British_
_Journal of Nutrition_ **98**, 1095–1100.
Eriksson JG, Forsen T, Tuomilehto J, Jaddoe VW, Osmond C, and
Barker DJ (2002a) Effects of size at birth and childhood growth
on the insulin resistance syndrome in elderly individuals. _Dia-_
_betologia_ **45**, 342–348.
Eriksson JG, Lindi V, Uusitupa M _et al_ . (2002b) The effects of
the Pro12Ala polymorphism of the peroxisome proliferatoractivated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth. _Diabetes_ **51**, 2321–

2324.
Esterbauer H, Schneitler C, Oberkofler H _et al_ . (2001) A common
polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. _Nature Genetics_
**28**, 178–183.
Ferrari SL, Rizzoli R, Slosman DO, and Bonjour JP (1998) Do dietary calcium and age explain the controversy surrounding the
relationship between bone mineral density and vitamin D receptor gene polymorphisms? _Journal of Bone and Mineral Research_
**13**, 363–370.
Gibney MJ, Walsh M, Brennan L, Roche HM, German B, and van
Ommen B (2005) Metabolomics in human nutrition: opportunities and challenges. _American Journal of Clinical Nutrition_ **82**,
497–503.
Hesketh J (2008) Nutrigenomics and selenium: gene expression
patterns, physiological targets, and genetics. _Annual Review of_
_Nutrition_ **28**, 157–177.
Hesketh JE and Villette S (2002) Intracellular trafficking of micronutrients: from gene regulation to nutrient requirements.
_Proceedings of the Nutrition Society_ **61**, 405–414.
Houlston RS and Tomlinson IP (2001) Polymorphisms and colorectal tumor risk. _Gastroenterology_ **121**, 282–301.
JangY,KimOY,LeeJH _etal_ .(2005)Geneticvariationattheperilipin
locus is associated with changes in serum free fatty acids and
abdominal fat following mild weight loss. _International Journal_
_of Obesity_ **30**, 1601–1608.
Jofre-Monseny L, Minihane AM, and Rimbach G (2008) Impact of apoE genotype on oxidative stress, inflammation and



**270** **Nutrition: A Lifespan Approach**


disease risk. _Molecular Nutrition and Food Research_ **52**, 131–

145.
Joost HG, Gibney MJ, Cashman KD _et al_ . (2007) Personalised nutrition: status and perspectives. _British Journal of Nutrition_ **98**,
26–31.
Kajantie E, Rautanen A, Kere J _et al_ . (2004) The effects of the ACE
gene insertion/deletion polymorphism on glucose tolerance and
insulin secretion in elderly people are modified by birth weight.
_Journal of Clinical Endocrinology and Metabolism_ **89**, 5738–
5741.
Klerk M, Verhoef P, Clarke R _et al_ . (2002) MTHFR 677C– _>_ T polymorphism and risk of coronary heart disease: a meta-analysis.
_Journal of the American Medical Association_ **288**, 2023–2031.
Kovacs P, Ma L, Hanson RL _et al_ . (2005) Genetic variation in UCP2
(uncoupling protein-2) is associated with energy metabolism in
Pima Indians. _Diabetologia_ **48**, 2292–2295.
Kubaszek A, Markkanen A, Eriksson JG _et al_ . (2004) The association
of the K121Q polymorphism of the plasma cell glycoprotein-1
gene with type 2 diabetes and hypertension depends on size at
birth. _Journal of Clinical Endocrinology and Metabolism_ **89**, 2044–
2047.
Laugerette F, Passilly-Degrace P, Patris B _et al_ . (2005) CD36 involvement in orosensory detection of dietary lipids, spontaneous fat
preference, and digestive secretions. _Journal of Clinical Investiga-_
_tion_ **115**, 3177–3184.
Li H, Kantoff PW, Giovannucci E _et al_ . (2005) Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status,
and risk of clinical significant prostate cancer. _Cancer Research_
**65**, 2498–2504.
Lichtenstein P, Holm NV, Verkasalo PK _et al_ . (2000) Environmental
and heritable factors in the causation of cancer–analyses of cohortsoftwinsfromSweden,Denmark,andFinland. _NewEngland_
_Journal of Medicine_ **343**, 78–85.
Majetschak M, Floh´e S, Obertacke U _et al_ . (1999) Relation of a TNF
gene polymorphism to severe sepsis in trauma patients. _Annals_
_of Surgery_ **230**, 207–214.
Meier M, Kaiser T, Herrmann A _et al_ . (2005) Identification of
urinary protein pattern in type 1 diabetic adolescents with early
diabetic nephropathy by a novel combined proteome analysis.
_Journal of Diabetes Complications_ **19**, 223–232.
Millet L, Vidal H, Andreelli F _et al_ . (1997) Increased uncoupling
protein-2 and -3 mRNA expression during fasting in obese and


**Self-Assessment Questions**


Assess your understanding of the concepts outlined in
this chapter using the following questions:


1 With reference to specific examples, explain how a nutrient can directly modify expression of genes.
2 Describe how genetic factors may influence food intake.
3 Describe the mode of action of the nuclear receptor
family of transcription factors.
4 What is a DNA microarray? How could this be technology be used to assess the sensitivity of an individual to
a specific nutrient or dietary pattern?



lean humans. _Journal of Clinical Investigation_ **100**, 2665–
2670.
Ordovas JM (2004) The quest for cardiovascular health in the genomic era: nutrigenetics and plasma lipoproteins. _Proceedings of_
_the Nutrition Society_ **63**, 145–152.
Ordovas JM, Corella D, Cupples LA _et al_ . (2002) Polyunsaturated
fattyacidsmodulatetheeffectsoftheAPOA1G-Apolymorphism
on HDL-cholesterol concentrations in a sex-specific manner: the
Framingham Study. _American Journal of Clinical Nutrition_ **75**,
38–46.
Paoloni-Giacobino A, Grimble R, and Pichard C (2003) Genomic
interactions with disease and nutrition. _Clinical Nutrition_ **22**,

507–514.
Phillips DI, Barker DJ, Hales CN, Hirst S, and Osmond C (1994)
Thinness at birth and insulin resistance in adult life. _Diabetologia_
**37**, 150–154.
Pizzuti A, Frittitta L, Argiolas A _et al_ . (1999) A polymorphism
(K121Q) of the human glycoprotein PC-1 gene coding region
is strongly associated with insulin resistance. _Diabetes_ **48**, 1881–
1884.
Poulsen P, Esteller M, Vaag A, and Fraga MF (2007) The epigenetic basis of twin discordance in age-related diseases. _Pediatric_
_Research_ **61**, 38R–42R.
Qi L, Shen H, Larson I _et al_ . (2004) Gender-specific association of a
perilipin gene haplotype with obesity risk in a white population.
_Obesity Research_ **12**, 1758–1765.
RankinenTandBouchardC(2006)Geneticsoffoodintakeandeating behavior phenotypes in humans. _Annual Review of Nutrition_
**26**, 413–434.
Reed DR, Bartoshuk LM, Duffy V, Marino S, and Price RA (1995)
Propylthiouracil tasting: determination of underlying threshold
distributions using maximum likelihood. _Chemical Senses_ **20**,
529–533.
Tanaka T, Reed DR, and Ordovas JM (2008) Taste as the gatekeeper to personalized nutrition. In: _Personalized Nutrition. Prin-_
_ciples and Applications_ (eds F Kok, L Bouwman, and F Desiere),
pp. 115–132. CRC Press, Boca Raton, FL.
Wang SC, Oelze B, and Schumacher A (2008) Age-specific epigenetic drift in late-ons _et al_ zheimer’s disease. _PLoS ONE_ **3**, e2698.
Xu A, Wang Y, Xu JY _et al_ . (2006) Adipocyte fatty acid-binding
protein is a plasma biomarker closely associated with obesity
and metabolic syndrome. _Clinical Chemistry_ **52**, 405–413.


5 Describe how polymorphisms within DNA sequences
may mediate risk of disease. What are the factors that
may modify such gene–disease associations?
6 Discuss the reasons why widespread use of ’omics technologies to provide personalized nutrition advice may
prove unacceptable to society.
7 With reference to specific examples, describe how
life-course factors may influence the nature of gene–
nutrient–disease interactions.



### **Glossary of Terms**

**17ß-Estradiol:** A steroid with potent affinity for the
estrogen receptor.
**Acetaldehyde:** Metabolic product of ethanol, formed
by action of alcohol dehydrogenase.
**Adipocyte:** A fat containing cell found in adipose tis
sue.

**Adipokines:** Cytokines secreted by the adipose tissue.
**Adiponectin:** Ahormonesecretedbyadiposetissue.It
enhances insulin sensitivity and promotes glucose
uptake.
**Adipose tissue:** The site of body fat deposition. Cells
within adipose tissue store and release fat.
**Adiposity rebound:** Body mass index rises rapidly in
the first 2 years of life and then declines until a point
between the age of 4 and 6 years when it starts to
increase again. This point where the trend reverses
is termed the adiposity rebound.
**Adrenal glands:** Endocrine organs located above
the kidneys. The adrenals are the sites for production and release of adrenaline, noradrenaline,
and steroid hormones, such as cortisol and aldo
sterone.

**Adrenarche:** The maturation of the adrenal cortex
into three distinct zones, resulting in secretion of
androgenic hormones during adolescence.
**Aflatoxins:** Mycotoxins formed by fungi such as _As-_
_pergillus_ .Aflatoxinsareimportantcontaminantson
peanuts and groundnuts stored in humid climates.
**Agouti-related protein, AgRP:** A neuropeptide produced in the arcuate nucleus of the hypothalamus.
AgRP increases appetite and decreases energy expenditure.
**Aldosterone receptor:** Receptor protein of the steroid
receptor superfamily. The aldosterone receptor is
found in target tissues for aldosterone (kidney and
hippocampus) where it regulates fluid balance.
**Alkaline phosphatase:** A hydrolase enzyme that removes phosphate groups from proteins and nucleotides. Activity in serum provides a marker of
bone formation.

**Alkaloids:** Toxic compounds found in plant foods
(e.g., potatoes) or as contaminants on cereals, produced by mildew.
**Allergic sensitization:** The process through which
exposure to foreign materials, either through in


gestion, inhalation, or skin contact, elicits immune responses that will manifest as allergic symptoms (rash or asthma). Initial contact with allergens may not produce a response but instead
primes (sensitizes) to produce responses at further

contacts.

**Allergy:** Adverse reaction to antigens (e.g., proteins in
certain foodstuffs) that is mediated by the immune
system (production of antibodies).
**Allium:** Plants of the onion family. Includes onions
and garlic.
**Alzheimer’s disease:** An irreversible and progressive neurodegenerative disorder leading to memory
loss, altered behavior, and dementia. The disease is
characterized by the formation of plaques of amyloid beta peptide in the brain.
**Amenorrhea:** The absence of a menstrual period in a
woman of reproductive age.
**Ames test:** A test used to determine the potential carcinogenicity of chemicals. The test uses cultures of
_Salmonella typhimurium_ that must undergo a mutation to be able to grow on a limiting medium.
Presence of colonies in the medium indicates potential mutagenicity of test compounds.
**Amino acids:** _α_ -amino acids are molecules with the
general formula H 2 NCHRCOOH, where R is an organic grouping. Amino acids are the basic building
blocks of proteins and peptides.
**Ammonia:** Compound with the formula NH 3 . It is a
product of the deamination of amino acids.
**Amyloid beta peptide:** Protein associated with damage to brain tissue and formation of neurofibrillary
tangles in Alzheimer’s disease.
**Anemia:** Deficiency of red blood cells or hemoglobin.
**Androgens:** The male sex hormones. The main androgens are the steroid hormones, testosterone, and
dehydroepiandrosterone.
**Anencephaly:** A defect of the formation of the embryonic neural tube, which results inthe nonformation

of the cerebral arches.

**Angina pectoris:** Chest pain caused by the partial occlusion of the coronary arteries due to atherosclerosis.

**Angiogenesis:** The process through which new blood
vessels branch off from existing vessels.



**272** **Glossary of Terms**


**Angiotensin II:** A circulating peptide hormone
(8 amino acid residues) that promotes vasoconstriction, increased blood pressure, and the release
of aldosterone from the adrenal cortex _._

**Angiotensinogen:** The precursor of angiotensin II.
Angiotensinogen is a protein (453 amino acid
residues) that is produced by the liver and adipose
tissue.

**Anorexia nervosa:** An eating disorder characterized
by body image distortion and fear of weight gain.
Anorexics, who are typically underweight, may voluntarily starve, indulge in excessive exercise, vomit
or purge after eating, and abuse laxatives or antiobesity drugs.
**Anovulation:** The absence of ovulation in women of

reproductive age.
**Anterior pituitary:** One of two lobes of the pituitary
gland. This endocrine tissue responds directly to
signals from the hypothalamus and plays a key role
in regulation of the production of hormones from
the adrenals and reproductive organs.
**Anthropometry:** The measurement of the human
body in terms of the dimensions of muscle and
adipose (fat) tissue. Simple measures of height and
weight, supplemented with measurements of skinfold thicknesses, mid-upper arm circumference,
waist and hip circumferences can be used to estimate body composition and distribution of body
fat.

**Antioxidants:** Molecules that are capable of quenchingthereactivityoffreeradicalsandotheroxidizing
agents (e.g., hydrogen peroxide). Antioxidants may
be scavenging antioxidants, which are destroyed in
reactions with reactive oxygen species, or enzymes
that are capable of rapid metabolism of high quantities of reactive oxygen species.
**Apatite:** A mineral found in the teeth and bones. It
exists in different forms, all based on calcium phosphate.
**Apolipoprotein B100:** The main protein of low density lipoprotein. It is responsible for the interaction
between LDL and receptors on target cells.
**Apoptosis:** Programmed cell death that involves a
coordinated series of biochemical events leading
to the death of the cell and removal of resulting
debris.
**Arachidonic acid:** A long-chain fatty acid (C20:4) of
the n-6 series. Arachidonic acid is an important
precursor of the prostaglandins and leukotrienes.



**Arginine:** Anaminoacidthatisconditionallyessential
(i.e., essential in certain circumstances). In addition
to being a constituent of proteins, arginine is the
precursor of nitric oxide.
**Arrhythmia:** Condition in which the heartbeat is irregular, or excessively slow or fast. Arrhythmias are
the product of damage to the heart during myocardial infarction.
**Arterial intima:** The innermost layer of the arterial
wall.

**Ascorbic acid:** Vitamin C, one of the water-soluble
vitamins. Ascorbic acid is an antioxidant and has a
key role in the production of bone and connective
tissues.

**Ataxia telangiectasia:** An immunodeficiency disorder.

**Atherosclerosis:** The process through which the
artery accumulates a plaque containing cholesterol,
collagen, and calcium. Atherosclerotic plaques
cause stiffening and narrowing of the arteries and
act as a focus for clots. Atherosclerosis is the basis of

all cardiovascular disease (coronary heart disease,
stroke, peripheral artery disease).
**Atopy:** A predisposition to allergic responses.
**Attentiondeficithyperactivitydisorder:** A neurological disturbance in children, which leads to inattention and impulsive behavior.
**Axillary hair:** Hair in the underarm region.
**Bacteroides:** One of the six main genera of bacteria
that contribute to the human intestinal microflora.
**Bariatric surgery:** Surgery to promote weight loss
throughrestrictionofthestomachcapacityinorder
to limit food intake.
**Basal metabolic rate, Resting metabolic rate:** BMR,
RMR. The energy cost associated with maintaining the basic physiological processes of the body at
rest (i.e., respiration, circulation, nerve, and muscle
tone). BMR is in proportion to body size, since it is
determined by the amount of metabolically active
tissue.

**Benzo(a)pyrene:** A polycyclic aromatic hydrocarbon
comprising 5 benzene rings. Benzo(a)pyrene and
its derivatives are potent carcinogens.
**Betel chewing:** The habit of chewing betel quid. The
quid is a mixture of areca nut and leaves. This habit
is most common in Pacific communities and in
some parts of Asia (e.g., Taiwan).
**Bifidobacteria:** One of the six main genera of bacteria
that contribute to the human intestinal microflora.



**Bisphosphonates:** A class of drugs used in the treatment of osteoporosis. Bisphosphonates inhibit the
action of osteoclasts.

**Bioimpedance:** The measurement of body fat content
through determination of the resistance of the body
to the flow of an electrical current.
**Biomarker:** A measurement used to assess the state

of a biological system. In nutrition, biomarkers
may include measurements of nutrient concentrations in suitable samples (e.g., blood, urine), or
measurements of nutrient dependent physiological
functions.

**Blood pressure:** The pressure generated within the
arteries due to the pumping of the heart. Between
beats the vessels are at rest and the pressure is at the
lowest point (diastolic pressure). Maximum pressure occurs with ejection of blood from the left
ventricle (systolic pressure).
**B-lymphocytes:** Cells of the immune system that are
responsible for the production of antibodies.
**Body mass index (BMI):** A measure of weight in relation to height (weight in kg/height in meters [2] ).
BMI is widely used as a tool to determine whether
an individual is of healthy weight (BMI between 20
and 25), underweight (BMI<20), overweight (BMI
25–30), or obese (BMI greater than 30).
**Bone mineral density:** A measure of bone mass.
Reduced BMD is generally indicative of conditions such as osteoporosis, in which fracture risk is
increased.
**BRCA1:** Breast cancer 1, early onset, gene. BRCA1
is a tumor suppressor gene. Mutations of BRCA1
increase risk of breast cancer.

**BRCA2:** Breast cancer 2, early onset, gene. BRCA2
is a tumor suppressor gene. Mutations of BRCA2
increase risk of breast cancer.

**Bulimia nervosa:** An eating disorder linked to body
image distortion and fear of weight gain. Affected
individuals periodically binge-eat, and then compensate for excessive intake through excessive exercise, vomiting, and purging.
**Butyricacid:** A short-chain fatty acid (4 carbons). Butyric acid has been found to have antitumor properties within the large intestine.
**C-reactiveprotein:** A plasma protein produced by the
liver as part of the response to inflammation.
**Cachexia:** Severelossofweightandmusclemass,often
accompanied by loss of appetite.



**Glossary of Terms** **273**


**Caffeine:** A methyl xanthine compound found in
tea, coffee, chocolate, and over-the-counter medications. Caffeine is a central nervous system stimulant.

**Calcitonin:** A peptide hormone that acts to lower
blood calcium concentrations.
**Cancer:** Disease involving the uncontrolled growth
of cells to form a tumor. Cancer cells can invade
tissues and organs at the point where they are first
formed (primary tumors), or can spread to other
organs through the process of metastasis, forming
secondary tumors.
**Cannabinoid receptors:** There are two cannabinoid
receptors (CB1 and CB2), which are both G protein
coupled receptors. They mediate the responses to
cannabinoids (e.g., marijuana and its derivatives)
in a wide variety of tissues.
**Capsaicin:** The active component of chili peppers,
providing the burning sensation associated with
their consumption.
**O** [6] **-carboxymethyl guanine:** An adduct of DNA
formed by the reaction of the guanine base with
carcinogenic material.
**Carcinogen:** Any agent that is capable of directly initiating the formation of a tumor, or which can promote the development or spread of existing tumors.
**Carcinogenesis:** The process through which exposure
of cells to carcinogens initiates the formation of
tumors, leading to cancer.
**Cardiac output:** The volume of blood pumped by
the heart in a given unit of time. Cardiac output
is generally measured in liters per minute. Cardiac
output is one of the determinants of blood pressure.
**Cardiovascular disease:** The term used to collectively
describe the diseases that involve the heart or blood
vessels. Most clinically significant cardiovascular
disease (coronary heart disease, stroke, peripheral
artery disease) is related to atherosclerosis.
**L-carnitine:** Compound formed from metabolism of
the amino acids lysine and methionine in the liver
and kidneys. Carnitine has a role in the shuttling of
fatty acids from the cytosolic compartment to the
mitochondria.

_**α**_ **-carotene:** The second most abundant isomer of

carotene.

**ß-carotene:** The major isomer of carotene. ß-carotene
is generally referred to as the plant form of vitamin
A.



**274** **Glossary of Terms**


**Carotenoids:** Organic pigments found primarily in
plants. This group of tetraterpenoids includes _α_  and ß-carotene, lutein, lycopene, and zeaxanthin.
**Carotid intima-media thickness:** A clinical measure
ment of the extent of atherosclerosis in the carotid
artery. Development of plaques results in increased
thickness of the arterial wall.

**Case-control studies:** An epidemiological study design in which characteristics of a group of individuals suffering from a disease (cases) are compared to
those of a group of healthy individuals (controls).
**Casein:** The predominant protein found in milks of
all mammalian species.
**Catabolism:** The metabolic breakdown of macromolecules to release energy.
**Catalase:** An antioxidant enzyme that catalyzes the
conversion of hydrogen peroxide to water and

oxygen.
**Catch-up growth:** Accelerated growth that follows a
period of growth restriction.
**Cellulose:** A polysaccharide formed from ß-glucose.
Celluloseisthemajorcomponentofplantcellwalls.
**Cholecystokinin:** A peptide hormone, mostly produced within the small intestine. Cholecystokinin
is a regulator of appetite, acting as a hunger suppressant.
**Cholesterol:** A sterol compound that is present in
cell membranes, and in the circulation. Cholesterol
adds rigidity to the lipid bilayer of membranes and
is an essential precursor of the steroid hormones.
**Chondrocyte:** Cells foundin cartilaginous tissues that
are responsible for secreting the characteristic proteins of cartilage.
**Chorion:** A membrane that surrounds the embryo
and fetus during development. Processes formed
in this membrane develop into the chorionic villi,
which invade the uterine lining during placentation.

**Claudication:** Pain, usually in the lower legs, caused
by poor circulation due to peripheral artery disease.
**Clotting factors:** Factors that promote the coagulation of blood. In humans, the major clotting factors
arefibrinogen,factorVII,factorVIII,prothrombin,
and von Willebrand factor.

**Cobalamin:** Vitamin B12.

**Celiac disease:** An autoimmune disorder of the bowel
in which an inflammatory response occurs in response to the ingestion of the gliadin portion of
gluten.



**Cohort studies:** An epidemiological study in which
a group of individuals are followed over a period of time in order to determine how characteristics observed early in the study might influence the later development of disease. Prospective cohort studies define the characteristics of the
population as soon as individuals are recruited,
and follow-ups are performed as the study progresses. Retrospective cohort studies assess population characteristics after the disease data is

collected.
**Collagen:** The major protein of bone and connective
tissue in mammalian species.
**Colonic microflora:** The bacterial species that colonize the human digestive tract. The human colon
is home to over 500 species of bacteria, some of
which are pathogenic, while others have benefits
for human health.

**Colostrum:** The first milk produced by the mammary
glands after giving birth. Colostrum is a proteinrich, thick fluid that is an important source of immunoprotective factors.
**Complement:** An element of the immune system that
involves a cascade of enzyme-mediated events that
kill infected cells and pathogens.
**Complementary feeding:** Weaning. Complementary
foods are foods added to the diet of breast-fed infants during the transition from full breast-feeding
to family foods.
**Complex carbohydrates:** Carbohydrates with a complex chemical structure. The complex carbohydrates include the soluble and insoluble starches
and those components of the diet that are generally referred to as dietary fiber (cellulose, lignans,
chitin).
**Confounding factor:** A factor in an epidemiological
study that can lead to a false conclusion regarding an apparently causal association between a risk
factor and disease endpoint, unless controlled for
statistically.
**Conjugatedlinoleicacid:** A family of naturally occurring trans-fatty acids, found in dairy products.
**Constipation:** Impaired bowel function in which
small hard stools are formed, which are difficult
to egest.
**Coronary heart disease:** Disease of the coronary arteries caused by the formation of atherosclerotic
plaques. Plaques and associated clots can prevent
blood and oxygen from reaching the muscles of the



heart. Cells of the heart subsequently die, leaving a
damaged area called an infarct.
**Corpus luteum:** The remnant of the Graafian follicle after the release of an egg during mammalian
ovulation. The corpus luteum becomes a temporary endocrine organ, producing progesterone to
maintain the uterine wall should pregnancy occur.
**Cortical bone:** Bone with a dense structure. Also

termed compact bone.
**Corticosterone:** The principal glucocorticoid hormone in rodents.
**Cortisol:** The principal glucocorticoid hormone in
humans. Cortisol is a steroid hormone, with the
classical function of increasing circulating glucose
and raising blood pressure as part of the response to
stress. Cortisol plays important roles in metabolic
regulation.
**Corticotrophin-releasing hormone:** CRH. A peptidehormoneproducedbythehypothalamus.CRH
stimulates production of adrenocorticotropin from
the anterior pituitary and is the central integrator
of the hypothalamic–pituitary–adrenal axis. It has
important roles in control of appetite, stress responses, and circadian cycles.
**Cruciferous vegetables:** Vegetables of the plant family _Brassicaceae_, which includes cabbage, Brussels
sprouts, kale, cauliflower, and broccoli.
**Cryptorchidism:** Condition in which the testicles fail
to descend during normal male reproductive development.
**ß-cryptoxanthine:** A carotenoid.
**Cysteine:** A sufur-containing amino acid.
**Cytochrome P450 system:** A large and diverse superfamily of enzymes, which are largely responsible for
the metabolism of xenobiotics. Most reactions cat
alyzed by cytochrome P450s involve the addition
of a hydroxyl group from water, which facilitates
the subsequent conjugation and excretion of the
agent.
**Cytokines:** Chemical messengers that can be produced by almost all cell types (unlike hormones
that are produced by specific endocrine cells). Cytokines are especially important in mediating inflammatory and immune responses.
**Daidzein:** An isoflavone. The main dietary sources are
soy and soybeans.
**Delta-6desaturase:** The enzyme that catalyzes the key
step in the pathway from the essential fatty acids to
long-chain fatty acids.



**Glossary of Terms** **275**


**Dementia:** Progressive loss of cognitive functions including memory, language, and problem- solving
skills. Dementia represents extreme loss of these
functions that goes beyond normal age-related decline.

**Developed countries:** The economically successful
countries, in which the national income translates into significant advantages for the health and
education of the population. The developed nations include Japan, Canada, the US, Australia, New
Zealand, and the nations of Western Europe, along
with Singapore, Hong Kong, South Korea, and Tai
wan.

**Developing countries:** Countries with a low industrial base and lacking economic wealth to invest in
the health, education, and welfare of the population.

**Diabetes mellitus:** A metabolic disorder characterized by raised circulating glucose concentrations,
attributable to defects of glucose homeostasis. Type
1 diabetes is due to insufficient insulin production, while type 2 diabetes arises from impaired
responses to insulin, which may be present in very
high concentrations.
**Diaphysis:** The shaft portion of a long bone.
**Dietary fiber:** One of several terms used to describe
the nondigestible matter present in food. Cellulose,
chitin, and insoluble starches all pass through the
digestive tract largely unchanged. Fiber is also referred to as nonstarch polysaccharides and complex
carbohydrates.
**Dieting:** The process of restricting food intake with
the intention of losing weight. Dieting may involve a reduction of all foods consumed, or the
exclusion of particular food items, or groups of
nutrients.

**Dietitian:** A health professional who uses dietary
change as a tool for the management and treatment
of disease states in her/his patients.
**Diuretic:** A pharmacological agent that stimulates the
excretion of water.
**Diverticulardisease:** Aconditionofthelargeintestine
whereby small sacs or pouches called diverticula
form in the wall of the large intestine. Diverticula
may become infected, leading to a condition known
as diverticulitis.
**Dizygotic twins:** Nonidentical twins.
**DNA Methylation:** Chemical modification of DNA
that can be inherited without changing the DNA



**276** **Glossary of Terms**


sequence. DNA methylation plays an important
role in the silencing of gene expression and is an
element of epigenetic regulation.
**Docosahexaenoic acid (** _DHA_ **):** One of the n-3 fatty
acids, DHA is a long-chain fatty acid C22:6. DHA
accumulates in the brain during development and
is thought to be critical in the accrual of complex
cognitive skills.
**Dopamine:** A neurotransmitter. Dopamine is a
catecholamine, related to adrenaline and noradrenaline. It is synthesized from the amino acid
tyrosine.
**Doubly-labeled water:** A method for measuring energy expenditure, in which subjects are administered water labeled with deuterium and [18] O. Elimi
nation of the isotopes allows determination of CO 2
production, which is a marker for total energy expenditure.
**Dual x-ray absorptiometry (DXA):** An x-ray technique in which patients are subjected to x-ray scans
in two different planes. The absorption of the x-ray
energy by soft tissues and by bone allows accurate
determination of bone mineral content and density. DXA can also be used to estimate the fat mass
of the body.
**Dyslipidemia:** Disruption of the normal concentrations of lipids (mostly triglycerides and cholesterol)
in circulation. The most commonly noted dyslipidemias involve increases in circulating lipid concentrations (hyperlipidemia).
**Dysphagia:** Difficulty in swallowing.
**Eclampsia:** A life-threatening complication of pregnancy, characterized by uncontrolled hypertension
and multiple organ failure.
**Ecological studies:** A type of study design in nutritional epidemiology. Ecological studies utilize
observations of the trends in disease prevalence
either over time or between different populations/geographicalareas,andattempttorelatethese
trends to variation in nutritional markers or other
risk factors. Ecological studies are the weakest
and least discerning approaches to studying diet–
disease relationships and should always be followed
up with more robust methods.
**Ectopicpregnancy:** An abnormal pregnancy in which
the embryo implants outside the uterus.
**Edema:** The swelling of organs or the extremities due
to movement of water from intracellular to extra
cellular compartments. Edema is often a response



to inflammation, as seen in protein–energy malnutrition.

**Eicosanoids:** Components of the inflammatory and
immune responses, which are synthesized from the
long-chain fatty acids of the n-3 and n-6 series.
**Eicosapentaenoic acid (** _EPA_ **):** One of the n-3 fatty
acids, C20:5.
**Embryogenesis:** The process through which an embryo forms and develops through mitotic divisions.
**Emetic:** An agent that stimulates vomiting.
**Endocrine disruptors:** Chemical agents that have the
capacity to interfere with normal hormone action,
either by mimicking the action of particular hormones (e.g., estrogen mimics) or antagonizing the
action of hormones (e.g., antiandrogens).
**Endometriosis:** Condition in which the cells that nor
mally line the uterus and slough off with each menstrual cycle grow on the outside of the uterus. Endometriosis can be a cause of infertility and pelvic
infections.

**Endothelial dysfunction:** Abnormal function of the
cells that comprise the inner layer surrounding the
lumen of arterial tissue. Altered function in terms
of clotting, immune, and inflammatory responses,
production of nitric oxide, and vasoconstriction or
vasodilation to maintain normal blood pressure, is
a key step in the development of atherosclerosis and
cardiovascular disease.
**Enteral feeding support:** The provision of nutrients
via a tube directly into the gastrointestinal tract.
Enteral tube feeding can be directed to the stomach, or if necessary to lower levels of the digestive

tract.

**Epigenetic regulation:** The expression of genes can
be modified by the environment to produce different phenotypes. Epigenetic gene regulation is the
process through which patterns of gene expression
can be modified through methylation of DNA or by
altering chromosome packing rather than by differences in DNA sequence.
**Epiphysis:** The end portion of a long bone, for example, the head of the femur.
**Erectile dysfunction:** Impotence. The inability for a
man to develop or maintain an erection.
**Erythropoiesis:** The process through which the red
blood cells are formed from stem cells in the bone

marrow.

**Erythropoietin:** A kidney derived hormone that recruits red cell precursors in bone marrow.



**Escherichiacoli:** One of the bacterial species that contribute to the human intestinal microflora.
**Esophagitis:** Inflammation of the esophagus, generally resulting from gastric reflux or injury to the
esophagus during radiotherapy.
**Essential fatty acids:** The fatty acids that cannot be
synthesized within the human body and which,
therefore, are required within the diet. The essential
fatty acids are linoleic acid (n-6) and linolenic acid
(n-3).
**Estragole:** An organic compound present in the oils
of many commonly consumed herbs, including tarragon and basil.
**Estrogen:** Collective term for the group of steroid
hormones that play a key role in the regulation of
female reproductive functions. Estrogens are primarily synthesized in the ovaries, but can also be
produced in adipose tissue, the adrenal glands, and
the liver.

**Estrogen-response-element:** A DNA sequence found
in certain gene promoters, which allows binding
of estrogen receptor–hormone complexes, which
activate gene transcription.
**Estimated Average Requirement (EAR):** One of the
dietary reference value terms used in the UK. The
EAR for a nutrient is the level of intake that should

meet the requirements of 50% of individuals within
a population.
**Expressing milk:** The process of drawing milk from
the breast through manual stimulation of the letdown reflex. Many women express milk using specially designed breast pumps in order to leave breast
milk for other individuals to feed to their infants via
a bottle and teat. Expressing milk may also be necessary to maintain lactation when mother or child
are ill, or if the mother requires brief treatment with
drugs that may be toxic to suckling infants.
**Factor VII:** Serine protease enzyme that is one of the
principal clotting factors.
**Factor VIII:** A glycoprotein that acts as a clotting factor. Deficiency of Factor VIII is the cause of the
genetic disorder, hemophilia.
**Faddy eating:** A common eating behavior of young
children, in which food is periodically refused or
only a very narrow range of food items is habitually
consumed.
**Fatty acids:** Organic acid molecules with long hydrocarbon tails. Fatty acids can be saturated or unsaturated (having double-bonded carbons within the



**Glossary of Terms** **277**


hydrocarbon chain). The fatty acids are the basic
building blocks of lipids within the body.
**Fatty streak:** The earliest stages of atherosclerosis
are characterized by the appearance of deposits of
macrophages bearing cholesterol and other fats in
vesicles within the cytoplasm.
**Fibrinogen:** The inactive precursor of fibrin. Fibrinogen is a peptide that plays a central role in the
coagulation of blood.
**Flavonoids:** Secondary metabolites of plants. The
flavonoids are a broad class of bioactive molecules,
many of which have antioxidant properties.
**Foam cells:** Foam cells are derived from macrophages
within the intimal layer of arteries. Foam cells are
the basic constituents of atherosclerotic plaques.
**Folicacid,folate:** VitaminB9.Therichestfoodsources
of folic acid are liver, leafy vegetables such as
spinach, broccoli, dried beans and peas, and fortified cereal products.
**Follicle stimulating hormone (FSH):** A hormone
of the anterior pituitary, which in both men and
women regulates the production of sex steroids
from the gonads. In women, FSH stimulates maturation of follicles. In men, FSH has a critical role in
the production of spermatozoa.
**Follicularphase:** The early phase of the menstrual cycle in which the Graafian follicles mature in preparation for ovulation.

**Food allergy:** An adverse reaction to proteins in food.
Allergies arise due to immune responses directed at
allergenic proteins.
**Food groups:** Food groups are a means of classifying
foods of similar types in order to simplify health
promotion advice for the population. For example, within the UK Balance of Good Health model,
there are five food groups: fruits and vegetables,
breads, cereals and potatoes, meat and alternatives,
milk and dairy products, foods containing fat and

sugar.
**Food intolerance:** An adverse reaction to particular
food items or components of food. Intolerance reactions are distinct from food allergies as there is
noinvolvementoftheimmunesystem.Intolerances
often arise due to a lack of digestive enzymes or secretions necessary to process particular items.
**Food neophobia:** A food behavior often seen in children.Neophobiainvolvestherejectionoffoodsthat
have not been previously encountered, often based
purely on their appearance or aroma.



**278** **Glossary of Terms**


**Food tables:** Databases showing the macronutrient
and micronutrient composition of foods.
**Fortification:** The process through which a nutrient
is added to a staple foodstuff at the point of production in order to increase intakes of that nutrient

within the whole population. In the UK, for example, margarines have been fortified with vitamin D
to maintain intakes at similar levels to those asso
ciated with consumption of butter.
**Fortifiers:** Nutrient supplements that can be added
to milk products used in infant nutrition. Fortifiers
are mixed with human milk when feeding some
premature infants to ensure that intakes of protein,
micronutrients, and energy are optimal.
**Free radical:** A free radical is any atom or molecule
that has one or more unpaired electrons within its
orbitals. The presence of unpaired electrons makes
freeradicalshighlyreactiveandtheyhavethecapacity to bond to, or remove constituents from other
molecules in their vicinity. In biological systems,
this reactivity can be highly damaging to cells, and
is the basis of many major disease processes.
**Functional foods:** Foods that have been developed to
have ingredients that have health-promoting properties.

**Galactose:** A monosaccharide, which is one of the
components of lactose.
**Galactosemia:** An inherited disorder in which sufferers lack the enzyme galactose-1-phosphate uridyl
transferase, which prevents the normal metabolism
of galactose. Unmanaged, this will lead to renal failure, enlarged liver, and brain damage.
**Galanin:** A polypeptide hormone with regulatory
roles in processes such as appetite, neurodevelopment, gastrointestinal function, and reproduction.
**Gallstones (choleliths):** Solid, crystalline accretions
of bile components that form within the gall bladder or bile duct.

**Gastricparietalcells:** Cells of the stomach epithelium
that secrete intrinsic factor and hydrochloric acid.
**Gastric reflux:** Escape of acidic gastric secretions into
the esophagus. Also termed “heartburn.”
**Gastritis:** Inflammation of the lining of the stomach.
**Genistein:** One of the principal isoflavone compounds present in soy.
**Genomic imprinting:** Process through which epigenetic marking of genes ensures that they are expressed in a specific manner. For example, certain
genes in mammalian systems are expressed in a par


ent of origin specific manner. This process allows
paternally derived alleles that could be harmful to
maternal health to be suppressed.
**Genomic instability:** Events associated with aging
and cancer. Genomic instability results in abnormalities in the chromosomal arrangement of DNA,
often due to defects of DNA repair or high background levels of damage.
**Ghrelin:** An appetite-stimulating hormone, secreted
by cells of the stomach and pancreas.
**Glitazones:** A class of drugs developed to treat type
2 diabetes. The glitazones are agonists of peroxisome proliferator activated receptor (PPAR) _γ_ and
promote expression of insulin sensitive genes.
**Glomerular filtration rate:** The rate at which blood
is filtered through the kidney.
**Glucokinase:** One of the key enzymes of glucose
metabolism. Glucokinase catalyzes the conversion
of glucose to glucose-6 phosphate.
**Gluconeogenesis:** The metabolic pathway leading
to the generation of glucose from nonsugar
substrates, including pyruvate, lactate, glycerol,
and the glucogenic amino acids (e.g., glycine,
serine, aspartate, glutamate).
**Glucose homeostasis:** Homeostasis is the regulation
of metabolic and physiological systems in order to
maintain a normal steady state function in response
to environmental fluctuations. Glucose homeostasis describes the processes that maintain circulating
and tissue glucose concentrations within optimal

ranges.
**Glucosinolates:** Secondary products of plants of the
_Brassicaceae_ family. Glucosinolates are derivatives
of glucose, with side chains containing sulfur and
nitrogen.
**Glutathione:** A tripeptide synthesized from glycine,
cysteine, and glutamine. Glutathione is one of the
most abundant compounds within the mammalian
body and plays a key role in antioxidant defenses
and the metabolism of xenobiotics.
**Glutathione peroxidase:** An antioxidant enzyme responsible for the removal of hydrogen peroxide and
organic hydroperoxides. There are 7 mammalian
isoforms of glutathione peroxidase, all of which use
glutathioneasasubstrateandhaveseleniumattheir
active site.

**Glycemic control:** A term used to describe the ability
of patients with diabetes to maintain blood glucose concentrations within optimal ranges, either



through dietary change or use of pharmacological
agents.
**Glycemicindex(GI):** Asystemusedtorankfoodstuffs
in order of their ability to increase blood glucose
concentrations following consumption. Foods with
high GI contain simple sugars that are rapidly absorbed and lead to a rapid peaking of blood glucose.
Foods with low GI contain complex carbohydrates
that release glucose to the bloodstream more slowly.
**Glycogen synthase:** Enzyme responsible for the conversion of glucose to glycogen within liver and
skeletal muscle.

**Glycosylated hemoglobin A1c (HbA1c):** HbA1c is a
form of hemoglobin that is generated in the presence of excessive concentrations of blood glucose.
Glucose binds to the hemoglobin and the glycosylated hemoglobin begins to accumulate on red
blood cells. Measurement of HbA1c provides a
good measure of the quality of habitual glycemic
control of diabetic individuals.
**Gonadotropin-releasing hormone (GnRH):** Peptide
hormone released in a pulsatile manner by the
hypothalamus. GnRH is the principal regulator of
the reproductive axes in both males and females.
**Great apes:** Species belonging to the family _Ho-_
_minidae_ . This includes gorillas, orang utans, chimpanzees, bonobos, and humans.
**Growth hormone:** A polypeptide hormone with
largely anabolic functions. Growth hormone stimulates growth, increases muscle mass, promotes
protein synthesis and hepatic glucose uptake and
gluconeogenesis.
**Hemochromatosis:** An inherited disorder in which
iron accumulates within organs, particularly the
liver and pancreas.
**Hemorrhoids:** Blood filled swellings around the anus,
caused by dilation of varicose veins.
**Hayflick limit:** All differentiated cells have a limited
capacity to divide. The number of divisions that
can occur before cell death is termed the Hayflick
limit. In humans the Hayflick limit is 52 divisions.
**Heightvelocity:** The rate at which height is increasing
during growth, usually measured as cm gained per

year.
**Helicobacter pylori:** A bacterial species that can colonize the human stomach and small intestine. _H._
_pylori_ infection is associated with gastritis and peptic ulcers and is a major risk factor for stomach

cancer.



**Glossary of Terms** **279**


**Hepatic steatosis:** Fatty liver.
**Hepatocyte nuclear factor 1** _**α**_ **(HNF1** _**α**_ **):** A member
of a superfamily of transcription factors, mainly
expressed within the liver. Mutations of HNF1 _α_
are associated with the early onset form of diabetes,
MODY3.
**Hepatocyte nuclear factor 1ß (HNF1ß):** A member
of a superfamily of transcription factors, mainly
expressed within the liver. Mutations of HNF1ß are
associated with the early onset form of diabetes,
MODY5.
**Hepatocyte nuclear factor 4** _**α**_ **(HNF4** _**α**_ **):** A member
of a superfamily of transcription factors, mainly
expressed within the liver. Mutations of HNF4 _α_
are associated with the early onset form of diabetes,
MODY1.

**Heterocyclic amines:** Carcinogenic compounds that
are generated during the cooking of meat.
**High-density lipoprotein (HDL)-cholesterol:** HDL
is one of the lipoprotein transporters that are required to carry cholesterol around the body. HDL
transports cholesterol from peripheral tissues back
to the liver for reutilization or excretion, and as
such higher concentrations of HDL-cholesterol are
associated with lower risk of atherosclerosis.
**Hirsutism:** Excessive growth of hair in women. Hirsutism generally occurs in response to increased
production of androgens and is associated with
growth of facial or chest hair, or increased growth
of hair on the legs and arms.
**Homocysteine:** A sulfur-containing amino acid
formed in the metabolism of methionine.
**Humanchorionicgonadotropin:** Apeptidehormone
produced by the embryo and early placenta in the
first trimester of pregnancy. Human chorionic gonadotropin plays a critical role in establishing the
endocrine environment needed to sustain preg
nancy.
**Humanchorionicsomatomammotropin:** One of the
human lactogenic hormones.
**Hydrogen peroxide (H** **2** **O** **2** **):** A powerful oxidizing
agent that is formed as a by-product of mitochondrial respiration. All tissues produce the antioxidant enzyme catalase as a means of preventing cellular damage associated with this reactive oxygen
species.
**3-hydroxy-3-methyl-glutaryl-CoA** **reductase:**
HMG-CoA reductase. This enzyme catalyzes
the key step in the biosynthesis of cholesterol.



**280** **Glossary of Terms**


HMG-CoA reductase is the target for statins, which
reduce circulating cholesterol and hence lower risk
of cardiovascular disease.
**11ß-hydroxysteroid** **dehydrogenase** **(11ßHSD):**
There are two isoforms of 11ßHSD. 11ßHSD1 is
found in liver, adipose tissue, and other organs and
is responsible for the regeneration of active cortisol
from inactive cortisone. 11ßHSD2 is found in
kidney and placenta and deactivates cortisol.
**Hydroxyl radical (OH):** A powerful and short-lived
reactive oxygen species that can be generated in biological systems from superoxide radicals and hydrogen peroxide. OH _[.]_ can be particularly damaging
as there are no antioxidant enzymes that are able to
catalyze the quenching of this free radical.
**Hyperemesis gravidarum:** Intractable and excessive
nausea and vomiting associated with pregnancy.
**Hyperglycemia:** Circulating glucose concentrations
that are above normal ranges. Blood glucose concentrations that are persistently over 126 mg/dL
(7 mmol/L) are generally accepted as indicative of
hyperglycemia.
**Hyperhomocysteinemia:** Elevated plasma homocysteine concentrations (in excess of 15 µmol/L). A
risk factor for cardiovascular disease.
**Hyperphagia:** An abnormally increased appetite
leading to habitually excessive consumption of
food.
**Hypertension:** Raised blood pressure. In clinical settings, hypertension is generally defined as a systolic
pressure over 140 mmHg and diastolic pressure
over 90 mmHg.
**Hypertriglyceridemia:** Elevated plasma triglyceride
concentrations (over 1.7 mmol/L).
**Hypocalcemia:** Low circulating concentrations of calcium.

**Hypospadias:** A congenital defect of the penis in
which the urethral opening is misplaced.
**Hypothalamic–pituitary–adrenal axis:** Hormonal
cascade that regulates stress responses, the immune
system, metabolism, appetite, and sexual behavior.
**Hypothalamic–pituitary–gonadal axis:** Hormonal
cascade that regulates reproductive physiology. Elements of this axis also regulate skeletal development, body composition, and immune functions.
**Hypothalamus:** A region of the brain seated above
the pituitary gland. The hypothalamus is the central integrator of sensory input and responses to
maintain homeostasis. The hypothalamus plays a



critical role in the control of temperature, circadian cycles, thirst, appetite, and reproductive
functions.

**Immunoglobulins:** Immunoglobulins are also
known as antibodies. These globular proteins occur
in several different classes (isotypes, IgG, IgA, IgM,
IgE), all of which mediate specific functions within
the immune system.
**Incontinence:** Involuntary leakage of urine or feces.
**Indoles:** Indolesareorganiccompoundswithtwoaromatic rings, one six-membered benzene ring, and
a five-membered pyrolle ring.
**Infertility:** The inability of a man or woman to conceive a child. Infertility is clinically defined on the
basis of failure to conceive within 12 months of

attempting to do so.
**Inflammatory bowel disease:** Chronic disease states
involving inflammation of the small or large intestines. Crohn’s disease generally impacts upon the
ileum and parts of the large intestine, while ulcerative colitis affects the wall of the bowel within the

colon and rectum.

**Inhibin-B:** A hormone of the reproductive axis. Inhibininhibitsthereleaseoffollicle-stimulatinghormone. In women, this promotes an increase in
luteinizing hormone concentrations during the follicular phase of the menstrual cycle, and in men
serves to limit the production of sperm.
**Insulin:** Peptide hormone produced by the pancreas.
The main physiological function of insulin is to regulate blood glucose concentrations by stimulating
uptake by liver and muscle. Insulin also stimulates
synthesis of triglycerides and is a driver of anabolic

processes.
**Insulin-like growth factor-1 (IGF-1):** A nutrient responsive peptide hormone that is responsible for
promotion of growth and development.
**Insulin promoter factor 1 (IPF-1):** A transcription
factor involved in the development of the pancreas.
Mutations of IPF-1 are associated with the early
onset diabetes (MODY4).
**Insulin receptor substrate 1 (IRS-1):** A protein of the
insulin signaling pathway. Binding of insulin to the
insulin receptor leads to phosphorylation of IRS-1.
This promotes the uptake of glucose via the GLUT4
transporter.
**Insulin resistance:** The condition in which normal

circulating concentrations of insulin are insufficient to allow normal responses to the hormone.



**Intelligence quotient (IQ):** IQ is a measure of performance in tests designed to assess intelligence.
IQ tests are normalized against the typical performance of the population, with a score of 100 rated

as average.
**Interleukin** **6** **(IL-6):** A pro-inflammatory cytokine that can be synthesized by adipose tissue,
macrophages,andTcells.IL-6orchestratestheearly
metabolic responses to trauma.
**Intervention studies:** Epidemiological studies in
which the impact of limiting a potentially harmful exposure (e.g., reduction of red meat intake),
or of increasing exposure to a potentially beneficial
agent (e.g., increasing intake of dietary fiber) upon
disease risk can be evaluated.

**Intracellularadhesionmolecule-1(ICAM-1):** An adhesion molecule expressed on the surface of endothelial cells. Cytokines released in response to
trauma or as part of an inflammatory response increase expression of ICAM-1, and this allows interaction between the endothelial cells and cells of the

immune system.
**Intrinsic factor:** A stomach derived glycoprotein that
is essential for the absorption of vitamin B12.
**Invitrofertilization:** The process through which eggs
are fertilized to create embryos outside the body. In
vitro fertilization is one of the techniques used in
assisted reproduction.
**Isothiocyanates:** Organic compounds containing sulfur and nitrogen that are produced as part of the
response of some plants to injury. Isothiocyanates
have been identified as potential anticancer agents
in humans.

**Isoflavones:** Organic compounds produced by plants
of the bean family. Isoflavones are antioxidants and
potent phytoestrogens.
**Junk food:** Foods that are high in sugar and fat, but
whichcontainfewmicronutrients.Manynutritionists dislike the use of this term as it is a poor means
of defining the composition of food and is only
selectively applied to convenience foods.
**Ketones:** Breakdown products of fatty acids, which
can be used by heart and brain as energy
substrates.

**Ketosis:** The metabolic state in which the liver

switches to the breakdown of fatty acids to ketones.
This state is usually associated with the response to
starvation, but can also be initiated by trauma and
inflammation.



**Glossary of Terms** **281**


**Kwashiorkor:** A form of protein–energy malnutrition, characterized by edematous swelling, fatty
liver, bleaching of the hair and dermatitis. Classically defined as protein deficiency.
**Lactation:** The secretion of milk from the mammary
glands.
**Lactobacillus:** One of the six main genera of bacteria
that contribute to the human intestinal microflora.
**Lactoferrin:** A protein found in colostrum and milk.
Lactoferrin is important in antimicrobial defense
of the newborn and the breast tissue as it sequesters
free iron that could otherwise be used as a bacterial

substrate.

**Lactose:** Disaccharide found only in milk. Lactose is
synthesized from glucose and galactose.
**Lactose intolerance:** Condition in which a deficiency
of lactase prevents the digestion of lactose. Consumption of dairy products will lead to abdominal
distension and diarrhea.
**Laxative:** A pharmacological agent that loosens stools
and induces defecation.
**Leptin:** Peptide hormone synthesized from adipose
tissue. Leptin suppresses appetite and has important roles in regulation of metabolism and reproduction.

**Let-down reflex:** Hormonal response to stimulation
of the nipples in breastfeeding women. Stimulation
of mechanoreceptors leads to release of oxytocin
(stimulates milk release) and prolactin (stimulates
milk synthesis).
**Leydig cells:** Cells of the testis that synthesize testos
terone.

**Life expectancy:** The average number of years a human is expected to live. This figure is conventionally
calculated from the time of birth and is highly dependent upon infant mortality rates in the region
of birth.

**Lignans:** Polyphenolic compounds formed in plants.
In the human diet, lignans are generally consumed
via seeds and certain vegetables (broccoli and other
_Brassicacae_ ). Lignans are one of the major classes of
phytoestrogens.
**Limonene:** Hydrocarbon found in high concentrations in the rind of citrus fruits.

**Lipid hydroperoxides:** Stable forms of oxidized lipids
that are formed via the peroxidation cascade following free radical activity.
**Lipolysis:** The breakdown of fat stores to release free
fatty acids to the circulation.



**282** **Glossary of Terms**


**Lipoproteins:** Complexes of lipids and proteins that
are primarily involved in the transport of cholesterol and other fats. Lipoproteins may also be structural proteins, adhesion molecules, and transmembrane receptors.
**Lipoprotein lipase:** The enzyme responsible for the
hydrolysis of lipids transported by very low density
lipoprotein (VLDL) or chylomicrons. The products
of this activity are glycerol and free fatty acids.
**Low-density lipoprotein (LDL):** LDL is one of
the lipoprotein transporters that are required to
carry cholesterol around the body. LDL transports
cholesterol from the liver to peripheral tissues.
LDL-cholesterol is vulnerable to oxidation within

the arterial endothelium, and this process is one
of the prerequisite events for the development of
atherosclerotic plaques.
**Lower Reference Nutrient Intake (LRNI):** One of the
dietary reference value terms used in the UK. The
LRNI for a nutrient is the level of intake that should
meet the requirements of just 2.5% of individuals
within a population.
**Luteal phase:** The phase of the menstrual cycle that
follows ovulation.

**Lutein:** A carotenoid.
**Luteinizing hormone (LH):** A hormone of the anterior pituitary, which in both men and women regulatestheproductionofsexsteroidsfromthegonads.
In women, LH promotes ovulation. In men, LH has
a critical role in the production of testosterone.
**Lycopene:** A red carotenoid pigment.
**Lymphocyte:** A class of white blood cell, operative
within the mammalian immune system. There are
three major types of lymphocyte: T cells, B cells,
and natural killer cells.
**Macrosomia:** A term used to describe a baby that is
large-for-gestational age.
**Macrophages:** Phagocytes of the immune system.
Macrophages are derived from monocytes.
**Malnutrition:** State in which an individual is chronically deprived of the macro- and micronutrients
required to maintain normal physiological functions at an optimal level.
**Mammaryalveoli:** The glandular tissues of the breast,
which are the sites of milk synthesis.
**Marasmus:** A form of protein–energy malnutrition,
characterized by hunger, weight loss, muscle wasting, and loss of adipose tissue reserves. Classically
defined as energy deficiency.



**MaturityOnsetDiabetesoftheYoung(MODY):** Rare
hereditaryformsoftype2diabetes,causedbymutations of transcription factors and enzymes involved
in the normal response to insulin. There are at least
six identified MODY defects.
**Menarche:** The onset of reproductive cycling in females. The first menstrual bleeding.
**Menopause:** The end of reproductive cycling in females triggered by the cessation of ovarian function.

**Meta-analysis:** A statistical approach that overcomes
problems of small sample size in epidemiological
studies by combining the results of several studies
that all address a related research hypothesis.
**Metabolic syndrome:** Cluster of metabolic disorders
(hyperinsulinemia, hypertriglyceridemia), cardiovascular disorders (hypertension), and obesity,
driven by insulin resistance. Metabolic syndrome
is a major risk factor for cardiovascular disease.
**Metabolomics:** The systematic study of metabolites
to obtain a profile of the metabolic response to a
particular challenge.
**Metallothioneins:** A family of metal binding proteins,
mainly synthesized in the liver and kidneys.
**Metastasis:** The spread of cancerous cells from the
initial site of tumor formation to other parts of the
body.
**Metformin:** A drug used in the control of type 2 diabetes. Metformin increases insulin sensitivity and
delaystheuptakeofglucosefromthedigestivetract.
**Methionine synthase:** Enzyme responsible for the
conversion of homocysteine to methionine. MethioninesynthaserequiresvitaminB12asacofactor
and 5-methyltetrahydrofolate as a substrate.
**Methyl-tetrahydrofolate:** A methylated derivative of
folic acid.
**Methyl-tetrahydrofolate** **reductase** **(MTHFR):**
Enzyme responsible for generation of 5methyltetrahydrofolate from 5,10-Methylenetetrahydrofolate. This is an essential step in the removal
of potentially harmful homocysteine. Polymorphisms of the MTHFR play an important role in
establishing an individual’s risk of cardiovascular
disease and certain cancers.

**Microalbuminuria:** The leakage of albumin into the
urine. This is indicative of kidney damage, which
increases the permeability of the glomeruli.
**Micronutrientdeficiency:** Themicronutrientsarethe
vitamins, minerals, and trace elements required by



the body. Where the supply of these nutrients is insufficient to meet demands over a sustained period,
deficiency may result. True deficiencies of micronutrients will be associated with clinically important
disorders, each being characteristic of the nutrient concerned (e.g., ascorbate deficiency leads to
scurvy, niacin deficiency leads to pellagra).
**Miscarriage:** The spontaneous loss of an embryo or
fetus at a time before it is capable of survival.
**Mitogen:** An agent that stimulates cell division.
**Monocytes:** An immature form of phagocytic white
blood cell. Monocytes have the capacity to differentiate into macrophages as they mature.
**Monocyte chemoattractant protein 1 (MCP-1):** A
protein that is often produced at sites of tissue
injury or inflammation. MCP-1 recruits monocytes and other immune cells to the injured

area.

**Monosodium glutamate:** A salt of glutamate that is
widely used as a flavor enhancer in processed foods
and takeaway items.
**Monounsaturated fatty acids (MUFA):** Fatty acids
in which there is a single double-bonded carbon.
Oleic acid (C18:1) is an example.
**Monozygotic twins:** Genetically identical twins derived from a single fertilized egg that subsequently
splits into two.
**Morbidity:** The state of being diseased.
**Morphogenesis:** The process through which the cells
of the embryo become organized into specialist
structures and organs, and by which it develops
a human shape and form.
**Mullerian ducts:** The early embryonic structures that
eventually develop into the reproductive tract. In
the absence of androgenic factors the ducts develop
into the female reproductive organs.
**Myocardial infarction:** A heart attack. Occlusion of
the coronary arteries due to formation of blood
clots at atherosclerotic plaques starves the heart
muscle of oxygen. This causes damage to the heart
tissue (infarction) and can lead to death.
**Myoglobin:** A muscle protein with a structure that includes an iron-containing, heme prosthetic group.
**Myricetin:** A flavonoid, mainly consumed in fruits
and herbs.
**n-3 fatty acids:** The family of fatty acids with the
shared property of having a double-bonded carbon
at the -3 position. _α_ -linolenic acid is the essential
precursor of the n-3 series.



**Glossary of Terms** **283**


**n-6 fatty acids:** The family of fatty acids with the
shared property of having a double-bonded carbon
at the ω-6 position. Linoleic acid is the essential
precursor of the n-6 series.
**Natural killer cell:** A type of lymphocyte. Natural
killer cells contain enzymes and cytokines that are
capable of killing tumor cells and microbial agents.
**Negative feedback:** A term used in endocrinology
to describe the process through which a hormone
switches off the processes that lead to its own synthesis or release.

**Neural tube defects:** Birth defects in which the embryonic neural tube, which is destined to become
the spinal cord and brain, fails to close over. This
means that the affected individual will either have

exposed nerves in the spinal cord (spina bifida) or
will lack the bone covering for the cerebral tissues
(anencephaly).
**Neurogenic differentiation factor 1:** Transcription
factor that promotes the transcription of the insulin gene. Mutations of this transcription factor
are associated with the early onset form of diabetes,
MODY6.

**Neuropeptide Y (NPY):** A peptide neurotransmitter
with a key role in appetite regulation. NPY promotes food intake through actions within the arcuate nucleus of the hypothalamus.
**Nitricoxide(NO.):** Afreeradicalthatisutilizedwithin
mammalian systems as a bactericidal agent and a
signaling molecule.
**Nitrosamines:** A class of carcinogens formed from
nitrites and secondary amines.
**Nonstarchpolysaccharides:** An alternative term used
to describe dietary fiber.
**Noradrenaline:** One of the catecholamines. It is produced by the adrenal medulla and is also produced
at synapses within the central nervous system.
**Nutrient density:** Term used to describe the ratio of
the content of specific nutrients to energy within a
foodstuff.
**Nutrigenomics:** The study of the molecular relationships between nutrition and the gene expression.
**Nutritional analysis software:** Software developed to
provide simple access to food table based databases.
An important tool in the analysis of food records
and food frequency questionnaires.
**Nutritional epidemiology:** The study of how nutrients and nutrition-related factors influence patterns of disease within human populations.



**284** **Glossary of Terms**


**Nutritional status:** The state of a person’s health in
relation to the nutrients in his/her diet and subsequently within his/her body.
**Obesity:** A state of excessive body fat storage. Obesity
can be diagnosed using a variety of anthropometric
measures, such as body mass index, and is associated with increased risk of death due to cardiovas
cular disease and cancer.
**Occult bleeding:** Loss of blood in the feces. Occult
bleeding is a symptom of gastrointestinal diseases
including colon cancer, inflammatory bowel disease, esophagitis, or gastritis.
**Ochratoxins:** Toxins produced by fungal contamination of food. Ochratoxins are known to be carcinogenic within the liver.
**Oligorrhea:** Defective menstrual cycling in which the
normal 28-day cycle is extended for periods of up
to 90 days.
**Oncogenes:** A gene, or mutated gene, that encodes a
protein that promotes cancer. Proto-oncogenes are
genes that have the potential to become oncogenes
if mutated. Antioncogenes are genes that encode
proteins that block development and progression
of cancer.

**Oral glucose tolerance test:** A test used to diagnose
diabetes mellitus. Patients are given an oral load
of glucose and blood sampled at baseline and at
intervals up to 3 h. Failure to restore baseline glucose concentrations within this time is indicative of

diabetes and/or insulin resistance.
**Organic farming:** The production of foodstuffs (animal and plant) without the use of synthetic pesticides, fertilizers, or feed additives.
**Ossification:** The process through which cartilaginous tissue becomes mineralized and transformed

to bone tissue.

**Osteoblast:** A cell responsible for bone formation
through the production of collagen and deposition
of bone mineral.

**Osteocalcin:** A hormone secreted by osteoblasts
in bone tissue. It stimulates bone minerali
zation.

**Osteoclast:** A cell responsible for the removal of bone
tissue during skeletal repair or remodeling.
**Osteopenia:** Low bone density. In children, this may
be due to a failure to deposit minerals such as calcium. In adults, osteopenia may be a precursor of
osteoporosis, caused by loss of calcium and other
minerals from bone.



**Osteoporosis:** Condition of bone in which loss of
bone mineral leads to increased risk of fracture.

**Overnutrition:** Condition in which the supply of
nutrients (usually nutrient intakes) exceeds the
physiological requirement for those nutrients.
Overnutrition may be associated with adverse
health consequences.
**Ovulation:** The process through which a mature
Graafian follicle ruptures to release an ovum during
the menstrual cycle.
**Oxidative damage:** The cellular and tissue damage
that is caused by free radicals and other reactive
oxygen species. All components of cells are vulnerable to such damage, which may include peroxidation of lipids, protein strand scission, or DNA
mutation.

**Oxidative phosphorylation:** The metabolic pathway
found within mitochondria, through which energy
substrates generate ATP through the donation of
electrons to the electron transport chain.
**Oxyntomodulin:** An appetite suppressing peptide
produced by the colon.
**Oxytocin:** Ahormoneproducedbytheposteriorpituitary gland. In pregnancy, oxytocin promotes contractionoftheuterusandhasakeyroleintriggering
labor. In lactation, oxytocin promotes the ejection
of milk from the nipple.
**Paget’s disease of bone:** A chronic disease of the
skeleton in which the bones become enlarged and
weaker, creating an increased risk of fracture.
**Palatability:** The acceptability of a food to the senses.
Aroma, taste, and texture all determine palatability.
**Pancreatitis:** Inflammation of the pancreas, often
caused by other conditions of the gastrointestinal
tract, such as gallstones.
**Parathyroid hormone:** Hormone responsible for
increasing circulating calcium concentrations by
stimulating loss from bone and enhancing absorption within the kidney and gastrointestinal

tract.

**Parenteral nutrition:** A form of nutritional support
in which simple nutrients are delivered to the body
intravenously.
**Peptide YY:** An appetite suppressing peptide produced by the colon and ileum.
**Periodontaldisease:** Inflammatorydiseaseofthegum
caused by infection with bacterial species. Severe
periodontitis will result in loss of teeth and has been
linked to systemic inflammation and infection.



**Peripheral resistance:** The resistance of the arterial
system to the flow of blood. Resistance is one the
determinants of blood pressure.
**Perniciousanemia:** AcauseofvitaminB12deficiency,
arising due to the loss of gastric parietal cells and
hence intrinsic factor.

**Peroxisome proliferator activated receptor** γ **(PPAR**
γ **):** A transcription factor that regulates cellular differentiation and the metabolism of lipids, carbohydrates, and proteins.
**Personalized nutrition:** An approach to providing
nutritional advice that is based upon assessment of
geneticbackgroundandhowthiswilldeterminethe
response to nutrients, and of measures of biomarkers of risk of disease.

**Phase I xenobiotic metabolism:** Xenobiotics are

exogenous chemicals such as drugs, toxins, and
pollutants, which may be harmful to the body.
These agents are removed in two steps. In Phase
I metabolism, the cytochromes P450 add hydroxyl
groups to xenobiotics, facilitating their removal in
Phase II metabolism.

**Phase II xenobiotic metabolism:** Xenobiotics that

have been modified in Phase I metabolism can
be readily conjugated to sulphonates or glucuronic
acid, to yield soluble products that are excreted via
the urine.

**Phenolics:** Organic compounds comprising a benzene ring with a hydroxyl group.
**Phenothiazines:** A class of antipsychotic drugs.
**Phenylketonuria:** An inherited disorder in which individuals lack the enzyme phenylalanine hydroxylase. Accumulation of phenylalanine can lead to
mental retardation, so the condition requires restriction of the intake of this amino acid.
**Phosphatidylcholine:** A phospholipid.
**Phosphatidylethanolamine:** A phospholipid found
in membranes. It is particularly concentrated in
the brain.

**Phosphatidylserine:** A phospholipid with a key function in the membranes of neurones.

**Phospholipids:** Lipids comprising a hydrophilic head
group (e.g., phosphatidyl choline, phosphatidylserine)andhydrophobicfattyacidtails.Phospholipids
are the principal components of biological membranes.

**Phthalates:** Chemicals used as plasticizers.
**Phytoestrogens:** Plant-derived molecules that can
mimic the actions of estrogens.



**Glossary of Terms** **285**


**Pica:** The consumption of nonnutritive substances
such as clay or laundry starch.
**Placental previa:** A dangerous complication of pregnancy in which the placenta lies close to or across
the cervix and hence blocks access of the baby to
the birth canal.

**Placental abruption:** A complication of pregnancy in
which the placenta breaks away from the uterine
wall.

**Placental growth hormone:** An alternative name for
placental lactogen.
**Placental lactogen:** A placentally derived hormone
that mimics the effects of prolactin and growth hor
mone.

**Plasminogen activation inhibitor 1 (PAI-1):** A serine
proteaseinhibitorthatinhibitstheenzymesresponsible for the breakdown of blood clots. Elevated expression of plasminogen activation inhibitor 1 is
consequently a risk factor for thrombosis.
**Plasticity:** The ability of an organism to adapt in response to changes in the environment.
**Polycystic ovary syndrome:** Disease of the ovaries
characterized by the formation of cysts, leading to
disruption of normal menstrual cycling and infertility.
**Polymorphisms:** Polymorphisms are multiple variables of a gene within a population. Individuals
with variant alleles may be at greater, or lesser, risk
of disease depending upon interactions with environmental or dietary factors.
**Polyphenolics:** Plant products comprising two or
more phenol rings. The polyphenolics include the
flavonoids, tannins, and lignin. Many polyphenolics are antioxidants and may have other bioactivities within the human body.
**Polyunsaturated fatty acids (PUFA):** Fatty acids in
which there are two or more double-bonded car
bons.

**Ponderal index (PI):** An alternative to BMI that is
sometimes applied to infants. PI is calculated as
weight (kg)/ length (m) [3] .
**Positive feedback:** A term used in endocrinology
to describe the means through which a hormone stimulates the processes that drive its own
production.
**Posterior pituitary:** One of two lobes of the pituitary
gland. This endocrine tissue responds directly to
nerve signals from the hypothalamus and has two
main products: vasopressin and oxytocin.



**286** **Glossary of Terms**


**Postpartum hemorrhage:** Excessive maternal bleeding after the delivery of the baby and placenta.
**Prebiotics:** Substances added to food to induce the

multiplication of beneficial bacterial species in the
colon.

**Pre-eclampsia:** A hypertensive disorder of pregnancy,
characterized by elevated blood pressure and proteinuria.

**Premature infant:** A baby born before full-term gestation. Full-term is 40 weeks and prematurity is
generally defined as birth before 38 weeks.
**Prevalence rates:** A measure of the level of a disease
within a population. The prevalence rate is usually
expressedasthenumberofdiseasecasesper100 000
people in the population. Prevalence rates should
not be confused with incidence rates, which are
defined as the number of new cases arising within
a population over a given period of time.
**Probiotics:** Bacterial cultures added to foodstuffs to

increase the populations of those bacteria within
the human digestive tract.
**Procollagen 1C terminal peptide:** Procollagen 1C is
the main collagen form synthesized by osteoblasts
during bone formation. The N and C terminals of
the protein are cleaved off and excreted. They can
be used as biomarkers of bone formation.
**Progesterone:** A steroid hormone that acts in the
menstrual cycle to prepare the uterus for implantation of the embryo. During pregnancy, progesterone is produced by the placenta and is essential
for preventing uterine contractions.
**Programming:** The process through which exposure
of the developing fetus to an insult during a critical period of development, permanently alters the
structure and function of tissues and organs.
**Prolactin:** Peptide hormone synthesized by the anterior pituitary. Prolactin stimulates the mammary
glands to synthesize milk.
**Prolactin-releasinghormone:** Peptide hormone produced by the hypothalamus. Prolactin-releasing
hormone stimulates production of prolactin.
**Prostaglandins:** A class of hormones derived from
fatty acids. Prostaglandins are short-lived and exert
only paracrine or autocrine effects.
**Protein–energy malnutrition:** Chronic undernutrition arising through insufficient intakes of protein
and energy to meet metabolic and physiological
demands. Protein–energy malnutrition is the most
common form of clinically significant malnutrition



and may arise due to inadequate food supply (as
in developing countries) or high nutrient requirements associated with trauma.
**Proteomics:** The study of proteins in relation to their
functions within cells, tissues, and body fluids.
**Proteolysis:** The degradation of proteins through the
actions of proteases.
**Pseudotumor cerebri:** A medical condition characterized by persistent headache. It is often caused by
increased blood and cerebrospinal fluid pressure
within the brain.

**Pubarche:** The first appearance of pubic hair during
sexual maturation.

**Puberty:** The process of physical change that marks
the transition from childhood to sexual maturity.
**Publication bias:** A form of bias in research reports
that arises from the tendency for researchers and
journal editors to highlight study results that are
positive rather than study results that are inconclusive.

**Public health nutrition:** The application of the science of nutrition for the benefit of the population.
Public health nutritionists are involved in investigation of the links between human nutrition and
disease states, and the development of suitable disease prevention and health promotion strategies.
**Pulmonary thromboembolism:** Blockage of the pulmonary artery due to a clot from another site becoming dislodged and transferring to the lungs.
**Quartile:** Populations may be divided into equally
sized groups based upon key characteristics such as
their nutrient intake, body mass index, height, or
weight. Where the division is into four groups, each
group is termed as a quartile.
**Quercetin:** A flavonoid with antioxidant and antiinflammatory properties.
**Quiescence:** A resting state, or state of dormancy.
**Quintile:** Populations may be divided into equally
sized groups based upon key characteristics such as
their nutrient intake, body mass index, height, or
weight. Where the division is into five groups, each
group is termed as a quintile.
**Reactive oxygen species:** Collective term used to describe free radicals and other oxidizing species that
are formed in biological systems through the use of
oxygen in metabolic processes, such as respiration.
**Reference nutrient intake (RNI):** One of the dietary
reference value terms used in the UK. The RNI for

a nutrient is the level of intake that should meet



the requirements of 97.5% of individuals within a
population.
**Renin:** An enzyme that is a key element of the renin–
angiotensin system. It is a key regulator of blood
pressure and blood volume.
**Resistin:** A hormone produced by adipose tissue. Resistin contributes to inflammatory responses, and
concentrations are elevated in insulin resistance.

**Retinoic acid:** A metabolite of retinol.

**Retinoid X receptor:** A transcription factor involved
in reproduction, embryonic development, cellular
differentiation, and hematopoiesis.
**Retinol:** The animal form of vitamin A. Retinol is a

fat-soluble vitamin with key roles in growth and
maintenance of vision.

**Retinol activity equivalents:** As vitamin A exists in
different forms (retinol, _α_ -carotene, ß-carotene)
and as each form difference in biological potency,
retinol activity equivalents are used to define the
standard units of vitamin A intake.
**Reverse transcription:** The process of generating a
double stranded copy DNA from single stranded
RNA using the enzyme reverse transcriptase.
**Rheumatoid arthritis:** A chronic inflammatory disorder, in which autoimmune responses result in
damage to tendons and joints.
**Rhodopsin:** The pigment present in the retina that is
used to form the photoreceptors that permit perception of light.
**Riboflavin:** Vitamin B2. Riboflavin is a vitamin with
a key role in energy metabolism.
**Rootingreflex:** The innate ability of the human infant
to locate and grasp the breast in preparation for
suckling.
**Safe intake:** One of the dietary reference value terms
used in the UK. Safe intake is applied to certain
nutrients, for which there is insufficient evidence
to define more detailed references. The Safe intake would represent an intake expected to meet
demands without posing a risk associated with ex
cess.

**Safrole:** An oily, organic compound produced by certain plants. Safrole is a known carcinogen and its
use as a food additive is not permitted. However, it
is naturally present in cinnamon and nutmeg.
**Sarcopenia:** Age-related degeneration of muscle mass
and strength.
**Satiety:** The sensation of fullness leading to the loss
of desire to eat.



**Glossary of Terms** **287**


**Saturated fatty acids:** Fatty acids that have no double
bonds in their carbon chain. Stearic acid (C18:0) is
an example of a saturated fatty acid.
**Sedentary:** Inactive.
**Senescence:** The process of aging. Senescence refers
to the biological processes that are associated with
advanced age.
**Serotonin:** Amonoamineneurotransmitterproduced
within the central nervous system and the gastrointestinal tract.

**Sertoli cells:** Cells of the testes that are responsible for
supporting spermatozoa as they differentiate from
immature forms.

**Sexhormonebindingglobulin:** Circulatinghormone
that binds free testosterone and estrogens. Sex hormone binding globulin determines the availability
of these hormones for interaction with their recep
tors.

**Short-chain fatty acids:** Fatty acids with carbon
chains of 6 or fewer carbons.

**Shoulder dystocia:** A complication of pregnancy,
in which the shoulders of the baby cannot pass
through the birth canal following delivery of the
head. This can be life threatening and often results
in fractures of the clavicle and injury to the nerves
that supply the shoulders and arms.
**Singlelocusmutation:** Mutationofasinglegeneleading to disease consequences.
**Single nucleotide polymorphism:** Many genes exist
in variant forms (alleles) that differ by the substitution of a single base pair. For example, one allele
couldincludethesequenceTTCGAC,withavariant
sequence TTTGAC. This difference is called a single
nucleotide polymorphism (SNP). Some SNPs have
been identified as having links to human disease

states.
**Skinfold thicknesses:** Body composition can be estimated using a skinfold test in which a pinch of
skin is precisely measured using calipers at standardized points on the body. This determines the
subcutaneous fat layer thickness, which can then be
included in equations that converted the measurements to an estimated body fat percentage. Typically measured sites are the triceps, subscapular,
suprailiac, and abdominal regions.
**Spina bifida:** A defect of the formation of the embryonic neural tube, which results in a lesion of the
spinal cord. Spina bifida is one of the most common
human birth defects.



**288** **Glossary of Terms**


**Stanols:** Compoundsofplantoriginthatareknownto
lower circulating LDL-cholesterol concentrations
in humans.

**Starch:** Complex carbohydrate formed in plants
through the polymerization of _α_ -glucose.
**Statins:** Class of drugs that lower circulating cholesterol concentrations by inhibiting the enzyme,
HMG-CoA reductase.

**Steatorrhea:** Production of nonsolid, often foulsmelling, feces. Often an indicator of malabsorption of fats.

**Stillbirth:** The delivery of a dead baby.
**Stools:** Feces.

**Stroke:** Cerebrovascular accident. Strokes may be
hemorrhagic, in which blood leaks from blood
vessels in the brain causing damage to local tissue, or thrombotic. Thrombotic strokes are caused
by atherosclerosis in vessels supplying the brain.
Blockage of vessels by clots starve the brain of oxygen and cause tissue damage.
**Stroke volume:** The volume of blood that is ejected in
a single contraction of the left ventricle. It is a key
determinant of the cardiac output.
**Strontium ranelate:** A drug used in the treatment of
osteoporosis. It acts by stimulating the activity of
osteoblasts and inhibiting action of osteoclasts.
**Stunting:** Growth-faltering in which the full stature
(height) of a growing child is not achieved.
**Subcutaneous fat:** The layer of fat that lies beneath
the skin.

**Subconjunctival hemorrhage:** Damage to the blood
vessels in the eye.
**Sulphonylurea receptor:** A membrane bound receptor protein that is responsible for promoting the
secretion of insulin by pancreatic ß-cells.
**Superoxide dismutase (SOD):** Antioxidant enzyme
responsible for the conversion of the superoxide
radical to hydrogen peroxide. There are different
isoforms of SOD. The cytosolic form uses copper
and zinc at the catalytic center, while mitochondrial
SOD requires manganese.
**Superoxide radical (O** [−·] **2** **[):]** [ Superoxide is a free rad-]
ical found in biological systems. Most superoxide
is a by-product of mitochondrial respiration, but
it can also be formed by cells of the immune system that utilize it in the destruction of pathogens.
Superoxide is generally damaging in cells, but is required for some processes, for example, spermatogenesis.



**Supplementation:** Supplementation of the diet with a
nutrient involves the consumption of that nutrient
in a purified and artificial form, for example, a multivitamin pill or a soluble fiber drink. Supplements
usually deliver nutrients in high doses, for example,
the equivalent of the requirement for a full day in a
single dose.
**Systematicreview:** Aresearchapproachinwhichaliterature review is written to focus solely on a single
question. The systematic review attempts to synthesize together the findings of all high-quality research evidence in the area, in an unbiased manner.
**Telomere:** A region of repetitive, noncoding DNA
found at the end of a linear chromosome.
**N-telopeptide:** A urinary marker of bone resorption.
**Teratogen:** An agent that interferes with normal processes of development during embryonic or fetal
life,andhencepromotescongenitalmalformations.
**Terpenoids:** Plant compounds that provide the distinctive aromas found in cinnamon and ginger.
**Testosterone:** The principal androgenic hormone of
mammals. Testosterone is a steroid hormone.
**Thelarche:** The first stage of breast development during puberty.
**Thermogenesis:** The process of endogenous heat production. Most thermogenesis is the product of
metabolism within the liver, which maintains a
constant body temperature. There are also components of thermogenesis that are activated by coldexposure (shivering and nonshivering thermogenesis) and by diet. Consumption of food generates
heat associated with the digestion and metabolism
of nutrients. Thermogenesis is an important component of total energy expenditure.
**Thiamin:** Vitamin B1. Thiamin has important roles
in energy metabolism. Deficiency of this vitamin is
associated with neurodegenerative problems such
as beriberi.

**Thirstcenter:** Region of the hypothalamus that senses
fluid balance and stimulates the desire to drink.
**Threoninekinase:** A class of protein kinase that phosphorylates threonine residues. Such enzymes play
a key role in intracellular signaling cascades.
**Thrombosis:** The process of blood clot formation.
**Thyroid-stimulating hormone:** A hormone of the
anterior pituitary, responsible for stimulation of
thyroxine and tri-iodothyronine from the thyroid.
_**α**_ **-tocopherol:** The major isomer of tocopherol. The
tocopherols are collectively termed vitamin E.



**Totalenergyexpenditure:** The total energy utilized by
an organism in a given period of time (usually measured over 24 h). The components of total energy
expenditure in an adult are the resting metabolic
rate, thermogenesis, and physical activity.
**Trabecular bone:** Bone of low density comprising a
lattice-type structure through which bone marrow,
nerves, and blood vessels pass. Also called cancellous or spongy bone.
**Trans-fatty acids:** Unsaturated fatty acids with double bonds in the trans-configuration as opposed
to the cis-arrangement of these isomers, which
is more usually seen in nature. Most trans-fatty
acids in the human diet are the product of hydrogenation of vegetable oils in order to make them
solidify.
**Transformed cell:** A cell that has become immortal
(i.e., it as unlimited capacity to divide) through the
mutation of an proto- or antioncogene.
**Transit time:** The time taken for components of food
to pass from the mouth to the anus. This essentially measures the speed of digestion and elimination of waste products. Transit time can be measured through ingestion of a colored marker such
as carmine, which will appear in the stools.
**Trauma:** Physiological stress to the body. Trauma
includes surgery, burns, infections, fractures, and
other injuries. All trauma events trigger a commonmetabolicresponsemediatedbypro-andantiinflammatory cytokines.
**Triacylglycerides:** Lipids formed by the conjugation
of glycerol and three fatty acids. Triacylglycerides
(also called triglycerides) are transported in the
circulation via chylomicrons and very low density
lipoprotein. They are the main constituents of animal fats and vegetable oils.
**Trimester:** A period of time relating to approximately
one-third of pregnancy.
**Tryptophan:** An essential amino acid.
**Tuberculosis (TB):** An infectious disease caused by
_Mycobacterium tuberculosis_ . TB effects the lungs,
and if untreated is fatal in approximately 50% of

cases.

**Tumor** **necrosis** **factor-** _**α**_ **(TNF** _**α**_ **):** A proinflammatory cytokine.
**Tumorsuppressorgene:** Agenethatencodesaprotein
product that inhibits cell division.
**Tyrosine kinase:** A class of protein kinases that catalyze the phosphorylation of tyrosine residues.



**Glossary of Terms** **289**


These enzymes play important roles in intracellular
signaling cascades.
**Ubiquinone:** Also called coenzyme Q. Ubiquinone
is an element of the electron transport chain in
mitochondria and plays a key role in generation
of ATP. Ubiquinone also has an antioxidant role
within mitochondria and in cell membranes.

**Ulcerative colitis:** An inflammatory disease of the
bowel in which ulcers develop within the colon. Ulcerativecolitisiswidelyregardedasanautoimmune
disease and is often treated by surgical removal of
affected portions of bowel.
**Umami:** The specialized component of taste perception that detects monosodium glutamate.
**Uracil misincorporation:** DNA and RNA differ in
their profile of bases. While DNA contains thymine,
in RNA this is replaced with uracil. The term
uracil misincorporation describes faulty DNA repair, in which a lack of thymine results in uracil
being included within DNA strands. As this cannot be transcribed the affected genes are effectively
mutated.
**Urea:** Waste product of the metabolism of nitrogenous compounds in mammals. Most urea is excreted via the urine and is formed by the deamination of amino acids in the liver.

**Vascular cell adhesion molecule-1 (VCAM-1):** A cell
surface protein that allows the binding of immune
cells such as monocytes, lymphocytes, or basophils.
**Vascular smooth muscle cells:** Cells of the outer layers of arteries that provide the blood vessels with
contractile properties.
**Vegans:** Individuals who follow an exclusively vegetarian diet, excluding all animal produce.
**Vegetarians:** Individuals who predominantly follow
a diet that is of plant origin. There are different
classes of vegetarian with varying dietary patterns.
Vegans, for example, exclude all animal produce,
while lactoovo-vegetarians will include eggs and
milk in their diet, but not eat meat.
**Visceral fat:** The fat that is stored around the organs
of the peritoneal cavity.
**Vital capacity:** A marker of lung function. Vital capacity is the maximum volume of air that can be
exhaled after maximum inhalation.
**Wasting:** Loss of weight due to utilization of fat and
muscle reserves. In children, wasting will manifest
as a failure to increase weight during the period of
growth.



**290** **Glossary of Terms**


**Waist circumference:** The measurement of the waist

circumference provides a proxy measure for the
amount of fat stored within the abdomen. Men of
healthy weight should have a waist circumference
of less than 94 cm, while in women it should be less

than 80 cm.

**Waist–hip ratio:** The waist circumference divided by
the circumference measured around the hips provides a proxy measurement for body fatness. The
adverse health consequences associated with over


weight and obesity correlate closely with a waist–
hip ratio greater than 0.9 in men and 0.8 in women.
**Weaning:** See Complementary Foods _._
**Whey:** A by-product of cheese production formed by
the curdling of milk using rennet. Whey is a liquid,
also called milk plasma.
**Xeroderma pigmentosa:** An inherited disorder of
DNA repair in which sensitivity to ultraviolet damage leads to early onset skin cancers.



### **Index**

abortifacient, 64
acetaldehyde, 178–9
active transport, 48
acute phase response, 4, 168, 265
adenosine triphosphate, ATP, 6, 36, 263–4
Adequate Intake, 20
adipocyte, 193, 263
adipogenesis, 35
adipokines, 27, 190, 200, 263
adiponectin, 200
adipose tissue, 5, 16, 27, 28, 110, 193, 196,
200, 241, 261, 263
adiposity, 35, 44, 68, 150, 190, 200, 263
adiposity rebound, 110, 144, 145
adolescence, 1, 2, 12, 81, 95, 124, 135, 143,

148–50, 158–84, 185, 240, 241,

254

alcohol, 173, 178–80, 182
body composition, 159, 160, 162, 167,
173, 174, 181
body image, 169–70, 175, 180
dieting, 169, 172, 182
drug abuse, 181, 182
eating disorders, 165, 172, 173, 174–6,
181, 182
growth, 11, 27, 68, 158–9, 160, 163–6,
167–9, 172, 178, 181
nutrient intakes, 168–72, 173
nutritional requirements, 158, 165–8,
181

energy, 166–7, 171
guidelines, 169
macronutrients, 166–7, 169, 171
micronutrients, 166–9
pregnancy, 55, 68, 71, 176–8, 182
psychosocial development, 158, 165–6,
175
puberty, 159–63, 165, 167, 175, 176, 181
skeletal age, 160, 164
skeletal growth, 163–5, 167, 172, 173,
174, 181
smoking, 172–3, 178, 180–81
sport, 165, 170, 173–4
vegetarianism, 172–3
adrenal glands, 160, 162, 196
adrenarche, 160, 162
adulthood, 1, 2, 11, 79, 91, 95, 124, 128,

149, 152, 166, 167
advertising, 137–8
aflatoxins, 217
aging, 1, 11, 186, 227–53, 254
agouti-related protein, AgRP, 27, 147, 257
AIDS, 6
albumin, 7, 16, 50, 236, 262
alcohol, 39, 40, 44, 108–9, 173, 178–82, 194
blood pressure, 206



cancer, 179, 210, 215–16
cirrhosis, 179
fertility, 30–32,
metabolism, 178–80
osteoporosis, 242
pregnancy, 48, 57, 59, 68, 71–2
alcohol dehydrogenase, 178–9
alcoholism, 179, 186, 242
alcohol-related birth defects, 39, 59, 68,

71–2
alcohol-related neurodevelopmental
disorders, 71
aldehyde dehydrogenase, 178–9
aldosterone, 48
aldosterone receptor, 206
alkaline phosphatase, 241, 244
alkaloids, 217
allergic sensitization, 111
allergy, 121–2
allium, 222
Alzheimer’s disease, 249–50, 264, 266–7
amenorrhea, 25–8, 107, 173, 174
Ames Test, 216–17, 222
amino acids, 51, 117, 120, 128, 201, 209,

214, 216
ammonia, 214, 246
amphetamines, 181
amylophagia, 66–7
anabolic steroids, 181
androgens, 25, 33, 35, 161–2, 164, 214
android shape, 189, 199
androstenedione, 162
anemia, 6, 67, 247–50
chronic disease, 248
definition, 247
iron deficiency anemia, 6–8, 11, 16, 50,
54, 59, 67–8, 70, 83, 106, 133, 134,

136, 138, 168, 169, 177, 178, 247–8
megaloblastic, 247–9
microcytic, 247–8
normocytic, 247
pernicious, 248–50
pregnancy, 50, 54, 59, 67, 68–70
anencephaly, 41, 43
angina pectoris, 197
angiogenesis, 57, 222
angiotensin II, 93, 200
angiotensinogen, 200
animal models, disease, 82–5, 95, 232, 260
animal protein, 214–15, 248
animal welfare, 173
anorexia nervosa. _See_ eating disorders
anorexia of chronic illness, 4, 6
anovulation, 26–7, 31, 173
anterior pituitary, 24, 28, 32, 33, 104, 107
anthropometry, 12, 16, 21, 79, 189, 235–6



antioxidants, 6, 35, 44, 235, 264–5

cancer, 212, 219–22
cardiovascular disease, 204–5
fat soluble, 204–5
fertility, 28–30, 36–8
supplements, 36, 62, 233
apatite, 128
apolipoprotein A1, 256
apolipoprotein B100, 196, 204
apolipoprotein E, 230, 264, 266–8
apoptosis, 179, 207, 218, 220, 228–9, 231–2
appetite, 5, 7, 11, 16, 27, 83, 89, 129, 134,
145, 146, 153, 167, 170–71, 176,

179, 190, 192, 235–9, 244, 248,

256

arachidonic acid, 53, 54, 102, 111, 128
areola, 99, 100, 101, 161
arrhythmia, 198
ascorbic acid, 29, 30, 36, 42, 62, 71, 106,

118, 121, 127, 135, 136, 140, 166,

171, 180, 181, 205, 220, 233, 234,

236
assisted reproduction, 26, 30, 44, 57, 69, 70
ataxia telangiectasia, 230
atherosclerosis. _See_ cardiovascular disease

atopy, 111–12, 121
atrophic gastritis, 248
attention deficit hyperactivity disorder,
111, 134
autoimmune disorders, 232
aversions, 66–7, 135


Baby Friendly Initiative, 115–16,
_Bacteriodes,_ 218
balance, 2–10, 21
Balance of Good Health (Eatwell), 139,

187–8

balance studies, 8–9
Bardet–Biedl Syndrome, 146–7
bariatric surgery, 191–2
basal metabolic rate. _See_ resting metabolic

rate

basil, 217

Bax, 231
Bcl2, 231
benzo(a)pyrene, 209, 216
beta cells, 86, 192
betaine, 93
betel chewing, 217
bicarbonate ion, 51
_Bifidobacteria,_ 102, 218–19
binge-drinking, 71, 178
bingeing and purging, 174, 176
bioavailability, 11, 16, 52, 109, 119, 132,
168, 173, 181, 216, 228, 238, 258
bioimpedance, 12, 199



**292** **Index**


biomarkers of nutritional status. _See_

nutritional assessment

biotin, 18
birth anthropometry, 79–80, 90, 95, 266–7
birth defects, 3, 10, 39–41, 71–2
birth weight, 10, 54, 55, 64, 76–85, 87, 90,
91, 93, 94, 108, 177, 179, 266
bisphonates, 242, 244
bitter taste receptors, 257–8
blindness, 9
blood loss, 4, 16, 54, 107, 133, 168, 248
blood pressure, 50, 58, 60, 79–82, 84, 87,
88, 90, 92–5, 150, 195, 196,

198–201, 205–7, 228
blood volume, 49–50, 65, 168, 199, 206
Blounts disease, 148
B-lymphocytes, 76, 109
body composition, 27, 124–5, 159, 160,
166, 173, 181, 189–90, 228
body fat, 23, 26, 27, 28, 34, 81, 141, 142,
144, 148–50, 174, 181, 189–90,

200, 213
body image dissatisfaction, 169–70, 172,
181
body mass index (BMI), 12, 34, 57, 58, 62,
63, 70, 80, 90, 105, 141, 151, 189,

199, 245
body temperature, 127, 233
bone, 108, 133, 168, 235
bone mineral density, 69, 108, 164, 165,
181, 241–2, 244, 267
cortical (compact), 163, 239, 241
degradation markers, 241
formation markers, 241
fractures, 4, 6, 69, 90, 181, 236, 240–43,

245, 247, 250
growth, 56, 163–5, 167, 173
mineralization, 11, 108, 120, 128, 164–5,

172, 173, 239–43
genetics, 164, 267
nutrition, 165, 239–44
Paget’s disease, 244
peak bone mass, 128, 164, 172, 239–42
remodeling and repair, 239
trabecular (cancellous), 163, 173, 239,

241

bottle feeding, 99, 107, 110, 113, 116,
118–23, 145
brain, 61, 91, 110, 111, 125, 128, 130, 162,

181, 195, 198
brain development, 11, 57, 110, 120, 125,
132–4
branding, 137–8
Brazil nuts, 37
BRCA1, 265
BRCA2, 265
bread, 56, 129, 131, 136, 140, 172, 187, 188,

235

breakfast, 136, 140–41, 154, 172, 186
breakfast skipping, 140, 144, 145, 171
breast anatomy, 99–100, 161



breastfeeding, 11, 99–118, 127, 129, 131,
145, 153
contraindications, 117–18
media influences, 115
problems, 114–15
promotion, 115–17
social and cultural issues, 114–17
trends, 112–14
bulk food distribution systems, 234, 238
burns, 4, 5
butyric acid, 218–19
B vitamins, 4, 178, 204, 244, 249, 250


_α_ -carotene. _See_ vitamin A

_β_ -carotene. _See_ vitamin A
_β_ -cryptoxanthine, 205
cachexia, 6, 12
_Caenorhabditis elegans_, 232
caffeine, 30–32, 44, 57, 59, 64, 66, 108, 244
calcitonin, 240, 242
calcium, 11, 31, 51, 55, 56, 71, 103, 104,

106, 108, 118, 120, 121, 127, 128,

129, 132, 133, 136, 140, 165, 166,

167, 168, 169, 172, 173, 174, 178,

181, 182, 196–7, 207, 235, 239–43,

258
binding proteins, 258
supplementation, 62, 81, 83, 165, 242,
244, 246
caloric restriction, 230, 232–3, 250
calpains, 5, 255
cancer, 5, 6, 11, 43, 108, 173, 186, 191,

207–22, 229–30, 232–3, 238–9,

247, 255
alcohol, 210, 215–16
antioxidants, 212, 219–21
bladder, 266
breast, 43, 108, 122, 210–17, 220, 221,

265

cervix, 221
colon, 210–14, 216, 221, 248
colorectal, 214–15, 218, 220–21
complex carbohydrates, 217–19, 221
endometrium, 213
esophagus, 209, 213, 215–16
fat intake, 210, 212, 214
folate, 221–2
gallbladder, 210, 211, 213
gastrointestinal tract, 209–22, 257, 265
genetics, 265
kidney, 213
liver, 210, 211, 213, 216, 219, 220
lung, 211, 212, 216, 219–21, 266
meat, 209, 211, 212, 214–15, 217–18
mortality, 212
mouth, 216
nutritional epidemiology, 209–12
obesity, 213–14
ovary, 108, 122, 217, 268
pancreas, 214, 219
pharynx, 216



prostate, 210, 211, 213, 219–20, 265, 266
protein intake, 214
rectum, 209, 213, 216
risk factors, 208–10, 212–22
stomach, 209–11, 214, 215, 217, 219,

222, 248
testicular, 34

uterus, 213
cannabinoid receptor, 192
cannabis, 181, 192
capsaicin, 217
carbenoxolone, 90
carbohydrates, 101, 144, 145, 167, 171, 186,
187, 191, 257
carbon dioxide, 51
_O_ [6] -carboxymethyl guanine, 215
carcinogen, 2, 179, 208, 215–17
carcinogenesis, 207–9, 221
cardiac output, 50
cardiovascular disease, 1, 61, 75, 78, 81, 83,

85, 93, 94, 148, 150, 154, 186, 191,

196–207, 222, 232, 233, 238, 239,

247–9, 255
atherosclerosis, 61, 149, 196–7, 260,

264–5

cerebrovascular disease (stroke), 80, 198,
206, 207, 245
coronary heart disease, 43, 60, 75, 78, 79,
80, 95, 150, 195, 197–8, 255, 260,

266

diabetes, 194, 200, 201
genetics, 203, 264–5
hypertension, 198, 205–7
mortality, 78, 79, 80, 195, 198–202, 206,
207
obesity, 199–200
peripheral artery disease, 198
risk factors, 149–50, 195, 199–207
L-carnitine, 36
carotenoids, 180, 220
carotid intima-media thickness, 149–50
cartilage, 159, 163
case-control studies, 211
casein, 103, 120
caspase, 231
catabolism, 4–5
catalase, 36, 179, 230
catch-up growth, 94, 95, 127, 132
catecholamines, 5, 59
celiac disease, 241, 246
cell cycle, 229, 231, 259
cellular senescence, 228–32, 234, 250
cellulose, 217
cereals, 129, 131, 136, 138, 171, 172, 187,

188, 235
cesarian section, 63, 64, 65, 68
chewing reflexes, 131, 236
childhood, 2, 80, 95, 124–57, 158, 166,

239–41, 254
children, 7, 8, 9, 10, 11, 12, 15, 17, 18, 79, 80
chitin, 217



chloride, 118
chocolate, 66, 129, 144, 151, 171
cholecystokinin, 48
cholesterol, 87, 102, 149, 150, 196, 201, 202,

204, 222, 260, 264
choline, 93
chondrocytes, 163–4
chorion, 47
chromatin, 35, 92
chronic illness, 228, 234, 238, 250
chylomicrons, 264
cinnamon, 217
claudication, 198
clotting factors, 80, 199–200
cobalamin, 4, 93, 106, 127, 166, 168, 181,
202–3, 228, 235- absorption, 248–9
deficiency, 43, 138, 248–50, 255
cocaine, 181
coffee, 30–32, 57, 59, 244
cognitive function, 127, 133, 166, 247
cognitive impairment, 127, 249
cohort studies, 79, 211
prospective cohorts, 211
collagen, 30, 168, 196, 197, 239
collagen 1 _α_ 1, 90, 164, 241
colonic microflora, 218–19, 244, 263
colostrum, 102, 107
comfrey, 217
coming-of-age, 158
complement, 109
complementary feeding, 112–13, 118, 120,
130–32
complex carbohydrates, 19, 26, 64, 87, 130,
140, 144, 191, 235

cancer, 217–19, 221
conception, 10, 23, 31, 39, 70, 71, 254
confidence intervals, 31
confounding factors, 81–2, 144, 148, 210,
211

conjugated linoleic acid, 202
constipation, 56, 68, 228, 247
convenience foods, 145
copper, 3, 55, 71, 106
coronary heart disease. _See_ cardiovascular
disease
corpus luteum, 24, 25, 30, 48
corticosteroids, 241
corticosterone, 89, 90
corticotrophin-releasing hormone, 48, 89
cortisol, 5, 48, 89, 174, 196, 206
cravings, 66–7
C-reactive protein, 200
cretinism, 8, 56
crocodilians, 75
Crohn’s disease, 246
cruciferous vegetables, 222, 257
cryptorchidism, 33–4, 37
cubilin receptor, 248–9
cystathionine _β_ -synthetase, 202–3
cytochrome P450 system, 117, 178–9, 209
cytokines, 4, 5, 47, 62, 196, 200, 244, 265



anti-inflammatory, 5
pro-inflammatory, 5, 60, 197, 200, 213,
247, 265


daidzein, 38, 244
dairy produce, 111, 171, 187, 202, 211,
238

_db/db_ mouse, 27, 165
dehydration, 65, 125, 139, 175, 176, 235,
246

delta-6 desaturase, 111, 202
dementia, 228, 239, 249–50
demographic shift, 227
dental caries, 128, 136
dentition, 228, 238, 245
deoxyribose nucleic acid, DNA, 95, 132,
168, 258
adducts, 209, 215
damage, 29, 34, 36, 207, 208, 216,
230–32, 250
methylation, 92–3, 147, 202, 221, 267
methyltransferases, 92–3, 267
microarray, 260–61
oxidation, 220, 222, 265
repair, 207, 221, 230, 231
strand breaks, 29, 209, 221
depression, 228, 233
_O_ -desmethylangolensin, 244
development, 10–12, 75–9, 82, 83, 88, 92,
102, 110, 111, 124–5, 127, 128,

131, 134, 139, 169, 173, 182, 185
developmental origins of adult disease
hypothesis, 75–98
dexamethasone, 89, 95
diabetes, 1, 75, 85, 87, 90, 148, 186, 191,

192–5, 232, 238, 258, 263, 266
type I, 34, 68, 86, 192
type II, 34, 68–9, 79–81, 84, 86, 90, 94,
95, 192–5, 222, 255
candidate genes, 192
cardiovascular disease, 193–4,

199–201

causes, 148, 192–5
genetic factors, 193–4
gestational, 58, 63, 65, 67–9, 71, 85, 95
MODY, 85, 193
neuropathy, 194
pharmacological treatment, 194–5
prevalence, 193
renal failure, 194
retinopathy, 194
thrifty genotype hypothesis, 85–6, 87,
194
thrifty phenotype hypothesis, 85–6,
87, 94 194
treatment and management, 194–5
diaphysis, 163, 164
diarrhea, 16, 102, 109, 112, 130, 133, 246,

247
diet diversification, 8, 9
diet modification, 151, 191–2, 201



**Index** **293**


dietary fiber, 126, 135, 138, 173, 180, 194,
207, 210, 212, 215, 217–19, 221,

246
dietary reference values, 16–21, 166, 169,
234

Australia and New Zealand, 20
European Union, 20
United Kingdom, 16, 17–19
United States of America and Canada,

16, 20
dietary surveys. _See_ nutritional surveys
dieting, 151, 169, 172, 180, 191–2, 236, 264
Atkins diet, 191
high protein diet, 26
low carbohydrate diet, 26, 191, 218
low fat diet, 26, 173, 191, 207, 235, 256,

257
low glycaemic index diet, 191–2
very low calorie diet (VLCD), 151, 192
dietitian, 194
dihydroepiandrosterone sulfate, 162
diverticular disease, 228, 246, 247
DNA. _See_ deoxyribose nucleic acid
docosahexaenoic acid, 53, 54, 102, 111, 128,

202
dopamine, 134, 192, 257
doubly labeled water, 15
_Drosophila melanogaster,_ 230, 232
dual x-ray absorptiometry, 12, 108, 241
Dutch famine, 77, 80, 94
dyslipidemia, 195, 198, 200–201
dyspepsia, 68
dysphagia, 245


17 _β_ -estradiol, 164, 214
eating disorders, 165, 172, 173, 174–6, 181,
182, 257
anorexia nervosa, 26, 165, 174–6, 181,

241

binge-eating disorder, 174
bulimia nervosa, 174, 176–7, 181
genetics, 175
partial eating disorders, 174
risk factors, 175
eclampsia, 60
ecological studies, 78, 210
ectopic pregnancy, 64
edema, 7, 60, 61, 62
eggs, 54, 66, 71, 129, 131, 180
eicosanoids, 53, 54
eicosapentaenoic acid, 202
elderly people, 1, 3, 8, 11, 17, 43, 82, 108,
186, 227–53, 255
nutrient requirements, 234–5, 250
elongase, 111
embryo, 10, 30, 31, 33, 39, 44, 47, 63, 64,
70, 76, 83, 88, 91
embryogenesis, 71
embryo transfers, 76
endocrine disruptors, 37, 44
endometriosis, 24, 30, 31



**294** **Index**


endoplasmic reticulum, 259
endosteum, 163
endothelial dysfunction, 61, 62, 84, 85, 200,
202, 203, 264, 265
energy, 2, 3, 5, 10, 15, 58, 59, 101, 120, 121,
126, 127, 128, 169, 171, 239
balance, 53, 142, 145, 146, 147, 174, 190,

232, 233
density, 125–6, 128, 129, 131, 144–5,
154, 171, 191, 192
expenditure, 27, 51–3, 84, 126, 127, 142,
144, 151, 154, 192, 250, 255
metabolism, 190
requirements, 4, 106–8, 124, 126, 129,
139–41, 144, 154, 166, 167, 186,

212, 234, 238, 244
enteral feeding support, 120
EPIC, 206, 212, 214, 219
epigenetic drift, 267
epigenetic regulation, 92–5, 202, 258, 269
epiphysis, 163–5
equol, 244
erythropoiesis, 247–8
_Escherichia coli,_ 218
esophagitis, 246
esophagus, 63, 245
essential fatty acids, 19, 53, 71, 118, 128, 202
Estimated Average Requirement, EAR,
17–19
Estimated Energy Requirement, EER, 20
estragole, 217
estrogen, 24, 25, 28, 48, 51, 63, 99, 104, 159,
174, 213, 214
estrogen receptor, 164, 176, 242
ethical issues, 82, 169, 268
ethnicity, 42, 67, 112, 114, 131, 133, 136,
141, 147, 149, 189, 193, 198, 206
exercise, 10, 25, 40, 110, 151, 177, 192, 198,

228
expressing milk, 106, 115
eye, 128, 194


5-fluorouracil, 268
_fa/fa_ rat, 27–8
factor VII, 200
factor VIII, 200
faddy eating, 134–6
Falasha, 86
falls, 241–3, 247, 250
famine, 7, 85, 105, 194
fast-food, 138, 145, 170, 171
fat, 4, 101, 102, 105, 120, 126, 127, 130, 138,

171, 180, 239, 254, 257, 258
central, 189, 196, 199
deposition, 159, 178, 189, 199
distribution, 159, 189
intake, 128, 129, 137, 144, 145, 167,

169–71, 186–8, 190, 192, 210, 214,

218

mass, 125, 160, 189, 228, 233
oxidation, 191



fat-soluble vitamins, 176
fatty acids, 5, 61, 68, 102, 110, 111, 119,
122, 130, 204
essential fatty acids, 19, 53, 71, 102, 118,
128, 202
long-chain polyunsaturated fatty acids,
53, 54, 102, 111, 128
monounsaturated, 19, 169, 187, 201–2,

214

n-3, 53, 54, 62, 110, 128, 202, 214, 222

n-6, 53, 54, 62, 110, 128
polyunsaturated, 19, 36, 53, 54, 187, 196,
201–2, 256
saturated, 19, 84, 154, 169, 187, 188,

201–2, 212, 215, 222, 238
short chain, 218–19

trans, 202, 222
fatty acid synthase, 91, 102
fatty liver, 84
fatty streak, 197, 200, 265
fecal losses, 181, 192, 238
female athlete triad, 174
ferritin, 7, 62, 181, 262
fertility, 11, 23–46, 121, 173
female fertility, 24–32, 44
male fertility, 32–9, 44
fetal alcohol syndrome (FAS), 48, 57, 59,
68, 71–2
fetal death, 55–7, 60, 64–5, 68, 72, 177
fetal growth, 10, 11, 38, 39, 49, 53, 55, 59,
66, 69, 76–83, 85, 86, 95
fetal nutrition, 75–98
fetus, 10, 38, 39, 41, 44, 48, 49, 51, 64, 65,

68, 69, 78, 79, 82, 85–91, 94, 95,

107, 120, 133, 163, 178, 254
fever, 5
fibrinogen, 200
fish, 66, 71, 129, 131, 186, 187, 212, 214
fish oils, 54, 111, 265
five-a-day campaign, 140, 186, 187
flatulence, 246
fluid homeostasis, 174, 228, 235
fluid intake, 235
fluoridation, 128
fluoride, 128, 239
foam cells, 196–7, 200, 201
folic acid, folate, 4, 39, 41, 43, 44, 55, 93,

106, 121, 127, 129, 135, 140, 166,

168, 178, 180–82, 202–4, 219, 220,

228, 235, 248, 250, 255
folate cycle, 202–4, 221, 267
deficiency, 248–50
supplementation, 42–4, 58, 71, 178, 221,
249
follicle stimulating hormone (FSH), 24, 25,
27, 28, 32, 33, 107
follicular phase, 24, 25
food additives, 134
food allergy, 121–2, 138
food balance sheets, 13, 17, 84
food-borne disease, 64, 239



food choice, 51, 126, 129, 140, 145, 165,

169, 170, 182, 256
food colorings, 134
food groups, 187–8
food industry, 138, 152–3, 254
food intake, 85, 141, 143–7, 263
genetics, 256–7, 269
food labeling, 17, 188, 254
food neophobia, 135–6
food pyramid, 139, 187–8, 268
food security, 8, 136
fortification, 8, 9, 43, 44, 56, 129, 131, 133,
140, 249, 254, 255
fortifiers, 120
free fatty acids, 5, 61, 68
free radical, 28, 61, 179, 230
fruit juices, 66, 129, 140, 141, 146, 187
fruits and vegetables, 38, 58, 66, 129, 131,
135, 139, 140, 145, 151, 171–172,

180, 188, 191–2, 204, 212, 219,

220, 235, 265, 268
_FTO_ gene, 146–7, 263
functional capacity, 229, 256
functional foods, 219
galactose, 102, 117
galactosemia, 117
galanin, 48
gallstones, 148
Gambia, 77
gastric mucosa, 246
gastric parietal cells, 248–9
gastric surgery, 192
gastritis, 209
gastroenteritis, 131
gastrointestinal tract, 7, 130–32, 175, 238
bleeding, 133, 247
disorders, 131, 235, 246
esophagus, 63, 245
infections, 109, 112, 130, 132
large intestine, 219, 228, 246, 255
motility, 51, 55, 67, 218, 228, 246
parasites, 127, 246
peristalsis, 120, 245, 246
pregnancy, 51, 55
small intestine, 56, 132, 228, 238, 246,

248
bacterial overgrowth, 228, 246, 248
stomach, 51, 68, 246, 248
gastric reflux, 63, 68, 246
peptic ulcer, 246, 248
gender, 186, 199, 241, 267
gene expression, 92–3, 256, 258, 269
genetic disorders, 117, 202
genistein, 38, 244
genome, 95, 142, 230, 256, 260, 263
genotype, 255, 266
geophagia, 66, 67
gestational diabetes, 58, 63, 65, 67, 68–9,
71, 85, 95
gestation period
guinea pig, 82



human, 47

mouse, 82

rat, 82
sheep, 82
ghrelin, 257
gingivitis, 60
glitazones, 195
glomerular filtration rate, 50
glucagon, 5
glucocorticoid receptor, 89
glucocorticoids, 89, 90
glucokinase, 85, 193
gluconeogenesis, 5, 6, 195
glucose, 5, 6, 51, 69, 70, 102, 117, 121, 130,
140, 193, 194, 195, 257
glucose homeostasis, 81, 88, 95, 192,
222

glucose intolerance, 80, 95, 193, 195
glucose uptake, 51, 195
glucosinolates, 222
GLUT4, 51–2
glutaminergic neurones, 162
glutathione, 6, 36
glutathione peroxidase, 36, 37, 220, 258,
266
glycemic control, 194–5
glycemic index, 191–2, 194
glycerol, 102, 103
glycogen, 70
glycogen synthase, 193
glycosylated hemoglobin A1c, 194
goiter, 8
golgi body, 100, 102, 103
gonadotrophin releasing hormone, 24, 25,
27, 28, 32, 34, 174
great apes, 124
growth, 8, 9, 10, 12, 16, 105, 124–8, 130,
131, 133, 138, 154, 162–4, 169,

174, 178, 181, 182, 185, 242, 266
faltering, 132, 135, 139, 154
rates, 125, 158–61, 166
growth factors, 48, 104
growth hormone, 164, 174, 228, 240, 241
guideline daily allowance, 188
guidelines for healthy eating, 128, 138, 154,
169, 186–8, 194, 234
gynoid shape, 189


3-hydroxy-3-methyl-glutaryl-CoA
reductase, 201
11 _β_ -hydroxysteroid dehydrogenase, 89–90,
206

hair, 16
haptocorrin, 248–9
Hayflick limit, 207, 229, 231
head circumference, 79, 125
health education, 254
health promotion, 139, 153, 254, 256
heart, 83, 91, 198
_Helicobacter pylori,_ 209, 215, 222, 246
hemochromatosis, 243



hemoglobin, 6, 7, 50, 54, 55, 67, 81, 83, 173,
247, 262
hepatic steatosis, 84, 91, 148
hepatocyte nuclear factors, 193
hepcidin, 248
heterocyclic amines, 215
high-density lipoprotein (HDL)
cholesterol, 61, 148, 150, 196–7,

200, 201, 256
hippocampus, 180
hirsutism, 25–6
histone acetylation, 92, 267
HIV, 68, 117–18, 186
Homeostasis Model Assessment-insulin

resistance, 195
homocysteine, 4, 202–4, 248–9, 255
hookworm, 67
hormone response elements, 259
human chorionic gonadotrophin, 48, 51,
63, 64
human chorionic somatomammotropin,
89, 104
humanitarian aid, 17, 137
human placental lactogen, 48, 51
hunter gatherer, 85
hydrogenated fats, 136, 202
hydrogen peroxide, 28, 203, 230
hydroxyl radical, 28, 29, 209
hydroxyproline, 168
hyperemesis gravidarum, 63, 65–6, 70, 72
hyperglycemia, 69, 200
hyperhomocysteinemia, 202–4
hypermetabolic response, 4–6
hyperparathyroidism, 241
hypertension, 82, 84, 90, 95, 148, 196, 198,
200, 205–7, 222
pregnancy, 60–62, 68
hyperthyroidism, 241
hypertriglyceridemia, 148
hypoglycemia, 69
hypospadias, 33–4, 37–8
hypothalamic–pituitary–adrenal axis, 89,
124, 160, 233
hypothalamic–pituitary–gonadal axis,
27–8, 32, 44, 108, 124, 160, 174
hypothalamus, 5, 24, 25, 27, 28, 32, 33, 76,
85, 89, 104, 105, 110, 122, 146, 147,

173, 257


immigrants, 8, 136
implantation, 48, 49, 92
immune function, 1, 8, 94, 120, 128, 133,

139, 228, 234, 244
immune senescence, 228, 244, 245
immune system, 30, 60, 76, 94, 130, 132,
208, 209
immunoglobulins, 109
IgA, 102, 103
inborn errors of metabolism, 117, 202
indoles, 222
infancy, 1, 11, 18, 79, 81, 99–123, 124, 139



**Index** **295**


allergy, 121, 122, 131
body composition, 125
brain growth, 125, 132, 133
developing countries, 127–9, 132, 136,
137
developmental milestones, 124
faddy eating, 134–6
growth rates, 125, 128, 132
hyperactivity, 134
malnutrition, 128, 130–32, 136, 154
micronutrient deficiency, 127, 128,
132–4, 136–8
milk, 99–123, 131, 133, 136, 137
nutrient requirements, 115, 124–7, 130,
154
complex carbohydrates, 128, 130
energy, 124, 126–8, 154
fats, 126, 128, 130
fiber, 126
micronutrients, 127, 128–9, 130
protein, 127–30
restrictive diets, 138, 154
salt, 128–9
supplementation, 128, 129, 133, 134
weaning, 1, 10, 105, 109, 120, 125, 126,
129–33
infant mortality rates, 27, 44, 78, 117, 127,
130, 133
infection, 2, 7, 10, 16, 30, 39–40, 58, 60, 67,

76, 81, 102, 109, 112, 117–18, 122,

124, 127, 130, 131–3, 136, 154, 168,

186, 194, 197, 236, 237, 244, 247
infertility, 23–46, 233
inflammatory bowel disorders, 5, 246
inflammatory response, 4–6, 16, 60, 128,
195, 197, 202, 233, 244, 265
inhibin-B, 33–4
injury. _See_ trauma
INK4a, 230–32, 250
Innocenti Declaration, 112
institutionalized people, 186, 228, 234–8,
245, 248, 250
insulin, 26, 51, 69, 70, 80, 85, 86, 88, 89,

103, 130, 150, 191–3, 195–6, 201,

233
insulin-like growth factor 1, 69, 103, 164,
165, 174, 213
insulin promoter factor-1, 193
insulin receptor substrate 1, 51, 193
insulin resistance, 26, 35, 51, 58, 61, 62,

68–9, 84, 87, 95, 195, 199, 222
insulin resistance syndrome, 79, 84, 148,
195–6, 222
intelligence quotient (IQ), 71, 111, 134
interleukin-1, IL-1, 4, 5, 244, 247, 265
interleukin-2, IL-2, 4, 5, 245
interleukin-6, IL-6, 4, 5, 164, 200, 244, 247
interleukin-10, IL-10, 5, 244
intracellular adhesion molecule 1, ICAM-1,

200

intrinsic factor, 248–9



**296** **Index**


in vitro fertilization, 23, 70
involution

breast, 105

uterus, 107
iodine, 8, 55–6, 136
iodine deficiency disorders, 8, 11, 56
iron, 3, 6, 7, 8, 10, 31, 103, 107, 112, 118,

119, 121, 127, 130, 131, 136, 140,

166, 168, 169, 173, 174, 178, 182,

228, 235, 243
fortification, 248
iron deficiency anemia. _See_ anemia
overload, 3
pregnancy, 54–5, 62, 67, 70
supplements, 3, 55, 58, 68, 70, 133, 134,
246

ischemic heart disease. _See_ cardiovascular

disease
isoflavones, 38, 222, 244
isothiocyanates, 222, 257
isotope dilution, 12


JAK-STAT pathway, 28–9
Japanese spinning top, 188
junk food, 84–5, 137


ketones, 68
ketosis, 65, 191
keyhole symbol, 188
kidney, 50, 56, 60–61, 84, 87–8, 194, 195,
206, 228
kwashiorkor. _See_ protein, protein-energy
malnutrition


_α_ -lactalbumin, 101–3, 119
_β_ -lactoglobulin, 103, 119
lactation, 4, 7, 9, 10, 11, 19, 49, 85, 89, 95,

99–122

lactiferous duct, 99, 100, 104, 105
lactiferous sinus, 99, 100
_Lactobacillus_, 102, 219
lactoferrin, 101–3, 109, 120
lactose, 101–3, 105, 117, 118, 122
lactose intolerance, 121–2, 238
large-for-gestational age, 63
large intestine, 246, 255
laxatives, 176, 177, 181, 246
lead, 67
lean body mass, 125, 160, 162, 167, 174,
181, 189, 228, 233, 234
legumes, 171, 212
Leningrad siege, 81
leptin, 27–9, 44, 48, 57, 85, 146–7, 164, 165,
173, 174, 200, 257
leptin receptor, 28–9, 146–7, 263
leptin resistance, 28–9
reproduction, 27–9
letdown reflex, 101, 105, 107
leukotrienes, 265
Leydig cells, 33
life expectancy, 253



lifespan, 75, 82, 84, 230, 232, 234, 241, 250
lifespan approach to nutrition, 1–22
lignans, 217
limonene, 222
linoleic acid, 19, 10, 53
linolenic acid, 53, 111
lipid hydroperoxides, 28
lipid oxidation, 29, 191, 256
lipids, 80, 83, 84, 90, 148, 179, 264
lipolysis, 5, 34, 35, 191, 195, 264
lipoprotein lipase, 102–3, 200
liver, 40–41, 44, 51, 56, 61, 85, 91, 148, 168,

178, 179, 192, 193, 195, 201, 209,

233, 261, 264
liver X receptor, 260
longevity, 230, 233, 234
low-density lipoprotein (LDL) cholesterol,
61, 148, 150, 196, 200–202, 204,

264, 265
LDL receptor, 196, 201, 202
oxidation, 200–202
low-density lipoprotein receptor-related
protein 5, 164
lower reference nutrient intake, LRNI,

18–19
lung, 84, 87, 90, 120, 125, 228
luteal phase, 24, 25, 173
lutein, 205
luteinising hormone (LH), 24, 25, 28, 32,
33, 34, 48, 107, 173
lycopene, 204–5, 266


macronutrient preferences, 257
macrophages, 5, 30, 109, 197, 200, 201, 204,
264, 265
magnesium, 55, 62, 106, 132, 166, 168, 169,
174, 207, 243
malabsorption, 132, 176, 234, 238, 246,
248, 250
malaria, 134
malnutrition, 7–8, 11, 12, 21, 67, 105, 118,

128, 130, 131, 136, 179, 186,

234–9, 250
Malnutrition Action Group, 235
mammary alveoli, 99–100, 102, 104, 122
manganese superoxide dismutase, 265–6
marginal nutrition, 7
mass spectrometry, 262–3
mastitis, 115
maternal death, 23, 44, 60, 65, 72
maternal distress, 77, 81
maternal mortality rates, 68, 177
maturation, 10, 125, 128, 154, 159, 166,

174, 185
maturity onset diabetes of the young
(MODY), 85, 193
meal pattern, 131, 171–2, 180
meals-on-wheels, 239

meat, 54, 64, 66, 87, 131, 136, 141, 172, 173,

180, 187, 209, 210–12, 214,

217–18, 222, 238



media influences, 115, 170, 172, 254
medication, 228, 238
melanocortin receptor, 85, 146–7, 257,
263

menarche, 24–8, 68, 162, 176, 178, 210
menopause, 1, 199, 210, 213, 214, 241–3,
267
menstrual cycle, 24, 54, 162, 168, 174,
233

mental retardation, 71
metabolic syndrome, 35, 79, 80, 84, 148,
195–6, 222, 263
cardiovascular disease, 195
metabolomics, 260, 263, 269
metallothionein, 16, 258
metastasis, 208
metformin, 195
methionine, 4, 202–4
methionine cycle, 202–4, 267
methionine synthase, 203
methylmalonate, 248–9
methyltetrahydrofolate reductase, 42, 203,
255, 265, 267–8
C677T polymorphism, 203, 221, 255,
260, 265, 268
microalbuminuria, 80, 195, 196, 201
micronutrient deficiency, 7–8, 11, 21, 128,
132–4, 139, 180
micronutrient requirements, 10, 128–9,
167–8, 185–6, 234–9
mid-arm muscle circumference, 12, 236
migrants, 86, 193–4, 210
milk, 10, 114, 125, 128–30, 136, 137, 140,

187, 211
artificial formula, 106, 107, 110–12, 117,
118–22, 130, 145
amino acid formula, 121
cows milk formula, 118, 120, 121
follow-on formula, 120
goats milk formula, 121–2
hydrolysed protein formula, 121
preterm formula, 121
sheeps milk formula, 121–2
soy formula, 38, 121
cow, 111, 118, 120, 133
composition, 118
human, 38, 99, 103, 110, 117, 120, 133
composition, 101–6, 109, 118
colostrum, 102, 107
vouchers, 120
Millennium Development Goals, 136
miscarriage, 57–8, 59, 64, 71–2, 177
mitochondria, 3, 28, 102, 178, 230, 231,

262, 264
mitosis, 32, 163, 229
molybdenum, 18
monocyte chemoattractant protein 1, 200
monocytes, 5, 197, 200, 203
monounsaturated fatty acids, MUFA, 19,
169, 187, 201, 202, 214
Montgomery’s tubercules, 99, 100



morning sickness. _See_ pregnancy; nausea;
vomiting
morphogenesis, 71
motor neurons, 125
mouth, 245
periodontal disease, 60, 228, 238
soreness, 245
Mullerian duct, 33
muscle, 5, 159, 173, 196, 261
muscle function, 243
muscle wasting, 5, 175, 236
MUST tool, 238
mutation, 209, 230
mutual gazing, 107
myocardial infarction, 197–8, 199, 201, 204
myoepithelial cells, 105
myoglobin, 168
myricetin, 222


n-3 fatty acids, 53, 54, 62, 110, 128, 202,
214, 222
n-6 fatty acids, 53, 54, 62, 110, 128
Nauruan islanders, 86, 194

nausea, 16, 63–6, 67
negative feedback, 24
neonatal death, 23, 57, 62, 70, 108
nephron, 87–8, 194, 228
neural tube defects, 41–4, 255
neurodegenerative disorders, 232
neurodevelopment, 88, 119
neurogenic differentiation factor-1, 193
neuropeptide Y, NPY, 27, 257
neutrophils, 30
NF _κ_ B, 265
niacin, 168
nicotinic acid, 178
nipple, 100–101, 105, 115, 161
nitric oxide, 28, 30, 203
nitrites, 209
nitrogen, 102, 107, 118
balance studies, 8–9, 127, 167
nitrosamines, 209, 210, 215
_N_ -nitroso compounds, 215
_N_ -nitrosodimethylamine, 209
NMR scanner, 12
NMR spectroscopy, 263
nonalcoholic fatty liver disease, 91
nonhuman primates, 232
noradrenaline, 192
nuclear receptors, 259
nuns, 210
Nurses Health Study, USA, 108, 212, 214,
217, 218, 22
nursing homes, 235, 238, 246
nutmeg, 217
nutrient density, 126, 130, 131, 154, 186,
235, 250
nutrigenomics, 260–62, 269
nutritional assessment, 11–16, 21
anthropometry, 12, 16, 21, 79, 235, 236
biomarkers, 12, 15–16, 17, 236



clinical examination, 12, 16
dietary assessment, 12
direct measures, 13–15
food accounts, 13–14
food balance sheets, 13, 17
food frequency questionnaire, 14–15,
36

food record, 14–15
indirect measures, 12–13
overreporting, 14
photographic atlases, 14
portion sizes, 14
recall methods, 13–14
underreporting, 14
weighed food record, 14
functional tests, 15–16
nutritional deficiency, 6, 7–8, 15, 16, 17, 19,
21, 118, 136, 254
nutritional epidemiology, 209–12, 214
nutritional status, 2, 6, 10, 15, 26, 29, 77,

81, 135, 158, 173, 177, 178,

180–82, 235, 236, 244, 245, 258
nutritional support, 6, 8, 236, 238, 245
nutritional surveys, 15, 168, 169, 178,
246

nutritional transition, 87, 94, 194, 198

nuts, 111, 131


_ob/ob_ mouse, 27, 28, 165
obesity, 1, 3, 11, 12, 14, 26, 34, 35, 44, 57,
58, 62, 63, 68, 70, 71, 80, 83, 84, 85,

94, 95, 109, 122, 130, 139, 141–54,

165, 167, 171, 173, 186, 194, 222,

233, 255
abdominal, central, 189, 196, 199

cancer, 191, 213–14
cardiovascular disease, 191, 199–200

causes, 142–8, 190–91
childhood, 110, 130, 139, 141–54, 171
definitions, 141–2, 189
drug therapy, 147, 172, 192
genetics, 142–3, 146–8, 190–91, 257,
263–4
prevalence, 141–2, 189–90
prevention, 152–4
surgery, 191–2
tracking, 148–52
treatment, 150–52, 191–2
type 2 diabetes, 192–5
ochratoxins, 217
odds ratios, 31
offal, 215
oily fish, 186
Okinawa, 233
oligorrhea, 25
oligosaccharides, 102
‘omics, 260, 268, 269
oncogenes, 207–8, 231
oral contraceptives, 37, 63, 173, 210
oral glucose tolerance test, 193
organic farming, 39



**Index** **297**


organogenesis, 47–8
orlistat, 192
ossification, 163
osteoblast, 163–4, 240–41
osteocalcin, 164
osteoclast, 240–42, 244
osteopenia, 120, 174, 242
osteoporosis, 90–91, 108–9, 128, 174, 181,
233, 241–4, 247, 267
caffeine, 244
calcium, 241–4
diagnosis, 241
dietary intervention, 241–4
phytoestrogens, 243–4
protein, 243
risk factors, 241–4

treatment, 241
vitamin D, 241–4
ovary, 25, 28, 162
overnutrition, 2–3, 21, 75, 82, 85, 91, 95,

186
overweight, 11, 14, 17, 27, 34, 57–8, 63, 70,
109, 139–54, 165, 167, 171, 173,

174, 194, 213, 263
ovulation, 24, 30, 48
oxidative damage, 29, 36, 61, 62, 180, 196,
199, 220, 222, 230, 232, 234, 249,

250
oxidative phosphorylation, 3
oxidative senescence, 230–31, 233
oxygen, 28, 29, 49, 50, 51, 197
oxyntomodulin, 257
oxytocin, 104–5, 107, 122
p53 tumor suppressor gene, 207, 221,
230–32
Paget’s disease of bone, 244
pagophagia, 66
palatability, 129, 257, 258
pancreas, 85, 86, 88, 95, 131, 192
pancreatitis, 246
pantothenic acid, 18
parabens, 37
parathyroid hormone, 168, 240
parenteral feeding, 110
Parkinson’s disease, 245
peer group, 116, 126, 135, 148, 166, 170,
172

penis, 33, 159–62
peppercorns, 217
peppers, 217
pepsin, 248
peptic ulcers, 246, 248
peptide YY, 257
perilipin, 263–4
periodontal disease, 60, 228, 238
periosteum, 163, 165
peripheral resistance, 50, 198
peristalsis, 120, 245
peroxisome proliferator-activated
receptors, 85, 90, 193, 195, 259,
260, 263, 266



**298** **Index**


personalized nutrition advice, 93, 188,
254–70
pesticides, 38, 39
phagocytes, 133
phase I xenobiotic metabolism, 117, 181,
209, 216
phase II xenobiotic metabolism, 181, 216,

222

phenolics, 168
phenothiazines, 238
phenotype, 255, 257
phenylketonuria, 117
phenylthiocarbamide, 257–8
phosphate, 103, 120, 121, 239
phosphatidylcholine, 54, 202
phosphatidylinositol 3-kinase, 29, 51
phosphatidylserine, 54
phospholipids, 29, 102, 204
phosphorus, 55, 118, 168, 174
phthalates, 37–8
physical activity, 10, 19, 20, 51, 52, 53, 58,
68, 69, 81, 83, 126, 139, 140, 142,

143, 150, 152, 153, 164, 167, 173,

186, 191, 194, 199, 200, 206, 234,

235, 241, 245, 246, 247
phytate, 132–3, 168, 173, 235
phytoestrogens, 37–8, 121, 222, 243–4
pica, 66–7
pictorial models of healthy eating, 187–8
Pima Indians, 194
placenta, 11, 47–9, 52–6, 59–63, 66, 69, 71,
78, 82, 85, 87, 89–91, 95, 104, 178
placental growth hormone. _See_ human
placental lactogen
placenta previa, 68
place of birth, 78
plasma, 263
plasma volume, 49–50, 55
plasma volume expansion, 49–50, 66, 70
plasminogen activation inhibitor 1, 200
plasticity, 76
platelet aggregation, 202, 264
polyacrylamide gel electrophoresis, 261–3
polycyclic aromatic hydrocarbons, 209
polycystic ovary syndrome, 24, 25–6, 57
polymorphisms, 90–91, 190, 193, 203, 209,
221, 241, 244, 255, 258, 260, 263,

264, 266, 269
polyphenolics, 204–5, 257
polyunsaturated fatty acids, PUFA, 19, 36,
53, 54, 102, 111, 154, 187 196, 201,

202, 256
ponderal index, 80, 266
population average, 19
_Porphyromonas gingivalis,_ 60
portion size, 131, 144, 190, 191, 239
positive feedback, 24
posterior pituitary, 104, 105
posttranslational modification, 258
potassium, 51, 102, 118, 128
poultry, 215



poverty, 7, 8, 10, 81, 115, 118, 130, 132–3,
136–7, 139–41, 154, 236, 237, 250
Prader–Willi syndrome, 146–7
prebiotics, 102, 219
predictive adaptive response, 87
pre-eclampsia, 58, 60–62, 68, 70
pregnancy, 7–10, 19, 23, 25, 30, 32, 40, 43,
47–74, 75, 79, 81, 87, 91, 94–5,

104, 110, 130, 133, 267
adolescents, 55, 68, 176–8, 182
alcohol, 57, 59, 71–2
body composition changes, 49
cardiovascular system adaptations,
49–50, 55
cravings and aversions, 66–7
first trimester, 47, 48, 49, 54, 55, 57, 58,
59, 70, 71, 178
gastrointestinal adaptations, 51, 55, 67
gestational diabetes, 58, 63, 65, 67, 68–9,
71
hyperemesis gravidarum, 63, 65–6, 70,
72
hypertensive disorders, 58, 60–62, 68, 71
pre-eclampsia, 58, 60–62, 68, 70
iron deficiency anemia, 54, 83
labor, 62–3, 89, 90, 177
miscarriage, 57–9, 71–2, 177
multiple pregnancy, 58, 69–70
nausea and vomiting (NVP), 63–6, 67,
72

nutrient requirements, 4, 7, 8, 52–6, 71
energy, 52–3, 70–71
essential fatty acids, 52–3
micronutrients, 55–6, 70
calcium, 55
iodine, 55–6
iron, 54
vitamin D, 56
protein, 51–2, 58–9
pica, 66–8
placentation, 47–8
plasma volume expansion, 49–50, 55,
70, 83
postpartum hemorrhage, 54, 63, 107,
177
premature delivery, 10, 54–5, 59, 64–5,
68, 70, 71, 77, 120
renal adaptations, 49, 50, 60
respiratory adaptations, 49, 50–51
second trimester, 48, 51, 53, 54, 71, 178
third trimester, 48, 51 53, 54, 55, 110,

178
weight gain, 49, 53, 58, 69, 71
premature birth, 10, 54, 58–9, 64, 71, 77,
120
premature infant, 65, 90, 102, 110–11, 120,
122

preservatives, 134
pressure sores, 245
probiotics, 219
processed meat, 180, 209, 212, 215, 222



procollagen terminal peptides, 241, 244
progesterone, 24, 48, 51, 63, 89, 104, 162,
214

programming, 75–98, 186, 233, 255, 266
prolactin, 104–5, 122
prolactin releasing hormone, 104
proline, 168
prolyl hydroxylase, 168
pro-opiomelanocortin,
prostaglandins, 53, 60, 202
protein, 5, 9, 10, 13, 84, 87, 101–2, 105, 107,
120–21, 127, 130, 144, 168, 171,

239, 243, 257

cancer, 209
deficiency, 6, 7–8, 236
low-protein diet, 16, 77, 84, 90–92, 94,
233
protein–energy malnutrition, 4, 6, 7–8,
11, 16, 127, 236, 237, 244
kwashiorkor, 6, 7–8

marasmus, 7–8
requirements, 4, 5, 10, 106, 127–9, 140,
166–7, 173, 185–6, 234, 238, 244
restriction, 83
synthesis, 35, 103
proteolysis, 5
proteome, 257, 263
proteomics, 260–62, 269
pseudotumor cerebri, 148
psychosocial factors, 124, 125
pubarche, 162
puberty, 1, 11, 27, 32, 104, 139, 159–63,
165, 176, 181, 239, 242
pubic hair, 160–63
publication bias, 82
pulmonary thromboembolism, 200
purine nucleotides, 42
pyridoxine, 4, 15, 42, 71, 108, 168, 202–3,
228, 234
pyrimidine nucleotides, 268


quercetin, 222


reactive oxygen species, 28–30, 36–7,
60–61, 196–7, 204, 220–21, 230
recommended daily amount, RDA, 20
red blood cells, 42, 50, 54, 83, 168, 247–8
red palm oil, 9
reference nutrient intake, RNI, 17–19
religion, 169–70
renal failure, 88, 194, 238
renal function, 60, 80, 88, 175, 206, 241
renin, 48
reproduction, 76, 159–63, 85
assisted, 26, 30, 44, 57, 69, 70
endocrine control, 24–5, 27–8, 32–4
female reproductive function, 24–6, 109,
173
male reproductive function, 32–4
resting metabolic rate, 52, 107, 126, 127,
186, 233



**Index** **299**


substance abuse, 68
Sudden Infant Death Syndrome, 109, 122
sugars, 19, 66, 126, 137, 146, 169–71, 180,
186–8, 190, 212, 238, 254
sugar-sweetened beverages, 129, 134,
144–6, 171
sulfonylurea receptor, 193
supermarkets, 17, 138, 153, 188
superoxide dismutase, 36, 230
superoxide radical, 28, 29, 230
supplementation, 8, 9, 36–7, 41–2, 54–5,
58, 62, 71, 77, 81, 83, 110–11, 128,

129, 133, 134, 202, 204, 207, 212,

219–20, 238, 243, 245, 249, 265,

267
supply and demand model, 2–10, 125
suppressor of the cytokine signaling-3
(SOCS3), 28–9
surface area to volume ratio, 127, 218
surgery, 4, 186, 236, 245
swallowing, 228
problems, 245
Swedish Food Circle, 188
syndrome of apparent mineralocorticoid
excess, 206
syndrome X. _See_ metabolic syndrome
systematic reviews, 110


_α_ -tocopherol, 16, 29, 36, 62, 118, 135, 180,
204–5, 220, 245, 266
Tanner stage. _See_ sexual maturation rating
tarragon, 217
taste, 228, 238
bitterness, 135, 257–8
saltiness, 171, 257

sourness, 257–8

sweetness, 171, 257–8
umami, 257–8
T cells, 133, 244

tea, 30, 31, 59, 66, 205, 222, 257
teenager. _See_ adolescence
television watching, 137, 143, 151, 169, 171
telomerase, 231–2
telomeres, 230–33, 250
_N_ -telopeptide, 241
tempeh, 38
temperature-dependent sex determination,
75–6

teratogens, 40, 44, 54, 64
terpenoids, 222
testes, 33, 160–62

testosterone, 25–6, 32–4, 38, 76, 162
thelarche, 160, 162
thermogenesis, 27, 107, 126, 192, 233
thiamine, 31, 66, 166, 168, 178, 180
thiazolidenediones. _See_ glitazones
threonine kinase, 207
thrifty genotype hypothesis, 85–7, 194
thrifty phenotype hypothesis, 85–7, 94, 194
thrombosis, 196–200, 203
thymidinylate, 42



retina, 40, 194
retinoic acid, 40
13- _cis_ -retinoic acid, 40
13- _cis_ -4-oxo-retinoic acid, 40
retinoic acid receptor, 40, 260
retinoids, 179
retinoid X receptor, 40, 259–60
retinol, 40, 41
retinol activity equivalents, 40
rheumatoid arthritis, 241
rhodopsin, 40
riboflavin, 16, 106, 129, 166, 168, 169, 173,
178

ribose nucleic acid, RNA, 168, 258–60
rice, 9, 132, 188
rickets, 133
rimonabant, 192
RNA polymerase, 259
rooting reflex, 99–100, 120
Rubella, 39


Safe Intake, 18
safrole, 209, 217
saliva, 228, 263
_Salmonella typhimurium,_ 120, 216
salt, 62, 128, 129, 140, 187–8, 206–7, 238
sarcopenia, 228
satiety, 27, 176, 191
saturated fatty acids, 19, 84, 154, 169, 187,
201, 202, 215, 222, 238
school-aged children, 139–41
energy requirements, 139–41, 154
nutrient requirements, 139–41, 154
performance in school,
school-based interventions, 9, 140–41,

153–4

School Fruit Scheme, 140
school meals, 139–40, 153–4, 171
school milk, 137
undernutrition, 139
screening tools, 238
secondary sexual characteristics, 162
sedentary lifestyle, 10, 107, 145, 150, 151,
186, 189–91, 255
seed oils, 54
selenium, 13, 36–7, 44, 180, 220, 245, 258,

266
selenocysteine, 258
selenoproteins, 258
sensory impairment, 228
sensory neurones, 125
septicemia, 265
serotonin, 48, 175–6, 192, 257
serotonin receptor 5-HT2a, 175–6, 257
Sertoli cells, 32–4
Seventh Day Adventists, 211
sex hormone binding globulin, 26, 34, 38
sex steroids, 30, 75, 104, 115, 160, 164, 173,

213, 228, 233, 240, 241
sexual maturation rating (Tanner staging),
160–61, 164, 181



shellfish, 37
Shetland pony, 76
Shire horse, 76
short-chain fatty acids, 218–19
shoulder dystocia, 63, 69
sibutramine, 192
single nucleotide polymorphism. _See_
polymorphisms
skeletal age, 160, 164, 181
skeletal mass, 106, 167, 173, 228
skeletal muscle, 51, 192, 193, 195, 228
skinfolds, 12, 81, 144, 236
slipped epiphysis, 148
small-for-gestational age, 58, 64, 65, 68, 70,
77, 110, 177
small intestine, 132, 202, 228, 238, 246, 248
smell, 228, 238, 257
smoking, 25, 31, 39, 40, 58, 59, 60, 77, 109,
172, 173, 178, 180, 182, 194,

208–11, 216, 241, 255
snacking, 70, 126, 139, 144, 153, 171, 172,
179, 191
social isolation, 236–7, 239, 250
socioeconomic status, 31, 40, 59, 67, 68, 77,

81, 84, 112, 114, 171, 175, 177, 199,

206

sodium, 51, 62, 83, 87, 102, 105, 118, 120,

121, 128, 129, 171, 174, 205–7,

209, 239, 254
somatotrophic axis, 124
somatotrophic hormones,
soya, 38, 222
soybeans, 131, 173
sperm, 29
acrosome reaction, 36
spermatogenesis, 32–3, 36, 37
sperm count, 32, 34, 35, 36, 38, 39
sperm morphology, 32, 34, 35, 36, 38, 39
sperm motility, 32, 34, 35, 36, 37, 38, 39
spina bifida, 41–3, 249
spontaneous abortion. _See_ miscarriage
sport, 26, 165, 170, 173
stanols, 202
starch, 19, 201
starvation, 4
statins, 201–2
steatorrhea, 16
stem cells, 229, 231
steroid hormones, 67, 89, 90, 179
steroid receptors, 259
sterol-response element binding proteins,
259

stillbirth, 57–8, 71
stomach, 51, 246, 248
stomach acid, 228
_Streptococcus mutans,_ 128
stroke. _See_ cardiovascular disease

stroke volume, 50
strontium ranelate, 242
stunting, 7, 8, 9, 11, 71, 127
subfecundity. _See_ infertility



**300** **Index**


thymine, 221
thyroid hormones, 48, 233
thyroid receptor, 259
tissue remodeling, 87–9
tofu, 38
tolerable upper limit, UL, 18
total energy expenditure, 126
traffic light labeling, 188
transcobalamin, 248–9
transcription, 89, 92, 258–9
transcription factors, 90, 92, 207, 259, 269
transcriptomics, 260–61
trans-fatty acids, 202, 222
transferrin, 7, 62, 262
transformed cell, 208–9, 218, 220–21
translation, 258
trans-sulfuration pathway, 202–3
trauma, 4–6, 7, 10, 186, 236, 265
triacylglycerides, 61, 68, 87, 101, 102, 149,
150, 193, 196, 201, 202
tributytin, 37
triceps skinfold thickness, 236
tryptophan, 15, 120
tryptophan hydroxylase, 134
tuberculosis, 6, 117, 118

tumor. _See_ cancer

tumorigenesis. _See_ carcinogenesis
tumor necrosis factor- _α_, TNF _α_, 4, 200,

247, 263, 265
tumor suppressor genes, 207, 229, 231
twins, 87, 105, 142
tyrosine hydroxylase, 134
tyrosine kinase,


ubiquinone, 204
ubiquitine-proteasome, 5
ulcerative colitis, 221
uncoupling proteins, 263–4
undernutrition, 3, 4–10, 17, 21, 52, 75,

77–9, 81–3, 85, 88, 90–91, 94–5,



110, 129, 139, 168, 169, 181, 186,

194, 222, 236, 245
underwater weighing, 12
underweight, 53, 58, 62–3, 68, 70, 149, 165,
173, 174, 189, 233
Universal Salt Iodization, 8, 56, 254
uracil misincorporation, 221
urea, 51, 246
uric acid, 61
urine, 15, 37, 51, 127, 206, 238, 263

uterus, 11, 24, 47, 68, 82, 107, 162


vascular cell adhesion molecule 1,
VCAM-1, 197, 200
vascular smooth muscle cells, 196–7
vascular tissue, 195
vegans, 54, 138, 171–2, 211
vegetarians, 38, 54, 133, 136, 138, 171–2,
182, 210–11, 215, 218
very low density lipoprotein, VLDL,
264

vinclozolin, 38
visual function, 111, 128
vital capacity, 228
vitamin A, 3, 15, 36, 39, 42, 44, 121, 129,

130, 132, 133, 140, 168, 169, 178,

209, 237, 244

_α_ -carotene, 205
_β_ -carotene, 9, 16, 29, 36, 40, 106, 136,
204, 205, 212, 220
dark adaptation test, 15
deficiency, 8, 9, 16, 106, 132, 168,
176

retinol, 40, 41
supplements, 41
vitamin B6. _See_ pyridoxine
vitamin B12. _See_ cobalamin

vitamin C. _See_ ascorbic acid

vitamin D, 2, 19, 42, 56, 121, 128, 129, 165,

168, 179, 181, 235–7, 241–2



deficiency, 56, 133
supplements, 56, 71, 242, 244
vitamin D3, 56, 240, 258
vitamin D receptor, 90–91, 164, 241,
244, 258–60, 267
vitamin E. _See α_ -tocopherol
vitamin K, 66
vomiting, 16, 63–7, 176, 181


waist circumference, 12, 189
waist–hip ratio, 12, 189, 199
wasting, 8
weaning, 1, 10, 105, 109, 120, 125, 126,
130–32, 154
weight cycling, 191
weight gain, 49, 53, 58, 69, 71, 145, 176,
178, 180, 213
weight loss, 7, 26, 27, 62, 65, 77, 174, 191–2,
200, 233, 264
wheat bran, 235
whey, 119, 120
widowhood, 237
Wolffian duct, 33
wound healing, 236–7


xanthurenic acid, 15
xenobiotics, 179, 181
xeroderma pigmentosa, 230


yeast, 216, 232
yolk sac, 10


zinc, 3, 16, 31, 35–6, 44, 55, 71, 106,

127–30, 132, 133, 166, 168, 173,

178, 182, 235, 245
deficiency, 94, 132, 134, 168, 169
zona fasciculata, 160
zona glomerulosa, 160
zona reticularis, 162
zygote, 10


